Citrus Sinensis ID: 022826
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 291 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FID6 | 813 | Probable receptor-like pr | no | no | 0.896 | 0.321 | 0.525 | 6e-85 | |
| Q9FID5 | 806 | Probable receptor-like pr | no | no | 0.890 | 0.321 | 0.538 | 1e-83 | |
| Q3ECH2 | 892 | Probable receptor-like pr | no | no | 0.931 | 0.303 | 0.514 | 2e-83 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.876 | 0.292 | 0.396 | 1e-53 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.876 | 0.310 | 0.404 | 1e-51 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.848 | 0.297 | 0.386 | 1e-49 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.876 | 0.307 | 0.381 | 6e-49 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.914 | 0.257 | 0.355 | 2e-45 | |
| Q9SYS7 | 659 | Putative cysteine-rich re | no | no | 0.903 | 0.399 | 0.372 | 3e-45 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.941 | 0.265 | 0.350 | 2e-44 |
| >sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 313 bits (803), Expect = 6e-85, Method: Compositional matrix adjust.
Identities = 153/291 (52%), Positives = 196/291 (67%), Gaps = 30/291 (10%)
Query: 1 MTNSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG---------------------- 38
+T SF + +G+GG+G VY+G L +GR VA+KVL + KG
Sbjct: 494 ITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVTSMSQTSHVNIVS 553
Query: 39 ---FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
FC+EG +RA+I EF+ +GSL++FI L N LY IA+GIARGLEYLH
Sbjct: 554 LLGFCYEGSKRAIISEFLEHGSLDQFISRNKSLTPNVT----TLYGIALGIARGLEYLHY 609
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
GC TRI+HFDIKP NILLD++FCPK++DFGLAK+C RESI+S+ RGT+GYIAPEV
Sbjct: 610 GCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGTIGYIAPEVVS 669
Query: 156 RNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215
R +G +S+KSDVYSYGM+V +M G +N S YFP W+YK LE + + G
Sbjct: 670 RMYGGISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIYKDLENGDQTWIIGD 729
Query: 216 E-NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRP 265
E NEED + +KMILVSLWCI+ PSDRP MN+VVEM+EGSLD+L +PP+P
Sbjct: 730 EINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALELPPKP 780
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 309 bits (792), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 159/295 (53%), Positives = 202/295 (68%), Gaps = 36/295 (12%)
Query: 1 MTNSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG---------------------- 38
+T SF +G+GG+G VY G L +GR VA+KVL + KG
Sbjct: 496 ITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASMSQTSHVNIVS 555
Query: 39 ---FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEV--LYKIAVGIARGLEYL 93
FCFEG +RA++YEF+ NGSL++F + N+ L +V LY IA+GIARGLEYL
Sbjct: 556 LLGFCFEGSKRAIVYEFLENGSLDQF------MSRNKSLTQDVTTLYGIALGIARGLEYL 609
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEV 153
H GC TRI+HFDIKP NILLD + CPK+SDFGLAK+C RES++S+ RGT+GYIAPEV
Sbjct: 610 HYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYIAPEV 669
Query: 154 FCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANV-AVDR-SSEIYFPHWVYKRLELEEDLG 211
F R +G VS+KSDVYS+GM+V +M G ++ V VD +S YFP W+YK LE E
Sbjct: 670 FSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDGEQTW 729
Query: 212 LQGIE-NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRP 265
+ G E +E+KE A+KMI+V LWCIQ PSDRP+MNRVVEM+EGSLD+L IPP+P
Sbjct: 730 IFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIPPKP 784
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 309 bits (791), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 163/317 (51%), Positives = 207/317 (65%), Gaps = 46/317 (14%)
Query: 1 MTNSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG---------------------- 38
MT SF +G+GG+G VY G L D VA+KVL ++KG
Sbjct: 554 MTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTDGEDFINEVASMSQTSHVNIV 613
Query: 39 ----FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
FC EG RRA+IYEF+ NGSL+KFI +K ++ L + LY IA+G+ARGLEYLH
Sbjct: 614 SLLGFCCEGSRRAIIYEFLGNGSLDKFISDK----SSVNLDLKTLYGIALGVARGLEYLH 669
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF 154
GC TRI+HFDIKP N+LLD++ CPK+SDFGLAK+C +ESI+S+ RGT+GYIAPE+
Sbjct: 670 YGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESILSLLDTRGTIGYIAPEMI 729
Query: 155 CRNFGEVSYKSDVYSYGMMVFEMTGVKN----NANVAVDRSSEIYFPHWVYKRLELEEDL 210
R +G VS+KSDVYSYGM+V EM G + + N D SS IYFP W+YK LE
Sbjct: 730 SRLYGSVSHKSDVYSYGMLVLEMIGARKKERFDQNSRSDGSS-IYFPEWIYKDLEKANIK 788
Query: 211 GLQGIEN---------EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRI 261
++ EN E++E ARKM LV LWCIQ++PSDRP MN+VVEM+EGSLD+L +
Sbjct: 789 DIEKTENGGLIENGISSEEEEIARKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALEV 848
Query: 262 PPRPFL--LSSGSQPDS 276
PPRP L +S+ S DS
Sbjct: 849 PPRPVLQQISASSVSDS 865
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 209 bits (533), Expect = 1e-53, Method: Compositional matrix adjust.
Identities = 117/295 (39%), Positives = 166/295 (56%), Gaps = 40/295 (13%)
Query: 2 TNSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------ 37
TN+F LG GG+G VYKG + VA+K L+
Sbjct: 529 TNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNTIGSMHHMNLVR 588
Query: 38 --GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
G+C E R L+YE++ NGSL+K+I+ +T L W ++IAV A+G+ Y H
Sbjct: 589 LCGYCSEDSHRLLVYEYMINGSLDKWIFSSE--QTANLLDWRTRFEIAVATAQGIAYFHE 646
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
C RI+H DIKP NILLD++FCPK+SDFGLAK+ GRE +T RGT GY+APE
Sbjct: 647 QCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKM-MGREHSHVVTMIRGTRGYLAPEWVS 705
Query: 156 RNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG---- 211
++ K+DVYSYGM++ E+ G + N +++ D + + ++P W YK L L
Sbjct: 706 NR--PITVKADVYSYGMLLLEIVGGRRNLDMSYD-AEDFFYPGWAYKELTNGTSLKAVDK 762
Query: 212 -LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRP 265
LQG+ EE+ K + V+ WCIQ+ S RP+M VV++LEG+ D + +PP P
Sbjct: 763 RLQGVAEEEE---VVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMP 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 203 bits (516), Expect = 1e-51, Method: Compositional matrix adjust.
Identities = 117/289 (40%), Positives = 173/289 (59%), Gaps = 34/289 (11%)
Query: 2 TNSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLN-------------------------ET 36
TN+F KLGQGG+G VY+G L DG +A+K L
Sbjct: 492 TNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVRL 551
Query: 37 KGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
+GFC EG R L YEF+S GSLE++I+ K + + L W+ + IA+G A+GL YLH
Sbjct: 552 RGFCAEGAHRLLAYEFLSKGSLERWIFRKK--DGDVLLDWDTRFNIALGTAKGLAYLHED 609
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156
C+ RI+H DIKP NILLD++F K+SDFGLAK+ +S V T RGT GY+APE +
Sbjct: 610 CDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHV-FTTMRGTRGYLAPE-WIT 667
Query: 157 NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEE--DLGLQG 214
N+ +S KSDVYSYGM++ E+ G + N + + + S + +FP + +K++E + D+
Sbjct: 668 NYA-ISEKSDVYSYGMVLLELIGGRKNYDPS-ETSEKCHFPSFAFKKMEEGKLMDIVDGK 725
Query: 215 IEN-EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262
++N + E ++ + +LWCIQ + RP+M++VV+MLEG ++ P
Sbjct: 726 MKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPP 774
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 196 bits (499), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 109/282 (38%), Positives = 159/282 (56%), Gaps = 35/282 (12%)
Query: 2 TNSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------ 37
T SFK KLG GG+G VY+G L + VA+K L +
Sbjct: 483 TKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRL 542
Query: 38 -GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
GFC +G R L+YEF+ NGSL+ F++ ++ + L WE + IA+G A+G+ YLH
Sbjct: 543 IGFCSQGRHRLLVYEFMRNGSLDNFLFTT---DSAKFLTWEYRFNIALGTAKGITYLHEE 599
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156
C I+H DIKP NIL+D++F K+SDFGLAK+ + +++ +M+ RGT GY+APE +
Sbjct: 600 CRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPE-WLA 658
Query: 157 NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216
N ++ KSDVYSYGM++ E+ K N +V+ ++++ F W Y+ E +
Sbjct: 659 NL-PITSKSDVYSYGMVLLELVSGKRNFDVS-EKTNHKKFSIWAYEEFEKGNTKAILDTR 716
Query: 217 NEEDK----EYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254
ED+ E +M+ S WCIQ P RP M +VV+MLEG
Sbjct: 717 LSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEG 758
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 194 bits (493), Expect = 6e-49, Method: Compositional matrix adjust.
Identities = 113/296 (38%), Positives = 166/296 (56%), Gaps = 41/296 (13%)
Query: 2 TNSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLN-------------------------ET 36
T +F +KLG GG+G V+KG L D ++A+K L
Sbjct: 492 TKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGTIQHVNLVRL 551
Query: 37 KGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
+GFC EG ++ L+Y+++ NGSL+ ++ +E L W++ ++IA+G ARGL YLH
Sbjct: 552 RGFCSEGSKKLLVYDYMPNGSLDSHLFLNQ-VEEKIVLGWKLRFQIALGTARGLAYLHDE 610
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156
C I+H DIKP NILLD FCPK++DFGLAK+ GR+ +T RGT GY+APE
Sbjct: 611 CRDCIIHCDIKPENILLDSQFCPKVADFGLAKLV-GRDFSRVLTTMRGTRGYLAPEWI-- 667
Query: 157 NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL------ 210
+ ++ K+DVYSYGMM+FE+ + N + + +FP W L + D+
Sbjct: 668 SGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVR-FFPSWAATILTKDGDIRSLVDP 726
Query: 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPF 266
L+G + D E + V+ WCIQ+ S RPAM++VV++LEG L+ + P PF
Sbjct: 727 RLEG--DAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLE---VNPPPF 777
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 182 bits (462), Expect = 2e-45, Method: Compositional matrix adjust.
Identities = 107/301 (35%), Positives = 168/301 (55%), Gaps = 35/301 (11%)
Query: 6 KNKLGQGGYGGVYKGKLLDGRNVAIKVLN--------------------------ETKGF 39
NKLG+GG+G VYKG L DGR VA+K+L+ + G
Sbjct: 697 SNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGC 756
Query: 40 CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
CFEG R L+YE++ NGSL++ ++ L L W Y+I +G+ARGL YLH +
Sbjct: 757 CFEGEHRMLVYEYLPNGSLDQALFGDKTLH----LDWSTRYEICLGVARGLVYLHEEASV 812
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFG 159
RI+H D+K NILLD P+ISDFGLAK+ +++ +S T GT+GY+APE R G
Sbjct: 813 RIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHIS-TRVAGTIGYLAPEYAMR--G 869
Query: 160 EVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE-NE 218
++ K+DVY++G++ E+ + N++ ++ + Y W + E D+ L + +
Sbjct: 870 HLTEKTDVYAFGVVALELVSGRPNSDENLEEEKK-YLLEWAWNLHEKSRDIELIDDKLTD 928
Query: 219 EDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLSSGSQPDSSG 278
+ E A++MI ++L C Q + + RP M+RVV ML G ++ + +P +S D++G
Sbjct: 929 FNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIGDVTSKPGYVSDWRFDDTTG 988
Query: 279 T 279
+
Sbjct: 989 S 989
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYS7|CRK39_ARATH Putative cysteine-rich receptor-like protein kinase 39 OS=Arabidopsis thaliana GN=CRK39 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (462), Expect = 3e-45, Method: Compositional matrix adjust.
Identities = 111/298 (37%), Positives = 157/298 (52%), Gaps = 35/298 (11%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVL------------NETK-------------- 37
S +N LGQGG+G VYKG LL+G+ VA+K L NE
Sbjct: 354 SSENTLGQGGFGTVYKGTLLNGQEVAVKRLTKGSGQGDIEFKNEVSLLTRLQHRNLVKLL 413
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
GFC EG + L+YEFV N SL+ FI++ E L WE+ Y+I GIARGL YLH
Sbjct: 414 GFCNEGDEQILVYEFVPNSSLDHFIFDD---EKRSLLTWEMRYRIIEGIARGLLYLHEDS 470
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
+I+H D+K NILLD + PK++DFG A++ E+ GT GY+APE N
Sbjct: 471 QLKIIHRDLKASNILLDAEMNPKVADFGTARLFDSDETRAETKRIAGTRGYMAPEYL--N 528
Query: 158 FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217
G++S KSDVYS+G+M+ EM + N + + + + WV + E+ D L
Sbjct: 529 HGQISAKSDVYSFGVMLLEMISGERNNSFEGEGLAAFAWKRWVEGKPEIIIDPFLI---- 584
Query: 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLSSGSQPD 275
E+ + K+I + L C+Q NP+ RP M+ V+ L + + +P P S SQ +
Sbjct: 585 EKPRNEIIKLIQIGLLCVQENPTKRPTMSSVIIWLGSETNIIPLPKAPAFTGSRSQSE 642
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 179 bits (454), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 110/314 (35%), Positives = 171/314 (54%), Gaps = 40/314 (12%)
Query: 6 KNKLGQGGYGGVYKGKLLDGRNVAIKVLN--------------------------ETKGF 39
NKLG+GG+G VYKGKL DGR VA+K+L+ + G
Sbjct: 696 SNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVAISAVQHRNLVKLYGC 755
Query: 40 CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
C+EG R L+YE++ NGSL++ ++ + L L W Y+I +G+ARGL YLH
Sbjct: 756 CYEGEHRLLVYEYLPNGSLDQALFGEKTLH----LDWSTRYEICLGVARGLVYLHEEARL 811
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFG 159
RI+H D+K NILLD PK+SDFGLAK+ +++ +S T GT+GY+APE R G
Sbjct: 812 RIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHIS-TRVAGTIGYLAPEYAMR--G 868
Query: 160 EVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE-NE 218
++ K+DVY++G++ E+ + N++ ++ Y W + E ++ L + E
Sbjct: 869 HLTEKTDVYAFGVVALELVSGRPNSDENLEDEKR-YLLEWAWNLHEKGREVELIDHQLTE 927
Query: 219 EDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLSSGSQPDS-- 276
+ E ++MI ++L C Q + + RP M+RVV ML G ++ + +P L+ D+
Sbjct: 928 FNMEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEVSDVTSKPGYLTDWRFDDTTA 987
Query: 277 ---SGTLVRQTEPS 287
SG +R T+ S
Sbjct: 988 SSISGFPLRNTQAS 1001
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 291 | ||||||
| 147769927 | 1001 | hypothetical protein VITISV_010117 [Viti | 0.924 | 0.268 | 0.670 | 1e-114 | |
| 359472674 | 637 | PREDICTED: probable receptor-like protei | 0.924 | 0.422 | 0.673 | 1e-113 | |
| 147795963 | 624 | hypothetical protein VITISV_039936 [Viti | 0.924 | 0.431 | 0.673 | 1e-113 | |
| 224108441 | 324 | predicted protein [Populus trichocarpa] | 0.917 | 0.824 | 0.678 | 1e-111 | |
| 224108429 | 365 | predicted protein [Populus trichocarpa] | 0.958 | 0.764 | 0.648 | 1e-110 | |
| 255572156 | 435 | receptor serine/threonine kinase, putati | 0.941 | 0.629 | 0.655 | 1e-109 | |
| 225452094 | 858 | PREDICTED: probable receptor-like protei | 0.927 | 0.314 | 0.650 | 1e-109 | |
| 255572160 | 405 | receptor serine/threonine kinase, putati | 1.0 | 0.718 | 0.620 | 1e-109 | |
| 357444671 | 385 | Protein kinase-coding resistance protein | 0.924 | 0.698 | 0.656 | 1e-108 | |
| 145839451 | 627 | receptor-like protein kinase [Capsicum a | 0.948 | 0.440 | 0.640 | 1e-107 |
| >gi|147769927|emb|CAN76446.1| hypothetical protein VITISV_010117 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 417 bits (1071), Expect = e-114, Method: Compositional matrix adjust.
Identities = 197/294 (67%), Positives = 235/294 (79%), Gaps = 25/294 (8%)
Query: 1 MTNSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG---------------------- 38
MT+SFK+++G+GGYG VYKGKLL+G VA+KVL+ETKG
Sbjct: 694 MTSSFKDRVGEGGYGAVYKGKLLNGDLVAVKVLSETKGNGEEFINEIASISRTSHVNIVS 753
Query: 39 ---FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
FCF+G +RALIYEF+ NGSLEKFIY+K+ T KL WE LY IA+GIARGLEYLHR
Sbjct: 754 LLGFCFQGSKRALIYEFMPNGSLEKFIYDKNSSMTYHKLGWETLYNIAIGIARGLEYLHR 813
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
GCNTRILH DIKPHNILL++DFCPKISDFGL+K+C +ESI+SM+GARGT GYIAPEVFC
Sbjct: 814 GCNTRILHLDIKPHNILLNQDFCPKISDFGLSKLCTRKESIISMSGARGTAGYIAPEVFC 873
Query: 156 RNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215
RNFG+VS KSDVYSYGMMV EM G + N + ++ +SEIYFPHW+YKRLEL+E+LGLQG
Sbjct: 874 RNFGDVSPKSDVYSYGMMVLEMVGGRKNTDDGINHTSEIYFPHWIYKRLELDEELGLQGF 933
Query: 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLS 269
NEE++ ARKMI+VSLWCIQ NPS+RP MN VV+MLEGSL+SL+IPP+PFL S
Sbjct: 934 MNEEERTSARKMIIVSLWCIQTNPSNRPPMNGVVDMLEGSLESLQIPPKPFLYS 987
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359472674|ref|XP_002279652.2| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 414 bits (1064), Expect = e-113, Method: Compositional matrix adjust.
Identities = 198/294 (67%), Positives = 235/294 (79%), Gaps = 25/294 (8%)
Query: 1 MTNSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG---------------------- 38
MT+SFK+++G+GGYG VYKGKLL+G VA+KVL+ETKG
Sbjct: 330 MTSSFKDRVGEGGYGAVYKGKLLNGDLVAVKVLSETKGNGEEFINEIASISRTSHVNIVS 389
Query: 39 ---FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
FCF+G +RALIYEF+ NGSLEKFIY+K+ T KL WE LY IA+GIARGLEYLHR
Sbjct: 390 LLGFCFQGSKRALIYEFMPNGSLEKFIYDKNSSMTYDKLGWETLYNIAIGIARGLEYLHR 449
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
GCNTRILH DIKPHNILL++DFCPKISDFGL+K+C +ESIVSM+GARGT GYIAPEVFC
Sbjct: 450 GCNTRILHLDIKPHNILLNQDFCPKISDFGLSKLCTRKESIVSMSGARGTAGYIAPEVFC 509
Query: 156 RNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215
RNFG+VS KSDVYSYGMMV EM G + N + ++ +SEIYFPHW+YKRLEL+E+LGLQG
Sbjct: 510 RNFGDVSPKSDVYSYGMMVLEMVGGRKNIDDGINHTSEIYFPHWIYKRLELDEELGLQGF 569
Query: 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLS 269
NEE++ ARKMI+VSLWCIQ NPS+RP MN VV+MLEGSL+SL+IPP+PFL S
Sbjct: 570 MNEEERTSARKMIIVSLWCIQTNPSNRPPMNGVVDMLEGSLESLQIPPKPFLYS 623
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147795963|emb|CAN69599.1| hypothetical protein VITISV_039936 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 414 bits (1063), Expect = e-113, Method: Compositional matrix adjust.
Identities = 198/294 (67%), Positives = 235/294 (79%), Gaps = 25/294 (8%)
Query: 1 MTNSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG---------------------- 38
MT+SFK+++G+GGYG VYKGKLL+G VA+KVL+ETKG
Sbjct: 317 MTSSFKDRVGEGGYGAVYKGKLLNGDLVAVKVLSETKGNGEEFINEIASISRTSHVNIVS 376
Query: 39 ---FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
FCF+G +RALIYEF+ NGSLEKFIY+K+ T KL WE LY IA+GIARGLEYLHR
Sbjct: 377 LLGFCFQGSKRALIYEFMPNGSLEKFIYDKNSSMTYDKLGWETLYNIAIGIARGLEYLHR 436
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
GCNTRILH DIKPHNILL++DFCPKISDFGL+K+C +ESIVSM+GARGT GYIAPEVFC
Sbjct: 437 GCNTRILHLDIKPHNILLNQDFCPKISDFGLSKLCTRKESIVSMSGARGTAGYIAPEVFC 496
Query: 156 RNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215
RNFG+VS KSDVYSYGMMV EM G + N + ++ +SEIYFPHW+YKRLEL+E+LGLQG
Sbjct: 497 RNFGDVSPKSDVYSYGMMVLEMVGGRKNIDDGINHTSEIYFPHWIYKRLELDEELGLQGF 556
Query: 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLS 269
NEE++ ARKMI+VSLWCIQ NPS+RP MN VV+MLEGSL+SL+IPP+PFL S
Sbjct: 557 MNEEERTSARKMIIVSLWCIQTNPSNRPPMNGVVDMLEGSLESLQIPPKPFLYS 610
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108441|ref|XP_002314847.1| predicted protein [Populus trichocarpa] gi|222863887|gb|EEF01018.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 406 bits (1043), Expect = e-111, Method: Compositional matrix adjust.
Identities = 198/292 (67%), Positives = 230/292 (78%), Gaps = 25/292 (8%)
Query: 1 MTNSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------- 37
MT +FK KLGQGGYG V+KG LLDGR VA+KVL ++K
Sbjct: 33 MTKNFKEKLGQGGYGSVFKGNLLDGRLVAVKVLKKSKSNGEEFVNEVSSIGMTSHVNIVT 92
Query: 38 --GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
GFCFEG +RALIYEF+SNGSL+K IYE++ + KL WE LY+IAVGIARGLEYLHR
Sbjct: 93 LLGFCFEGPKRALIYEFMSNGSLDKHIYEENLSKAQPKLGWETLYQIAVGIARGLEYLHR 152
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
GCNTRILHFDIKPHNILLDE+FCPKISDFGLAKIC G+ESIVSM GARGT GYIAPEVFC
Sbjct: 153 GCNTRILHFDIKPHNILLDENFCPKISDFGLAKICPGKESIVSMLGARGTAGYIAPEVFC 212
Query: 156 RNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215
RNFG VS+KSDVYSYGM+V EM G + N V VD +SEIYFPHW+YKRLE+ E+L L+G
Sbjct: 213 RNFGGVSHKSDVYSYGMLVLEMIGGRKNFRVGVDNTSEIYFPHWIYKRLEIGEELQLRGA 272
Query: 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFL 267
NE ++E ARKMIL SLWCIQ +PS+RP M+RVV+ML+GSL+SL IPP+P+L
Sbjct: 273 GNEVEEENARKMILASLWCIQTDPSNRPPMSRVVDMLQGSLESLPIPPKPYL 324
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108429|ref|XP_002314844.1| predicted protein [Populus trichocarpa] gi|222863884|gb|EEF01015.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 404 bits (1037), Expect = e-110, Method: Compositional matrix adjust.
Identities = 197/304 (64%), Positives = 234/304 (76%), Gaps = 25/304 (8%)
Query: 1 MTNSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------- 37
MT +FK KLGQGG+G V+KG LLDGR VA+KVL ++K
Sbjct: 60 MTKNFKEKLGQGGFGSVFKGNLLDGRLVAVKVLKKSKSNGEEFVNEVSSIGRTSHVNIVT 119
Query: 38 --GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
GFCFEG +RALIYEF+SNGSL+K IYE++ + + KL WE LY+IAVGIARGLEYLHR
Sbjct: 120 LLGFCFEGPKRALIYEFMSNGSLDKHIYEENLSKAHPKLGWETLYQIAVGIARGLEYLHR 179
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
GCNTRILHFDIKPHNILLDE+FCPKISDFGLAKIC +ESIVSM GARGT GYIAPEVFC
Sbjct: 180 GCNTRILHFDIKPHNILLDENFCPKISDFGLAKICPSKESIVSMLGARGTAGYIAPEVFC 239
Query: 156 RNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215
RNFG VS+KSDVYSYGM+V EM G + N V VD +SEIYFPHW+Y+RLE+ E+L L+G
Sbjct: 240 RNFGGVSHKSDVYSYGMLVLEMIGGRKNFRVGVDNTSEIYFPHWIYRRLEIGEELQLRGA 299
Query: 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLSSGSQPD 275
NE +++ ARKMIL SLWCIQ +PS+RP M+RVV+ML+GSL+SL IPP+P+L S P
Sbjct: 300 GNEVEEQNARKMILASLWCIQTDPSNRPPMSRVVDMLQGSLESLPIPPKPYLSSPPRSPH 359
Query: 276 SSGT 279
S +
Sbjct: 360 GSNS 363
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572156|ref|XP_002527018.1| receptor serine/threonine kinase, putative [Ricinus communis] gi|223533653|gb|EEF35390.1| receptor serine/threonine kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 400 bits (1028), Expect = e-109, Method: Compositional matrix adjust.
Identities = 196/299 (65%), Positives = 227/299 (75%), Gaps = 25/299 (8%)
Query: 1 MTNSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG---------------------- 38
MT SFK+KLGQGGYGGV+KGKL DGR+VA+K+L E+KG
Sbjct: 91 MTQSFKDKLGQGGYGGVFKGKLPDGRDVAVKILKESKGNGEEFINEVASISRTSHVNVVT 150
Query: 39 ---FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
FC+EG +RALIYEF+SNGSLEK+I ++ N++L WE LY+IAVG+ARGLEYLHR
Sbjct: 151 LLGFCYEGCKRALIYEFMSNGSLEKYISKEKSSRANRELGWETLYEIAVGVARGLEYLHR 210
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
GCNTRILHFDIKPHNILLDE+F PKISDFGLAKIC GRESIVSM ARGTVGYIAPEVF
Sbjct: 211 GCNTRILHFDIKPHNILLDEEFRPKISDFGLAKICPGRESIVSMLDARGTVGYIAPEVFY 270
Query: 156 RNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215
RNFG VSYKSDVYSYGM+V EM G + N + V +SEIYFP W+YKR+E+ EDLGL GI
Sbjct: 271 RNFGRVSYKSDVYSYGMLVLEMVGARKNICLEVGNTSEIYFPDWIYKRIEIIEDLGLCGI 330
Query: 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLSSGSQP 274
+N E+ + ARK+ILVSLWCIQ NP++RP M VVEML GS+ SL IPPRP S P
Sbjct: 331 DNGEENQIARKLILVSLWCIQTNPTNRPPMGSVVEMLLGSVASLSIPPRPCWSSPSRSP 389
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452094|ref|XP_002280747.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 399 bits (1026), Expect = e-109, Method: Compositional matrix adjust.
Identities = 192/295 (65%), Positives = 227/295 (76%), Gaps = 25/295 (8%)
Query: 1 MTNSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG---------------------- 38
MTNSF KLGQGG+G VY+GKL DGR VA+K+L+E+KG
Sbjct: 553 MTNSFTCKLGQGGFGCVYQGKLPDGRQVAVKLLSESKGNGEEFINEVASFSRTSHVNIVT 612
Query: 39 ---FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
FCFEG RRALIYEF+ NGSL+K IY+K N KL+W+ +Y+IAVGIARGLEYL+R
Sbjct: 613 LVGFCFEGTRRALIYEFMPNGSLDKLIYQKGSPNANLKLEWKTMYQIAVGIARGLEYLYR 672
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
GCNTRILHFDIKPHNILLDEDFCPKISDFGLAK+C +ES+VSM ARGT GYIAPEVFC
Sbjct: 673 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKLCQRKESMVSMAHARGTAGYIAPEVFC 732
Query: 156 RNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215
RNFG VS+KSDVYSYGM+VFEM G + N + V +S+IYFP W+YK+L+ EDL L I
Sbjct: 733 RNFGGVSHKSDVYSYGMLVFEMIGGRKNIDAQVSHTSQIYFPTWIYKQLQPGEDLILHSI 792
Query: 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLSS 270
NEE++E ARKM+LVSLWCIQ NPSDRP++++VVEMLEGSL SL IPP PF+ +
Sbjct: 793 TNEEEEETARKMVLVSLWCIQLNPSDRPSIDKVVEMLEGSLQSLEIPPNPFMFPT 847
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572160|ref|XP_002527020.1| receptor serine/threonine kinase, putative [Ricinus communis] gi|223533655|gb|EEF35392.1| receptor serine/threonine kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 399 bits (1025), Expect = e-109, Method: Compositional matrix adjust.
Identities = 198/319 (62%), Positives = 235/319 (73%), Gaps = 28/319 (8%)
Query: 1 MTNSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG---------------------- 38
MT SFK+KLGQGGYGGV+KGKL DGR+VA+K+L E+KG
Sbjct: 86 MTQSFKDKLGQGGYGGVFKGKLPDGRDVAVKILKESKGNGEEFINEVASISRTSHVNVVT 145
Query: 39 ---FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
FC+EG +RALIYEF+SNGSLEK+I ++ N +L WE LY+IAVG+ARGLEYLHR
Sbjct: 146 LLGFCYEGCKRALIYEFMSNGSLEKYISKEKSSRANHELGWETLYEIAVGVARGLEYLHR 205
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
GCNTRILHFDIKPHNILLDE+F PKISDFGLAKIC GRESIVSM GARGTVGYIAPEVF
Sbjct: 206 GCNTRILHFDIKPHNILLDEEFRPKISDFGLAKICPGRESIVSMLGARGTVGYIAPEVFY 265
Query: 156 RNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215
RNFG VSYKSDVYSYGM+V EM G + N + V +SEIYFP W+YKR+E+ EDLGL GI
Sbjct: 266 RNFGGVSYKSDVYSYGMLVLEMVGARKNICLEVGNTSEIYFPDWIYKRIEINEDLGLCGI 325
Query: 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLSSGSQPD 275
+N E+ + ARK+ILVSLWCIQ NP++RP M VVEM+ GS+ SL +PPRP S P
Sbjct: 326 DNGEENQIARKLILVSLWCIQTNPTNRPPMGSVVEMMLGSVASLSVPPRPCWSSLSRSPP 385
Query: 276 ---SSGTLVRQTEPSMATC 291
++ + + S+ TC
Sbjct: 386 QLLANSSTTNEQSNSVLTC 404
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357444671|ref|XP_003592613.1| Protein kinase-coding resistance protein [Medicago truncatula] gi|355481661|gb|AES62864.1| Protein kinase-coding resistance protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 397 bits (1019), Expect = e-108, Method: Compositional matrix adjust.
Identities = 193/294 (65%), Positives = 230/294 (78%), Gaps = 25/294 (8%)
Query: 1 MTNSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG---------------------- 38
+TNSF+NKLGQGG+G VYKG+L D R VA+KVL+E+KG
Sbjct: 79 ITNSFRNKLGQGGFGSVYKGRLRDERVVAVKVLSESKGDGDDFINEVASINRTSHVNVLR 138
Query: 39 ---FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
FC +G ++ALIYEF+ NGSLEKFIYEK+PL+ + +L+ ++LY IAVG+ARGLEY+HR
Sbjct: 139 LLGFCLDGSKKALIYEFMLNGSLEKFIYEKNPLKDDGQLECKMLYDIAVGVARGLEYMHR 198
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
GCNTRILHFDIKPHNILLD+D CPKISDFGLAKIC +ESIVS+ GARGT GYIAPE+F
Sbjct: 199 GCNTRILHFDIKPHNILLDDDLCPKISDFGLAKICPRKESIVSIFGARGTPGYIAPELFS 258
Query: 156 RNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215
R+FG VS+KSDVYSYGMMV EM G + N V VD SSE+YFPHW+YKRLEL +DLGL+ I
Sbjct: 259 RHFGGVSHKSDVYSYGMMVLEMVGRRKNIKVEVDCSSELYFPHWIYKRLELNQDLGLKCI 318
Query: 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLS 269
+NE D+E RKM +VSLWCI +PS RPAMN+VVEMLEGSL L IPP+PFL S
Sbjct: 319 KNEIDEEMVRKMTMVSLWCIPTDPSHRPAMNKVVEMLEGSLQVLEIPPKPFLSS 372
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145839451|gb|ABP96804.1| receptor-like protein kinase [Capsicum annuum] | Back alignment and taxonomy information |
|---|
Score = 395 bits (1014), Expect = e-107, Method: Compositional matrix adjust.
Identities = 194/303 (64%), Positives = 231/303 (76%), Gaps = 27/303 (8%)
Query: 1 MTNSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG---------------------- 38
+T+ FKNKL QGG+G VY+G L +G VA+KVLNE KG
Sbjct: 314 ITSRFKNKLVQGGFGTVYRGSLGNGSQVAVKVLNELKGSGENFINEVASISRTSHVNVVS 373
Query: 39 ---FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
FCFEG +RAL+YEF+ NGSLEKFIYE+ +T ++L W LYKIA+GIARGLEYLHR
Sbjct: 374 LVGFCFEGRKRALVYEFMPNGSLEKFIYEERS-DTVRQLGWPTLYKIALGIARGLEYLHR 432
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
GC TRILHFDIKPHNILLDEDFCPKISDFGLAK+C ESIVSM GARGT+GYIAPE+ C
Sbjct: 433 GCTTRILHFDIKPHNILLDEDFCPKISDFGLAKLCMKNESIVSMLGARGTIGYIAPEIVC 492
Query: 156 RNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215
RN G VS+KSD YSYGMMV EM G + N + DR+SEIYFPHW+Y+R+EL+EDL L GI
Sbjct: 493 RNLGGVSHKSDAYSYGMMVLEMIGGRKNVDAGADRTSEIYFPHWLYQRIELDEDLQLVGI 552
Query: 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLS-SGSQP 274
NEE+ E ARKM++ SLWCIQ +PS+RP+M++VVEMLEG LDSL+IPP+P+L S S +
Sbjct: 553 MNEEENECARKMVIASLWCIQTDPSNRPSMSKVVEMLEGKLDSLQIPPKPYLYSPSRIEV 612
Query: 275 DSS 277
DSS
Sbjct: 613 DSS 615
|
Source: Capsicum annuum Species: Capsicum annuum Genus: Capsicum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 291 | ||||||
| TAIR|locus:2141862 | 853 | AT4G18250 [Arabidopsis thalian | 0.773 | 0.263 | 0.607 | 3.6e-76 | |
| TAIR|locus:2020583 | 799 | AT1G70250 [Arabidopsis thalian | 0.776 | 0.282 | 0.585 | 5.9e-74 | |
| TAIR|locus:2019713 | 892 | AT1G67000 [Arabidopsis thalian | 0.800 | 0.261 | 0.592 | 7.6e-74 | |
| TAIR|locus:2019688 | 674 | AT1G66930 [Arabidopsis thalian | 0.776 | 0.335 | 0.582 | 7.6e-74 | |
| TAIR|locus:2176717 | 638 | AT5G38260 [Arabidopsis thalian | 0.769 | 0.351 | 0.610 | 8.4e-74 | |
| TAIR|locus:2176737 | 665 | PR5K "PR5-like receptor kinase | 0.804 | 0.351 | 0.581 | 2e-73 | |
| TAIR|locus:2177152 | 806 | AT5G39030 [Arabidopsis thalian | 0.762 | 0.275 | 0.600 | 4.1e-73 | |
| TAIR|locus:2204480 | 666 | AT1G66910 [Arabidopsis thalian | 0.773 | 0.337 | 0.576 | 4.1e-73 | |
| TAIR|locus:2177142 | 813 | AT5G39020 [Arabidopsis thalian | 0.769 | 0.275 | 0.585 | 8.6e-73 | |
| TAIR|locus:2176707 | 579 | AT5G38250 [Arabidopsis thalian | 0.752 | 0.378 | 0.576 | 2.4e-67 |
| TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 742 (266.3 bits), Expect = 3.6e-76, Sum P(2) = 3.6e-76
Identities = 144/237 (60%), Positives = 182/237 (76%)
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
GFC+EG +RA+IYEF+ NGSL+KFI E + T K++W+ LY IAVG+ARGLEYLH C
Sbjct: 581 GFCYEGSQRAIIYEFMPNGSLDKFISEN--MST--KIEWKTLYNIAVGVARGLEYLHNSC 636
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
++I+HFDIKP NIL+DED CPKISDFGLAK+C +ESI+SM ARGTVGYIAPE+F +N
Sbjct: 637 VSKIVHFDIKPQNILIDEDLCPKISDFGLAKLCKKKESIISMLDARGTVGYIAPEMFSKN 696
Query: 158 FGEVSYKSDVYSYGMMVFEMTGVKNNANV---AVDRSSEIYFPHWVYKRLELEEDLGLQG 214
+G VS+KSDVYSYGM+V EM G V A D+SS +YFP WVY+ LE +E + L
Sbjct: 697 YGGVSHKSDVYSYGMVVLEMIGATKREEVETSATDKSS-MYFPDWVYEDLERKETMRLLE 755
Query: 215 ---IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS-LDSLRIPPRPFL 267
IE EE+++ ++M LV LWCIQ NPSDRP M +VVEMLEGS L++L++PP+P L
Sbjct: 756 DHIIEEEEEEKIVKRMTLVGLWCIQTNPSDRPPMRKVVEMLEGSRLEALQVPPKPLL 812
|
|
| TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 728 (261.3 bits), Expect = 5.9e-74, Sum P(2) = 5.9e-74
Identities = 137/234 (58%), Positives = 175/234 (74%)
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
GFC+EG ++A+IYE + NGSL+KFI + + K++W+ LY IAVG++ GLEYLH C
Sbjct: 520 GFCYEGRKKAIIYELMPNGSLDKFISKN----MSAKMEWKTLYNIAVGVSHGLEYLHSHC 575
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
+RI+HFDIKP NIL+D D CPKISDFGLAK+C ESI+SM ARGT+GYIAPEVF +N
Sbjct: 576 VSRIVHFDIKPQNILIDGDLCPKISDFGLAKLCKNNESIISMLHARGTIGYIAPEVFSQN 635
Query: 158 FGEVSYKSDVYSYGMMVFEMTGVKN--NANVAVDRSSEIYFPHWVYKRLELEEDLGLQG- 214
FG VS+KSDVYSYGM+V EM G +N A A ++ +YFP W+YK LE E +
Sbjct: 636 FGGVSHKSDVYSYGMVVLEMIGARNIGRAQNAGSSNTSMYFPDWIYKDLEKGEIMSFLAD 695
Query: 215 -IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFL 267
I EED++ +KM+LV LWCIQ NP DRP M++VVEMLEGSL++L+IPP+P L
Sbjct: 696 QITEEEDEKIVKKMVLVGLWCIQTNPYDRPPMSKVVEMLEGSLEALQIPPKPLL 749
|
|
| TAIR|locus:2019713 AT1G67000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 724 (259.9 bits), Expect = 7.6e-74, Sum P(2) = 7.6e-74
Identities = 151/255 (59%), Positives = 187/255 (73%)
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
GFC EG RRA+IYEF+ NGSL+KFI +K + N LK LY IA+G+ARGLEYLH GC
Sbjct: 617 GFCCEGSRRAIIYEFLGNGSLDKFISDKSSV--NLDLK--TLYGIALGVARGLEYLHYGC 672
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
TRI+HFDIKP N+LLD++ CPK+SDFGLAK+C +ESI+S+ RGT+GYIAPE+ R
Sbjct: 673 KTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESILSLLDTRGTIGYIAPEMISRL 732
Query: 158 FGEVSYKSDVYSYGMMVFEMTGVKN----NANVAVDRSSEIYFPHWVYKRLE------LE 207
+G VS+KSDVYSYGM+V EM G + + N D SS IYFP W+YK LE +E
Sbjct: 733 YGSVSHKSDVYSYGMLVLEMIGARKKERFDQNSRSDGSS-IYFPEWIYKDLEKANIKDIE 791
Query: 208 --EDLGL--QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPP 263
E+ GL GI +EE+ E ARKM LV LWCIQ++PSDRP MN+VVEM+EGSLD+L +PP
Sbjct: 792 KTENGGLIENGISSEEE-EIARKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALEVPP 850
Query: 264 RPFL--LSSGSQPDS 276
RP L +S+ S DS
Sbjct: 851 RPVLQQISASSVSDS 865
|
|
| TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 719 (258.2 bits), Expect = 7.6e-74, Sum P(2) = 7.6e-74
Identities = 137/235 (58%), Positives = 176/235 (74%)
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
GFC EG RRA+IYEF+ NGSL+KFI EK T+ L LY IA+G+ARGLEYLH GC
Sbjct: 407 GFCSEGSRRAIIYEFLENGSLDKFISEK----TSVILDLTALYGIALGVARGLEYLHYGC 462
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
TRI+HFDIKP N+LLD++ PK+SDFGLAK+C +ES++S+ RGT+GYIAPE+ R
Sbjct: 463 KTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCEKKESVMSLMDTRGTIGYIAPEMISRV 522
Query: 158 FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRS--SEIYFPHWVYKRLELEEDLGLQGI 215
+G VS+KSDVYSYGM+VFEM G + + + S +YFP W+YK LE ++ L+ I
Sbjct: 523 YGSVSHKSDVYSYGMLVFEMIGARKKERFGQNSANGSSMYFPEWIYKDLEKADNGDLEHI 582
Query: 216 E---NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFL 267
E + E++E A+KM LV LWCIQ++PSDRP MN+VVEM+EGSLD+L +PPRP L
Sbjct: 583 EIGISSEEEEIAKKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALEVPPRPVL 637
|
|
| TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 745 (267.3 bits), Expect = 8.4e-74, P = 8.4e-74
Identities = 141/231 (61%), Positives = 172/231 (74%)
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
GFC+EG +RA++YEF+ NGSL++F+ EK L L LY+IA+G+ARGL+YLH GC
Sbjct: 381 GFCYEGSKRAIVYEFLENGSLDQFLSEKKSLN----LDVSTLYRIALGVARGLDYLHHGC 436
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
TRI+HFDIKP NILLD+ FCPK+SDFGLAK+C RESI+S+ ARGT+GYIAPEVF
Sbjct: 437 KTRIVHFDIKPQNILLDDTFCPKVSDFGLAKLCEKRESILSLLDARGTIGYIAPEVFSGM 496
Query: 158 FGEVSYKSDVYSYGMMVFEMTGVKNNA--NVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215
+G VS+KSDVYSYGM+V EM G KN A SS YFP W+YK LE ED G
Sbjct: 497 YGRVSHKSDVYSYGMLVLEMIGAKNKEIEETAASNSSSAYFPDWIYKNLENGEDTWKFGD 556
Query: 216 E-NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRP 265
E + EDKE A+KM LV LWCIQ +P +RP MNR+VEM+EGSLD L +PP+P
Sbjct: 557 EISREDKEVAKKMTLVGLWCIQPSPLNRPPMNRIVEMMEGSLDVLEVPPKP 607
|
|
| TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 723 (259.6 bits), Expect = 2.0e-73, Sum P(2) = 2.0e-73
Identities = 142/244 (58%), Positives = 182/244 (74%)
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
GFC+E ++RA+IYEF+ NGSL+K+I + T K++WE LY +AVGI+RGLEYLH C
Sbjct: 392 GFCYEKNKRAIIYEFMPNGSLDKYISAN--MST--KMEWERLYDVAVGISRGLEYLHNRC 447
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
TRI+HFDIKP NIL+DE+ CPKISDFGLAK+C +ESI+SM RGT GYIAPE+F +N
Sbjct: 448 VTRIVHFDIKPQNILMDENLCPKISDFGLAKLCKNKESIISMLHMRGTFGYIAPEMFSKN 507
Query: 158 FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSE--IYFPHWVYKRLELEEDLGLQG- 214
FG VS+KSDVYSYGM+V EM G KN V S+ +YFP WVYK E E + G
Sbjct: 508 FGAVSHKSDVYSYGMVVLEMIGAKNIEKVEYSGSNNGSMYFPEWVYKDFEKGEITRIFGD 567
Query: 215 -IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLS-SGS 272
I +EE+K A+K++LV+LWCIQ NPSDRP M +V+EMLEG+L++L++PP P L S +
Sbjct: 568 SITDEEEK-IAKKLVLVALWCIQMNPSDRPPMIKVIEMLEGNLEALQVPPNPLLFSPEET 626
Query: 273 QPDS 276
PD+
Sbjct: 627 VPDT 630
|
|
| TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 716 (257.1 bits), Expect = 4.1e-73, Sum P(2) = 4.1e-73
Identities = 140/233 (60%), Positives = 176/233 (75%)
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEV--LYKIAVGIARGLEYLHR 95
GFCFEG +RA++YEF+ NGSL++F + N+ L +V LY IA+GIARGLEYLH
Sbjct: 558 GFCFEGSKRAIVYEFLENGSLDQF------MSRNKSLTQDVTTLYGIALGIARGLEYLHY 611
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
GC TRI+HFDIKP NILLD + CPK+SDFGLAK+C RES++S+ RGT+GYIAPEVF
Sbjct: 612 GCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYIAPEVFS 671
Query: 156 RNFGEVSYKSDVYSYGMMVFEMTGVKNNANV-AVDRS-SEIYFPHWVYKRLELEEDLGLQ 213
R +G VS+KSDVYS+GM+V +M G ++ V VD + S YFP W+YK LE E +
Sbjct: 672 RMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDGEQTWIF 731
Query: 214 GIE-NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRP 265
G E +E+KE A+KMI+V LWCIQ PSDRP+MNRVVEM+EGSLD+L IPP+P
Sbjct: 732 GDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIPPKP 784
|
|
| TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 714 (256.4 bits), Expect = 4.1e-73, Sum P(2) = 4.1e-73
Identities = 135/234 (57%), Positives = 173/234 (73%)
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
GFC EG++RA+IYEF+ NGSL+KFI K + + W LY IA+G+ARGLEYLH GC
Sbjct: 408 GFCSEGYKRAIIYEFMENGSLDKFISSKK----SSTMDWRELYGIALGVARGLEYLHHGC 463
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
TRI+HFDIKP N+LLD++ PK+SDFGLAK+C +ESI+S+ RGT+GYIAPEVF R
Sbjct: 464 RTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCERKESILSLMDTRGTIGYIAPEVFSRV 523
Query: 158 FGEVSYKSDVYSYGMMVFEMTGVKNNANV--AVDRSSEIYFPHWVYKRLELEED-LGLQ- 213
+G VS+KSDVYSYGM+V ++ G +N + +S +YFP W+Y+ LE + ++
Sbjct: 524 YGRVSHKSDVYSYGMLVLDIIGARNKTSTEDTTSSTSSMYFPEWIYRDLEKAHNGKSIET 583
Query: 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFL 267
I NEED E A+KM LV LWCIQ P DRPAMNRVVEM+EG+LD+L +PPRP L
Sbjct: 584 AISNEED-EIAKKMTLVGLWCIQPWPLDRPAMNRVVEMMEGNLDALEVPPRPVL 636
|
|
| TAIR|locus:2177142 AT5G39020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 711 (255.3 bits), Expect = 8.6e-73, Sum P(2) = 8.6e-73
Identities = 134/229 (58%), Positives = 168/229 (73%)
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
GFC+EG +RA+I EF+ +GSL++FI L N LY IA+GIARGLEYLH GC
Sbjct: 556 GFCYEGSKRAIISEFLEHGSLDQFISRNKSLTPNVT----TLYGIALGIARGLEYLHYGC 611
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
TRI+HFDIKP NILLD++FCPK++DFGLAK+C RESI+S+ RGT+GYIAPEV R
Sbjct: 612 KTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGTIGYIAPEVVSRM 671
Query: 158 FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE- 216
+G +S+KSDVYSYGM+V +M G +N S YFP W+YK LE + + G E
Sbjct: 672 YGGISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIYKDLENGDQTWIIGDEI 731
Query: 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRP 265
NEED + +KMILVSLWCI+ PSDRP MN+VVEM+EGSLD+L +PP+P
Sbjct: 732 NEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALELPPKP 780
|
|
| TAIR|locus:2176707 AT5G38250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 684 (245.8 bits), Expect = 2.4e-67, P = 2.4e-67
Identities = 135/234 (57%), Positives = 170/234 (72%)
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
GFC+EG +RA+IYEF+ NGSL++ + L LY IA+G+ARGLEYLH GC
Sbjct: 333 GFCYEGSKRAIIYEFLENGSLDQSL----------NLDVSTLYGIALGVARGLEYLHYGC 382
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
TRI+HFDIKP N+LLDE+ PK++DFGLAK+C +ESI+S+ RGT+GYIAPE+F R
Sbjct: 383 KTRIVHFDIKPQNVLLDENLRPKVADFGLAKLCEKQESILSLLDTRGTIGYIAPELFSRM 442
Query: 158 FGEVSYKSDVYSYGMMVFEMTGVKNNANV--AVDRSSEIYFPHWVYKRLELEEDLGL--Q 213
+G VS+KSDVYSYGM+V EM G +N V A +S YFP W+YK LE ++ L
Sbjct: 443 YGSVSHKSDVYSYGMLVLEMIGARNKERVQNADPNNSSAYFPDWIYKDLENFDNTRLLGD 502
Query: 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFL 267
G+ EE+K A+KMILV LWCIQ PSDRP+MN+VVEM+EGSLDSL PP+P L
Sbjct: 503 GLTREEEKN-AKKMILVGLWCIQFRPSDRPSMNKVVEMMEGSLDSLDPPPKPLL 555
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00030383001 | SubName- Full=Chromosome chr1 scaffold_5, whole genome shotgun sequence; (960 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 291 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-38 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-37 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-36 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-20 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-18 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-11 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.001 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.002 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.002 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.002 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.003 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 1e-41
Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 40/203 (19%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIKVLN---------------------------ETKGFC 40
LG+GG+G VY + G+ VAIK++ + G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 41 FEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
+ + L+ E+ GSL+ + E KL + + +I + I GLEYLH +
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN-----EGKLSEDEILRILLQILEGLEYLH---SNG 112
Query: 101 ILHFDIKPHNILLDED-FCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFG 159
I+H D+KP NILLD D K++DFGL+K+ +S+ + GT Y+APEV G
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVL-LGKG 169
Query: 160 EVSYKSDVYSYGMMVFEMTGVKN 182
S KSD++S G++++E+ +K+
Sbjct: 170 YYSEKSDIWSLGVILYELPELKD 192
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 1e-38
Identities = 72/281 (25%), Positives = 116/281 (41%), Gaps = 57/281 (20%)
Query: 4 SFKNKLGQGGYGGVYKGKLLD-----GRNVAIKVLNETK--------------------- 37
+ KLG+G +G VYKGKL VA+K L E
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 38 ------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLE 91
G C E ++ E++ G L ++ + P KL L A+ IARG+E
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP-----KLSLSDLLSFALQIARGME 116
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAP 151
YL +H D+ N L+ E+ KISDFGL++ + G + + ++AP
Sbjct: 117 YLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRD-LYDDDYYRKRGGKLPIRWMAP 172
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211
E G+ + KSDV+S+G++++E+ + P+ E+ E L
Sbjct: 173 ESL--KEGKFTSKSDVWSFGVLLWEIF-------------TLGEQPYPGMSNEEVLEYL- 216
Query: 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252
G + ++ + L C +P DRP + +VE+L
Sbjct: 217 KNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 4e-37
Identities = 72/294 (24%), Positives = 118/294 (40%), Gaps = 82/294 (27%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDG-----RNVAIKVLNETK--------------------- 37
+ KLG+G +G VYKG L VA+K L E
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 38 ------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLE 91
G C E ++ E++ G L ++ + P ++L L A+ IARG+E
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP----KELSLSDLLSFALQIARGME 117
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAP 151
YL +H D+ N L+ E+ KISDFGL++ + + G + + ++AP
Sbjct: 118 YLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRD-LYDDDYYKVKGGKLPIRWMAP 173
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211
E G+ + KSDV+S+G++++E+ + P+
Sbjct: 174 ESL--KEGKFTSKSDVWSFGVLLWEIF-------------TLGEEPYP------------ 206
Query: 212 LQGIENEEDKEYARK-------------MILVSLWCIQNNPSDRPAMNRVVEML 252
G+ N E EY +K + + L C +P DRP + +VE+L
Sbjct: 207 --GMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-36
Identities = 66/199 (33%), Positives = 87/199 (43%), Gaps = 41/199 (20%)
Query: 8 KLGQGGYGGVYKGKLL-DGRNVAIKVLN----------------------------ETKG 38
KLG G +G VYK K G+ VA+K+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
+ L+ E+ G L L L + KIA+ I RGLEYLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDL------FDYLSRGGPLSEDEAKKIALQILRGLEYLHS--- 116
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
I+H D+KP NILLDE+ KI+DFGLAK S S+T GT Y+APEV
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEV-LLGG 173
Query: 159 GEVSYKSDVYSYGMMVFEM 177
K DV+S G++++E+
Sbjct: 174 NGYGPKVDVWSLGVILYEL 192
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 7e-35
Identities = 75/289 (25%), Positives = 119/289 (41%), Gaps = 69/289 (23%)
Query: 7 NKLGQGGYGGVYKGKLLDGRN----VAIKVLNETK------------------------- 37
KLG+G +G VYKGKL VA+K L E
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 38 --GFCFEGHRRALIYEFVSNGSLEKFI---YEKHPLETNQKLKWEVLYKIAVGIARGLEY 92
G C E L+ E++ G L ++ P L + L A+ IA+G+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPE 152
L + + +H D+ N L+ ED KISDFGL++ + + TG + + ++APE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 153 VFCRNFGEVSYKSDVYSYGMMVFEMT--------GVKNNANVAVDRSSEIYFPHWVYKRL 204
G + KSDV+S+G++++E+ G+ N V + L
Sbjct: 178 SL--KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---------------EEVLEYL 220
Query: 205 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
+G + + ++ + L C Q +P DRP + +VE LE
Sbjct: 221 R-------KGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-33
Identities = 55/201 (27%), Positives = 84/201 (41%), Gaps = 42/201 (20%)
Query: 5 FKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------- 37
KLG+G +G VY + G+ VAIKV+ + K
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 38 -GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
+ + L+ E+ G L + ++ L ++ I LEYLH
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF------YLRQILSALEYLHS- 115
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156
I+H D+KP NILLDED K++DFGLA+ +T GT Y+APEV
Sbjct: 116 --KGIVHRDLKPENILLDEDGHVKLADFGLARQLD---PGEKLTTFVGTPEYMAPEVLLG 170
Query: 157 NFGEVSYKSDVYSYGMMVFEM 177
D++S G++++E+
Sbjct: 171 K--GYGKAVDIWSLGVILYEL 189
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 6e-33
Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 86/295 (29%)
Query: 5 FKNKLGQGGYGGVYKGKLLD-----GRNVAIKVLNET----------------------- 36
KLG+G +G VYKG L VA+K L E
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 37 ----KGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEY 92
G C +G ++ E++ G L F+ + +KL + L ++A+ IA+G+EY
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH-----GEKLTLKDLLQMALQIAKGMEY 117
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPE 152
L +H D+ N L+ E+ KISDFGL++ + + G + + ++APE
Sbjct: 118 LESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE 174
Query: 153 VFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212
G+ + KSDV+S+G++++E+ + Y
Sbjct: 175 SL--KDGKFTSKSDVWSFGVLLWEI----------FTLGEQPY----------------- 205
Query: 213 QGIENEEDKEYARK---------------MILVSLWCIQNNPSDRPAMNRVVEML 252
G+ NEE E +++ C +P DRP + +VE L
Sbjct: 206 PGMSNEEVLELLEDGYRLPRPENCPDELYELMLQ--CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-29
Identities = 63/205 (30%), Positives = 84/205 (40%), Gaps = 43/205 (20%)
Query: 7 NKLGQGGYGGVYKGKLLD-GRNVAIKVLNETKGFCFE----------------------- 42
LG+G +G VY D G +A+K + + E
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 43 GHRRA-------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
G R + E+VS GSL + + KL V+ K I GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL------KKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
I+H DIK NIL+D D K++DFG AK E+ RGT ++APEV
Sbjct: 120 ---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-I 175
Query: 156 RNFGEVSYKSDVYSYGMMVFEM-TG 179
R E +D++S G V EM TG
Sbjct: 176 RG-EEYGRAADIWSLGCTVIEMATG 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 5e-24
Identities = 60/201 (29%), Positives = 89/201 (44%), Gaps = 40/201 (19%)
Query: 4 SFKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKG--------------FC-------- 40
K+G+GG+G VYK + G+ VAIKV+ C
Sbjct: 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKY 62
Query: 41 ----FEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
+ ++ EF S GSL+ + TNQ L + + + +GLEYLH
Sbjct: 63 YGSYLKKDELWIVMEFCSGGSLKDLL-----KSTNQTLTESQIAYVCKELLKGLEYLH-- 115
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156
+ I+H DIK NILL D K+ DFGL+ ++ +M GT ++APEV
Sbjct: 116 -SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVI-- 169
Query: 157 NFGEVSYKSDVYSYGMMVFEM 177
N YK+D++S G+ E+
Sbjct: 170 NGKPYDYKADIWSLGITAIEL 190
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 95.6 bits (236), Expect = 2e-22
Identities = 64/206 (31%), Positives = 88/206 (42%), Gaps = 44/206 (21%)
Query: 8 KLGQGGYGGVYKGKLLDGRNVAIKVLN------------------------------ETK 37
KLG+G +G VY + D + VA+KVL +
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
F + L+ E+V GSLE + + L I I LEYLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIG---RKGPLSESEALFILAQILSALEYLHSK- 120
Query: 98 NTRILHFDIKPHNILLDED-FCPKISDFGLAKICHGRESIVS----MTGARGTVGYIAPE 152
I+H DIKP NILLD D K+ DFGLAK+ S S + + GT GY+APE
Sbjct: 121 --GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 153 VF-CRNFGEVSYKSDVYSYGMMVFEM 177
V + S SD++S G+ ++E+
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYEL 204
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 2e-21
Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 52/204 (25%)
Query: 8 KLGQGGYGGVYKGKL-LDGRNVAIKV-------------LNETK---------------G 38
LGQG G VYK + G+ A+K L E K
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
F EG +++ E++ GSL + + K+ VL IA I +GL+YLH
Sbjct: 68 FYKEG-EISIVLEYMDGGSLADLLKKV------GKIPEPVLAYIARQILKGLDYLHT--K 118
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR-----GTVGYIAPEV 153
I+H DIKP N+L++ KI+DFG++K ++ T + GTV Y++PE
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISK-------VLENTLDQCNTFVGTVTYMSPER 171
Query: 154 FCRNFGEVSYKSDVYSYGMMVFEM 177
SY +D++S G+ + E
Sbjct: 172 I--QGESYSYAADIWSLGLTLLEC 193
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-21
Identities = 69/274 (25%), Positives = 115/274 (41%), Gaps = 50/274 (18%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------G 38
+F +LG G +G V+ GK +VAIK++ E G
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
C + ++ E+++NG L ++ E+ KL E L + + +EYL
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRER-----KGKLGTEWLLDMCSDVCEAMEYLESNG- 120
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
+H D+ N L+ ED K+SDFGLA+ + S G + V + PEVF ++
Sbjct: 121 --FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEVF--DY 175
Query: 159 GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 218
S KSDV+S+G++++E+ SE P+ + E+ E + G
Sbjct: 176 SRFSSKSDVWSFGVLMWEVF-------------SEGKMPYERFSNSEVVESV-SAGYRLY 221
Query: 219 EDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252
K ++ + C P DRPA +++ L
Sbjct: 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-21
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 45/208 (21%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRN-----VAIKVLNET----------------------- 36
F +LG+G +G V + + VA+K LN +
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 37 ----KGFCFEGHRRA--LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGL 90
KG C + R+ LI E++ +GSL ++ LK +L+ + I +G+
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLF--SSQICKGM 122
Query: 91 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC-HGRESIVSMTGARGTVGYI 149
+YL + R +H D+ NIL++ + KISDFGLAK+ ++ + +
Sbjct: 123 DYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179
Query: 150 APEVFCRNFGEVSYKSDVYSYGMMVFEM 177
APE C + S SDV+S+G+ ++E+
Sbjct: 180 APE--CLRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 7e-21
Identities = 57/195 (29%), Positives = 88/195 (45%), Gaps = 35/195 (17%)
Query: 8 KLGQGGYGGVYKGKLLDGRNVAIKVLNE----TKGF---------------------CFE 42
KLG G +G V+ G VA+K L + F C E
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 43 GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRIL 102
++ E++S GSL F+ +KL+ L +A IA G+ YL +
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKS----GEGKKLRLPQLVDMAAQIAEGMAYLES---RNYI 125
Query: 103 HFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVS 162
H D+ NIL+ E+ KI+DFGLA++ E GA+ + + APE N+G +
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE-GAKFPIKWTAPEAA--NYGRFT 182
Query: 163 YKSDVYSYGMMVFEM 177
KSDV+S+G+++ E+
Sbjct: 183 IKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-20
Identities = 65/274 (23%), Positives = 118/274 (43%), Gaps = 50/274 (18%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------G 38
+ ++G G +G V+ G L+ R VAIK + E G
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
C E L++EF+ +G L ++ + K E L + + + G+ YL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQ-----RGKFSQETLLGMCLDVCEGMAYLESSN- 120
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
++H D+ N L+ E+ K+SDFG+ + + S TG + V + +PEVF +F
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVF--SF 175
Query: 159 GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 218
+ S KSDV+S+G++++E+ SE P+ E+ E + G
Sbjct: 176 SKYSSKSDVWSFGVLMWEVF-------------SEGKTPYENRSNSEVVETIN-AGFRLY 221
Query: 219 EDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252
+ + ++ + + C + P DRP+ + ++ L
Sbjct: 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 3e-20
Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 44/208 (21%)
Query: 6 KNKLGQGGYGGVYKGK-LLDGRNVAIKVLN------ETKGFCF----------------- 41
++G+G +G VY + DG+ +K ++ + +
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 42 -----EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
E + ++ E+ G L + I K + + E + V + L+YLH
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWFVQLCLALKYLHS- 121
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVG---YIAPEV 153
+ILH DIKP NI L + K+ DFG++K+ S V + A+ VG Y++PE+
Sbjct: 122 --RKILHRDIKPQNIFLTSNGLVKLGDFGISKVL---SSTVDL--AKTVVGTPYYLSPEL 174
Query: 154 FCRNFGEVSYKSDVYSYGMMVFEMTGVK 181
C+N +YKSD++S G +++E+ +K
Sbjct: 175 -CQNKP-YNYKSDIWSLGCVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 7e-20
Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 44/200 (22%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKV-----------LNETK--------------GF 39
+G+G +G V G G+ VA+K L E G
Sbjct: 10 LGATIGKGEFGDVMLG-DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 40 CFEGHRRALIYEFVSNGSLEKFIY--EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
+G+ ++ E+++ GSL ++ + + Q+L + A+ + G+EYL
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGF------ALDVCEGMEYLE--- 119
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
+H D+ N+L+ ED K+SDFGLAK E+ + V + APE R
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-RE 173
Query: 158 FGEVSYKSDVYSYGMMVFEM 177
+ S KSDV+S+G++++E+
Sbjct: 174 -KKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-19
Identities = 68/276 (24%), Positives = 114/276 (41%), Gaps = 67/276 (24%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKV--------------LNETKGF---------CF-- 41
KLG+G YG VYK K L D + A+K +NE + +
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 42 ---EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
+G++ ++ E+ G L K I ++ + + +++I + + RGL+ LH
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRK--LIPEQEIWRIFIQLLRGLQALH---E 121
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR-GTVGYIAPEVFCRN 157
+ILH D+K NILL + KI D G++K+ M + GT Y+APEV+
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-----MAKTQIGTPHYMAPEVWKGR 176
Query: 158 FGEVSYKSDVYSYGMMVFEMTGVKN--NANVAVDRSSEI---YFPHWVYKRLELEEDLGL 212
SYKSD++S G +++EM A D ++ +P
Sbjct: 177 --PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP-------------- 220
Query: 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRV 248
I Y++ + +Q P RP +++
Sbjct: 221 --IPP----IYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-19
Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 37/198 (18%)
Query: 7 NKLGQGGYGGVYKGKLLDGRNVAIKVL---NETK-----------------------GFC 40
KLG G +G V++G + VAIK+L + K C
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 41 FEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
G +I E + GSL F+ + P + L +A +A G+ YL
Sbjct: 72 SVGEPVYIITELMEKGSLLAFL--RSPEGQVLPV--ASLIDMACQVAEGMAYLE---EQN 124
Query: 101 ILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGE 160
+H D+ NIL+ ED K++DFGLA++ +E + + + + APE + G
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAA--SHGT 180
Query: 161 VSYKSDVYSYGMMVFEMT 178
S KSDV+S+G++++EM
Sbjct: 181 FSTKSDVWSFGILLYEMF 198
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 41/110 (37%), Positives = 51/110 (46%), Gaps = 8/110 (7%)
Query: 68 LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127
L K E + I LEYLH + I+H DIKP NILLDE I+DF +A
Sbjct: 91 LSQKVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIA 147
Query: 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
S + GT GY+APEV CR S D +S G+ +E
Sbjct: 148 TKVTPDTLTTSTS---GTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYEC 192
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-18
Identities = 59/204 (28%), Positives = 87/204 (42%), Gaps = 46/204 (22%)
Query: 9 LGQGGYGGVYKGKLL-DGRN----VAIKVLNETK-------------------------- 37
LG G +G VYKG + +G VAIKVL E
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 38 -GFCFEGHRRALIYEFVSNGSLEKFIYE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
G C + LI + + G L ++ K + + L W V IA+G+ YL
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLE- 126
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
R++H D+ N+L+ KI+DFGLAK+ E G + + ++A E
Sbjct: 127 --EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE--S 182
Query: 156 RNFGEVSYKSDVYSYGMMVFE-MT 178
++KSDV+SYG+ V+E MT
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 1e-18
Identities = 53/202 (26%), Positives = 77/202 (38%), Gaps = 49/202 (24%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVLNETKGFCFEGHRRA-------------------- 47
LG+G +G V + D G+ A+KVL K +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK--KKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 48 -----------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
L+ E+ G L + ++ + Y A I LEYLH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRF----SEERARFY--AAEIVLALEYLHS- 111
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKI-CHGRESIVSMTGARGTVGYIAPEVFC 155
I++ D+KP NILLD D K++DFGLAK + GT Y+APEV
Sbjct: 112 --LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC---GTPEYLAPEVLL 166
Query: 156 RNFGEVSYKSDVYSYGMMVFEM 177
D +S G++++EM
Sbjct: 167 G--KGYGKAVDWWSLGVLLYEM 186
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-18
Identities = 60/194 (30%), Positives = 91/194 (46%), Gaps = 34/194 (17%)
Query: 8 KLGQGGYGGVYKGKLLDGRNVAIKVLNE----TKGFCFEG-------HRRA--------- 47
KLG G +G V+ G VAIK L + + F E H R
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 48 ----LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILH 103
+I E++ NGSL F+ KL L +A IA G+ ++ R +H
Sbjct: 73 EPIYIITEYMENGSLVDFL----KTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIH 125
Query: 104 FDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSY 163
D++ NIL+ E C KI+DFGLA++ E + GA+ + + APE N+G +
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NYGTFTI 182
Query: 164 KSDVYSYGMMVFEM 177
KSDV+S+G+++ E+
Sbjct: 183 KSDVWSFGILLTEI 196
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 3e-18
Identities = 60/212 (28%), Positives = 88/212 (41%), Gaps = 57/212 (26%)
Query: 5 FKNKLGQGGYGGVYKG-KLLDGRNVAIKVLNETKGFC----------------------- 40
+ +G+G +G VYKG L G VAIK ++ K
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 41 FEGHRR-----ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIA---RGLEY 92
+ G +I E+ NGSL + I + P + +AV + +GL Y
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL---------VAVYVYQVLQGLAY 114
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA----KICHGRESIVSMTGARGTVGY 148
LH ++H DIK NIL +D K++DFG+A + S+V GT +
Sbjct: 115 LH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV------GTPYW 165
Query: 149 IAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TG 179
+APEV S SD++S G V E+ TG
Sbjct: 166 MAPEVI--EMSGASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 9e-18
Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 44/203 (21%)
Query: 7 NKLGQGGYGGVYKGKLL--DGR--NVAIKVLNETK------------------------- 37
+LG G +G V KG L G+ VA+K L +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 38 --GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
G C +G L+ E G L K++ +K LK ++A +A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYL-KKRREIPVSDLK-----ELAHQVAMGMAYLE- 112
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICHGRESIVSMTGARGTVGYIAPEVF 154
+ +H D+ N+LL KISDFG+++ + G + + T R + + APE
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE-- 168
Query: 155 CRNFGEVSYKSDVYSYGMMVFEM 177
C N+G+ S KSDV+SYG+ ++E
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEA 191
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-17
Identities = 73/276 (26%), Positives = 124/276 (44%), Gaps = 50/276 (18%)
Query: 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------- 37
+ K+KLG G YG VY+G VA+K L E
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
G C +I EF++ G+L ++ E + Q++ VL +A I+ +EYL +
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECN----RQEVNAVVLLYMATQISSAMEYLEK-- 122
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
+H D+ N L+ E+ K++DFGL+++ G ++ + GA+ + + APE N
Sbjct: 123 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN 180
Query: 158 FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217
+ S KSDV+++G++++E+ + +D S VY+ LE +G
Sbjct: 181 --KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE-------KGYRM 224
Query: 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
E + K+ + C Q NPSDRP+ + + E
Sbjct: 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 43/206 (20%)
Query: 7 NKLGQGGYGGVYKGKLL-DGRNVAIK--------------------VLNETK-----GFC 40
+G+G +G V K + DG+ + K +L E K +
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 41 FEGHRRA-----LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
R+ ++ E+ G L + I + + + ++ E +++I + L H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 96 GC--NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEV 153
+LH D+KP NI LD + K+ DFGLAKI S T GT Y++PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK-TYV-GTPYYMSPEQ 181
Query: 154 FCRNFGEVSY--KSDVYSYGMMVFEM 177
SY KSD++S G +++E+
Sbjct: 182 LNHM----SYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-17
Identities = 73/283 (25%), Positives = 108/283 (38%), Gaps = 74/283 (26%)
Query: 9 LGQGGYGGVYKG-KLLDGRNVAIKVLN-----------------ETK------------- 37
LG G +G VY+G L DG A+K ++ E
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 38 -GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
G E + E V GSL K + +K+ V+ I GLEYLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAK-LLKKY-----GSFPEPVIRLYTRQILLGLEYLH-- 119
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156
+ +H DIK NIL+D + K++DFG+AK S +G+ ++APEV
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF---KGSPYWMAPEV-IA 174
Query: 157 NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYK------RLELEEDL 210
G +D++S G V EM K S++ V+K + + L
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGK-------PPWSQLEGVAAVFKIGRSKELPPIPDHL 227
Query: 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
+ K++ K C+Q +PS RP E+LE
Sbjct: 228 SDEA------KDFILK-------CLQRDPSLRPT---AAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-17
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 47/202 (23%)
Query: 9 LGQGGYGGVYKGKL-LDGRN---VAIKVLNETKGFCFEGHRR------------------ 46
+G G +G V +G+L L G+ VAIK L K + R
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTL---KAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 47 ------------ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
+I E++ NGSL+KF+ E + K L + GIA G++YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRE-----NDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF 154
+H D+ NIL++ + K+SDFGL++ E+ + G + + + APE
Sbjct: 124 EMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI 180
Query: 155 CRNFGEVSYKSDVYSYGMMVFE 176
+ + + SDV+S+G++++E
Sbjct: 181 --AYRKFTSASDVWSFGIVMWE 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 2e-17
Identities = 56/222 (25%), Positives = 83/222 (37%), Gaps = 60/222 (27%)
Query: 5 FKNKLGQGGYGGVYKGKLL-DGRNVAIKV------------------------LNETKGF 39
F +G+G + V K + AIK+ LN G
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 40 -----CFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
F+ + E+ NG L ++I L + A I LEYL
Sbjct: 65 IKLYYTFQDEENLYFVLEYAPNGELLQYI------RKYGSLDEKCTRFYAAEILLALEYL 118
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR---------- 143
H + I+H D+KP NILLD+D KI+DFG AK+ S S G
Sbjct: 119 H---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 144 --------GTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
GT Y++PE+ N SD+++ G ++++M
Sbjct: 176 RRRFASFVGTAEYVSPELL--NEKPAGKSSDLWALGCIIYQM 215
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 6e-17
Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 45/229 (19%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------G 38
+F +LG G +G V+ GK VAIK +NE G
Sbjct: 7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
C + ++ EF+ NG L ++ ++ KL ++L + + G+EYL R
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQ-----GKLSKDMLLSMCQDVCEGMEYLER--- 118
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
+H D+ N L+ K+SDFG+ + E S +GA+ V + PEVF NF
Sbjct: 119 NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVF--NF 175
Query: 159 GEVSYKSDVYSYGMMVFEMTG-------VKNNANV--AVDRSSEIYFPH 198
+ S KSDV+S+G++++E+ K+N V + R +Y P
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPK 224
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-17
Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 42 EGHRRALIYEFVSNGSL-EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
E R ++ + + L E F K E Q+ E ++ I V + L YLH+ R
Sbjct: 80 ENDRLYIVMDLIEGAPLGEHFNSLK---EKKQRFTEERIWNIFVQMVLALRYLHK--EKR 134
Query: 101 ILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN--F 158
I+H D+ P+NI+L ED I+DFGLAK ES +T GT+ Y PE+ +N +
Sbjct: 135 IVHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPES--KLTSVVGTILYSCPEIV-KNEPY 190
Query: 159 GEVSYKSDVYSYGMMVFEMTGVK------NNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212
GE K+DV+++G ++++M ++ N ++A +Y P L E +
Sbjct: 191 GE---KADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP--------LPEGM-- 237
Query: 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252
Y+ + V C+ + RP + +V M+
Sbjct: 238 ----------YSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-17
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 39/197 (19%)
Query: 8 KLGQGGYGGVYKGKLLDGRNVAIKVLNETK---------------------------GFC 40
K+G+G +G VYKG L VA+K T G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 41 FEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RGCNT 99
+ ++ E V GSL F+ +K +L + L ++++ A G+EYL + C
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKK-----KNRLTVKKLLQMSLDAAAGMEYLESKNC-- 114
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFG 159
+H D+ N L+ E+ KISDFG+++ G VS + + + APE N+G
Sbjct: 115 --IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL--NYG 170
Query: 160 EVSYKSDVYSYGMMVFE 176
+ +SDV+SYG++++E
Sbjct: 171 RYTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 51/209 (24%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVLNET--------------KGFCF------------ 41
+G+G YG VYK + G+ VAIK+++ + +
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFI 73
Query: 42 ------EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
+ L+ E GS+ + K + ++LK E + I RGL YLH
Sbjct: 74 KKNPPGNDDQLWLVMELCGGGSVTDLV--KGLRKKGKRLKEEWIAYILRETLRGLAYLHE 131
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT-VG---YIAP 151
+++H DIK NILL ++ K+ DFG++ + S G R T +G ++AP
Sbjct: 132 ---NKVIHRDIKGQNILLTKNAEVKLVDFGVSA------QLDSTLGRRNTFIGTPYWMAP 182
Query: 152 EVF-CRNFGEVSY--KSDVYSYGMMVFEM 177
EV C + SY +SDV+S G+ E+
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-16
Identities = 66/260 (25%), Positives = 120/260 (46%), Gaps = 40/260 (15%)
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHP------LET----NQKLKWEVLYKIAVGIA 87
G C + ++ E+ S G+L +++ + P +T ++L ++ L A +A
Sbjct: 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVA 144
Query: 88 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVG 147
RG+EYL + + +H D+ N+L+ ED KI+DFGLA+ H + T R V
Sbjct: 145 RGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK 201
Query: 148 YIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206
++APE +F R + +++SDV+S+G++++E+ + + Y + +
Sbjct: 202 WMAPEALFDRVY---THQSDVWSFGVLLWEIFTLGGSP----------------YPGIPV 242
Query: 207 EEDLGL--QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE-----GSLDSL 259
EE L +G ++ ++ ++ C PS RP ++VE L+ S D
Sbjct: 243 EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEY 302
Query: 260 RIPPRPFLLSSGSQPDSSGT 279
PF S PDS +
Sbjct: 303 LDLSVPFEQYSPGCPDSPSS 322
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-16
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 48/205 (23%)
Query: 6 KNKLGQGGYGGVYKG-KLLDGRNVAIK--------------VLNETKGF----------- 39
NK+G+G +G V+K + D R A+K ++E +
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 40 --CF-EGHRRALIYEFVSNGSLEKFI--YEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
F + + ++ E+ NG L K + PL +Q +++ + I GL +LH
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQ------VWRFFIQILLGLAHLH 118
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF 154
+ +ILH DIK N+ LD KI D G+AK+ + + T GT Y++PE+
Sbjct: 119 ---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANT-IVGTPYYLSPEL- 172
Query: 155 CRN--FGEVSYKSDVYSYGMMVFEM 177
C + + E KSDV++ G++++E
Sbjct: 173 CEDKPYNE---KSDVWALGVVLYEC 194
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 6e-16
Identities = 72/285 (25%), Positives = 116/285 (40%), Gaps = 74/285 (25%)
Query: 7 NKLGQGGYGGVYK------GK-------LLDGRNVAIK-------VLNETK--------G 38
+LG G G V K GK L+ K +L++ G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
+ ++ E++ GSL+K + E ++ +L KIAV + +GL YLH
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKE-----VQGRIPERILGKIAVAVLKGLTYLHE--K 119
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR-GTVGYIAPEVFCRN 157
+I+H D+KP NIL++ K+ DFG++ + + S+ GT Y+APE R
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPE---RI 171
Query: 158 FGEV-SYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKR-----LELEEDLG 211
G S KSD++S G+ + E+ A R FP+ EL
Sbjct: 172 QGNDYSVKSDIWSLGLSLIEL---------ATGR-----FPYPPENDPPDGIFEL----- 212
Query: 212 LQGIENEE-----DKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251
LQ I NE +++ C+ +P +RP+ ++E
Sbjct: 213 LQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 8e-16
Identities = 66/204 (32%), Positives = 87/204 (42%), Gaps = 54/204 (26%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIK-----------------VLNETKGFCFE---- 42
KLG+G Y VYK + GR VAIK L E K E
Sbjct: 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIK-LLQELKHP 62
Query: 43 ---------GHRRA--LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLE 91
GH+ L++EF+ LEK I +K + T +K + RGLE
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIK-----SYMLMTLRGLE 116
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC--HGRESIVSMTGARGTVGYI 149
YLH ILH D+KP+N+L+ D K++DFGLA+ R+ MT T Y
Sbjct: 117 YLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK----MTHQVVTRWYR 169
Query: 150 APEVFCRNFGEVSYKS--DVYSYG 171
APE+ FG Y D++S G
Sbjct: 170 APELL---FGARHYGVGVDMWSVG 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 8e-16
Identities = 63/206 (30%), Positives = 91/206 (44%), Gaps = 42/206 (20%)
Query: 7 NKLGQGGYGGVYKGKLLD-GRNVAIKVL--------------------------NETKGF 39
NK+G G +G VY LD G +A+K + N K +
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 40 CFEGHR-RALIY-EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
E HR + I+ E+ S G+LE+ LE + L V+ + + GL YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEEL------LEHGRILDEHVIRVYTLQLLEGLAYLH--- 116
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKIC--HGRESIVSMTGARGTVGYIAPEVFC 155
+ I+H DIKP NI LD + K+ DFG A + + GT Y+APEV
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 156 RNFGEVSYKS-DVYSYGMMVFEM-TG 179
G+ ++ D++S G +V EM TG
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATG 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (186), Expect = 8e-16
Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 59/210 (28%)
Query: 6 KNKLGQGGYGGVYKGK-LLDGRNVAIKVL---NETKGF---------------------- 39
KLG+G YG VYK + G VA+K + NE +G
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 40 ---CFEGHRRALIYEFVSNGSLEKFIYEKH--PLETNQKLKWEVLYKIAVGIARGLEYLH 94
+ L++E+ L+K++ +K PL N +K I + RGL Y H
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNL-IK-----SIMYQLLRGLAYCH 115
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH--GR---ESIVSMTGARGTVGYI 149
RILH D+KP NIL++ D K++DFGLA+ R +V T+ Y
Sbjct: 116 SH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-------TLWYR 165
Query: 150 APEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
APE+ G Y + D++S G + EM
Sbjct: 166 APEIL---LGSKHYSTAVDIWSVGCIFAEM 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-15
Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 49/201 (24%)
Query: 8 KLGQGGYGGVYKGKLLD-GRNVAIKVLNETKGF------------C------------FE 42
KLG+G YG VYK + G+ VAIKV+ + C F+
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69
Query: 43 GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRIL 102
++ E+ GS+ + TN+ L E + I +GLEYLH + + +
Sbjct: 70 NTDLWIVMEYCGAGSVSDIMKI-----TNKTLTEEEIAAILYQTLKGLEYLH---SNKKI 121
Query: 103 HFDIKPHNILLDEDFCPKISDFGLAKICHG----RESIVSMTGARGTVGYIAPEVFCRNF 158
H DIK NILL+E+ K++DFG++ R +++ GT ++APEV
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI------GTPFWMAPEV----I 171
Query: 159 GEVSY--KSDVYSYGMMVFEM 177
E+ Y K+D++S G+ EM
Sbjct: 172 QEIGYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 5e-15
Identities = 57/205 (27%), Positives = 86/205 (41%), Gaps = 48/205 (23%)
Query: 4 SFKNKLGQGGYGGVYKGK-LLDGRNVAIKV-----------LNET--------------- 36
K+G+G G VYK G+ VAIK +NE
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYY 81
Query: 37 KGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
+ ++ E++ GSL I + ++ + + + +GLEYLH
Sbjct: 82 DSYLVGDEL-WVVMEYMDGGSLTDIITQ-----NFVRMNEPQIAYVCREVLQGLEYLH-- 133
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLA----KICHGRESIVSMTGARGTVGYIAPE 152
+ ++H DIK NILL +D K++DFG A K R S+V GT ++APE
Sbjct: 134 -SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV------GTPYWMAPE 186
Query: 153 VFCRNFGEVSYKSDVYSYGMMVFEM 177
V R + K D++S G+M EM
Sbjct: 187 VIKRK--DYGPKVDIWSLGIMCIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-15
Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 34/195 (17%)
Query: 8 KLGQGGYGGVYKGKLLDGRNVAIKVLN----ETKGFCFEG-------HRRA--------- 47
KLGQG +G V+ G VAIK L + F E H +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 48 ----LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILH 103
++ E++S GSL F+ E + L+ L +A IA G+ Y+ R +H
Sbjct: 73 EPIYIVTEYMSKGSLLDFLKG----EMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 125
Query: 104 FDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSY 163
D++ NIL+ E+ K++DFGLA++ E + GA+ + + APE +G +
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTI 182
Query: 164 KSDVYSYGMMVFEMT 178
KSDV+S+G+++ E+T
Sbjct: 183 KSDVWSFGILLTELT 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-15
Identities = 47/134 (35%), Positives = 69/134 (51%), Gaps = 13/134 (9%)
Query: 47 ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDI 106
+ E+ GSL+ IY K + ++ +VL KIA + +GL YLH + +I+H DI
Sbjct: 77 GIAMEYCEGGSLDS-IY-KKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDI 131
Query: 107 KPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGA-RGTVGYIAPEVFCRNFGEVSYKS 165
KP NILL K+ DFG++ E + S+ G GT Y+APE S S
Sbjct: 132 KPSNILLTRKGQVKLCDFGVSG-----ELVNSLAGTFTGTSFYMAPERI--QGKPYSITS 184
Query: 166 DVYSYGMMVFEMTG 179
DV+S G+ + E+
Sbjct: 185 DVWSLGLTLLEVAQ 198
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 9e-15
Identities = 58/230 (25%), Positives = 104/230 (45%), Gaps = 47/230 (20%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------G 38
+F +LG G +G V GK +VAIK++ E G
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
C + ++ E++SNG L ++ E + +Q L ++ + G+ YL
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ------LLEMCKDVCEGMAYLE--- 117
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
+ + +H D+ N L+D+ C K+SDFGL++ E S+ G++ V + PEV
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVL--L 174
Query: 158 FGEVSYKSDVYSYGMMVFEMTGVK-------NNANVA--VDRSSEIYFPH 198
+ + S KSDV+++G++++E+ + NN+ V + +Y PH
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPH 224
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-15
Identities = 64/271 (23%), Positives = 120/271 (44%), Gaps = 56/271 (20%)
Query: 8 KLGQGGYGGVYKGKLLDGRNVAIKV----------LNETKGFCFEGHRRA---------- 47
+G+G +G V +G+ G+ VA+K L ET H+
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN 71
Query: 48 ---LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHF 104
++ E +S G+L F+ + + L + ++ +A G+EYL + +++H
Sbjct: 72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQ----LLQFSLDVAEGMEYLE---SKKLVHR 124
Query: 105 DIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYK 164
D+ NIL+ ED K+SDFGLA++ G + + ++ V + APE + S K
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV--GSMGVDN---SKLPVKWTAPEAL--KHKKFSSK 177
Query: 165 SDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEE--DLGLQGIENEEDKE 222
SDV+SYG++++E+ + Y ++ L+E + +G E +
Sbjct: 178 SDVWSYGVLLWEV----------------FSYGRAPYPKMSLKEVKECVEKGYRMEPPEG 221
Query: 223 YARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
+ ++ C + P RP+ +++ E LE
Sbjct: 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 60/213 (28%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIK--------------------VLNETKGF------ 39
++G+G YG VYK + L GR VA+K +L + + F
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 40 ----CFEGHRR------ALIYEFVSNGSLEKFIYEKHP---LETNQKLKWEVLYKIAVGI 86
G R L++E V L ++ K P L +K ++ ++
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL-SKCPKPGLPPE-TIKD-LMRQLL--- 117
Query: 87 ARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTV 146
RG+++LH + RI+H D+KP NIL+ D KI+DFGLA+I + E ++T T+
Sbjct: 118 -RGVDFLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLARI-YSFEM--ALTSVVVTL 170
Query: 147 GYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
Y APEV + SY + D++S G + E+
Sbjct: 171 WYRAPEVLLQ----SSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 43/201 (21%)
Query: 9 LGQGGYGGVYKGKLL-DGRNV----AIKVLNETKG------FCFEGHRRA---------- 47
LG G +G VYKG + +G V AIK+LNET G F E A
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 48 ----------LIYEFVSNGSLEKFIYE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
L+ + + +G L +++E K + + L W V IA+G+ YL
Sbjct: 75 LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE- 127
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156
R++H D+ N+L+ KI+DFGLA++ G E + G + + ++A E C
Sbjct: 128 --RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE--CI 183
Query: 157 NFGEVSYKSDVYSYGMMVFEM 177
++ + +++SDV+SYG+ ++E+
Sbjct: 184 HYRKFTHQSDVWSYGVTIWEL 204
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-14
Identities = 55/195 (28%), Positives = 91/195 (46%), Gaps = 35/195 (17%)
Query: 8 KLGQGGYGGVYKGKLLDGRNVAIKVLN----ETKGFCFEG-------HRRA--------- 47
KLG G +G V+ G + VA+K L + F E H +
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 48 -----LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRIL 102
+I E+++ GSL F+ + K+ L + IA G+ Y+ R +
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKS----DEGGKVLLPKLIDFSAQIAEGMAYIER---KNYI 125
Query: 103 HFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVS 162
H D++ N+L+ E KI+DFGLA++ E + GA+ + + APE NFG +
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--NFGSFT 182
Query: 163 YKSDVYSYGMMVFEM 177
KSDV+S+G++++E+
Sbjct: 183 IKSDVWSFGILLYEI 197
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-14
Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 42/197 (21%)
Query: 9 LGQGGYGGVYKGKLLDGRNVA-------------IKVLNETK--------------GFCF 41
LG+G +G V+KG L D VA IK L+E + G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 42 EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RGCNTR 100
+ ++ E V G F+ +K +LK + L K A+ A G+ YL + C
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKK-----KDELKTKQLVKFALDAAAGMAYLESKNC--- 114
Query: 101 ILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT-VGYIAPEVFCRNFG 159
+H D+ N L+ E+ KISDFG+++ + I S +G + + + APE N+G
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEAL--NYG 169
Query: 160 EVSYKSDVYSYGMMVFE 176
S +SDV+SYG++++E
Sbjct: 170 RYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 3e-14
Identities = 69/267 (25%), Positives = 103/267 (38%), Gaps = 68/267 (25%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIK--------------VLNETKGFCFEGHRRAL- 48
+G G YG V GR VAIK +L E K H +
Sbjct: 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 49 IYEFVSNGSLEKF-----------------IYEKHPLETNQKLKWEVLYKIAVGIARGLE 91
+ + + S E F I PL T+ +++ LY+I RGL+
Sbjct: 64 LLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPL-TDDHIQY-FLYQIL----RGLK 117
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS-MTGARGTVGYIA 150
YLH N ++H D+KP NIL++ + KI DFGLA+ E +T T Y A
Sbjct: 118 YLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFP-HWVYKRLEL--- 206
PE+ + + D++S G + E+ K FP +L L
Sbjct: 175 PELLL-SSSRYTKAIDIWSVGCIFAELLTRK------------PLFPGRDYIDQLNLIVE 221
Query: 207 ------EEDLGLQGIENEEDKEYARKM 227
EED L+ I +E+ + Y + +
Sbjct: 222 VLGTPSEED--LKFITSEKARNYLKSL 246
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-14
Identities = 60/232 (25%), Positives = 112/232 (48%), Gaps = 35/232 (15%)
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHP--LE--------TNQKLKWEVLYKIAVGIA 87
G C + +I E+ S G+L +++ + P +E ++L ++ L A +A
Sbjct: 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVA 150
Query: 88 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVG 147
RG+EYL + + +H D+ N+L+ ED KI+DFGLA+ H + T R V
Sbjct: 151 RGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 207
Query: 148 YIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206
++APE +F R + +++SDV+S+G++++E+ + + Y + +
Sbjct: 208 WMAPEALFDRIY---THQSDVWSFGVLLWEIFTLGGSP----------------YPGVPV 248
Query: 207 EEDLGL--QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256
EE L +G ++ ++ ++ C PS RP ++VE L+ L
Sbjct: 249 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-14
Identities = 68/270 (25%), Positives = 117/270 (43%), Gaps = 48/270 (17%)
Query: 8 KLGQGGYGGVYKGKLLDGRNVAIKVLN----ETKGFCFEG-------HRRA--------- 47
KLGQG +G V+ G VAIK L + F E H +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 48 ----LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILH 103
++ EF+ GSL F+ E + LK L +A IA G+ Y+ R +H
Sbjct: 73 EPIYIVTEFMGKGSLLDFLKEG----DGKYLKLPQLVDMAAQIADGMAYIER---MNYIH 125
Query: 104 FDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSY 163
D++ NIL+ ++ KI+DFGLA++ E + GA+ + + APE +G +
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTI 182
Query: 164 KSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY 223
KSDV+S+G+++ E+ + +P V + + + + G + + E
Sbjct: 183 KSDVWSFGILLTELV-----------TKGRVPYPGMVNREVLEQVERGYRMPCPQGCPES 231
Query: 224 ARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
+++ + C + +P +RP + LE
Sbjct: 232 LHELMKL---CWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-14
Identities = 78/294 (26%), Positives = 119/294 (40%), Gaps = 73/294 (24%)
Query: 9 LGQGGYGGVYKGKLL--DGR--NVAIKVL-------NETKGF------------------ 39
LG+G +G V +G+L DG VA+K + +E + F
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 40 ---CFEGHRRA------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGL 90
CFE +I F+ +G L F+ +KL + L K V IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 91 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIA 150
EYL N +H D+ N +L ED ++DFGL+K + + A+ V +IA
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVFEMT--------GVKNNANVAVDRSSEIYFPHWVYK 202
E + KSDV+++G+ ++E+ GV+N EIY
Sbjct: 184 IESLADRV--YTSKSDVWAFGVTMWEIATRGQTPYPGVEN---------HEIYDYLRHGN 232
Query: 203 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256
RL+ ED D+ Y ++ S W P DRP ++ E+LE L
Sbjct: 233 RLKQPEDC--------LDELYD---LMYSCWRAD--PKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 49/217 (22%)
Query: 5 FKNKLGQGGYGGVYKGKLL-DG--RNVAIKVLN-------------ETKGFCFEGHRRAL 48
F++ +G+G +G V K ++ DG + AIK + E + C GH +
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 49 IY---------------EFVSNGSLEKFIYEKHPLETN----------QKLKWEVLYKIA 83
I E+ +G+L F+ + LET+ L + L A
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 84 VGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR 143
+ARG++YL + + +H D+ NIL+ E++ KI+DFGL++ G+E V T R
Sbjct: 131 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 184
Query: 144 GTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGV 180
V ++A E N+ + SDV+SYG++++E+ +
Sbjct: 185 LPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSL 219
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-14
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 34/211 (16%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107
+I EF++ GSL F+ + K L + IA G+ ++ + +H D++
Sbjct: 77 IITEFMAKGSLLDFLKS----DEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLR 129
Query: 108 PHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDV 167
NIL+ KI+DFGLA++ E + GA+ + + APE NFG + KSDV
Sbjct: 130 AANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--NFGSFTIKSDV 186
Query: 168 YSYGMMVFEM-----TGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKE 222
+S+G+++ E+ +N V R+ LE + EN ++
Sbjct: 187 WSFGILLMEIVTYGRIPYPGMSNPEVIRA--------------LERGYRMPRPENCPEEL 232
Query: 223 YARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
Y + + C +N P +RP + +L+
Sbjct: 233 YN-----IMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-14
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 45/201 (22%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVLN---ETKGFC----------------------- 40
K+G+G YG VYK + L G VAIK + E++G
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 41 --FEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
L++EF+ L K I ++ +K LY++ +GL + H
Sbjct: 66 VFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKS-YLYQLL----QGLAFCHS--- 116
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
ILH D+KP N+L++ + K++DFGLA+ + T T Y APE+
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELL---L 171
Query: 159 GEVSYKS--DVYSYGMMVFEM 177
G+ Y + D++S G + E+
Sbjct: 172 GDKGYSTPVDIWSVGCIFAEL 192
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-14
Identities = 54/229 (23%), Positives = 109/229 (47%), Gaps = 35/229 (15%)
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLE----------TNQKLKWEVLYKIAVGIA 87
G C + +I E+ S G+L +++ + P ++++ ++ L +A
Sbjct: 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVA 147
Query: 88 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVG 147
RG+EYL + + +H D+ N+L+ E+ KI+DFGLA+ + + T R V
Sbjct: 148 RGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVK 204
Query: 148 YIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206
++APE +F R + +++SDV+S+G++++E+ + + Y + +
Sbjct: 205 WMAPEALFDRVY---THQSDVWSFGVLMWEIFTLGGSP----------------YPGIPV 245
Query: 207 EEDLGL--QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
EE L +G ++ ++ ++ C PS RP ++VE L+
Sbjct: 246 EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-14
Identities = 36/92 (39%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT 145
I GLE+LH RI++ D+KP N+LLD+ +ISD GLA G + I G GT
Sbjct: 104 IICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---KGRAGT 157
Query: 146 VGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
GY+APEV + D ++ G ++EM
Sbjct: 158 PGYMAPEVLQG--EVYDFSVDWFALGCTLYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-13
Identities = 43/134 (32%), Positives = 60/134 (44%), Gaps = 23/134 (17%)
Query: 51 EFVSNGSLEKFIYEKHPLE-------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILH 103
E+V GS+ + E T Q L+ GL YLH + ILH
Sbjct: 88 EYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE-------------GLAYLH---SKGILH 131
Query: 104 FDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSY 163
D+K N+L+D D KISDFG++K +G+V ++APEV S
Sbjct: 132 RDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSA 191
Query: 164 KSDVYSYGMMVFEM 177
K D++S G +V EM
Sbjct: 192 KVDIWSLGCVVLEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 1e-13
Identities = 60/201 (29%), Positives = 86/201 (42%), Gaps = 40/201 (19%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKVL---NETKGFCFEGHR-----RAL-------IY 50
++G+G YG VYK + G VA+K + NE +GF R + L +
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 51 EFV-SNGSLEKFI---YEKHPLETNQKLKWEVLYKIAVG--------IARGLEYLHRGCN 98
E V S G ++ Y H L L K + GL+YLH +
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDL---TGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---S 118
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
ILH DIK NIL++ D K++DFGLA+ R S T T+ Y PE+
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELL---L 174
Query: 159 GEVSYKS--DVYSYGMMVFEM 177
G Y D++S G ++ E+
Sbjct: 175 GATRYGPEVDMWSVGCILAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-13
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 37/199 (18%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLN----ETKGFCFEG-------HRRAL----- 48
KLG G +G V++G + VA+K L + K F E H + +
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 49 ------IY---EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
IY E + GSL +++ + LK L +A +A G+ YL
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQG----GAGRALKLPQLIDMAAQVASGMAYLEA---Q 122
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV-SMTGARGTVGYIAPEVFCRNF 158
+H D+ N+L+ E+ K++DFGLA++ +E I + GA+ + + APE +
Sbjct: 123 NYIHRDLAARNVLVGENNICKVADFGLARVI--KEDIYEAREGAKFPIKWTAPEAA--LY 178
Query: 159 GEVSYKSDVYSYGMMVFEM 177
S KSDV+S+G+++ E+
Sbjct: 179 NRFSIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 49/168 (29%), Positives = 89/168 (52%), Gaps = 21/168 (12%)
Query: 21 KLLDGRNVAIKVLNETKGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETN--------- 71
KL+ I +L G C + +I E+ + G+L +F+ + P +
Sbjct: 72 KLIGKHKNIINLL----GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127
Query: 72 -QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130
++L ++ L A +ARG+EYL + R +H D+ N+L+ ED KI+DFGLA+
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGV 184
Query: 131 HGRESIVSMTGARGTVGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEM 177
H + + R V ++APE +F R + +++SDV+S+G++++E+
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRVY---THQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 51/214 (23%)
Query: 9 LGQGGYGGVYKGKL--LDGRN----VAIKVLNETK------------------------- 37
LG+G +G V K + LD N VA+K+L +
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 38 ---GFCFEGHRRALIYEFVSNGSLEKFIYEKHP----------LETNQKLKWEVLYKIAV 84
G C + ++ E+ ++G+L F+ + P + L + L A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 85 GIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARG 144
+ARG+E+L + + +H D+ N+L+ ED KI+DFGLA+ H + T R
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 145 TVGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEM 177
V ++APE +F R + +++SDV+S+G++++E+
Sbjct: 197 PVKWMAPEALFDRVY---THQSDVWSFGVLLWEI 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-13
Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 34/194 (17%)
Query: 8 KLGQGGYGGVYKGKLLDGRNVAIKVLN----ETKGFCFEGH-----------------RR 46
KLG G +G V+ G VA+K L + F E
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 47 ALIY---EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILH 103
IY E++S GSL F+ + + LK L +A +A G+ Y+ R +H
Sbjct: 73 EPIYIVTEYMSKGSLLDFLKDGE----GRALKLPNLVDMAAQVAAGMAYIER---MNYIH 125
Query: 104 FDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSY 163
D++ NIL+ + KI+DFGLA++ E + GA+ + + APE +G +
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTI 182
Query: 164 KSDVYSYGMMVFEM 177
KSDV+S+G+++ E+
Sbjct: 183 KSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-13
Identities = 54/160 (33%), Positives = 74/160 (46%), Gaps = 20/160 (12%)
Query: 21 KLLDGRNVAIKVLNETKGFCFEGHRRA--LIYEFVSNGSLEKFIYEKHPLETNQKLKWEV 78
K L N+ + KG C E + LI E+V GSL ++ KH L Q
Sbjct: 61 KTLYHENIV-----KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQ------ 108
Query: 79 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICHGRESIV 137
L A I G+ YLH + +H D+ N+LLD D KI DFGLAK + G E
Sbjct: 109 LLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 165
Query: 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
V + A E C + SY SDV+S+G+ ++E+
Sbjct: 166 VREDGDSPVFWYAVE--CLKENKFSYASDVWSFGVTLYEL 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-13
Identities = 66/230 (28%), Positives = 99/230 (43%), Gaps = 56/230 (24%)
Query: 7 NKLGQGGYGGVYKGKLLDGRNVAIK------------------------VLNETK----- 37
LG+G YG VY G G+ +A+K +L K
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 38 ---GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
G C + + ++ EFV GS+ + PL V K I G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE------PVFCKYTKQILDGVAYLH 119
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLA-KIC----HGRESIVSMTGARGTVGYI 149
C ++H DIK +N++L + K+ DFG A ++ HG S + + GT ++
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM-LKSMHGTPYWM 175
Query: 150 APEVFCRNFGEVSY--KSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYF 196
APEV E Y KSD++S G VFEM TG A+ +DR + +++
Sbjct: 176 APEV----INESGYGRKSDIWSIGCTVFEMATGKPPLAS--MDRLAAMFY 219
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-13
Identities = 45/130 (34%), Positives = 66/130 (50%), Gaps = 16/130 (12%)
Query: 57 SLEKF---IYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL 113
SL+KF +YE + E+L KIAV + L YL +I+H D+KP NILL
Sbjct: 88 SLDKFYKYVYEV----LKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILL 141
Query: 114 DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSY--KSDVYSYG 171
D + K+ DFG I ++ T G Y+APE + + Y +SDV+S G
Sbjct: 142 DRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERIDPSARD-GYDVRSDVWSLG 197
Query: 172 MMVFEM-TGV 180
+ ++E+ TG
Sbjct: 198 ITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 5e-13
Identities = 41/123 (33%), Positives = 65/123 (52%), Gaps = 9/123 (7%)
Query: 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 116
SL+KF K + + ++L KIAV I + LEYLH ++H D+KP N+L++ +
Sbjct: 85 SLDKFY--KKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRN 140
Query: 117 FCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF--CRNFGEVSYKSDVYSYGMMV 174
K+ DFG++ + +S+ A G Y+APE N KSDV+S G+ +
Sbjct: 141 GQVKLCDFGISG--YLVDSVAKTIDA-GCKPYMAPERINPELNQKGYDVKSDVWSLGITM 197
Query: 175 FEM 177
E+
Sbjct: 198 IEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-13
Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 42/199 (21%)
Query: 8 KLGQGGYGGVYKGKL-LDGRNVAIKVLNETK---------------------------GF 39
++G+G +G V+ G+L D VA+K ET G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 40 CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
C + ++ E V G F+ + P +LK + L ++ A G+EYL
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGP-----RLKVKELIQMVENAAAGMEYLESKH-- 114
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGA--RGTVGYIAPEVFCRN 157
+H D+ N L+ E KISDFG+++ + + + TG + V + APE N
Sbjct: 115 -CIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEAL--N 169
Query: 158 FGEVSYKSDVYSYGMMVFE 176
+G S +SDV+S+G++++E
Sbjct: 170 YGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-13
Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 45/207 (21%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKV------------------------LNETKGFCF- 41
K+G+G + VYK LLDGR VA+K L+ +
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 42 ----EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
E + ++ E G L + I KH + + + ++K V + LE++H
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTIWKYFVQLCSALEHMH--- 123
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVG---YIAPEVF 154
+ RI+H DIKP N+ + K+ D GL GR T A VG Y++PE
Sbjct: 124 SKRIMHRDIKPANVFITATGVVKLGDLGL-----GRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 155 CRNFGEVSYKSDVYSYGMMVFEMTGVK 181
N ++KSD++S G +++EM ++
Sbjct: 179 HEN--GYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-13
Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 46/204 (22%)
Query: 9 LGQGGYGGVYKGKLLDG----RNVAIKVLN------ETKGFCFEG-------HRRAL--- 48
+G+G +G VY G L+D + A+K LN E + F EG H L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 49 ------------IYEFVSNGSLEKFIY-EKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
+ ++ +G L FI E H N +K L + +A+G+EYL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETH----NPTVK--DLIGFGLQVAKGMEYL-- 114
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE--SIVSMTGARGTVGYIAPEV 153
+ + +H D+ N +LDE F K++DFGLA+ + +E S+ + TGA+ V ++A E
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 154 FCRNFGEVSYKSDVYSYGMMVFEM 177
+ + KSDV+S+G++++E+
Sbjct: 174 LQTQ--KFTTKSDVWSFGVLLWEL 195
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-13
Identities = 76/288 (26%), Positives = 125/288 (43%), Gaps = 82/288 (28%)
Query: 5 FKNKLGQGGYGGVYKG-KLLDGRNVAIKVLN---------------------------ET 36
++ LG G G VYK LL R +A+KV+
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 37 KGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
G F +R ++ EF+ GSL+ +Y K P VL +IAV + +GL YL
Sbjct: 65 YGAFFVENRISICTEFMDGGSLD--VYRKIP--------EHVLGRIAVAVVKGLTYL--- 111
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSM-TGARGTVGYIAPEVFC 155
+ +ILH D+KP N+L++ K+ DFG++ + + S+ GT Y+APE
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVS-----TQLVNSIAKTYVGTNAYMAPE--- 163
Query: 156 RNFGE-VSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG--- 211
R GE SDV+S G+ E+ A+ R FP+ +++++ G
Sbjct: 164 RISGEQYGIHSDVWSLGISFMEL---------ALGR-----FPY-----PQIQKNQGSLM 204
Query: 212 ----LQGIENEE-----DKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250
LQ I +E+ +++ K + C++ P +RPA +++
Sbjct: 205 PLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-13
Identities = 72/286 (25%), Positives = 125/286 (43%), Gaps = 63/286 (22%)
Query: 4 SFKNKLGQGGYGGVYKGKLL-DGR--NVAIKVL------NETKGF-------CFEGHR-- 45
F++ +G+G +G V + + DG N AIK+L N+ + F C GH
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 46 ----------RALIY---EFVSNGSLEKFIYEKHPLETN----------QKLKWEVLYKI 82
R +Y E+ G+L F+ + LET+ L + L +
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 83 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGA 142
A +A G++YL + +H D+ N+L+ E+ KI+DFGL++ G E V T
Sbjct: 125 ASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMG 178
Query: 143 RGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYK 202
R V ++A E N+ + KSDV+S+G++++E+ + P+
Sbjct: 179 RLPVRWMAIESL--NYSVYTTKSDVWSFGVLLWEIVSLGGT-------------PYCGMT 223
Query: 203 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRV 248
EL E L QG E+ + ++ + C ++ P +RP ++
Sbjct: 224 CAELYEKLP-QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 9e-13
Identities = 64/209 (30%), Positives = 89/209 (42%), Gaps = 50/209 (23%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIK--------------VLNETKGFCFEGHRRAL----- 48
+G G +G V+ DG+ VA+K V E K CF H L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 49 -----------IYEFVS--NGSLEKFIYEKHPLETNQ-KLKWEVLYKIAVGIARGLEYLH 94
IY L K I PL ++ K+ LY+I RGL+YLH
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKV---FLYQIL----RGLKYLH 120
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF 154
+ ILH DIKP N+L++ + KI DFGLA++ ES MT T Y APE+
Sbjct: 121 ---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-KHMTQEVVTQYYRAPEIL 176
Query: 155 --CRNFGEVSYKSDVYSYGMMVFEMTGVK 181
R++ D++S G + E+ G +
Sbjct: 177 MGSRHYTS---AVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 60/221 (27%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRN------VAIKVLNET---------------------- 36
K +LG+G +G V+ G+ VA+K L ET
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 37 -----KGFCFEGHRRALIYEFVSNGSLEKFI--------YEKHPLETNQKLKWEVLYKIA 83
G C EG +++E++ +G L KF+ + K P +L L +IA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 84 VGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR 143
V IA G+ YL + +H D+ N L+ D KI DFG+++ + + R
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR------DVYTTDYYR 179
Query: 144 --GT----VGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEM 177
G + ++ PE + R F + +SDV+S+G++++E+
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKF---TTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-12
Identities = 65/210 (30%), Positives = 85/210 (40%), Gaps = 52/210 (24%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVLN------ETKGFC--FEG---------HRRALIY 50
LGQG +G VY +D GR +A+K + ETK E H R + Y
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 51 --------------EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
E++ GS++ + L V K I G+EYLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTET------VTRKYTRQILEGVEYLHS- 122
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAK----ICHGRESIVSMTGARGTVGYIAPE 152
I+H DIK NIL D K+ DFG +K IC S M GT +++PE
Sbjct: 123 --NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC---SSGTGMKSVTGTPYWMSPE 177
Query: 153 VFCRNFGE-VSYKSDVYSYGMMVFEMTGVK 181
V GE K+DV+S G V EM K
Sbjct: 178 VIS---GEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 68/295 (23%), Positives = 110/295 (37%), Gaps = 82/295 (27%)
Query: 9 LGQGGYGGVYKGKLLD------GRNVAIKVLNET----------------KGF------- 39
LGQG +G VY+G VAIK +NE K F
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 40 ----CFEGHRRALIYEFVSNGSLEKFIYEKHPLETN----QKLKWEVLYKIAVGIARGLE 91
G ++ E ++ G L+ ++ + P N + ++A IA G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAP 151
YL + +H D+ N ++ ED KI DFG+ + + + V ++AP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211
E G + KSDV+S+G++++EM A +A +
Sbjct: 191 ESL--KDGVFTTKSDVWSFGVVLWEM------ATLA---------------------EQP 221
Query: 212 LQGIENEE------DKEYAR-------KMILVSLWCIQNNPSDRPAMNRVVEMLE 253
QG+ NEE D + K++ + C Q NP RP +V L+
Sbjct: 222 YQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 2e-12
Identities = 37/102 (36%), Positives = 54/102 (52%), Gaps = 12/102 (11%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI-CHGRESIVSMTGAR- 143
I LEYLH I+H D+KP NIL+D + K++DFGL+K+ R+ ++
Sbjct: 102 IVLALEYLHS-NG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158
Query: 144 ----GTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGV 180
GT YIAPEV G S D +S G +++E + G+
Sbjct: 159 KRIVGTPDYIAPEVI-LGQGH-SKTVDWWSLGCILYEFLVGI 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 42/98 (42%), Positives = 61/98 (62%), Gaps = 14/98 (14%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR-- 143
+A L++LH + I++ D+KP NILLDE+ K++DFGL+K ESI A
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-----ESIDHEKKAYSF 158
Query: 144 -GTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TG 179
GTV Y+APEV R G + +D +S+G+++FEM TG
Sbjct: 159 CGTVEYMAPEVVNRR-GH-TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 61/215 (28%), Positives = 88/215 (40%), Gaps = 66/215 (30%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKV--LNETKGF------------C--------- 40
++G G YG VYK + + G VAIKV L F C
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 41 ---FEGHRRALIYEFVSNGSLEKFIYEK--HPLETNQKLKWEVLYKIAVGIA-------R 88
+ ++ E+ GSL+ IY+ PL Q IA +
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQ-------------IAYVCRETLK 112
Query: 89 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL-AKICHG---RESIVSMTGARG 144
GL YLH T +H DIK NILL ED K++DFG+ A++ R+S + G
Sbjct: 113 GLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI------G 163
Query: 145 TVGYIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM 177
T ++APEV + Y K D+++ G+ E+
Sbjct: 164 TPYWMAPEVAAVE-RKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107
LI+E++ +L + + + L WE KIA+GIA+ L +LH C+ ++ ++
Sbjct: 760 LIHEYIEGKNLSEVL---------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLS 810
Query: 108 PHNILLDEDFCPKISDFGLAKICHGRESIVSM-TGARGTVGYIAPEVFCRNFGEVSYKSD 166
P I++D P + ++ T + Y+APE R +++ KSD
Sbjct: 811 PEKIIIDGKDEP--------HLRLSLPGLLCTDTKCFISSAYVAPET--RETKDITEKSD 860
Query: 167 VYSYGMMVFEMTGVKNNANVAVD-RSSEIYFPHWVYKRLELEE--DLGLQGIENEEDKEY 223
+Y +G+++ E+ K+ A+ S + + + Y L+ D ++G + E
Sbjct: 861 IYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEI 920
Query: 224 ARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258
M L +L C +P+ RP N V++ LE + S
Sbjct: 921 VEVMNL-ALHCTATDPTARPCANDVLKTLESASRS 954
|
Length = 968 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 79/292 (27%), Positives = 119/292 (40%), Gaps = 79/292 (27%)
Query: 5 FKNKLGQGGYGGVYKGKLLD-GRNVAIKVLN-------------ETKG------------ 38
+G G VY L VAIK ++ E +
Sbjct: 5 LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY 64
Query: 39 FC--FEGHRRALIYEFVSNGSLEKFIYEKHPLETNQK------LKWEVLYKIAVGIARGL 90
+ G L+ ++S GSL + +P + LK EVL +GL
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK-EVL--------KGL 115
Query: 91 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL-AKICHG-------RESIVSMTGA 142
EYLH N +I H DIK NILL ED KI+DFG+ A + G R++ V
Sbjct: 116 EYLHS--NGQI-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV----- 167
Query: 143 RGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVY 201
GT ++APEV + G +K+D++S+G+ E+ TG + Y P V
Sbjct: 168 -GTPCWMAPEVMEQVHG-YDFKADIWSFGITAIELATGAAPYSK---------YPPMKVL 216
Query: 202 KRLELEEDLGLQGIENEEDKEYA---RKMILVSLWCIQNNPSDRPAMNRVVE 250
+ L+ + K+Y+ RKMI + C+Q +PS RP +++
Sbjct: 217 MLTLQNDPPSLE--TGADYKKYSKSFRKMISL---CLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 64/201 (31%), Positives = 89/201 (44%), Gaps = 41/201 (20%)
Query: 9 LGQGGYGGVYKGKL-LDGRNVAIKVLNETKGFCFEGH-RRA-----------------LI 49
+G G YG V GR VAIK L+ F H +R L+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRP--FQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 50 YEFVSNGSLEKF--IYEKHPL---ETNQKLKWEVLYK-----IAVGIARGLEYLHRGCNT 99
F SLE F +Y L + N +K + L + I RGL+Y+H +
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH---SA 137
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFG 159
I+H D+KP NI ++ED KI DFGLA R + MTG T Y APE+ N+
Sbjct: 138 GIIHRDLKPSNIAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRAPEIML-NWM 191
Query: 160 EVSYKSDVYSYGMMVFEM-TG 179
+ D++S G ++ E+ TG
Sbjct: 192 HYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-12
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 48/216 (22%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRN------VAIKVLNETK--------------------- 37
F +LG+G +G VYKG+L VAIK L E
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 38 ------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPL----------ETNQKLKWEVLYK 81
G C + +++E++++G L +F+ P L
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 82 IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTG 141
IA+ IA G+EYL + +H D+ N L+ E KISDFGL++ + + +
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 142 ARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
+ V ++ PE +G+ + +SD++S+G++++E+
Sbjct: 186 SLLPVRWMPPEAIL--YGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-12
Identities = 41/98 (41%), Positives = 54/98 (55%), Gaps = 13/98 (13%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR-- 143
I +GL YLH N I+H DIK NIL+D KISDFG++K GAR
Sbjct: 115 ILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171
Query: 144 --GTVGYIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM 177
G+V ++APEV + SY K+D++S G +V EM
Sbjct: 172 LQGSVFWMAPEV----VKQTSYTRKADIWSLGCLVVEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-12
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 47/203 (23%)
Query: 9 LGQGGYGGVYKGKLL-DGRN----VAIKVLNETK-------------------------- 37
LG G +G VYKG + DG N VAIKVL E
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 38 -GFCFEGHRRALIYEFVSNGSLEKFIYE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
G C + L+ + + G L ++ E K + + L W V IA+G+ YL
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE- 126
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPE-VF 154
R++H D+ N+L+ KI+DFGLA++ E+ G + + ++A E +
Sbjct: 127 --EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 155 CRNFGEVSYKSDVYSYGMMVFEM 177
R F +++SDV+SYG+ V+E+
Sbjct: 185 HRRF---THQSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 8e-12
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 60/210 (28%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVL---NETKG------------------------- 38
K+G+G YG VYK + L G VA+K + E +G
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
++ L++EF+ + L+K++ + P L ++ + +G+ Y H +
Sbjct: 66 VVHSENKLYLVFEFL-DLDLKKYM-DSSP---LTGLDPPLIKSYLYQLLQGIAYCH---S 117
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKI--------CHGRESIVSMTGARGTVGYIA 150
R+LH D+KP N+L+D + K++DFGLA+ H +V T+ Y A
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-------TLWYRA 167
Query: 151 PEVFCRNFGEVSYKS--DVYSYGMMVFEMT 178
PE+ G Y + D++S G + EM
Sbjct: 168 PEIL---LGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-12
Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 38 GFCFEGHRR------ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLE 91
G C + +I F+ +G L F+ + Q L ++L K IA G+E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAP 151
YL + +H D+ N +L+E+ ++DFGL+K + + A+ V +IA
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211
E + KSDV+S+G+ ++E+ V+ +SEIY RL+ D
Sbjct: 184 ESLADRV--YTTKSDVWSFGVTMWEIATRGQTPYPGVE-NSEIYDYLRQGNRLKQPPDC- 239
Query: 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256
L G+ Y+ ++ S W NP DRP+ + LE +L
Sbjct: 240 LDGL-------YS---LMSSCW--LLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 49/130 (37%), Positives = 71/130 (54%), Gaps = 12/130 (9%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107
L+ ++ G L+ IY H E + V Y A I GLE LH+ RI++ D+K
Sbjct: 77 LVLTLMNGGDLKFHIY--HMGEAGFEEGRAVFY--AAEICCGLEDLHQ---ERIVYRDLK 129
Query: 108 PHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDV 167
P NILLD+ +ISD GLA H E ++ G GTVGY+APEV +N ++ D
Sbjct: 130 PENILLDDHGHIRISDLGLA--VHVPEG-QTIKGRVGTVGYMAPEV-VKN-ERYTFSPDW 184
Query: 168 YSYGMMVFEM 177
++ G +++EM
Sbjct: 185 WALGCLLYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 48/211 (22%)
Query: 7 NKLGQGGYGGVYKGKL--LDGRN----VAIKVLNETK----------------------- 37
LG G +G VY+G DG VA+K L E+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 38 ----GFCFEGHRRALIYEFVSNGSLEKFIYEKHP-LETNQKLKWEVLYKIAVGIARGLEY 92
G FE R ++ E ++ G L+ F+ E P E L + L A +A+G +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCP------KISDFGLAKICHGRESIVSMTGARGTV 146
L +H DI N LL C KI+DFG+A+ + A +
Sbjct: 132 LE---ENHFIHRDIAARNCLLT---CKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 147 GYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
++ PE F G + K+DV+S+G++++E+
Sbjct: 186 KWMPPEAFLD--GIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 40/96 (41%), Positives = 55/96 (57%), Gaps = 10/96 (10%)
Query: 83 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA-KICHGRESIVSMTG 141
A I GLE LHR RI++ D+KP NILLD+ +ISD GLA +I G ++ G
Sbjct: 108 AAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----TIRG 160
Query: 142 ARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
GTVGY+APEV ++ D + G +++EM
Sbjct: 161 RVGTVGYMAPEVV--KNERYTFSPDWWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 49/206 (23%), Positives = 96/206 (46%), Gaps = 34/206 (16%)
Query: 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHN 110
E+ + G+L I + +++ L++I ++ Y+H+ ILH DIK N
Sbjct: 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS----YIHK---AGILHRDIKTLN 131
Query: 111 ILLDEDFCPKISDFGLAKIC----HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSD 166
I L + K+ DFG++KI E++V GT Y++PE+ C+ + ++KSD
Sbjct: 132 IFLTKAGLIKLGDFGISKILGSEYSMAETVV------GTPYYMSPEL-CQGV-KYNFKSD 183
Query: 167 VYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 226
+++ G +++E+ +K D ++ L L + +QG Y+ +
Sbjct: 184 IWALGCVLYELLTLKR----TFDATNP----------LNLVVKI-VQGNYTPVVSVYSSE 228
Query: 227 MILVSLWCIQNNPSDRPAMNRVVEML 252
+I + +Q +P RP + V++
Sbjct: 229 LISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 52/203 (25%)
Query: 8 KLGQGGYGGVYKGKLLD-GRNVAIKVLN-------------E------------TKGF-C 40
+G+G +G VYK + VAIKV++ E TK +
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 41 F-EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
F +G + +I E+ GS + KL + I + GLEYLH
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKP-------GKLDETYIAFILREVLLGLEYLHEE--- 117
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR-----GTVGYIAPEVF 154
+H DIK NILL E+ K++DFG++ ++ T ++ GT ++APEV
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVS-------GQLTSTMSKRNTFVGTPFWMAPEVI 170
Query: 155 CRNFGEVSYKSDVYSYGMMVFEM 177
+ K+D++S G+ E+
Sbjct: 171 KQ--SGYDEKADIWSLGITAIEL 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 53/205 (25%)
Query: 8 KLGQGGYGGVYKGKLLD-GRNVAIKV-------------LNETKGF-----------CFE 42
+LG G +G VY + + G VAIK L E K E
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 43 GHRRA----LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR-GC 97
R ++E++ G+L + + ++ + V+ I I +GL ++H+ G
Sbjct: 66 VFRENDELYFVFEYM-EGNLYQLMKDR----KGKPFSESVIRSIIYQILQGLAHIHKHG- 119
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSM---TGARGTVGYIAPEVF 154
H D+KP N+L+ KI+DFGLA RE I S T T Y APE+
Sbjct: 120 ---FFHRDLKPENLLVSGPEVVKIADFGLA-----RE-IRSRPPYTDYVSTRWYRAPEIL 170
Query: 155 CRNFGEVSYKS--DVYSYGMMVFEM 177
R+ SY S D+++ G ++ E+
Sbjct: 171 LRS---TSYSSPVDIWALGCIMAEL 192
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 39/125 (31%), Positives = 63/125 (50%), Gaps = 14/125 (11%)
Query: 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 117
L I+ PL T + +++ LY++ RGL+Y+H ++H D+KP N+L++ED
Sbjct: 94 LHHIIHSDQPL-TEEHIRY-FLYQLL----RGLKYIHSAN---VIHRDLKPSNLLVNEDC 144
Query: 118 CPKISDFGLAKICHGRESIVS---MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMV 174
+I DFG+A+ MT T Y APE+ + E + D++S G +
Sbjct: 145 ELRIGDFGMAR-GLSSSPTEHKYFMTEYVATRWYRAPELLL-SLPEYTTAIDMWSVGCIF 202
Query: 175 FEMTG 179
EM G
Sbjct: 203 AEMLG 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 47/201 (23%), Positives = 82/201 (40%), Gaps = 44/201 (21%)
Query: 8 KLGQGGYGGVYKGKLLD-GRNVAIKVLNETKGF-----------CF-------------- 41
++G+G +G V+K K + G VA+K + +
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 42 ---EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
G L+ E++ + E E+ PL ++K + +G+ Y+H
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVLRDEERPL-PEAQVK-----SYMRMLLKGVAYMH---A 117
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
I+H D+KP N+L+ D KI+DFGLA++ E + T Y APE+ +
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELL---Y 173
Query: 159 GEVSYKS--DVYSYGMMVFEM 177
G Y D+++ G + E+
Sbjct: 174 GARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-11
Identities = 52/191 (27%), Positives = 74/191 (38%), Gaps = 49/191 (25%)
Query: 78 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICHGRESI 136
L AV IA G+ YL + R +H D+ NILL D KI DFGL + + +
Sbjct: 98 TLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154
Query: 137 VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF 196
V + + APE S+ SDV+ +G+ ++EM F
Sbjct: 155 VMEEHLKVPFAWCAPE--SLRTRTFSHASDVWMFGVTLWEM------------------F 194
Query: 197 PH----WVYKRLELEEDLGLQGIENEE--DKEYAR---------KMILVSLWCIQNNPSD 241
+ W GL G + + DKE R + V L C +NP+D
Sbjct: 195 TYGEEPWA----------GLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPAD 244
Query: 242 RPAMNRVVEML 252
RP + E L
Sbjct: 245 RPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-11
Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 63/285 (22%)
Query: 9 LGQGGYGGVYKGKLL-DG--RNVAIKVLNETKG-------------FCFEGHR------- 45
+G+G +G V K ++ DG + AIK + E C GH
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 46 -----RALIY---EFVSNGSLEKFIYEKHPLETN----------QKLKWEVLYKIAVGIA 87
R +Y E+ +G+L F+ + LET+ L + L A +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 88 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVG 147
RG++YL + + +H D+ NIL+ E++ KI+DFGL++ G+E V T R V
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176
Query: 148 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207
++A E N+ + SDV+SYG++++E+ + P+ EL
Sbjct: 177 WMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGT-------------PYCGMTCAELY 221
Query: 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252
E L QG E+ ++ + C + P +RP+ +++ L
Sbjct: 222 EKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-11
Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 44/201 (21%)
Query: 8 KLGQGGYGGVYKG--KLLDG-RNVAIKVL-NETK-------------------------- 37
+LG G +G V KG K+ + VA+K+L N+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 38 -GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
G C E L+ E G L KF L+ N+ + + + ++ ++ G++YL
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKF------LQKNKHVTEKNITELVHQVSMGMKYLEE- 113
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV-SMTGARGTVGYIAPEVFC 155
T +H D+ N+LL KISDFGL+K E+ + T + V + APE C
Sbjct: 114 --TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE--C 169
Query: 156 RNFGEVSYKSDVYSYGMMVFE 176
N+ + S KSDV+S+G++++E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-11
Identities = 69/279 (24%), Positives = 110/279 (39%), Gaps = 86/279 (30%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIKVLN------------------------------ETK 37
+G+G YG VY+GK + GR VA+K++N +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 38 GFCFEGHRRALIYEFVSNGSLEKF-----IYEKHPLETNQKLKWEVLYKIAVGIAR---- 88
G +G R +I E+ GS+ I EK+ I+V I R
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKY---------------ISV-IIREVLV 112
Query: 89 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR----G 144
L+Y+H+ ++H DIK NIL+ K+ DFG+A + + R G
Sbjct: 113 ALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAA------LLNQNSSKRSTFVG 163
Query: 145 TVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKR 203
T ++APEV K+D++S G+ ++EM TG ++V R+ + P R
Sbjct: 164 TPYWMAPEVI-TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-IPKSKPPR 221
Query: 204 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDR 242
L ED Y++ + C+ P +R
Sbjct: 222 L--------------EDNGYSKLLREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-11
Identities = 46/128 (35%), Positives = 69/128 (53%), Gaps = 16/128 (12%)
Query: 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHN 110
EF+ GSL++ + P+ E+L KIAV + GL YL+ RI+H DIKP N
Sbjct: 83 EFMDCGSLDRIYKKGGPIPV------EILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSN 134
Query: 111 ILLDEDFCPKISDFGLAKICHGRESIVSMTGA-RGTVGYIAPEVFCRNFGEVSYKSDVYS 169
IL++ K+ DFG++ E I S+ GT Y++PE G+ + KSDV+S
Sbjct: 135 ILVNSRGQIKLCDFGVSG-----ELINSIADTFVGTSTYMSPERI--QGGKYTVKSDVWS 187
Query: 170 YGMMVFEM 177
G+ + E+
Sbjct: 188 LGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-11
Identities = 52/172 (30%), Positives = 87/172 (50%), Gaps = 28/172 (16%)
Query: 86 IARGLEYL-HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARG 144
+ARG+E+L R C +H D+ NILL E+ KI DFGLA+ + V AR
Sbjct: 182 VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237
Query: 145 TVGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKR 203
+ ++APE +F + + + +SDV+S+G++++E+ + + Y
Sbjct: 238 PLKWMAPESIFDKVY---TTQSDVWSFGVLLWEIFSLGASP----------------YPG 278
Query: 204 LELEEDL--GLQGIENEEDKEYARKMIL-VSLWCIQNNPSDRPAMNRVVEML 252
++++E+ L+ EYA I + L C NNP DRP + +VE+L
Sbjct: 279 VQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-11
Identities = 44/128 (34%), Positives = 66/128 (51%), Gaps = 14/128 (10%)
Query: 68 LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127
L NQ ++W V IA L+YLH ILH D+K N+ L K+ D G+A
Sbjct: 99 LPENQVVEW------FVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIA 149
Query: 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVA 187
++ + + S GT Y++PE+F +YKSDV++ G V+EM +K+ N A
Sbjct: 150 RVLENQCDMASTL--IGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFN-A 204
Query: 188 VDRSSEIY 195
D +S +Y
Sbjct: 205 KDMNSLVY 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 39/114 (34%), Positives = 62/114 (54%), Gaps = 13/114 (11%)
Query: 66 HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 125
H L T++ L+ + + I RGL+Y+H + ++H D+KP NIL++E+ KI DFG
Sbjct: 97 HRLLTSRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFG 153
Query: 126 LAKICHGRESIVSMTGARGTVGYIAPEVFC--RNFGEVSYKSDVYSYGMMVFEM 177
LA+I + MTG T Y APE+ + + + D++S G + EM
Sbjct: 154 LARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDV---EVDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 48/207 (23%)
Query: 6 KNKLGQGGYGGVYKGK-LLDGRNVAIKVLN--ETKGFCFEGHRRAL-------------- 48
+ +G+G YG V G VAIK ++ E + FC +R L
Sbjct: 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFC----QRTLREIKILRRFKHENI 65
Query: 49 --IYEFVSNGSLEKF--IY--------EKHPLETNQKLKWE----VLYKIAVGIARGLEY 92
I + + S E F +Y + + L Q L + LY+I RGL+Y
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQIL----RGLKY 121
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS--MTGARGTVGYIA 150
+H N +LH D+KP N+LL+ + KI DFGLA+I E + +T T Y A
Sbjct: 122 IH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARI-ADPEHDHTGFLTEYVATRWYRA 177
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVFEM 177
PE+ N + D++S G ++ EM
Sbjct: 178 PEIML-NSKGYTKAIDIWSVGCILAEM 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 6e-11
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 41/206 (19%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIK---VLNETKGFCFEGHRRALIYEFVS-------- 54
K+GQG +G V+K + + VA+K + NE +GF R I + +
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 55 ----------NGSLEKF--IYE--KHPL-----ETNQKLKWEVLYKIAVGIARGLEYLHR 95
N F ++E +H L N K + K+ + GL Y+HR
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR 137
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE--SIVSMTGARGTVGYIAPEV 153
+ILH D+K NIL+ +D K++DFGLA+ + T T+ Y PE+
Sbjct: 138 ---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPEL 194
Query: 154 F--CRNFGEVSYKSDVYSYGMMVFEM 177
R++G D++ G ++ EM
Sbjct: 195 LLGERDYGP---PIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-11
Identities = 48/131 (36%), Positives = 65/131 (49%), Gaps = 14/131 (10%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107
L+ ++ G L+ IY N + E A I GLE LHR ++ D+K
Sbjct: 77 LVLTIMNGGDLKFHIYNM----GNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLK 129
Query: 108 PHNILLDEDFCPKISDFGLA-KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSD 166
P NILLD+ +ISD GLA KI G S+ G GTVGY+APEV N + D
Sbjct: 130 PENILLDDYGHIRISDLGLAVKIPEGE----SIRGRVGTVGYMAPEVL--NNQRYTLSPD 183
Query: 167 VYSYGMMVFEM 177
+ G +++EM
Sbjct: 184 YWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 8e-11
Identities = 71/291 (24%), Positives = 124/291 (42%), Gaps = 66/291 (22%)
Query: 8 KLGQGGYGGVYKGKLLD------GRNVAIKVLNET----------------KGF-CF--- 41
+LGQG +G VY+G D VA+K +NE+ KGF C
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 42 -------EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLK----WEVLYKIAVGIARGL 90
+G ++ E +++G L+ ++ P N + + + ++A IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 91 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARG--TVGY 148
YL+ + +H D+ N ++ DF KI DFG+ + + E+ G +G V +
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRW 187
Query: 149 IAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEE 208
+APE G + SD++S+G++++E+T + Y+ L E+
Sbjct: 188 MAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQP----------------YQGLSNEQ 229
Query: 209 DLGL---QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256
L G ++ D R L+ + C Q NP RP +V +L+ L
Sbjct: 230 VLKFVMDGGYLDQPDNCPERVTDLMRM-CWQFNPKMRPTFLEIVNLLKDDL 279
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 8e-11
Identities = 61/206 (29%), Positives = 90/206 (43%), Gaps = 45/206 (21%)
Query: 9 LGQGGYGGVY------KGKLLDGRNVAIKVLNETKGFCFEG-----------HRR---AL 48
LG+GG+G V GKL + + K L + KG+ EG H R +L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGY--EGAMVEKRILAKVHSRFIVSL 58
Query: 49 IYEF------------VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
Y F ++ G L IY E N I GLE+LH+
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVD--EENPGFPEPRACFYTAQIISGLEHLHQ- 115
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLA-KICHGRESIVSMTGARGTVGYIAPEVFC 155
RI++ D+KP N+LLD D +ISD GLA ++ G+ G GT G++APE+
Sbjct: 116 --RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS---KTKGYAGTPGFMAPELLQ 170
Query: 156 RNFGEVSYKSDVYSYGMMVFEMTGVK 181
E + D ++ G+ ++EM +
Sbjct: 171 GE--EYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 47/203 (23%)
Query: 9 LGQGGYGGVYKGKLL-DGRN----VAIKVLNETK-------------------------- 37
LG G +G VYKG + +G VAIK L E
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 38 -GFCFEGHRRALIYEFVSNGSLEKFIYE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
G C + LI + + G L ++ E K + + L W V IA+G+ YL
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 126
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPE-VF 154
R++H D+ N+L+ KI+DFGLAK+ E G + + ++A E +
Sbjct: 127 --ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 155 CRNFGEVSYKSDVYSYGMMVFEM 177
R + +++SDV+SYG+ V+E+
Sbjct: 185 HRIY---THQSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-10
Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 39/198 (19%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVLNETKGFCFEGHRRAL----IYEFVSNGSLEKFIY 63
+G+GG+G VY + D G+ A+K L++ + +G AL + VS G +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 64 EKHPLETNQKLKW--------EVLYKI--------------AVGIARGLEYLHRGCNTRI 101
+ T KL + ++ Y + A I GLE++H N +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH---NRFV 118
Query: 102 LHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEV 161
++ D+KP NILLDE +ISD GLA ++ S+ GT GY+APEV + V
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKG---V 171
Query: 162 SYKS--DVYSYGMMVFEM 177
+Y S D +S G M+F++
Sbjct: 172 AYDSSADWFSLGCMLFKL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 1e-10
Identities = 44/132 (33%), Positives = 68/132 (51%), Gaps = 20/132 (15%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107
L+ E+V G L F + L + + V A + LEYLH + I++ D+K
Sbjct: 78 LVMEYVPGGEL--FSH----LRKSGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLK 128
Query: 108 PHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF-CRNFGEVSYKS- 165
P N+LLD D KI+DFG AK GR + GT Y+APE+ + +G K+
Sbjct: 129 PENLLLDSDGYIKITDFGFAKRVKGRTYTLC-----GTPEYLAPEIILSKGYG----KAV 179
Query: 166 DVYSYGMMVFEM 177
D ++ G++++EM
Sbjct: 180 DWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 44/144 (30%), Positives = 74/144 (51%), Gaps = 13/144 (9%)
Query: 37 KGFCFEGHRRA--LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
KG C+ RR L+ E++ GSL ++ +KH ++L L A I +G+EYL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKH----RERLDHRKLLLYASQICKGMEYLG 125
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC-HGRESIVSMTGARGTVGYIAPEV 153
+ R +H D+ NIL++ + KI DFGL K+ +E + + APE
Sbjct: 126 ---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPES 182
Query: 154 FCRNFGEVSYKSDVYSYGMMVFEM 177
+ + S SDV+S+G++++E+
Sbjct: 183 LTES--KFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-10
Identities = 38/131 (29%), Positives = 73/131 (55%), Gaps = 11/131 (8%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107
++ E++ NGSL+ F+ KH + + L + GIA G++YL + +H D+
Sbjct: 82 IVTEYMENGSLDAFL-RKH----DGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLA 133
Query: 108 PHNILLDEDFCPKISDFGLAKICHGR-ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSD 166
NIL++ + K+SDFGL+++ E+ + G + + + APE + + + SD
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA--YRKFTSASD 191
Query: 167 VYSYGMMVFEM 177
V+SYG++++E+
Sbjct: 192 VWSYGIVMWEV 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-10
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 50/206 (24%)
Query: 9 LGQGGYGGVYKGKL-LDGRN---VAIKVLNETKGFCFEGHRR------------------ 46
+G G +G V +G+L L G+ VAIK L K E RR
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTL---KSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 47 ------------ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
+I EF+ NG+L+ F+ + T +L + GIA G++YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-----VGMLRGIAAGMKYL- 122
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARG---TVGYIAP 151
+H D+ NIL++ + K+SDFGL++ S + T + G + + AP
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEM 177
E + + + SDV+SYG++++E+
Sbjct: 181 EAIA--YRKFTSASDVWSYGIVMWEV 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 48/203 (23%)
Query: 8 KLGQGGYGGVYKG------KLLDGRNVAIKVL--NETK---------------------- 37
+LG G +G V KG K +D VAIKVL K
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQID---VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 38 ---GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
G C E L+ E S G L KF+ K T + E+++++++G ++YL
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVV-ELMHQVSMG----MKYLE 112
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV-SMTGARGTVGYIAPEV 153
+H D+ N+LL KISDFGL+K +S + + + + + APE
Sbjct: 113 ---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE- 168
Query: 154 FCRNFGEVSYKSDVYSYGMMVFE 176
C NF + S +SDV+SYG+ ++E
Sbjct: 169 -CINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 43/136 (31%), Positives = 71/136 (52%), Gaps = 26/136 (19%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107
++ EF+ G+L + T+ ++ E + + + + + L +LH ++H DIK
Sbjct: 93 VVMEFLEGGALTDIV-------THTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIK 142
Query: 108 PHNILLDEDFCPKISDFG----LAKICHGRESIVSMTGARGTVGYIAPEVFCRN-FG-EV 161
+ILL D K+SDFG ++K R+S+V GT ++APEV R +G EV
Sbjct: 143 SDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPEVISRLPYGTEV 196
Query: 162 SYKSDVYSYGMMVFEM 177
D++S G+MV EM
Sbjct: 197 ----DIWSLGIMVIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-10
Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 42/201 (20%)
Query: 9 LGQGGYGGVYKGKL-LDGRN---VAIKVLN------ETKGFCFEG-------HRR----- 46
+G G +G V++G L + GR VAIK L + + F E H
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 47 ---------ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
+I E++ NG+L+K++ + + + L + GIA G++YL
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDH-----DGEFSSYQLVGMLRGIAAGMKYL---S 124
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR-ESIVSMTGARGTVGYIAPEVFCR 156
+ +H D+ NIL++ + K+SDFGL+++ E + +G + + + APE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI-- 182
Query: 157 NFGEVSYKSDVYSYGMMVFEM 177
+ + + SDV+S+G++++E+
Sbjct: 183 AYRKFTSASDVWSFGIVMWEV 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 46/159 (28%), Positives = 66/159 (41%), Gaps = 40/159 (25%)
Query: 8 KLGQGGYGGVYKG-KLLDGRNVAIK---VLNETKGFCFEGHRRALIYEFVSNGS---LEK 60
KLG+G +G VYK ++ GR VA+K + NE GF R I + + + + L
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLID 74
Query: 61 FIYEKHPLETNQKLKWEVLYKIA-------VG--------------------IARGLEYL 93
E+ ++ +Y + G + G+ YL
Sbjct: 75 MAVERPDKSKRKRG---SVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYL 131
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132
H N ILH DIK NIL+D KI+DFGLA+ G
Sbjct: 132 H--EN-HILHRDIKAANILIDNQGILKIADFGLARPYDG 167
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 46/202 (22%)
Query: 9 LGQGGYGGVYK-------------------GKLLDGRNVAIKVLNETK---------GFC 40
LG G +G VYK + L+ V I +L+E K +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 41 FEGHRRALIYEFVSNGSLEKFIYE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
+E LI EF G+L+ + E + L Q + + + L +LH +
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLELERGLTEPQ------IRYVCRQMLEALNFLH---SH 122
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGL-AKICHGRESIVSMTGARGTVGYIAPEVF-CRN 157
+++H D+K NILL D K++DFG+ AK + + GT ++APEV C
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPYWMAPEVVACET 179
Query: 158 FGEVSY--KSDVYSYGMMVFEM 177
F + Y K+D++S G+ + E+
Sbjct: 180 FKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 55/209 (26%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKV--LNETKGFCFEGHRRA----------------- 47
KLG+G Y VYKG+ L G+ VA+K L +G F R A
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 48 --------LIYEFVSNGSLEKFIYEKHP---LETNQKLKWEVLYKIAVGIARGLEYLHRG 96
L++E++ L++++ + N +L L++ + RGL Y H+
Sbjct: 72 IHTKKTLTLVFEYLDT-DLKQYM-DDCGGGLSMHNVRL---FLFQ----LLRGLAYCHQ- 121
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARG--TVGYIAPEVF 154
R+LH D+KP N+L+ E K++DFGLA+ +S+ S T + T+ Y P+V
Sbjct: 122 --RRVLHRDLKPQNLLISERGELKLADFGLARA----KSVPSKTYSNEVVTLWYRPPDVL 175
Query: 155 CRNFGEVSYKS--DVYSYGMMVFEM-TGV 180
G Y + D++ G + +EM TG
Sbjct: 176 ---LGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-10
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 48/214 (22%)
Query: 48 LIYEFVSNGSLEKFIYEKH--PLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFD 105
++ ++ G L K I + +Q L W V I L+++H + +ILH D
Sbjct: 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKHVH---DRKILHRD 126
Query: 106 IKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR---GTVGYIAPEVFCRNFGEVS 162
IK NI L +D K+ DFG+A++ + ++ AR GT Y++PE+ C N +
Sbjct: 127 IKSQNIFLTKDGTIKLGDFGIARVLNS-----TVELARTCIGTPYYLSPEI-CEN-RPYN 179
Query: 163 YKSDVYSYGMMVFEMTGVK------NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216
KSD+++ G +++EM +K N N+ + Y P + +L
Sbjct: 180 NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDL---------- 229
Query: 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250
+ ++ L+ + NP DRP++N ++E
Sbjct: 230 ---------RNLVSQLF--KRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 49/204 (24%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVL---NETKGF------------------------ 39
K+G+G YG VYKG+ G+ VA+K + +E +G
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 40 -CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
+ R LI+EF+S L+K++ L Q + E++ I +G+ + H
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYL---DSLPKGQYMDAELVKSYLYQILQGILFCHS--- 119
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAK---ICHGRESIVSMTGARGTVGYIAPEVFC 155
R+LH D+KP N+L+D K++DFGLA+ I + T T+ Y APEV
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-----PVRVYTHEVVTLWYRAPEVL- 173
Query: 156 RNFGEVSYKS--DVYSYGMMVFEM 177
G Y + D++S G + EM
Sbjct: 174 --LGSPRYSTPVDIWSIGTIFAEM 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-10
Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 50/203 (24%)
Query: 8 KLGQGGYGGVYKG-KLLDGRNVAIKV--LNETKGFCFEGHRRA------------LIYEF 52
KLG+G Y VYKG ++G+ VA+KV + +G F R A L+++
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 53 VSNGSLEKFIYE-----------KHP---LETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
+ F++E +HP N +L + RGL Y+H
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-------FMFQLLRGLAYIHG--- 121
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARG--TVGYIAPEVFCR 156
ILH D+KP N+L+ K++DFGLA+ +SI S T + T+ Y P+V
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLAR----AKSIPSQTYSSEVVTLWYRPPDVL-- 175
Query: 157 NFGEVSYKS--DVYSYGMMVFEM 177
G Y S D++ G + EM
Sbjct: 176 -LGATDYSSALDIWGAGCIFIEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 55/205 (26%), Positives = 85/205 (41%), Gaps = 53/205 (25%)
Query: 8 KLGQGGYGGVYKGKLLD-GRNVAIKVLNETKG---------------------------- 38
+G+G YG V K K + G+ VAIK E++
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHP----LETNQKLKWEVLYKIAVGIARGLEYLH 94
R L++EFV + L+ EK+P +K +++L RG+E+ H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL--EKYPNGLDESRVRKYLFQIL--------RGIEFCH 117
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF 154
+ I+H DIKP NIL+ + K+ DFG A+ + T T Y APE+
Sbjct: 118 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YTDYVATRWYRAPELL 172
Query: 155 CRNFGEVSYKS--DVYSYGMMVFEM 177
G+ Y D+++ G +V EM
Sbjct: 173 ---VGDTKYGRAVDIWAVGCLVTEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-10
Identities = 66/295 (22%), Positives = 114/295 (38%), Gaps = 83/295 (28%)
Query: 9 LGQGGYGGVYKGKL--LDGRN----VAIKVLNETK------------------------- 37
LG+G +G V+ K ++ V +K L +TK
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 38 --GFCFEGHRRALIYEFVSNGSLEKFI---------YEKHPLETNQKLKWEVLYKIAVGI 86
G C E +I E+ G L++F+ + PL T QK+ + I
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA------LCTQI 126
Query: 87 ARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK------ICHGRESIVSMT 140
A G+++L N R +H D+ N L+ K+S L+K R +++
Sbjct: 127 ALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP-- 181
Query: 141 GARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM--TGVKNNANVAVDRSSEIYFPH 198
+ ++APE + S KSDV+S+G++++E+ G ++ +
Sbjct: 182 -----LRWLAPE--AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------- 226
Query: 199 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
V RL+ L L E + Y ++ W + NP DRP+ + +V L
Sbjct: 227 -VLNRLQ-AGKLELPVPEGCPSRLYK---LMTRCWAV--NPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 39/96 (40%), Positives = 56/96 (58%), Gaps = 10/96 (10%)
Query: 83 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA-KICHGRESIVSMTG 141
A + GLE L R RI++ D+KP NILLD+ +ISD GLA +I G ++ G
Sbjct: 108 AAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----TVRG 160
Query: 142 ARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
GTVGY+APEV N + ++ D + G +++EM
Sbjct: 161 RVGTVGYMAPEVI--NNEKYTFSPDWWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 50/203 (24%)
Query: 8 KLGQGGYGGVYKGKL-LDGRNVAIKV--LNETKGFCFEGHRRA------------LIYEF 52
KLG+G Y VYKGK ++G+ VA+KV L E +G F R A L+++
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 53 VSNGSLEKFIYE-----------KHP---LETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
+ ++E KHP N KL L+++ RGL Y+H+
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL---FLFQLL----RGLSYIHQ--- 121
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARG--TVGYIAPEVFCR 156
ILH D+KP N+L+ + K++DFGLA+ +S+ S T + T+ Y P+V
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARA----KSVPSHTYSNEVVTLWYRPPDVL-- 175
Query: 157 NFGEVSYKS--DVYSYGMMVFEM 177
G Y + D++ G + EM
Sbjct: 176 -LGSTEYSTCLDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 28/172 (16%)
Query: 86 IARGLEYL-HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARG 144
+ARG+E+L R C +H D+ NILL E+ KI DFGLA+ + V AR
Sbjct: 183 VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 145 TVGYIAPEVFCRNFGEV-SYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKR 203
+ ++APE F +V + +SDV+S+G++++E+ + + Y
Sbjct: 239 PLKWMAPESI---FDKVYTTQSDVWSFGVLLWEIFSLGASP----------------YPG 279
Query: 204 LELEEDL--GLQGIENEEDKEYARKMIL-VSLWCIQNNPSDRPAMNRVVEML 252
+++ E+ L+ E A I + L C Q +P +RP + +VE+L
Sbjct: 280 VQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 6/98 (6%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS--MTGAR 143
I GL+Y+H + +LH D+KP N+L++ D KI DFGLA+ + MT
Sbjct: 114 ILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 144 GTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVK 181
T Y APE+ +F + DV+S G ++ E+ G K
Sbjct: 171 ATRWYRAPEIML-SFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-10
Identities = 40/135 (29%), Positives = 70/135 (51%), Gaps = 13/135 (9%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107
++ E+ G+L ++I ++ N L + + V I L ++H ILH D+K
Sbjct: 76 IVMEYAPGGTLAEYIQKR----CNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLK 128
Query: 108 PHNILLDE-DFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSD 166
NILLD+ KI DFG++KI + ++ GT YI+PE+ C + KSD
Sbjct: 129 TQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV---GTPCYISPEL-CEG-KPYNQKSD 183
Query: 167 VYSYGMMVFEMTGVK 181
+++ G +++E+ +K
Sbjct: 184 IWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-10
Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 35/196 (17%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVLNETKGFCFEGHRRAL----IYEFVSNGSLEKFIY 63
+G+GG+G VY + D G+ A+K L++ + +G AL + VS G +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 64 EKHPLETNQKLKW--------EVLYKI--------------AVGIARGLEYLHRGCNTRI 101
+ T KL + ++ Y + A I GLE++H N +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH---NRFV 118
Query: 102 LHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEV 161
++ D+KP NILLDE +ISD GLA ++ S+ GT GY+APEV +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGTAYD 174
Query: 162 SYKSDVYSYGMMVFEM 177
S +D +S G M+F++
Sbjct: 175 S-SADWFSLGCMLFKL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-10
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 44/205 (21%)
Query: 9 LGQGGYGGVYK-GKLLDGRNVAIKVLNET------------------------------- 36
+G+G YG VYK DG A+K+L+
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 37 KGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
K G + L+ E + GS+ + + K L Q+L ++ I G GL++LH
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELV--KGLLICGQRLDEAMISYILYGALLGLQHLH-- 145
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGL-AKICHGRESIVSMTGARGTVGYIAPEVF- 154
N RI+H D+K +NILL + K+ DFG+ A++ R + + GT ++APEV
Sbjct: 146 -NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEVIA 201
Query: 155 CRNFGEVSY--KSDVYSYGMMVFEM 177
C + SY + DV+S G+ E+
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-10
Identities = 45/147 (30%), Positives = 77/147 (52%), Gaps = 22/147 (14%)
Query: 42 EGHRRALIYEFVSNGSLEKFIYEKHPL--ETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
E R ++ E+ G L K I + + +Q L W V I+ GL+++H +
Sbjct: 70 ENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKHIH---DR 120
Query: 100 RILHFDIKPHNILLDED-FCPKISDFGLAKICHGRESIVSMTGARGTVG---YIAPEVFC 155
+ILH DIK NI L ++ K+ DFG+A+ + SM A VG Y++PE+ C
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-----SMELAYTCVGTPYYLSPEI-C 174
Query: 156 RNFGEVSYKSDVYSYGMMVFEMTGVKN 182
+N + K+D++S G +++E+ +K+
Sbjct: 175 QN-RPYNNKTDIWSLGCVLYELCTLKH 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-10
Identities = 58/256 (22%), Positives = 108/256 (42%), Gaps = 61/256 (23%)
Query: 2 TNSFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNET------KGFCFEGHRRA-- 47
T F +LG+ +G VYKG L + VAIK L + + F E R+
Sbjct: 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL 65
Query: 48 -------------------LIYEFVSNGSLEKFIYEKHP------LETNQKLKWEV---- 78
+I+ + S+ L +F+ + P + ++ +K +
Sbjct: 66 QHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPAD 125
Query: 79 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138
I IA G+E+L + ++H D+ N+L+ + KISD GL + + +
Sbjct: 126 FVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182
Query: 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM--------TGVKNNANVAVDR 190
M + + +++PE +G+ S SD++SYG++++E+ G N + + R
Sbjct: 183 MGNSLLPIRWMSPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240
Query: 191 SSEIYF-----PHWVY 201
+ ++ P WVY
Sbjct: 241 NRQVLPCPDDCPAWVY 256
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-10
Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 44/201 (21%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVL---NETKGFCFEGHRRA---------------- 47
K+G+G YG VYK + L G VA+K + ET+G R
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 48 ---------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
L++EF+ + L+KF+ L L+++ G+A + H +
Sbjct: 67 VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----FCH---S 118
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF--CR 156
R+LH D+KP N+L++ + K++DFGLA+ G + + T T+ Y APE+ C+
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGV-PVRTYTHEVVTLWYRAPEILLGCK 176
Query: 157 NFGEVSYKSDVYSYGMMVFEM 177
+ S D++S G + EM
Sbjct: 177 YY---STAVDIWSLGCIFAEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 8e-10
Identities = 60/198 (30%), Positives = 91/198 (45%), Gaps = 40/198 (20%)
Query: 9 LGQGGYGGVYKGKLLDGRN---VAIKVLN---ETKGFCFEGHRR-------------ALI 49
+G G YG V LD R VAIK L +++ F +R L+
Sbjct: 23 VGSGAYGTVCSA--LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 50 YEFVSNGSLEKF--IYEKHP--------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
F + SL++F Y P L ++KL + + + + +GL+Y+H
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AA 137
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFG 159
I+H D+KP N+ ++ED KI DFGLA R++ MTG T Y APEV N+
Sbjct: 138 GIIHRDLKPGNLAVNEDCELKILDFGLA-----RQTDSEMTGYVVTRWYRAPEVIL-NWM 191
Query: 160 EVSYKSDVYSYGMMVFEM 177
+ D++S G ++ EM
Sbjct: 192 HYTQTVDIWSVGCIMAEM 209
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-10
Identities = 40/131 (30%), Positives = 60/131 (45%), Gaps = 19/131 (14%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RGCNTRILHFDI 106
L+ E+++ G I L W Y + G+E LH RG I+H DI
Sbjct: 74 LVMEYLNGGDCASLIKTLGGLP----EDWAKQY--IAEVVLGVEDLHQRG----IIHRDI 123
Query: 107 KPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSD 166
KP N+L+D+ K++DFGL++ + V GT Y+APE + SD
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPETILGVGDDKM--SD 175
Query: 167 VYSYGMMVFEM 177
+S G ++FE
Sbjct: 176 WWSLGCVIFEF 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 9e-10
Identities = 37/108 (34%), Positives = 55/108 (50%), Gaps = 12/108 (11%)
Query: 78 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137
+L K+ V I + L YL ++H D+KP NILLD K+ DFG++ GR +
Sbjct: 115 ILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS----GR-LVD 167
Query: 138 SM--TGARGTVGYIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM-TGV 180
S T + G Y+APE Y ++DV+S G+ + E+ TG
Sbjct: 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-10
Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 28/207 (13%)
Query: 52 FVSNGSLEKFIYEKHPLETNQK--LKWEVLYKIAVGIARGLEYL-HRGCNTRILHFDIKP 108
FV SL E+ E K L E L + +A+G+E+L R C +H D+
Sbjct: 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKC----IHRDLAA 207
Query: 109 HNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPE-VFCRNFGEVSYKSDV 167
NILL E+ KI DFGLA+ + V AR + ++APE +F R + + +SDV
Sbjct: 208 RNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDV 264
Query: 168 YSYGMMVFEM--TGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYAR 225
+S+G++++E+ G V +D +RL+ +G
Sbjct: 265 WSFGVLLWEIFSLGASPYPGVKIDEE--------FCRRLK-------EGTRMRAPDYTTP 309
Query: 226 KMILVSLWCIQNNPSDRPAMNRVVEML 252
+M L C PS RP + +VE L
Sbjct: 310 EMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 50/209 (23%)
Query: 8 KLGQGGYGGVYKG-----------KLLDGRN--------VAIKVLNETK---------GF 39
+LG G +G VYK K+++ ++ V I++L F
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 40 CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
++G +I EF G+++ + LE ++ L + I + L+YLH +
Sbjct: 79 YWDGKLWIMI-EFCPGGAVDAIM-----LELDRGLTEPQIQVICRQMLEALQYLH---SM 129
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLA----KICHGRESIVSMTGARGTVGYIAPE-VF 154
+I+H D+K N+LL D K++DFG++ K R+S + GT ++APE V
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAPEVVM 183
Query: 155 CRNFGEV--SYKSDVYSYGMMVFEMTGVK 181
C + YK+D++S G+ + EM ++
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEMAQIE 212
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 50/211 (23%), Positives = 83/211 (39%), Gaps = 45/211 (21%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKGFCFEGHRRA---------------- 47
+ +G+G +G VY+G + N I V +T C R
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 48 --------------LIYEFVSNGSLEKFIYEKHPLETNQ-KLKWEVLYKIAVGIARGLEY 92
++ E G L + L+ N+ L L + ++ L Y
Sbjct: 69 IVKLIGVITENPVWIVMELAPLGELRSY------LQVNKYSLDLASLILYSYQLSTALAY 122
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPE 152
L + R +H DI N+L+ C K+ DFGL++ ES + + + ++APE
Sbjct: 123 LE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPE 178
Query: 153 VFCRNFGEVSYKSDVYSYGMMVFE--MTGVK 181
NF + SDV+ +G+ ++E M GVK
Sbjct: 179 SI--NFRRFTSASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 64/214 (29%)
Query: 8 KLGQGGYGGVYKGKLLD-GRNVAIK---VLNETKGFCFEGHRR----------------- 46
++G G YG VYK + G VA+K V G R
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 47 ----------------ALIYEFVSN---GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIA 87
L++E V L+K P ET + L + L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL-------- 118
Query: 88 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI--CHGRESIVSMTGARGT 145
RGL++LH C I+H D+KP NIL+ K++DFGLA+I C +++T T
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ-----MALTPVVVT 170
Query: 146 VGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
+ Y APEV ++ +Y + D++S G + EM
Sbjct: 171 LWYRAPEVLLQS----TYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 53/206 (25%), Positives = 80/206 (38%), Gaps = 52/206 (25%)
Query: 8 KLGQGGYGGVYKGKLLD-GRNVAIKVLNET----------------------------KG 38
+G+G YG V K + G VAIK E+ K
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHP----LETNQKLKWEVLYKIAVGIARGLEYLH 94
R L++E+V LE E P + + W++L + + Y H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELL--EASPGGLPPDAVRSYIWQLL--------QAIAYCH 117
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF 154
I+H DIKP NIL+ E K+ DFG A+ R + +T T Y APE+
Sbjct: 118 S---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELL 173
Query: 155 CRNFGEVSYKS--DVYSYGMMVFEMT 178
G+ +Y DV++ G ++ E+
Sbjct: 174 ---VGDTNYGKPVDVWAIGCIMAELL 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-09
Identities = 40/146 (27%), Positives = 72/146 (49%), Gaps = 20/146 (13%)
Query: 32 VLNETKGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLE 91
V+ E KG + ++ E+++ GSL ++ + L + L K ++ + +E
Sbjct: 67 VIVEEKGGLY------IVTEYMAKGSLVDYLRSR----GRSVLGGDCLLKFSLDVCEAME 116
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAP 151
YL +H D+ N+L+ ED K+SDFGL K E+ + + V + AP
Sbjct: 117 YLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 168
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEM 177
E + S KSDV+S+G++++E+
Sbjct: 169 EALREK--KFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 1e-09
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 15/94 (15%)
Query: 90 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE---SIVSMTGARGTV 146
EYLH N I++ D+KP N+LLD + K+ DFG AK + + GT
Sbjct: 106 FEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------GTP 156
Query: 147 GYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTG 179
Y+APE+ N G + D +S G++++E +TG
Sbjct: 157 EYVAPEI-ILNKGY-DFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 35/116 (30%), Positives = 50/116 (43%), Gaps = 34/116 (29%)
Query: 90 LEYLHR-GCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-------------------- 128
L+ +H+ G +H DIKP NIL+D D K++DFGL K
Sbjct: 114 LDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 129 ----ICHGRESIVSMTGARGTVG---YIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
+ R+ A TVG YIAPEV + D +S G++++EM
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEM 223
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 40/141 (28%), Positives = 70/141 (49%), Gaps = 13/141 (9%)
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
G C G L+ + GSL + + + L+ + L W V IA+G+ YL
Sbjct: 76 GIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLEEH 128
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156
++H ++ NILL D +I+DFG+A + + + + + + ++A E
Sbjct: 129 R---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI-- 183
Query: 157 NFGEVSYKSDVYSYGMMVFEM 177
FG +++SDV+SYG+ V+EM
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEM 204
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 44/135 (32%), Positives = 71/135 (52%), Gaps = 24/135 (17%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107
++ EF+ G+L + T+ ++ E + + + + R L YLH N ++H DIK
Sbjct: 96 VVMEFLEGGALTDIV-------THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIK 145
Query: 108 PHNILLDEDFCPKISDFG----LAKICHGRESIVSMTGARGTVGYIAPEVFCR-NFGEVS 162
+ILL D K+SDFG ++K R+S+V GT ++APEV R +G
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV------GTPYWMAPEVISRLPYGT-- 197
Query: 163 YKSDVYSYGMMVFEM 177
+ D++S G+MV EM
Sbjct: 198 -EVDIWSLGIMVIEM 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 45/212 (21%)
Query: 4 SFKNKLGQGGYGGVYKGK-LLDGRNVAIKVLN-------ETKGFCF-------------- 41
+ K+G+G + VY+ LLDG VA+K + + + C
Sbjct: 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 64
Query: 42 --------EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
E + ++ E G L + I KH + + + + ++K V + LE++
Sbjct: 65 IKYYASFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVG---YIA 150
H + R++H DIKP N+ + K+ D GL GR T A VG Y++
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGL-----GRFFSSKTTAAHSLVGTPYYMS 174
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKN 182
PE N ++KSD++S G +++EM +++
Sbjct: 175 PERIHEN--GYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 13/155 (8%)
Query: 26 RNVAIKVLNETKGFCFEGHRRA--LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIA 83
RN+ + + + KG C E LI EF+ +GSL++++ P N K+ + K A
Sbjct: 61 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PRNKN-KINLKQQLKYA 115
Query: 84 VGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR 143
V I +G++YL + + +H D+ N+L++ + KI DFGL K + ++
Sbjct: 116 VQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 144 GT-VGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
+ V + APE C + SDV+S+G+ ++E+
Sbjct: 173 DSPVFWYAPE--CLIQSKFYIASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 46/164 (28%), Positives = 72/164 (43%), Gaps = 33/164 (20%)
Query: 49 IYEFVSNGSLEKFIYEKHPL--ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDI 106
++E+V +L + + L +L +VL +A +G I+H D+
Sbjct: 57 VFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQG-----------IVHRDL 105
Query: 107 KPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTGAR-----GTVGYIAPEVFCRNF 158
KP NI++ K+ DFG+ + G T R GT Y APE R
Sbjct: 106 KPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-R-- 162
Query: 159 GE-VSYKSDVYSYGMMVFE-MTG--VKNNANVAVDRSSEIYFPH 198
GE V+ SD+Y++G++ E +TG V A+VA EI +
Sbjct: 163 GEPVTPNSDLYAWGLIFLECLTGQRVVQGASVA-----EILYQQ 201
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 3e-09
Identities = 61/209 (29%), Positives = 89/209 (42%), Gaps = 53/209 (25%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVLNETKG------------FCFEGHRRA-------- 47
+G G YG VYKG+ + G+ AIKV++ T + HR
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 48 ------------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
L+ EF GS+ I LK E + I I RGL +LH+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNT----KGNTLKEEWIAYICREILRGLSHLHQ 129
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR----GTVGYIAP 151
+++H DIK N+LL E+ K+ DFG++ + G R GT ++AP
Sbjct: 130 ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA------QLDRTVGRRNTFIGTPYWMAP 180
Query: 152 EVF-CRNFGEVSY--KSDVYSYGMMVFEM 177
EV C + +Y KSD++S G+ EM
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 41/205 (20%)
Query: 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHN 110
E + GSL++ L+ ++ +L KI++ + RGL YL +I+H D+KP N
Sbjct: 79 EHMDGGSLDQV------LKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSN 130
Query: 111 ILLDEDFCPKISDFGLAKICHGRESIVSMTGA-RGTVGYIAPEVFCRNFG-EVSYKSDVY 168
IL++ K+ DFG++ + I SM + GT Y++PE R G + +SD++
Sbjct: 131 ILVNSRGEIKLCDFGVSG-----QLIDSMANSFVGTRSYMSPE---RLQGTHYTVQSDIW 182
Query: 169 SYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMI 228
S G+ + EM A+ R +P + + L+ + E K
Sbjct: 183 SLGLSLVEM---------AIGR-----YP------IPPPDAKELEAMFGRPVSEGEAKES 222
Query: 229 LVSLWCIQNNPSDRPAMNRVVEMLE 253
+ +P D P + E+L+
Sbjct: 223 HRPV---SGHPPDSPRPMAIFELLD 244
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-09
Identities = 41/133 (30%), Positives = 67/133 (50%), Gaps = 20/133 (15%)
Query: 48 LIYEFVSNGSLE-KFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDI 106
++ EF+ GSLE I ++ L +A I G+ YLHR I+H DI
Sbjct: 149 VLLEFMDGGSLEGTHIADEQFLA-----------DVARQILSGIAYLHR---RHIVHRDI 194
Query: 107 KPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR--NFGEVS-Y 163
KP N+L++ KI+DFG+++I +++ + GT+ Y++PE N G Y
Sbjct: 195 KPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGY 252
Query: 164 KSDVYSYGMMVFE 176
D++S G+ + E
Sbjct: 253 AGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 41/112 (36%), Positives = 57/112 (50%), Gaps = 11/112 (9%)
Query: 68 LETNQKLKWEV-LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL 126
LE ++K EV + I G +GL YLH + +H DIK NILL E K++DFG
Sbjct: 105 LEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGS 161
Query: 127 AKICHGRESIVSMTGARGTVGYIAPEV-FCRNFGEVSYKSDVYSYGMMVFEM 177
A + S V GT ++APEV + G+ K DV+S G+ E+
Sbjct: 162 ASLVSPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-09
Identities = 60/202 (29%), Positives = 85/202 (42%), Gaps = 46/202 (22%)
Query: 9 LGQGGYGGVYKGKLLDG-RNVAIKVLNETK--------------------------GFCF 41
LG+G YG VY + L +AIK + E G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 42 EGHRRALIYEFVSNGSLEKFIYEK-HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
E + E V GSL + K PL+ N+ + + I GL+YLH + +
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE----QTIIFYTKQILEGLKYLH---DNQ 128
Query: 101 ILHFDIKPHNILLDE-DFCPKISDFGLAKICHGRESIVSMTGA-RGTVGYIAPEVF---C 155
I+H DIK N+L++ KISDFG +K G I T GT+ Y+APEV
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG---INPCTETFTGTLQYMAPEVIDKGP 185
Query: 156 RNFGEVSYKSDVYSYGMMVFEM 177
R +G +D++S G + EM
Sbjct: 186 RGYGA---PADIWSLGCTIVEM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 71/296 (23%), Positives = 118/296 (39%), Gaps = 70/296 (23%)
Query: 9 LGQGGYGGVYKGKL--LDGR----NVAIKVLNETK------------------------- 37
LG+G +G V K L GR VA+K+L E
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 38 --GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETN------------------QKLKWE 77
G C + LI E+ GSL F+ E + + + L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 78 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137
L A I+RG++YL +++H D+ N+L+ E KISDFGL++ + +S V
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFP 197
+ R V ++A E + + +SDV+S+G++++E+ + N +P
Sbjct: 185 KRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNP-----------YP 231
Query: 198 HWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
+RL +L G E + + +M + L C + P RP + + LE
Sbjct: 232 GIAPERL---FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-09
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 42/204 (20%)
Query: 9 LGQGGYGGVYKGKLLDGRN----VAIKVLNETKGFCFE---GHRRA-------------- 47
LG+GGYG V++ + + G + A+KVL + + H +A
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 48 -LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVG------IARGLEYLHRGCNTR 100
LIY F + G L + E L+ E ++ I+ LE+LH+
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ---QG 120
Query: 101 ILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV--SMTGAR-GTVGYIAPEVFCRN 157
I++ D+KP NILLD K++DFGL K ESI ++T GT+ Y+APE+ R+
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCK-----ESIHEGTVTHTFCGTIEYMAPEILMRS 175
Query: 158 FGEVSYKSDVYSYGMMVFEM-TGV 180
G D +S G ++++M TG
Sbjct: 176 -GH-GKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-09
Identities = 38/148 (25%), Positives = 70/148 (47%), Gaps = 6/148 (4%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107
+I F+ +G L F+ E L + L + + IA G+EYL + +H D+
Sbjct: 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLA 140
Query: 108 PHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDV 167
N +L+E+ ++DFGL+K + + ++ V ++A E N SDV
Sbjct: 141 ARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTT--HSDV 198
Query: 168 YSYGMMVFEMTGVKNNANVAVDRSSEIY 195
+++G+ ++E+ V+ +SEIY
Sbjct: 199 WAFGVTMWEIMTRGQTPYAGVE-NSEIY 225
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-09
Identities = 60/212 (28%), Positives = 89/212 (41%), Gaps = 56/212 (26%)
Query: 9 LGQGGYGGVY----KGKLLDGRNVAIKVLNE--------------TKGFCFEGHRRA--- 47
LG G YG V+ G G+ A+KVL + T+ E RR
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 48 --------------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
LI ++V+ G L +Y++ + EV IA I L++L
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-----EVRVYIA-EIVLALDHL 121
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR-----GTVGY 148
H+ I++ DIK NILLD + ++DFGL+K ++ R GT+ Y
Sbjct: 122 HQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKE------FLAEEEERAYSFCGTIEY 172
Query: 149 IAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTG 179
+APEV G D +S G++ FE +TG
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 72 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131
QKL + + + I RGL+Y+H + I+H D+KP N+ ++ED KI DFGLA
Sbjct: 115 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 167
Query: 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
R + MTG T Y APE+ N+ + D++S G ++ E+
Sbjct: 168 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 211
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 45/144 (31%), Positives = 65/144 (45%), Gaps = 16/144 (11%)
Query: 35 ETKGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
E KG + H L+ E+ + + K PL+ + + I G +GL YLH
Sbjct: 85 EYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVE------IAAITHGALQGLAYLH 138
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEV- 153
++H DIK NILL E K++DFG A S V GT ++APEV
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVI 189
Query: 154 FCRNFGEVSYKSDVYSYGMMVFEM 177
+ G+ K DV+S G+ E+
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 48/216 (22%)
Query: 5 FKNKLGQGGYGGVYKGKL-LDGRN----VAIKVLNETK---------------------- 37
F +LG+ +G +YKG L L G + VAIK L +
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 38 -----GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLE-----------TNQKLKWEVLYK 81
G + +++E+++ G L +F+ + P L
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 82 IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTG 141
IA+ IA G+EYL + +H D+ NIL+ E KISD GL++ + +
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 142 ARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
+ + ++ PE +G+ S SD++S+G++++E+
Sbjct: 186 SLLPIRWMPPEAIM--YGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 7e-09
Identities = 40/143 (27%), Positives = 67/143 (46%), Gaps = 32/143 (22%)
Query: 45 RRALIYEFVSNGSLEKFIYE-----KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
R AL++E ++ +YE K PL + + +Y++ + L+++HR
Sbjct: 74 RLALVFEL-----MDMNLYELIKGRKRPLPEKRVKSY--MYQLL----KSLDHMHR---N 119
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGR----ESIVSMTGARGTVGYIAPEVFC 155
I H DIKP NIL+ +D K++DFG + + + E I T Y APE
Sbjct: 120 GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYI-------STRWYRAPECLL 171
Query: 156 RNFGEVSYKSDVYSYGMMVFEMT 178
+ G K D+++ G + FE+
Sbjct: 172 TD-GYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 47/216 (21%), Positives = 90/216 (41%), Gaps = 49/216 (22%)
Query: 5 FKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK--------------------- 37
K +LG+G +G V+ + D VA+K L +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 38 -----GFCFEGHRRALIYEFVSNGSLEKF----------IYEKHPLETNQKLKWEVLYKI 82
G C +G +++E++ +G L KF + + P + +L + I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 83 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGA 142
A IA G+ YL + +H D+ N L+ + KI DFG+++ + +
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 143 RGTVGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEM 177
+ ++ PE + R F + +SDV+S+G++++E+
Sbjct: 186 MLPIRWMPPESIMYRKF---TTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 20/142 (14%)
Query: 40 CFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RGC 97
CF+ R + E+V+ G L I + + Y A I GL++LH RG
Sbjct: 64 CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA----RFY--AAEIVLGLQFLHERG- 116
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICHGRESIVSMTGARGTVGYIAPEVFC 155
I++ D+K N+LLD + KI+DFG+ K I G V+ + GT YIAPE+
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG----VTTSTFCGTPDYIAPEIL- 168
Query: 156 RNFGEVSYKSDVYSYGMMVFEM 177
++ D ++ G++++EM
Sbjct: 169 -SYQPYGPAVDWWALGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-09
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 46/209 (22%)
Query: 8 KLGQGGYGGVYKG------KLLDGRNVAIKVLNETK------------------------ 37
+LGQG +G VY+G K VAIK +NE
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 38 ---GFCFEGHRRALIYEFVSNGSLEKFIYEKHP-LETNQKLKWEVLYKI---AVGIARGL 90
G +G +I E ++ G L+ ++ P +E N L K+ A IA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 91 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARG--TVGY 148
YL+ + +H D+ N ++ EDF KI DFG+ + + E+ G +G V +
Sbjct: 133 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRW 187
Query: 149 IAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
++PE G + SDV+S+G++++E+
Sbjct: 188 MSPESL--KDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-09
Identities = 42/130 (32%), Positives = 64/130 (49%), Gaps = 16/130 (12%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107
L+ EFV G F L N++ +V A I EYL + I++ D+K
Sbjct: 108 LVLEFVIGGEFFTF------LRRNKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLK 158
Query: 108 PHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDV 167
P N+LLD+D K++DFG AK+ R + GT YIAPE+ N G +D
Sbjct: 159 PENLLLDKDGFIKMTDFGFAKVVDTRTYTLC-----GTPEYIAPEILL-NVGH-GKAADW 211
Query: 168 YSYGMMVFEM 177
++ G+ ++E+
Sbjct: 212 WTLGIFIYEI 221
|
Length = 340 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-09
Identities = 39/132 (29%), Positives = 71/132 (53%), Gaps = 16/132 (12%)
Query: 47 ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDI 106
++ E + GSL++ + E +++ E+L K+++ + RGL YL +I+H D+
Sbjct: 79 SICMEHMDGGSLDQVLKEA------KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDV 130
Query: 107 KPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGA-RGTVGYIAPEVFCRNFGEVSYKS 165
KP NIL++ K+ DFG++ + I SM + GT Y++PE S +S
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG-----QLIDSMANSFVGTRSYMSPERL--QGTHYSVQS 183
Query: 166 DVYSYGMMVFEM 177
D++S G+ + E+
Sbjct: 184 DIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-09
Identities = 74/293 (25%), Positives = 122/293 (41%), Gaps = 76/293 (25%)
Query: 8 KLGQGGYGGVYKGKLLD--GRNVAIK---VLNETKGFCFEGHRR---------------- 46
++G+G YG V+K + L GR VA+K V +G R
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 47 -----------------ALIYEFVSNG---SLEKFIYEKHPLETNQKLKWEVLYKIAVGI 86
L++E V L+K P ET + + +++L
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL------- 120
Query: 87 ARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTV 146
RGL++LH + R++H D+KP NIL+ K++DFGLA+I + ++ S+ T+
Sbjct: 121 -RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTL 173
Query: 147 GYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEMTGVKN--NANVAVDRSSEIYFPHWVYK 202
Y APEV ++ SY + D++S G + EM K + VD+ +I +
Sbjct: 174 WYRAPEVLLQS----SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 229
Query: 203 RLELEEDLGL----------QGIEN-EEDKEYARKMILVSLWCIQNNPSDRPA 244
+ D+ L Q IE D + K +L+ C+ NP+ R +
Sbjct: 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK--CLTFNPAKRIS 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 11/141 (7%)
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL-HRG 96
G C G +I E+ G L F+ K L E L + +A+G+ +L +
Sbjct: 106 GACTIGGPILVITEYCCYGDLLNFLRRK----RESFLTLEDLLSFSYQVAKGMAFLASKN 161
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156
C +H D+ N+LL KI DFGLA+ + V AR V ++APE
Sbjct: 162 C----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN 217
Query: 157 NFGEVSYKSDVYSYGMMVFEM 177
+++SDV+SYG++++E+
Sbjct: 218 CV--YTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 63/222 (28%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 35 ETKGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
E KG H L+ E+ + + K PL+ + + I G +GL YLH
Sbjct: 89 EYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE------IAAITHGALQGLAYLH 142
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEV- 153
+ ++H DIK NILL E K++DFG A I S V GT ++APEV
Sbjct: 143 ---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEVI 193
Query: 154 FCRNFGEVSYKSDVYSYGMMVFEMTGVKN---NANVAVDRSSEIYFPHWVYKRLELEEDL 210
+ G+ K DV+S G+ E+ K N N S +Y + E
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALY-------HIAQNESP 242
Query: 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252
LQ + E +Y R + C+Q P DRP +++ +
Sbjct: 243 TLQ---SNEWSDYFRNFVDS---CLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 55/220 (25%), Positives = 85/220 (38%), Gaps = 50/220 (22%)
Query: 35 ETKGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
+ +G H L+ E+ + + K PL+ + + + G +GL YLH
Sbjct: 79 QYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE------IAAVTHGALQGLAYLH 132
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEV- 153
+ ++H D+K NILL E K+ DFG A I V GT ++APEV
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVI 183
Query: 154 FCRNFGEVSYKSDVYSYGMM----------VFEMTGVKNNANVAVDRSSEIYFPHWVYKR 203
+ G+ K DV+S G+ +F M + ++A + S + HW
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---- 239
Query: 204 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRP 243
EY R + C+Q P DRP
Sbjct: 240 -----------------SEYFRNFVDS---CLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 12/94 (12%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS--MTGAR 143
I GL YLH RI+H D+K NI +++ I D G A+ +V+ G
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-----PVVAPAFLGLA 217
Query: 144 GTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
GTV APEV R+ + + K+D++S G+++FEM
Sbjct: 218 GTVETNAPEVLARD--KYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 47/211 (22%)
Query: 6 KNKLGQGGYGGVYKGK-LLDGRNVAIK------------------------------VLN 34
+ K+G+G + VY+ LLD + VA+K V+
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66
Query: 35 ETKGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
F E + ++ E G L + I K+ + + + ++K V + +E++H
Sbjct: 67 YLDSF-IEDNELNIVLELADAGDLSQMI--KYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVG---YIAP 151
+ R++H DIKP N+ + K+ D GL GR T A VG Y++P
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGL-----GRFFSSKTTAAHSLVGTPYYMSP 175
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEMTGVKN 182
E N ++KSD++S G +++EM +++
Sbjct: 176 ERIHEN--GYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 59/209 (28%), Positives = 89/209 (42%), Gaps = 53/209 (25%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVLNETKGFCFE-----------GHRRA--------- 47
+G G YG VYKG+ + G+ AIKV++ T+ E H R
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 48 ------------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
L+ EF GS+ + LK + + I I RGL +LH
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNT----KGNALKEDWIAYICREILRGLAHLHA 139
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR----GTVGYIAP 151
+++H DIK N+LL E+ K+ DFG++ + G R GT ++AP
Sbjct: 140 ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA------QLDRTVGRRNTFIGTPYWMAP 190
Query: 152 EVF-CRNFGEVS--YKSDVYSYGMMVFEM 177
EV C + + Y+SD++S G+ EM
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 50/154 (32%), Positives = 71/154 (46%), Gaps = 34/154 (22%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT 145
+ RGL+Y+H + +LH D+KP N+LL+ + KI DFGLA+ + MT T
Sbjct: 117 LLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF--MTEYVVT 171
Query: 146 VGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVY-K 202
Y APE+ C + DV+S G + E+ G K FP Y
Sbjct: 172 RWYRAPELLLNCSEYTTA---IDVWSVGCIFAELLGRKP------------LFPGKDYVH 216
Query: 203 RLEL---------EEDLGLQGIENEEDKEYARKM 227
+L+L EEDLG I NE+ + Y R +
Sbjct: 217 QLKLITELLGSPSEEDLGF--IRNEKARRYIRSL 248
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 44/147 (29%), Positives = 71/147 (48%), Gaps = 30/147 (20%)
Query: 40 CFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
CF+ R + E+V+ G L I + K K A IA GL +LH +
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYHI------QQVGKFKEPHAVFYAAEIAIGLFFLH---S 119
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR---GTVGYIAPEVFC 155
I++ D+K N++LD + KI+DFG+ K E+I R GT YIAPE+
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGMCK-----ENIFGGKTTRTFCGTPDYIAPEI-- 172
Query: 156 RNFGEVSYKS-----DVYSYGMMVFEM 177
++Y+ D +++G++++EM
Sbjct: 173 -----IAYQPYGKSVDWWAFGVLLYEM 194
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 22/185 (11%)
Query: 74 LKWEVLYKIAVGIARGLEYL-HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132
L E L + +A+G+ +L + C +H D+ NILL KI DFGLA+
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRN 266
Query: 133 RESIVSMTGARGTVGYIAPEVFCRNFGEV-SYKSDVYSYGMMVFEMTGVKNNANVAVDRS 191
+ V AR V ++APE F V +++SDV+SYG++++E+ + ++ +
Sbjct: 267 DSNYVVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323
Query: 192 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251
S+ Y ++E + E + Y I+ S W +P RP ++V++
Sbjct: 324 SKFY--------KMIKEGYRMLSPECAPSEMYD---IMKSCW--DADPLKRPTFKQIVQL 370
Query: 252 LEGSL 256
+E L
Sbjct: 371 IEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 42/130 (32%), Positives = 66/130 (50%), Gaps = 16/130 (12%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107
++ E+V G L F Y L + + A I LEYLH + I++ D+K
Sbjct: 78 MLMEYVPGGEL--FSY----LRNSGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLK 128
Query: 108 PHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDV 167
P NILLD++ K++DFG AK R + GT Y+APEV ++ G + D
Sbjct: 129 PENILLDKEGHIKLTDFGFAKKLRDRTWTLC-----GTPEYLAPEVI-QSKGH-NKAVDW 181
Query: 168 YSYGMMVFEM 177
++ G++++EM
Sbjct: 182 WALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 52/217 (23%)
Query: 5 FKNKLGQGGYGGVYKGK---LL---DGRNVAIKVLNETK--------------------- 37
K +LG+G +G V+ + LL D VA+K L E
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 38 -----GFCFEGHRRALIYEFVSNGSLEKFIYEKHP----LETNQ-----KLKWEVLYKIA 83
G C EG +++E++ +G L +F+ P L + +L + IA
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 84 VGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR 143
IA G+ YL + +H D+ N L+ + KI DFG+++ + + G R
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD--YYRVGGR 183
Query: 144 GT--VGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEM 177
+ ++ PE + R F + +SD++S+G++++E+
Sbjct: 184 TMLPIRWMPPESILYRKF---TTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 45/142 (31%), Positives = 70/142 (49%), Gaps = 20/142 (14%)
Query: 40 CFEG-HRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
CF+ R + E+V+ G L I + + Q V Y A I+ GL +LHR
Sbjct: 69 CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQA----VFY--AAEISVGLFFLHR--- 119
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR---GTVGYIAPEVFC 155
I++ D+K N++LD + KI+DFG+ K E +V R GT YIAPE+
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDYIAPEIIA 174
Query: 156 RNFGEVSYKSDVYSYGMMVFEM 177
+ D ++YG++++EM
Sbjct: 175 --YQPYGKSVDWWAYGVLLYEM 194
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 46/201 (22%)
Query: 7 NKLGQGGYGGVYKGKLLDGRN---VAIKVLNETK-------------------------- 37
++G+G +G VYKG +D R VAIK+++ +
Sbjct: 10 ERIGKGSFGEVYKG--IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRY 67
Query: 38 -GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
G +G + +I E++ GS + + PLE + I I +GL+YLH
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEET------YIATILREILKGLDYLH-- 118
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156
+ R +H DIK N+LL E K++DFG+A ++ + GT ++APEV +
Sbjct: 119 -SERKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 157 NFGEVSYKSDVYSYGMMVFEM 177
+ +K+D++S G+ E+
Sbjct: 176 S--AYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 37/106 (34%), Positives = 59/106 (55%), Gaps = 9/106 (8%)
Query: 72 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131
QKL E + + + RGL+Y+H + I+H D+KP N+ ++ED +I DFGLA
Sbjct: 113 QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA---- 165
Query: 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
R++ MTG T Y APE+ N+ + D++S G ++ E+
Sbjct: 166 -RQADDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 3e-08
Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 11/95 (11%)
Query: 88 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICHGRESIVS--MTGARG 144
+ L+Y+H G ++H D+KP NILL+ D K++DFGLA+ + E+ + +T
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 145 TVGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
T Y APE+ G Y D++S G ++ EM
Sbjct: 175 TRWYRAPEIL---LGSTRYTKGVDMWSVGCILGEM 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 47/202 (23%)
Query: 8 KLGQGGYGGVYKGKLLD-GRNVAIKVLNET------KGFCF------------------E 42
K+G+G YG V+K + + G+ VAIK E+ K E
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 43 GHRRA----LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR-GC 97
RR L++E+ + L + EK+P + + ++ KI + + + H+ C
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNEL--EKNP----RGVPEHLIKKIIWQTLQAVNFCHKHNC 121
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
+H D+KP NIL+ + K+ DFG A+I G T T Y APE+
Sbjct: 122 ----IHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLV-- 173
Query: 158 FGEVSYKS--DVYSYGMMVFEM 177
G+ Y DV++ G + E+
Sbjct: 174 -GDTQYGPPVDVWAIGCVFAEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-08
Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 43/198 (21%)
Query: 8 KLGQGGYGGVYKG-KLLDGRNVAIKVLNETKGFCFE------------------------ 42
K+GQG G VY + G+ VAIK +N + E
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 43 --GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
G ++ E+++ GSL + E ++ Q + + + LE+LH + +
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETC-MDEGQ------IAAVCRECLQALEFLH---SNQ 135
Query: 101 ILHFDIKPHNILLDEDFCPKISDFGL-AKICHGRESIVSMTGARGTVGYIAPEVFCRNFG 159
++H DIK NILL D K++DFG A+I + +M GT ++APEV R
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRK-- 190
Query: 160 EVSYKSDVYSYGMMVFEM 177
K D++S G+M EM
Sbjct: 191 AYGPKVDIWSLGIMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-08
Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 88 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVG 147
GL+Y+H I+H D+KP N+ ++ED KI DFGLA R + MTG T
Sbjct: 128 CGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLA-----RHADAEMTGYVVTRW 179
Query: 148 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
Y APEV N+ + D++S G ++ EM
Sbjct: 180 YRAPEVIL-NWMHYNQTVDIWSVGCIMAEM 208
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 5e-08
Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 48/215 (22%)
Query: 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHN 110
E+++ GS+ + + + V+ + RGL YLH +I+H D+K N
Sbjct: 83 EWMAGGSVSHLLSKYGAFKEA------VIINYTEQLLRGLSYLH---ENQIIHRDVKGAN 133
Query: 111 ILLD---EDFCPKISDFGLAKICHGRESIVSMTGAR-------GTVGYIAPEVF-CRNFG 159
+L+D + +I+DFG A R + TGA GT+ ++APEV +G
Sbjct: 134 LLIDSTGQRL--RIADFGAA----ARLA-AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYG 186
Query: 160 EVSYKSDVYSYGMMVFEMTGVKN--NANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217
DV+S G ++ EM K NA + + I+ + E L G+ +
Sbjct: 187 R---SCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS-PGLRD 242
Query: 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252
V+L C++ P DRP E+L
Sbjct: 243 ------------VTLRCLELQPEDRPP---SRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-08
Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 70/219 (31%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIK-----------------------VLNET----KGF 39
K+G+G YG VYK + G+ VA+K +L+E+ +
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 40 CFEGHRRA-------LIYEFVSNGSLEKFI-----YEKHPLETN--QKLKWEVLYKIAVG 85
E L++E++ + L+KF+ PL + +++L
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLL------ 120
Query: 86 IARGLEYLH-RGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICHGRE---SIVSMT 140
+G+ + H G ++H D+KP N+L+D+ KI+D GL GR + S T
Sbjct: 121 --KGVAHCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGL-----GRAFSIPVKSYT 169
Query: 141 GARGTVGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
T+ Y APEV G Y + D++S G + EM
Sbjct: 170 HEIVTLWYRAPEVL---LGSTHYSTPVDIWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 7e-08
Identities = 41/136 (30%), Positives = 69/136 (50%), Gaps = 25/136 (18%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKI---AVGIARGLEYLHRGCNTRILHF 104
+ EF++ G L I +K + LY+ A I GL++LH + I++
Sbjct: 73 FVMEFLNGGDLMFHIQDKGRFD---------LYRATFYAAEIVCGLQFLH---SKGIIYR 120
Query: 105 DIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR---GTVGYIAPEVFCRNFGEV 161
D+K N++LD D KI+DFG+ K E++ A GT YIAPE+ +
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCK-----ENVFGDNRASTFCGTPDYIAPEIL--QGLKY 173
Query: 162 SYKSDVYSYGMMVFEM 177
++ D +S+G++++EM
Sbjct: 174 TFSVDWWSFGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-08
Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 26/195 (13%)
Query: 40 CFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RGC 97
CF+ R L+ E+V+ G L ++ +KL E A I L +LH RG
Sbjct: 64 CFQTTSRLFLVIEYVNGGDL------MFHMQRQRKLPEEHARFYAAEICIALNFLHERG- 116
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
I++ D+K N+LLD D K++D+G+ K G + + GT YIAPE+
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEIL--R 169
Query: 158 FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDR---SSEIYF-------PHWVYKRLELE 207
E + D ++ G+++FEM ++ ++ D ++E Y P + + L ++
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVK 229
Query: 208 EDLGLQGIENEEDKE 222
L+G N++ KE
Sbjct: 230 ASHVLKGFLNKDPKE 244
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 9e-08
Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 22/139 (15%)
Query: 43 GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRIL 102
G ++ EF+ G+L + + +L E + + + + L YLH + ++
Sbjct: 90 GEELWVLMEFLQGGALTDIVSQT-------RLNEEQIATVCESVLQALCYLH---SQGVI 139
Query: 103 HFDIKPHNILLDEDFCPKISDFG----LAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
H DIK +ILL D K+SDFG ++K R+S+V GT ++APEV R
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVISRT- 192
Query: 159 GEVSYKSDVYSYGMMVFEM 177
+ D++S G+MV EM
Sbjct: 193 -PYGTEVDIWSLGIMVIEM 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-08
Identities = 38/132 (28%), Positives = 70/132 (53%), Gaps = 16/132 (12%)
Query: 47 ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDI 106
++ E + GSL++ L+ ++ ++L K+++ + +GL YL +I+H D+
Sbjct: 79 SICMEHMDGGSLDQV------LKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDV 130
Query: 107 KPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGA-RGTVGYIAPEVFCRNFGEVSYKS 165
KP NIL++ K+ DFG++ + I SM + GT Y++PE S +S
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG-----QLIDSMANSFVGTRSYMSPERL--QGTHYSVQS 183
Query: 166 DVYSYGMMVFEM 177
D++S G+ + EM
Sbjct: 184 DIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 9e-08
Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 14/148 (9%)
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHP-----LETN--QKLKWEVLYKIAVGIARGL 90
G C EG +++E++ +G L KF+ P E N +L + IA IA G+
Sbjct: 74 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGM 133
Query: 91 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIA 150
YL + +H D+ N L+ E+ KI DFG+++ + + + ++
Sbjct: 134 VYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 190
Query: 151 PE-VFCRNFGEVSYKSDVYSYGMMVFEM 177
PE + R F + +SDV+S G++++E+
Sbjct: 191 PESIMYRKF---TTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 40/135 (29%), Positives = 69/135 (51%), Gaps = 24/135 (17%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107
++ EF+ G+L + T+ ++ E + + + + + L LH ++H DIK
Sbjct: 94 VVMEFLEGGALTDIV-------THTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIK 143
Query: 108 PHNILLDEDFCPKISDFG----LAKICHGRESIVSMTGARGTVGYIAPEVFCR-NFGEVS 162
+ILL D K+SDFG ++K R+S+V GT ++APE+ R +G
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPELISRLPYGP-- 195
Query: 163 YKSDVYSYGMMVFEM 177
+ D++S G+MV EM
Sbjct: 196 -EVDIWSLGIMVIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 43/202 (21%)
Query: 7 NKLGQGGYGGVYKGKLLD-GRNVAIKVL---NETKGFCFEGHR--RALI----------Y 50
N++G+G YG VY+ + G VA+K + NE G R L+
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 51 EFVSNGSLEK----FIYEKHPL----ETNQKLKWEVLYK-IAVGIARGLEYLHRGCNTRI 101
E V L+ Y + L + E K + + + RGL+YLH I
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---I 129
Query: 102 LHFDIKPHNILLDEDFCPKISDFGLAK----ICHGRESIVSMTGARGTVGYIAPEVFCRN 157
+H D+K N+LL + C KI+DFGLA+ MT T+ Y APE+
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK------PMTPKVVTLWYRAPELL--- 180
Query: 158 FGEVSYKS--DVYSYGMMVFEM 177
G +Y + D+++ G ++ E+
Sbjct: 181 LGCTTYTTAIDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 54/203 (26%), Positives = 78/203 (38%), Gaps = 52/203 (25%)
Query: 8 KLGQGGYGGVYKGKLLD-GRNVAIKVLNETKGFCFEGHRRAL------------------ 48
++GQGGYG V+ K D G VA+K + ++ F R L
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 49 --------IY---EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
+Y E+V G + L + + AV L Y+HR
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHR-- 125
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVG---YIAPEVF 154
D+KP N L+D K++DFGL+K IV+ A VG Y+APEV
Sbjct: 126 -------DLKPENFLIDASGHIKLTDFGLSK------GIVTY--ANSVVGSPDYMAPEVL 170
Query: 155 CRNFGEVSYKSDVYSYGMMVFEM 177
+ D +S G M++E
Sbjct: 171 --RGKGYDFTVDYWSLGCMLYEF 191
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 65/286 (22%), Positives = 110/286 (38%), Gaps = 61/286 (21%)
Query: 9 LGQGGYGGVYKGKLLD-------GRNVAIKVLNETK------------------------ 37
LG G +G VY+G D VA+K L +
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 38 ---GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQK--LKWEVLYKIAVGIARGLEY 92
G C + +I E + G L ++ +E L + L I + +A+G Y
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 93 LHRGCNTRILHFDIKPHNILLDED--FCP---KISDFGLAKICHGRESIVSMTGARGTVG 147
L + +H D+ N L+ E KI DFGLA+ + + V
Sbjct: 122 LEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 148 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207
++APE G+ + +SDV+S+G++++E+ + A++ + +
Sbjct: 179 WMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH---------VT 227
Query: 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
LQ EN DK Y + C +PS+RP +R+ E+L+
Sbjct: 228 AGGRLQKPENCPDKIYQ-----LMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 41/130 (31%), Positives = 65/130 (50%), Gaps = 15/130 (11%)
Query: 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKP 108
+ E+++ G L I + Y A I GL++LH+ I++ D+K
Sbjct: 74 VMEYLNGGDLMFHIQSSGRFD----EARARFY--AAEIICGLQFLHK---KGIIYRDLKL 124
Query: 109 HNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKS-DV 167
N+LLD+D KI+DFG+ K E S GT YIAPE+ G+ +S D
Sbjct: 125 DNVLLDKDGHIKIADFGMCKENMNGEGKASTFC--GTPDYIAPEIL---KGQKYNESVDW 179
Query: 168 YSYGMMVFEM 177
+S+G++++EM
Sbjct: 180 WSFGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 8/105 (7%)
Query: 75 KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134
KW Y V +A L+ +H + +H D+KP N+LLD+ K++DFG +
Sbjct: 142 KWARFYTAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDAN 195
Query: 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM 177
+V A GT YI+PEV G+ Y + D +S G+ ++EM
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 46/200 (23%)
Query: 8 KLGQGGYGGVYKGKLLDGRN---VAIKVLN---------------------------ETK 37
K+G+G +G V+KG +D R VAIK+++ +
Sbjct: 11 KIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
G + + +I E++ GS + E PL+ Q + I I +GL+YLH
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQ------IATILREILKGLDYLH--- 118
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
+ + +H DIK N+LL E K++DFG+A ++ + GT ++APEV ++
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 158 FGEVSYKSDVYSYGMMVFEM 177
K+D++S G+ E+
Sbjct: 177 --AYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 45/167 (26%), Positives = 65/167 (38%), Gaps = 53/167 (31%)
Query: 8 KLGQGGYGGVYKGKLL---DGRNVAIKVLNETK----GFCFEGHR-----RALIYE---- 51
+G+G YG VYK K DG+ AIK K G R R L +E
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 52 ----FVSNGSLEKFI---YEKHPLETNQKLKWEVLY----KIAVGIAR------------ 88
F+ + ++ Y +H L W+++ V I
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDL-------WQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 89 GLEYLHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAKICH 131
G+ YLH + +LH D+KP NIL+ E KI D GLA++ +
Sbjct: 120 GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 52/210 (24%)
Query: 8 KLGQGGYGGVYKG-----------KLLDGRN--------VAIKVLNETK---------GF 39
+LG G +G VYK K++D ++ V I +L F
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 40 CFEGHRRALIYEFVSNGSLEKFIYE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
+E + LI EF + G+++ + E + PL Q + + L YLH
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVMLELERPLTEPQ------IRVVCKQTLEALNYLH---E 121
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLA----KICHGRESIVSMTGARGTVGYIAPE-V 153
+I+H D+K NIL D K++DFG++ + R+S + GT ++APE V
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI------GTPYWMAPEVV 175
Query: 154 FCRNFGE--VSYKSDVYSYGMMVFEMTGVK 181
C + YK+DV+S G+ + EM ++
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQIE 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 19/133 (14%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107
+ E+++ G L I H + L Y A I GL++LH + I++ D+K
Sbjct: 73 FVMEYLNGGDLMFHIQSCHKFD----LPRATFY--AAEIICGLQFLH---SKGIVYRDLK 123
Query: 108 PHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR---GTVGYIAPEVFCRNFGEVSYK 164
NILLD D KI+DFG+ K E+++ GT YIAPE+ + +
Sbjct: 124 LDNILLDTDGHIKIADFGMCK-----ENMLGDAKTCTFCGTPDYIAPEILLGQ--KYNTS 176
Query: 165 SDVYSYGMMVFEM 177
D +S+G++++EM
Sbjct: 177 VDWWSFGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 7/92 (7%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT 145
I L+YLH G +I++ D+K N++LD+D KI+DFGL K G +M GT
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGT 158
Query: 146 VGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
Y+APEV N + D + G++++EM
Sbjct: 159 PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 50/225 (22%), Positives = 92/225 (40%), Gaps = 68/225 (30%)
Query: 9 LGQGGYGGVYKGK---LLDGRN---VAIKVLNETK------------------------- 37
+GQG +G V++ + LL VA+K+L E
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 38 --GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQ----------------KLKWEVL 79
G C G L++E+++ G L +F+ + P L
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 80 YKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSM 139
IA +A G+ YL + +H D+ N L+ E+ KI+DFGL++ +I S
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR------NIYSA 183
Query: 140 TGARGT------VGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEM 177
+ + + ++ PE +F + + +SDV++YG++++E+
Sbjct: 184 DYYKASENDAIPIRWMPPESIF---YNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 2e-07
Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 45/199 (22%)
Query: 8 KLGQGGYGGVYKG-KLLDGRNVAIKVLN------------------ETKG--------FC 40
K+GQG G VY + G+ VAIK +N E K
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 41 FEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
G ++ E+++ GSL + E ++ Q + + + L++LH + +
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTET-CMDEGQ------IAAVCRECLQALDFLH---SNQ 135
Query: 101 ILHFDIKPHNILLDEDFCPKISDFGL-AKICHGRESIVSMTGARGTVGYIAPEVFCRN-F 158
++H DIK NILL D K++DFG A+I + +M GT ++APEV R +
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAY 192
Query: 159 GEVSYKSDVYSYGMMVFEM 177
G K D++S G+M EM
Sbjct: 193 GP---KVDIWSLGIMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-07
Identities = 41/132 (31%), Positives = 67/132 (50%), Gaps = 16/132 (12%)
Query: 48 LIYEFVSNGSLEKFIYE--KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFD 105
L+ ++ G L+ IY + LE + V++ A I G+ +LH + I++ D
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMER-----VIHYSA-QITCGILHLH---SMDIVYRD 120
Query: 106 IKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKS 165
+KP N+LLD+ ++SD GLA ++I T GT GY+APE+ SY
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEE--PYSYPV 175
Query: 166 DVYSYGMMVFEM 177
D ++ G ++EM
Sbjct: 176 DWFAMGCSIYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 33/88 (37%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 90 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYI 149
LE+LH+ I++ D+KP NILLD + DFGL+K + GT Y+
Sbjct: 109 LEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC--GTTEYL 163
Query: 150 APEVFCRNFGEVSYKSDVYSYGMMVFEM 177
APEV G + D +S G++VFEM
Sbjct: 164 APEVLLDEKG-YTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 34/95 (35%), Positives = 50/95 (52%), Gaps = 13/95 (13%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICHGRESIVSMTGAR 143
I L YLH +++ D+K N++LD+D KI+DFGL K I G +M
Sbjct: 104 IVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFC 156
Query: 144 GTVGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEM 177
GT Y+APEV N +G D + G++++EM
Sbjct: 157 GTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 3e-07
Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 45/199 (22%)
Query: 8 KLGQGGYGGVYKG-KLLDGRNVAIKVLN------------------ETKG--------FC 40
K+GQG G VY + G+ VAI+ +N E K
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 41 FEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
G ++ E+++ GSL + E ++ Q + + + LE+LH + +
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTET-CMDEGQ------IAAVCRECLQALEFLH---SNQ 136
Query: 101 ILHFDIKPHNILLDEDFCPKISDFGL-AKICHGRESIVSMTGARGTVGYIAPEVFCRN-F 158
++H DIK NILL D K++DFG A+I + +M GT ++APEV R +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAY 193
Query: 159 GEVSYKSDVYSYGMMVFEM 177
G K D++S G+M EM
Sbjct: 194 GP---KVDIWSLGIMAIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 38/142 (26%), Positives = 72/142 (50%), Gaps = 13/142 (9%)
Query: 37 KGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
+G G+ ++ E++SNG+L+ F+ KH +L L + G+A G++YL
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFL-RKH----EGQLVAGQLMGMLPGLASGMKYL--- 123
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR-ESIVSMTGARGTVGYIAPEVFC 155
+H + H +L++ D KIS F ++ + E+I + + V + APE
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAI- 180
Query: 156 RNFGEVSYKSDVYSYGMMVFEM 177
+ S SDV+S+G++++E+
Sbjct: 181 -QYHHFSSASDVWSFGIVMWEV 201
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 42/133 (31%), Positives = 67/133 (50%), Gaps = 17/133 (12%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVG-IARGLEYLHRGCNTRILHFDI 106
LI ++VS G + +Y++ E + G I LE+LH+ I++ DI
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFS-------EDEVRFYSGEIILALEHLHK---LGIVYRDI 131
Query: 107 KPHNILLDEDFCPKISDFGLAK--ICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYK 164
K NILLD + ++DFGL+K + +E S GT+ Y+APE+ R G
Sbjct: 132 KLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC---GTIEYMAPEII-RGKGGHGKA 187
Query: 165 SDVYSYGMMVFEM 177
D +S G+++FE+
Sbjct: 188 VDWWSLGILIFEL 200
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 8/105 (7%)
Query: 75 KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134
KW Y V +A L+ +H + +H D+KP N+LLD+ K++DFG + +E
Sbjct: 142 KWARFYTAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKE 195
Query: 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM 177
+V A GT YI+PEV G+ Y + D +S G+ ++EM
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT 145
I LEYLH + +++ DIK N++LD+D KI+DFGL K G +M GT
Sbjct: 104 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158
Query: 146 VGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
Y+APEV N + D + G++++EM
Sbjct: 159 PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 34/94 (36%), Positives = 54/94 (57%), Gaps = 10/94 (10%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARG- 144
I RGL Y HR ++LH D+KP N+L++E K++DFGLA+ +S+ + T +
Sbjct: 113 ILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARA----KSVPTKTYSNEV 165
Query: 145 -TVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
T+ Y P+V + E S + D++ G + FEM
Sbjct: 166 VTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 5e-07
Identities = 47/147 (31%), Positives = 73/147 (49%), Gaps = 25/147 (17%)
Query: 35 ETKGFCFEGHRRALIYEFVSNGSLEKFIYE-KHPLET---NQKLKWEVLYKIAVGIARGL 90
E FC +I E+ L+ + E KH +T NQ +W + + G+
Sbjct: 73 ERDAFC-------IITEYCEGRDLDCKLEELKHTGKTLSENQVCEW------FIQLLLGV 119
Query: 91 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIA 150
Y+H+ RILH D+K NI L + KI DFG++++ G S T GT Y++
Sbjct: 120 HYMHQ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMG--SCDLATTFTGTPYYMS 173
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVFEM 177
PE ++ G S KSD++S G +++EM
Sbjct: 174 PEAL-KHQGYDS-KSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 6e-07
Identities = 46/135 (34%), Positives = 63/135 (46%), Gaps = 20/135 (14%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107
+ E++ GS+ K L+ L V K I G+ YLH + I+H DIK
Sbjct: 83 IFMEYMPGGSV------KDQLKAYGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIK 133
Query: 108 PHNILLDEDFCPKISDFGLAK----ICHGRESIVSMTGARGTVGYIAPEVFC-RNFGEVS 162
NIL D K+ DFG +K IC I S+T GT +++PEV +G
Sbjct: 134 GANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT---GTPYWMSPEVISGEGYGR-- 188
Query: 163 YKSDVYSYGMMVFEM 177
K+DV+S G V EM
Sbjct: 189 -KADVWSLGCTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 37/126 (29%), Positives = 65/126 (51%), Gaps = 11/126 (8%)
Query: 69 ETNQKLKWEVLYKIAVGIARGLEYL-HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127
E + L + L + + +A+G+++L + C +H D+ N+LL + KI DFGLA
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLA 259
Query: 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEV-SYKSDVYSYGMMVFEM--TGVKNNA 184
+ + V AR V ++APE F V + +SDV+SYG++++E+ G
Sbjct: 260 RDIMNDSNYVVKGNARLPVKWMAPESI---FDCVYTVQSDVWSYGILLWEIFSLGKSPYP 316
Query: 185 NVAVDR 190
+ V+
Sbjct: 317 GILVNS 322
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-07
Identities = 62/208 (29%), Positives = 86/208 (41%), Gaps = 54/208 (25%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVLN------ET--------------KGFCFE----- 42
LGQG +G VY D GR +A+K + ET K E
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 43 -GHRR-------ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
G R ++ E + GS+ K L++ L V K I G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSI------KDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK----ICHGRESIVSMTGARGTVGYIA 150
+ I+H DIK NIL D K+ DFG +K IC + S+T GT +++
Sbjct: 124 ---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT---GTPYWMS 177
Query: 151 PEVFC-RNFGEVSYKSDVYSYGMMVFEM 177
PEV +G K+D++S G V EM
Sbjct: 178 PEVISGEGYGR---KADIWSVGCTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 8e-07
Identities = 57/223 (25%), Positives = 83/223 (37%), Gaps = 60/223 (26%)
Query: 8 KLGQGGYGGVYKG-KLLDGRNVAIKVLNETKGFCFEGHRRAL----------------IY 50
+G+GG G VY + R VA+K + E +R L +Y
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 51 EFVSNG----------------SLEKFIYEKHPLETNQKLKWEV--LYKIAVGIARGLEY 92
S+G SL K +++K L K V I I +EY
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 93 LH-RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI-----VSMTGAR--- 143
+H +G +LH D+KP NILL I D+G A E V
Sbjct: 129 VHSKG----VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 144 --------GTVGYIAPEVFCRNFG-EVSYKSDVYSYGMMVFEM 177
GT Y+APE R G S +D+Y+ G+++++M
Sbjct: 185 MTIPGKIVGTPDYMAPE---RLLGVPASESTDIYALGVILYQM 224
|
Length = 932 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 9e-07
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 45/206 (21%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVL---NETKG----------FCFEGH--------- 44
K+G+G YG VYK + + +A+K + E +G E
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 45 ------RRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
R L++E++ + L+K + N +L LY+I GIA Y H +
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----YCH---S 120
Query: 99 TRILHFDIKPHNILLDEDFCP-KISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
R+LH D+KP N+L+D K++DFGLA+ G + + T T+ Y APE+
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGI-PVRTFTHEVVTLWYRAPEIL--- 175
Query: 158 FGEVSYKS--DVYSYGMMVFEMTGVK 181
G Y + D++S G + EM K
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 9e-07
Identities = 36/107 (33%), Positives = 52/107 (48%), Gaps = 12/107 (11%)
Query: 90 LEYLHRGCNTRILHFDIKPHNILLD--EDFCPKISDFGLAKICHGRESIVSMTGARGTVG 147
++Y+H I+H DIK N+L++ ED C + DFG A G S G GTV
Sbjct: 273 IDYIHG---EGIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 148 YIAPEVFCRNFGEVSYKS-DVYSYGMMVFEMTGVKNNANVAVDRSSE 193
APEV G+ S D++S G+++FE V + + R E
Sbjct: 328 TNAPEVLA---GDPYTPSVDIWSAGLVIFE-AAVHTASLFSASRGDE 370
|
Length = 461 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 8/105 (7%)
Query: 75 KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134
KW Y V +A L+ +H + ++H D+KP N+LLD+ K++DFG +
Sbjct: 142 KWAKFYTAEVVLA--LDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDET 195
Query: 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM 177
+V A GT YI+PEV G+ Y + D +S G+ +FEM
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 57/203 (28%), Positives = 81/203 (39%), Gaps = 50/203 (24%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIKVL--------NETKGFCFEGHRRALI---------- 49
+G+G +G V K DG+ A+KVL E K E R L+
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAE--RNVLLKNVKHPFLVG 60
Query: 50 --YEFVSNGSL----------EKFIY---EKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
Y F + L E F + E+ E + A IA L YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-------YAAEIASALGYLH 113
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF 154
+ I++ D+KP NILLD ++DFGL K G E + + GT Y+APEV
Sbjct: 114 ---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVL 168
Query: 155 CRNFGEVSYKSDVYSYGMMVFEM 177
+ D + G +++EM
Sbjct: 169 RKQ--PYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 45/141 (31%), Positives = 66/141 (46%), Gaps = 20/141 (14%)
Query: 42 EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRI 101
E + ++ E++ GS+ K L+ L V + I +G+ YLH + I
Sbjct: 77 EEKKLSIFVEYMPGGSI------KDQLKAYGALTENVTRRYTRQILQGVSYLH---SNMI 127
Query: 102 LHFDIKPHNILLDEDFCPKISDFGLAK----ICHGRESIVSMTGARGTVGYIAPEVFC-R 156
+H DIK NIL D K+ DFG +K IC I S+T GT +++PEV
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT---GTPYWMSPEVISGE 184
Query: 157 NFGEVSYKSDVYSYGMMVFEM 177
+G K+DV+S V EM
Sbjct: 185 GYGR---KADVWSVACTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 12/88 (13%)
Query: 91 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIA 150
EYLH + I++ D+KP N+LLD K++DFG AK R + GT Y+A
Sbjct: 132 EYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC-----GTPEYLA 183
Query: 151 PEVF-CRNFGEVSYKSDVYSYGMMVFEM 177
PEV + G+ D ++ G++++E
Sbjct: 184 PEVIQSKGHGKA---VDWWTMGVLLYEF 208
|
Length = 329 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 54/205 (26%)
Query: 9 LGQGGYGGVYKGKLL-DGRNVAIKVLNE----------------------------TKGF 39
LG+G +G V +L GR A+KVL + T+ +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 40 -CFEGHRRAL-IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RG 96
CF+ R + EFV+ G L I + + + + A I L +LH +G
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY------AAEITSALMFLHDKG 116
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICHGRESIVSMTGARGTVGYIAPEVF 154
I++ D+K N+LLD + K++DFG+ K I +G + + GT YIAPE+
Sbjct: 117 ----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIAPEI- 167
Query: 155 CRNFGEVSYKSDV--YSYGMMVFEM 177
E+ Y V ++ G++++EM
Sbjct: 168 ---LQEMLYGPSVDWWAMGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 44/141 (31%), Positives = 65/141 (46%), Gaps = 19/141 (13%)
Query: 40 CFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
CF+ + E+ + G L I+ E V Y A + GL+YLH
Sbjct: 70 CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSE-----PRAVFY--AACVVLGLQYLH---E 119
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
+I++ D+K N+LLD + KI+DFGL K G S GT ++APEV
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC--GTPEFLAPEVLT--- 174
Query: 159 GEVSYKSDV--YSYGMMVFEM 177
E SY V + G++++EM
Sbjct: 175 -ETSYTRAVDWWGLGVLIYEM 194
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 59/211 (27%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKV--LNETKGFCFEGHRR------------------ 46
KLG+G Y VYKG+ G VA+K L+ +G R
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 47 -------ALIYEFVSNGSLEKFI---YEKHPLETNQ--KLKWEVLYKIAVGIARGLEYLH 94
L++E++ L+K++ + L+ N +++L +G+ + H
Sbjct: 67 IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL--------KGIAFCH 117
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK---ICHGRESIVSMTGARGTVGYIAP 151
R+LH D+KP N+L+++ K++DFGLA+ I + + + T+ Y AP
Sbjct: 118 ---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI-----PVNTFSNEVVTLWYRAP 169
Query: 152 EVFCRNFGEVSYKS--DVYSYGMMVFEM-TG 179
+V G +Y + D++S G ++ EM TG
Sbjct: 170 DVL---LGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 18/153 (11%)
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQK-------------LKWEVLYKIAV 84
G C + +I E++ NG L +F+ H + + + + L +A+
Sbjct: 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVAL 145
Query: 85 GIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARG 144
IA G++YL + +H D+ N L+ E+ KI+DFG+++ + + A
Sbjct: 146 QIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVL 202
Query: 145 TVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
+ ++A E C G+ + SDV+++G+ ++E+
Sbjct: 203 PIRWMAWE--CILMGKFTTASDVWAFGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 43/150 (28%), Positives = 67/150 (44%), Gaps = 26/150 (17%)
Query: 88 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC-HGRESIVSMTGARGTV 146
R L+Y+H + H D+KP NIL + D KI DFGLA++ + + + T T
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 147 GYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFP-HWVYKRL 204
Y APE+ F + + D++S G + E+ TG + FP V +L
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-------------KPLFPGKNVVHQL 217
Query: 205 ELEEDL-------GLQGIENEEDKEYARKM 227
+L DL + + NE+ + Y M
Sbjct: 218 DLITDLLGTPSPETISRVRNEKARRYLSSM 247
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 42/141 (29%), Positives = 71/141 (50%), Gaps = 18/141 (12%)
Query: 40 CFEGHRRAL-IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RGC 97
CF+ R + E+V+ G L ++ +KL E + I+ L YLH RG
Sbjct: 64 CFQTESRLFFVIEYVNGGDL------MFHMQRQRKLPEEHARFYSAEISLALNYLHERG- 116
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF-CR 156
I++ D+K N+LLD + K++D+G+ K G + + GT YIAPE+
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGE 171
Query: 157 NFGEVSYKSDVYSYGMMVFEM 177
++G + D ++ G+++FEM
Sbjct: 172 DYG---FSVDWWALGVLMFEM 189
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 34/110 (30%), Positives = 54/110 (49%), Gaps = 22/110 (20%)
Query: 82 IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE--DFCPKISDFGLAKICHGRESIVSM 139
I + R ++YLH RI+H DIK NI ++ D C + DFG A C V +
Sbjct: 187 IERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVC--LGDFGAA--CFP----VDI 235
Query: 140 TGAR-----GTVGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGVKNN 183
+ GT+ APE+ R+ +G D++S G+++FEM ++
Sbjct: 236 NANKYYGWAGTIATNAPELLARDPYGPA---VDIWSAGIVLFEMATCHDS 282
|
Length = 391 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 55/230 (23%), Positives = 78/230 (33%), Gaps = 71/230 (30%)
Query: 5 FKNK-LGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRALIYE----------- 51
K LG+G YG V K L G+ VAIK + + R L+
Sbjct: 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 52 -----------------FVS-----------NGSLEKFIYEKHPL-ETNQKLKWEVLYKI 82
+V L+K + K L E+ K I
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKC-------I 124
Query: 83 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS---- 138
+ I GL LH +H D+ P NI ++ KI+DFGLA+ +G
Sbjct: 125 LLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR-RYGYPPYSDTLSK 180
Query: 139 ---------MTGARGTVGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
MT T+ Y APE+ G Y D++S G + E+
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELL---MGAEKYHFAVDMWSVGCIFAEL 227
|
Length = 335 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 46/201 (22%)
Query: 7 NKLGQGGYGGVYKGKLLDGRN---VAIKVLN---------------------------ET 36
++G+G +G V+KG +D R VAIK+++ +
Sbjct: 10 ERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 37 KGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
G +G + +I E++ GS + P + Q + + I +GL+YLH
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQ------IATMLKEILKGLDYLH-- 118
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156
+ + +H DIK N+LL E K++DFG+A ++ + GT ++APEV +
Sbjct: 119 -SEKKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 157 NFGEVSYKSDVYSYGMMVFEM 177
+ K+D++S G+ E+
Sbjct: 176 S--AYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-06
Identities = 55/199 (27%), Positives = 85/199 (42%), Gaps = 45/199 (22%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFE------------------------ 42
K+GQG G V+ + G+ VAIK +N K E
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 43 --GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
G ++ E+++ GSL + E E + + + LE+LH +
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQ-------IAAVCRECLQALEFLHA---NQ 135
Query: 101 ILHFDIKPHNILLDEDFCPKISDFGL-AKICHGRESIVSMTGARGTVGYIAPEVFCRN-F 158
++H DIK N+LL D K++DFG A+I + +M GT ++APEV R +
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAY 192
Query: 159 GEVSYKSDVYSYGMMVFEM 177
G K D++S G+M EM
Sbjct: 193 GP---KVDIWSLGIMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 22/149 (14%)
Query: 40 CFEGHRRALI-YEFVSNGSLEKFIYE-KHPLETN-QKLKWEVLYKIAVGIARGLEYLHRG 96
C E + Y +++ G+L+ F+ + + N Q L + L +A+ IA G+ YLH+
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK- 135
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKI-------CHGRESIVSMTGARGTVGYI 149
++H DI N ++DE+ KI+D L++ C G V ++
Sbjct: 136 --RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG-------DNENRPVKWM 186
Query: 150 APEVFCRNFGEVSYKSDVYSYGMMVFEMT 178
A E S SDV+S+G++++E+
Sbjct: 187 ALESLVNKE--YSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 34/91 (37%), Positives = 48/91 (52%), Gaps = 12/91 (13%)
Query: 89 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGY 148
G+++LH + I+H D+KP NI++ D KI DFGLA+ MT T Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYY 183
Query: 149 IAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
APEV G + YK D++S G ++ EM
Sbjct: 184 RAPEVI---LG-MGYKENVDIWSVGCIMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT 145
I L+YLH +++ D+K N++LD+D KI+DFGL K G + +M GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159
Query: 146 VGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
Y+APEV N + D + G++++EM
Sbjct: 160 PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 32/94 (34%), Positives = 53/94 (56%), Gaps = 14/94 (14%)
Query: 88 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARG--T 145
RGL Y H+ +ILH D+KP N+L++E K++DFGLA+ +S+ + T + T
Sbjct: 114 RGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARA----KSVPTKTYSNEVVT 166
Query: 146 VGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
+ Y P+V G Y + D++ G +++EM
Sbjct: 167 LWYRPPDVL---LGSTEYSTPIDMWGVGCILYEM 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 37/146 (25%), Positives = 67/146 (45%), Gaps = 11/146 (7%)
Query: 38 GFCFEGHRRALIYEFVSNGSLEKF-----IYEKHPLETN-QKLKWEVLYKIAVGIARGLE 91
G C +I E++ NG L +F I N + L +AV IA G++
Sbjct: 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMK 143
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAP 151
YL + +H D+ N L+ + KI+DFG+++ + + A + ++A
Sbjct: 144 YL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAW 200
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEM 177
E G+ + SDV+++G+ ++EM
Sbjct: 201 ESIL--LGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 21/142 (14%)
Query: 88 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARG--T 145
RGL Y HR ++LH D+KP N+L++E K++DFGLA+ +SI + T + T
Sbjct: 115 RGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARA----KSIPTKTYSNEVVT 167
Query: 146 VGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYK 202
+ Y P++ G Y + D++ G + +EM TG V+ H++++
Sbjct: 168 LWYRPPDIL---LGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL-----HFIFR 219
Query: 203 RLELEEDLGLQGI-ENEEDKEY 223
L + GI NEE K Y
Sbjct: 220 ILGTPTEETWPGILSNEEFKSY 241
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 21/43 (48%), Positives = 30/43 (69%), Gaps = 4/43 (9%)
Query: 88 RGLEYLHRGCNTRILHFDIKPHNILLD-EDFCPKISDFGLAKI 129
RGL+Y+H + +LH D+KP N+ ++ ED KI DFGLA+I
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 37/131 (28%), Positives = 67/131 (51%), Gaps = 12/131 (9%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVG-IARGLEYLHRGCNTRILHFDI 106
LI ++++ G L + ++ + + +I G I LE+LH+ I++ DI
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQE-------VQIYSGEIVLALEHLHK---LGIIYRDI 131
Query: 107 KPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSD 166
K NILLD + ++DFGL+K H E + + GT+ Y+AP++ G D
Sbjct: 132 KLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-GTIEYMAPDIVRGGDGGHDKAVD 190
Query: 167 VYSYGMMVFEM 177
+S G++++E+
Sbjct: 191 WWSMGVLMYEL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 36/106 (33%), Positives = 54/106 (50%), Gaps = 30/106 (28%)
Query: 90 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMT--------- 140
LEYLH N I+H D+KP N+L+ K++DFGL+KI ++S+T
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI-----GLMSLTTNLYEGHIE 165
Query: 141 -GAR--------GTVGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFE 176
R GT YIAPEV R +G+ D ++ G++++E
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT 145
+ARG+E+L + +H D+ N+LL + KI DFGLA+ + VS
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 146 VGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
V ++APE N + SDV+SYG++++E+
Sbjct: 303 VKWMAPESIFDNL--YTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-06
Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 49/209 (23%)
Query: 5 FKNKLGQGGYGGVYK------GKLLDGRNVAIKVLNETKGFCFEG--------HRRALIY 50
++LG+G YG VYK G + + + ++ L+E+K F H+ Y
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESK---FNQIIMELDILHKAVSPY 60
Query: 51 ------------------EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEY 92
E++ GSL+K E + +VL +I + +GL++
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATE---GIPEDVLRRITYAVVKGLKF 117
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPE 152
L N I+H D+KP N+L++ + K+ DFG++ + ++ T G Y+APE
Sbjct: 118 LKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSG---NLVASLAKTNI-GCQSYMAPE 171
Query: 153 VF----CRNFGEVSYKSDVYSYGMMVFEM 177
+ +SDV+S G+ + EM
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR---GTVGYI 149
+H + ++H DIK NILL + K+ DFG +K+ + VS R GT Y+
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM---YAATVSDDVGRTFCGTPYYV 212
Query: 150 APEVFCRNFGEVSYKSDVYSYGMMVFEMTGVK 181
APE++ R S K+D++S G++++E+ +K
Sbjct: 213 APEIWRRK--PYSKKADMFSLGVLLYELLTLK 242
|
Length = 496 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 6e-06
Identities = 42/140 (30%), Positives = 69/140 (49%), Gaps = 16/140 (11%)
Query: 40 CFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RGC 97
CF+ R + EFVS G L ++ +KL E + I+ L +LH RG
Sbjct: 64 CFQTESRLFFVIEFVSGGDL------MFHMQRQRKLPEEHARFYSAEISLALNFLHERG- 116
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
I++ D+K N+LLD + K++D+G+ K G + + GT YIAPE+
Sbjct: 117 ---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEIL--R 169
Query: 158 FGEVSYKSDVYSYGMMVFEM 177
+ + D ++ G+++FEM
Sbjct: 170 GEDYGFSVDWWALGVLMFEM 189
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 6e-06
Identities = 43/141 (30%), Positives = 69/141 (48%), Gaps = 18/141 (12%)
Query: 40 CFEGHRRAL-IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
CF+ R + E+V+ G L I + + Y V +A L +LHR
Sbjct: 64 CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS----RFYAAEVTLA--LMFLHR--- 114
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
+++ D+K NILLD + K++DFG+ K G + V+ T GT YIAPE+
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEI----L 168
Query: 159 GEVSYKSDV--YSYGMMVFEM 177
E+ Y V ++ G++++EM
Sbjct: 169 QELEYGPSVDWWALGVLMYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 6e-06
Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 51/282 (18%)
Query: 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------- 37
+++G G +G V G+ G + A V+ E +
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 38 -GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
G C E L+ EF G L+ ++ + K +VL ++A +A GL +LH+
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVASGLLWLHQ- 118
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156
+H D+ N L D KI D+GLA + + ++ + ++APE+
Sbjct: 119 --ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV-E 175
Query: 157 NFG------EVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210
G + + KS+++S G+ ++E+ D S E V K++ E+D+
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELF--TAADQPYPDLSDE-----QVLKQVVREQDI 228
Query: 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252
L + + D +Y+ + V +C +P RP V E+L
Sbjct: 229 KLP--KPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 57/208 (27%)
Query: 8 KLGQGGYGGVYKGKLLD-GRNVAIK--------------------VLNETK--------G 38
K+G+G YG V+K K + VA+K +L E K
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
+ L++E+ L+K+ N + E++ + +GL + H +
Sbjct: 67 VLHSDKKLTLVFEYCDQ-DLKKYFDS-----CNGDIDPEIVKSFMFQLLKGLAFCH---S 117
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKI------CHGRESIVSMTGARGTVGYIAPE 152
+LH D+KP N+L++++ K++DFGLA+ C+ E + T+ Y P+
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--------TLWYRPPD 169
Query: 153 VFCRNFGEVSYKS--DVYSYGMMVFEMT 178
V FG Y + D++S G + E+
Sbjct: 170 VL---FGAKLYSTSIDMWSAGCIFAELA 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYK-IAVG-----IARGLEYLHRGCNTRI 101
LI E+ S G L K I Q+LK + ++ VG I L+ +H + ++
Sbjct: 142 LIMEYGSGGDLNKQI--------KQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKM 190
Query: 102 LHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEV 161
+H D+K NI L K+ DFG +K S+ + GT Y+APE++ R
Sbjct: 191 MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK--RY 248
Query: 162 SYKSDVYSYGMMVFEM 177
S K+D++S G++++E+
Sbjct: 249 SKKADMWSLGVILYEL 264
|
Length = 478 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 9e-06
Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 41/199 (20%)
Query: 8 KLGQGGYGGVYKGKLLD-GRNVAIKVLNETKGFCFEGHRRALIY---------------- 50
++G G YG VYK + ++ G AIKV+ G F ++ +I
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 51 ----------EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
EF GSL+ + PL +Q + ++ +GL YLH +
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQ------IAYVSRETLQGLYYLH---SKG 126
Query: 101 ILHFDIKPHNILLDEDFCPKISDFGL-AKICHGRESIVSMTGARGTVGYIAPEVFC-RNF 158
+H DIK NILL ++ K++DFG+ A+I +I GT ++APEV
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQIT---ATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 159 GEVSYKSDVYSYGMMVFEM 177
G + D+++ G+ E+
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 34/91 (37%), Positives = 46/91 (50%), Gaps = 9/91 (9%)
Query: 89 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGY 148
GL Y H LH DIK NILL+ K++DFGLA++ + ES T T+ Y
Sbjct: 128 GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWY 183
Query: 149 IAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
PE+ GE Y DV+S G ++ E+
Sbjct: 184 RPPELL---LGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 37/118 (31%), Positives = 57/118 (48%), Gaps = 12/118 (10%)
Query: 63 YEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-FCPKI 121
Y KH N L ++ + + R L Y+H + I H D+KP N+L+D + K+
Sbjct: 156 YMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKL 212
Query: 122 SDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
DFG AK + VS +R Y APE+ G +Y + D++S G ++ EM
Sbjct: 213 CDFGSAKNLLAGQRSVSYICSR---FYRAPELM---LGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 34/125 (27%), Positives = 48/125 (38%), Gaps = 49/125 (39%)
Query: 90 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-------------ICHGRESI 136
L Y+HR DIKP N+LLD K+SDFGL + H S
Sbjct: 120 LGYIHR---------DIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 137 VSMTGAR-----------------------GTVGYIAPEVFCRN-FGEVSYKSDVYSYGM 172
++ GT YIAPEVF + + + D +S G+
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE---CDWWSLGV 227
Query: 173 MVFEM 177
+++EM
Sbjct: 228 IMYEM 232
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 50/208 (24%)
Query: 9 LGQGGYGGVYK-GKLLDGRNVAIKVLNETK--------------------------GFCF 41
+G+G YG V+K +G A+K+L+ G +
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 42 E-----GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
+ G + L+ E + GS+ + K L+ ++++ ++ I GL++LH
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLV--KGFLKRGERMEEPIIAYILHEALMGLQHLH-- 141
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFG----LAKICHGRESIVSMTGARGTVGYIAPE 152
+ +H D+K +NILL + K+ DFG L R + V GT ++APE
Sbjct: 142 -VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV------GTPFWMAPE 194
Query: 153 VF-CRNFGEVSY--KSDVYSYGMMVFEM 177
V C + +Y + DV+S G+ E+
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 56/200 (28%), Positives = 85/200 (42%), Gaps = 44/200 (22%)
Query: 9 LGQGGYGGVYKGKL-LDGRNVAIKVLNETKGFCFEGHRRALIYEFVSNGSLEKFIYEKHP 67
+G+G +G V K LDG+ A+KVL + +R+ + L K + KHP
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL----NRKEQKHIMAERNVLLKNV--KHP 56
Query: 68 L--------ETNQKLKW--------EVLYKI--------------AVGIARGLEYLHRGC 97
+T +KL + E+ + + A IA L YLH
Sbjct: 57 FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH--- 113
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
+ I++ D+KP NILLD ++DFGL K G + T GT Y+APEV +
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 158 FGEVSYKSDVYSYGMMVFEM 177
D + G +++EM
Sbjct: 172 --PYDNTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 2e-05
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 10/92 (10%)
Query: 88 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVG 147
G+ +LH ILH D+K N+LL+ KI DFGLA+ + T T+
Sbjct: 117 SGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREY--GSPLKPYTQLVVTLW 171
Query: 148 YIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM 177
Y APE+ G Y D++S G + E+
Sbjct: 172 YRAPELL---LGAKEYSTAIDMWSVGCIFAEL 200
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 43/142 (30%), Positives = 70/142 (49%), Gaps = 20/142 (14%)
Query: 40 CFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
CF+ R + E+V+ G L I + K V Y A IA GL +LH +
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQIQQVGRF----KEPHAVFY--AAEIAIGLFFLH---S 119
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI---VSMTGARGTVGYIAPEVFC 155
I++ D+K N++LD + KI+DFG+ K E++ V+ GT YIAPE+
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENMWDGVTTKTFCGTPDYIAPEIIA 174
Query: 156 RNFGEVSYKSDVYSYGMMVFEM 177
+ D +++G++++EM
Sbjct: 175 --YQPYGKSVDWWAFGVLLYEM 194
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 48/205 (23%), Positives = 82/205 (40%), Gaps = 39/205 (19%)
Query: 8 KLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------------ 37
++G G +G V G++ G A V+ E +
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
G C E L+ EF G L+ ++ E L ++A IA GL +LH+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAE-LMTPDPTTLQRMACEIALGLLHLHK-- 118
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
+H D+ N LL D KI D+GL+ + + V+ + +IAPE+
Sbjct: 119 -NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 158 FGEV-----SYKSDVYSYGMMVFEM 177
G + + +S+V+S G+ ++E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 39/143 (27%), Positives = 71/143 (49%), Gaps = 16/143 (11%)
Query: 42 EGHRRALIYEFVSNGSL-EKFIYEKHPLETNQK-LKWEVLYKIAVGIARGLEYLHRGCNT 99
+GH ++ E+ G L +K ++ L L+W V + G++++H
Sbjct: 70 DGHLY-IVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHE---K 119
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFG 159
R+LH DIK NI L ++ K+ DFG A++ + GT Y+ PE++ N
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY--VGTPYYVPPEIW-ENM- 175
Query: 160 EVSYKSDVYSYGMMVFEMTGVKN 182
+ KSD++S G +++E+ +K+
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKH 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 32/135 (23%), Positives = 66/135 (48%), Gaps = 17/135 (12%)
Query: 45 RRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHF 104
R +LI E+ + G L + + + + L ++ +A+ +GL L++ N +
Sbjct: 96 RLSLILEYCTRGYLREVLDK------EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YK 147
Query: 105 DIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR--GTVGYIAPEVFCRNFGEVS 162
++ + L+ E++ KI ICHG E I+S + + Y + ++ F E +
Sbjct: 148 NLTSVSFLVTENYKLKI-------ICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYT 200
Query: 163 YKSDVYSYGMMVFEM 177
K D+YS G++++E+
Sbjct: 201 IKDDIYSLGVVLWEI 215
|
Length = 283 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 7/95 (7%)
Query: 83 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGA 142
A +A + YLH + I++ D+KP NILLD ++DFGL K G E + +
Sbjct: 102 AAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTF 156
Query: 143 RGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
GT Y+APEV + D + G +++EM
Sbjct: 157 CGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-05
Identities = 53/199 (26%), Positives = 80/199 (40%), Gaps = 41/199 (20%)
Query: 8 KLGQGGYGGVYKG-KLLDGRNVAIKVLNETKGFCFE------------GHRRALIY---- 50
++G G YG VYK L G A+K++ G F H + Y
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 51 ----------EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
E+ GSL+ + PL Q + + +GL YLH
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSELQ------IAYVCRETLQGLAYLHSKGK-- 127
Query: 101 ILHFDIKPHNILLDEDFCPKISDFGL-AKICHGRESIVSMTGARGTVGYIAPEVFC-RNF 158
+H DIK NILL ++ K++DFG+ AKI +I GT ++APEV
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKIT---ATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 159 GEVSYKSDVYSYGMMVFEM 177
G + D+++ G+ E+
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 48/175 (27%), Positives = 68/175 (38%), Gaps = 49/175 (28%)
Query: 39 FCFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
+ F+ R LI EF+ G + + +K L + +A+ L ++HR
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHR-- 125
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLA---KICHGRE-------------SIVSMTG 141
DIKP N+LLD K+SDFGL K H E S +M
Sbjct: 126 -------DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 142 AR-----------------GTVGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
R GT YIAPEVF + Y D +S G++++EM
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFM----QTGYNKLCDWWSLGVIMYEM 229
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 21/49 (42%), Positives = 32/49 (65%), Gaps = 3/49 (6%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134
+A L+YLHR I+H D+KP N+L+ + K++DFGL+K+ RE
Sbjct: 113 VALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 6e-05
Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 22/109 (20%)
Query: 82 IAVGIARGLEYLH-RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMT 140
I + L YLH RG I+H D+K NI LDE + DFG A C +
Sbjct: 190 IQRRLLEALAYLHGRG----IIHRDVKTENIFLDEPENAVLGDFGAA--CKLDAHPDTPQ 243
Query: 141 --GARGTVGYIAPEV-----FCRNFGEVSYKSDVYSYGMMVFEMTGVKN 182
G GT+ +PE+ +C K+D++S G+++FEM+ VKN
Sbjct: 244 CYGWSGTLETNSPELLALDPYCA-------KTDIWSAGLVLFEMS-VKN 284
|
Length = 392 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 45/165 (27%), Positives = 65/165 (39%), Gaps = 48/165 (29%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107
LI EF+ G + + +K L + + +A+ L ++HR DIK
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHR---------DIK 128
Query: 108 PHNILLDEDFCPKISDFGLA---KICHGRE-------------SIVSMTGAR-------- 143
P N+LLD K+SDFGL K H E + +M R
Sbjct: 129 PDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRN 188
Query: 144 ---------GTVGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
GT YIAPEVF + Y D +S G++++EM
Sbjct: 189 RRQLAFSTVGTPDYIAPEVFMQT----GYNKLCDWWSLGVIMYEM 229
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 8e-05
Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 16/102 (15%)
Query: 78 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137
+LY++ GI ++LH + I+H D+KP NI++ D KI DFGLA+ +
Sbjct: 128 LLYQMLCGI----KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNF 177
Query: 138 SMTGARGTVGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
MT T Y APEV + YK D++S G ++ E+
Sbjct: 178 MMTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 26/81 (32%), Positives = 45/81 (55%), Gaps = 4/81 (4%)
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR--- 156
+H DIKP N+LLD + +++DFG + + ++ V + A GT YI+PE+
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 157 NFGEVSYKSDVYSYGMMVFEM 177
G+ + D +S G+ ++EM
Sbjct: 181 GMGKYGPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 33/95 (34%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 83 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGA 142
A IA L YLH + I++ D+KP NILLD ++DFGL K E + +
Sbjct: 102 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTF 156
Query: 143 RGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
GT Y+APEV + D + G +++EM
Sbjct: 157 CGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 16/102 (15%)
Query: 78 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137
+LY++ GI ++LH + I+H D+KP NI++ D KI DFGLA+ +
Sbjct: 124 LLYQMLCGI----KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSF 173
Query: 138 SMTGARGTVGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
MT T Y APEV + YK D++S G ++ EM
Sbjct: 174 MMTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 30/105 (28%), Positives = 54/105 (51%), Gaps = 7/105 (6%)
Query: 74 LKWEVLYKIAVGIARGLEYL-HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132
L + L + +A G+E+L + C +H D+ N+L+ E KI DFGLA+
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMR 291
Query: 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
+ +S + ++APE N + SDV+S+G++++E+
Sbjct: 292 DSNYISKGSTFLPLKWMAPESIFNNL--YTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 40 CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQK-----LKWEVLYKIAVGIARGLEYLH 94
C +I E++ NG L +F+ P E +K + + L +A IA G++YL
Sbjct: 88 CITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS 147
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128
+ +H D+ N L+ +++ KI+DFG+++
Sbjct: 148 ---SLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 29/80 (36%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 102 LHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC--RNFG 159
+H DIKP N+L+D K++DFG A + + S GT YIAPEV G
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTMNGDG 182
Query: 160 EVSY--KSDVYSYGMMVFEM 177
+ +Y + D +S G++ +EM
Sbjct: 183 KGTYGVECDWWSLGVIAYEM 202
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 16/102 (15%)
Query: 78 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137
+LY++ GI ++LH + I+H D+KP NI++ D KI DFGLA+ +
Sbjct: 131 LLYQMLCGI----KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSF 180
Query: 138 SMTGARGTVGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
MT T Y APEV + YK D++S G ++ EM
Sbjct: 181 MMTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGEM 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 5e-04
Identities = 43/205 (20%), Positives = 84/205 (40%), Gaps = 40/205 (19%)
Query: 8 KLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------------ 37
++G G +G V ++ VA V+ E K
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
G C E L++E+ G L+ ++ ++ N +L +L ++A IA G+ ++H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL--LLQRMACEIAAGVTHMHK-- 117
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
LH D+ N L D K+ D+G+ + + I + + ++APE+
Sbjct: 118 -HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 158 FG-----EVSYKSDVYSYGMMVFEM 177
G E + S+V++ G+ ++E+
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 6e-04
Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 24/160 (15%)
Query: 26 RNVAIKVLNETKGFCFEGHRRALIYEFVSNGSLEKFIYEK-HPLETNQKLKWEVLYKIAV 84
R V+ K + G C ++ EFV G L+ F++ K L T K +K+A
Sbjct: 59 RQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK------FKVAK 112
Query: 85 GIARGLEYLHRGCNTRILHFDIKPHNILL-----DEDFCP--KISDFGLAKICHGRESIV 137
+A L YL + ++H ++ NILL D + P K+SD G+ R+ V
Sbjct: 113 QLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECV 169
Query: 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
+ +IAPE + +S +D +S+G ++E+
Sbjct: 170 E------RIPWIAPEC-VEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 6e-04
Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 13/99 (13%)
Query: 82 IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTG 141
IA+ L Y+HR DIKP NIL+D + +++DFG + + + V +
Sbjct: 113 IAIDSVHQLHYVHR---------DIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSV 162
Query: 142 ARGTVGYIAPEVF-CRNFGEVSY--KSDVYSYGMMVFEM 177
A GT YI+PE+ G+ Y + D +S G+ ++EM
Sbjct: 163 AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 6e-04
Identities = 35/131 (26%), Positives = 49/131 (37%), Gaps = 50/131 (38%)
Query: 90 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL----------------------- 126
+E +H +H DIKP NIL+D D K++DFGL
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 127 -------AKICHGRESIVSMTGAR-----------GTVGYIAPEVFCRNFGEVSYKS--D 166
++I R + R GT YIAPEV R Y D
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR----TGYTQLCD 226
Query: 167 VYSYGMMVFEM 177
+S G++++EM
Sbjct: 227 WWSVGVILYEM 237
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 8e-04
Identities = 35/138 (25%), Positives = 67/138 (48%), Gaps = 18/138 (13%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR-GCNTRILHFDI 106
+I F++ GS + P ++ L +L+ G RGL YLH+ G +H +I
Sbjct: 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILF----GALRGLNYLHQNGY----IHRNI 127
Query: 107 KPHNILLDEDFCPKISDFGLAK----ICHGRESIVSM---TGARGTVGYIAPEVFCRNFG 159
K +IL+ D +S GL+ + +G+++ V + + +++PE+ ++
Sbjct: 128 KASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY 185
Query: 160 EVSYKSDVYSYGMMVFEM 177
+ KSD+YS G+ E+
Sbjct: 186 GYNVKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.001
Identities = 35/116 (30%), Positives = 47/116 (40%), Gaps = 32/116 (27%)
Query: 89 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC---------HGR------ 133
LEYLH I++ D+KP NILL E +SDF L+K R
Sbjct: 115 ALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 134 -------ESIVSMTGAR-----GTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
E+ R GT YIAPEV G D ++ G++++EM
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVI-SGDGH-GSAVDWWTLGILLYEM 225
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 44/148 (29%), Positives = 65/148 (43%), Gaps = 14/148 (9%)
Query: 40 CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYK-IAVGIARGLEYLHRGCN 98
C R + Y F+ LEK + + K K + L K I + LEY+H
Sbjct: 91 CGSFKRCRMYYRFIL---LEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIH---E 144
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAK--ICHGRE---SIVSMTGARGTVGYIAPEV 153
I H DIKP NI++D + I D+G+A I HG+ S RGT+ Y +
Sbjct: 145 HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLD- 203
Query: 154 FCRNFGEVSYKSDVYSYGMMVFEMTGVK 181
N V+ + D+ S G + + G+K
Sbjct: 204 -AHNGACVTRRGDLESLGYCMLKWAGIK 230
|
Length = 294 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 34/120 (28%), Positives = 47/120 (39%), Gaps = 47/120 (39%)
Query: 102 LHFDIKPHNILLDEDFCPKISDFGLAKICH----------------------GRESIV-- 137
+H DIKP NIL+D K+SDFGL+ H R S+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182
Query: 138 ----SMTG--------------ARGTVG---YIAPEVFCRNFGEVSYKSDVYSYGMMVFE 176
+M+ A TVG YIAPE+F + + D +S G ++FE
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.002
Identities = 37/134 (27%), Positives = 62/134 (46%), Gaps = 24/134 (17%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107
LI +++ +G L + ++ L ++K KI + L LH I+H DIK
Sbjct: 86 LIMDYIKDGDLFDLLKKEGKLSE-AEVK-----KIIRQLVEALNDLH---KHNIIHNDIK 136
Query: 108 PHNILLDEDFCPK----ISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSY 163
N+L D K + D+GL KI G S GT+ Y +PE + +VS+
Sbjct: 137 LENVLYDR---AKDRIYLCDYGLCKII-GTPSCY-----DGTLDYFSPEKIKGHNYDVSF 187
Query: 164 KSDVYSYGMMVFEM 177
D ++ G++ +E+
Sbjct: 188 --DWWAVGVLTYEL 199
|
Length = 267 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 46/209 (22%)
Query: 8 KLGQGGYGGVYKGKLLDGRN---VAIKVLNETKGFCFEGHRR-ALIYEFVSNG--SLEK- 60
K+G+G YG VYK K DG++ A+K + E G R AL+ E SL+K
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI-EGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 61 ------------FIYEKHPL----------ETNQK---LKWEVLYKIAVGIARGLEYLHR 95
F Y +H L + N+K L ++ + I G+ YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 96 GCNTRILHFDIKPHNILL----DEDFCPKISDFGLAKICHGR-ESIVSMTGARGTVGYIA 150
+LH D+KP NIL+ E KI+D G A++ + + + + T Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 151 PEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
PE+ G Y D+++ G + E+
Sbjct: 184 PELL---LGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 42/155 (27%), Positives = 65/155 (41%), Gaps = 26/155 (16%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR---GCN-TRILH 103
++ EF G L + I + + + K++ + I + L Y H G N R+LH
Sbjct: 91 ILMEFCDAGDLSRNIQKCYKMFG--KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLH 148
Query: 104 FDIKPHNILLDEDF-----------------CPKISDFGLAKICHGRESIVSMTGARGTV 146
D+KP NI L KI DFGL+K G ES+ GT
Sbjct: 149 RDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI-GIESMAH--SCVGTP 205
Query: 147 GYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVK 181
Y +PE+ KSD+++ G +++E+ K
Sbjct: 206 YYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 13/91 (14%)
Query: 90 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYI 149
L Y+HR DIKP N+LLD++ +++DFG ++ S A GT YI
Sbjct: 121 LGYVHR---------DIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV-AVGTPDYI 170
Query: 150 APEVF-CRNFGEVSY--KSDVYSYGMMVFEM 177
+PE+ G+ Y + D +S G+ ++EM
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 54/213 (25%)
Query: 8 KLGQGGYGGVYKGKLLDGRN---VAIKVLNETKGFCFEGHRR-ALIYE------------ 51
K+G+G YG VYK K DG++ A+K + E G R AL+ E
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI-EGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 52 FVSNGSLEK---FIYEKH-----------------PLETNQKLKWEVLYKIAVGIARGLE 91
F+S+ + F Y +H P++ + + +LY+I GI
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI----H 122
Query: 92 YLHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAKICHGR-ESIVSMTGARGTV 146
YLH +LH D+KP NIL+ E KI+D G A++ + + + + T
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 147 GYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
Y APE+ G Y D+++ G + E+
Sbjct: 180 WYRAPELL---LGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 291 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.58 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.48 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.42 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.12 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.11 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.03 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.94 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.94 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.91 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.89 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.86 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.79 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.69 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.65 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.64 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.57 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.48 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.3 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.28 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.14 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.97 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.83 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.78 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.64 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.51 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.46 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.38 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.17 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.17 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 97.16 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.14 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.06 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.06 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.0 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.96 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.9 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.84 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.81 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.78 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 96.53 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.35 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.13 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.06 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.88 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.64 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.54 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.45 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.44 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.32 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.2 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.15 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.65 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.39 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.38 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.36 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.34 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.32 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.08 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.73 | |
| PLN02236 | 344 | choline kinase | 93.43 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=307.26 Aligned_cols=222 Identities=27% Similarity=0.403 Sum_probs=180.3
Q ss_pred hcccccCCceeEEEEEecC-CCeEEEEEeccCc---------------------------ceeecCC-cceeeehhhcCC
Q 022826 6 KNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK---------------------------GFCFEGH-RRALIYEFVSNG 56 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---------------------------~~~~~~~-~~~lv~e~~~~g 56 (291)
...||+|..|+||+++++. ++.+|+|++.... +.+..+. ...++|||+++|
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG 163 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG 163 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence 4679999999999998864 8999999995433 5555566 599999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
||.+++... +++++....+|+.+|++||.|||. +.+|+||||||+||+++..|.+||+|||++..+.+.
T Consensus 164 SLd~~~k~~------g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 164 SLDDILKRV------GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 999999765 589999999999999999999994 299999999999999999999999999999876554
Q ss_pred eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 137 VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
......||..|||||.+.+. .|+.++||||||++++|+.+|+.|+........ -. ......+.....+
T Consensus 233 -~a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~---~~------~~Ll~~Iv~~ppP 300 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL---DI------FELLCAIVDEPPP 300 (364)
T ss_pred -hcccccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCCcCCCCC---CH------HHHHHHHhcCCCC
Confidence 23556789999999999997 899999999999999999999999887621111 01 1111112111111
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......++.++..|+..||++||.+|||++||++
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1112258999999999999999999999999876
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=318.39 Aligned_cols=220 Identities=26% Similarity=0.400 Sum_probs=188.7
Q ss_pred chhhcccccCCceeEEEEEe-cCCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKL-LDGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+..++.||+|+|+.+|++++ ..|+.||+|+++++. .++.+.+..|+|+|+
T Consensus 20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLEL 99 (592)
T KOG0575|consen 20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLEL 99 (592)
T ss_pred eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEe
Confidence 56789999999999999988 669999999998744 788899999999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
|..++|..+++.+ ..+.+..++.+++||+.||.|||+ .+|+|||||..|+|++++-++||+|||+|..+..
T Consensus 100 C~~~sL~el~Krr------k~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 100 CHRGSLMELLKRR------KPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred cCCccHHHHHHhc------CCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999865 589999999999999999999999 9999999999999999999999999999998875
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
.... ....||||.|+|||++... ..+..+||||+||+||-|+.|++||....- ......+....
T Consensus 171 ~~Er--k~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~v--------kety~~Ik~~~---- 234 (592)
T KOG0575|consen 171 DGER--KKTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKTV--------KETYNKIKLNE---- 234 (592)
T ss_pred cccc--cceecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccchH--------HHHHHHHHhcC----
Confidence 5332 3678999999999999865 899999999999999999999999986521 11112222111
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
-..+...+.+..+||.++|+.||.+|||+++++.-
T Consensus 235 ----Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 ----YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ----cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22334677889999999999999999999999863
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=298.90 Aligned_cols=220 Identities=25% Similarity=0.394 Sum_probs=177.7
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||.|+||+||+|++.+ +..||||.+.++. +++..++..++|||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 4566789999999999998865 8999999998874 6777888999999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC------CceEEeccCCc
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED------FCPKISDFGLA 127 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~------~~~kl~Dfg~~ 127 (291)
+||+|.++++.+ .++++..+++++.||+.||++||+ ++||||||||+||+++.. ..+||+|||++
T Consensus 92 ~gGDLs~yi~~~------~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 92 NGGDLSDYIRRR------GRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999876 589999999999999999999999 999999999999999764 56899999999
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
+.+.++.. ....||+|.|||||++..+ .|+.|+|+||+|+++|++++|..||+..... +......
T Consensus 163 R~L~~~~~---a~tlcGSplYMAPEV~~~~--~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~--------eL~~~~~-- 227 (429)
T KOG0595|consen 163 RFLQPGSM---AETLCGSPLYMAPEVIMSQ--QYDAKADLWSIGTILYQCLTGKPPFDAETPK--------ELLLYIK-- 227 (429)
T ss_pred hhCCchhH---HHHhhCCccccCHHHHHhc--cccchhhHHHHHHHHHHHHhCCCCccccCHH--------HHHHHHh--
Confidence 98876543 4668899999999999865 8999999999999999999999999855321 1111111
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVV 249 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell 249 (291)
.........+...+..+.+++...|+.+|.+|.+..+-+
T Consensus 228 ---k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 228 ---KGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred ---ccccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 111111223344555566777778888888887666543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=299.43 Aligned_cols=225 Identities=26% Similarity=0.379 Sum_probs=181.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------------ceeecCCccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------------GFCFEGHRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------------~~~~~~~~~~l 48 (291)
+-+.+.||+|+||.|-+|..+ +++.||||++++.. +++......|+
T Consensus 174 yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Ym 253 (475)
T KOG0615|consen 174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYM 253 (475)
T ss_pred eEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEE
Confidence 345789999999999999765 49999999998655 67777788899
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC---CceEEeccC
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED---FCPKISDFG 125 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~---~~~kl~Dfg 125 (291)
||||++||.|.+.+-.+ ..+.+..-..+++|++.|+.|||+ +||+||||||+||+++.+ --+||+|||
T Consensus 254 VlE~v~GGeLfd~vv~n------k~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 254 VLEYVEGGELFDKVVAN------KYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred EEEEecCccHHHHHHhc------cccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999765 467777789999999999999999 999999999999999766 578999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCcc-ccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVS-YKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRL 204 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~-~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~ 204 (291)
++....++. .....||||.|.|||++.+....+. .++||||+||++|-+++|-.||........ ...++
T Consensus 325 lAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-------l~eQI 394 (475)
T KOG0615|consen 325 LAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-------LKEQI 394 (475)
T ss_pred hhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-------HHHHH
Confidence 999765433 4578999999999999987644444 489999999999999999999986543210 01111
Q ss_pred hhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 205 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. +... .....-...+++.++||.+||..||++|||+.|+|+
T Consensus 395 ~~-G~y~---f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 395 LK-GRYA---FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hc-Cccc---ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 11 1111 112334568999999999999999999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=299.83 Aligned_cols=239 Identities=31% Similarity=0.485 Sum_probs=192.4
Q ss_pred hhhcccccCCceeEEEEEecCCCeEEEEEeccCc----------------------------ceeecCC-cceeeehhhc
Q 022826 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------GFCFEGH-RRALIYEFVS 54 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------------~~~~~~~-~~~lv~e~~~ 54 (291)
.+.+.||+|+||+||+|.+.....||+|++.... +.+.+.. ..++||||+.
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3467799999999999999554459999998632 6666666 7899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCC-eeeeccCCCceEEcCCC-ceEEeccCCccccCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR-ILHFDIKPHNILLDEDF-CPKISDFGLAKICHG 132 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~-ivH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~ 132 (291)
+|+|.+++... ....+++..+..|+.||+.|+.|||+ .+ |||+|||++||+++.++ ++||+|||+++....
T Consensus 124 ~GsL~~~l~~~----~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 124 GGSLSVLLHKK----RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999773 34799999999999999999999999 88 99999999999999997 999999999986543
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
.. ...+...||+.|+|||++.+....++.++||||||+++|||++|+.||...... ........
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--------------~~~~~v~~ 260 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--------------QVASAVVV 260 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--------------HHHHHHHh
Confidence 22 223446789999999999853248999999999999999999999998876431 11111112
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCCCC
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRP 265 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 265 (291)
.+.+...+..+...+..++.+||+.||+.||++.+++..|+.+..........
T Consensus 261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~ 313 (362)
T KOG0192|consen 261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPE 313 (362)
T ss_pred cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCcc
Confidence 22233334447788999999999999999999999999999988766654333
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=283.78 Aligned_cols=232 Identities=24% Similarity=0.396 Sum_probs=186.1
Q ss_pred chhhcccccCCceeEEEEEe-cCCCeEEEEEeccCc------------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKL-LDGRNVAIKVLNETK------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e 51 (291)
+.+.++||.|+||+||++.+ .+|..+|.|.++-.. .+..+++-.+||||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE 100 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME 100 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence 45678999999999999965 569999999987433 23344455889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCC-CCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC-NTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~-~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
+|..|+|...++... .....+++..+|+++.|++.||.++|+-- -.-|.||||||.|||++.+|.+||+|||+++.+
T Consensus 101 ~c~~GDLsqmIk~~K--~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 101 LCDAGDLSQMIKHFK--KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred hhcccCHHHHHHHHH--hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999997753 45678999999999999999999999811 133899999999999999999999999999988
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
.+... ......|||.||+||.+.+. .|+.++||||+||++|||+....||....- .... ..+
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--------~~L~------~KI 240 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYGDNL--------LSLC------KKI 240 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCcccccH--------HHHH------HHH
Confidence 66543 23456789999999999887 999999999999999999999999987611 0111 122
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
.....+.-....++..+..|+..|+..||+.||+...+++.+..
T Consensus 241 ~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 241 EQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 22222223346799999999999999999999997777666654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=291.92 Aligned_cols=212 Identities=23% Similarity=0.297 Sum_probs=176.2
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehhh
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~ 53 (291)
.+.+.||+|+||.||.++.++ ++.+|+|++++.. .-+.+....|+|++|+
T Consensus 28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~ 107 (357)
T KOG0598|consen 28 EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYL 107 (357)
T ss_pred eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEecc
Confidence 345889999999999998765 9999999998776 4566788999999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.||.|..+|.+. ..|++..+.-++.+|+.||.|||+ ++||||||||+|||++.+|.++|+|||++......
T Consensus 108 ~GGeLf~hL~~e------g~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 108 NGGELFYHLQRE------GRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred CCccHHHHHHhc------CCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 999999999643 689999999999999999999999 99999999999999999999999999999854333
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
.. .....+||+.|+|||++.+. .++.++|.||||+++|+|++|..||....... ....+...
T Consensus 179 ~~--~t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~~~~--------------~~~~I~~~ 240 (357)
T KOG0598|consen 179 GD--ATRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK--------------MYDKILKG 240 (357)
T ss_pred CC--ccccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCccHHH--------------HHHHHhcC
Confidence 22 23557999999999999987 99999999999999999999999998664211 11111111
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCC
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRP 243 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp 243 (291)
.....+.-++.+.++++..+|+.||++|.
T Consensus 241 -k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 241 -KLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -cCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 11222344778899999999999999995
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=297.92 Aligned_cols=222 Identities=27% Similarity=0.380 Sum_probs=184.7
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e 51 (291)
+.+++.||.|+|++|++|.... ++.||||++.+.. ..+.+....|+|+|
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 4678999999999999998755 9999999988765 45667889999999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+++|+|.++++.. +.|++...+.++.+|+.||+|||+ .|||||||||+|||++.+++++|.|||.+..+.
T Consensus 155 ~A~nGdll~~i~K~------Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 155 YAPNGDLLDLIKKY------GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ecCCCcHHHHHHHh------CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 99999999999876 689999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCce---------ee--ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhh
Q 022826 132 GRESI---------VS--MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWV 200 (291)
Q Consensus 132 ~~~~~---------~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~ 200 (291)
..... .. .....||..|.+||++... ..++.+|||+|||++|.|+.|..||....+. ..
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--------li 295 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSDLWALGCILYQMLAGQPPFRAANEY--------LI 295 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCC--CCCcccchHHHHHHHHHHhcCCCCCccccHH--------HH
Confidence 42221 00 1335689999999999876 8899999999999999999999999876321 11
Q ss_pred hhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 201 YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.++ +..+. -+.++.+++.+.+|+++.|..||.+|+|+.+|.+.
T Consensus 296 Fqk---I~~l~-----y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 FQK---IQALD-----YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHH---HHHhc-----ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 111 11111 22344566788999999999999999999998764
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=295.49 Aligned_cols=249 Identities=42% Similarity=0.742 Sum_probs=194.0
Q ss_pred Ccchhh--cccccCCceeEEEEEecCCCeEEEEEeccC-----c---------------------ceeecCC-cceeeeh
Q 022826 1 MTNSFK--NKLGQGGYGGVYKGKLLDGRNVAIKVLNET-----K---------------------GFCFEGH-RRALIYE 51 (291)
Q Consensus 1 ~~~~~~--~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~---------------------~~~~~~~-~~~lv~e 51 (291)
||+++. +.||+|+||.||+|...++..||||.+... . ++|.+.. ..+||+|
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 467777 799999999999999988999999987652 2 7888888 4999999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+..|+|.++|.... .. .++|..+.+|+.++|+||+|||..+...|+|||||+.|||+|.++++||+|||+++...
T Consensus 153 ym~nGsL~d~L~~~~---~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKK---GE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred ccCCCCHHHHhCCCC---CC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 999999999997753 11 88999999999999999999999777789999999999999999999999999996544
Q ss_pred CCCceeeccCC-CCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh--hh
Q 022826 132 GRESIVSMTGA-RGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL--EE 208 (291)
Q Consensus 132 ~~~~~~~~~~~-~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 208 (291)
..... .... .||..|++||.+... ..+.++||||||++++||++|+.+.+...... +.....|....... ..
T Consensus 229 ~~~~~--~~~~~~gt~gY~~PEy~~~g--~lt~KsDVySFGVvllElitgr~~~d~~~~~~-~~~l~~w~~~~~~~~~~~ 303 (361)
T KOG1187|consen 229 EGDTS--VSTTVMGTFGYLAPEYASTG--KLTEKSDVYSFGVVLLELITGRKAVDQSRPRG-ELSLVEWAKPLLEEGKLR 303 (361)
T ss_pred ccccc--eeeecCCCCccCChhhhccC--CcCcccccccchHHHHHHHhCCcccCCCCCcc-cccHHHHHHHHHHCcchh
Confidence 31111 1112 789999999999764 89999999999999999999998777543111 11134443222222 22
Q ss_pred hhcccCCC-ChhhH-HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 209 DLGLQGIE-NEEDK-EYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 209 ~~~~~~~~-~~~~~-~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
.+..+.+. ..... .....+..+..+|++.+|.+||+|.|+++.|+.+...
T Consensus 304 eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 304 EIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred heeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 22222222 22222 5677799999999999999999999999999665443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=300.55 Aligned_cols=237 Identities=28% Similarity=0.441 Sum_probs=187.7
Q ss_pred hhhcccccCCceeEEEEEecCCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhcC
Q 022826 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
.++++||+|+||+||+|++.. .||||++.... +++.+... .||..+|+|
T Consensus 395 ~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeG 471 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEG 471 (678)
T ss_pred hccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccC
Confidence 357899999999999998855 79999998776 66666666 899999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
.+|..+++... .+|.+.....|++|+++|+.|||. ++|+|+|||..|||+.++++|||+|||++..-.--..
T Consensus 472 sSLY~hlHv~e-----tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 472 SSLYTHLHVQE-----TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred chhhhhccchh-----hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 99999998753 799999999999999999999999 9999999999999999999999999999875332211
Q ss_pred eeeccCCCCCccccCcccccccC-CCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNF-GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~-~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
........+...|+|||++..+. ..|++.+||||||+|+|||++|..|+. ......-+.+.... ....
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG----------~l~p 612 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRG----------YLMP 612 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEeccc----------ccCc
Confidence 12234456788999999996432 488999999999999999999999887 33322211111100 0011
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCC
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 262 (291)
.......+..+++.+|+..||++++++||...+|+..|+.++.++..-
T Consensus 613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki 660 (678)
T KOG0193|consen 613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKI 660 (678)
T ss_pred cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccccc
Confidence 112334567789999999999999999999999999998887764333
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=269.47 Aligned_cols=237 Identities=23% Similarity=0.302 Sum_probs=187.6
Q ss_pred chhhcccccCCceeEEEEEe-cCCCeEEEEEeccCc-------------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKL-LDGRNVAIKVLNETK-------------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-------------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+|+.||+++. .+++.||+|++.+.. +.....+..|+++
T Consensus 23 yri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~ 102 (302)
T KOG2345|consen 23 YRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLL 102 (302)
T ss_pred EEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEe
Confidence 34678999999999999975 569999999998765 2223455688999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCC--eeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR--ILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
+|+..|+|.+.+.... .++..+++.++++|+.+|++||.+||+ .. +.|+||||.||++++++.+++.|||.+.
T Consensus 103 Pyy~~Gsl~d~i~~~k--~kg~~~sE~~iL~if~gic~gL~~lH~---~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 103 PYYKRGSLLDEIERLK--IKGNFVSEAQILWIFLGICRGLEALHE---KEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred ehhccccHHHHHHHHh--hcCCccCHHHHHHHHHHHHHHHHHHhc---cCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999998864 456789999999999999999999999 66 9999999999999999999999999987
Q ss_pred ccCCCCc-------eeeccCCCCCccccCccccccc-CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhh
Q 022826 129 ICHGRES-------IVSMTGARGTVGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWV 200 (291)
Q Consensus 129 ~~~~~~~-------~~~~~~~~~~~~y~aPE~l~~~-~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~ 200 (291)
..+-.-. .........|..|+|||++.-+ ...+++++|||||||++|.|++|..||+..........+...
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~- 256 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ- 256 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee-
Confidence 6542110 0111223358899999998432 247899999999999999999999999877664443332211
Q ss_pred hhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 022826 201 YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256 (291)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~ 256 (291)
...+.+ +....+++.+.++++.||+.||.+||++.+++..+++++
T Consensus 257 ------n~q~s~-----P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 257 ------NAQISI-----PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------cccccc-----CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111 122238899999999999999999999999999998865
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=294.47 Aligned_cols=230 Identities=28% Similarity=0.492 Sum_probs=189.2
Q ss_pred hhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCCH
Q 022826 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
.+.+.||+|.||+||.|.+.....||+|.++... ++|..++-++|||||+..|+|
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 5678999999999999999777799999998744 788888889999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
.++|... .+..++..+.+.++.||++|++||++ +++|||||.+.||||+++..+||+|||+++....+.. ..
T Consensus 289 l~yLr~~----~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y-~~ 360 (468)
T KOG0197|consen 289 LDYLRTR----EGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY-TA 360 (468)
T ss_pred HHHhhhc----CCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCce-ee
Confidence 9999873 55789999999999999999999999 9999999999999999999999999999995443332 22
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCCh
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 218 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (291)
.....-+.-|.|||.+... .++.++|||||||++|||.|....+.....+.. +.... ..+.+-.
T Consensus 361 ~~~~kfPIkWtAPEa~~~~--~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-------v~~~l-------e~GyRlp 424 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYG--KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-------VLELL-------ERGYRLP 424 (468)
T ss_pred cCCCCCCceecCHHHHhhC--CcccccceeehhhhHHHHhccCCCCCCCCCHHH-------HHHHH-------hccCcCC
Confidence 2333345689999999765 899999999999999999986555444332211 11111 2333345
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 219 EDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 219 ~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
.+..++.++.+++..||+.+|++|||.+.+...|+++..
T Consensus 425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 566688899999999999999999999999999998755
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=275.53 Aligned_cols=232 Identities=21% Similarity=0.312 Sum_probs=182.1
Q ss_pred cccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehhhcCCC
Q 022826 7 NKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
-++|+|+||.||++++++ |+-||||++..+. .++......++|+|||+. +
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-T 86 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-T 86 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-H
Confidence 468999999999999876 9999999997654 677888999999999988 6
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
+.+.|.. ...+++...+..++.|++.|+.|+|+ ++++||||||+||+|+.+|.+||||||.++.+.....
T Consensus 87 vL~eLe~-----~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-- 156 (396)
T KOG0593|consen 87 VLHELER-----YPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-- 156 (396)
T ss_pred HHHHHHh-----ccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCcc--
Confidence 6666654 33689999999999999999999999 9999999999999999999999999999998763221
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhh--------
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEED-------- 209 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 209 (291)
.+++...|.-|+|||++.|. ..|+..+|||++||++.||++|...|+...+.+..+......-.-....+.
T Consensus 157 ~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred hhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 24455568889999999985 489999999999999999999999999887765433222211111111111
Q ss_pred --hcccCCC-----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 210 --LGLQGIE-----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 210 --~~~~~~~-----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
+.++... ....++.+..+++|++.||+.||.+|++-++++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111111 1123456678999999999999999999999874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=292.54 Aligned_cols=220 Identities=25% Similarity=0.362 Sum_probs=179.0
Q ss_pred cchhhcccccCCceeEEEEEec-CCCeEEEEEeccC-------c-------------------------ceeecCCccee
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNET-------K-------------------------GFCFEGHRRAL 48 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-------~-------------------------~~~~~~~~~~l 48 (291)
.+.+++.||+|+||.|+.|.+. +++.||+|++... . .+......+++
T Consensus 18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i 97 (370)
T KOG0583|consen 18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI 97 (370)
T ss_pred ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence 3567899999999999999764 5899999987764 1 34444556889
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC-CceEEeccCCc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLA 127 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~-~~~kl~Dfg~~ 127 (291)
|||||.+|+|.+++.+. .++.+..+..+|+|+++|++|||+ .+|+||||||+||+++.+ +++||+|||++
T Consensus 98 vmEy~~gGdL~~~i~~~------g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 98 VMEYCSGGDLFDYIVNK------GRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEecCCccHHHHHHHc------CCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999774 588889999999999999999999 999999999999999999 99999999999
Q ss_pred cccC-CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh
Q 022826 128 KICH-GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 128 ~~~~-~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
.... .+. .....+|++.|+|||++.+.......++||||+|+++|.|++|..||++... +. ....
T Consensus 169 ~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-------~~-l~~k--- 234 (370)
T KOG0583|consen 169 AISPGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-------PN-LYRK--- 234 (370)
T ss_pred cccCCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-------HH-HHHH---
Confidence 9874 222 3467899999999999998732346899999999999999999999998321 11 1111
Q ss_pred hhhhcccCCCChhhHHH-HHHHHHHHHHhhhcCCCCCCCHHHHH
Q 022826 207 EEDLGLQGIENEEDKEY-ARKMILVSLWCIQNNPSDRPAMNRVV 249 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~-~~~l~~l~~~~l~~dP~~Rps~~ell 249 (291)
+ .......+..+ +.++..|+.+||..||.+|+|+.+++
T Consensus 235 ---i--~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 235 ---I--RKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ---H--hcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1 11111222333 78899999999999999999999998
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=281.97 Aligned_cols=235 Identities=23% Similarity=0.386 Sum_probs=188.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||.|.-+.||+|++. .+..||||++..++ ..+..+...++||+|+.
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa 107 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA 107 (516)
T ss_pred eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence 467799999999999999774 58999999998665 45667788999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC-CC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH-GR 133 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~-~~ 133 (291)
+||+.++++.. -...+++..++.|+++++.||.|||+ +|.+|||||+.||+|+.+|.++|+|||.+..+- .+
T Consensus 108 ~GS~ldIik~~----~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 108 GGSLLDIIKTY----YPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred CCcHHHHHHHH----ccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999886 34579999999999999999999999 999999999999999999999999999876543 33
Q ss_pred Cceee-ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 134 ESIVS-MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 134 ~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
..... .....++++|+|||++..+..+|+.|+||||||++..|+.+|..||..-... .....+-...-..+..
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn~pp~~~t 254 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQNDPPTLLT 254 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcCCCCCccc
Confidence 22222 2556789999999997666679999999999999999999999998743210 0000000000001112
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.....+....+.+.+++++..||++||.+|||++++++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 24445667789999999999999999999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=290.72 Aligned_cols=236 Identities=22% Similarity=0.315 Sum_probs=183.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCC-cceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGH-RRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~-~~~lv~e~ 52 (291)
+.+.++||.|.||.||+|+.. .+..||||.++.+. .+..+.+ ..++||||
T Consensus 12 Y~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~ 91 (538)
T KOG0661|consen 12 YTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEF 91 (538)
T ss_pred HHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHh
Confidence 456799999999999999764 49999999988765 4445555 89999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
++. +|.++++.+. ..|++..+..|+.||++||+|+|. +|+.|||+||||||+..+..+||+|||+|+....
T Consensus 92 Md~-NLYqLmK~R~-----r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 92 MDC-NLYQLMKDRN-----RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred hhh-hHHHHHhhcC-----CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccccc
Confidence 977 9999998763 789999999999999999999999 9999999999999999888999999999998766
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhh---------hh-h
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHW---------VY-K 202 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~---------~~-~ 202 (291)
..+ ++....|.=|+|||++... +.|+.+.|+|++||+++|+.+.+..|+...+.+.-+-.-+. .. .
T Consensus 163 kpP---YTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 163 KPP---YTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred CCC---cchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 554 3344457889999998764 58999999999999999999999888866554431111110 00 0
Q ss_pred hhhhhhhhcccCCC----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 203 RLELEEDLGLQGIE----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 203 ~~~~~~~~~~~~~~----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.......+..+... .......+.++.+++.+|+++||.+||||.+.++.
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00011111111111 12223478889999999999999999999999874
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=287.36 Aligned_cols=219 Identities=25% Similarity=0.373 Sum_probs=178.9
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcC
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
.-.+.||+|+||.||+|.+.. ++.||+|++.-+. +....+....++||||.|
T Consensus 16 ~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~g 95 (467)
T KOG0201|consen 16 TKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGG 95 (467)
T ss_pred ccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcC
Confidence 335899999999999998754 9999999998655 333445566789999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
|++.+.+... ..+++..+..++++++.|+.|||. .+.+|+|||+.||++..+|.+||+|||++.++.....
T Consensus 96 Gsv~~lL~~~------~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 96 GSVLDLLKSG------NILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred cchhhhhccC------CCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999544 345788888999999999999999 9999999999999999999999999999988766544
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
.. ....|||.|||||++.+. .|+.++||||||++.+||++|.+|+.....-...+..+ ...
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~--~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp---------------k~~ 227 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQS--GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP---------------KSA 227 (467)
T ss_pred cc--ccccccccccchhhhccc--cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc---------------CCC
Confidence 32 567799999999999865 99999999999999999999999887664422111111 111
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
+......++..|.+|+..||+.||+.||+|.+|++
T Consensus 228 PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 228 PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 11222378889999999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=262.04 Aligned_cols=257 Identities=25% Similarity=0.264 Sum_probs=196.6
Q ss_pred chhhcccccCCceeEEEEEe-cCCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKL-LDGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.-.++||+|.||.||+|++ .+|+.||||+++... +.+.......+|+||+
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 44568899999999999976 459999999998765 5566677788999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
+. +|+..++.. .-.++...+..++.++++||+|||+ +.|+||||||+|++++.+|.+||+|||+++.+...
T Consensus 84 ~t-dLe~vIkd~-----~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 84 PT-DLEVVIKDK-----NIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred cc-cHHHHhccc-----ccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 77 999999764 4688999999999999999999999 99999999999999999999999999999988765
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcc------------ccchhhhh
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSE------------IYFPHWVY 201 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~------------~~~~~~~~ 201 (291)
....... .-|.=|+|||++.|. ..|+..+|+||.||++.||+.+...|+...+.+.. ..+|.+..
T Consensus 155 ~~~~~~~--V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 155 NRIQTHQ--VVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred Ccccccc--eeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 5433222 346789999999886 68999999999999999999888777766553320 01111100
Q ss_pred hhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCCCCcccCCCCC
Q 022826 202 KRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLSSGSQ 273 (291)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~~~~ 273 (291)
-..-..................+..+++|+..||..||.+|+|++|.++. ...+++..|..+..++-++.
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~P~pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSLPLPTPPSKLPIPST 301 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcCCCCCChhhCcCCcc
Confidence 00000000011111122345577788999999999999999999999874 45666777777777776666
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=286.59 Aligned_cols=237 Identities=27% Similarity=0.416 Sum_probs=176.1
Q ss_pred chhhcccccCCceeEEEEEec------CCCeEEEEEeccCc----------------------------ceee-cCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK----------------------------GFCF-EGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----------------------------~~~~-~~~~~~ 47 (291)
+.+.++||+|+||.||+|.+. .++.||+|+++... +.+. .+...+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (338)
T cd05102 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM 88 (338)
T ss_pred ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence 346789999999999999642 25689999986432 1222 234578
Q ss_pred eeehhhcCCCHHHHHhhcCCCC--------------------------------------------------------CC
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLE--------------------------------------------------------TN 71 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~--------------------------------------------------------~~ 71 (291)
++|||+.+|+|.+++....... ..
T Consensus 89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (338)
T cd05102 89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK 168 (338)
T ss_pred EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence 8999999999999997632100 02
Q ss_pred CCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeeccCCCCCccccCc
Q 022826 72 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAP 151 (291)
Q Consensus 72 ~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 151 (291)
..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||+++...............++..|+||
T Consensus 169 ~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 169 SPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 357888999999999999999999 99999999999999999999999999999765432222112223346789999
Q ss_pred ccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHH
Q 022826 152 EVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILV 230 (291)
Q Consensus 152 E~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 230 (291)
|.+.+. .++.++||||||+++|+|++ |..||...... .......... .....+...+..+.++
T Consensus 246 E~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~-------~~~~~~~~~~~~l~~l 309 (338)
T cd05102 246 ESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-------EEFCQRLKDG-------TRMRAPENATPEIYRI 309 (338)
T ss_pred HHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-------HHHHHHHhcC-------CCCCCCCCCCHHHHHH
Confidence 999765 78999999999999999996 88887653221 0000100000 0011122355678999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 231 SLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 231 ~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
+.+||+.||++|||+.++++.|++++++
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=277.71 Aligned_cols=228 Identities=29% Similarity=0.376 Sum_probs=176.7
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------------ce-eecCC-cceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------GF-CFEGH-RRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------------~~-~~~~~-~~~lv~e~~ 53 (291)
...++.||+|+||.||++.+.+ |...|||.+.... +. ..... .++++|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 3457899999999999998765 9999999988752 22 11222 688999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC-CCceEEeccCCccccCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-DFCPKISDFGLAKICHG 132 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~-~~~~kl~Dfg~~~~~~~ 132 (291)
.+|+|.+++.+. . .++++..+..+.+|+++||.|||+ ++++|+||||+||+++. ++.+||+|||++.....
T Consensus 99 ~~GsL~~~~~~~----g-~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 99 PGGSLSDLIKRY----G-GKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred CCCcHHHHHHHc----C-CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999764 2 279999999999999999999999 99999999999999999 79999999999887653
Q ss_pred C-CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 133 R-ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 133 ~-~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
. ..........||+.|+|||++.+. .....++|||||||++.||+||..||..... ...... .+.
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~------~~~~~~-------~ig 236 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFFE------EAEALL-------LIG 236 (313)
T ss_pred ccccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhcc------hHHHHH-------HHh
Confidence 1 111122346789999999999852 2344699999999999999999888775410 011000 011
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L 252 (291)
........+..++....+|+.+|++.||++|||+.++|+..
T Consensus 237 ~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 237 REDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11111133455788899999999999999999999999866
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=285.53 Aligned_cols=218 Identities=26% Similarity=0.352 Sum_probs=181.0
Q ss_pred hhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCCC
Q 022826 5 FKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
--++||+|+-|.||.|... +++.||||.+.... .-...+...+.||||++||+
T Consensus 277 ~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggs 356 (550)
T KOG0578|consen 277 DFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGS 356 (550)
T ss_pred chhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCc
Confidence 3478999999999999654 58999999987655 22233477889999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+.+.. ..+++.+++.|++++++||.|||. ++|+|+|||.+||++..+|.+||+|||+|..+......
T Consensus 357 LTDvVt~-------~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K- 425 (550)
T KOG0578|consen 357 LTDVVTK-------TRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK- 425 (550)
T ss_pred hhhhhhc-------ccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-
Confidence 9999954 469999999999999999999999 99999999999999999999999999999987766542
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc-CCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ-GIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 216 (291)
.....|||.|+|||++... .|++++||||||++.+||+-|..|+..+.... ....+... ...
T Consensus 426 -R~TmVGTPYWMAPEVvtrk--~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr--------------AlyLIa~ng~P~ 488 (550)
T KOG0578|consen 426 -RSTMVGTPYWMAPEVVTRK--PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------------ALYLIATNGTPK 488 (550)
T ss_pred -cccccCCCCccchhhhhhc--ccCccccchhhhhHHHHHhcCCCCccCCChHH--------------HHHHHhhcCCCC
Confidence 3556789999999999877 99999999999999999999998877532211 11111122 222
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
...+..++..|.+|+.+||+.|+++|+++.|||+
T Consensus 489 lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 489 LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 3345678999999999999999999999999986
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=266.29 Aligned_cols=206 Identities=26% Similarity=0.345 Sum_probs=176.3
Q ss_pred hhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehhhc
Q 022826 5 FKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~~ 54 (291)
....||.|+||.|.+++.+ +|..+|+|++.+.+ +.+.+....++||||.+
T Consensus 48 ~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~ 127 (355)
T KOG0616|consen 48 RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVP 127 (355)
T ss_pred heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccC
Confidence 4577999999999999875 48999999998766 56777889999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
||-|..++++. +++++..++-++.||+.||+|||+ .+|++||+||+|||+|.+|.+||.|||.+......
T Consensus 128 GGElFS~Lrk~------~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 128 GGELFSYLRKS------GRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred CccHHHHHHhc------CCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 99999999765 689999999999999999999999 99999999999999999999999999999876554
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
....||||.|+|||+++.. .++.++|.|+||+++|||+.|..||...... ....++. +
T Consensus 198 ----T~TlCGTPeYLAPEii~sk--~ynkavDWWalGVLIYEMlaG~pPF~~~~~~--------~iY~KI~-~------- 255 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSK--GYNKAVDWWALGVLIYEMLAGYPPFYDDNPI--------QIYEKIL-E------- 255 (355)
T ss_pred ----EEEecCCccccChHHhhcC--CCCcchhHHHHHHHHHHHHcCCCCCcCCChH--------HHHHHHH-h-------
Confidence 3568999999999999987 9999999999999999999999999876431 0111111 1
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCC
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDR 242 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~R 242 (291)
.....+..++..+.+|++.+|+.|-.+|
T Consensus 256 ~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 GKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1123455677889999999999999999
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=276.56 Aligned_cols=225 Identities=27% Similarity=0.388 Sum_probs=176.6
Q ss_pred cchhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeeh
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e 51 (291)
|+.+.+.||+|+||.||++.+. +++.||+|++.... ..+..+...++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 4667889999999999999764 59999999876432 34456677889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+|+|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~g~L~~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 81 IMNGGDLKFHIYNM----GNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIP 153 (285)
T ss_pred ecCCCcHHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence 99999999888653 22468999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
.... .....++..|+|||.+.+. .++.++|||||||++|+|++|..||........ ..... ...
T Consensus 154 ~~~~---~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~~~------~~~- 217 (285)
T cd05631 154 EGET---VRGRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----REEVD------RRV- 217 (285)
T ss_pred CCCe---ecCCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCCCCcchh----HHHHH------HHh-
Confidence 3321 2334578999999999875 789999999999999999999999875533211 00000 000
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPA-----MNRVVE 250 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps-----~~ell~ 250 (291)
..........++..+.+|+++||+.||.+||+ +.++++
T Consensus 218 -~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 218 -KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11111223346778899999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=281.92 Aligned_cols=221 Identities=24% Similarity=0.338 Sum_probs=176.6
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehhh
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~ 53 (291)
++...||+|+||.||+|+.++ |+.+|+|+++++. .-+.+....||||||+
T Consensus 144 e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEyl 223 (550)
T KOG0605|consen 144 ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYL 223 (550)
T ss_pred hhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEec
Confidence 445789999999999998765 9999999999876 4566788999999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
+||++..+|.+. ..+++..+..++.+++.||+.+|+ .|++|+||||+|+|||..|.+||+|||+|..+...
T Consensus 224 PGGD~mTLL~~~------~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 224 PGGDMMTLLMRK------DTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred CCccHHHHHHhc------CcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 999999999765 689999999999999999999999 99999999999999999999999999998544210
Q ss_pred --------------------Cceee-------------------------ccCCCCCccccCcccccccCCCccccccch
Q 022826 134 --------------------ESIVS-------------------------MTGARGTVGYIAPEVFCRNFGEVSYKSDVY 168 (291)
Q Consensus 134 --------------------~~~~~-------------------------~~~~~~~~~y~aPE~l~~~~~~~~~~~Diw 168 (291)
..... .....|||-|+|||++.+. .|+..+|.|
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k--gY~~~cDwW 372 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK--GYGKECDWW 372 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--CCCccccHH
Confidence 00000 0112489999999999998 799999999
Q ss_pred hHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh-hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCC---
Q 022826 169 SYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL-EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPA--- 244 (291)
Q Consensus 169 slG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps--- 244 (291)
||||++||||.|-+||.... +...++.+.. ...+..+ .....+.+..+||.+||- ||++|..
T Consensus 373 SLG~ImyEmLvGyPPF~s~t--------p~~T~rkI~nwr~~l~fP-----~~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSET--------PQETYRKIVNWRETLKFP-----EEVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHhhhccCC-----CcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 99999999999999998764 3333333322 2122222 222345789999999999 9999965
Q ss_pred HHHHH
Q 022826 245 MNRVV 249 (291)
Q Consensus 245 ~~ell 249 (291)
++||.
T Consensus 439 ~~EIK 443 (550)
T KOG0605|consen 439 AEEIK 443 (550)
T ss_pred HHHHh
Confidence 55543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=280.69 Aligned_cols=254 Identities=23% Similarity=0.296 Sum_probs=188.2
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeec--CCcceeeehh
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFE--GHRRALIYEF 52 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~--~~~~~lv~e~ 52 (291)
.-.++||+|.||.||+|++. +|+.||+|++.... +.... ...+|+|+||
T Consensus 120 eki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeY 199 (560)
T KOG0600|consen 120 EKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEY 199 (560)
T ss_pred HHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEec
Confidence 34588999999999999774 59999999998765 33333 4789999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
++. +|..++.. .+-+|++.++.++|+||+.||+|||+ ++|+|||||..|||||.+|.+||+|||+++.+..
T Consensus 200 Mdh-DL~GLl~~-----p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 200 MDH-DLSGLLSS-----PGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred ccc-hhhhhhcC-----CCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 987 99999854 34689999999999999999999999 9999999999999999999999999999997655
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc-c-----hhh-hhh--h
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY-F-----PHW-VYK--R 203 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~-~-----~~~-~~~--~ 203 (291)
.... .++...-|.=|+|||++.|. ..|+.++|+||.||+|.||..|+..++...+...... + |.. .|. +
T Consensus 271 ~~~~-~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 271 SGSA-PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCc-ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 4332 24445558889999999986 5899999999999999999999988876544321000 0 000 000 0
Q ss_pred hhhhhhhcc----cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCCCCcccCC
Q 022826 204 LELEEDLGL----QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLSS 270 (291)
Q Consensus 204 ~~~~~~~~~----~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~ 270 (291)
......... .....+....++...++|+..+|..||.+|.|+.+.++- +....-..+..+..++.
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s--eyF~t~p~~~~p~~Lp~ 417 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS--EYFTTEPLPCDPSSLPK 417 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC--cccccCCCCCCcccCCC
Confidence 000000000 011123345677889999999999999999999998752 33333344444444443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=286.40 Aligned_cols=220 Identities=25% Similarity=0.300 Sum_probs=186.4
Q ss_pred hhhcccccCCceeEEEEEe-cCCCeEEEEEeccCc-----------------------------ceeecCCcceeeehhh
Q 022826 4 SFKNKLGQGGYGGVYKGKL-LDGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+|++.||+|+-|.|-+|++ .+|+.+|||++.+.. ++-.+.+.+|+|.||+
T Consensus 15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence 6789999999999999976 469999999998873 5666788999999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+|-|++++..+ +++++..++++++||+.|+.|+|. .+|+|+|+||+|++++..+++||+|||.|..-.++
T Consensus 95 ~gGELFdylv~k------G~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 95 PGGELFDYLVRK------GPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred CCchhHHHHHhh------CCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999766 689999999999999999999999 99999999999999999999999999999865444
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
. ...+.||+|.|++||++.|. ...+.++||||+||+||.|++|..||+++.... . . .+..
T Consensus 166 k---lLeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~-------L-L--------lKV~ 225 (786)
T KOG0588|consen 166 K---LLETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV-------L-L--------LKVQ 225 (786)
T ss_pred c---cccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccHHH-------H-H--------HHHH
Confidence 3 24678999999999999987 355789999999999999999999999552211 0 0 0111
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L 252 (291)
....+.+..++.+..+|+.+||..||+.|+|++|+++--
T Consensus 226 ~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 226 RGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred cCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 112344567888899999999999999999999998853
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=260.72 Aligned_cols=251 Identities=22% Similarity=0.234 Sum_probs=188.0
Q ss_pred hcccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeehhhc
Q 022826 6 KNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~~~ 54 (291)
.++|++|.||.||+|++.+ ++.||+|.++.+. -+..+-+.+|+|||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 3789999999999998865 9999999999876 23444567899999998
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
. +|..++.+.. ++|+...+..++.|++.|+.|||. ..|+|||||++|++++..|.+||+|||+|+.+....
T Consensus 161 h-DLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 161 H-DLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred h-hHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 8 9999998753 799999999999999999999999 999999999999999999999999999999876542
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc------chhhhh----hhh
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY------FPHWVY----KRL 204 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~------~~~~~~----~~~ 204 (291)
. .++...-|.=|+|||++.|. ..|+.+.|+||+||++.||+++...|+.......... .|.... ...
T Consensus 232 k--~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 232 K--PYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred c--cCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 2 23444457889999999886 5899999999999999999999988876544322000 000000 000
Q ss_pred hhhhhhcccCCCC----hhhH--HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCCCCcccCC
Q 022826 205 ELEEDLGLQGIEN----EEDK--EYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLSS 270 (291)
Q Consensus 205 ~~~~~~~~~~~~~----~~~~--~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~ 270 (291)
........+..+. .... .+++.-.+|+..+|..||.+|.|++|.|+ .+.....+.|..|...|+
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~--h~~F~e~P~p~~P~~~Pt 378 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK--HEYFRETPLPIDPSMFPT 378 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc--ccccccCCCCCChhhcCC
Confidence 0000011110000 0011 15578889999999999999999999876 355566555655555554
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=278.93 Aligned_cols=215 Identities=23% Similarity=0.319 Sum_probs=171.0
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehhhcCC
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.||+|+||.||++++. +++.||+|+++... +.+......++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 58999999987532 4556677889999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+|.+++... ..+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~- 150 (323)
T cd05571 81 ELFFHLSRE------RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA- 150 (323)
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-
Confidence 999998654 478999999999999999999999 9999999999999999999999999999875322111
Q ss_pred eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 137 VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
......|++.|+|||.+.+. .++.++|||||||++|+|++|..||...... . ..... ....
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~-~~~~~-~~~~------- 211 (323)
T cd05571 151 -TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------K-LFELI-LMEE------- 211 (323)
T ss_pred -cccceecCccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCCCCHH-------H-HHHHH-HcCC-------
Confidence 12334689999999999775 7899999999999999999999998643210 0 00000 0000
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVE 250 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~ 250 (291)
...+..++..+.+++.+||+.||++|| ++.++++
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 112234567789999999999999999 7998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=272.34 Aligned_cols=239 Identities=22% Similarity=0.347 Sum_probs=173.1
Q ss_pred chhhcccccCCceeEEEEEecC-----------------CCeEEEEEeccCc---------------------------c
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-----------------GRNVAIKVLNETK---------------------------G 38 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~---------------------------~ 38 (291)
+.+.++||+|+||.||++.+.+ +..||+|++.... +
T Consensus 7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 86 (304)
T cd05096 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLG 86 (304)
T ss_pred CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 3467899999999999997532 3479999987532 4
Q ss_pred eeecCCcceeeehhhcCCCHHHHHhhcCCC-------------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeec
Q 022826 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPL-------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFD 105 (291)
Q Consensus 39 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~d 105 (291)
.+......++||||+.+++|.+++...... .....+++..++.++.|++.||.|||+ .+++|+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~d 163 (304)
T cd05096 87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRD 163 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccccC
Confidence 555667789999999999999998664321 122457889999999999999999999 9999999
Q ss_pred cCCCceEEcCCCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCC--CC
Q 022826 106 IKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVK--NN 183 (291)
Q Consensus 106 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~--~~ 183 (291)
|||+||+++.++.+||+|||+++...............++..|+|||.+.+. .++.++||||||+++|+|+++. .|
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC--CCCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999865444332222333457789999998765 7899999999999999998644 33
Q ss_pred CccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 184 ANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
+...... . ....................+..++..+.+++.+||+.||++|||+.++.+.|++
T Consensus 242 ~~~~~~~-------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDE-------Q-VIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHH-------H-HHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 4322110 0 0000000000000000011122345678999999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=277.35 Aligned_cols=216 Identities=24% Similarity=0.326 Sum_probs=172.2
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|++.. ++.||+|++.... +.+..+...++||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 3456889999999999998754 8999999986431 455667888999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 100 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 100 VVGGELFTHLRKA------GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred CCCChHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999654 478899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
.. ....+++.|+|||.+.+. .++.++|||||||++|+|++|..||..... ........ ....
T Consensus 171 ~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~-~~~~-- 232 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKIL-AGRL-- 232 (329)
T ss_pred Cc-----ceecCChhhcCHHHHcCC--CCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHHh-cCCc--
Confidence 22 234678999999999876 678999999999999999999999864321 10111110 0111
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPA-----MNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps-----~~ell~ 250 (291)
..+..++..+.+|+.+||+.||.+||+ +.++++
T Consensus 233 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 -----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 112224567889999999999999987 677763
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=290.57 Aligned_cols=226 Identities=24% Similarity=0.329 Sum_probs=175.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeec--------CCc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFE--------GHR 45 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~--------~~~ 45 (291)
+.+.+.||+|+||.||++++. +++.||||++.... ..+.. ...
T Consensus 34 Y~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~ 113 (496)
T PTZ00283 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLM 113 (496)
T ss_pred EEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceE
Confidence 456789999999999999764 59999999986532 00000 113
Q ss_pred ceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccC
Q 022826 46 RALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 46 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
.++||||+.+|+|.+++..+. .....+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||
T Consensus 114 i~lV~Ey~~~gsL~~~l~~~~--~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 114 IALVLDYANAGDLRQEIKSRA--KTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred EEEEEeCCCCCcHHHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 578999999999999997643 234679999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLE 205 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (291)
+++...............||+.|+|||.+.+. .++.++|||||||++|+|++|..||..... .. .....
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~-~~~~~- 257 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGENM-------EE-VMHKT- 257 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HH-HHHHH-
Confidence 99876543332233456689999999999875 789999999999999999999998864321 00 00000
Q ss_pred hhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 LEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
........+..++..+.+++.+||+.||.+||++.++++
T Consensus 258 ------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 258 ------LAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred ------hcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 011111223346678999999999999999999999876
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=290.26 Aligned_cols=230 Identities=21% Similarity=0.300 Sum_probs=176.6
Q ss_pred hhhcccccCCceeEEEEEecCC-CeEEEEEeccCc------------------------ceee---------c-CCccee
Q 022826 4 SFKNKLGQGGYGGVYKGKLLDG-RNVAIKVLNETK------------------------GFCF---------E-GHRRAL 48 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~------------------------~~~~---------~-~~~~~l 48 (291)
.|.+.|.+|+|+.||.|.+..+ ..||+|.+-..+ .++. . ..+++|
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 4578999999999999998775 999999976554 1111 1 246778
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
+||||.+|+|.++++.+ ...+|++..+++|+.|+++|+.+||. ....|+|||||.|||||+.+|..||||||.+.
T Consensus 120 LmEyC~gg~Lvd~mn~R----lq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTR----LQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred ehhhccCCcHHHHHHHH----HhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 99999999999999887 34569999999999999999999998 22449999999999999999999999999875
Q ss_pred cc-CCCCceeec------cCCCCCccccCccccccc-CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhh
Q 022826 129 IC-HGRESIVSM------TGARGTVGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWV 200 (291)
Q Consensus 129 ~~-~~~~~~~~~------~~~~~~~~y~aPE~l~~~-~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~ 200 (291)
-. ......... ....-|+.|++||.|.-. ...+++|+|||+|||+||.|++...||+..-..
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------- 264 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------- 264 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----------
Confidence 32 111010000 111238999999987422 128999999999999999999999988765110
Q ss_pred hhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 022826 201 YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256 (291)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~ 256 (291)
....... ..+..+.++..|.+||+.||+.||.+||++-++++.+-.+.
T Consensus 265 ---aIlng~Y-----~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 265 ---AILNGNY-----SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred ---eEEeccc-----cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 0001111 12233679999999999999999999999999999996644
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=273.98 Aligned_cols=226 Identities=24% Similarity=0.307 Sum_probs=178.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------------------------ce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------------------------GF 39 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------------------------~~ 39 (291)
+.++..||+|.||.|-+|++. +++.||||++.+.. -.
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 567789999999999999875 49999999998765 22
Q ss_pred eecCCcceeeehhhcCCCHHHHHhhcCCCCCCCC-CCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCc
Q 022826 40 CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQK-LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 118 (291)
Q Consensus 40 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~-~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~ 118 (291)
+.+....|+|+|||..|.+...= .... +++.++++++++++.||+|||. ++|+||||||.|+||+.+|+
T Consensus 179 DP~s~~~YlVley~s~G~v~w~p-------~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWCP-------PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred CcccCceEEEEEeccCCccccCC-------CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCc
Confidence 33456789999999988874442 2234 9999999999999999999999 99999999999999999999
Q ss_pred eEEeccCCccccCCC---CceeeccCCCCCccccCcccccccC--CCccccccchhHHHHHHHHhCCCCCCccccCCCcc
Q 022826 119 PKISDFGLAKICHGR---ESIVSMTGARGTVGYIAPEVFCRNF--GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSE 193 (291)
Q Consensus 119 ~kl~Dfg~~~~~~~~---~~~~~~~~~~~~~~y~aPE~l~~~~--~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~ 193 (291)
+||+|||++..+..+ ..........|||.|+|||.+.+.. ...+.+.||||+||++|.|++|..||......
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~--- 325 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL--- 325 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH---
Confidence 999999999877432 1112234477999999999987632 23467889999999999999999999876431
Q ss_pred ccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 022826 194 IYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252 (291)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L 252 (291)
....++....+..+..++..+.+.+||.+||.+||++|+++.++....
T Consensus 326 -----------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 326 -----------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -----------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 112222223333333446788899999999999999999999986655
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=278.94 Aligned_cols=234 Identities=28% Similarity=0.426 Sum_probs=175.0
Q ss_pred chhhcccccCCceeEEEEEe------cCCCeEEEEEeccCc----------------------------ceeecCCccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKL------LDGRNVAIKVLNETK----------------------------GFCFEGHRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~----------------------------~~~~~~~~~~l 48 (291)
+.+++.||+|+||.||+|.+ .++..||||+++... +.+..+...++
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l 116 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV 116 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence 45678999999999999963 136689999986432 45566777889
Q ss_pred eehhhcCCCHHHHHhhcCCC------------------------------------------------------------
Q 022826 49 IYEFVSNGSLEKFIYEKHPL------------------------------------------------------------ 68 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~------------------------------------------------------------ 68 (291)
||||+.+|+|.+++......
T Consensus 117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (375)
T cd05104 117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID 196 (375)
T ss_pred eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence 99999999999999754210
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeec
Q 022826 69 ---------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSM 139 (291)
Q Consensus 69 ---------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 139 (291)
.....+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++............
T Consensus 197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 273 (375)
T cd05104 197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273 (375)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence 012357889999999999999999999 99999999999999999999999999999865443322212
Q ss_pred cCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCCh
Q 022826 140 TGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 218 (291)
Q Consensus 140 ~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (291)
....++..|+|||.+.+. .++.++||||||+++|+|++ |..||....... ....... .. ....
T Consensus 274 ~~~~~~~~y~aPE~~~~~--~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-------~~~~~~~-~~------~~~~ 337 (375)
T cd05104 274 GNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-------KFYKMIK-EG------YRML 337 (375)
T ss_pred CCCCCCcceeChhHhcCC--CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-------HHHHHHH-hC------ccCC
Confidence 223345679999999775 78999999999999999997 666665432110 0000000 00 0011
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 219 EDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 219 ~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
.+...+.++.+++.+||+.||++||++.++++.|++.
T Consensus 338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1122356788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=276.95 Aligned_cols=224 Identities=21% Similarity=0.282 Sum_probs=176.6
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|++.+ ++.||+|+++... +.+..+...++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 4677899999999999998864 8999999987432 355567788999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 83 VPGGDFRTLLNNL------GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999654 478899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh-hhhc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE-EDLG 211 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 211 (291)
......+++.|+|||.+.+. .++.++|||||||++|+|++|..||....... ........ ....
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~~~~ 218 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--------TWENLKYWKETLQ 218 (333)
T ss_pred -----ccCCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCHHH--------HHHHHHhcccccc
Confidence 12345678999999999876 78999999999999999999999986532110 00111000 0000
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.+. .......++.++.+++.+||..+|.+||++.++++.
T Consensus 219 ~~~-~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPV-YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCC-CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 110 011112457788999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=272.61 Aligned_cols=217 Identities=23% Similarity=0.240 Sum_probs=173.0
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +.+.++...++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 567789999999999999875 48999999986421 445566778899999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 83 VPGGELFSYLRNS------GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999654 478999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
.. ....+++.|+|||.+.+. .++.++|||||||++|+|++|..||...... ....... ...
T Consensus 154 ~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--------~~~~~i~-~~~--- 214 (291)
T cd05612 154 RT-----WTLCGTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFDDNPF--------GIYEKIL-AGK--- 214 (291)
T ss_pred Cc-----ccccCChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHH-hCC---
Confidence 21 234578999999999776 7889999999999999999999988653210 0011110 001
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPA-----MNRVVEM 251 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps-----~~ell~~ 251 (291)
...+..++..+.+++++||+.||.+||+ +.++++.
T Consensus 215 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 ----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1112234567889999999999999995 8887654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=277.92 Aligned_cols=224 Identities=26% Similarity=0.403 Sum_probs=187.2
Q ss_pred cchhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCc-ceeeeh
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHR-RALIYE 51 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~-~~lv~e 51 (291)
.+.+.+.+|+|+||.++.++++ +.+.+++|.+.... +.+.+++. .+|||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 4567899999999999999765 48899999987655 33334444 999999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
||+||++.+.+.+. .+..++++.+..|+.|++.|+.|||+ .+|+|||||+.|||++.++.++|+|||+++...
T Consensus 85 Y~eGg~l~~~i~~~----k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQ----KGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred ecCCCCHHHHHHHH----hhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999999999886 46789999999999999999999999 999999999999999999999999999999877
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
+.... .....||+.|++||++.+. .|+.++|||||||++|||++-+.+|....- +....+ +.
T Consensus 158 ~~~~~--a~tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-------~~Li~k-------i~ 219 (426)
T KOG0589|consen 158 PEDSL--ASTVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKASNM-------SELILK-------IN 219 (426)
T ss_pred Cchhh--hheecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCccch-------HHHHHH-------Hh
Confidence 65522 2446689999999999987 999999999999999999999988775532 111111 11
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.....+.+..++.++..+++.||..+|..||++.+|+..
T Consensus 220 -~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 -RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 112345567789999999999999999999999999875
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=266.83 Aligned_cols=233 Identities=27% Similarity=0.437 Sum_probs=179.0
Q ss_pred cchhhcccccCCceeEEEEEecC------CCeEEEEEeccCc---------------------------ceeecCCccee
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLLD------GRNVAIKVLNETK---------------------------GFCFEGHRRAL 48 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~---------------------------~~~~~~~~~~l 48 (291)
++.+.+.||+|+||.||+|.+.+ ++.|++|+++... +.+......++
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 85 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIM 85 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEE
Confidence 45678999999999999997632 5789999987532 45566678899
Q ss_pred eehhhcCCCHHHHHhhcCC--------CCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceE
Q 022826 49 IYEFVSNGSLEKFIYEKHP--------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 120 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~k 120 (291)
+|||+.+++|.+++..... ......+++..+..++.|++.|+.+||+ .+++|+||||+||+++.++.++
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred EEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeEE
Confidence 9999999999999976532 1223568899999999999999999999 9999999999999999999999
Q ss_pred EeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhh
Q 022826 121 ISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHW 199 (291)
Q Consensus 121 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~ 199 (291)
|+|||++................+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.......
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-------- 232 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------- 232 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhccC--CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------
Confidence 9999998754332221112223346789999999775 78999999999999999998 888775432110
Q ss_pred hhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 200 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
.... .. .......+..++..+.+++.+||+.||++||++.|+++.|++
T Consensus 233 ~~~~---~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 233 VIEC---IT----QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHH---HH----cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 0000 00 111111223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=276.06 Aligned_cols=218 Identities=25% Similarity=0.349 Sum_probs=183.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+-+.+.||+|+||.||+|+-+ +.+.||+|.+.+.. ..+......++|.|||
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 456799999999999999754 48999999997654 5677788899999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.| +|..++... ..++++.+..++.++++||.|||+ .+|.|+|+||.||++...|.+|++|||+++.+...
T Consensus 84 ~g-~L~~il~~d------~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 84 VG-DLFTILEQD------GKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hh-hHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 87 999999654 699999999999999999999999 99999999999999999999999999999987654
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
.. ..+.+.|||.|+|||+..+. .|+..+|.||+||++||+..|++||..... ......+...
T Consensus 154 t~--vltsikGtPlYmAPElv~e~--pyd~~sDlWslGcilYE~~~G~PPF~a~si--------------~~Lv~~I~~d 215 (808)
T KOG0597|consen 154 TS--VLTSIKGTPLYMAPELVEEQ--PYDHTSDLWSLGCILYELYVGQPPFYARSI--------------TQLVKSILKD 215 (808)
T ss_pred ce--eeeeccCcccccCHHHHcCC--CccchhhHHHHHHHHHHHhcCCCCchHHHH--------------HHHHHHHhcC
Confidence 32 34667899999999999876 999999999999999999999998875421 1111111111
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
+...+.+.+..+.++++..|.+||.+|.|+.+++.
T Consensus 216 --~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 216 --PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred --CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 12234478889999999999999999999999885
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=271.84 Aligned_cols=215 Identities=23% Similarity=0.303 Sum_probs=168.8
Q ss_pred cccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.||+|+||.||+|++.+ ++.||+|+++... +.+..+...++||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999998754 8899999986431 344556778899999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
|+|.+++... ..+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++........
T Consensus 81 g~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 151 (316)
T cd05592 81 GDLMFHIQSS------GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG 151 (316)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC
Confidence 9999998654 478999999999999999999999 9999999999999999999999999999875433221
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
......|++.|+|||.+.+. .++.++|||||||++|+|++|..||...... ...... . . .
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--------~~~~~i---~---~--~ 211 (316)
T cd05592 152 --KASTFCGTPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDED--------ELFDSI---L---N--D 211 (316)
T ss_pred --ccccccCCccccCHHHHcCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCHH--------HHHHHH---H---c--C
Confidence 22345689999999999876 7889999999999999999999998754210 000000 0 0 0
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMN-RVVE 250 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~-ell~ 250 (291)
....+..++..+.+++.+||+.||.+||++. ++++
T Consensus 212 ~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 212 RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 0112233566788999999999999999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=278.64 Aligned_cols=235 Identities=26% Similarity=0.450 Sum_probs=176.8
Q ss_pred chhhcccccCCceeEEEEEec------CCCeEEEEEeccCc----------------------------ceeecCCccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK----------------------------GFCFEGHRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----------------------------~~~~~~~~~~l 48 (291)
+.+.+.||+|+||.||+|.+. +++.||+|+++... +.+......++
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~l 119 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLV 119 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEE
Confidence 456799999999999999742 24579999987532 44556677889
Q ss_pred eehhhcCCCHHHHHhhcCC-------------------------------------------------------------
Q 022826 49 IYEFVSNGSLEKFIYEKHP------------------------------------------------------------- 67 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~------------------------------------------------------------- 67 (291)
||||+.+|+|.+++.....
T Consensus 120 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (374)
T cd05106 120 ITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKD 199 (374)
T ss_pred eHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccc
Confidence 9999999999999865321
Q ss_pred ---CCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeeccCCCC
Q 022826 68 ---LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARG 144 (291)
Q Consensus 68 ---~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 144 (291)
......+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++................+
T Consensus 200 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred hhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 0112357889999999999999999999 9999999999999999999999999999876543322222222334
Q ss_pred CccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHH
Q 022826 145 TVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY 223 (291)
Q Consensus 145 ~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (291)
+..|+|||.+.+. .++.++||||||+++|+|++ |..||........ ....... ......+...
T Consensus 277 ~~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-------~~~~~~~-------~~~~~~~~~~ 340 (374)
T cd05106 277 PVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-------FYKMVKR-------GYQMSRPDFA 340 (374)
T ss_pred ccceeCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccHH-------HHHHHHc-------ccCccCCCCC
Confidence 5679999998765 78999999999999999997 8888765422110 0000000 0001111223
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 022826 224 ARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256 (291)
Q Consensus 224 ~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~ 256 (291)
+.++.+++.+||+.||.+|||+.++++.|++++
T Consensus 341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=280.98 Aligned_cols=220 Identities=28% Similarity=0.456 Sum_probs=184.3
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEeccCc-------------------ceeecCCcceeeehhhcCCCHHHHHhhcCC
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------GFCFEGHRRALIYEFVSNGSLEKFIYEKHP 67 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~ 67 (291)
+-||+|+.|.||+|+. .++.||||+++.-+ ++|...-.+|||||||..|.|...|+..
T Consensus 130 eWlGSGaQGAVF~Grl-~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~-- 206 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRL-HNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAG-- 206 (904)
T ss_pred hhhccCcccceeeeec-cCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhcc--
Confidence 4599999999999988 78899999987544 8999999999999999999999999765
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeeccCCCCCcc
Q 022826 68 LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVG 147 (291)
Q Consensus 68 ~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 147 (291)
+.+.......|.++|+.|++|||. +.|+|||||.-||+|+.+..+||+|||.++...... .....+||..
T Consensus 207 ----~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSFaGTVa 276 (904)
T KOG4721|consen 207 ----RPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSFAGTVA 276 (904)
T ss_pred ----CccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhhhhhHh
Confidence 688889999999999999999999 999999999999999999999999999988655442 2345778999
Q ss_pred ccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHH
Q 022826 148 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKM 227 (291)
Q Consensus 148 y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 227 (291)
|||||+|... ..++|+||||||||+|||+||..|..+....- ..+... ...+....+..+++-|
T Consensus 277 WMAPEvIrne--PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-------IIwGVG-------sNsL~LpvPstcP~Gf 340 (904)
T KOG4721|consen 277 WMAPEVIRNE--PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-------IIWGVG-------SNSLHLPVPSTCPDGF 340 (904)
T ss_pred hhCHHHhhcC--CcccccceehhHHHHHHHHhcCCCccccchhe-------eEEecc-------CCcccccCcccCchHH
Confidence 9999999887 88999999999999999999998776543211 111111 1122234556677788
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 228 ILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 228 ~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
.-|+++||+-.|..||++++++.-|+=.
T Consensus 341 klL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 341 KLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 8899999999999999999999998643
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=273.38 Aligned_cols=219 Identities=24% Similarity=0.310 Sum_probs=171.1
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|+..+ ++.||+|++.... ..+......++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 4577899999999999998754 7899999986421 34455677889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+|+|.+++... ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 82 ~~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 82 YVNGGDLMYHIQQV------GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 99999999998654 468899999999999999999999 999999999999999999999999999986532
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
.... ......|++.|+|||.+.+. .++.++|||||||++|+|++|..||...... ...... .
T Consensus 153 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i------~ 214 (324)
T cd05587 153 FGGK--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQSI------M 214 (324)
T ss_pred CCCC--ceeeecCCccccChhhhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHH------H
Confidence 2211 12334679999999999876 7889999999999999999999988643210 000000 0
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAM-----NRVVE 250 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~-----~ell~ 250 (291)
.. ....+..++..+.+++.+||..||.+|++. .++++
T Consensus 215 ~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 215 EH--NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred cC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 00 011123456678899999999999999976 55554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=275.26 Aligned_cols=225 Identities=25% Similarity=0.329 Sum_probs=172.7
Q ss_pred chhhcccccCCceeEEEEEec----CCCeEEEEEeccCc-------------------------------ceeecCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL----DGRNVAIKVLNETK-------------------------------GFCFEGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-------------------------------~~~~~~~~~~ 47 (291)
+.+.+.||+|+||.||+++.. +++.||+|++.... ..+..+...+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 567899999999999999753 48899999986421 3444566788
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+||||+.+|+|.+++..+ ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 82 lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 82 LILDYVSGGEMFTHLYQR------DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 999999999999998654 478999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
......... ......|++.|+|||.+.+. ..++.++|||||||++|+|++|..||........ .......
T Consensus 153 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~~~~~---- 222 (332)
T cd05614 153 KEFLSEEKE-RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNT----QSEVSRR---- 222 (332)
T ss_pred ccccccCCC-ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCC----HHHHHHH----
Confidence 765332221 12235689999999998764 3578899999999999999999999864322111 0000000
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVE 250 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~ 250 (291)
.... ....+..++..+.+++.+||+.||++|| +++++++
T Consensus 223 -~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 223 -ILKC---DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -HhcC---CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0000 0111233566788999999999999999 7778765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=283.20 Aligned_cols=212 Identities=24% Similarity=0.338 Sum_probs=176.0
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeehh
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~ 52 (291)
.+...||+|+||+|+++..+. ++.+|||++++.. ..+....+.|+||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 456889999999999998764 8999999999876 566788999999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.||++..+. ....|++..+.-++.+|+.||.|||+ ++|++||||.+||++|.+|.+||+|||+++.--.
T Consensus 451 ~~Ggdm~~~~-------~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 451 VAGGDLMHHI-------HTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred cCCCcEEEEE-------ecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCC
Confidence 9999954444 33689999999999999999999999 9999999999999999999999999999985332
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... ...+.||||.|+|||++.+. .|+.++|.|+|||++|+|+.|..||..+.... .-.++..
T Consensus 521 ~g~--~TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee--------------~FdsI~~ 582 (694)
T KOG0694|consen 521 QGD--RTSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE--------------VFDSIVN 582 (694)
T ss_pred CCC--ccccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCCCCCHHH--------------HHHHHhc
Confidence 221 35778999999999999987 99999999999999999999999998664321 0111111
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAM 245 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~ 245 (291)
. ....+..++.+..++++++|..+|++|..+
T Consensus 583 d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 D--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred C--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1 122345678889999999999999999755
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=263.33 Aligned_cols=228 Identities=25% Similarity=0.417 Sum_probs=178.1
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.++||+|+||.||+|...++..|++|.+.... +.+......++++||+.+++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87 (261)
T ss_pred eEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence 35678999999999999988778889999887543 45556677889999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 88 L~~~l~~~----~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05072 88 LLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT- 159 (261)
T ss_pred HHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence 99998654 34578899999999999999999999 99999999999999999999999999999875443221
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
......++..|+|||.+.+. .++.++||||||+++|+|++ |..||...... ...... .... .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~--~~~~-----~ 222 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--------DVMSAL--QRGY-----R 222 (261)
T ss_pred ccCCCccceecCCHHHhccC--CCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--------HHHHHH--HcCC-----C
Confidence 12233456789999998765 68889999999999999998 77777543211 000000 0000 1
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
......++..+.+++.+||+.+|++||+++++++.|+++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 111223566789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=273.06 Aligned_cols=216 Identities=24% Similarity=0.324 Sum_probs=170.7
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehhhcCC
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.||+|+||.||++++. +++.||+|++.... ..+......++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 48999999987532 4456677889999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+|..++... ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~- 150 (328)
T cd05593 81 ELFFHLSRE------RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA- 150 (328)
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-
Confidence 999888543 478999999999999999999999 9999999999999999999999999999875322211
Q ss_pred eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 137 VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
......+++.|+|||.+.+. .++.++|||||||++|+|++|..||...... . ..... ....
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~~~-------~-~~~~~-~~~~------- 211 (328)
T cd05593 151 -TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------K-LFELI-LMED------- 211 (328)
T ss_pred -ccccccCCcCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCCHH-------H-HHHHh-ccCC-------
Confidence 12335689999999999765 7899999999999999999999998643210 0 00000 0000
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVEM 251 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~~ 251 (291)
...+..++..+.+++.+||+.||++|+ ++.++++.
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 212 IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 112234567788999999999999997 89998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=263.91 Aligned_cols=227 Identities=29% Similarity=0.471 Sum_probs=179.8
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.+.+.||+|+||.||+|.+.+++.+++|++.... +.+......+++|||+.++
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG 87 (261)
T ss_pred HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence 45679999999999999998789999999987554 4566677889999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+|.+++... .+..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.+.........
T Consensus 88 ~L~~~~~~~----~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 88 SLLAFLRSP----EGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred CHHHHHhcC----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999764 33578999999999999999999999 99999999999999999999999999998765432211
Q ss_pred eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 137 VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
.....++..|++||.+.+. .++.++||||||+++|+|++ |..|+..... ........ ...
T Consensus 161 --~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~-------~~~ 221 (261)
T cd05148 161 --SSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--------HEVYDQIT-------AGY 221 (261)
T ss_pred --ccCCCCceEecCHHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHH-------hCC
Confidence 1233356789999998765 78899999999999999998 6777754321 00111111 111
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
....+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1112234567789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=265.74 Aligned_cols=232 Identities=25% Similarity=0.451 Sum_probs=178.2
Q ss_pred chhhcccccCCceeEEEEEecC-C-----CeEEEEEeccCc---------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-G-----RNVAIKVLNETK---------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~---------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|.... + ..|++|.+.... +.+......+++
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence 4567899999999999997643 2 579999986432 344556778899
Q ss_pred ehhhcCCCHHHHHhhcCCCCC----------CCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCce
Q 022826 50 YEFVSNGSLEKFIYEKHPLET----------NQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 119 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~----------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~ 119 (291)
+||+.+++|.+++........ ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCcE
Confidence 999999999999976532111 1568899999999999999999999 999999999999999999999
Q ss_pred EEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchh
Q 022826 120 KISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPH 198 (291)
Q Consensus 120 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~ 198 (291)
+|+|||++................+++.|+|||.+.+. .++.++|||||||++|+|++ |..||......
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------- 233 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------- 233 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccC--cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 99999998765433222222333457889999998765 78999999999999999997 88777643211
Q ss_pred hhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 199 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
..... +.. ......+..++.++.+|+.+||+.||.+||++.++++.|++
T Consensus 234 ~~~~~------i~~-~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 EVIEM------IRS-RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHH------HHc-CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 01111 100 11112234567889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=263.82 Aligned_cols=227 Identities=24% Similarity=0.390 Sum_probs=175.4
Q ss_pred chhhcccccCCceeEEEEEec----CCCeEEEEEeccCc---------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL----DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|.+. .+..||+|+++... +.+..+...++|||
T Consensus 7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 86 (266)
T cd05064 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTE 86 (266)
T ss_pred eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEE
Confidence 457799999999999999653 36789999987652 45667788999999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++++|||.+....
T Consensus 87 ~~~~~~L~~~l~~~-----~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 87 YMSNGALDSFLRKH-----EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred eCCCCcHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999998653 2478999999999999999999999 999999999999999999999999999866432
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
.... .......++..|+|||.+.+. .++.++|||||||++|++++ |..||...... . ......
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-------~-~~~~~~----- 222 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-------D-VIKAVE----- 222 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhC--CccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------H-HHHHHH-----
Confidence 2111 111122345789999998765 78999999999999999775 88877543211 0 000000
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
.......+..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 223 --~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 223 --DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0001112334667789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=262.18 Aligned_cols=229 Identities=28% Similarity=0.484 Sum_probs=177.5
Q ss_pred chhhcccccCCceeEEEEEecC----CCeEEEEEeccCc---------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD----GRNVAIKVLNETK---------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|.+.. ...|++|.++... +.+..+...+++||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 5677999999999999998742 4589999987543 34556677889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++... ...+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 86 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 86 YMENGSLDKFLREN-----DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred cCCCCCHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999998653 2478999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
............++..|+|||.+.+. .++.++||||||+++|+|++ |..|+..... .. ...... .
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-------~~-~~~~~~---~- 223 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMSN-------QD-VIKAVE---D- 223 (266)
T ss_pred ccccceeccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCCH-------HH-HHHHHH---c-
Confidence 32222222233346789999998765 78999999999999999987 7777643211 00 001110 0
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~ 256 (291)
.........++..+.+++.+||+.+|++||++.++++.|++++
T Consensus 224 ---~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 224 ---GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 0011112235667899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=271.24 Aligned_cols=217 Identities=24% Similarity=0.318 Sum_probs=170.5
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------------ceeecCCcceeee
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------------~~~~~~~~~~lv~ 50 (291)
.+.+.||+|+||.||++.+. +++.||||+++... +.+..+...++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 56789999999999999875 48999999986421 4455667889999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
||+.+++|..++.. ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 82 E~~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 82 EYAAGGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred cCCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 99999999888743 478999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
..... ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||...... ......
T Consensus 152 ~~~~~--~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~~~--------~~~~~i------ 213 (324)
T cd05589 152 MGFGD--RTSTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--------EVFDSI------ 213 (324)
T ss_pred CCCCC--cccccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHH------
Confidence 22211 12345679999999999775 7889999999999999999999998644211 000000
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVE 250 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~ 250 (291)
.... ...+..++..+.+++.+||+.||.+|| ++.++++
T Consensus 214 ~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 214 VNDE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HhCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0000 112233567788999999999999999 5777665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=272.49 Aligned_cols=213 Identities=21% Similarity=0.316 Sum_probs=167.9
Q ss_pred cccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehhhcCCCH
Q 022826 9 LGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 9 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
||+|+||.||++++.+ ++.||+|++.... +.+......++||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999998754 8899999986421 455667788999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 149 (312)
T cd05585 81 FHHLQRE------GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--K 149 (312)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--c
Confidence 9998654 468999999999999999999999 9999999999999999999999999999875332221 1
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCCh
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 218 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (291)
.....|++.|+|||.+.+. .++.++|||||||++|+|++|..||..... .. ..... .. . ...
T Consensus 150 ~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~-~~~~~-----~~-~--~~~ 211 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENV-------NE-MYRKI-----LQ-E--PLR 211 (312)
T ss_pred cccccCCcccCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCCH-------HH-HHHHH-----Hc-C--CCC
Confidence 2345689999999999875 789999999999999999999999875321 00 00100 00 0 111
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 022826 219 EDKEYARKMILVSLWCIQNNPSDRPA---MNRVVE 250 (291)
Q Consensus 219 ~~~~~~~~l~~l~~~~l~~dP~~Rps---~~ell~ 250 (291)
.+..++..+.+++.+||+.||.+||+ +.++++
T Consensus 212 ~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 212 FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 22345677899999999999999985 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=261.40 Aligned_cols=227 Identities=31% Similarity=0.500 Sum_probs=177.1
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
.+.+.||+|+||.||+|.+.+ ++.+++|++.... +.+......+++|||+.+++
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (263)
T cd05052 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 88 (263)
T ss_pred EEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCc
Confidence 456889999999999998754 8899999987543 45556777889999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++.........
T Consensus 89 L~~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~- 160 (263)
T cd05052 89 LLDYLREC----NRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT- 160 (263)
T ss_pred HHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence 99998654 23568999999999999999999999 99999999999999999999999999998765443211
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
.......+..|+|||.+.+. .++.++||||||+++|+|++ |..|+..... ......... ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~~~~-------~~~ 223 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYELLEK-------GYR 223 (263)
T ss_pred ccCCCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHC-------CCC
Confidence 11122335679999998765 78899999999999999998 7777654311 001111100 011
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
...+..++..+.+++.+||+.||++||++.++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 122234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=265.67 Aligned_cols=221 Identities=19% Similarity=0.307 Sum_probs=173.3
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEeccCc-----------------------------ceeec----CCcceeeehhh
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-----------------------------GFCFE----GHRRALIYEFV 53 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~----~~~~~lv~e~~ 53 (291)
..|++|+++.||+|.. +|+.||+|+++... +++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 4689999999999988 78999999987542 33333 34678999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+|+|.+++... ..+++.....++.+++.||.+||+ ..+++|+||||+||+++.++.+||+|||++......
T Consensus 105 ~~g~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 105 TRGYLREVLDKE------KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCcHHHHHhhC------CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999999653 478899999999999999999997 138899999999999999999999999998765332
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
. ....++..|+|||.+.+....++.++|||||||++|+|++|..||...... . ...... ..
T Consensus 177 ~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-------~-~~~~i~------~~ 237 (283)
T PHA02988 177 P-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-------E-IYDLII------NK 237 (283)
T ss_pred c-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHH------hc
Confidence 1 223468899999999764347899999999999999999999998743210 0 000000 00
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
......+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 238 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 238 NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 001111223567899999999999999999999999999875
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=260.99 Aligned_cols=228 Identities=25% Similarity=0.404 Sum_probs=177.6
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||+|++|.||+|...+++.|++|.++... +.+......+++|||+.+++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05068 8 IQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGS 87 (261)
T ss_pred eeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCc
Confidence 45679999999999999988778899999987543 45666777889999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ....+++..+..++.|++.||.+||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 88 L~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05068 88 LLEYLQGG----AGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE- 159 (261)
T ss_pred HHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence 99999654 23578999999999999999999999 99999999999999999999999999998876532111
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
.......+..|+|||.+.+. .++.++||||||+++|+|++ |..||..... ........ ... .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~--~~~-----~ 222 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQQVD--QGY-----R 222 (261)
T ss_pred ccCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHH--cCC-----C
Confidence 11122234579999998765 78999999999999999998 7777653311 00000000 000 0
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
.......+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 111233567899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=270.44 Aligned_cols=211 Identities=23% Similarity=0.292 Sum_probs=166.5
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.||+|+||.||+|++. +++.||+|++.... +.+......++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999875 49999999986432 344566778999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|..++... ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (323)
T cd05575 81 GELFFHLQRE------RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK 151 (323)
T ss_pred CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence 9999998654 478999999999999999999999 9999999999999999999999999999875322211
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
......|++.|+|||.+.+. .++.++|||||||++|+|++|..||...... . ...... ...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------~-~~~~i~-~~~------ 212 (323)
T cd05575 152 --TTSTFCGTPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-------E-MYDNIL-NKP------ 212 (323)
T ss_pred --ccccccCChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCCCCHH-------H-HHHHHH-cCC------
Confidence 12345689999999999775 7889999999999999999999988643210 0 000000 000
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMN 246 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ 246 (291)
.......+..+.+++.+||+.||.+||++.
T Consensus 213 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 213 -LRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 111223467788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=272.53 Aligned_cols=210 Identities=24% Similarity=0.323 Sum_probs=166.3
Q ss_pred cccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.||+|+||.||+|++.. ++.||+|++.... +.+......++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999998754 8999999986421 445566778999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 g~L~~~i~~~------~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~ 151 (320)
T cd05590 81 GDLMFHIQKS------RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK 151 (320)
T ss_pred chHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence 9999988654 478999999999999999999999 9999999999999999999999999999875322211
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
......|++.|+|||.+.+. .++.++|||||||++|+|++|..||...... . ...... ...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~-~~~~i~-~~~------ 212 (320)
T cd05590 152 --TTSTFCGTPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEAENED-------D-LFEAIL-NDE------ 212 (320)
T ss_pred --cccccccCccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------H-HHHHHh-cCC------
Confidence 12345689999999999765 7889999999999999999999998754211 0 000000 000
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAM 245 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~ 245 (291)
...+..++..+.+++.+||+.||.+||++
T Consensus 213 -~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 213 -VVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 11122356678999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=271.47 Aligned_cols=223 Identities=23% Similarity=0.349 Sum_probs=169.8
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.||+|+||.||++++. +++.||+|+++... +.+......++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999875 48999999987532 445566778999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
|+|.+++... .++++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++........
T Consensus 81 g~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~ 151 (329)
T cd05588 81 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD 151 (329)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC
Confidence 9999888543 479999999999999999999999 9999999999999999999999999999864322111
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCc-cccchhhhhhhhhhhhhhcccC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSS-EIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||........ ......+..... ....
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~----- 221 (329)
T cd05588 152 --TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI-LEKQ----- 221 (329)
T ss_pred --ccccccCCccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH-HcCC-----
Confidence 12345689999999999875 788999999999999999999999864322110 000011111111 0000
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCC------HHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPA------MNRVVE 250 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps------~~ell~ 250 (291)
...+..++..+.+++.+||+.||.+|++ +.++++
T Consensus 222 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 222 --IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred --CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1112235567889999999999999997 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=269.68 Aligned_cols=234 Identities=24% Similarity=0.342 Sum_probs=174.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||++++. ++..+|+|++.... +.+..+...++||||+.
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (331)
T cd06649 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (331)
T ss_pred ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCC
Confidence 345688999999999999875 48899999987542 45566778899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCC-CeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT-RILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
+++|.+++... ..+++..+..++.|++.||.|||+ . +++|+||||+||+++.++.++|+|||++......
T Consensus 87 ~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 87 GGSLDQVLKEA------KRIPEEILGKVSIAVLRGLAYLRE---KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhh---cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 99999999654 468999999999999999999998 5 5999999999999999999999999998765332
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccch-----------h----
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFP-----------H---- 198 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~-----------~---- 198 (291)
. .....+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+. .
T Consensus 158 ~----~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 158 M----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred c----cccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCc
Confidence 1 2334578999999999875 78999999999999999999999986432110000000 0
Q ss_pred ----------------h-hhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 199 ----------------W-VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 199 ----------------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
. ..........+............++.++.+|+.+||+.||++|||+.++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 0000000000000001111122356789999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=261.84 Aligned_cols=232 Identities=27% Similarity=0.460 Sum_probs=175.2
Q ss_pred hhhcccccCCceeEEEEEecC----CCeEEEEEeccCc----------------------------ceeecCC------c
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD----GRNVAIKVLNETK----------------------------GFCFEGH------R 45 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~----------------------------~~~~~~~------~ 45 (291)
.+.+.||+|+||.||+|.... +..||+|.++... +.+.... .
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 578899999999999997642 4789999987542 2222222 3
Q ss_pred ceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccC
Q 022826 46 RALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 46 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
.++++||+.+++|..++...........+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence 68899999999999998665332334578999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRL 204 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~ 204 (291)
+++................+..|+|||.+.+. .++.++||||||+++|+|++ |..|+...... . ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-------~-~~~-- 226 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-------E-IYD-- 226 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHH--
Confidence 98865433222111222346689999998765 78999999999999999998 66666443210 0 000
Q ss_pred hhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 205 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
.+. .......+..++..+.+++.+||+.||.+||++.++++.|+++
T Consensus 227 ----~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 ----YLR-HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ----HHH-cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 0011112334567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=272.81 Aligned_cols=215 Identities=25% Similarity=0.340 Sum_probs=170.1
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehhhcCC
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.||+|+||.||+++.. +|+.||+|++.... +.+......++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999875 48999999986431 4556677889999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+|..++... ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~- 150 (323)
T cd05595 81 ELFFHLSRE------RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 150 (323)
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-
Confidence 999888654 478999999999999999999999 9999999999999999999999999998875322211
Q ss_pred eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 137 VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
......+++.|+|||.+.+. .++.++|||||||++|+|++|..||....... ..... .....
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~~~-~~~~~------ 212 (323)
T cd05595 151 -TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELI-LMEEI------ 212 (323)
T ss_pred -ccccccCCcCcCCcccccCC--CCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHH-hcCCC------
Confidence 12335679999999999765 78999999999999999999999886442110 00000 00001
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVE 250 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~ 250 (291)
..+..++..+.+++.+||+.||.+|| ++.++++
T Consensus 213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 213 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 11234567788999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=267.23 Aligned_cols=236 Identities=19% Similarity=0.243 Sum_probs=172.5
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||++++.+ ++.||+|++.... +.+..+...++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 5677899999999999998864 8899999987532 4556677889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.++.+..+... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~l~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 83 EKNMLELLEEM------PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred CCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 98766554322 2578999999999999999999999 99999999999999999999999999998875432
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc-------hhhhhhhhhh
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF-------PHWVYKRLEL 206 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 206 (291)
... ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||............ +.........
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 154 SNA-NYTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ccc-cccccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 211 12334578999999999775 6889999999999999999999888754321100000 0000000000
Q ss_pred h---hhhcccCCCC------hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 E---EDLGLQGIEN------EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~---~~~~~~~~~~------~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. .....+.... .....++..+.+|+++||+.||++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 0000000000 011235677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=269.64 Aligned_cols=214 Identities=23% Similarity=0.327 Sum_probs=168.4
Q ss_pred cccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.||+|+||.||+|++.. ++.||+|+++... +.+..+...++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999998764 8999999986431 345567788999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|..++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 g~L~~~i~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05620 81 GDLMFHIQDK------GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN 151 (316)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence 9999998654 478899999999999999999999 9999999999999999999999999999864322111
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
......|++.|+|||.+.+. .++.++|||||||++|+|++|..||...... ...... ......
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~----~~~~~~- 214 (316)
T cd05620 152 --RASTFCGTPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESI----RVDTPH- 214 (316)
T ss_pred --ceeccCCCcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHH----HhCCCC-
Confidence 12345679999999999876 7899999999999999999999998644210 001110 001111
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHH-HHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMN-RVV 249 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~-ell 249 (291)
.+..++..+.+++.+||+.||++||++. +++
T Consensus 215 ---~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 ---YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1223566788999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=259.63 Aligned_cols=222 Identities=26% Similarity=0.418 Sum_probs=169.9
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcCCCH
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
+.||+|+||.||+|.+. +++.+++|.+.... +.+......++|+||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999875 58999999876432 566677788999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 81 LTFLRTE-----GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 9998643 2468899999999999999999999 9999999999999999999999999999875443211111
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
......+..|+|||.+.+. .++.++||||||+++|+|++ |..|+..... ........ .....
T Consensus 153 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~~~~~~~-------~~~~~ 215 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYG--RYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQTREAIE-------QGVRL 215 (252)
T ss_pred CCCCCCceeecCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HHHHHHHH-------cCCCC
Confidence 1111234579999998765 68899999999999999997 6666643211 00000000 01111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
..+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 222345678899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=264.14 Aligned_cols=220 Identities=23% Similarity=0.361 Sum_probs=183.7
Q ss_pred chhhcccccCCceeEEEEEe-cCCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKL-LDGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|.||.|-+|.. ..|+.||||.++++. .++.+.+.++|||||
T Consensus 55 yE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEY 134 (668)
T KOG0611|consen 55 YEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEY 134 (668)
T ss_pred HHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEe
Confidence 45678999999999999976 459999999998776 678888899999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
..+|.|.+|+.++ +.+++..++++++||++++.|+|. +++||+|||.+||+++.++++||+|||++..+..
T Consensus 135 aS~GeLYDYiSer------~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 135 ASGGELYDYISER------GSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred cCCccHHHHHHHh------ccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999766 689999999999999999999999 9999999999999999999999999999988765
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
+. .....||+|-|.+||++.|. ..-++.+|-||||+++|-|+.|.+||+...... ..+.+..
T Consensus 206 ~k---fLqTFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~--------------lvrQIs~ 267 (668)
T KOG0611|consen 206 KK---FLQTFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR--------------LVRQISR 267 (668)
T ss_pred cc---HHHHhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCchHHH--------------HHHHhhc
Confidence 54 34678999999999999986 244789999999999999999999998764311 1111111
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L 252 (291)
... ..+.-+....-||++||..||++|.|+.++..-+
T Consensus 268 GaY---rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 268 GAY---REPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ccc---cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 111 1122344566799999999999999999998766
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=271.92 Aligned_cols=216 Identities=24% Similarity=0.307 Sum_probs=169.8
Q ss_pred cccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.||+|+||.||+|++.. ++.||+|+++... +.+......++||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999998754 8899999986431 445566778999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|..++... ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 151 (321)
T cd05591 81 GDLMFQIQRS------RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV 151 (321)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence 9999888654 478999999999999999999999 9999999999999999999999999999875332221
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
......+++.|+|||.+.+. .++.++|||||||++|+|++|..||...... ....... ...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--------~~~~~i~-~~~------ 212 (321)
T cd05591 152 --TTTTFCGTPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADNED--------DLFESIL-HDD------ 212 (321)
T ss_pred --cccccccCccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCCCCHH--------HHHHHHH-cCC------
Confidence 12345679999999999765 7899999999999999999999998754211 0011100 000
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCC-------CHHHHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRP-------AMNRVVEM 251 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-------s~~ell~~ 251 (291)
...+..++..+.+++.+||+.||++|| ++.++++.
T Consensus 213 -~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 213 -VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 011223456788999999999999999 78887643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=261.76 Aligned_cols=232 Identities=25% Similarity=0.406 Sum_probs=173.0
Q ss_pred hhhcccccCCceeEEEEEecC-CC--eEEEEEeccCc----------------------------ceeec------CCcc
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GR--NVAIKVLNETK----------------------------GFCFE------GHRR 46 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~----------------------------~~~~~------~~~~ 46 (291)
.+++.||+|+||.||+|.+.+ ++ .+|+|.++... +.+.. ....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 578999999999999998754 33 68999876432 12211 1245
Q ss_pred eeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCC
Q 022826 47 ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL 126 (291)
Q Consensus 47 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~ 126 (291)
+++++|+.+|+|.+++...........+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 7899999999999988543322234568999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhh
Q 022826 127 AKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLE 205 (291)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (291)
+.................++.|++||.+.+. .++.++||||||+++|+|++ |..||...... . ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~-~~~~~~ 228 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-------E-IYDYLR 228 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------H-HHHHHH
Confidence 9876543322222233456789999998765 78999999999999999998 66666542110 0 000000
Q ss_pred hhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 206 LEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
.. . .......++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 229 ~~-----~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 QG-----N--RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred cC-----C--CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 0 0111223556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=270.74 Aligned_cols=218 Identities=23% Similarity=0.356 Sum_probs=167.0
Q ss_pred cccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.||+|+||.||++++.. ++.+|+|+++... +.+......++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999998754 8899999987532 455566788999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|..++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~L~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~ 151 (329)
T cd05618 81 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 151 (329)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence 9999888543 478999999999999999999999 9999999999999999999999999999875322111
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcc-ccchhhhhhhhhhhhhhcccC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSE-IYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 214 (291)
......|++.|+|||.+.+. .++.++|||||||++|+|++|..||......... ........... ....
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i-~~~~----- 221 (329)
T cd05618 152 --TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-LEKQ----- 221 (329)
T ss_pred --ccccccCCccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH-hcCC-----
Confidence 12335679999999999876 7889999999999999999999998643221110 00011111100 0000
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAM 245 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~ 245 (291)
...+...+..+.+++.+||+.||.+||++
T Consensus 222 --~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 222 --IRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11223456678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=271.88 Aligned_cols=214 Identities=24% Similarity=0.320 Sum_probs=169.1
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|.+.. ++.||+|++.... +.+......++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 4577899999999999998764 8899999987432 34455667889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+|+|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 82 ~~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 82 YVNGGDLMYQIQQV------GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred CCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999998654 468899999999999999999999 999999999999999999999999999987533
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
.... ......|++.|+|||.+.+. .++.++|||||||++|+|++|..||...... ....... ...
T Consensus 153 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--------~~~~~i~-~~~-- 217 (323)
T cd05616 153 WDGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIM-EHN-- 217 (323)
T ss_pred CCCC--ccccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCCCCHH--------HHHHHHH-hCC--
Confidence 2211 12345679999999999875 7899999999999999999999998643211 0001100 000
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAM 245 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~ 245 (291)
...+...+..+.+++.+||+.||.+|++.
T Consensus 218 -----~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 -----VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -----CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11223456778999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=263.93 Aligned_cols=236 Identities=23% Similarity=0.401 Sum_probs=179.1
Q ss_pred chhhcccccCCceeEEEEEec------CCCeEEEEEeccCc--------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK--------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||++... ++..+++|.+.... +.+......++++
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 86 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 456789999999999999742 24578999986532 4566778899999
Q ss_pred hhhcCCCHHHHHhhcCC-------CCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEec
Q 022826 51 EFVSNGSLEKFIYEKHP-------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISD 123 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~D 123 (291)
||+.+++|.+++..... ......+++..++.++.|++.+|.|||+ .+++|+||||+||+++.++.++|+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEecc
Confidence 99999999999975431 0122458999999999999999999999 9999999999999999999999999
Q ss_pred cCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhh
Q 022826 124 FGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYK 202 (291)
Q Consensus 124 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~ 202 (291)
||++................++..|+|||.+.+. .++.++||||||+++|+|++ |..||...... . ...
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-------~-~~~ 233 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------E-VIE 233 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHH
Confidence 9998765433222122223346789999998765 78899999999999999998 77776543211 0 000
Q ss_pred hhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 203 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
..... ........++..+.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus 234 ~i~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 CITQG-------RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHcC-------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 00000 00111123456789999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=268.94 Aligned_cols=236 Identities=24% Similarity=0.319 Sum_probs=170.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||+|+.. +++.||+|++.... +++......++||||+.
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH 86 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence 556789999999999999875 58999999986432 45556778899999996
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 87 -~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 87 -TDLCQYMDKH-----PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred -cCHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 5888887543 2568899999999999999999999 999999999999999999999999999987543221
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhh--------hhhhhh
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWV--------YKRLEL 206 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~--------~~~~~~ 206 (291)
. ......+++.|+|||++.+. ..++.++|||||||++|+|++|..||....+........... +.....
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 H--TYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred c--cCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 1 12334578899999998654 367889999999999999999999987543211000000000 000000
Q ss_pred hhhhcccCC----CChhh-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 EEDLGLQGI----ENEED-----KEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~~~~~~~~~----~~~~~-----~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......... ..... ..++..+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000 00000 012356789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=274.91 Aligned_cols=224 Identities=25% Similarity=0.341 Sum_probs=176.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|++. +++.||+|+++... ..+..+...++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 567789999999999999875 49999999986432 445567788999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 83 MPGGDLMNLLIRK------DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999654 578999999999999999999999 9999999999999999999999999999876543
Q ss_pred CC---------------------------ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCc
Q 022826 133 RE---------------------------SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNAN 185 (291)
Q Consensus 133 ~~---------------------------~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~ 185 (291)
.. .........+++.|+|||.+.+. .++.++|||||||++|+|++|..||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCC
Confidence 32 00112334578999999999876 88999999999999999999999987
Q ss_pred cccCCCccccchhhhhhhhhh-hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 022826 186 VAVDRSSEIYFPHWVYKRLEL-EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPA-MNRVVEM 251 (291)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps-~~ell~~ 251 (291)
..... ........ ......+ ....++..+.+++.+||. ||.+||+ +.++++.
T Consensus 232 ~~~~~--------~~~~~i~~~~~~~~~p-----~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 232 SDTLQ--------ETYNKIINWKESLRFP-----PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCHH--------HHHHHHhccCCcccCC-----CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 54311 00000000 0111111 111256788999999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=265.02 Aligned_cols=233 Identities=27% Similarity=0.473 Sum_probs=177.3
Q ss_pred hhhcccccCCceeEEEEEecC------CCeEEEEEeccCc----------------------------ceeecCCcceee
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD------GRNVAIKVLNETK----------------------------GFCFEGHRRALI 49 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~----------------------------~~~~~~~~~~lv 49 (291)
.+.+.||+|+||.||++...+ ...+++|.+.... +.+..+...+++
T Consensus 15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li 94 (293)
T cd05053 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVV 94 (293)
T ss_pred EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEE
Confidence 456889999999999997642 3689999887532 345556678899
Q ss_pred ehhhcCCCHHHHHhhcCC----------CCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCce
Q 022826 50 YEFVSNGSLEKFIYEKHP----------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 119 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~ 119 (291)
|||+.+++|.+++..+.. ......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCCeE
Confidence 999999999999976431 1234678999999999999999999999 999999999999999999999
Q ss_pred EEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchh
Q 022826 120 KISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPH 198 (291)
Q Consensus 120 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~ 198 (291)
+|+|||+++...............++..|+|||.+.+. .++.++|||||||++|+|++ |..|+..... .
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~- 241 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-------E- 241 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhccC--CcCcccceeehhhHHHHHhcCCCCCCCCCCH-------H-
Confidence 99999999876543322222223345789999998765 78899999999999999987 7766643211 0
Q ss_pred hhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 022826 199 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256 (291)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~ 256 (291)
....... . ......+...+..+.+|+.+||+.||++|||+.++++.|++++
T Consensus 242 ~~~~~~~------~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ELFKLLK------E-GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHH------c-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0000000 0 0001112234567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=267.16 Aligned_cols=229 Identities=26% Similarity=0.417 Sum_probs=173.5
Q ss_pred chhhcccccCCceeEEEEEecC-CC----eEEEEEeccCc---------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GR----NVAIKVLNETK---------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~---------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||+|.+.. ++ .||+|+++... +.+.. ...++++
T Consensus 9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-~~~~~v~ 87 (316)
T cd05108 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIT 87 (316)
T ss_pred ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-CCceeee
Confidence 3456889999999999997643 33 48999986432 33333 3567899
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
+|+.+|+|.+++... ...+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||+++..
T Consensus 88 e~~~~g~l~~~l~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 88 QLMPFGCLLDYVREH-----KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred ecCCCCCHHHHHHhc-----cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999753 2468899999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
..............+..|++||.+.+. .++.++||||||+++|+|++ |..|+..... .. ...... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-------~~-~~~~~~--~~ 227 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-------SE-ISSILE--KG 227 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------HH-HHHHHh--CC
Confidence 544333222333346689999998765 78999999999999999987 8877754211 00 000000 00
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
.. ...+..+...+.+++.+||+.||++||++.++++.|.++.+
T Consensus 228 ~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 228 ER-----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CC-----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 00 11112244568899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=271.55 Aligned_cols=225 Identities=24% Similarity=0.288 Sum_probs=168.5
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||++.+.. ++.||+|++.... +.+.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 4567899999999999997754 8999999986532 345566788999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.....
T Consensus 83 ~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 83 LPGGDMMTLLMKK------DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999654 478999999999999999999999 9999999999999999999999999999875432
Q ss_pred CCce---------------------------------eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC
Q 022826 133 RESI---------------------------------VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 179 (291)
Q Consensus 133 ~~~~---------------------------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~ 179 (291)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~ 231 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLI 231 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHh
Confidence 1100 001234689999999999775 78899999999999999999
Q ss_pred CCCCCccccCCCccccchhhhhhhhhh-hhhhcccCCCChhhHHHHHHHHHHHHHhhh--cCCCCCCCHHHHHHH
Q 022826 180 VKNNANVAVDRSSEIYFPHWVYKRLEL-EEDLGLQGIENEEDKEYARKMILVSLWCIQ--NNPSDRPAMNRVVEM 251 (291)
Q Consensus 180 g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~--~dP~~Rps~~ell~~ 251 (291)
|..||..... ......... ...+..+ ....++..+.+++.+++. .++..||++.|+++.
T Consensus 232 G~~Pf~~~~~--------~~~~~~i~~~~~~~~~p-----~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 232 GYPPFCSETP--------QETYKKVMNWKETLIFP-----PEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCCCH--------HHHHHHHHcCcCcccCC-----CcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9999865421 111111110 0011111 111244567777777553 233456899999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=264.59 Aligned_cols=225 Identities=28% Similarity=0.519 Sum_probs=170.6
Q ss_pred hhhcccccCCceeEEEEEec-----CCCeEEEEEeccCc---------------------------ceeecCCcceeeeh
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-----DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e 51 (291)
.+.+.||.|+||.||+|.+. .+..|+||.++... +++......++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46789999999999999775 26789999996532 67777777999999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+|+|.+++... ....+++..++.|+.|++.||.|||+ .+++|++|+++||+++.++.+||+|||++....
T Consensus 82 ~~~~g~L~~~L~~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK----NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp --TTEBHHHHHHHT----CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccc----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 99999999999875 34689999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
................|+|||.+.+. .++.++||||||+++|||++ |..|+..... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--------~~~~~~~~~~~-- 222 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--------EEIIEKLKQGQ-- 222 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--------HHHHHHHHTTE--
T ss_pred cccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccc--------ccccccccccc--
Confidence 33333333334457799999999876 68999999999999999999 5555433211 00011111110
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L 252 (291)
....+..++..+.+++.+||..||++|||+.++++.|
T Consensus 223 -----~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 -----RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0112233566788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=258.55 Aligned_cols=241 Identities=23% Similarity=0.284 Sum_probs=188.4
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehhh
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~ 53 (291)
.+.++||.|.-|+||+++..+ +..+|+|++.+.. ..+..++..|++||||
T Consensus 80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyC 159 (459)
T KOG0610|consen 80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYC 159 (459)
T ss_pred HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecC
Confidence 456889999999999999866 7999999998754 6788889999999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.||+|..+++.+ .+..|++..++.++.+|+-||+|||- .|||.|||||+||||-++|.+.|+||.++..+...
T Consensus 160 pGGdL~~LrqkQ----p~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 160 PGGDLHSLRQKQ----PGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred CCccHHHHHhhC----CCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999998875 77899999999999999999999999 99999999999999999999999999998554210
Q ss_pred --------------------------------Ccee-----------------e-----ccCCCCCccccCcccccccCC
Q 022826 134 --------------------------------ESIV-----------------S-----MTGARGTVGYIAPEVFCRNFG 159 (291)
Q Consensus 134 --------------------------------~~~~-----------------~-----~~~~~~~~~y~aPE~l~~~~~ 159 (291)
.... . .....||-.|+|||++.|.
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~-- 310 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE-- 310 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC--
Confidence 0000 0 0112378899999999997
Q ss_pred CccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCC
Q 022826 160 EVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNP 239 (291)
Q Consensus 160 ~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP 239 (291)
..+.++|.|+||+++|||+.|..||....... .+.. +....+........+..+.+||+++|.+||
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~---Tl~N-----------Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---TLRN-----------IVGQPLKFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchh---hHHH-----------HhcCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence 89999999999999999999999998764421 1111 111111122223677889999999999999
Q ss_pred CCCCC----HHHHHHH--H----HhhhccCCCCCCCcc
Q 022826 240 SDRPA----MNRVVEM--L----EGSLDSLRIPPRPFL 267 (291)
Q Consensus 240 ~~Rps----~~ell~~--L----~~~~~~~~~~~~~~~ 267 (291)
.+|.. +.||-+- + ..+++..+.|-.|..
T Consensus 377 ~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~ 414 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKP 414 (459)
T ss_pred hhhhccccchHHhhcCccccCCChhheeccCCCcCCCc
Confidence 99987 7776542 1 225555555543333
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=266.19 Aligned_cols=238 Identities=27% Similarity=0.438 Sum_probs=178.8
Q ss_pred chhhcccccCCceeEEEEEecC--------CCeEEEEEeccCc----------------------------ceeecCCcc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD--------GRNVAIKVLNETK----------------------------GFCFEGHRR 46 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~----------------------------~~~~~~~~~ 46 (291)
+.+.+.||+|+||.||++++.. ...+|+|.+.... +.+......
T Consensus 20 ~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 99 (307)
T cd05098 20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 99 (307)
T ss_pred eEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 3467899999999999997532 3579999987532 345556778
Q ss_pred eeeehhhcCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC
Q 022826 47 ALIYEFVSNGSLEKFIYEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 116 (291)
Q Consensus 47 ~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~ 116 (291)
++||||+.+++|.+++...... .....+++..++.++.|++.||.|||+ .+++|+||||+||+++.+
T Consensus 100 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~~ 176 (307)
T cd05098 100 YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTED 176 (307)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEcCC
Confidence 8999999999999999775321 123468999999999999999999999 999999999999999999
Q ss_pred CceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCcccc
Q 022826 117 FCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIY 195 (291)
Q Consensus 117 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~ 195 (291)
+.++|+|||++................+++.|+|||.+.+. .++.++||||||+++|+|++ |..|+.....
T Consensus 177 ~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------ 248 (307)
T cd05098 177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 248 (307)
T ss_pred CcEEECCCcccccccccchhhccccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH------
Confidence 99999999998765432211111222335689999998765 78899999999999999998 6666643210
Q ss_pred chhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCC
Q 022826 196 FPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLR 260 (291)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 260 (291)
........ . ......+...+..+.+++.+||+.+|.+||++.++++.|+.++....
T Consensus 249 --~~~~~~~~------~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 249 --EELFKLLK------E-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred --HHHHHHHH------c-CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 00000000 0 11111223456788899999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=269.82 Aligned_cols=215 Identities=25% Similarity=0.340 Sum_probs=169.6
Q ss_pred cchhhcccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------------ceeecCCcceeee
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~ 50 (291)
++++.+.||+|+||.||+|++. +++.||+|++.... ..+......++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3567889999999999999875 48999999986431 3445566788999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
||+.+|+|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 81 Ey~~~g~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~ 151 (323)
T cd05615 81 EYVNGGDLMYHIQQV------GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEH 151 (323)
T ss_pred cCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEecccccccc
Confidence 999999999998654 478999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
..... ......|++.|+|||.+.+. .++.++|||||||++|+|++|..||..... ........ ...
T Consensus 152 ~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~-~~~- 217 (323)
T cd05615 152 MVDGV--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIM-EHN- 217 (323)
T ss_pred CCCCc--cccCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-hCC-
Confidence 32211 12334579999999999775 788999999999999999999998865421 00111110 000
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAM 245 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~ 245 (291)
...+..++..+.+++.+||+.+|.+|++.
T Consensus 218 ------~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 ------VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ------CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11223456678899999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=272.94 Aligned_cols=226 Identities=20% Similarity=0.261 Sum_probs=175.1
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+++.. +++.||+|+++... ..+......++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 567899999999999999875 48999999987532 345566788999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~L~~~l~~~-----~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 83 QPGGDLLSLLNRY-----EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999764 2478999999999999999999999 9999999999999999999999999999986644
Q ss_pred CCceeeccCCCCCccccCccccccc----CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRN----FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEE 208 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~----~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (291)
.... ......+++.|+|||.+.+. ...++.++|||||||++|+|++|..||...... .........
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~- 224 (330)
T cd05601 155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--------KTYNNIMNF- 224 (330)
T ss_pred CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH--------HHHHHHHcC-
Confidence 3322 12334578999999998631 236788999999999999999999998654221 001111000
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
...........++..+.+|+..||. +|.+||++.++++
T Consensus 225 ---~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 225 ---QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ---CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0000111122356778899999998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=272.25 Aligned_cols=239 Identities=22% Similarity=0.249 Sum_probs=170.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeec-----CCccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFE-----GHRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~-----~~~~~l 48 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +++.. ....++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 467889999999999999875 48999999986421 11111 124789
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
||||+. ++|.+++... ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++.
T Consensus 82 v~e~~~-~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 82 VFELME-SDLHQVIKAN------DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEecCC-CCHHHHHHhc------ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 999995 5899888654 468999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCc-eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc-------chhhh
Q 022826 129 ICHGRES-IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY-------FPHWV 200 (291)
Q Consensus 129 ~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~-------~~~~~ 200 (291)
....... ........+++.|+|||++.+....++.++|||||||++|+|++|..||........... .+...
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6433221 111234567899999999876434788999999999999999999988865432100000 00000
Q ss_pred hhhhh------hhhhhc--ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 201 YKRLE------LEEDLG--LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 201 ~~~~~------~~~~~~--~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
..... ...... .+.............+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 000000 0000001112245668899999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=279.49 Aligned_cols=248 Identities=18% Similarity=0.207 Sum_probs=172.4
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-------------------------------cee-ecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------------GFC-FEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------------------------------~~~-~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|.+.. ++.||||+++... .++ ......|+|
T Consensus 131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv 210 (467)
T PTZ00284 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIV 210 (467)
T ss_pred EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEE
Confidence 3456789999999999998754 8899999985321 111 223567889
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC------------
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF------------ 117 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~------------ 117 (291)
|+++ +++|.+++... ..+++..+..++.||+.||.|||+ ..+|+|+||||+||+++.++
T Consensus 211 ~~~~-g~~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 211 MPKY-GPCLLDWIMKH------GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred Eecc-CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 9988 66898888654 478999999999999999999996 14999999999999998765
Q ss_pred ----ceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcc
Q 022826 118 ----CPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSE 193 (291)
Q Consensus 118 ----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~ 193 (291)
.+||+|||.+..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.........
T Consensus 282 ~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred CCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 499999998754221 12345679999999999876 7899999999999999999999998654321100
Q ss_pred cc-------chh-hhhhh-hhhhhhh-cc-cC---------------CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 022826 194 IY-------FPH-WVYKR-LELEEDL-GL-QG---------------IENEEDKEYARKMILVSLWCIQNNPSDRPAMNR 247 (291)
Q Consensus 194 ~~-------~~~-~~~~~-~~~~~~~-~~-~~---------------~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~e 247 (291)
.. ++. +.... ......+ .. .. ............+.+||.+||+.||++|||++|
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 00 000 00000 0000000 00 00 000000112356789999999999999999999
Q ss_pred HHH--HHHhhhccCCCCCCCc
Q 022826 248 VVE--MLEGSLDSLRIPPRPF 266 (291)
Q Consensus 248 ll~--~L~~~~~~~~~~~~~~ 266 (291)
+++ ++.+.....+.-+.++
T Consensus 435 ~L~Hp~~~~~~~~~~~~~~~~ 455 (467)
T PTZ00284 435 MTTHPYVLKYYPECRQHPNYP 455 (467)
T ss_pred HhcCccccccCCccccCCCCC
Confidence 997 6666555555544444
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=262.87 Aligned_cols=221 Identities=25% Similarity=0.373 Sum_probs=171.0
Q ss_pred cccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehhhcCCCH
Q 022826 9 LGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 9 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
||+|+||+||++.+. +++.+|+|++.... ..+..+...++||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999775 58999999986432 344556778899999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
..++.... .....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-- 153 (280)
T cd05608 81 RYHIYNVD--EENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-- 153 (280)
T ss_pred HHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence 98875432 234578999999999999999999999 99999999999999999999999999998765443221
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCCh
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 218 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (291)
.....+++.|+|||.+.+. .++.++||||||+++|+|++|..||.......... .. ..... .....
T Consensus 154 ~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--------~~--~~~~~--~~~~~ 219 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--------EL--KQRIL--NDSVT 219 (280)
T ss_pred ccccCCCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--------HH--HHhhc--ccCCC
Confidence 2334678999999999876 78899999999999999999999987543211100 00 00000 00111
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 022826 219 EDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVE 250 (291)
Q Consensus 219 ~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~ 250 (291)
.+..++..+.+++.+||+.||++|| +++++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 2334677889999999999999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=268.83 Aligned_cols=236 Identities=29% Similarity=0.440 Sum_probs=176.5
Q ss_pred chhhcccccCCceeEEEEEec------CCCeEEEEEeccCc----------------------------cee-ecCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK----------------------------GFC-FEGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----------------------------~~~-~~~~~~~ 47 (291)
+.+.+.||+|+||.||+|... +++.||+|+++... +.+ ..+...+
T Consensus 9 ~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~ 88 (337)
T cd05054 9 LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (337)
T ss_pred hhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEE
Confidence 457799999999999999642 25789999986432 122 2345677
Q ss_pred eeehhhcCCCHHHHHhhcCCC-------------------------------------------------------CCCC
Q 022826 48 LIYEFVSNGSLEKFIYEKHPL-------------------------------------------------------ETNQ 72 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------~~~~ 72 (291)
+++||+.+++|.+++...... ....
T Consensus 89 ~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (337)
T cd05054 89 VIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKE 168 (337)
T ss_pred EEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhc
Confidence 899999999999998653210 0013
Q ss_pred CCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeeccCCCCCccccCcc
Q 022826 73 KLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPE 152 (291)
Q Consensus 73 ~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 152 (291)
.+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++................++..|+|||
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 68999999999999999999999 999999999999999999999999999998654333222222334567899999
Q ss_pred cccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHH
Q 022826 153 VFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS 231 (291)
Q Consensus 153 ~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 231 (291)
.+.+. .++.++|||||||++|+|++ |..||....... ...... ... .....+......+.+++
T Consensus 246 ~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-------~~~~~~-~~~------~~~~~~~~~~~~~~~l~ 309 (337)
T cd05054 246 SIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-------EFCRRL-KEG------TRMRAPEYATPEIYSIM 309 (337)
T ss_pred HhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-------HHHHHH-hcc------CCCCCCccCCHHHHHHH
Confidence 98775 88999999999999999997 887775432110 000000 000 00111233556789999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 232 LWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 232 ~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
.+||+.+|++||++.++++.|+++++
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=269.51 Aligned_cols=215 Identities=23% Similarity=0.299 Sum_probs=169.8
Q ss_pred cccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.||+|+||.||++++.. ++.||+|+++... +.+......++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999998764 8899999987431 455667788999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|..++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 151 (318)
T cd05570 81 GDLMFHIQRS------GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV 151 (318)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence 9999988654 478999999999999999999999 9999999999999999999999999999864322111
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
......+++.|+|||.+.+. .++.++|||||||++|+|++|..||...... ..... +....
T Consensus 152 --~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--------~~~~~------i~~~~- 212 (318)
T cd05570 152 --TTSTFCGTPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAGQSPFEGDDED--------ELFQS------ILEDE- 212 (318)
T ss_pred --cccceecCccccCHHHhcCC--CCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--------HHHHH------HHcCC-
Confidence 12234578999999999876 7889999999999999999999998643210 00000 00000
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAM-----NRVVE 250 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~-----~ell~ 250 (291)
...+..++..+.+++.+||+.||.+||++ .++++
T Consensus 213 -~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 213 -VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 11123356778999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=262.31 Aligned_cols=221 Identities=24% Similarity=0.369 Sum_probs=170.4
Q ss_pred cccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehhhcCCCH
Q 022826 9 LGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 9 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
||+|+||.||+++... ++.||+|++.... ..+..+...++||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999998754 9999999986321 455566788999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--- 150 (277)
T cd05607 81 KYHIYNV----GERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--- 150 (277)
T ss_pred HHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---
Confidence 9888654 23468899999999999999999999 9999999999999999999999999999876544322
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCCh
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 218 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (291)
.....++..|+|||.+.+. .++.++|||||||++|+|++|..||........ ..... .... ... ...
T Consensus 151 ~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~----~~~~~-----~~~~-~~~-~~~ 217 (277)
T cd05607 151 ITQRAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA----KEELK-----RRTL-EDE-VKF 217 (277)
T ss_pred eeccCCCCCccCHHHHccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh----HHHHH-----HHhh-ccc-ccc
Confidence 2234578999999999776 689999999999999999999999864322111 00000 0000 000 011
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 022826 219 EDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252 (291)
Q Consensus 219 ~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L 252 (291)
....++.++.+++.+||+.||++||++.|+++.+
T Consensus 218 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 218 EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 1224677789999999999999999997766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=263.75 Aligned_cols=226 Identities=28% Similarity=0.385 Sum_probs=176.5
Q ss_pred cchhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeeh
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e 51 (291)
|+.+.+.||+|+||.||++.+. +++.||+|++.... +.+..+...++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4667889999999999999875 58999999986421 34455677899999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++....
T Consensus 81 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 81 LMNGGDLKFHIYNM----GNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred ccCCCcHHHHHHhc----CcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999888653 23468999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
.... .....+++.|+|||.+.+. .++.++||||+|+++|+|++|..||....... ...... ..+
T Consensus 154 ~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--------~~~~~~--~~~- 217 (285)
T cd05605 154 EGET---IRGRVGTVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--------KREEVE--RRV- 217 (285)
T ss_pred CCCc---cccccCCCCccCcHHhcCC--CCCccccchhHHHHHHHHHHCCCCCCCCchhh--------HHHHHH--HHh-
Confidence 3321 1234578999999999765 78899999999999999999999887532211 000000 001
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVEM 251 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~~ 251 (291)
.......+..++..+.+++.+||+.||++|| ++.++++.
T Consensus 218 -~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 218 -KEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -hhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1111222344677889999999999999999 88888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=261.77 Aligned_cols=235 Identities=24% Similarity=0.415 Sum_probs=179.8
Q ss_pred chhhcccccCCceeEEEEEec------CCCeEEEEEeccCc--------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK--------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||+++.. ++..+++|.+.... +.+......++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence 345688999999999999742 25678999986543 5666677889999
Q ss_pred hhhcCCCHHHHHhhcCC----------CCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceE
Q 022826 51 EFVSNGSLEKFIYEKHP----------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 120 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~k 120 (291)
||+.+++|.+++..... ......+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 99999999999976431 1123458999999999999999999999 9999999999999999999999
Q ss_pred EeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhh
Q 022826 121 ISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHW 199 (291)
Q Consensus 121 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~ 199 (291)
|+|||++................++..|+|||.+.+. .++.++||||||+++|+|++ |..|+...... .
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------~ 233 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--------E 233 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------H
Confidence 9999998765433222222333457789999998775 78899999999999999998 88776543211 0
Q ss_pred hhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 200 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
.... .. ...........+..+.+++.+||+.||++||++.++++.|+++.+
T Consensus 234 ~~~~------~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 234 VIEC------IT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHH------Hh-CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 0000 00 011111122345678999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=268.13 Aligned_cols=211 Identities=22% Similarity=0.276 Sum_probs=165.3
Q ss_pred cccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.||+|+||.||+|++.. ++.||+|++.... +.+......++||||+.+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999998754 8999999986432 345567788999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|...+... ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (321)
T cd05603 81 GELFFHLQRE------RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE 151 (321)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence 9999888543 468899999999999999999999 9999999999999999999999999999875322111
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
......+++.|+|||.+.+. .++.++|||||||++|+|++|..||...... . ..... ...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~-~~~~i-~~~------- 211 (321)
T cd05603 152 --TTSTFCGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-------Q-MYDNI-LHK------- 211 (321)
T ss_pred --ccccccCCcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCCCCHH-------H-HHHHH-hcC-------
Confidence 12344678999999999765 7889999999999999999999998654210 0 00000 000
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMN 246 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ 246 (291)
....+......+.+++.+||+.||.+||++.
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 212 PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0111223456788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=268.62 Aligned_cols=215 Identities=24% Similarity=0.324 Sum_probs=168.9
Q ss_pred cccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.||+|+||.||+|++.+ ++.||+|+++... +.+......++||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 468999999999998755 8899999986531 445566778899999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
|+|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 g~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05619 81 GDLMFHIQSC------HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA 151 (316)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence 9999998654 478899999999999999999999 9999999999999999999999999999875322211
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
......+++.|+|||.+.+. .++.++|||||||++|+|++|..||..... ........ ...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~i~------~~~- 212 (316)
T cd05619 152 --KTCTFCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--------EELFQSIR------MDN- 212 (316)
T ss_pred --ceeeecCCccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH------hCC-
Confidence 12334578999999999775 789999999999999999999998864321 10111110 000
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMN-RVVE 250 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~-ell~ 250 (291)
...+..++..+.+++.+||+.||.+||++. ++++
T Consensus 213 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 213 -PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 111223566788999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=271.70 Aligned_cols=217 Identities=23% Similarity=0.322 Sum_probs=169.5
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehhhcCC
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.||+|+||.||++.+. +++.||+|++.... ..+......++||||+.++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 58999999987532 3455677889999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+|..++... ..+++..+..++.||+.||.|||+ ..+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~- 151 (325)
T cd05594 81 ELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA- 151 (325)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-
Confidence 999888653 478999999999999999999995 16999999999999999999999999999875322211
Q ss_pred eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 137 VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
......+++.|+|||.+.+. .++.++|||||||++|+|++|..||...... ...... .....
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--------~~~~~i-~~~~~------ 213 (325)
T cd05594 152 -TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELI-LMEEI------ 213 (325)
T ss_pred -ccccccCCcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCCHH--------HHHHHH-hcCCC------
Confidence 12334689999999999775 7899999999999999999999998643210 000000 00000
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVEM 251 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~~ 251 (291)
..+..++..+.+++.+||+.||++|+ ++.++++.
T Consensus 214 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 -RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11223556788999999999999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=267.01 Aligned_cols=215 Identities=26% Similarity=0.334 Sum_probs=169.0
Q ss_pred cccccCCceeEEEEEec----CCCeEEEEEeccCc------------------------------ceeecCCcceeeehh
Q 022826 7 NKLGQGGYGGVYKGKLL----DGRNVAIKVLNETK------------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~ 52 (291)
+.||+|+||.||+++.. .++.||+|+++... +.+..+...++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999752 47899999986421 455667788999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 82 LSGGELFMHLERE------GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCchHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 9999999998654 467888999999999999999999 9999999999999999999999999999875332
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...... ....... ...
T Consensus 153 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~pf~~~~~~--------~~~~~~~-~~~--- 216 (323)
T cd05584 153 EGT--VTHTFCGTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTGAPPFTAENRK--------KTIDKIL-KGK--- 216 (323)
T ss_pred CCC--cccccCCCccccChhhccCC--CCCCcceecccHHHHHHHhcCCCCCCCCCHH--------HHHHHHH-cCC---
Confidence 221 12334679999999999775 6789999999999999999999998653210 0000000 000
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~ 250 (291)
...+..++..+.+++.+||+.||++|| ++.++++
T Consensus 217 ----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 ----LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111223456788999999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=262.89 Aligned_cols=235 Identities=25% Similarity=0.345 Sum_probs=169.7
Q ss_pred chhhcccccCCceeEEEEEec--CCCeEEEEEeccCc-------------------------------ceee-----cCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL--DGRNVAIKVLNETK-------------------------------GFCF-----EGH 44 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-------------------------------~~~~-----~~~ 44 (291)
+.+.+.||+|+||.||+|++. +++.||+|+++... +.+. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 567789999999999999873 36889999876422 1111 234
Q ss_pred cceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEecc
Q 022826 45 RRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 124 (291)
Q Consensus 45 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Df 124 (291)
..++|+||+. ++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+||
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 5789999996 5999998654 33568999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhh-----
Q 022826 125 GLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHW----- 199 (291)
Q Consensus 125 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~----- 199 (291)
|++....... ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||...............
T Consensus 155 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~ 229 (290)
T cd07862 155 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 229 (290)
T ss_pred cceEeccCCc---ccccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence 9987654331 12344578999999999765 7889999999999999999999888754321100000000
Q ss_pred --hhhhhhhhhhhcccCCC----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 200 --VYKRLELEEDLGLQGIE----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 200 --~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.+............... ......++..+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000000000000000 0111235567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=262.41 Aligned_cols=235 Identities=25% Similarity=0.274 Sum_probs=176.6
Q ss_pred hcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------cee-ec---CCcceeeehhhcCCC
Q 022826 6 KNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------GFC-FE---GHRRALIYEFVSNGS 57 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------~~~-~~---~~~~~lv~e~~~~g~ 57 (291)
.+.+|.|+||.||+|.... ++.||||++..++ .+. .. .-...+||||++. +
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-t 107 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-T 107 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-H
Confidence 4789999999999998754 7999999987766 111 11 2244589999987 9
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC-CceEEeccCCccccCCCCce
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~ 136 (291)
|.+.++.. ...+...+...+.-++.||.+||.|||+ .+|+||||||.|+++|.+ |.+||||||.|+....+.+.
T Consensus 108 L~~~~r~~--~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn 182 (364)
T KOG0658|consen 108 LYRVIRHY--TRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN 182 (364)
T ss_pred HHHHHHHH--hhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence 99998752 2345788888899999999999999999 999999999999999976 99999999999988776655
Q ss_pred eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhh-hhhhhhhhhh-----
Q 022826 137 VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWV-YKRLELEEDL----- 210 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----- 210 (291)
..+. .|..|+|||++.|. ..|+.+.||||.||++.||+-|+..|................ ..........
T Consensus 183 iSYi---cSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 183 ISYI---CSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred eeEE---EeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 4332 37799999999986 589999999999999999999999888765543211111100 0000001100
Q ss_pred -------cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 211 -------GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 211 -------~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.............+.++.+|+.++|+.+|.+|.++.|++.
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0011111133456778999999999999999999999874
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=281.28 Aligned_cols=226 Identities=20% Similarity=0.254 Sum_probs=176.2
Q ss_pred chhhcccccCCceeEEEEEec-C-CCeEEEEEeccCc--------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-D-GRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||+|... + ++.||+|.+.... +.+..+...++||||+.
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 456789999999999999653 3 6788888765433 55667788999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+|+|.+++.... .....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 149 gg~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 149 GGDLNKQIKQRL--KEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCHHHHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999886532 233578999999999999999999999 999999999999999999999999999998765433
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
.........||+.|+|||.+.+. .++.++|||||||++|+|++|..||..... ........ . .
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~~~------~-~ 286 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQVL------Y-G 286 (478)
T ss_pred ccccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH------h-C
Confidence 22223445689999999999775 789999999999999999999998864311 00000000 0 0
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.....+..++..+.+++.+||+.||++||++.++++
T Consensus 287 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 287 KYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011122345677899999999999999999999864
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=261.60 Aligned_cols=240 Identities=25% Similarity=0.403 Sum_probs=174.9
Q ss_pred chhhcccccCCceeEEEEEe-----cCCCeEEEEEeccCc---------------------------ceeec--CCccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKL-----LDGRNVAIKVLNETK---------------------------GFCFE--GHRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~---------------------------~~~~~--~~~~~l 48 (291)
+.+.+.||+|+||.||+++. ..++.|++|.++... +.+.. ....++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 45668899999999999974 247899999987443 22222 256789
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
+|||+++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.
T Consensus 86 v~e~~~g~~L~~~l~~~-----~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 86 IMEFLPSGSLKEYLPRN-----KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEccCCCCHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence 99999999999998653 2468999999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCce-eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc---hhhhhhhh
Q 022826 129 ICHGRESI-VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF---PHWVYKRL 204 (291)
Q Consensus 129 ~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~---~~~~~~~~ 204 (291)
........ .......++..|+|||.+.+. .++.++||||||+++|+|+++..+............. ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 66543221 112334456789999998765 7889999999999999999977654332211100000 00000000
Q ss_pred hhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 205 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
...+.. .........++..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 236 --~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 --VRVLEE-GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred --HHHHHc-CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000000 011111233567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=273.86 Aligned_cols=226 Identities=21% Similarity=0.264 Sum_probs=170.2
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|++.+ ++.||+|++.... +.+.+....++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 4567899999999999997754 8999999986532 455667789999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++... ..+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.++|+|||++..+..
T Consensus 83 ~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 83 IPGGDMMSLLIRM------EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 9999999998654 468999999999999999999999 9999999999999999999999999999754321
Q ss_pred CCce---------------------------------------------eeccCCCCCccccCcccccccCCCccccccc
Q 022826 133 RESI---------------------------------------------VSMTGARGTVGYIAPEVFCRNFGEVSYKSDV 167 (291)
Q Consensus 133 ~~~~---------------------------------------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~Di 167 (291)
.... .......||+.|+|||.+.+. .++.++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~Di 231 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDW 231 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCCccce
Confidence 0000 001124589999999999775 78899999
Q ss_pred hhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHH--hhhcCCCCCCCH
Q 022826 168 YSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLW--CIQNNPSDRPAM 245 (291)
Q Consensus 168 wslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--~l~~dP~~Rps~ 245 (291)
|||||++|+|++|..||........ ............ ......++.++.+|+.+ |+..+|..||++
T Consensus 232 wSlG~il~elltG~~Pf~~~~~~~~-------~~~i~~~~~~~~-----~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 232 WSVGVILFEMLVGQPPFLAPTPTET-------QLKVINWENTLH-----IPPQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred eehhhHHHHHHhCCCCCcCCCHHHH-------HHHHHccccccC-----CCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 9999999999999999875432110 000000000111 11112345677788887 456667779999
Q ss_pred HHHHHH
Q 022826 246 NRVVEM 251 (291)
Q Consensus 246 ~ell~~ 251 (291)
.++++.
T Consensus 300 ~~~l~h 305 (381)
T cd05626 300 DDIKAH 305 (381)
T ss_pred HHHhcC
Confidence 999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=273.98 Aligned_cols=224 Identities=21% Similarity=0.264 Sum_probs=172.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||++++. +++.||||++.... +.+..+...++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 556789999999999999875 48999999987431 455677889999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++..+..
T Consensus 83 ~~~g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 83 LPGGDMMTLLMKK------DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCcHHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999654 468999999999999999999999 9999999999999999999999999999875432
Q ss_pred CCcee------------------------------------eccCCCCCccccCcccccccCCCccccccchhHHHHHHH
Q 022826 133 RESIV------------------------------------SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 176 (291)
Q Consensus 133 ~~~~~------------------------------------~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ 176 (291)
..... ......||+.|+|||++.+. .++.++|||||||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~e 231 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYE 231 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchhHHHH
Confidence 11100 00123589999999998765 78999999999999999
Q ss_pred HhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 022826 177 MTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPA---MNRVVE 250 (291)
Q Consensus 177 ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps---~~ell~ 250 (291)
|++|..||...... ....... ... ..........++..+.+++.+||. +|.+|++ +.++++
T Consensus 232 l~~G~~Pf~~~~~~--------~~~~~i~---~~~-~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 232 MLVGYPPFCSDNPQ--------ETYRKII---NWK-ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred hhcCCCCCCCCCHH--------HHHHHHH---cCC-CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999998654211 0000000 000 000111112356678899999996 9999997 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=270.75 Aligned_cols=214 Identities=21% Similarity=0.251 Sum_probs=167.8
Q ss_pred cccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.||+|+||.||++++.. ++.||+|++.... ..+......++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999998764 7899999986432 344566778999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++... ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~L~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 81 GELFYHLQRE------RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence 9999998654 468888999999999999999999 9999999999999999999999999999875322211
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
......|++.|+|||.+.+. .++.++|||||||++|+|++|..||...... ....... . ..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~-~----~~-- 212 (325)
T cd05602 152 --TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNIL-N----KP-- 212 (325)
T ss_pred --CcccccCCccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCCCCHH--------HHHHHHH-h----CC--
Confidence 12345689999999999875 7889999999999999999999998643211 0001100 0 00
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVV 249 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell 249 (291)
......++..+.+++.+||+.||.+|+++.+.+
T Consensus 213 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 213 -LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred -cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 111224566788999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=270.95 Aligned_cols=235 Identities=20% Similarity=0.217 Sum_probs=172.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------ceeecCCcceeeehhhcCCCHHHH
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------GFCFEGHRRALIYEFVSNGSLEKF 61 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------~~~~~~~~~~lv~e~~~~g~L~~~ 61 (291)
+.+.+.||+|+||.||++.+. +++.||+|...... +.+..+...+++++++. ++|..+
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~ 172 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCY 172 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHH
Confidence 456789999999999999875 48999999876433 45666778899999995 589888
Q ss_pred HhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeeccC
Q 022826 62 IYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTG 141 (291)
Q Consensus 62 l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 141 (291)
+... ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++.++|+|||++........ .....
T Consensus 173 l~~~------~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~ 242 (391)
T PHA03212 173 LAAK------RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYG 242 (391)
T ss_pred HHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-ccccc
Confidence 8654 468899999999999999999999 9999999999999999999999999999865322111 11233
Q ss_pred CCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhh------------------hhhh
Q 022826 142 ARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHW------------------VYKR 203 (291)
Q Consensus 142 ~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~------------------~~~~ 203 (291)
..||+.|+|||++.+. .++.++|||||||++|+|++|..|+............... ....
T Consensus 243 ~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 243 WAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred ccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 5689999999999775 7899999999999999999999876544322111000000 0000
Q ss_pred hh--h---hh-hhcccC-CCC-hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 204 LE--L---EE-DLGLQG-IEN-EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 204 ~~--~---~~-~~~~~~-~~~-~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. . .. ....+. ... ......+..+.+|+.+||+.||++|||++|+++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 0 00 000000 000 112245678999999999999999999999985
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=257.77 Aligned_cols=232 Identities=22% Similarity=0.394 Sum_probs=180.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|+.. +++.|++|.++... +.+......++++||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 567789999999999999875 58999999875321 455556788899999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++.... .....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 84 ADAGDLSQMIKYFK--KQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred cCCCcHHHHHHHhh--hccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999886532 123568999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
.... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|+....... .. ....+..
T Consensus 159 ~~~~--~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~------~~------~~~~~~~ 222 (267)
T cd08228 159 KTTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------FS------LCQKIEQ 222 (267)
T ss_pred hhHH--HhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCccccccH------HH------HHHHHhc
Confidence 3221 1234568899999998765 67889999999999999999999876432211 00 0011111
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
..........++..+.+++.+||+.+|++||++.++++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1111222335667899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=275.80 Aligned_cols=169 Identities=27% Similarity=0.354 Sum_probs=146.5
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-------------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||.|.+|.+.. ++.||||+++... +++....+.|||+
T Consensus 188 Y~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVf 267 (586)
T KOG0667|consen 188 YEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVF 267 (586)
T ss_pred EEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeee
Confidence 3567899999999999997754 9999999999776 6777788999999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC--CceEEeccCCcc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED--FCPKISDFGLAK 128 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~--~~~kl~Dfg~~~ 128 (291)
|.+.- +|.++++.+ ...+++...++.|+.||+.||.+||+ .+|||+|||||||||.+. ..+||+|||++.
T Consensus 268 ELL~~-NLYellK~n----~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 268 ELLST-NLYELLKNN----KFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred hhhhh-hHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 99965 999999987 55789999999999999999999999 999999999999999543 479999999998
Q ss_pred ccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCcc
Q 022826 129 ICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANV 186 (291)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~ 186 (291)
....... ....+..|+|||+|.|. .|+.+.|+|||||+++||.+|...|+.
T Consensus 340 ~~~q~vy-----tYiQSRfYRAPEVILGl--pY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 340 FESQRVY-----TYIQSRFYRAPEVILGL--PYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred ccCCcce-----eeeeccccccchhhccC--CCCCccceeehhhhHHhHhcCccccCC
Confidence 6544332 33457899999999997 999999999999999999999766653
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=256.87 Aligned_cols=224 Identities=28% Similarity=0.444 Sum_probs=173.7
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||+|+||.||++...++..+++|.+.... +.+......+++|||+.+|+
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence 45678899999999999988778899999877543 46667778899999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.+.........
T Consensus 86 L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 86 LLNYLRQRQ-----GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred HHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 999986532 468999999999999999999999 99999999999999999999999999988765432221
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
......++..|+|||.+.+. .++.++||||||+++|+|++ |..||..... .. ......... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-------~~-~~~~i~~~~-------~ 219 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-------YE-VVEMISRGF-------R 219 (256)
T ss_pred ccCCCCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-------HH-HHHHHHCCC-------C
Confidence 11222345689999998765 78899999999999999999 7777654321 00 000010000 0
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L 252 (291)
...+...+..+.+++.+||+.+|.+||++.++++.|
T Consensus 220 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 220 LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 011122346789999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=259.32 Aligned_cols=227 Identities=27% Similarity=0.450 Sum_probs=171.4
Q ss_pred hhhcccccCCceeEEEEEec-CCC----eEEEEEeccCc---------------------------ceeecCCcceeeeh
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGR----NVAIKVLNETK---------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~---------------------------~~~~~~~~~~lv~e 51 (291)
.+.+.||+|+||.||+|.+. +++ .||+|++.... +.+. ....+++++
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~l~~~ 88 (279)
T cd05109 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICL-TSTVQLVTQ 88 (279)
T ss_pred eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEc-CCCcEEEEE
Confidence 35688999999999999753 344 48999986433 2222 345678999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+++|+|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 89 ~~~~g~l~~~l~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 89 LMPYGCLLDYVREN-----KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred cCCCCCHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 99999999998653 2468999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
............++..|+|||.+.+. .++.++||||||+++|+|++ |..|+..... ........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~----- 225 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHR--RFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--------REIPDLLE----- 225 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHH-----
Confidence 43322222223346789999998765 78899999999999999988 7776643211 00000000
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~ 256 (291)
..........++..+.+++.+||+.||++||++.++++.|+.+.
T Consensus 226 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 226 --KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred --CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 00011112335667889999999999999999999999987763
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=256.48 Aligned_cols=229 Identities=28% Similarity=0.439 Sum_probs=175.3
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------ceeecCCcceeeehhhcCCCH
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
+.+.++||+|+||.||+|.+.+...|++|+++... .........+++|||+.+++|
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L 87 (262)
T cd05071 8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSL 87 (262)
T ss_pred eeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCCCcH
Confidence 45678999999999999988666779999987533 111234557899999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
.+++... ....+++..+..++.|++.||.+||+ .+++|+||||+||+++.++.++|+|||.+......... .
T Consensus 88 ~~~~~~~----~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~ 159 (262)
T cd05071 88 LDFLKGE----MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-A 159 (262)
T ss_pred HHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc-c
Confidence 9999653 23468999999999999999999999 99999999999999999999999999998765433211 1
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
.....++..|+|||.+.+. .++.++||||||+++|+|++ |..||..... ........ .....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~~~~~~~-------~~~~~ 222 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVE-------RGYRM 222 (262)
T ss_pred ccCCcccceecCHhHhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HHHHHHHh-------cCCCC
Confidence 1223346689999998765 78999999999999999999 6656543311 00000000 00011
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~ 256 (291)
.....++..+.+++.+||+.||++||++.++++.|++..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 123346678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=269.58 Aligned_cols=217 Identities=25% Similarity=0.357 Sum_probs=167.4
Q ss_pred cccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.||+|+||.||+++... ++.||+|+++... +.+......++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999998754 8899999997532 345566778999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|..++... ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~L~~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 151 (327)
T cd05617 81 GDLMFHMQRQ------RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD 151 (327)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence 9999888643 479999999999999999999999 9999999999999999999999999999875322111
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
......|++.|+|||.+.+. .++.++|||||||++|+|++|..||.......... .......... . .
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~-~-----~-- 218 (327)
T cd05617 152 --TTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-TEDYLFQVIL-E-----K-- 218 (327)
T ss_pred --ceecccCCcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-cHHHHHHHHH-h-----C--
Confidence 12345689999999999775 78999999999999999999999996543321110 0111111110 0 0
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAM 245 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~ 245 (291)
....+...+..+.+++.+||+.||.+|+++
T Consensus 219 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 219 PIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 011222355678899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=271.49 Aligned_cols=215 Identities=24% Similarity=0.320 Sum_probs=165.6
Q ss_pred cccCCceeEEEEEecC-CCeEEEEEeccCc--------------------------------ceeecCCcceeeehhhcC
Q 022826 9 LGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 9 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
||+|+||.||+|++.. ++.||+|++.... ..+......++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999998754 8999999986421 223456678999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++... ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++.++|+|||++........
T Consensus 81 g~L~~~l~~~------~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 151 (330)
T cd05586 81 GELFWHLQKE------GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK 151 (330)
T ss_pred ChHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence 9999988653 578999999999999999999999 9999999999999999999999999999875322221
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
......|++.|+|||.+.+. ..++.++|||||||++|+|++|..||...... ........ .....
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--------~~~~~i~~-~~~~~--- 216 (330)
T cd05586 152 --TTNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--------QMYRNIAF-GKVRF--- 216 (330)
T ss_pred --CccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHH--------HHHHHHHc-CCCCC---
Confidence 12345689999999998654 35789999999999999999999988653210 00111100 00001
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCC----CHHHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRP----AMNRVVE 250 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rp----s~~ell~ 250 (291)
....++..+.+++++||+.||.+|| ++.++++
T Consensus 217 ---~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 217 ---PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ---CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1123566788999999999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=263.34 Aligned_cols=236 Identities=20% Similarity=0.290 Sum_probs=170.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.++||+|+||.||+|... +++.||+|+++... +........++||||+.
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 455689999999999999875 48999999986432 34555667889999997
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+ +|.+++... +..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 87 ~-~l~~~l~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 87 S-DLKQYLDNC-----GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred c-CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 5 999888653 2467899999999999999999999 999999999999999999999999999987643322
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc-------hhhhhhhhhhh
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF-------PHWVYKRLELE 207 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 207 (291)
. ......+++.|+|||.+.+. ..++.++|||||||++|+|++|..||............ +...+......
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 158 K--TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred c--cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 1 12334568899999998653 36789999999999999999999988654221100000 00000000000
Q ss_pred h---hhcccCCC----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 208 E---DLGLQGIE----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 208 ~---~~~~~~~~----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. ....+... .......+.++.+|+.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 00000000 0001124567889999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=256.83 Aligned_cols=227 Identities=28% Similarity=0.462 Sum_probs=175.9
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------ceeecCCcceeeehhhcCCCH
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
+.+.++||+|+||.||+|...+++.|++|.+.... .........++++||+.+++|
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L 87 (260)
T cd05067 8 LKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMENGSL 87 (260)
T ss_pred ceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCCCCH
Confidence 45779999999999999998788999999987644 112234567899999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
.+++... .+..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......... .
T Consensus 88 ~~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05067 88 VDFLKTP----EGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred HHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-c
Confidence 9998653 34578999999999999999999999 99999999999999999999999999998765422211 1
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
.....++..|+|||.+.+. .++.++||||||+++|++++ |..||..... +.. .... .... ..
T Consensus 160 ~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~-~~~~--~~~~-----~~ 222 (260)
T cd05067 160 REGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-------PEV-IQNL--ERGY-----RM 222 (260)
T ss_pred ccCCcccccccCHHHhccC--CcCcccchHHHHHHHHHHHhCCCCCCCCCCh-------HHH-HHHH--HcCC-----CC
Confidence 1223346789999998765 78899999999999999998 8877754321 110 0000 0000 01
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
......+.++.+++.+||+.+|++||+++++++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1122345679999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=271.23 Aligned_cols=217 Identities=26% Similarity=0.317 Sum_probs=171.9
Q ss_pred chhhcccccCCceeEEEEEecC--CCeEEEEEeccCc-----------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD--GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|.+.+ +..||+|++.... +.+......++|||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence 4467899999999999997643 4689999985421 45667778999999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+|+|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 112 y~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 112 FVIGGEFFTFLRRN------KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999654 478999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
... ....||+.|+|||.+.+. .++.++|||||||++|+|++|..||..... ........ ...
T Consensus 183 ~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~i~-~~~-- 244 (340)
T PTZ00426 183 TRT-----YTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQKIL-EGI-- 244 (340)
T ss_pred CCc-----ceecCChhhcCHHHHhCC--CCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHHHHh-cCC--
Confidence 322 234678999999999775 788999999999999999999999875421 11111111 000
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVEM 251 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~~ 251 (291)
...+..++..+.+++++||+.||++|+ +++++++.
T Consensus 245 -----~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 -----IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 011223455678999999999999995 89888763
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=262.59 Aligned_cols=236 Identities=25% Similarity=0.439 Sum_probs=177.9
Q ss_pred chhhcccccCCceeEEEEEec--------CCCeEEEEEeccCc----------------------------ceeecCCcc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL--------DGRNVAIKVLNETK----------------------------GFCFEGHRR 46 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~----------------------------~~~~~~~~~ 46 (291)
+.+.+.||+|+||.||+++.. ++..|++|.+.... +.+......
T Consensus 17 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (304)
T cd05101 17 LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 96 (304)
T ss_pred eeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCce
Confidence 356789999999999999642 24579999986432 345556678
Q ss_pred eeeehhhcCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC
Q 022826 47 ALIYEFVSNGSLEKFIYEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 116 (291)
Q Consensus 47 ~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~ 116 (291)
+++|||+.+++|.+++...... .....+++..+..++.|++.||.|||+ .+++|+||||+||+++.+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili~~~ 173 (304)
T cd05101 97 YVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTEN 173 (304)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEEcCC
Confidence 8999999999999999875321 123468889999999999999999999 999999999999999999
Q ss_pred CceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCcccc
Q 022826 117 FCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIY 195 (291)
Q Consensus 117 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~ 195 (291)
+.++|+|||++................+++.|+|||.+.+. .++.++||||||+++|+|++ |..|+.....
T Consensus 174 ~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------ 245 (304)
T cd05101 174 NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------ 245 (304)
T ss_pred CcEEECCCccceecccccccccccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCH------
Confidence 99999999999876543322222333456789999998765 78899999999999999998 5555542210
Q ss_pred chhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 196 FPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
.. .... +... .....+..++..+.+++.+||+.+|.+||++.++++.|++++..
T Consensus 246 -~~-~~~~------~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 -EE-LFKL------LKEG-HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -HH-HHHH------HHcC-CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 00 0000 0000 01111234567889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=269.80 Aligned_cols=221 Identities=26% Similarity=0.371 Sum_probs=167.3
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcC
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
.+.+.||+|+||.||++.+. +++.||||++.... +++..+...++||||+.+
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 34578999999999999875 48999999986432 455667788899999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|... ...++..+..++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 157 ~~L~~~----------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 157 GSLEGT----------HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred Cccccc----------ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 998543 245677888999999999999999 9999999999999999999999999999876543221
Q ss_pred eeeccCCCCCccccCccccccc---CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 136 IVSMTGARGTVGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
......++..|+|||.+... ....+.++|||||||++|+|++|+.||....... + .. ......
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~--~~-----~~~~~~--- 289 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--W--AS-----LMCAIC--- 289 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--H--HH-----HHHHHh---
Confidence 12334578999999987432 1234578999999999999999999987322111 0 00 000000
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
..........++..+.+|+.+||+.||++||++.|+++.
T Consensus 290 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 290 MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111233466789999999999999999999999874
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=272.12 Aligned_cols=235 Identities=25% Similarity=0.398 Sum_probs=178.2
Q ss_pred hhhcccccCCceeEEEEEecC------CCeEEEEEeccCc----------------------------ceeecCCcceee
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD------GRNVAIKVLNETK----------------------------GFCFEGHRRALI 49 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~----------------------------~~~~~~~~~~lv 49 (291)
.+++.||+|+||.||+|.+.. +..||||+++... +.+......++|
T Consensus 40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv 119 (400)
T cd05105 40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYII 119 (400)
T ss_pred ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEE
Confidence 367899999999999997532 3479999997532 566667788999
Q ss_pred ehhhcCCCHHHHHhhcCCC-------------------------------------------------------------
Q 022826 50 YEFVSNGSLEKFIYEKHPL------------------------------------------------------------- 68 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~------------------------------------------------------------- 68 (291)
||||.+|+|.+++......
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (400)
T cd05105 120 TEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASK 199 (400)
T ss_pred EEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhh
Confidence 9999999999998764210
Q ss_pred -----------------------------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCce
Q 022826 69 -----------------------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 119 (291)
Q Consensus 69 -----------------------------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~ 119 (291)
.....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~~~ 276 (400)
T cd05105 200 YSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIV 276 (400)
T ss_pred hhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCCEE
Confidence 012357888899999999999999999 999999999999999999999
Q ss_pred EEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchh
Q 022826 120 KISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPH 198 (291)
Q Consensus 120 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~ 198 (291)
+|+|||++................++..|+|||.+.+. .++.++||||||+++|+|++ |..||.......
T Consensus 277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~------- 347 (400)
T cd05105 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS------- 347 (400)
T ss_pred EEEeCCcceeccccccccccCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-------
Confidence 99999998865433222222233456789999998765 78999999999999999986 777776432110
Q ss_pred hhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 199 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
....... ..........++..+.+++.+||+.||++||++.++.+.|+++++
T Consensus 348 ~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 TFYNKIK-------SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHh-------cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0000000 001111223456788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=272.33 Aligned_cols=225 Identities=19% Similarity=0.256 Sum_probs=173.5
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehhh
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~ 53 (291)
.+.+.||+|+||.||++++.. ++.||+|++.... +.+..+...++||||+
T Consensus 46 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05596 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYM 125 (370)
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCC
Confidence 456889999999999998754 8999999986421 3556677889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+|+|.+++.. ..+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.++|+|||++......
T Consensus 126 ~gg~L~~~l~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 126 PGGDLVNLMSN-------YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred CCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999854 357888999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeccCCCCCccccCcccccccC--CCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNF--GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~--~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
... ......|++.|+|||.+.+.. ..++.++|||||||++|+|++|..||...... .........
T Consensus 196 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~---- 262 (370)
T cd05596 196 GMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMDH---- 262 (370)
T ss_pred Ccc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--------HHHHHHHcC----
Confidence 211 123456899999999986532 35789999999999999999999998754321 001111000
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSD--RPAMNRVVEM 251 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~--Rps~~ell~~ 251 (291)
...........++..+.+++++||+.+|.+ |+++.++++.
T Consensus 263 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 263 KNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 001111112235778899999999999988 9999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=260.17 Aligned_cols=232 Identities=24% Similarity=0.399 Sum_probs=174.3
Q ss_pred chhhcccccCCceeEEEEEecC------CCeEEEEEeccCc---------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD------GRNVAIKVLNETK---------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~---------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|...+ ++.||+|+++... +.+......+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 4567899999999999997632 5789999987442 344555677889
Q ss_pred ehhhcCCCHHHHHhhcCC----------CCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCce
Q 022826 50 YEFVSNGSLEKFIYEKHP----------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 119 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~ 119 (291)
++|+.+++|.+++..... ......+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCce
Confidence 999999999999854321 1123468889999999999999999999 999999999999999999999
Q ss_pred EEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchh
Q 022826 120 KISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPH 198 (291)
Q Consensus 120 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~ 198 (291)
||+|||+++...............+++.|+|||.+.+. .++.++||||||+++|+|++ |..|+..... ..
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~ 234 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QD 234 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence 99999998765433322222333456789999998765 78899999999999999998 6655543211 00
Q ss_pred hhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 199 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
. ..... .. .....+..++..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 235 -~---~~~i~---~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 -V---IEMIR---NR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -H---HHHHH---cC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 0 00000 00 0111223466778899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=259.60 Aligned_cols=232 Identities=25% Similarity=0.424 Sum_probs=172.6
Q ss_pred chhhcccccCCceeEEEEEec------CCCeEEEEEeccCc---------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK---------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|.+. .+..||+|++.... +.+..+...++|
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 87 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 87 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence 345689999999999999753 25679999886422 455666788999
Q ss_pred ehhhcCCCHHHHHhhcCCCC----CCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccC
Q 022826 50 YEFVSNGSLEKFIYEKHPLE----TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~----~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
|||+.+++|.+++....... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~dfg 164 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFG 164 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECCCC
Confidence 99999999999997643111 12356888999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRL 204 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~ 204 (291)
++................+++.|+|||.+.+. .++.++||||||+++|+|++ |..||..... .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--------~~~~~~~ 234 (277)
T cd05062 165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------EQVLRFV 234 (277)
T ss_pred CccccCCcceeecCCCCccCHhhcChhHhhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHH
Confidence 98765433222222223346789999998765 78999999999999999998 5666543211 0000000
Q ss_pred hhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 205 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
. .. ... ..+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 235 ~-~~--~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 M-EG--GLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred H-cC--CcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 0 00 001 1122345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=260.44 Aligned_cols=226 Identities=28% Similarity=0.459 Sum_probs=175.1
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+++.||+|+||+||+++... ++.+|+|++.... +........+++|+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 3567899999999999998865 6789999998775 4555678888999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+++|.+++... ..+++..+..++.|++.||.+||+ .+++|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQKN------KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp TTEBHHHHHHHH------SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST
T ss_pred cccccccccccc------cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 999999999733 578999999999999999999999 99999999999999999999999999998764211
Q ss_pred CceeeccCCCCCccccCccccc-ccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFC-RNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~-~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
........+++.|+|||.+. +. .++.++||||||+++|+|++|..|+........ ........ ......
T Consensus 152 --~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-----~~~~~~~~-~~~~~~ 221 (260)
T PF00069_consen 152 --NENFNPFVGTPEYMAPEVLQQGK--KYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ-----LEIIEKIL-KRPLPS 221 (260)
T ss_dssp --TSEBSSSSSSGGGSCHHHHTTTS--SBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-----HHHHHHHH-HTHHHH
T ss_pred --ccccccccccccccccccccccc--cccccccccccccccccccccccccccccchhh-----hhhhhhcc-cccccc
Confidence 12234556789999999987 44 889999999999999999999988875511100 00000000 000000
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. .........+.+++.+||+.||++||++.++++
T Consensus 222 ~~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 222 SS---QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HT---TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cc---cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000011278999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=266.79 Aligned_cols=234 Identities=23% Similarity=0.345 Sum_probs=173.0
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.++||+|+||.||++.+. ++..+++|++.... +.+..+...++||||+.
T Consensus 7 y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (333)
T cd06650 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (333)
T ss_pred hheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCC
Confidence 456789999999999999876 48899999876542 56677888999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++... ..+++..+..++.+++.||.|||+ ..+++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 87 GGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 99999999654 468899999999999999999997 1379999999999999999999999999987543221
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc--------------hhhh
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF--------------PHWV 200 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~--------------~~~~ 200 (291)
.....++..|+|||.+.+. .++.++|||||||++|+|++|..||............ +...
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 159 ----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred ----cccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 1234578899999999775 7889999999999999999999998654321100000 0000
Q ss_pred ----------------hhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 201 ----------------YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 201 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.........+............++.++.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 00000000000000000011124567899999999999999999999965
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=260.29 Aligned_cols=235 Identities=28% Similarity=0.451 Sum_probs=177.5
Q ss_pred chhhcccccCCceeEEEEEecC------CCeEEEEEeccCc---------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD------GRNVAIKVLNETK---------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~---------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|.... ...+++|.+.... +.+......+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 4567899999999999997532 3578999876432 455566778899
Q ss_pred ehhhcCCCHHHHHhhcCCC------------------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCce
Q 022826 50 YEFVSNGSLEKFIYEKHPL------------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNI 111 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Ni 111 (291)
+||+.+++|.+++...... .....+++..++.++.|++.||.|||+ .+++|+||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheE
Confidence 9999999999998753211 122468899999999999999999999 9999999999999
Q ss_pred EEcCCCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCC
Q 022826 112 LLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDR 190 (291)
Q Consensus 112 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~ 190 (291)
++++++.++|+|||+++...............++..|+|||.+.+. .++.++||||||+++|+|++ |..||....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~-- 234 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-- 234 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhcCCCCCCCCC--
Confidence 9999999999999998765433221111223346789999998765 78999999999999999998 777775331
Q ss_pred CccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 191 SSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
+........ .......+..++..+.+++.+||+.+|++||++.++++.|++++.
T Consensus 235 ------~~~~~~~~~-------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 235 ------PERLFNLLK-------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ------HHHHHHHHh-------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111111110 000111123355678899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=255.82 Aligned_cols=224 Identities=26% Similarity=0.482 Sum_probs=173.3
Q ss_pred hhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCCH
Q 022826 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
.+.+.||+|+||.||+++..++..+|+|.+.... +++......+++|||+.+++|
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 86 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86 (256)
T ss_pred EEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcH
Confidence 4668899999999999988777789999887543 455566678999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
.+++... ...+++..++.++.|++.||.|||+ .+++|+||||.||+++.++.++|+|||.+......... .
T Consensus 87 ~~~i~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~ 157 (256)
T cd05113 87 LNYLREH-----GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-S 157 (256)
T ss_pred HHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-e
Confidence 9998653 2368999999999999999999999 99999999999999999999999999998765332211 1
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
.....++..|++||.+.+. .++.++||||||+++|+|++ |..||..... .. ....... ....
T Consensus 158 ~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~-~~~~~~~-------~~~~ 220 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-------SE-TVEKVSQ-------GLRL 220 (256)
T ss_pred cCCCccChhhCCHHHHhcC--cccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HH-HHHHHhc-------CCCC
Confidence 1223345689999999765 68899999999999999998 7777653321 00 0001100 0011
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
......+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112224678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=260.81 Aligned_cols=240 Identities=28% Similarity=0.391 Sum_probs=173.4
Q ss_pred hhhcccccCCceeEEEEEe-----cCCCeEEEEEeccCc---------------------------ceeec--CCcceee
Q 022826 4 SFKNKLGQGGYGGVYKGKL-----LDGRNVAIKVLNETK---------------------------GFCFE--GHRRALI 49 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~---------------------------~~~~~--~~~~~lv 49 (291)
.+.+.||+|+||.||++.. .+++.||+|+++... +++.. ....+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 4568899999999988642 247899999987532 22222 3357899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
|||+.+++|.+++.. ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++..
T Consensus 87 ~e~~~~~~l~~~~~~-------~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 87 MEYVPLGSLRDYLPK-------HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred ecCCCCCCHHHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccc
Confidence 999999999999854 368999999999999999999999 9999999999999999999999999999887
Q ss_pred cCCCCceee-ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhh
Q 022826 130 CHGRESIVS-MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEE 208 (291)
Q Consensus 130 ~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (291)
......... .....++..|+|||.+.+. .++.++||||||+++|+|++|..|+........+...............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 654332111 1222345679999998765 7889999999999999999999887543221110000000000000000
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
...........+..++..+.+++.+||+.+|++|||++++++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 00000011111234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=255.70 Aligned_cols=224 Identities=29% Similarity=0.476 Sum_probs=173.6
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||+|+||.||++.+.++..+++|++.... +.+......++|+||+++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC 85 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence 45778999999999999988777889999987542 45556677889999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++.... ..+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||+++........
T Consensus 86 L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 86 LLNYLRERK-----GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred HHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 999986542 478999999999999999999999 99999999999999999999999999998765332111
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
......++..|+|||.+.+. .++.++||||||+++|+|++ |..||...... . ...... . ...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~-~~~~~~--~-----~~~ 219 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-------E-VVESVS--A-----GYR 219 (256)
T ss_pred ccCCCCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-------H-HHHHHH--c-----CCc
Confidence 11222234579999998765 78899999999999999998 67766543211 0 000110 0 001
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L 252 (291)
...+..++..+.+++.+||+.+|++|||+.++++.|
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111223567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=262.38 Aligned_cols=239 Identities=26% Similarity=0.462 Sum_probs=178.1
Q ss_pred chhhcccccCCceeEEEEEec--------CCCeEEEEEeccCc----------------------------ceeecCCcc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL--------DGRNVAIKVLNETK----------------------------GFCFEGHRR 46 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~----------------------------~~~~~~~~~ 46 (291)
+.+.+.||+|+||.||++... ....+++|.+.... +.+......
T Consensus 14 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 93 (314)
T cd05099 14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPL 93 (314)
T ss_pred eeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCce
Confidence 346789999999999999752 24578999877432 345556678
Q ss_pred eeeehhhcCCCHHHHHhhcCC----------CCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC
Q 022826 47 ALIYEFVSNGSLEKFIYEKHP----------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 116 (291)
Q Consensus 47 ~lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~ 116 (291)
++++||+.+++|.+++..... ......+++..+..++.|++.||.|||+ .+++|+||||+||+++.+
T Consensus 94 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~~ 170 (314)
T cd05099 94 YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTED 170 (314)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEcCC
Confidence 899999999999999976432 1123568999999999999999999999 999999999999999999
Q ss_pred CceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCcccc
Q 022826 117 FCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIY 195 (291)
Q Consensus 117 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~ 195 (291)
+.++|+|||+++...............++..|+|||.+.+. .++.++||||||+++|+|++ |..||.....
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~~g~~p~~~~~~------ 242 (314)
T cd05099 171 NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR--VYTHQSDVWSFGILMWEIFTLGGSPYPGIPV------ 242 (314)
T ss_pred CcEEEccccccccccccccccccccCCCCccccCHHHHccC--CcCccchhhHHHHHHHHHHhCCCCCCCCCCH------
Confidence 99999999999765432221111222335679999998765 78899999999999999998 6666643211
Q ss_pred chhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCC
Q 022826 196 FPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRI 261 (291)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 261 (291)
....... . . ......+..++..+.+++.+||+.||++||++.++++.|+++...+..
T Consensus 243 --~~~~~~~---~---~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 243 --EELFKLL---R---E-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred --HHHHHHH---H---c-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 0000000 0 0 000111233456788999999999999999999999999998765433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=257.75 Aligned_cols=228 Identities=26% Similarity=0.382 Sum_probs=172.1
Q ss_pred hhhcccccCCceeEEEEEecC-CC----eEEEEEeccCc---------------------------ceeecCCcceeeeh
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GR----NVAIKVLNETK---------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~---------------------------~~~~~~~~~~lv~e 51 (291)
.+.+.||+|+||.||+|.+.. ++ .+++|++.... +++ .+...++++|
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~-~~~~~~~i~e 88 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQ 88 (279)
T ss_pred eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEE-CCCccEEEEE
Confidence 456889999999999998743 44 47888875332 222 2445678999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+|+|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 89 ~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 89 LSPLGSLLDHVRQH-----RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred eCCCCcHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999653 2578999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
............++..|++||.+.+. .++.++||||||+++|++++ |..|+..... ........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~~~----- 225 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFG--RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--------HEVPDLLE----- 225 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHH-----
Confidence 43322223334456789999998765 78999999999999999998 8877754321 00000000
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
..........+...+.+++.+||..||++|||+.|+++.|..+.+
T Consensus 226 --~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 226 --KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred --CCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 000011111234567889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=254.17 Aligned_cols=233 Identities=24% Similarity=0.409 Sum_probs=180.8
Q ss_pred cchhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeeh
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e 51 (291)
.+.+.+.||+|+||.||+|... +++.+++|.++... +.+......+++||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 3567899999999999999876 69999999886321 44555677889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++.... .....+++..+..++.+++.||.+||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 83 LADAGDLSRMIKHFK--KQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred cCCCCCHHHHHHHhc--ccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999986532 234568999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
..... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..|+....... .. . ...+.
T Consensus 158 ~~~~~--~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~-~------~~~~~ 221 (267)
T cd08224 158 SKTTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YS-L------CKKIE 221 (267)
T ss_pred CCCcc--cceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcccCCccH-----HH-H------Hhhhh
Confidence 32211 1233567889999998765 78899999999999999999998875442110 00 0 00000
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
...........++..+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 222 KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 00011111225667899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=254.78 Aligned_cols=226 Identities=27% Similarity=0.470 Sum_probs=174.2
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.++||+|+||.||++...++..+++|.+.... +.. .....+++|||+.+++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-~~~~~~lv~e~~~~~~ 86 (260)
T cd05070 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV-SEEPIYIVTEYMSKGS 86 (260)
T ss_pred hhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEE-CCCCcEEEEEecCCCc
Confidence 45678999999999999988778889999987643 222 3456789999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ....+++..+..++.+++.||.|||+ .+++|+||||+||++++++.++|+|||++.........
T Consensus 87 L~~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 87 LLDFLKDG----EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred HHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 99998653 23568999999999999999999999 99999999999999999999999999998765432211
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
......++..|+|||.+.+. .++.++||||||+++|+|++ |..||...... . ..... . ....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~-~~~~~--~-----~~~~ 221 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-------E-VLEQV--E-----RGYR 221 (260)
T ss_pred cccCCCCCccccChHHHhcC--CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-------H-HHHHH--H-----cCCC
Confidence 11222345679999998765 78899999999999999998 77666542110 0 00000 0 0011
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
...+...+..+.+++.+||..+|.+|||+.++.+.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11223456779999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=286.15 Aligned_cols=245 Identities=27% Similarity=0.439 Sum_probs=191.5
Q ss_pred hhhcccccCCceeEEEEEecC--CC----eEEEEEeccCc---------------------------ceeecCCcceeee
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD--GR----NVAIKVLNETK---------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~~~---------------------------~~~~~~~~~~lv~ 50 (291)
.+.+.||+|+||+||.|...+ +. .||+|.+++.. +++......++++
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l 774 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL 774 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence 456889999999999997654 44 38999988764 8888899999999
Q ss_pred hhhcCCCHHHHHhhcCCCCC-CCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 51 EFVSNGSLEKFIYEKHPLET-NQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
||+++|+|..+|++.+.... ...++....+.++.||++|+.||++ +++|||||.+.|+|++....+||+|||+|+.
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchhHh
Confidence 99999999999988533222 4678999999999999999999999 9999999999999999999999999999996
Q ss_pred cCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 130 CHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
....+.........-...|||||.+... .++.++|||||||++||+++....++....+.. +...
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~--iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-------v~~~------ 916 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDG--IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-------VLLD------ 916 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhc--ccccccchhhhHHHHHHHHhCCCCCCCCcchHH-------HHHH------
Confidence 5443332221112234689999999764 999999999999999999985544443322111 0110
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCCCCcc
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFL 267 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 267 (291)
...+.+...+..++..+.+++.+||+.+|++||++..|++++.++.+.+........
T Consensus 917 -~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~~ 973 (1025)
T KOG1095|consen 917 -VLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGPL 973 (1025)
T ss_pred -HHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCccccc
Confidence 111114555677888999999999999999999999999999998877665544433
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=273.54 Aligned_cols=225 Identities=20% Similarity=0.256 Sum_probs=170.1
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||++++.. ++.||+|++.... ..+..+...++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 4577899999999999998754 8999999986421 345567789999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.++|+|||++..+..
T Consensus 83 ~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 83 IPGGDMMSLLIRL------GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 9999999999654 468899999999999999999999 9999999999999999999999999999753321
Q ss_pred CCc-----------------------------------------eeeccCCCCCccccCcccccccCCCccccccchhHH
Q 022826 133 RES-----------------------------------------IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYG 171 (291)
Q Consensus 133 ~~~-----------------------------------------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG 171 (291)
... ........||+.|+|||++.+. .++.++||||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG 231 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVG 231 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeecc
Confidence 000 0001124689999999999776 788999999999
Q ss_pred HHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCC---CHHHH
Q 022826 172 MMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRP---AMNRV 248 (291)
Q Consensus 172 ~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp---s~~el 248 (291)
|++|+|++|..||....... ...... .. ...........++..+.+++.+|+ .+|.+|+ ++.++
T Consensus 232 vilyell~G~~Pf~~~~~~~--------~~~~i~---~~-~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 232 VILYEMLVGQPPFLADTPAE--------TQLKVI---NW-ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred ceeeehhhCCCCCCCCCHHH--------HHHHHh---cc-CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 99999999999987543211 000000 00 000011111235566778888876 5999999 88888
Q ss_pred HHH
Q 022826 249 VEM 251 (291)
Q Consensus 249 l~~ 251 (291)
++.
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=253.75 Aligned_cols=227 Identities=29% Similarity=0.464 Sum_probs=173.7
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------ceeecCCcceeeehhhcCCCH
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
+.+.+.||+|+||.||++.+..+..+++|.+.... .........+++|||+.+++|
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L 87 (260)
T cd05069 8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSL 87 (260)
T ss_pred eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCCCCH
Confidence 35678999999999999988777789999877543 112234567899999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++......... .
T Consensus 88 ~~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05069 88 LDFLKEG----DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred HHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-c
Confidence 9999753 23468999999999999999999999 99999999999999999999999999998765332211 1
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
.....++..|+|||.+.+. .++.++||||||+++|+|++ |..|+...... . ...... . ....
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~-~~~~~~--~-----~~~~ 222 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-------E-VLEQVE--R-----GYRM 222 (260)
T ss_pred cCCCccchhhCCHHHhccC--CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHH--c-----CCCC
Confidence 1222346789999998765 78899999999999999998 77766543210 0 000000 0 0001
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
..+...+..+.+++.+||+.||++||++.++++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1223456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=248.95 Aligned_cols=219 Identities=25% Similarity=0.330 Sum_probs=179.0
Q ss_pred hcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------------ceeecCCcceee
Q 022826 6 KNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------------GFCFEGHRRALI 49 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------------~~~~~~~~~~lv 49 (291)
.+.||.|..++|-++.++ +++++++|++.... ++...+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 578999999999998654 58999999986543 344556677899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
++.++.|-|.++|.+. -.+|++..++||+|+.+|+.|||. .+|||+||||+||+++++-+++|+|||.+..
T Consensus 102 Fdl~prGELFDyLts~------VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSK------VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhcccchHHHHhhhh------eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeec
Confidence 9999999999999765 689999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCceeeccCCCCCccccCcccccc----cCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhh
Q 022826 130 CHGRESIVSMTGARGTVGYIAPEVFCR----NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLE 205 (291)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~y~aPE~l~~----~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (291)
+..+.. ....||||+|+|||.+.- ...+|+..+|+|++|+++|.++.|..||... ++..
T Consensus 173 l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--------------kQml 235 (411)
T KOG0599|consen 173 LEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--------------KQML 235 (411)
T ss_pred cCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--------------HHHH
Confidence 877664 466899999999998732 3357889999999999999999999877654 2222
Q ss_pred hhhhhcccCC--CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 LEEDLGLQGI--ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ~~~~~~~~~~--~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
+.+.+..... ..+.=.+.+....+|+.+||+.||.+|.|++|.|+
T Consensus 236 MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 236 MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 2222222111 12222457888999999999999999999999875
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=242.16 Aligned_cols=220 Identities=25% Similarity=0.346 Sum_probs=184.8
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
.++++.||+|.||.||.|+.+. +--||+|++.++. +++.+..+.|+++||
T Consensus 24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence 4678999999999999998755 7789999987765 788889999999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
...|.|...|+.+ ....+++...+.+.+|++.|+.|+|. ++++||||||+|++++..|.+|++|||-+.....
T Consensus 104 a~~gel~k~L~~~----~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 104 APRGELYKDLQEG----RMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred cCCchHHHHHHhc----ccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 9999999999864 34678999999999999999999999 9999999999999999999999999998876432
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
. .....|||.-|.+||...+. ..+..+|+|++|++.||++.|..||....... ..+.+
T Consensus 177 ~----kR~tlcgt~dyl~pEmv~~~--~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e--------tYkrI-------- 234 (281)
T KOG0580|consen 177 N----KRKTLCGTLDYLPPEMVEGR--GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE--------TYKRI-------- 234 (281)
T ss_pred C----CceeeecccccCCHhhcCCC--CccchhhHHHHHHHHHHHHhcCCchhhhhhHH--------HHHHH--------
Confidence 2 23567899999999999887 89999999999999999999999998664211 11111
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.......+..++....++|.+||.++|.+|.+..|+++.
T Consensus 235 ~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 235 RKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 111122335677889999999999999999999998764
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=271.84 Aligned_cols=224 Identities=19% Similarity=0.250 Sum_probs=168.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|+.. +++.||+|++.... +.+..+...++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 456789999999999999875 48899999986532 455667788999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++.+. ..+++..+..++.||+.||.|||+ .+|+|+||||+||+++.+|.++|+|||++..+..
T Consensus 83 ~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 83 IPGGDMMSLLIRM------GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 9999999998654 468899999999999999999999 9999999999999999999999999999754321
Q ss_pred CCc---------------------------------------------eeeccCCCCCccccCcccccccCCCccccccc
Q 022826 133 RES---------------------------------------------IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDV 167 (291)
Q Consensus 133 ~~~---------------------------------------------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~Di 167 (291)
... ........||+.|+|||++.+. .++.++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~Di 231 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDW 231 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCCeeeE
Confidence 000 0001123578999999999775 78899999
Q ss_pred hhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCC---
Q 022826 168 YSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPA--- 244 (291)
Q Consensus 168 wslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps--- 244 (291)
|||||++|+|++|..||...... ...... ... ...........++.++.+++.+|+ .+|.+|++
T Consensus 232 wSlGvil~elltG~~Pf~~~~~~--------~~~~~i---~~~-~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~ 298 (382)
T cd05625 232 WSVGVILYEMLVGQPPFLAQTPL--------ETQMKV---INW-QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG 298 (382)
T ss_pred EechHHHHHHHhCCCCCCCCCHH--------HHHHHH---Hcc-CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence 99999999999999998754221 000000 000 001111112335667778888776 59999987
Q ss_pred HHHHHH
Q 022826 245 MNRVVE 250 (291)
Q Consensus 245 ~~ell~ 250 (291)
+.++++
T Consensus 299 ~~ei~~ 304 (382)
T cd05625 299 ADEIKA 304 (382)
T ss_pred HHHHhc
Confidence 777664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=253.54 Aligned_cols=239 Identities=24% Similarity=0.302 Sum_probs=173.6
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCC------cce
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGH------RRA 47 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~------~~~ 47 (291)
...++||+|+||+||+|+.. +|+.||+|++..+. +++.... ..+
T Consensus 14 ~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~ 93 (323)
T KOG0594|consen 14 EKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLY 93 (323)
T ss_pred HHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEE
Confidence 34577999999999999875 49999999997654 2333333 677
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+|+||+.- +|..++....... ..++...+..+++||+.||+|||+ ++|+||||||+||+|+.+|.+||+|||++
T Consensus 94 lvfe~~d~-DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 94 LVFEFLDR-DLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEeecc-cHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence 99999966 9999997753211 567778999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc------hh-hh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF------PH-WV 200 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~------~~-~~ 200 (291)
+...-... .++....|.-|+|||++.|. ..|+...||||+||+++||++++..|+...+....... |. ..
T Consensus 168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHhcCCcc--cccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 96542222 23444457789999999887 36999999999999999999988888766552210000 00 00
Q ss_pred hhhhhh--hhhhcccCCC--Ch---hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 201 YKRLEL--EEDLGLQGIE--NE---EDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 201 ~~~~~~--~~~~~~~~~~--~~---~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
|..... ......+... .. ..+.......+++.+||+.+|.+|.|++..++.
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000000 0000000000 00 111222478899999999999999999999875
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=253.76 Aligned_cols=227 Identities=32% Similarity=0.530 Sum_probs=177.6
Q ss_pred cccccCCceeEEEEEecC----CCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLLD----GRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.||+|+||.||++.... +..+++|.++... +++......++++||+.+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999997753 8899999987653 455567788999999999
Q ss_pred CCHHHHHhhcCCC---CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 56 GSLEKFIYEKHPL---ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 56 g~L~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
++|.+++...... .....+++..++.++.|++.||.+||+ .+++|+||||+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999764100 113689999999999999999999999 9999999999999999999999999999987655
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
...........++..|+|||.+.+. .++.++||||||+++|+|++ |..|+..... .........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~----- 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEYLRK----- 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHc-----
Confidence 4322223344567899999998765 78999999999999999998 4766654411 001111110
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
......+..++..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 223 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 --GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111223345778999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=257.08 Aligned_cols=236 Identities=23% Similarity=0.380 Sum_probs=179.5
Q ss_pred chhhcccccCCceeEEEEEecC-----CCeEEEEEeccCc---------------------------ceeec-CCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-----GRNVAIKVLNETK---------------------------GFCFE-GHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~---------------------------~~~~~-~~~~~lv 49 (291)
+.+.+.||+|+||.||+|.+.+ ++.|++|++.... +.+.. +...+++
T Consensus 8 ~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 87 (280)
T cd05043 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVL 87 (280)
T ss_pred eEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEE
Confidence 4567899999999999998755 6889999887542 33333 4677889
Q ss_pred ehhhcCCCHHHHHhhcCCC--CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 50 YEFVSNGSLEKFIYEKHPL--ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
++|+.+++|.+++...... .....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 88 ~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~g~~ 164 (280)
T cd05043 88 YPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALS 164 (280)
T ss_pred EEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCCCCc
Confidence 9999999999998764211 122578999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
+.+.............++..|+|||.+.+. .++.++||||||+++|++++ |..||..... .........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~ 234 (280)
T cd05043 165 RDLFPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDP--------FEMAAYLKD 234 (280)
T ss_pred ccccCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--------HHHHHHHHc
Confidence 865443322222233456689999998765 78999999999999999998 8877754311 000011100
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
. . .......++..+.+++.+||..||++|||+.++++.|+.+.+.
T Consensus 235 ~--~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 235 G--Y-----RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred C--C-----CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 0 0 0111123456789999999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=254.75 Aligned_cols=227 Identities=28% Similarity=0.476 Sum_probs=176.1
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||+|+||.||+|...+++.+++|.+.... +.+......++++||+.+++
T Consensus 8 ~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 87 (261)
T cd05034 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS 87 (261)
T ss_pred eeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCC
Confidence 34678999999999999988778899999988643 45555678899999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ....+++..+..++.+++.|+.|||+ .+++|+||||+||+++.++.++|+|||++..+......
T Consensus 88 L~~~i~~~----~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~- 159 (261)
T cd05034 88 LLDFLKSG----EGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT- 159 (261)
T ss_pred HHHHHhcc----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhh-
Confidence 99999664 33578999999999999999999999 99999999999999999999999999998765432111
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
.......+..|+|||.+.+. .++.++||||||+++|++++ |+.||...... ....... ... .
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~~~--~~~-----~ 222 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--------EVLEQVE--RGY-----R 222 (261)
T ss_pred hhhccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHH--cCC-----C
Confidence 11122235689999999765 78899999999999999998 77776432110 0000000 000 0
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
...+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11112235678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=264.68 Aligned_cols=234 Identities=21% Similarity=0.295 Sum_probs=168.2
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------ceeecCCcceeeehhhcCCCHHHH
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------GFCFEGHRRALIYEFVSNGSLEKF 61 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------~~~~~~~~~~lv~e~~~~g~L~~~ 61 (291)
+.+.+.||+|+||.||+|.... ++.||+|+..... +.+......++|++++. ++|.++
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~ 146 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTY 146 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHH
Confidence 5567899999999999998754 7899999855432 56667778899999995 488888
Q ss_pred HhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeeccC
Q 022826 62 IYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTG 141 (291)
Q Consensus 62 l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 141 (291)
+... ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.++|+|||+++...... ....
T Consensus 147 l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~ 215 (357)
T PHA03209 147 LTKR-----SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLG 215 (357)
T ss_pred HHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc---cccc
Confidence 8653 2578999999999999999999999 999999999999999999999999999987532221 1233
Q ss_pred CCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc--cCCC---
Q 022826 142 ARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL--QGIE--- 216 (291)
Q Consensus 142 ~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~--- 216 (291)
..++..|+|||.+.+. .++.++|||||||++|+|+++..++............................ ....
T Consensus 216 ~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 293 (357)
T PHA03209 216 LAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP 293 (357)
T ss_pred ccccccccCCeecCCC--CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence 4578999999999875 78999999999999999998665543322211100000000000000000000 0000
Q ss_pred ------------------C-----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 217 ------------------N-----EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 217 ------------------~-----~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. .....++..+.+||.+||+.||.+|||+.|+++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 0 001123445677999999999999999999875
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=253.69 Aligned_cols=223 Identities=25% Similarity=0.417 Sum_probs=172.0
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------ce-eecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------GF-CFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------~~-~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||+|+||.||++.. .++.+++|.++... +. ...+...++++||+.+++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 86 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86 (256)
T ss_pred CeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCc
Confidence 45678999999999999976 58889999987553 22 234456889999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 87 L~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 87 LVDYLRSR----GRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred HHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 99999764 23458899999999999999999999 999999999999999999999999999987543322
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
.....+..|+|||.+.+. .++.++||||||+++|+|++ |+.|+..... ... ...... ...
T Consensus 157 --~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-------~~~-~~~~~~-------~~~ 217 (256)
T cd05082 157 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDV-VPRVEK-------GYK 217 (256)
T ss_pred --CCCccceeecCHHHHccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------HHH-HHHHhc-------CCC
Confidence 122335679999998765 78899999999999999997 7776653211 000 000000 001
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
......++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 111233566788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=268.10 Aligned_cols=214 Identities=23% Similarity=0.271 Sum_probs=167.2
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.||+|+||.||+++.. +++.+|+|++.... ..+......++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999875 48999999986431 345566788999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|..++... ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 151 (325)
T cd05604 81 GELFFHLQRE------RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151 (325)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence 9999888643 578999999999999999999999 9999999999999999999999999999875322111
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
......+++.|+|||.+.+. .++.++|||||||++|+|++|..||...... . ...... ...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~-~~~~~~-~~~------ 212 (325)
T cd05604 152 --TTTTFCGTPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-------E-MYDNIL-HKP------ 212 (325)
T ss_pred --CcccccCChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCCCCHH-------H-HHHHHH-cCC------
Confidence 12345679999999999775 7889999999999999999999988654211 0 001100 000
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVV 249 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell 249 (291)
.......+..+.+++++||+.+|.+||++.+.+
T Consensus 213 -~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 213 -LVLRPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred -ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 011123456788999999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=270.19 Aligned_cols=238 Identities=18% Similarity=0.216 Sum_probs=171.9
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------ceeecCCcceeeehhhcCCCHHHH
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------GFCFEGHRRALIYEFVSNGSLEKF 61 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------~~~~~~~~~~lv~e~~~~g~L~~~ 61 (291)
+.+.+.||+|+||.||++.+.. ++.|+||...... +++..+...++|++++. ++|.++
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~ 249 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTY 249 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHH
Confidence 4566889999999999998755 8899999643221 45666778899999995 589888
Q ss_pred HhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeeccC
Q 022826 62 IYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTG 141 (291)
Q Consensus 62 l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 141 (291)
+... ...+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||+++.............
T Consensus 250 l~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 321 (461)
T PHA03211 250 LGAR-----LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321 (461)
T ss_pred HHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence 8653 2479999999999999999999999 9999999999999999999999999999986544322222234
Q ss_pred CCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhh------------
Q 022826 142 ARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEED------------ 209 (291)
Q Consensus 142 ~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------ 209 (291)
..||..|+|||++.+. .++.++|||||||++|+|++|..++...........+.............
T Consensus 322 ~~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 322 IAGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred cCCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 5689999999999876 78999999999999999998776544322111111111111111000000
Q ss_pred -----------hcccC-CCChh--hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 210 -----------LGLQG-IENEE--DKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 210 -----------~~~~~-~~~~~--~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
..... ..... .......+.+|+.+||+.||.+|||+.|+|+.
T Consensus 400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 00000 11234578899999999999999999999864
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=256.93 Aligned_cols=230 Identities=26% Similarity=0.417 Sum_probs=174.3
Q ss_pred hhhcccccCCceeEEEEEecC------CCeEEEEEeccCc---------------------------ceeecCCcceeee
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD------GRNVAIKVLNETK---------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~ 50 (291)
.+.+.||+|+||.||++...+ +..|++|.+.... +.+......++||
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 88 (277)
T cd05032 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVM 88 (277)
T ss_pred eEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEE
Confidence 456889999999999997643 4789999986442 4556677889999
Q ss_pred hhhcCCCHHHHHhhcCCCC----CCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCC
Q 022826 51 EFVSNGSLEKFIYEKHPLE----TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL 126 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~----~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~ 126 (291)
||+.+++|.+++....... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~dfg~ 165 (277)
T cd05032 89 ELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGM 165 (277)
T ss_pred ecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECCccc
Confidence 9999999999997643211 12357889999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhh
Q 022826 127 AKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLE 205 (291)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (291)
++...............++..|+|||.+.+. .++.++||||||+++|++++ |..|+..... ........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~~~~~~~~ 235 (277)
T cd05032 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--------EEVLKFVI 235 (277)
T ss_pred chhhccCcccccCCCCCccccccCHHHHhcC--CCCcccchHHHHHHHHHhhccCCCCCccCCH--------HHHHHHHh
Confidence 8765433221112233456789999998765 78899999999999999998 7766643211 10111111
Q ss_pred hhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 206 LEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
.. .. ...+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 236 ~~---~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 DG---GH----LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cC---CC----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 00 01 1112224678899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=257.90 Aligned_cols=235 Identities=24% Similarity=0.417 Sum_probs=174.2
Q ss_pred chhhcccccCCceeEEEEEec------CCCeEEEEEeccCc---------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK---------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|... .+..||+|.+.... +.+......+++
T Consensus 8 ~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (288)
T cd05061 8 ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV 87 (288)
T ss_pred ceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 456789999999999999653 24589999876432 455566778999
Q ss_pred ehhhcCCCHHHHHhhcCCCC----CCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccC
Q 022826 50 YEFVSNGSLEKFIYEKHPLE----TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~----~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
|||+.+|+|.+++....... .....++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~Dfg 164 (288)
T cd05061 88 MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFG 164 (288)
T ss_pred EeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEECcCC
Confidence 99999999999997643211 12445778899999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRL 204 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~ 204 (291)
+++...............++..|+|||.+.+. .++.++|||||||++|+|++ |..|+..... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--------~~~~~-- 232 (288)
T cd05061 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQVLK-- 232 (288)
T ss_pred ccccccccccccccCCCcccccccCHHHhccC--CCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH--
Confidence 98754432221111222346789999998765 78899999999999999998 5656543211 00000
Q ss_pred hhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 205 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
.+.... ....+...+..+.+++.+||+.||.+|||+.++++.|++.+.
T Consensus 233 ----~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 233 ----FVMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred ----HHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 000000 011112335679999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=261.10 Aligned_cols=237 Identities=27% Similarity=0.456 Sum_probs=177.0
Q ss_pred chhhcccccCCceeEEEEEecC--------CCeEEEEEeccCc----------------------------ceeecCCcc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD--------GRNVAIKVLNETK----------------------------GFCFEGHRR 46 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~----------------------------~~~~~~~~~ 46 (291)
+.+.+.||+|+||.||++.+.. ...|++|++.... +.+......
T Consensus 14 ~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 93 (334)
T cd05100 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 93 (334)
T ss_pred eeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCce
Confidence 4567899999999999997521 2368999887432 445556678
Q ss_pred eeeehhhcCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC
Q 022826 47 ALIYEFVSNGSLEKFIYEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 116 (291)
Q Consensus 47 ~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~ 116 (291)
++++||+.+++|.+++...... .....+++..+..++.|++.||.|||+ .+++|+||||+||+++.+
T Consensus 94 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~~~ 170 (334)
T cd05100 94 YVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTED 170 (334)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCC
Confidence 8999999999999999764321 123468889999999999999999999 999999999999999999
Q ss_pred CceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCcccc
Q 022826 117 FCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIY 195 (291)
Q Consensus 117 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~ 195 (291)
+.++|+|||+++...............++..|+|||.+.+. .++.++||||||+++|+|++ |..||.....
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~------ 242 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------ 242 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhccC--CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH------
Confidence 99999999998765443222122223345679999999765 78899999999999999998 6666543211
Q ss_pred chhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccC
Q 022826 196 FPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSL 259 (291)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~ 259 (291)
.. ..... .. ......+...+..+.+++.+||+.+|++||++.++++.|+++...-
T Consensus 243 -~~-~~~~~------~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 243 -EE-LFKLL------KE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -HH-HHHHH------Hc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 00 00000 00 0011112234567889999999999999999999999999887433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=253.59 Aligned_cols=233 Identities=23% Similarity=0.412 Sum_probs=181.1
Q ss_pred cchhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeeh
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e 51 (291)
.+.+.+.||+|+||.||++.+. +++.++||.+.... +.+..+...++++|
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 3567899999999999999864 69999999876422 45556678889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++.... .....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 83 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 83 LADAGDLSRMIKHFK--KQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCHHHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 999999999986532 123578999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
..... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||........ . ... .+.
T Consensus 158 ~~~~~--~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~-~~~------~~~ 221 (267)
T cd08229 158 SKTTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----S-LCK------KIE 221 (267)
T ss_pred cCCcc--cccccCCcCccCHHHhcCC--CccchhhHHHHHHHHHHHHhCCCCcccccchHH-----H-Hhh------hhh
Confidence 33221 1234578899999999765 788899999999999999999998764321100 0 000 000
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
...........++..+.+++.+||+.||.+|||+.++++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 222 QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred cCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 01111112234677899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=270.68 Aligned_cols=224 Identities=24% Similarity=0.290 Sum_probs=169.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||++... +++.||||++.... +.+.+....++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 456789999999999999775 58999999985421 455667789999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++... ..+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||+++.+..
T Consensus 83 ~~gg~L~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 83 LPGGDLMTMLIKY------DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999998654 478899999999999999999999 9999999999999999999999999999863321
Q ss_pred CCce------------e---------------------------------eccCCCCCccccCcccccccCCCccccccc
Q 022826 133 RESI------------V---------------------------------SMTGARGTVGYIAPEVFCRNFGEVSYKSDV 167 (291)
Q Consensus 133 ~~~~------------~---------------------------------~~~~~~~~~~y~aPE~l~~~~~~~~~~~Di 167 (291)
.... . ......||+.|+|||++.+. .++.++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di 231 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDW 231 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceee
Confidence 0000 0 00123589999999999775 78999999
Q ss_pred hhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhh-hhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCC---C
Q 022826 168 YSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLE-LEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDR---P 243 (291)
Q Consensus 168 wslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~R---p 243 (291)
|||||++|+|++|..||...... ....... ....+.. .....++..+.+++.+||. +|.+| +
T Consensus 232 wSlGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~-----p~~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 232 WSLGAIMFECLIGWPPFCSENSH--------ETYRKIINWRETLYF-----PDDIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred EecchhhhhhhcCCCCCCCCCHH--------HHHHHHHccCCccCC-----CCCCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 99999999999999998654221 0001100 0001111 1112345678899999997 77775 5
Q ss_pred CHHHHHHH
Q 022826 244 AMNRVVEM 251 (291)
Q Consensus 244 s~~ell~~ 251 (291)
++.++++.
T Consensus 298 ~~~~~l~h 305 (377)
T cd05629 298 GAHEIKSH 305 (377)
T ss_pred CHHHHhcC
Confidence 99998774
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=252.52 Aligned_cols=221 Identities=27% Similarity=0.419 Sum_probs=169.6
Q ss_pred ccccCCceeEEEEEec---CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhcCC
Q 022826 8 KLGQGGYGGVYKGKLL---DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 8 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
.||+|+||.||+|.+. +++.+|+|+++... +.+ .....++||||+.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE-cCCCcEEEEecCCCC
Confidence 6899999999999643 47899999986442 222 345678999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||.||+++.++.++|+|||++.........
T Consensus 81 ~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 81 PLNKFLQKN------KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 999998643 468999999999999999999999 99999999999999999999999999998865433321
Q ss_pred e-eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 137 V-SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 137 ~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
. ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||...... .........
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~i~~~------- 214 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYY--KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--------EVTQMIESG------- 214 (257)
T ss_pred eeecCCCCCCccccCHhHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHCC-------
Confidence 1 11222345789999998654 78889999999999999997 88777643211 001111100
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
.....+..++..+.+++.+||+.||++||++.+|.+.|++.
T Consensus 215 ~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 215 ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 01112233567788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=255.91 Aligned_cols=231 Identities=27% Similarity=0.417 Sum_probs=172.6
Q ss_pred chhhcccccCCceeEEEEEecC------CCeEEEEEeccCc---------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD------GRNVAIKVLNETK---------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~---------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|.+.. +..|++|.+.... +.+......+++
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL 87 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence 3456899999999999997743 5688999876432 455666778899
Q ss_pred ehhhcCCCHHHHHhhcCCC-CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC---ceEEeccC
Q 022826 50 YEFVSNGSLEKFIYEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF---CPKISDFG 125 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~---~~kl~Dfg 125 (291)
|||+.+++|.+++...... .....+++..+..++.||+.||.|||+ .+++|+||||+||+++.++ .++|+|||
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCc
Confidence 9999999999999765321 122468999999999999999999999 9999999999999998655 58999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRL 204 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~ 204 (291)
+++................+..|+|||.+.+. .++.++|||||||++|+|++ |..||...... . .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-------~-~~~~~ 234 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDG--IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-------E-VMEFV 234 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------H-HHHHH
Confidence 98865332211111122234689999999765 78999999999999999996 77776543210 0 00000
Q ss_pred hhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 205 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
. .......+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 235 ~-------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 T-------GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred H-------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0 00011122345667899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=268.33 Aligned_cols=226 Identities=20% Similarity=0.263 Sum_probs=171.7
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||++++.. ++.+|+|++.... +.+..+...++||||
T Consensus 45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey 124 (370)
T cd05621 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEY 124 (370)
T ss_pred CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcC
Confidence 3456889999999999998764 8999999986421 455667789999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++.. ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 125 ~~gg~L~~~l~~-------~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 125 MPGGDLVNLMSN-------YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999854 357889999999999999999999 9999999999999999999999999999886543
Q ss_pred CCceeeccCCCCCccccCcccccccC--CCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNF--GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~--~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
... .......||+.|+|||++.+.. ..++.++|||||||++|+|++|..||...... ........ .
T Consensus 195 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--------~~~~~i~~-~-- 262 (370)
T cd05621 195 TGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--------GTYSKIMD-H-- 262 (370)
T ss_pred CCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--------HHHHHHHh-C--
Confidence 221 1123456899999999986542 24788999999999999999999999754211 00011100 0
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSD--RPAMNRVVEM 251 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~--Rps~~ell~~ 251 (291)
...........++..+.+++..||..++.+ |+++.++++.
T Consensus 263 -~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 -KNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -CcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000111112245677888999999855543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=270.02 Aligned_cols=220 Identities=28% Similarity=0.402 Sum_probs=182.7
Q ss_pred ccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCCCHHH
Q 022826 8 KLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNGSLEK 60 (291)
Q Consensus 8 ~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g~L~~ 60 (291)
.||+|.||+||.|++.+ +..+|||.++... +.+.+++..-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 48999999999999866 7789999998765 67777788889999999999999
Q ss_pred HHhhcCCCCCCCCC--CHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc-CCCceEEeccCCccccCCCCcee
Q 022826 61 FIYEKHPLETNQKL--KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD-EDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 61 ~l~~~~~~~~~~~~--~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
++.... +++ ++.++..+.+||++||.|||. ..|||||||-+||+|+ -.|.+||+|||.+..+.+-.+.
T Consensus 662 LLrskW-----GPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~- 732 (1226)
T KOG4279|consen 662 LLRSKW-----GPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC- 732 (1226)
T ss_pred HHHhcc-----CCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCcc-
Confidence 998876 455 888999999999999999999 9999999999999996 5799999999999877655443
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
.....||..|||||++.....+|+.++|||||||++-||.||++||..... +...+-+. +..+ .-.
T Consensus 733 -TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs-------pqAAMFkV---GmyK---vHP 798 (1226)
T KOG4279|consen 733 -TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS-------PQAAMFKV---GMYK---VHP 798 (1226)
T ss_pred -ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC-------hhHhhhhh---ccee---cCC
Confidence 355778999999999987778999999999999999999999999875422 11111111 1111 113
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
+.+.+.+.+...++.+|..+||.+||+++++++
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 346678899999999999999999999999986
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=258.78 Aligned_cols=229 Identities=27% Similarity=0.436 Sum_probs=174.8
Q ss_pred hhhcccccCCceeEEEEEec------CCCeEEEEEeccCc----------------------------ceeecCCcceee
Q 022826 4 SFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK----------------------------GFCFEGHRRALI 49 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv 49 (291)
.+.+.||+|+||.||++.+. .+..+|+|+++... +.+......+++
T Consensus 38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 117 (302)
T cd05055 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVI 117 (302)
T ss_pred EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEE
Confidence 35688999999999999642 25589999886532 345556678899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
|||+.+++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++++|||++..
T Consensus 118 ~e~~~~~~L~~~i~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 118 TEYCCYGDLLNFLRRK----RESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEcCCCCcHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 9999999999999653 22348999999999999999999999 9999999999999999999999999999886
Q ss_pred cCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhh
Q 022826 130 CHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEE 208 (291)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (291)
..............++..|+|||.+.+. .++.++||||||+++|+|++ |..|+....... . ..... .
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-------~-~~~~~-~- 258 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-------K-FYKLI-K- 258 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccC--CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-------H-HHHHH-H-
Confidence 6543322222233456789999998765 68899999999999999998 777765432110 0 00000 0
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
.......+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 259 ----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 259 ----EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0001111223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=258.29 Aligned_cols=225 Identities=27% Similarity=0.393 Sum_probs=174.5
Q ss_pred cchhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeeh
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e 51 (291)
|+.+.+.||+|+||.||++.+. +++.||+|.+.... +.+..+...++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 4566788999999999999775 48999999986432 34445667889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~~g~~L~~~l~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 81 LMNGGDLKFHIYHM----GEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 153 (285)
T ss_pred ecCCCcHHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence 99999999988653 23468999999999999999999999 999999999999999999999999999987644
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
.... .....++..|+|||.+.+. .++.++||||||+++|+|++|..||......... . ........
T Consensus 154 ~~~~---~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~----~-~~~~~~~~---- 219 (285)
T cd05630 154 EGQT---IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR----E-EVERLVKE---- 219 (285)
T ss_pred CCcc---ccCCCCCccccChHHHcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCccchH----H-HHHhhhhh----
Confidence 3321 1234578999999999765 7889999999999999999999998754321110 0 00000000
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPA-----MNRVVE 250 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps-----~~ell~ 250 (291)
........++..+.+|+.+||+.||++||| +.|+++
T Consensus 220 ---~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 220 ---VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ---hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 001112235567889999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=258.21 Aligned_cols=237 Identities=26% Similarity=0.434 Sum_probs=177.2
Q ss_pred chhhcccccCCceeEEEEEecC-C--CeEEEEEeccCc----------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-G--RNVAIKVLNETK----------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~--~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|...+ + ..+++|.++... +.+......++++|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 4577899999999999997754 3 357888876421 34445567889999
Q ss_pred hhcCCCHHHHHhhcCCCC----------CCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEE
Q 022826 52 FVSNGSLEKFIYEKHPLE----------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 121 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl 121 (291)
|+.+++|.+++....... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEE
Confidence 999999999997643211 12468899999999999999999999 99999999999999999999999
Q ss_pred eccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhh
Q 022826 122 SDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWV 200 (291)
Q Consensus 122 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~ 200 (291)
+|||++....... .......+..|+|||.+.+. .++.++|||||||++|+|++ |..||...... . .
T Consensus 161 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-------~-~ 227 (297)
T cd05089 161 ADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-------E-L 227 (297)
T ss_pred CCcCCCcccccee---ccCCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------H-H
Confidence 9999986422111 11112224579999998765 78899999999999999997 88777543210 0 0
Q ss_pred hhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCC
Q 022826 201 YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262 (291)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 262 (291)
..... .......+..++..+.+++.+||+.+|.+||++.++++.|+++++..+..
T Consensus 228 ~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 282 (297)
T cd05089 228 YEKLP-------QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY 282 (297)
T ss_pred HHHHh-------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence 01100 01111112335677899999999999999999999999999988766544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=263.33 Aligned_cols=236 Identities=28% Similarity=0.405 Sum_probs=173.8
Q ss_pred chhhcccccCCceeEEEEEe------cCCCeEEEEEeccCc----------------------------cee-ecCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKL------LDGRNVAIKVLNETK----------------------------GFC-FEGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~----------------------------~~~-~~~~~~~ 47 (291)
+.+.+.||+|+||.||+|.+ .+++.||||+++... +.+ ..+...+
T Consensus 9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (343)
T cd05103 9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (343)
T ss_pred hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceE
Confidence 46789999999999999974 237899999987532 122 2345678
Q ss_pred eeehhhcCCCHHHHHhhcCCCC----------------------------------------------------------
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLE---------------------------------------------------------- 69 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~---------------------------------------------------------- 69 (291)
++|||+.+|+|.+++.......
T Consensus 89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (343)
T cd05103 89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ 168 (343)
T ss_pred EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence 8999999999999987532100
Q ss_pred ---CCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeeccCCCCCc
Q 022826 70 ---TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTV 146 (291)
Q Consensus 70 ---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 146 (291)
....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++................++.
T Consensus 169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 169 EDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 01246888899999999999999999 999999999999999999999999999987653322211122233456
Q ss_pred cccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHH
Q 022826 147 GYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYAR 225 (291)
Q Consensus 147 ~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (291)
.|+|||.+.+. .++.++||||||+++|+|++ |..|+...... ........... ....+...+.
T Consensus 246 ~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~-------~~~~~~~~~~ 309 (343)
T cd05103 246 KWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGT-------RMRAPDYTTP 309 (343)
T ss_pred ceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------HHHHHHHhccC-------CCCCCCCCCH
Confidence 79999998765 78899999999999999996 77776543211 00000000000 0111112345
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 226 KMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 226 ~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
.+.+++.+||+.||++|||+.++++.|+.+++
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 68899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=255.91 Aligned_cols=232 Identities=25% Similarity=0.425 Sum_probs=175.2
Q ss_pred chhhcccccCCceeEEEEEec-----CCCeEEEEEeccCc---------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-----DGRNVAIKVLNETK---------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~ 50 (291)
..+.+.||+|+||.||+|... .++.+++|.+.... +.+..+...+++|
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 356789999999999999742 36789999997422 4555667889999
Q ss_pred hhhcCCCHHHHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCce
Q 022826 51 EFVSNGSLEKFIYEKHPL-----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 119 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~ 119 (291)
||+.+++|.+++...... .....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCcE
Confidence 999999999998643210 112458899999999999999999999 999999999999999999999
Q ss_pred EEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchh
Q 022826 120 KISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPH 198 (291)
Q Consensus 120 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~ 198 (291)
+|+|||++................++..|+|||.+.+. .++.++||||||+++|+|++ |..||..... .
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------~ 233 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------Q 233 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 99999999765433322222333456789999998765 78999999999999999998 7766643211 0
Q ss_pred hhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 199 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
.......... ....+..++..+.+++.+||+.||++||++.++++.|.+
T Consensus 234 ~~~~~~~~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 EVIEMVRKRQ-------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHcCC-------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0011110000 011222355678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=256.08 Aligned_cols=223 Identities=25% Similarity=0.361 Sum_probs=182.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
.|+.++||+|+||.||+|.++ .|+.+|+|.++... +........++|||||.-|+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 467899999999999999664 59999999998765 33344566789999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
+.++++.+. .++++..+..++++-+.||+|||. ..-+|||||+.||+++-+|.+||+|||++.++.....
T Consensus 115 iSDI~R~R~-----K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-- 184 (502)
T KOG0574|consen 115 ISDIMRARR-----KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-- 184 (502)
T ss_pred HHHHHHHhc-----CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH--
Confidence 999997754 689999999999999999999999 9999999999999999999999999999987644322
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
......|||.|+|||++..- .|+.++||||||++..+|.-|+.|..+...-..-+..| ..+..-.
T Consensus 185 KRNTVIGTPFWMAPEVI~EI--GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP-------------T~PPPTF 249 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEI--GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP-------------TKPPPTF 249 (502)
T ss_pred hhCccccCcccccHHHHHHh--ccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc-------------CCCCCCC
Confidence 12445689999999999876 88999999999999999999998877654322111111 1111122
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..+..++.++-++++.||.++|++|.|+.+|++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 346679999999999999999999999998765
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=252.36 Aligned_cols=225 Identities=26% Similarity=0.286 Sum_probs=175.9
Q ss_pred cchhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------------ceeecCCcceee
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------------GFCFEGHRRALI 49 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------------~~~~~~~~~~lv 49 (291)
++.+.+.||+|++|.||++... +++.+++|.+.... +.+......+++
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 4678899999999999999865 48999999876431 555667788999
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
+||+.+++|.+++... ..+++..+..++.|++.||.+||+ .+++|+||+|+||+++.++.++|+|||++..
T Consensus 83 ~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 83 MEYMPGGSVKDQLKAY------GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEECCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 9999999999998654 468899999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCcee-eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhh
Q 022826 130 CHGRESIV-SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEE 208 (291)
Q Consensus 130 ~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (291)
........ ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...... . ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~-~~~------ 217 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------A-AIF------ 217 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccC--CCCchhhhHHHHHHHHHHHhCCCCccccchH-------H-HHH------
Confidence 54322111 11234567899999999876 6889999999999999999999887643211 0 000
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
...........+..+...+.+++.+||+.+|.+|||+.++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 218 KIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0001111112233466778999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=252.92 Aligned_cols=223 Identities=21% Similarity=0.318 Sum_probs=174.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||++.+. +++.+++|.++... +.+..+...++++||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 456789999999999999875 48999999985432 35556678899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++... ....+++..++.++.|++.||.+||+ .+++|+||||+||+++.++.++++|||++.......
T Consensus 82 ~~~l~~~~~~~----~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 82 GGDLMQKIKLQ----RGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCcHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 99999988653 23568899999999999999999999 999999999999999999999999999987654322
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
.. .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||..... ... .. .+. ..
T Consensus 155 ~~--~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-------~~~-~~------~~~-~~ 215 (255)
T cd08219 155 AY--ACTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANSW-------KNL-IL------KVC-QG 215 (255)
T ss_pred cc--cccccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCCCCH-------HHH-HH------HHh-cC
Confidence 11 1234568899999998765 688999999999999999999998864321 000 00 000 01
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.....+..++..+.+++.+||+.||++||++.+++..
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1111223456678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=250.30 Aligned_cols=223 Identities=28% Similarity=0.464 Sum_probs=171.2
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcCCCHH
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSNGSLE 59 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~g~L~ 59 (291)
++||+|+||.||++.+.+++.|++|++.... +.+......++|+||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 4799999999999988669999999877532 4556677788999999999999
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeec
Q 022826 60 KFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSM 139 (291)
Q Consensus 60 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 139 (291)
+++... ...+++..+..++.+++.+|.|||+ .+++|+||||+||+++.++.++|+|||++............
T Consensus 81 ~~l~~~-----~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 81 TFLRKK-----KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 998653 2468899999999999999999999 99999999999999999999999999998765422211111
Q ss_pred cCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCCh
Q 022826 140 TGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 218 (291)
Q Consensus 140 ~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (291)
.....+..|+|||.+.+. .++.++||||||+++|+|++ |..|+...... ....... . .....
T Consensus 153 ~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------~~~~~~~------~-~~~~~ 215 (251)
T cd05041 153 GLKQIPIKWTAPEALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------QTRERIE------S-GYRMP 215 (251)
T ss_pred ccCcceeccCChHhhccC--CCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------HHHHHHh------c-CCCCC
Confidence 122235679999998765 78899999999999999998 66655433210 0000000 0 00111
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 219 EDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 219 ~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
.+...+..+.+++.+||+.+|.+||++.|+++.|+.
T Consensus 216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 123356679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=256.59 Aligned_cols=231 Identities=23% Similarity=0.407 Sum_probs=173.8
Q ss_pred hhhcccccCCceeEEEEEec------CCCeEEEEEeccCc---------------------------ceeecCCcceeee
Q 022826 4 SFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK---------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~ 50 (291)
.+.+.||+|+||.||++.+. ++..+++|++.... +.+..+...++++
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 87 (288)
T cd05050 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF 87 (288)
T ss_pred eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEE
Confidence 45688999999999999763 36789999987542 4555667789999
Q ss_pred hhhcCCCHHHHHhhcCCC----------------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc
Q 022826 51 EFVSNGSLEKFIYEKHPL----------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 114 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~----------------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~ 114 (291)
||+.+++|.+++...... .....+++..++.++.|++.||.|||+ .+++|+||||+||+++
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~~ 164 (288)
T cd05050 88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVG 164 (288)
T ss_pred ecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEec
Confidence 999999999999764321 112457889999999999999999999 9999999999999999
Q ss_pred CCCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCcc
Q 022826 115 EDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSE 193 (291)
Q Consensus 115 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~ 193 (291)
.++.++|+|||++.................+..|+|||.+.+. .++.++|||||||++|+|++ |..||.....
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~~~~p~~~~~~---- 238 (288)
T cd05050 165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGMQPYYGMAH---- 238 (288)
T ss_pred CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 9999999999998765433221112222335679999998765 78999999999999999997 6666643211
Q ss_pred ccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 194 IYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
..... .+..... ...+..++..+.+++.+||+.||.+|||+.|+++.|++
T Consensus 239 ----~~~~~------~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ----EEVIY------YVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ----HHHHH------HHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 00000 0100100 11122356779999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=264.07 Aligned_cols=212 Identities=26% Similarity=0.320 Sum_probs=166.8
Q ss_pred cccccCCceeEEEEEec----CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhc
Q 022826 7 NKLGQGGYGGVYKGKLL----DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.||+|+||.||+++.. +++.+|+|++.... +.+..+...++||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 57999999999999752 48899999987432 45566778899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++... ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 82 GGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 99999998543 478999999999999999999999 999999999999999999999999999987643322
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
. ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||...... ....... ...
T Consensus 153 ~--~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~--------~~~~~i~-~~~----- 214 (318)
T cd05582 153 K--KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--------ETMTMIL-KAK----- 214 (318)
T ss_pred C--ceecccCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCCHH--------HHHHHHH-cCC-----
Confidence 1 12335678999999999765 7789999999999999999999988643210 0000000 000
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNR 247 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~e 247 (291)
...+..++..+.+++.+||+.||++||++.+
T Consensus 215 --~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 --LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1112335667889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=258.30 Aligned_cols=179 Identities=25% Similarity=0.384 Sum_probs=139.7
Q ss_pred hcccccCCceeEEEEEec---CCCeEEEEEeccCc------------------------cee--ecCCcceeeehhhcCC
Q 022826 6 KNKLGQGGYGGVYKGKLL---DGRNVAIKVLNETK------------------------GFC--FEGHRRALIYEFVSNG 56 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~------------------------~~~--~~~~~~~lv~e~~~~g 56 (291)
+.+||+|+||.||+|+.. +++.+|+|.+.... +.+ ..+...++++||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence 578999999999999864 36889999987542 112 234557889999865
Q ss_pred CHHHHHhhcCCC---CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE----cCCCceEEeccCCccc
Q 022826 57 SLEKFIYEKHPL---ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAKI 129 (291)
Q Consensus 57 ~L~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill----~~~~~~kl~Dfg~~~~ 129 (291)
+|.+++...... .....+++..+..++.||+.||.|||+ .+++|+||||+||++ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 888887643211 122468999999999999999999999 999999999999999 4567899999999986
Q ss_pred cCCCCc-eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccC
Q 022826 130 CHGRES-IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVD 189 (291)
Q Consensus 130 ~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~ 189 (291)
...... ........+|+.|+|||.+.+. ..++.++||||+||++|+|++|..||.....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 221 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcc
Confidence 543321 1122345678999999998764 3678999999999999999999999875443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=256.83 Aligned_cols=235 Identities=25% Similarity=0.317 Sum_probs=169.1
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------------ceee-----cCCc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------------GFCF-----EGHR 45 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------------~~~~-----~~~~ 45 (291)
+.+.+.||+|+||.||+|.+. +++.||+|.++... +++. ....
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 456789999999999999875 48999999886431 1111 1234
Q ss_pred ceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccC
Q 022826 46 RALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 46 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
.++++|++.+ +|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKV----PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred EEEEEccccc-CHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccC
Confidence 6899999975 898888654 23468999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhh--hh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVY--KR 203 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~--~~ 203 (291)
++........ .....++..|+|||.+.+. .++.++|||||||++|+|++|..+|................. ..
T Consensus 154 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 154 LARIYSCQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 228 (288)
T ss_pred ccccccCccc---CCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence 9876543221 1234568899999999765 789999999999999999999988754322110000000000 00
Q ss_pred hhhhhhhcc---------cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 204 LELEEDLGL---------QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 204 ~~~~~~~~~---------~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......... ........+.+...+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 00001112245677889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=255.58 Aligned_cols=231 Identities=24% Similarity=0.418 Sum_probs=173.4
Q ss_pred hhhcccccCCceeEEEEEec------CCCeEEEEEeccCc--------------------------ceeecCCcceeeeh
Q 022826 4 SFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e 51 (291)
.+.++||+|+||.||++... ++..+++|.+.... +.+..+...++++|
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence 46789999999999999642 35688999876532 45566677899999
Q ss_pred hhcCCCHHHHHhhcCC---------CCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEe
Q 022826 52 FVSNGSLEKFIYEKHP---------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 122 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~---------~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~ 122 (291)
|+.+++|.+++..... ......+++..+..++.|++.|+.|||+ .+++|+||||+||++++++.++|+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEEC
Confidence 9999999999976431 1112468999999999999999999999 999999999999999999999999
Q ss_pred ccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhh
Q 022826 123 DFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVY 201 (291)
Q Consensus 123 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~ 201 (291)
|||++................+++.|+|||.+.+. .++.++|||||||++|+|++ |..||...... . ..
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~-~~ 234 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-------E-AI 234 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-------H-HH
Confidence 99998755433221112222346789999998775 78999999999999999998 77666432210 0 00
Q ss_pred hhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 202 KRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
.... .......+..++..+.+++.+||+.||.+||++.++++.|+.
T Consensus 235 ~~~~-------~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECIT-------QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHH-------cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0000 000011122345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=262.17 Aligned_cols=220 Identities=21% Similarity=0.360 Sum_probs=185.2
Q ss_pred chhhcccccCCceeEEEEEe-cCCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKL-LDGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+|+.+.||+|.|+.|-+|++ .+|..||||++.+.+ .+.......|||+|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 68899999999999999976 579999999998876 4555667889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE-cCCCceEEeccCCccccCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL-DEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill-~~~~~~kl~Dfg~~~~~~~ 132 (291)
++|+|.+|+.... ..+++..+.++|+||+.+|.|+|+ .++||+||||+||.+ ..-|-+||.|||.+..+..
T Consensus 100 D~GDl~DyImKHe-----~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 100 DGGDLFDYIMKHE-----EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred CCchHHHHHHhhh-----ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999998753 789999999999999999999999 999999999999877 5679999999999988776
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
+.. ....||+..|-|||++.|. ...-+++|||||||++|.++.|+.||....+..- .. .+
T Consensus 172 G~k---L~TsCGSLAYSAPEILLGD-sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-----------LT-----mI 231 (864)
T KOG4717|consen 172 GKK---LTTSCGSLAYSAPEILLGD-SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-----------LT-----MI 231 (864)
T ss_pred cch---hhcccchhhccCchhhhcC-ccCCcchhhhHHHHHHHHHHhCCCccccccchhh-----------hh-----hh
Confidence 654 3567899999999999987 3445789999999999999999999986544211 01 11
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
-...-..+..++.+-.+||..||..||.+|.+.++|..
T Consensus 232 mDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 232 MDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 11223346678889999999999999999999998764
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=249.80 Aligned_cols=221 Identities=27% Similarity=0.422 Sum_probs=170.7
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcCCCHH
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSNGSLE 59 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~g~L~ 59 (291)
+.||+|+||.||+|...+++.+++|++.... +.+......++||||+.+++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4789999999999987778999999976432 4566677889999999999999
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeec
Q 022826 60 KFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSM 139 (291)
Q Consensus 60 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 139 (291)
+++... ...+++..+..++.+++.+|.|||+ .+++|+||||+||+++.++.++|+|||++......... ..
T Consensus 81 ~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~ 151 (250)
T cd05085 81 SFLRKK-----KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SS 151 (250)
T ss_pred HHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccc-cC
Confidence 998643 2467899999999999999999999 99999999999999999999999999998754322111 11
Q ss_pred cCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCCh
Q 022826 140 TGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 218 (291)
Q Consensus 140 ~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (291)
....++..|+|||.+.+. .++.++||||||+++|++++ |..||...... ........ .....
T Consensus 152 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~~~~~~-------~~~~~ 214 (250)
T cd05085 152 GLKQIPIKWTAPEALNYG--RYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAREQVEK-------GYRMS 214 (250)
T ss_pred CCCCCcccccCHHHhccC--CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHc-------CCCCC
Confidence 112335679999998765 78899999999999999998 77777543110 00000000 00011
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 219 EDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 219 ~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
....++..+.+++.+||+.+|++||++.++++.|.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 12235678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=251.87 Aligned_cols=228 Identities=24% Similarity=0.430 Sum_probs=175.3
Q ss_pred cchhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCC
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
.+.+.+.||+|+||.||++...++..+++|.+.... +.... ...++++||+.++
T Consensus 7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~ 85 (260)
T cd05073 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKG 85 (260)
T ss_pred ceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCC
Confidence 356789999999999999987778889999887533 23223 5678999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.+.........
T Consensus 86 ~L~~~~~~~----~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 86 SLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred cHHHHHHhC----CccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999653 33568889999999999999999999 99999999999999999999999999998765432211
Q ss_pred eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 137 VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
......++..|+|||.+.+. .++.++|+||||+++|++++ |..||...... .. .... ... .
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~-~~~~--~~~-----~ 220 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-------EV-IRAL--ERG-----Y 220 (260)
T ss_pred -cccCCcccccccCHhHhccC--CcCccccchHHHHHHHHHHhcCCCCCCCCCHH-------HH-HHHH--hCC-----C
Confidence 12223345679999998765 78899999999999999998 77777543210 00 0000 000 0
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
........+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 221 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 1112234566789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=250.88 Aligned_cols=222 Identities=27% Similarity=0.444 Sum_probs=170.5
Q ss_pred cccccCCceeEEEEEecC----CCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLLD----GRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
++||+|+||.||+|.+.. +..+++|.+.... ++ ......+++++|+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGV-CKGEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEE-EcCCceEEEEEeCCC
Confidence 479999999999997533 3789999987544 22 234567899999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++... ..+++..+..++.|++.+|.|||. .+++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 80 GPLLKYLKKR------REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 9999999654 378999999999999999999999 9999999999999999999999999999886644332
Q ss_pred eee-ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 136 IVS-MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 136 ~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
... .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||...... . .......
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-------~-~~~~~~~------- 213 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYG--KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-------E-VIAMLES------- 213 (257)
T ss_pred ccccccCccccccccCHHHhcCC--CCCccchHHHHHHHHHHHHcCCCCCcccCCHH-------H-HHHHHHc-------
Confidence 211 1122234679999998765 78999999999999999997 78777543210 0 0001100
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
......+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 214 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 214 GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 001122233556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=253.41 Aligned_cols=228 Identities=26% Similarity=0.435 Sum_probs=174.2
Q ss_pred chhhcccccCCceeEEEEEecC-C---CeEEEEEeccCc---------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-G---RNVAIKVLNETK---------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|.+.. + ..|++|++.... +.+..+...++|+|
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 5678999999999999998643 3 369999987542 45556777889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 86 ~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 86 FMENGALDSFLRQN-----DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred cCCCCcHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 99999999998653 2468999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccCCC---CCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhh
Q 022826 132 GRESIVSMTGAR---GTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 132 ~~~~~~~~~~~~---~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
............ .+..|+|||.+.+. .++.++||||||+++|++++ |..||...... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--------~~~~~i~-- 225 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------DVINAIE-- 225 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccC--cccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--------HHHHHHH--
Confidence 332221111111 13579999998765 78899999999999999886 88777543211 0000000
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
... ....+..++..+.+++.+||+.+|.+||++.+++..|+++
T Consensus 226 ~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 QDY-----RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCC-----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 1111223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=275.51 Aligned_cols=238 Identities=20% Similarity=0.277 Sum_probs=167.1
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------ceee--------cCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------GFCF--------EGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------~~~~--------~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +++. .....++|||
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE 147 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME 147 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEe
Confidence 456789999999999999875 48999999885432 1110 1123568999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC-ceEEeccCCcccc
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-CPKISDFGLAKIC 130 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-~~kl~Dfg~~~~~ 130 (291)
|+.+ +|.+++.... .....+++..++.++.||+.||.|||+ .+|+||||||+||+++.++ .+||+|||+++..
T Consensus 148 ~~~~-~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 148 FIPQ-TVHKYMKHYA--RNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred cCCc-cHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 9976 7877765421 234679999999999999999999999 9999999999999998664 7999999999866
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhh----hhhhh-
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWV----YKRLE- 205 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~----~~~~~- 205 (291)
...... ....+++.|+|||++.+. ..++.++|||||||++|+|++|..||................ .....
T Consensus 222 ~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 297 (440)
T PTZ00036 222 LAGQRS---VSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297 (440)
T ss_pred cCCCCc---ccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 443321 234568899999998664 368899999999999999999998886543211000000000 00000
Q ss_pred h---hhhhcccCCCC-----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 L---EEDLGLQGIEN-----EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ~---~~~~~~~~~~~-----~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. ...+..+.... ..+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus 298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0 00000111000 011224567899999999999999999999884
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=266.99 Aligned_cols=234 Identities=23% Similarity=0.365 Sum_probs=175.9
Q ss_pred hhhcccccCCceeEEEEEec------CCCeEEEEEeccCc----------------------------ceeecCCcceee
Q 022826 4 SFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK----------------------------GFCFEGHRRALI 49 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv 49 (291)
.+.+.||+|+||.||+|.+. .++.||+|+++... +.+......++|
T Consensus 40 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv 119 (401)
T cd05107 40 VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYII 119 (401)
T ss_pred ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEE
Confidence 45689999999999999753 24689999997542 345556778999
Q ss_pred ehhhcCCCHHHHHhhcCCC-------------------------------------------------------------
Q 022826 50 YEFVSNGSLEKFIYEKHPL------------------------------------------------------------- 68 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~------------------------------------------------------------- 68 (291)
+||+.+|+|.++++.....
T Consensus 120 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (401)
T cd05107 120 TEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTV 199 (401)
T ss_pred EeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhh
Confidence 9999999999999764210
Q ss_pred -------------------------------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC
Q 022826 69 -------------------------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 117 (291)
Q Consensus 69 -------------------------------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~ 117 (291)
.....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 200 KYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEeCCC
Confidence 112357788899999999999999999 9999999999999999999
Q ss_pred ceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccc
Q 022826 118 CPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYF 196 (291)
Q Consensus 118 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~ 196 (291)
.++|+|||+++...............++..|+|||.+.+. .++.++||||||+++|+|++ |..|+......
T Consensus 277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~------ 348 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN--LYTTLSDVWSFGILLWEIFTLGGTPYPELPMN------ 348 (401)
T ss_pred EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC--CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch------
Confidence 9999999998764332221112223457789999999765 68899999999999999997 67666432110
Q ss_pred hhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 022826 197 PHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256 (291)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~ 256 (291)
........ .......+..++..+.+++.+||+.+|.+||++++|++.|++++
T Consensus 349 -~~~~~~~~-------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 -EQFYNAIK-------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -HHHHHHHH-------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 00000000 00011112235678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=250.40 Aligned_cols=222 Identities=27% Similarity=0.424 Sum_probs=172.8
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceee-cCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCF-EGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~-~~~~~~lv~e~ 52 (291)
+.+.+.||+|++|.||++.+.. ++.+++|.+.... +.+. .+...++++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 5678899999999999998754 8899999986432 1222 23357899999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ....+++..+..++.+++.|+.+||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~l~~~l~~~----~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 82 CEGGDLYHKLKEQ----KGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred cCCCcHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 9999999999763 23568999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||..... ..... .. .
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~-~~-~------ 215 (257)
T cd08223 155 QCD--MASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVY-RI-I------ 215 (257)
T ss_pred cCC--ccccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHH-HH-H------
Confidence 222 12334578899999998775 788999999999999999999988764311 00000 00 0
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.......+..++..+.+++.+||+.||++||++.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 216 EGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred hcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 01111123456778999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=255.78 Aligned_cols=239 Identities=23% Similarity=0.375 Sum_probs=171.9
Q ss_pred chhhcccccCCceeEEEEEec-----------------CCCeEEEEEeccCc---------------------------c
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-----------------DGRNVAIKVLNETK---------------------------G 38 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~---------------------------~ 38 (291)
+.+.++||+|+||.||++.+. ++..+|+|++.... +
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 456789999999999998542 13468999987532 4
Q ss_pred eeecCCcceeeehhhcCCCHHHHHhhcCCC-----CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE
Q 022826 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPL-----ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL 113 (291)
Q Consensus 39 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill 113 (291)
.+......+++|||+.+++|.+++...... .....+++..++.++.|++.||.|||+ .+++|+||||+||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nili 163 (296)
T cd05095 87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEEE
Confidence 555667789999999999999999764321 112457888999999999999999999 999999999999999
Q ss_pred cCCCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC--CCCCCccccCCC
Q 022826 114 DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG--VKNNANVAVDRS 191 (291)
Q Consensus 114 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~--g~~~~~~~~~~~ 191 (291)
+.++.++|+|||++..+..............+..|++||...+. .++.++|||||||++|+|++ +..|+......
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE- 240 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC--CccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence 99999999999998765433221111122235689999987665 78999999999999999997 44555432111
Q ss_pred ccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 192 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
.............. .......+..++..+.+++.+||+.||.+||++.++++.|++
T Consensus 241 ------~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 ------QVIENTGEFFRDQG-RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ------HHHHHHHHHHhhcc-ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00000000000000 000011122345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=254.55 Aligned_cols=227 Identities=22% Similarity=0.337 Sum_probs=173.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||+|+||.||+|... +++.|++|++.... +.+..+...++|+||+.+
T Consensus 11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~ 90 (267)
T cd06646 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG 90 (267)
T ss_pred cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence 456789999999999999874 58999999987542 345566788899999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 91 ~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 91 GSLQDIYHVT------GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999998643 478999999999999999999999 9999999999999999999999999999876532211
Q ss_pred eeeccCCCCCccccCccccccc-CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~-~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
......+++.|+|||.+.+. ...++.++|+||||+++|+|++|..|+............. ......+.
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~---------~~~~~~~~ 230 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS---------KSNFQPPK 230 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee---------cCCCCCCC
Confidence 11234567899999988542 2357789999999999999999998875432111000000 00000000
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
......++..+.+++++||..+|++||+++++++.
T Consensus 231 --~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 231 --LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred --CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 11122456789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=256.73 Aligned_cols=221 Identities=24% Similarity=0.343 Sum_probs=173.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||+|+||.||++.+. +++.+++|.+.... +.+..+...++|+||+.+
T Consensus 22 y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~ 101 (296)
T cd06654 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (296)
T ss_pred eeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence 455688999999999999864 58999999987543 455567789999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 102 ~~L~~~~~~-------~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 102 GSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999853 357899999999999999999999 9999999999999999999999999998876433221
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
. .....+++.|+|||.+.+. .++.++|||||||++|+|++|..||........ . . .. .. ....
T Consensus 172 ~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~-~-~~--~~---~~~~ 234 (296)
T cd06654 172 K--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------L-Y-LI--AT---NGTP 234 (296)
T ss_pred c--cCcccCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------H-H-HH--hc---CCCC
Confidence 1 1234568899999998765 678999999999999999999999865432110 0 0 00 00 0000
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
....+..+...+.+++.+||..||++||++.++++
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 11123346677899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=256.18 Aligned_cols=239 Identities=23% Similarity=0.364 Sum_probs=170.8
Q ss_pred chhhcccccCCceeEEEEEecC---------------CCeEEEEEeccCc---------------------------cee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD---------------GRNVAIKVLNETK---------------------------GFC 40 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~---------------------------~~~ 40 (291)
+.+.+.||+|+||.||++...+ ...||+|.++... +.+
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 86 (295)
T cd05097 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVC 86 (295)
T ss_pred CeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence 3467899999999999997532 2358999987542 455
Q ss_pred ecCCcceeeehhhcCCCHHHHHhhcCCC------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc
Q 022826 41 FEGHRRALIYEFVSNGSLEKFIYEKHPL------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 114 (291)
Q Consensus 41 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~ 114 (291)
......++||||+.+++|.+++...... .....+++..++.++.|++.||.|||+ .+++|+||||+||+++
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nill~ 163 (295)
T cd05097 87 VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVG 163 (295)
T ss_pred cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEEEc
Confidence 6677889999999999999998653210 111347889999999999999999999 9999999999999999
Q ss_pred CCCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCC--CCCccccCCCc
Q 022826 115 EDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVK--NNANVAVDRSS 192 (291)
Q Consensus 115 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~--~~~~~~~~~~~ 192 (291)
.++.++|+|||++................++..|+|||.+.+. .++.++||||||+++|+|+++. .||.......
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC--CcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 9999999999998765433222111222346789999998765 7899999999999999998743 3443321100
Q ss_pred cccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 193 EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
............. ...........+..+.+++.+||+.||++|||+.++++.|++
T Consensus 241 ------~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 ------VIENTGEFFRNQG-RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ------HHHHHHHhhhhcc-ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 0000000000000 000001112245679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=283.19 Aligned_cols=228 Identities=21% Similarity=0.291 Sum_probs=170.4
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------cee--ecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFC--FEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~--~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||++++.. ++.+|+|++.... +.+ ......++|||
T Consensus 15 YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVME 94 (1021)
T PTZ00266 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILME 94 (1021)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEe
Confidence 4567899999999999998755 8899999986432 222 23456889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCC----CCCeeeeccCCCceEEcC------------
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC----NTRILHFDIKPHNILLDE------------ 115 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~----~~~ivH~dikp~Nill~~------------ 115 (291)
|+.+++|.+++.... .....+++..++.|+.||+.||.|||+.. ..+|+|+||||+||||+.
T Consensus 95 Y~~gGSL~~lL~k~~--~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 95 FCDAGDLSRNIQKCY--KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred CCCCCcHHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 999999999987532 12357999999999999999999999811 134999999999999954
Q ss_pred -----CCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCC
Q 022826 116 -----DFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDR 190 (291)
Q Consensus 116 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~ 190 (291)
.+.++|+|||++........ .....+++.|+|||++.+....++.++|||||||++|+|++|..||......
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred cccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 34589999999876543221 2334579999999998765456889999999999999999999998643210
Q ss_pred CccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 191 SSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. ...... . .+ .......+..+.+||..||+.+|.+||++.++++
T Consensus 250 ------~q-li~~lk--~---~p---~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 250 ------SQ-LISELK--R---GP---DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred ------HH-HHHHHh--c---CC---CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 10 000000 0 01 1111234567899999999999999999999984
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=255.16 Aligned_cols=238 Identities=24% Similarity=0.373 Sum_probs=173.8
Q ss_pred chhhcccccCCceeEEEEEecC-----------------CCeEEEEEeccCc---------------------------c
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-----------------GRNVAIKVLNETK---------------------------G 38 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~---------------------------~ 38 (291)
+.+.+.||+|+||.||++.+.+ +..|++|.+.... +
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 86 (296)
T cd05051 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG 86 (296)
T ss_pred CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 4678999999999999997643 2468999987542 4
Q ss_pred eeecCCcceeeehhhcCCCHHHHHhhcCCC-----CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE
Q 022826 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPL-----ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL 113 (291)
Q Consensus 39 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill 113 (291)
.+..+...++++|++.+++|.+++...... .....+++..++.++.|++.||.|||+ .+++|+||||+||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nili 163 (296)
T cd05051 87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhceee
Confidence 455667889999999999999999764311 112378999999999999999999999 999999999999999
Q ss_pred cCCCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC--CCCCCccccCCC
Q 022826 114 DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG--VKNNANVAVDRS 191 (291)
Q Consensus 114 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~--g~~~~~~~~~~~ 191 (291)
+.++.++|+|||++................+++.|+|||.+.+. .++.++||||||+++|+|++ +..|+.....
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-- 239 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC--CCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--
Confidence 99999999999998765433222222233456789999998765 78999999999999999987 4444432110
Q ss_pred ccccchhhhhhhhhhh-hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 192 SEIYFPHWVYKRLELE-EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 192 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
.......... .... .......+..++.++.+++.+||+.||.+|||+.++++.|++
T Consensus 240 ------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 ------QQVIENAGHFFRDDG-RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ------HHHHHHHHhcccccc-ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 0011110000 0000 000011122345689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=253.86 Aligned_cols=235 Identities=24% Similarity=0.234 Sum_probs=175.9
Q ss_pred hcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------------ceeecCCcceeeeh
Q 022826 6 KNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------------~~~~~~~~~~lv~e 51 (291)
.+.||+|+||.|+.+.+. +|+.||+|++.... .....-...|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 578999999999999875 49999999987322 12234457889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
+++. +|...++.. +.++...+.-++.|++.||.|+|+ .+++|||+||.|++++.+..+||+|||+++...
T Consensus 107 lMet-DL~~iik~~------~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 107 LMET-DLHQIIKSQ------QDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred HHhh-HHHHHHHcC------ccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeecc
Confidence 9954 999999654 459999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc------c-hhhhhhhh
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY------F-PHWVYKRL 204 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~------~-~~~~~~~~ 204 (291)
........+....|.-|+|||++... ..|+.+.||||+||+|.||++|+..|+.......-.. . ........
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 53222223444558889999998654 5899999999999999999999998886644322100 0 01111111
Q ss_pred h------hhhhh-cccCCC-ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 205 E------LEEDL-GLQGIE-NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 205 ~------~~~~~-~~~~~~-~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
. ...+. ..+..+ ....++.....++|+++||..||.+|+|++|.|+-
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1 01111 111111 12234567789999999999999999999998764
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=261.78 Aligned_cols=228 Identities=19% Similarity=0.242 Sum_probs=170.9
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+++... ++.||+|++.... ..+......++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 4677899999999999998754 8899999986421 344567788999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++... ...+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~gg~L~~~l~~~-----~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 83 YVGGDLLTLLSKF-----EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred CCCCcHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999753 2478999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccCCCCCccccCcccccccC---CCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh-h
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNF---GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE-E 208 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~---~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 208 (291)
.... ......|++.|+|||.+.+.. +.++.++||||||+++|+|++|..||...... ......... .
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~i~~~~~ 225 (331)
T cd05624 155 DGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHEE 225 (331)
T ss_pred CCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--------HHHHHHHcCCC
Confidence 3221 123346899999999986521 25788999999999999999999998643211 001111000 0
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSD--RPAMNRVVEM 251 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~--Rps~~ell~~ 251 (291)
.... ......++..+.+++.+||..++.+ |++++++++.
T Consensus 226 ~~~~----p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 226 RFQF----PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cccC----CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0000 1111235677889999999866544 4678887653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=249.82 Aligned_cols=222 Identities=25% Similarity=0.387 Sum_probs=176.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|++|.||++... +++.|++|.+.... +.+......++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 456789999999999999875 48999999986432 4556677889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+++|.+++... ....+++..++.++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~L~~~l~~~----~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 82 ENGDLHKLLKMQ----RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCcHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 999999999764 23578999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||..... ....... ..
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~------~~- 215 (256)
T cd08529 155 TNF--ANTIVGTPYYLSPELCEDK--PYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILKI------IR- 215 (256)
T ss_pred cch--hhccccCccccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH------Hc-
Confidence 221 2334568899999998765 688999999999999999999998864421 0000110 00
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.........++..+.+++.+||+.+|++||++.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 216 GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1111122246678999999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=259.33 Aligned_cols=228 Identities=19% Similarity=0.249 Sum_probs=171.2
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+++... ++.+|+|++.... ..+......++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 5677899999999999998755 8899999986421 345566778999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++.+. ...+++..+..++.||+.||.|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~g~L~~~l~~~-----~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 83 YVGGDLLTLLSKF-----EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred cCCCcHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999753 2468999999999999999999999 9999999999999999999999999999875433
Q ss_pred CCceeeccCCCCCccccCccccccc---CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh-h
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE-E 208 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 208 (291)
.... ......|++.|+|||++.+. ...++.++|||||||++|+|++|..||...... ......... .
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~--------~~~~~i~~~~~ 225 (332)
T cd05623 155 DGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHKE 225 (332)
T ss_pred CCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH--------HHHHHHhCCCc
Confidence 2211 12335689999999998631 236788999999999999999999998654210 011111000 0
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSD--RPAMNRVVEM 251 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~--Rps~~ell~~ 251 (291)
.... ......++..+.+++++||..++.. |+++.++++.
T Consensus 226 ~~~~----p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 RFQF----PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cccC----CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0001 1112345677888999988655444 6889998766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=260.93 Aligned_cols=221 Identities=24% Similarity=0.291 Sum_probs=183.8
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e 51 (291)
+.+++.||.|.||.||++.... |+.+|+|++.+.. +.+......++|||
T Consensus 37 Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmE 116 (382)
T KOG0032|consen 37 YELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVME 116 (382)
T ss_pred EEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEE
Confidence 5677899999999999998765 9999999997654 56666778899999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC----CCceEEeccCCc
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE----DFCPKISDFGLA 127 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~----~~~~kl~Dfg~~ 127 (291)
+|.||.|.+.+... .+++..+..+++|++.++.|||+ .+++|+||||+|+++.. ++.++++|||++
T Consensus 117 L~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 117 LCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred ecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999664 39999999999999999999999 99999999999999953 357999999999
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
.....+. .....+||+.|+|||++.+. .++..+||||+|+++|.|++|..||.......... . .
T Consensus 187 ~~~~~~~---~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--------~---i 250 (382)
T KOG0032|consen 187 KFIKPGE---RLHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--------A---I 250 (382)
T ss_pred eEccCCc---eEeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------H---H
Confidence 9876632 34667899999999999875 89999999999999999999999998775422100 0 0
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. .......+.-..++..+.++++.||..||.+|+|+.++++
T Consensus 251 ~~-~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 251 LR-GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred Hc-CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 00 0112223344567889999999999999999999999998
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=255.04 Aligned_cols=238 Identities=26% Similarity=0.424 Sum_probs=171.8
Q ss_pred hhhcccccCCceeEEEEEe-----cCCCeEEEEEeccCc--------------------------cee--ecCCcceeee
Q 022826 4 SFKNKLGQGGYGGVYKGKL-----LDGRNVAIKVLNETK--------------------------GFC--FEGHRRALIY 50 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~--------------------------~~~--~~~~~~~lv~ 50 (291)
.+.+.||+|+||.||++.. .+++.|++|.+.... +.+ ......++|+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 86 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence 4568899999999999974 247899999986543 222 2234578999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
||+.+++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 87 e~~~~~~L~~~l~~~-----~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 87 EYLPYGSLRDYLQKH-----RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EecCCCCHHHHHHhc-----CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999653 2468999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCceeec-cCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCc-----cccchhhhhhhh
Q 022826 131 HGRESIVSM-TGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSS-----EIYFPHWVYKRL 204 (291)
Q Consensus 131 ~~~~~~~~~-~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~-----~~~~~~~~~~~~ 204 (291)
......... ....++..|+|||.+.+. .++.++||||||+++|+|++|..++........ .......... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 235 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH-L 235 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccC--CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH-H
Confidence 443322111 112234569999998765 788999999999999999998765432211100 0000000000 0
Q ss_pred hhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 205 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
.... ...........++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 236 --~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 --IELL-KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred --HHHH-hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000 00111112233556799999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=255.25 Aligned_cols=224 Identities=26% Similarity=0.370 Sum_probs=172.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+...+.||+|+||+||++.+. +++.+|+|.+.... ..+..+...++++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 445688999999999999775 48999999986432 345556778899999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 82 MNGGDLKFHIYNM----GNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred ccCccHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence 9999999888653 23479999999999999999999999 9999999999999999999999999999875433
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||........ .. .. ....
T Consensus 155 ~~~---~~~~~g~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~----~~--~~~~-- 217 (285)
T cd05632 155 GES---IRGRVGTVGYMAPEVLNNQ--RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----RE----EV--DRRV-- 217 (285)
T ss_pred CCc---ccCCCCCcCccChHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HH----HH--HHhh--
Confidence 221 2334678999999999765 788999999999999999999998864421100 00 00 0000
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPA-----MNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps-----~~ell~ 250 (291)
..........++..+.+|+..||+.||++||+ +.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 218 LETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred hccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 00001122345667889999999999999999 667665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=257.88 Aligned_cols=236 Identities=27% Similarity=0.453 Sum_probs=175.2
Q ss_pred chhhcccccCCceeEEEEEecC-CC--eEEEEEeccCc----------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GR--NVAIKVLNETK----------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~----------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|.+.+ +. .+++|.++... +.+..+...++++|
T Consensus 9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 88 (303)
T cd05088 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 88 (303)
T ss_pred ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEE
Confidence 3567889999999999998643 44 45777765321 45556677889999
Q ss_pred hhcCCCHHHHHhhcCCCC----------CCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEE
Q 022826 52 FVSNGSLEKFIYEKHPLE----------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 121 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl 121 (291)
|+.+++|.+++....... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEEe
Confidence 999999999997653221 22468999999999999999999999 99999999999999999999999
Q ss_pred eccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhh
Q 022826 122 SDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWV 200 (291)
Q Consensus 122 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~ 200 (291)
+|||++........ ......+..|+|||.+.+. .++.++||||||+++|+|++ |..||....... .
T Consensus 166 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~ 232 (303)
T cd05088 166 ADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------L 232 (303)
T ss_pred CccccCcccchhhh---cccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCChHH--------H
Confidence 99999863211110 1111235679999988765 68899999999999999998 887775332110 0
Q ss_pred hhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCC
Q 022826 201 YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRI 261 (291)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 261 (291)
..... ...........+..+.+++.+||+.+|.+||++.++++.|+.++..-..
T Consensus 233 ~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 233 YEKLP-------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred HHHHh-------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 00000 0000111123456788999999999999999999999999887765543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=254.20 Aligned_cols=242 Identities=25% Similarity=0.401 Sum_probs=177.2
Q ss_pred chhhcccccCCceeEEEEEec-----CCCeEEEEEeccCc---------------------------ceeec--CCccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-----DGRNVAIKVLNETK---------------------------GFCFE--GHRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~---------------------------~~~~~--~~~~~l 48 (291)
+.+.+.||+|+||.||++... .++.+|+|++.... +++.. +...++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 456688999999999999753 37899999987543 23333 456789
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
++||+.+++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.+.
T Consensus 86 v~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHR-----DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEecCCCCCHHHHHHhCc-----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999996542 369999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCceee-ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhh-hhhh
Q 022826 129 ICHGRESIVS-MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYK-RLEL 206 (291)
Q Consensus 129 ~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~-~~~~ 206 (291)
.......... .....++..|++||.+.+. .++.++||||||+++|+|++|..|+............+..... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 7653322211 1122345679999998765 7889999999999999999999887554322211000000000 0000
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
...+. ..........++..+.+++.+||+.+|.+|||+.|+++.|+++
T Consensus 236 ~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLK-EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHH-cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00000 1111111233457799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=251.46 Aligned_cols=229 Identities=25% Similarity=0.429 Sum_probs=174.8
Q ss_pred chhhcccccCCceeEEEEEecC-C---CeEEEEEeccCc---------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-G---RNVAIKVLNETK---------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e 51 (291)
++..+.||+|+||.||+|.... + ..+++|.+.... +.+......++|||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence 3457899999999999998753 3 379999987542 45556677889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++... ...+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 87 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 87 YMENGALDKYLRDH-----DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred cCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999998653 2578999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceee-ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 132 GRESIVS-MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 132 ~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
....... ......+..|+|||.+.+. .++.++||||||+++|+|++ |..|+..... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~i~---- 224 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKAIN---- 224 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcC--CcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHh----
Confidence 3322111 1112234579999998765 78899999999999999987 8888754321 00011110
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~ 256 (291)
.. .........+..+.+++.+||+.+|++||++.++++.|++++
T Consensus 225 --~~-~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 225 --DG-FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred --cC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 00 011112235567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=265.68 Aligned_cols=226 Identities=18% Similarity=0.256 Sum_probs=170.9
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||++++.. ++.+|+|++.... +.+..+...++||||
T Consensus 45 y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey 124 (371)
T cd05622 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 124 (371)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 3456889999999999998754 8999999986421 455567788999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++.. ..+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.++|+|||++.....
T Consensus 125 ~~gg~L~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 125 MPGGDLVNLMSN-------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred CCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 999999999854 357888999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccCCCCCccccCcccccccC--CCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNF--GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~--~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
.... ......||+.|+|||++.+.. ..++.++|||||||++|+|++|..||...... .........
T Consensus 195 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~--- 262 (371)
T cd05622 195 EGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMNH--- 262 (371)
T ss_pred CCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--------HHHHHHHcC---
Confidence 2211 123456899999999987542 24789999999999999999999998754211 001111000
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSD--RPAMNRVVEM 251 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~--Rps~~ell~~ 251 (291)
...........++..+.+++..||..++.+ |+++.++++.
T Consensus 263 -~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 263 -KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred -CCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 000111122346778899999999844433 6799988874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=265.93 Aligned_cols=237 Identities=19% Similarity=0.208 Sum_probs=173.7
Q ss_pred chhhcccccCCceeEEEEEec---CCCeEEEEEeccCc---------------------ceeecCCcceeeehhhcCCCH
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL---DGRNVAIKVLNETK---------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
+.+.+.||+|+||.||++... .++.|++|.+.... +.+......+++|+++. ++|
T Consensus 94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 172 (392)
T PHA03207 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDL 172 (392)
T ss_pred eEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCH
Confidence 556789999999999999653 26789999986543 34555678899999996 588
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
.+++.. ...+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.++|+|||++...........
T Consensus 173 ~~~l~~------~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 173 FTYVDR------SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred HHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 888843 2579999999999999999999999 9999999999999999999999999999876554333222
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc--------------hhhhhhhh
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF--------------PHWVYKRL 204 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~--------------~~~~~~~~ 204 (291)
.....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+ +.......
T Consensus 244 ~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 244 CYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred ccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 2345689999999999775 7899999999999999999999998765432210000 00000000
Q ss_pred -hhhhhhcccCCC------ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 205 -ELEEDLGLQGIE------NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 205 -~~~~~~~~~~~~------~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
............ ......+...+.+++.+||..||++|||+.|++..
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 00011245678889999999999999999999864
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=252.14 Aligned_cols=229 Identities=27% Similarity=0.422 Sum_probs=175.0
Q ss_pred chhhcccccCCceeEEEEEecC-CC----eEEEEEeccCc---------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GR----NVAIKVLNETK---------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~---------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||+|.+.+ ++ .+++|.+.... +.+.. ...++++
T Consensus 9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 87 (279)
T cd05057 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT 87 (279)
T ss_pred cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence 3456889999999999997643 33 68999887543 33433 6788999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
||+.+|+|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++..
T Consensus 88 e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 88 QLMPLGCLLDYVRNH-----KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred ecCCCCcHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999653 2468999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
.............++..|+|||.+.+. .++.++||||||+++|++++ |..||..... .........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~--- 226 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHR--IYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEIPDLLEK--- 226 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcC--CcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhC---
Confidence 544332222222335689999998654 78899999999999999998 8887754311 100111110
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
......+...+..+.+++.+||..||++||++.++++.|+++.+
T Consensus 227 ----~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 227 ----GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00111122244568899999999999999999999999998755
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=258.80 Aligned_cols=237 Identities=21% Similarity=0.315 Sum_probs=173.0
Q ss_pred cchhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhh
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~ 53 (291)
++.+.+.||+|+||.||+|.+. +++.||+|.++... +.+..+...++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 3556789999999999999875 48899999987432 4566677889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+ +|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 87 ~~-~l~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 87 DK-DLKQYMDDC-----GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CC-CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 76 888887553 2468899999999999999999999 99999999999999999999999999998754332
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccch-------hhhhhhhhh
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFP-------HWVYKRLEL 206 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 206 (291)
.. ......+++.|+|||.+.+. ..++.++||||||+++|+|++|..||............. ...+.....
T Consensus 158 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 158 TK--TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred cc--ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 21 12234568899999998653 367889999999999999999999886543211000000 000000000
Q ss_pred h---hhhcccCCC----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 E---EDLGLQGIE----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~---~~~~~~~~~----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. .....+... ......++..+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0 000000000 0111235667889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=252.32 Aligned_cols=217 Identities=26% Similarity=0.380 Sum_probs=169.2
Q ss_pred ccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------------------ceeecCCcceeeehhhc
Q 022826 8 KLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 8 ~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------------------~~~~~~~~~~lv~e~~~ 54 (291)
.||+|+||.||++.+.+ ++.+|+|.+.... ..+...+..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999998754 8999999886432 23334567889999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 81 GGDLHYHLSQH------GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 99999988654 468999999999999999999999 999999999999999999999999999987543322
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
.....++..|+|||.+.+. ..++.++||||||+++|+|++|..||........ .. .... .. .
T Consensus 152 ----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~-~~~~----~~---~ 213 (279)
T cd05633 152 ----PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HE-IDRM----TL---T 213 (279)
T ss_pred ----ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-----HH-HHHH----hh---c
Confidence 1234578999999998642 3678999999999999999999999875433211 00 0000 00 0
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVEM 251 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~~ 251 (291)
.....+..++..+.+++.+||+.||.+|| ++.++++.
T Consensus 214 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 214 VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11122344677889999999999999999 59998873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=266.91 Aligned_cols=223 Identities=24% Similarity=0.306 Sum_probs=168.1
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||++.... ++.||+|+++... +.+..+...++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 4567899999999999998754 8999999986421 345566788999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++.+. ..+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 83 LPGGDMMTLLMKK------DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred CCCccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999998654 478999999999999999999999 9999999999999999999999999999875432
Q ss_pred CCce---------------------------------eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC
Q 022826 133 RESI---------------------------------VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 179 (291)
Q Consensus 133 ~~~~---------------------------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~ 179 (291)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~t 231 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLI 231 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceeccccceeeeccc
Confidence 1100 001124589999999999776 78899999999999999999
Q ss_pred CCCCCccccCCCccccchhhhhhhhhh-hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 022826 180 VKNNANVAVDRSSEIYFPHWVYKRLEL-EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPA---MNRVVE 250 (291)
Q Consensus 180 g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps---~~ell~ 250 (291)
|..||...... ........ ...+..+ ....++..+.+++.+|+ .||.+|++ +.++++
T Consensus 232 G~~Pf~~~~~~--------~~~~~i~~~~~~~~~p-----~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 232 GYPPFCSETPQ--------ETYRKVMNWKETLVFP-----PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCCCHH--------HHHHHHHcCCCceecC-----CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 99998654221 11111100 0001111 11124567788888876 49999985 556554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=250.99 Aligned_cols=228 Identities=25% Similarity=0.446 Sum_probs=175.2
Q ss_pred chhhcccccCCceeEEEEEecC----CCeEEEEEeccCc---------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD----GRNVAIKVLNETK---------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e 51 (291)
+++.+.||+|+||.||+|.+.. +..+++|.++... +.+..+...+++||
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (267)
T cd05066 6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE 85 (267)
T ss_pred eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence 5678999999999999997642 3479999986532 45566778899999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+++++|.+++... ...+++..+..++.|++.||.+||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 86 ~~~~~~L~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 86 YMENGSLDAFLRKH-----DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred cCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999653 2468999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCceee-ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 132 GRESIVS-MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 132 ~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
....... ......+..|++||.+.+. .++.++|+||||+++|++++ |..||....... ...... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~--~~ 225 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAIE--EG 225 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--------HHHHHh--CC
Confidence 4322111 1122235679999999765 78999999999999999886 887775432110 000000 00
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
. .......++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 226 ~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 Y-----RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred C-----cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 0111223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=249.09 Aligned_cols=222 Identities=26% Similarity=0.463 Sum_probs=174.3
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||.|+||.||++.. .++.|++|.+.... +.+......++|+||+.+++
T Consensus 8 ~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (256)
T cd05039 8 LKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS 86 (256)
T ss_pred ccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence 45678999999999999986 58899999987664 34555778889999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.++......
T Consensus 87 L~~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 87 LVDYLRSR----GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred HHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 99999764 22478999999999999999999999 999999999999999999999999999988653221
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
.....+..|+|||.+.+. .++.++||||||+++|++++ |..||..... ......... ...
T Consensus 157 --~~~~~~~~~~ape~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~-------~~~ 217 (256)
T cd05039 157 --DSGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPHVEK-------GYR 217 (256)
T ss_pred --ccCCCcccccCchhhcCC--cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHhc-------CCC
Confidence 122335679999998754 78889999999999999996 7777653311 000000000 001
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
...+..++..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11123356788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=248.88 Aligned_cols=222 Identities=29% Similarity=0.433 Sum_probs=169.1
Q ss_pred ccccCCceeEEEEEec---CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcCCC
Q 022826 8 KLGQGGYGGVYKGKLL---DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 8 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
.||+|+||.||+|.+. ++..||+|++.... +.+ .....++||||+.+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~-~~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE-cCCCeEEEEEeCCCCC
Confidence 4899999999999764 25679999987543 222 3456789999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++..........
T Consensus 81 L~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 81 LNKFLSGK-----KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred HHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 99998643 2578999999999999999999999 999999999999999999999999999987654332211
Q ss_pred e-ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 138 S-MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 138 ~-~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
. .....++..|+|||.+.+. .++.++||||||+++|++++ |..||...... ....... ...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~-------~~~ 215 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------EVMSFIE-------QGK 215 (257)
T ss_pred eccCCCCCCcccCCHHHHccC--CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHH-------CCC
Confidence 1 1222235689999998765 68899999999999999996 87777543211 0000000 011
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
....+...+.++.+++.+||+.||++||++.++.+.|+.+
T Consensus 216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1112234567888999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=250.52 Aligned_cols=227 Identities=27% Similarity=0.448 Sum_probs=169.5
Q ss_pred cccccCCceeEEEEEecC-CC--eEEEEEeccCc----------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLLD-GR--NVAIKVLNETK----------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.||+|+||.||+|...+ +. .+++|.++... +.+......+++|||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999998754 43 57888876421 344556678899999999
Q ss_pred CCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccC
Q 022826 56 GSLEKFIYEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 56 g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
++|.+++...... .....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 9999999765321 122468899999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRL 204 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~ 204 (291)
++....... .......+..|+|||.+.+. .++.++||||||+++|+|++ |..||...... . .....
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~-~~~~~ 224 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------E-LYEKL 224 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCccccCHH-------H-HHHHH
Confidence 975322111 01112235579999998765 78899999999999999996 88777542110 0 00111
Q ss_pred hhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 022826 205 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256 (291)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~ 256 (291)
.. ..........+..+.+++.+||+.||.+|||+.++++.|++++
T Consensus 225 ~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 PQ-------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred hC-------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00 0001112234567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=251.10 Aligned_cols=225 Identities=28% Similarity=0.405 Sum_probs=171.0
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------------ceeec------CCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------GFCFE------GHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------------~~~~~------~~~~~lv 49 (291)
+.+.+.||+|+||.||+|...+ ++.+|+|++.... +.+.. ....+++
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 87 (272)
T cd06637 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 87 (272)
T ss_pred hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence 4567889999999999998754 8999999986542 22221 2357899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
+||+.+++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 88 MEFCGAGSVTDLIKNT----KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEcCCCCcHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999998763 23578999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCceeeccCCCCCccccCccccccc---CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh
Q 022826 130 CHGRESIVSMTGARGTVGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
...... ......+++.|+|||.+.+. ...++.++|||||||++|+|++|..||........ ....
T Consensus 161 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~--------~~~~-- 228 (272)
T cd06637 161 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--------LFLI-- 228 (272)
T ss_pred cccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH--------HHHH--
Confidence 432211 12334578899999998632 23678899999999999999999998864321100 0000
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. ...........++..+.+|+.+||+.||.+|||+.++++
T Consensus 229 -~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 -P---RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -h---cCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 011111122235667899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=250.19 Aligned_cols=232 Identities=25% Similarity=0.340 Sum_probs=167.1
Q ss_pred cccccCCceeEEEEEecC---CCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcCC
Q 022826 7 NKLGQGGYGGVYKGKLLD---GRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.||+|+||.||+|...+ +..+++|.+.... +.+......++||||+.+|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999997643 4679999886543 4555666788999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+|.+++...... .....++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 81 DLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred cHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999764311 22356778888999999999999999 99999999999999999999999999998654333222
Q ss_pred eeccCCCCCccccCcccccccC-----CCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 137 VSMTGARGTVGYIAPEVFCRNF-----GEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~~-----~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
.......++..|+|||++.+.. ..++.++||||||+++|+|++ |..||....... ...........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~ 228 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--------VLTYTVREQQL 228 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--------HHHHHhhcccC
Confidence 2222344577899999986432 135789999999999999996 888875432110 00000000000
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
... ...........+.+++..|| .+|++|||+++|++.|+
T Consensus 229 ~~~--~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLP--KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCC--CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 011 01111124556788999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=280.17 Aligned_cols=238 Identities=23% Similarity=0.299 Sum_probs=179.6
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.++||+|+||.||+|.+.. ++.||+|++.... +.+..+...+++|||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 4577899999999999998754 8999999986431 455667788999999
Q ss_pred hcCCCHHHHHhhcCCC-----CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 53 VSNGSLEKFIYEKHPL-----ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+++++|.+++...... ......++..+..++.||+.||.|||+ .+++||||||+||+++.++.++|+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999998753210 112456778889999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCc----------------eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCC
Q 022826 128 KICHGRES----------------IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRS 191 (291)
Q Consensus 128 ~~~~~~~~----------------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~ 191 (291)
........ ........||+.|+|||.+.+. .++.++|||||||++|+|++|..||.......
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~--~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC--CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 76521100 0011224589999999999776 78999999999999999999999986532211
Q ss_pred ccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHhhhcc
Q 022826 192 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRP-AMNRVVEMLEGSLDS 258 (291)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-s~~ell~~L~~~~~~ 258 (291)
. ........+. .......++..+.+++.+||+.||++|| +++++++.|+..++.
T Consensus 239 i------------~~~~~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 I------------SYRDVILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred h------------hhhhhccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 0000000000 0011124566788999999999999995 778888888887764
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=251.62 Aligned_cols=228 Identities=26% Similarity=0.449 Sum_probs=171.7
Q ss_pred cccccCCceeEEEEEecC-------CCeEEEEEeccCc---------------------------ceeecCCcceeeehh
Q 022826 7 NKLGQGGYGGVYKGKLLD-------GRNVAIKVLNETK---------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~ 52 (291)
+.||+|+||.||+|...+ ++.+++|.+.... +++......++++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999997643 2578999876432 455667788999999
Q ss_pred hcCCCHHHHHhhcCCCC-CCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC-----ceEEeccCC
Q 022826 53 VSNGSLEKFIYEKHPLE-TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-----CPKISDFGL 126 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-----~~kl~Dfg~ 126 (291)
+.+++|.+++....... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997643211 23458899999999999999999999 9999999999999999877 899999999
Q ss_pred ccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhh
Q 022826 127 AKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLE 205 (291)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (291)
+................++..|+|||.+.+. .++.++||||||+++|+|++ |..||...... . .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-------~-~~~~~- 226 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDG--KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-------E-VLQHV- 226 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccC--CcccchhHHHHHHHHHHHHHcCCCCCcccCHH-------H-HHHHH-
Confidence 8765433222111223346789999998765 78999999999999999997 88777533210 0 00000
Q ss_pred hhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 206 LEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
.. ..........+..+.+++.+||+.+|.+||++.++++.|++
T Consensus 227 -----~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 227 -----TA-GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -----hc-CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 00111223456788999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=277.82 Aligned_cols=234 Identities=26% Similarity=0.455 Sum_probs=189.7
Q ss_pred hhhcccccCCceeEEEEEecC------CCeEEEEEeccCc---------------------------ceeecCCcceeee
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD------GRNVAIKVLNETK---------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~ 50 (291)
.+.+.||+|+||+||+|+... ...||||.++... ++|.+++-.|+|+
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF 568 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF 568 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence 356889999999999997532 4579999998776 8999999999999
Q ss_pred hhhcCCCHHHHHhhcCCCCC----CC----CCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEe
Q 022826 51 EFVSNGSLEKFIYEKHPLET----NQ----KLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 122 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~----~~----~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~ 122 (291)
||+..|+|.++|..+.+... +. .++..+.++|+.||+.|+.||-+ +.+||+||-..|++|.++-.|||+
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEEec
Confidence 99999999999988665322 23 38899999999999999999999 999999999999999999999999
Q ss_pred ccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhh
Q 022826 123 DFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVY 201 (291)
Q Consensus 123 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~ 201 (291)
|||+++..-..+........--...|||||.|... .++.++||||+||++||+.+ |..|+....+
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~--kFTteSDVWs~GVvLWEIFsyG~QPy~glSn------------ 711 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG--KFTTESDVWSFGVVLWEIFSYGKQPYYGLSN------------ 711 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcC--cccchhhhhhhhhhhhhhhccccCcccccch------------
Confidence 99999976554433222222235699999999876 99999999999999999986 5555544332
Q ss_pred hhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 202 KRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
.+.+..+....+ ...+.+++.++..|+..||+.+|.+||+++||-.+|+...+
T Consensus 712 --~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 712 --QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred --HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 122222222222 55667788999999999999999999999999999988644
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=248.57 Aligned_cols=227 Identities=28% Similarity=0.481 Sum_probs=167.2
Q ss_pred cccccCCceeEEEEEecC----CCeEEEEEeccCc---------------------------ceee-cCCcceeeehhhc
Q 022826 7 NKLGQGGYGGVYKGKLLD----GRNVAIKVLNETK---------------------------GFCF-EGHRRALIYEFVS 54 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~---------------------------~~~~-~~~~~~lv~e~~~ 54 (291)
+.||+|+||.||+|.+.+ ...+|+|.+.... +.+. .+...+++++|+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999997532 4579999885421 2232 3456789999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++.... ...++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 81 HGDLRNFIRSET-----HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 999999996532 356778889999999999999999 999999999999999999999999999987543321
Q ss_pred ce--eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 135 SI--VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 135 ~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
.. .......++..|+|||.+.+. .++.++||||||+++|+|++|..++...... .. ......
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~-~~~~~~------- 216 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FD-ITVYLL------- 216 (262)
T ss_pred ceeecccccCcCCccccChhHhccC--ccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HH-HHHHHh-------
Confidence 11 111223346789999998765 7889999999999999999965543322110 00 000000
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
.......+...+..+.+++.+||+.+|++||++.++++.|++++.
T Consensus 217 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 217 QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 000011112245678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=259.48 Aligned_cols=228 Identities=19% Similarity=0.274 Sum_probs=170.1
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+++... ++.||+|++.+.. +.+..+...++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 5677899999999999998754 8999999986421 345567788999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ...+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~g~~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 83 YVGGDLLTLLSKF-----EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred CCCCcHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999653 2578999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccCCCCCccccCccccccc---CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh-hh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL-EE 208 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 208 (291)
.... ......+++.|+|||++.+. ...++.++|||||||++|+|++|..||...... . ....... ..
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-------~-~~~~i~~~~~ 225 (331)
T cd05597 155 DGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------E-TYGKIMNHKE 225 (331)
T ss_pred CCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-------H-HHHHHHcCCC
Confidence 2211 11224579999999998642 235788999999999999999999998653210 0 0001100 00
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCC--CCCCHHHHHHH
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPS--DRPAMNRVVEM 251 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~--~Rps~~ell~~ 251 (291)
....+ .....++..+.+++++||..+++ .|+++.++++.
T Consensus 226 ~~~~~----~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 226 HFQFP----PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cccCC----CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 01111 11123566788899988865443 37899888775
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=251.10 Aligned_cols=223 Identities=27% Similarity=0.422 Sum_probs=171.3
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +.+......++++||+.
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 346688999999999999764 58999999986542 45566777889999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|..+ ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 83 GGSLDVY----------RKIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCChHHh----------hcCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999655 256788899999999999999999 999999999999999999999999999987653321
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|..||........... +... ........
T Consensus 150 ----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~------~~~~~~~~ 216 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-PLQL------LQCIVDED 216 (279)
T ss_pred ----ccCCCCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-hHHH------HHHHhccC
Confidence 2334678899999999876 789999999999999999999999875433221111 1000 00000011
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.........+..+.+++.+||+.+|++||+++++++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 217 PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1111122355678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=250.38 Aligned_cols=226 Identities=22% Similarity=0.346 Sum_probs=171.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||+|+||.||+|.+. +++.|++|+++... +.+......++++||+.+
T Consensus 11 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 90 (267)
T cd06645 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG 90 (267)
T ss_pred HHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence 356689999999999999775 48999999986542 344566788999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++... ..+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 91 ~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 91 GSLQDIYHVT------GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 9999998654 478999999999999999999999 999999999999999999999999999987553221
Q ss_pred eeeccCCCCCccccCccccccc-CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~-~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
.......++..|+|||.+... ...++.++|+|||||++|+|++|..|+........ ..... ......+.
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-------~~~~~--~~~~~~~~ 230 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------LFLMT--KSNFQPPK 230 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-------HHhhh--ccCCCCCc
Confidence 112344678999999987421 23578899999999999999999988754322110 00000 00000010
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......++..+.+++.+||+.+|++||++.++++
T Consensus 231 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 --LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0111134567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=250.94 Aligned_cols=225 Identities=24% Similarity=0.345 Sum_probs=172.5
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||.|+||.||+|++.. ++.+++|++.... +.+..+...++||||+.+
T Consensus 14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (292)
T cd06644 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG 93 (292)
T ss_pred hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence 3467889999999999998755 8999999987554 445667789999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|..++.+. ...+++..+..++.|++.+|.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 94 ~~l~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 94 GAVDAIMLEL-----DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CcHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9998887543 2568999999999999999999999 9999999999999999999999999998765322211
Q ss_pred eeeccCCCCCccccCccccccc---CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 136 IVSMTGARGTVGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
......+++.|+|||.+.+. ...++.++|||||||++|+|++|..||...... .. .... ...
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~---~~~~--~~~ 230 (292)
T cd06644 166 --RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RV---LLKI--AKS 230 (292)
T ss_pred --ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--------HH---HHHH--hcC
Confidence 11234467899999998542 235678999999999999999999887543210 00 0000 000
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.......+..++..+.+++.+||+.||++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 231 EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11111123345667899999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=253.52 Aligned_cols=221 Identities=25% Similarity=0.338 Sum_probs=173.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||.|+||.||++.+. +++.|++|.+.... +.+..+...++|+||+.+
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 456688999999999999764 58999999886543 456667789999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++.. ..+++..+..++.+++.|+.+||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 101 ~~L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 101 GSLTDVVTE-------TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999998843 368999999999999999999999 9999999999999999999999999999876543322
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
. .....++..|+|||.+.+. .++.++|||||||++|+|++|..||........ ...... ....
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-----------~~~~~~--~~~~ 233 (296)
T cd06655 171 K--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----------LYLIAT--NGTP 233 (296)
T ss_pred c--CCCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----------HHHHHh--cCCc
Confidence 1 1234568899999998765 688999999999999999999998865432110 000000 0000
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
....+..++..+.+++.+||..||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 11122345667889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=252.18 Aligned_cols=238 Identities=25% Similarity=0.310 Sum_probs=172.3
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|++|.||+|.+. +++.|++|+++... +.+..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 456789999999999999875 48999999986432 4556677889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
. ++|.+++.... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~-~~l~~~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 82 S-MDLKKYLDSLP---KGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred C-CCHHHHHhcCC---CCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 7 58988886532 33578999999999999999999999 99999999999999999999999999998754322
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc-------hhhhhhhhhh
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF-------PHWVYKRLEL 206 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 206 (291)
.. ......+++.|+|||.+.+. ..++.++||||||+++|+|++|+.||............ ....+.....
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 155 VR--VYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred cc--cccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 11 11223457889999988654 35788999999999999999999888644221100000 0000000000
Q ss_pred hh--hhcccCC----CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 EE--DLGLQGI----ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~~--~~~~~~~----~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. ....+.. .......++.++.+++++||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 0000000 00111235677889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=258.65 Aligned_cols=239 Identities=17% Similarity=0.242 Sum_probs=171.6
Q ss_pred hhcccccC--CceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 5 FKNKLGQG--GYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 5 ~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.||+| +|++||++... +|+.||+|.+.... +.+..+...++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 57889999 78999999774 59999999987542 5667778899999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+++.||+........
T Consensus 82 ~~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 82 AYGSAKDLICTH----FMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred CCCcHHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence 999999998654 22468999999999999999999999 99999999999999999999999999865433211
Q ss_pred Cc-ee----eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc-----chhh----
Q 022826 134 ES-IV----SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY-----FPHW---- 199 (291)
Q Consensus 134 ~~-~~----~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~-----~~~~---- 199 (291)
.. .. ......++..|+|||.+.+....++.++|||||||++|+|++|..||........... .+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccccc
Confidence 11 00 0112235678999999976434688999999999999999999999864321100000 0000
Q ss_pred --hhhhhhh-------------------hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 200 --VYKRLEL-------------------EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 200 --~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
....... ................++..+.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000000 00000000001122345678999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=248.72 Aligned_cols=228 Identities=21% Similarity=0.357 Sum_probs=174.0
Q ss_pred chhhcccccCCceeEEEEEecC----CCeEEEEEeccCc---------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD----GRNVAIKVLNETK---------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|.+.+ ...|++|.+.... +.+ .....++|||
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~lv~e 86 (270)
T cd05056 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI-TENPVWIVME 86 (270)
T ss_pred ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEE-cCCCcEEEEE
Confidence 4567899999999999997643 3478999876542 233 3455789999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++... ...+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 87 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 87 LAPLGELRSYLQVN-----KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred cCCCCcHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999653 2468999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
..... ......++..|+|||.+.+. .++.++||||||+++|++++ |..||....... . ........
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~-~~~~~~~~-- 225 (270)
T cd05056 159 DESYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-------V-IGRIENGE-- 225 (270)
T ss_pred cccce-ecCCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-------H-HHHHHcCC--
Confidence 43221 11222345689999998765 78899999999999999885 888775442210 0 00000000
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
....+..++..+.+++.+||..+|.+|||+.++++.|+++.+
T Consensus 226 -----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 226 -----RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 011123456689999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=249.04 Aligned_cols=223 Identities=26% Similarity=0.384 Sum_probs=173.5
Q ss_pred hhhcccccCCceeEEEEEecCCCeEEEEEeccCc--------------------------------ceeecCCcceeeeh
Q 022826 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK--------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------------------------~~~~~~~~~~lv~e 51 (291)
.+.+.||+|+||.||+|...+++.+|+|.+.... +.+......++++|
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82 (265)
T ss_pred cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence 4678899999999999988789999999876431 45566778899999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++.+. ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 83 FVPGGSISSILNRF------GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred cCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999654 468899999999999999999999 999999999999999999999999999987643
Q ss_pred CCC----ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 132 GRE----SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 132 ~~~----~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
... .........++..|+|||.+.+. .++.++|+||||+++|+|++|..||....... . ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~-----~~~~ 220 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------A-----MFYI 220 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCC--CCcchhhHHHHHHHHHHHHhCCCccccCChHH------H-----HHHh
Confidence 211 01112234578899999999765 67899999999999999999999886432110 0 0000
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. ........+..++..+.+++++||+.+|.+||++.++++
T Consensus 221 ~~--~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 221 GA--HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hh--ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 000111122346677899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=273.21 Aligned_cols=231 Identities=25% Similarity=0.458 Sum_probs=186.3
Q ss_pred chhhcccccCCceeEEEEEecC----CCeEEEEEeccCc---------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD----GRNVAIKVLNETK---------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e 51 (291)
.++.+.||.|.||+|++|+.+. ...||||.++... ++....+-..||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 3567899999999999998753 4689999998654 56666777889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|++.|+|+.+|+++. ..|.+.++.-+++.|+.|+.||-. .++|||||.+.|||++.+-..|++|||+++.+.
T Consensus 711 yMENGsLDsFLR~~D-----GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 711 YMENGSLDSFLRQND-----GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhCCcHHHHHhhcC-----CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 999999999998763 569999999999999999999999 999999999999999999999999999999775
Q ss_pred CCCcee-eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 132 GRESIV-SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 132 ~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
++.+.. ....-.-...|.|||.|... .++.++||||+|+++||+++ |.+|. |.+.....+..
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~R--KFTsASDVWSyGIVmWEVmSyGERPY--------------WdmSNQdVIka 846 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPY--------------WDMSNQDVIKA 846 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhc--ccCchhhccccceEEEEecccCCCcc--------------cccchHHHHHH
Confidence 544211 11222235689999999865 89999999999999999986 44433 22222222222
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
+ ..+.+.+.+.+++..|.+|+.+||++|-++||++.+|+..|++++++
T Consensus 847 I-e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 847 I-EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred H-HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 2 12333455677899999999999999999999999999999999764
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=245.85 Aligned_cols=223 Identities=27% Similarity=0.403 Sum_probs=177.0
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||+|+||.||++...+ ++.+++|.+.... +.+......++++||+.+++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 84 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCc
Confidence 4567899999999999998765 8999999987543 45666788899999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ...+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 85 L~~~l~~~-----~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 85 VSDIMKIT-----NKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred HHHHHHhC-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 99998653 2678999999999999999999999 9999999999999999999999999999886544321
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
......++..|+|||.+.+. .++.++||||||+++|+|++|..|+........ ...... ......
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-----------~~~~~~--~~~~~~ 219 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-----------IFMIPN--KPPPTL 219 (256)
T ss_pred ccccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-----------hhhhcc--CCCCCC
Confidence 11223467899999998776 788999999999999999999988865422110 000000 011111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.....+...+.+++.+||+.||++|||+.++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 123346678999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=247.66 Aligned_cols=221 Identities=27% Similarity=0.472 Sum_probs=170.7
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------ceeecCCcceeeehhhcCCCH
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
+.+.+.||+|+||.||++.. .++.+++|.++... +.+. ....+++|||+.+++|
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~v~e~~~~~~L 85 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL-HNGLYIVMELMSKGNL 85 (254)
T ss_pred ceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEc-CCCcEEEEECCCCCCH
Confidence 45678999999999999975 68889999987543 2332 3457899999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~l~~~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 86 VNFLRTR----GRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred HHHHHhc----CcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 9999764 23468999999999999999999999 999999999999999999999999999987543221
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
.....+..|+|||.+.+. .++.++|+||||+++|+|++ |..||..... .. ...... . ....
T Consensus 155 -~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~-~~~~~~--~-----~~~~ 216 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHK--KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-------KE-VKECVE--K-----GYRM 216 (254)
T ss_pred -CCCCCCceecCHHHhccC--CcCchhhHHHHHHHHHHHHhCCCCCCccCCH-------HH-HHHHHh--C-----CCCC
Confidence 122335689999998765 78899999999999999997 7777654321 00 000000 0 0111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
.....++..+.+++.+||+.+|++||++.++++.|++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1123456778899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=248.22 Aligned_cols=232 Identities=26% Similarity=0.422 Sum_probs=164.9
Q ss_pred cccccCCceeEEEEEecC---CCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcCC
Q 022826 7 NKLGQGGYGGVYKGKLLD---GRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.||+|+||.||+|...+ ...+++|.+.... +.+......++||||+.+|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999996533 4578888775432 4556677789999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+|.+++...... .....++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 81 DLKNYLRSNRGM-VAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred cHHHHHHhcccc-ccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999765311 12345678889999999999999999 99999999999999999999999999998653322211
Q ss_pred eeccCCCCCccccCccccccc-----CCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 137 VSMTGARGTVGYIAPEVFCRN-----FGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~-----~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
.......++..|+|||++... ...++.++||||||+++|+|++ |..|+...... ............
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~~~~~~~~~~~~ 228 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--------QVLKQVVREQDI 228 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhhccCc
Confidence 111223345679999987532 1356789999999999999998 55555433110 011111111111
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
..+. ......++..+.+++..|| .||++|||++++++.|.
T Consensus 229 ~~~~--~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPK--PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCC--CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111 1123346667778888898 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=244.28 Aligned_cols=221 Identities=23% Similarity=0.330 Sum_probs=173.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+-+.||+|+|+.|+++.+. +|+.+++|++..+. ....+....|+|+|++
T Consensus 13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m 92 (355)
T KOG0033|consen 13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 92 (355)
T ss_pred hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence 456789999999999999654 59999999887554 2334456788999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc---CCCceEEeccCCcccc
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---EDFCPKISDFGLAKIC 130 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~---~~~~~kl~Dfg~~~~~ 130 (291)
.|++|..-+-.+ ..+|+..+.+.++||+++|.|+|. .+|||||+||+|+++. ...-+||+|||++...
T Consensus 93 ~G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 93 TGGELFEDIVAR------EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred cchHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999996655444 578999999999999999999999 9999999999999994 3456899999999987
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
..+. ..-...|||.|+|||++... .++..+|||+.|+++|-++.|..||.+..... ....+. ....
T Consensus 164 ~~g~---~~~G~~GtP~fmaPEvvrkd--py~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--------lye~I~-~g~y 229 (355)
T KOG0033|consen 164 NDGE---AWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYEQIK-AGAY 229 (355)
T ss_pred CCcc---ccccccCCCcccCHHHhhcC--CCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--------HHHHHh-cccc
Confidence 7433 23456789999999999876 89999999999999999999999998742210 111111 1111
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVV 249 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell 249 (291)
..+...-..++++..+|+++||..||.+|+|+.|.|
T Consensus 230 ---d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 230 ---DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred ---CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 111212245778899999999999999999998865
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=259.06 Aligned_cols=237 Identities=23% Similarity=0.278 Sum_probs=168.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCC-----ccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGH-----RRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~-----~~~l 48 (291)
..+.+.||+|+||.||++.+. +++.||+|++.... +.+.... ..++
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 356789999999999999874 59999999986431 2222233 6789
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
|+||+. ++|.+++... ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++.
T Consensus 82 v~e~~~-~~l~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 82 VTELMQ-SDLHKIIVSP------QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred Eeeccc-cCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEecccccee
Confidence 999996 4888877543 578999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc--------hhhh
Q 022826 129 ICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF--------PHWV 200 (291)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~--------~~~~ 200 (291)
........ ......+++.|+|||.+.+. ..++.++|||||||++|+|++|+.||............ ....
T Consensus 152 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 152 VEEPDESK-HMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229 (372)
T ss_pred ecccCccc-cCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 64332211 12233468899999998764 35788999999999999999999988654321100000 0000
Q ss_pred hhhh-hhhhhh-cccCCCC------hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 201 YKRL-ELEEDL-GLQGIEN------EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 201 ~~~~-~~~~~~-~~~~~~~------~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.... .....+ ....... ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 000000 0000000 0111235678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=258.22 Aligned_cols=231 Identities=25% Similarity=0.233 Sum_probs=164.7
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceee------cCCccee
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCF------EGHRRAL 48 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~------~~~~~~l 48 (291)
.+.+.||+|+||.||++.+. +++.||+|++.... +++. .....++
T Consensus 24 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 103 (359)
T cd07876 24 QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL 103 (359)
T ss_pred EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEE
Confidence 45688999999999999875 48999999986431 1111 1134689
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
||||+.+ +|...+. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.
T Consensus 104 v~e~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 104 VMELMDA-NLCQVIH--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred EEeCCCc-CHHHHHh--------ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 9999976 6766652 257888999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccc------cchhh-hh
Q 022826 129 ICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEI------YFPHW-VY 201 (291)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~------~~~~~-~~ 201 (291)
...... ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||........-. ..+.. ..
T Consensus 172 ~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 172 TACTNF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccCc---cCCCCcccCCCCCchhccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 543221 12334578899999999875 78899999999999999999999987543211000 00000 00
Q ss_pred hhhh-hh-----hhhcccCC-------------CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 202 KRLE-LE-----EDLGLQGI-------------ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 202 ~~~~-~~-----~~~~~~~~-------------~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.... .. ........ ...........+.+|+.+||..||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 00 00000000 000111234678899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=257.37 Aligned_cols=231 Identities=25% Similarity=0.233 Sum_probs=165.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------cee------ecCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFC------FEGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~------~~~~~~~ 47 (291)
+.+.+.||+|+||.||++.+. .++.||||++.... +.+ ......+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~ 105 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105 (364)
T ss_pred eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence 345678999999999999875 48999999986432 111 1223468
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++
T Consensus 106 lv~e~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 106 IVMELMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred EEEeCCCC-CHHHHHH--------hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 99999975 7777763 247888999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccc--------cchhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEI--------YFPHW 199 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~--------~~~~~ 199 (291)
+...... ......++..|+|||.+.+. .++.++|||||||++|+|++|..||.......... ..+..
T Consensus 174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 174 RTAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred cccCCCC---cccCCcccCCcCCHHHHhCC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 7643322 12334578999999999876 78999999999999999999999986542211000 00000
Q ss_pred hhhhhh-h-----hhhhcccC-------------CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 200 VYKRLE-L-----EEDLGLQG-------------IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 200 ~~~~~~-~-----~~~~~~~~-------------~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
..... . ........ ............+.+|+.+||+.||++|||+.++++.
T Consensus 249 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 -MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred -HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 0 00000000 0000111234568899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=245.94 Aligned_cols=223 Identities=30% Similarity=0.447 Sum_probs=170.8
Q ss_pred cccccCCceeEEEEEecC--C--CeEEEEEeccCc---------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLLD--G--RNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.||+|++|.||+|.+.+ + ..+++|.+.... +.+.. ...++++||+.+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999997643 3 368999987653 23333 678899999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++.... . ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~L~~~l~~~~---~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 80 GSLLDRLRKDA---L-GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CcHHHHHHhcc---c-ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 99999997652 1 578999999999999999999999 9999999999999999999999999999987654322
Q ss_pred eeec-cCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 136 IVSM-TGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 136 ~~~~-~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
.... ....++..|+|||.+.+. .++.++||||||+++|+|++ |..|+...... . ....... .
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~-~~~~~~~------~ 216 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTR--TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-------Q-ILKKIDK------E 216 (257)
T ss_pred ceecccCCCCCceecCHHHhccc--CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHHh------c
Confidence 2111 223456789999998765 78899999999999999998 88877533110 0 0000000 0
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
......+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 217 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 217 GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0011112235667899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=248.70 Aligned_cols=225 Identities=22% Similarity=0.342 Sum_probs=172.0
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCC
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
.+.+.||+|+||.||++.+.. +..+++|.+.... +.+..+...++|+||+.++
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~ 87 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 87 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence 355779999999999998764 7889999986543 4566677889999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+|..++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 88 ~l~~~~~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 88 AVDAVMLEL-----ERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred cHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 999887542 2578999999999999999999999 9999999999999999999999999999875432211
Q ss_pred eeccCCCCCccccCcccccc---cCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 137 VSMTGARGTVGYIAPEVFCR---NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~---~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
......++..|+|||.+.. ....++.++|||||||++|+|++|..||....... ..... ... ...
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~--~~~-~~~ 226 (282)
T cd06643 159 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--------VLLKI--AKS-EPP 226 (282)
T ss_pred -ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--------HHHHH--hhc-CCC
Confidence 1233456889999999842 22357789999999999999999998876432100 00000 000 000
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
....+..++..+.+++.+||+.||.+||++.++++.
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 227 --TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111233466789999999999999999999988653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=246.49 Aligned_cols=224 Identities=27% Similarity=0.506 Sum_probs=171.9
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||+|+||.||++.+.+++.+++|.+.... +.+......++++||+.+++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 35678999999999999988678899999987543 45555677889999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ...++++.++.++.+++.++.+||+ .+++|+||||+||+++.++.++|+|||.+.........
T Consensus 86 L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 86 LSDYLRAQ-----RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred HHHHHHhC-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 99998653 2468899999999999999999999 99999999999999999999999999998755332111
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
.......+..|+|||.+.+. .++.++||||||+++|+|++ |..||...... . ........ . .
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~-~~~~~~~~----~---~ 219 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-------E-VVETINAG----F---R 219 (256)
T ss_pred ccCCCccchhhcCHhHhccC--CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-------H-HHHHHhCC----C---C
Confidence 11122245689999998765 78889999999999999998 77776543211 0 00000000 0 0
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L 252 (291)
...+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 220 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 011112356799999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=247.53 Aligned_cols=229 Identities=25% Similarity=0.350 Sum_probs=175.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------------------ceeecCCc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------------------GFCFEGHR 45 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------------------~~~~~~~~ 45 (291)
+.+.+.||+|+||.||+|... +++.+++|.+.... +.+.....
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 456789999999999999765 48999999875311 35566678
Q ss_pred ceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccC
Q 022826 46 RALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 46 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
.++|+||+.+++|.+++... ..+++..+..++.|++.||.+||+ .+++|+||+|+||+++.++.++|+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred eEEEEecCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecc
Confidence 88999999999999998654 478899999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLE 205 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (291)
++................++..|+|||.+......++.++|+||||+++|++++|..|+...... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~--- 223 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-------AAMFK--- 223 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-------HHHHH---
Confidence 98765433222222334568899999998765335789999999999999999999887532211 00000
Q ss_pred hhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 LEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.................++..+.+++.+||+.+|.+||++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 224 LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred hhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 000000111111222346788999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=253.04 Aligned_cols=178 Identities=25% Similarity=0.367 Sum_probs=138.9
Q ss_pred hcccccCCceeEEEEEecC---CCeEEEEEeccCc------------------------cee--ecCCcceeeehhhcCC
Q 022826 6 KNKLGQGGYGGVYKGKLLD---GRNVAIKVLNETK------------------------GFC--FEGHRRALIYEFVSNG 56 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~------------------------~~~--~~~~~~~lv~e~~~~g 56 (291)
+.+||+|+||.||+|+..+ ++.||+|.+.... +.+ ..+...++++||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 4689999999999998643 5789999987543 222 234567899999875
Q ss_pred CHHHHHhhcCCC---CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE----cCCCceEEeccCCccc
Q 022826 57 SLEKFIYEKHPL---ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAKI 129 (291)
Q Consensus 57 ~L~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill----~~~~~~kl~Dfg~~~~ 129 (291)
+|.+++...... .....+++..++.++.|++.||.|||+ .+++|+||||+||++ +.++.++|+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 888877543211 122468999999999999999999999 999999999999999 5667999999999987
Q ss_pred cCCCCce-eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCcccc
Q 022826 130 CHGRESI-VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAV 188 (291)
Q Consensus 130 ~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~ 188 (291)
....... .......+++.|+|||.+.+. ..++.++|||||||++|+|++|..||....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 6433221 112334568899999998763 367899999999999999999999886543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=253.06 Aligned_cols=221 Identities=24% Similarity=0.330 Sum_probs=173.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||+|+||.||++.+. +++.|++|.+.... +.+..+...++|+||+++
T Consensus 21 y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (297)
T cd06656 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 100 (297)
T ss_pred ceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCC
Confidence 456688999999999999874 59999999987543 456667788999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++.+ ..+++..+..++.|++.+|.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 101 ~~L~~~~~~-------~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 101 GSLTDVVTE-------TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999854 367889999999999999999999 9999999999999999999999999999876543321
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
. .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||........... . . .....
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~--------~---~--~~~~~ 233 (297)
T cd06656 171 K--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--------I---A--TNGTP 233 (297)
T ss_pred C--cCcccCCccccCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee--------e---c--cCCCC
Confidence 1 1234568899999998765 778999999999999999999998865432111000 0 0 00000
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
....+..++..+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01122345667889999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=252.23 Aligned_cols=236 Identities=20% Similarity=0.254 Sum_probs=170.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|.+. +|+.+++|.++... +........++++||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 456788999999999999875 48999999986431 3444566788999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+ +|.+++... ...+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~-~l~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 82 DQ-DLKKYFDSC-----NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 75 888887543 2568999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccch--------hhhhhhhh
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFP--------HWVYKRLE 205 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~--------~~~~~~~~ 205 (291)
... .....++..|+|||.+.+. ..++.++||||||+++|+|++|+.|+....+........ ...+....
T Consensus 153 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 153 VRC--YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred CCC--cCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhh
Confidence 221 2233457899999998764 357889999999999999999998865433211100000 00000000
Q ss_pred hhhh-hcccCCC-----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 LEED-LGLQGIE-----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ~~~~-~~~~~~~-----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.... ....... ....+.++..+.+++.+||+.||.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 0000000 0112235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=245.43 Aligned_cols=224 Identities=29% Similarity=0.528 Sum_probs=172.1
Q ss_pred hhhcccccCCceeEEEEEecC-C----CeEEEEEeccCc---------------------------ceeecCCcceeeeh
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-G----RNVAIKVLNETK---------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e 51 (291)
.+.+.||.|+||.||++++.+ + ..+++|++.... +.+......+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 467899999999999998754 3 889999997543 45555678899999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
++.+++|.+++.... ...+++..+..++.|++.+|.+||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 82 YMEGGDLLDYLRKNR----PKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred ccCCCCHHHHHHhhh----hccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 999999999997642 1228999999999999999999999 999999999999999999999999999988765
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
....... ....+++.|+|||.+.+. .++.++||||||+++|+|++ |..|+..... .. .........
T Consensus 155 ~~~~~~~-~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------~~-~~~~~~~~~-- 221 (258)
T smart00219 155 DDDYYKK-KGGKLPIRWMAPESLKDG--KFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------EE-VLEYLKKGY-- 221 (258)
T ss_pred ccccccc-ccCCCcccccChHHhccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHhcCC--
Confidence 4422111 123357899999998654 78999999999999999998 5555543110 00 000110000
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L 252 (291)
........+..+.+++.+||+.||++|||+.++++.|
T Consensus 222 -----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 -----RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111223677899999999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=252.81 Aligned_cols=235 Identities=23% Similarity=0.325 Sum_probs=173.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||++.+. ++..+++|.+.... +.+..+...++++||+.
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 456789999999999999875 48889999986542 46667788999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++... ..+++..+..++.|+++||.|||+ ..+++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 83 GGSLDQVLKKA------GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999999654 468999999999999999999996 1489999999999999999999999999886543221
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhh--------------
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWV-------------- 200 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~-------------- 200 (291)
.....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...........+....
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 155 ----ANSFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ----cccCCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccC
Confidence 2334578899999998765 68899999999999999999999876432111000000000
Q ss_pred --------hhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 201 --------YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 201 --------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
......................++..+.+++.+||..||++||++.++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000000011111256678999999999999999999998876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=254.37 Aligned_cols=232 Identities=22% Similarity=0.226 Sum_probs=165.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------cee------ecCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFC------FEGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~------~~~~~~~ 47 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +++ ......+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07878 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY 96 (343)
T ss_pred hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence 445688999999999999875 48899999987532 111 1123467
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
++++++ +++|.+++.. ..+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||++
T Consensus 97 ~~~~~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 97 LVTNLM-GADLNNIVKC-------QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred EEeecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccc
Confidence 888887 6699888743 479999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccc--------cchhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEI--------YFPHW 199 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~--------~~~~~ 199 (291)
....... ....+++.|+|||.+.+. ..++.++|||||||++|+|++|..||.......... ..+..
T Consensus 166 ~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 166 RQADDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred eecCCCc-----CCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 7654321 234578999999998763 367899999999999999999999886532110000 00000
Q ss_pred hhhhhh--hhhhh-cccCCCChh----hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 200 VYKRLE--LEEDL-GLQGIENEE----DKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 200 ~~~~~~--~~~~~-~~~~~~~~~----~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
...... ..... ..+...... .......+.+|+.+||+.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00000 000000000 01123457899999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=248.28 Aligned_cols=226 Identities=26% Similarity=0.392 Sum_probs=172.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||++.+. +|+.||+|.++... +.+..+...++++||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 456788999999999999875 49999999987542 4455667789999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCC-CeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT-RILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+ ++|.+++.... .....+++..++.++.|++.||.|||+ . +++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~-~~l~~~l~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 83 D-TSLDKFYKKVY--DKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred c-ccHHHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 6 58988886542 233679999999999999999999998 7 999999999999999999999999999876533
Q ss_pred CCceeeccCCCCCccccCcccccccC--CCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNF--GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~--~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
.. ......++..|+|||.+.+.. ..++.++|+||||+++|+|++|..||...... +.. .... .
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~--~~~~-----~ 221 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQ--LKQV-----V 221 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHH--HHHH-----H
Confidence 21 112244678899999886521 35688999999999999999999887532211 000 0000 0
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. ..........++..+.+++.+||+.+|.+||++.++++
T Consensus 222 ~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 222 E-EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred h-cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00011112236678999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=259.78 Aligned_cols=215 Identities=27% Similarity=0.393 Sum_probs=173.7
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehhhcCC
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.||-|+||.||.|++. +.+.||||+...+- ++...+...+||||||-|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG- 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG- 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-
Confidence 56999999999999875 48899999986543 666777788899999966
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
|-.+++.... .++-+..++.|+.+.+.||.|||+ .+.+|+|||+.||++++.|.|||+|||.+......
T Consensus 111 SAsDlleVhk-----KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 111 SASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred cHHHHHHHHh-----ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 8888887643 678889999999999999999999 99999999999999999999999999998765443
Q ss_pred eeccCCCCCccccCccccc-ccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 137 VSMTGARGTVGYIAPEVFC-RNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~-~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
....|||.|+|||+|. -..+.|+-++||||||+++.++.-.++|.. .++. -.....+.....
T Consensus 180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF-nMNA-------------MSALYHIAQNes 242 (948)
T KOG0577|consen 180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-NMNA-------------MSALYHIAQNES 242 (948)
T ss_pred ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc-CchH-------------HHHHHHHHhcCC
Confidence 4467899999999874 234689999999999999999986554432 2221 112223333333
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
+.-..++|+..|++|+..||++-|.+|||..+++.
T Consensus 243 PtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 PTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 34446789999999999999999999999988654
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=246.40 Aligned_cols=222 Identities=24% Similarity=0.343 Sum_probs=173.3
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------------ceeecCCcc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------------GFCFEGHRR 46 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------------~~~~~~~~~ 46 (291)
..++..||+|+||.||+|.+. +++.+++|.+.... +.+......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 456789999999999999775 48999999875321 455567788
Q ss_pred eeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCC
Q 022826 47 ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL 126 (291)
Q Consensus 47 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~ 126 (291)
++++||+.+++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY------GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred EEEEEecCCCCHHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCC
Confidence 8999999999999999654 468889999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCce----eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhh
Q 022826 127 AKICHGRESI----VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYK 202 (291)
Q Consensus 127 ~~~~~~~~~~----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~ 202 (291)
++........ .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----------- 219 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ----------- 219 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-----------
Confidence 8766422111 011223467899999998765 77889999999999999999999886532100
Q ss_pred hhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 203 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
....... ......+..++..+.+++++||+.||.+||++.++++
T Consensus 220 ~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 220 AIFKIGE----NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHhc----cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0000000 1111223346678899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=251.13 Aligned_cols=227 Identities=26% Similarity=0.454 Sum_probs=170.3
Q ss_pred hhcccccCCceeEEEEEecC-CC----eEEEEEeccCc---------------------------ceeecCCcceeeehh
Q 022826 5 FKNKLGQGGYGGVYKGKLLD-GR----NVAIKVLNETK---------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~ 52 (291)
..+.||+|+||.||+|.+.. ++ .+++|.+.... +.+. ....+++++|
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-~~~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL-SPTIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc-CCCceeeehh
Confidence 45789999999999997643 44 57889877543 2332 2346689999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++....
T Consensus 90 ~~~g~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 90 MPHGCLLDYVHEH-----KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred cCCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence 9999999998653 2468999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
...........++..|++||.+.+. .++.++||||||+++|+|++ |..|+..... ... ......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--------~~~-~~~~~~---- 226 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--------REI-PDLLEK---- 226 (303)
T ss_pred cccccccCCCccccccCCHHHhccC--CCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHH-HHHHHC----
Confidence 3332222233346789999998765 78999999999999999987 7777653311 000 000000
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
.........+...+.+++.+||..+|++||++.++++.|+.+.+
T Consensus 227 --~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 227 --GERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred --CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00011112234568899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=246.59 Aligned_cols=220 Identities=25% Similarity=0.360 Sum_probs=174.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+...+.||+|+||.||+|.+. +++.||+|++.... +.+..+...++||||+.
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCC
Confidence 445688999999999999875 48899999987542 55666788999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++.. ..+++..+..++.|++.||.+||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~i~~-------~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 86 GGSALDLLRA-------GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 9999998843 368889999999999999999999 999999999999999999999999999987654332
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
. ......++..|+|||.+.+. .++.++|+||||+++|+|++|..|+........ .. .....
T Consensus 156 ~--~~~~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----------~~----~~~~~ 216 (277)
T cd06640 156 I--KRNTFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----------LF----LIPKN 216 (277)
T ss_pred c--ccccccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----------hh----hhhcC
Confidence 1 11223467789999998765 788999999999999999999988764321100 00 00011
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
........++..+.+++.+||+.+|.+||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1122334567789999999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=260.11 Aligned_cols=231 Identities=25% Similarity=0.219 Sum_probs=165.5
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceee------cCCccee
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCF------EGHRRAL 48 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~------~~~~~~l 48 (291)
.+.+.||+|+||.||++.+. .++.||+|++.... +++. .....++
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 99 (355)
T cd07874 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL 99 (355)
T ss_pred eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEE
Confidence 35688999999999999875 48999999987532 1211 1234689
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
+|||+.+ +|.+.+. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++
T Consensus 100 v~e~~~~-~l~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 100 VMELMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred Ehhhhcc-cHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 9999976 6776663 257888999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccc--------cchhhh
Q 022826 129 ICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEI--------YFPHWV 200 (291)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~--------~~~~~~ 200 (291)
...... ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||.......... ..+...
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 168 TAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cCCCcc---ccCCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 643321 12334578999999999776 78899999999999999999999986542111000 000000
Q ss_pred hhhhhhhhhh-----cc-----c--------CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 201 YKRLELEEDL-----GL-----Q--------GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 201 ~~~~~~~~~~-----~~-----~--------~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.......... .. + .............+.+|+.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000 00 0 00001112235678899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=246.18 Aligned_cols=218 Identities=24% Similarity=0.311 Sum_probs=170.4
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.||+|+||.||+|... +++.||+|+++... +.+..+...++++||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999875 48999999986532 445566778999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 149 (260)
T cd05611 82 GDCASLIKTL------GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--- 149 (260)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc---
Confidence 9999999654 468999999999999999999999 9999999999999999999999999998875432
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
.....++..|++||.+.+. .++.++||||||+++|+|++|..||...... ...... ...... .
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~-~~~~~~---~ 212 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--------AVFDNI-LSRRIN---W 212 (260)
T ss_pred ---cccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHH-HhcccC---C
Confidence 1233467899999998876 5889999999999999999999988643211 000000 011111 1
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
.......++..+.+++.+||+.||++||++.++.+.|+
T Consensus 213 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 11122245678999999999999999998877666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=260.65 Aligned_cols=233 Identities=27% Similarity=0.421 Sum_probs=181.1
Q ss_pred hhhcccccCCceeEEEEEecC--C--Ce-EEEEEeccCc-----------------------------ceeecCCcceee
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD--G--RN-VAIKVLNETK-----------------------------GFCFEGHRRALI 49 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~--~--~~-vavK~~~~~~-----------------------------~~~~~~~~~~lv 49 (291)
.+.++||+|+||+||+|+... + .. ||+|..+.+. |+.....-.++|
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 356899999999999997643 2 23 8999988522 788888999999
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
||+|.||+|.++|+... ..++......++.+.+.||+|||+ ++++||||-+.|++++.++.+||+|||+++.
T Consensus 240 mEl~~gGsL~~~L~k~~-----~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNK-----KSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEecCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 99999999999998752 479999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhh
Q 022826 130 CHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEE 208 (291)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (291)
... .........-+..|+|||.+... .++.++|||||||++||+.+ |..|++..... ....
T Consensus 312 ~~~--~~~~~~~~klPirWLAPEtl~~~--~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------------~v~~ 373 (474)
T KOG0194|consen 312 GSQ--YVMKKFLKKLPIRWLAPETLNTG--IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------------EVKA 373 (474)
T ss_pred Ccc--eeeccccccCcceecChhhhccC--ccccccchhheeeeEEeeeccCCCCCCCCCHH--------------HHHH
Confidence 431 11111122346799999999876 99999999999999999987 55544433211 1111
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCC
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 262 (291)
.+...+.+-..+...+..+..++.+||..||++||++.++.+.|+.+.+....+
T Consensus 374 kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 374 KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 111112222223345667778889999999999999999999999988876654
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=249.24 Aligned_cols=231 Identities=18% Similarity=0.204 Sum_probs=162.3
Q ss_pred chhhcccccCCceeEEEEEecC----CCeEEEEEeccCcc-------------------------------------eee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD----GRNVAIKVLNETKG-------------------------------------FCF 41 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-------------------------------------~~~ 41 (291)
+.+.+.||+|+||.||+|.+.+ +..+++|+...... .+.
T Consensus 14 y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 93 (294)
T PHA02882 14 WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGS 93 (294)
T ss_pred eEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeee
Confidence 4567899999999999998644 45667775432210 000
Q ss_pred cC----CcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC
Q 022826 42 EG----HRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 117 (291)
Q Consensus 42 ~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~ 117 (291)
.. ...+++++++.. ++.+.+... ...++..+..++.|++.||.|||+ .+++||||||+||+++.++
T Consensus 94 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 94 FKRCRMYYRFILLEKLVE-NTKEIFKRI------KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNN 163 (294)
T ss_pred EecCCceEEEEEEehhcc-CHHHHHHhh------ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCC
Confidence 00 123566776644 666666432 345788899999999999999999 9999999999999999999
Q ss_pred ceEEeccCCccccCCCCce-----eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCc
Q 022826 118 CPKISDFGLAKICHGRESI-----VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSS 192 (291)
Q Consensus 118 ~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~ 192 (291)
.++|+|||+++.+...... .......+|+.|+|||.+.+. .++.++|||||||++|+|++|..||........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 9999999999866422111 111234589999999998876 789999999999999999999999876532221
Q ss_pred cccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 193 EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
....... .....+.... ......+..+.+++..||+.+|++||++.++++.|+
T Consensus 242 ~~~~~~~-----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKC-----DFIKRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHH-----HHHHHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1100000 0001111000 011223577889999999999999999999998873
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=249.91 Aligned_cols=216 Identities=21% Similarity=0.369 Sum_probs=162.9
Q ss_pred cccccCCceeEEEEEecC--------CCeEEEEEeccCc--------------------------ceeecCCcceeeehh
Q 022826 7 NKLGQGGYGGVYKGKLLD--------GRNVAIKVLNETK--------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~ 52 (291)
+.||+|+||.||+|.... ...+++|.+.... +.+..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 579999999999997532 2348888875432 566667788999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCc--------eEEecc
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC--------PKISDF 124 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~--------~kl~Df 124 (291)
+.+|+|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++. ++++||
T Consensus 81 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 81 VKFGSLDTYLKKNK-----NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred CCCCcHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999999996542 468999999999999999999999 99999999999999987765 699999
Q ss_pred CCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhh
Q 022826 125 GLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRL 204 (291)
Q Consensus 125 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~ 204 (291)
|++...... ....++..|+|||.+.+. ..++.++||||||+++|+|++|..++....... . ....
T Consensus 153 g~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------~--~~~~ 217 (258)
T cd05078 153 GISITVLPK------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------K--KLQF 217 (258)
T ss_pred ccccccCCc------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHH------H--HHHH
Confidence 987654322 223467889999998763 357889999999999999999864433221110 0 0000
Q ss_pred hhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 205 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
... .. ..+......+.+++.+||+.||++|||++++++.|+
T Consensus 218 -~~~---~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 218 -YED---RH----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -HHc---cc----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 00 111123356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=247.31 Aligned_cols=216 Identities=25% Similarity=0.360 Sum_probs=168.3
Q ss_pred ccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------------ceeecCCcceeeehhhc
Q 022826 8 KLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 8 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------------~~~~~~~~~~lv~e~~~ 54 (291)
.||+|+||.||++.+. +++.||+|++.... ..+......++|+||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999775 48999999886432 23345567889999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++... ..+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||++..+....
T Consensus 81 g~~L~~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 81 GGDLHYHLSQH------GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence 99999988543 479999999999999999999999 999999999999999999999999999987553322
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
.....++..|+|||.+.+. ..++.++||||+|+++|+|++|..||.......... .... .. .
T Consensus 152 ----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~------~~~~----~~---~ 213 (278)
T cd05606 152 ----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE------IDRM----TL---T 213 (278)
T ss_pred ----CcCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH------HHHH----hh---c
Confidence 1234578999999998653 257889999999999999999999987543221100 0000 00 0
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVE 250 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~ 250 (291)
.....+..++..+.+++.+||..+|.+|| ++.++++
T Consensus 214 ~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 214 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 01112223467899999999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=245.83 Aligned_cols=232 Identities=22% Similarity=0.370 Sum_probs=169.6
Q ss_pred hhhcccccCCceeEEEEEec----CCCeEEEEEeccCc----------------------------ceeecC------Cc
Q 022826 4 SFKNKLGQGGYGGVYKGKLL----DGRNVAIKVLNETK----------------------------GFCFEG------HR 45 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----------------------------~~~~~~------~~ 45 (291)
.+.+.||+|+||.||+|... +++.+|+|++..+. +.+... ..
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 46789999999999999753 36889999887542 111111 12
Q ss_pred ceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccC
Q 022826 46 RALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 46 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
.+++++|+.+++|.+++...........+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence 36788999999999887543222223468899999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRL 204 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~ 204 (291)
+++...............+++.|++||.+.+. .++.++||||||+++|+|++ |..|+...... . .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-------~-~~~~~ 228 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN--VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-------E-IYNYL 228 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcC--ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-------H-HHHHH
Confidence 98865433221112223345789999998765 77889999999999999998 66665432110 0 00000
Q ss_pred hhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 205 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
. .... .......+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 229 ~-----~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 I-----KGNR--LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred H-----cCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0000 011123456899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=243.52 Aligned_cols=223 Identities=23% Similarity=0.344 Sum_probs=176.4
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||.|+||.||.++... ++.+++|.+.... +.+.+....++++||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 4567899999999999998654 8999999876432 5666778888999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+++|.+++... ....+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 82 NGGTLYDKIVRQ----KGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred CCCcHHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 999999998754 23578999999999999999999999 99999999999999999999999999998765443
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
.. ......+++.|.|||.+.+. .++.++|+||||+++|+|++|..||..... .. ..... . ..
T Consensus 155 ~~--~~~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~-~~~~~---~---~~ 216 (256)
T cd08221 155 YS--MAETVVGTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDATNP-------LN-LVVKI---V---QG 216 (256)
T ss_pred cc--cccccCCCccccCHhhcCCC--CCCCcchhHHHHHHHHHHHHCCCCCCCCCH-------HH-HHHHH---H---cC
Confidence 32 12334578999999998765 678899999999999999999988754321 00 00000 0 01
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
. .......++..+.+++.+||+.+|.+||++.++++.
T Consensus 217 ~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 217 N-YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred C-CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1 111224456779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=245.31 Aligned_cols=228 Identities=25% Similarity=0.410 Sum_probs=176.0
Q ss_pred chhhcccccCCceeEEEEEecC--CCeEEEEEeccCc-------------------------------------ceeecC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD--GRNVAIKVLNETK-------------------------------------GFCFEG 43 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~-------------------------------------~~~~~~ 43 (291)
+.+.+.||+|+||.||++.+.. ++.+++|.+.... +.+..+
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 5678899999999999998754 7889999875211 455667
Q ss_pred CcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEec
Q 022826 44 HRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISD 123 (291)
Q Consensus 44 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~D 123 (291)
...++++||+.+++|.+++.... .....+++..++.++.|++.+|.|||+ ..+++|+||+|+||+++.++.++|+|
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLK--EKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence 78899999999999999885421 234578999999999999999999995 16799999999999999999999999
Q ss_pred cCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhh
Q 022826 124 FGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKR 203 (291)
Q Consensus 124 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~ 203 (291)
||++....... ......++..|++||.+.+. .++.++|+||||+++|+|++|..|+...... .. .
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-------~~-~-- 222 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNE--PYGEKADVWAFGCILYQMCTLQPPFYSTNML-------SL-A-- 222 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCC--CCchHHHHHHHHHHHHHHHhCCCcccccCHH-------HH-H--
Confidence 99987654432 22345578899999999765 6899999999999999999999887533110 00 0
Q ss_pred hhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 204 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
...............++..+.+++.+||+.||++||++.|+.+.++
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 223 ----TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ----HHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0000000001111235667899999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=247.14 Aligned_cols=219 Identities=25% Similarity=0.390 Sum_probs=172.5
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+...+.||+|+||.||+|.+. +++.||+|.+.... +.+..+...++|+||+.
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 345688999999999999765 48899999987432 55667778999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++.. ..+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 86 GGSALDLLKP-------GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 9999998843 468899999999999999999999 999999999999999999999999999987654322
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
. ......++..|+|||.+.+. .++.++|+||||+++|+|++|..|+........ .. ... ..
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--------~~------~~~-~~ 216 (277)
T cd06642 156 I--KRNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--------LF------LIP-KN 216 (277)
T ss_pred h--hhhcccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--------Hh------hhh-cC
Confidence 1 11223467889999999775 788999999999999999999988754322110 00 000 00
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
........++..+.+++.+||+.+|++||++.++++
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 217 SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011122345667889999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=243.74 Aligned_cols=231 Identities=21% Similarity=0.378 Sum_probs=162.4
Q ss_pred cccccCCceeEEEEEecC---CCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcCC
Q 022826 7 NKLGQGGYGGVYKGKLLD---GRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.||+|+||.||+++..+ ...+++|.+.... +.+......+++|||+.++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 369999999999997543 3456677665432 4555667789999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+|.+++..... .....++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 81 DLKSYLSQEQW--HRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred cHHHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 99999976421 12456777889999999999999999 99999999999999999999999999987643222111
Q ss_pred eeccCCCCCccccCccccccc-----CCCccccccchhHHHHHHHHhCCC-CCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 137 VSMTGARGTVGYIAPEVFCRN-----FGEVSYKSDVYSYGMMVFEMTGVK-NNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~-----~~~~~~~~DiwslG~~l~~ll~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
.......++..|+|||++... ...++.++||||||+++|+|+++. .|+..... .. ...........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~-~~~~~~~~~~~ 227 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------RE-VLNHVIKDQQV 227 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHHhhccc
Confidence 112334567899999997532 124578999999999999999754 44432211 11 11111111111
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
.. ........+...+.+++..|| .+|++||++.++++.|.
T Consensus 228 ~~--~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 KL--FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cc--CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 10 011112235667888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=246.18 Aligned_cols=227 Identities=24% Similarity=0.374 Sum_probs=174.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||++.+. .++.||+|.++... +.+......++++||+.
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 567789999999999999876 58999999886432 34556678889999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|..++.... ....+++..+..++.+++.||.|||+ ..+++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~l~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 83 AGSLDKLYAGGV---ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred CCCHHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999999886531 23478999999999999999999995 1599999999999999999999999999987653222
Q ss_pred ceeeccCCCCCccccCcccccccC----CCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNF----GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~----~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
.....+++.|+|||.+.+.. ..++.++|||||||++|+|++|..||....... .........
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~-- 223 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--------IFAQLSAIV-- 223 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--------HHHHHHHHh--
Confidence 12234678899999985431 245789999999999999999999986432110 001111111
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.......+..++..+.+++.+||+.+|.+||++.++++
T Consensus 224 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 224 --DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred --hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11112223347788999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=249.28 Aligned_cols=220 Identities=25% Similarity=0.340 Sum_probs=170.3
Q ss_pred hhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCCC
Q 022826 5 FKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
....||+|+||.||++.+. ++..|+||.+.... +.+..+...++|+||+.+++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 3567999999999999875 48999999986532 45556778899999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 106 L~~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 106 LTDIVTH-------TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred HHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence 9998743 368899999999999999999999 9999999999999999999999999999875433221
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
......++..|+|||.+.+. .++.++||||||+++|+|++|..||...... ..... .... .. ...
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~---~~~~-~~-~~~ 238 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--------QAMRR---IRDN-LP-PRV 238 (292)
T ss_pred cCceeecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH---HHhc-CC-Ccc
Confidence 11234568899999998765 7788999999999999999999987643210 00000 0000 00 011
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
......+..+.+++.+||..||.+|||+.++++.
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 239 KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1122356678899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=244.41 Aligned_cols=222 Identities=28% Similarity=0.394 Sum_probs=170.0
Q ss_pred hcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCCCH
Q 022826 6 KNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
...||+|+||.||+|.+. ++..|++|.+.... +.+..+...++++||+.+++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 467999999999999865 48899999887553 455667788999999999999
Q ss_pred HHHHhhcCCCCCCCCC--CHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC-CCceEEeccCCccccCCCCc
Q 022826 59 EKFIYEKHPLETNQKL--KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-DFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~--~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~-~~~~kl~Dfg~~~~~~~~~~ 135 (291)
.+++.... ..+ ++..+..++.|++.||.|||+ .+++|+||||+||+++. ++.++|+|||++........
T Consensus 93 ~~~l~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 93 SALLRSKW-----GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred HHHHHHhc-----ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 99997542 234 788899999999999999999 99999999999999976 67999999999876543222
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
......+++.|+|||.+.+....++.++|+||||+++|+|++|..|+......... .... .....
T Consensus 165 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~------~~~~-------~~~~~ 229 (268)
T cd06624 165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA------MFKV-------GMFKI 229 (268)
T ss_pred --ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh------Hhhh-------hhhcc
Confidence 11223468899999998765446789999999999999999999887543211000 0000 00001
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
....+..+...+.+++++||+.+|.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 230 HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 11123346677899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=247.02 Aligned_cols=226 Identities=23% Similarity=0.348 Sum_probs=174.3
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||.|+||.||++.+. +++.+++|.+.... +.+..+...++||||+.+
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 456789999999999999875 58999999986543 455667788999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 87 ~~L~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 87 GALDSIMLEL-----ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred CcHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999998653 2478999999999999999999999 9999999999999999999999999998765432221
Q ss_pred eeeccCCCCCccccCccccccc---CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 136 IVSMTGARGTVGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
......+++.|++||.+.+. ...++.++|+||||+++|+|++|..||...... . . ..... ..
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-------~-~---~~~~~--~~ 223 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-------R-V---LLKIL--KS 223 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-------H-H---HHHHh--cC
Confidence 11233468899999998532 235678999999999999999999887643211 0 0 00000 00
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.......+..++..+.+++.+||+.+|.+||++.++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 224 EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001111223456778899999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=248.42 Aligned_cols=245 Identities=26% Similarity=0.377 Sum_probs=184.4
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceee----cCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCF----EGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~----~~~~~~lv~e~~ 53 (291)
..+.+.||+|.||.||+|.. +++.||||+++... +... ....+.||++|.
T Consensus 212 l~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred hhhHHHhhcCccceeehhhc-cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 34678999999999999988 66999999998655 1111 134678999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCC------CCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC------NTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~------~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+.|+|.++|+. ..++|....+|+..+++||+|||+.. ...|+|||||..||+|-.|++..|+|||++
T Consensus 291 ~kGsL~dyL~~-------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 291 PKGSLCDYLKA-------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred cCCcHHHHHHh-------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 99999999965 48999999999999999999999832 356999999999999999999999999999
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCC----CccccccchhHHHHHHHHhCCCCCCccccCCCccccchhh--hh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFG----EVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHW--VY 201 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~----~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~--~~ 201 (291)
..+..+.+....-...||..|||||++.|... ..-.+.||||+|.|+|||++.-..++.. ...++..+.. .-
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~--~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPG--PVPEYQLPFEAEVG 441 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCC--CCCcccCchhHHhc
Confidence 98887766655666789999999999977421 1224689999999999998655444321 1222222222 11
Q ss_pred h-------hhhhhhhhcccCCCCh-hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 202 K-------RLELEEDLGLQGIENE-EDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 202 ~-------~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
. +.........+..++. ........+++.+..||..||+.|.|+.-+.+.+.++..
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 1 1111112222222222 233456678999999999999999999999999988755
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=249.38 Aligned_cols=225 Identities=24% Similarity=0.286 Sum_probs=173.9
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||++...+ ++.+++|.+.... +.+......+++|||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 4567889999999999998765 8999999987543 455566778999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~L~~~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 83 CPGGELFRLLQRQ----PGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred cCCCCHHHHHHhC----CCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999998653 34578999999999999999999999 9999999999999999999999999999875532
Q ss_pred CCcee---------------------------eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCc
Q 022826 133 RESIV---------------------------SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNAN 185 (291)
Q Consensus 133 ~~~~~---------------------------~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~ 185 (291)
..... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 21100 01123467889999999765 78899999999999999999999986
Q ss_pred cccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCC----HHHHHH
Q 022826 186 VAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPA----MNRVVE 250 (291)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps----~~ell~ 250 (291)
...... ..... .............+..+.+++.+||..||++||+ +.++++
T Consensus 234 ~~~~~~--------~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 234 GSNRDE--------TFSNI------LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCchHH--------HHHHH------hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 442210 00000 0001111111226788999999999999999999 777666
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=243.88 Aligned_cols=222 Identities=26% Similarity=0.395 Sum_probs=174.3
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||++... +++.|++|.+.... +.+......++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 567789999999999999775 48999999886431 4556677889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+++|.+++... ....+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~l~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 82 EGGDLYKKINAQ----RGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCcHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 999999998653 23468899999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..|+..... .... ... ..
T Consensus 155 ~~~--~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~-~~~-------~~ 215 (256)
T cd08218 155 VEL--ARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLV-LKI-------IR 215 (256)
T ss_pred hhh--hhhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHH-HHH-------hc
Confidence 211 1223467889999998765 678899999999999999999988754311 0000 000 01
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......+..++..+.+++.+||+.+|.+||++.++++
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 216 GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1111223446778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=247.35 Aligned_cols=225 Identities=28% Similarity=0.405 Sum_probs=170.7
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------------ceee------cCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------GFCF------EGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------------~~~~------~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|.+.. ++.+++|++.... +.+. .....+++
T Consensus 18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 97 (282)
T cd06636 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLV 97 (282)
T ss_pred hhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEE
Confidence 3456889999999999998754 8999999986543 1111 23567899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
|||+.+++|.+++... ....+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++..
T Consensus 98 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 98 MEFCGAGSVTDLVKNT----KGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEeCCCCcHHHHHHHc----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 9999999999998764 23568889999999999999999999 9999999999999999999999999999875
Q ss_pred cCCCCceeeccCCCCCccccCccccccc---CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh
Q 022826 130 CHGRESIVSMTGARGTVGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
...... ......+++.|+|||.+... ...++.++||||||+++|+|++|..||........ ...
T Consensus 171 ~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-----------~~~ 237 (282)
T cd06636 171 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-----------LFL 237 (282)
T ss_pred hhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-----------hhh
Confidence 432211 12234568899999987532 23678899999999999999999988864321100 000
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. ............++..+.+++.+||+.||.+||++.|+++
T Consensus 238 ~---~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 I---PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred H---hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 0111111223346778999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=246.23 Aligned_cols=233 Identities=26% Similarity=0.342 Sum_probs=175.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||++... +++.+++|++.... +.+......++|+||++
T Consensus 7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (284)
T cd06620 7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMD 86 (284)
T ss_pred HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCC
Confidence 456789999999999999875 48999999876432 45556678899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++... ..+++..+..++.+++.+|.|||+ ..+++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 87 CGSLDRIYKKG------GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999998653 468999999999999999999996 1589999999999999999999999999886543221
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
.....++..|+|||.+.+. .++.++|||||||++|++++|..||............+..... .........
T Consensus 159 ----~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 229 (284)
T cd06620 159 ----ADTFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD---LLQQIVQEP 229 (284)
T ss_pred ----cCccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH---HHHHHhhcc
Confidence 1234578899999998765 7889999999999999999999998765432111100110000 001111111
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L 252 (291)
........++..+.+++.+||+.||++|||+.|+++..
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11111123566789999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=247.26 Aligned_cols=229 Identities=20% Similarity=0.292 Sum_probs=171.4
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------------cee-----ecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------GFC-----FEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------------~~~-----~~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||++.... ++.+++|++.... +.+ ..+...++||
T Consensus 20 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 99 (286)
T cd06638 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVL 99 (286)
T ss_pred eeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEE
Confidence 4566889999999999997754 8899999976522 122 2345679999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
||+++++|.+++.... .....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 100 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 100 ELCNGGSVTDLVKGFL--KRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred eecCCCCHHHHHHHhh--ccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 9999999999886432 234578999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeccCCCCCccccCccccccc---CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
..... ......+++.|+|||.+.+. ...++.++|||||||++|+|++|..|+....... . . .. .
T Consensus 175 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~------~-~-~~---~ 241 (286)
T cd06638 175 TSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR------A-L-FK---I 241 (286)
T ss_pred ccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH------H-H-hh---c
Confidence 43221 12234578999999988532 1357889999999999999999998876432110 0 0 00 0
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.. ........+..+...+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 242 PR--NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cc--cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00 0000011122345678899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=248.67 Aligned_cols=236 Identities=22% Similarity=0.311 Sum_probs=172.3
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|.+.. ++.|++|++.... +.+......++|+||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 5667889999999999998764 8999999875322 4555667788999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
+++.|..++... ..+++..++.++.|++.+|.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~l~~~~~~~------~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 83 DHTVLNELEKNP------RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred CccHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 998887776432 468999999999999999999999 99999999999999999999999999998876443
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh------
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE------ 207 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 207 (291)
.. ......++..|+|||.+.+. ..++.++||||||+++|+|++|..||.......................
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred cc--cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence 22 11233457889999998653 3578899999999999999999988875432111000000000000000
Q ss_pred ----hhhcccCCC-----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 208 ----EDLGLQGIE-----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 208 ----~~~~~~~~~-----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.....+... ......++..+.+|+.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000 0111235677899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=241.79 Aligned_cols=227 Identities=25% Similarity=0.366 Sum_probs=174.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||+|+||.||++... +++.+++|++.... +....+...+++|||+.+
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~ 84 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence 456788999999999999875 48899999987643 455567788999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 85 ~~l~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 85 GSLQDIYQVT-----RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CcHHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999998653 2578999999999999999999999 9999999999999999999999999999876543221
Q ss_pred eeeccCCCCCccccCccccccc-CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~-~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
......++..|+|||.+.+. ...++.++|+||||+++|+|++|..|+....... ............
T Consensus 157 --~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-----------~~~~~~~~~~~~ 223 (262)
T cd06613 157 --KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-----------ALFLISKSNFPP 223 (262)
T ss_pred --ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-----------HHHHHHhccCCC
Confidence 11234567889999998653 1267889999999999999999998886432110 000000000011
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
........++..+.+++++||..+|.+|||+.+++.
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111123456778999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=245.63 Aligned_cols=220 Identities=26% Similarity=0.370 Sum_probs=173.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||.|++|.||+|++. +++.+++|++.... +.+..+...++|+||+.
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 456788999999999999875 48999999986432 45556678889999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++.. ..+++..++.++.|++.++.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~L~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 83 GGSCLDLLKP-------GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred CCcHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999853 378999999999999999999999 999999999999999999999999999987765432
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
. ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||....... .... .. ...
T Consensus 153 ~--~~~~~~~~~~y~~PE~~~~~--~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--------~~~~---~~---~~~ 214 (274)
T cd06609 153 S--KRNTFVGTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLHPMR--------VLFL---IP---KNN 214 (274)
T ss_pred c--ccccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccCchHH--------HHHH---hh---hcC
Confidence 1 12334567889999999876 68999999999999999999999886432110 0000 00 000
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
........++..+.+++.+||..+|++|||++++++
T Consensus 215 ~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 215 PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111111126677899999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=251.65 Aligned_cols=236 Identities=19% Similarity=0.307 Sum_probs=171.3
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||+|++. +++.||+|.+.... +.+......++|+||+.
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 445688999999999999875 48899999986432 45566778899999997
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+ +|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~-~l~~~l~~~-----~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 88 K-DLKQYLDDC-----GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred c-CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 4 998888653 2468899999999999999999999 999999999999999999999999999987543222
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc-------hhhhhhhhhhh
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF-------PHWVYKRLELE 207 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 207 (291)
. ......+++.|+|||.+.+. ..++.++||||||+++|+|++|..||............ ....+......
T Consensus 159 ~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 159 K--TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred C--cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 1 12233457899999998654 36788999999999999999999888654221000000 00000000000
Q ss_pred h---hhcccCCCC----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 208 E---DLGLQGIEN----EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 208 ~---~~~~~~~~~----~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. ....+.... .....++..+.+|+.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 000000000 011234567889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=243.23 Aligned_cols=224 Identities=23% Similarity=0.363 Sum_probs=175.0
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceee--cCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCF--EGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~--~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||++.+. +++.+++|++.... +.+. .+...++++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 456789999999999999764 58999999986432 2222 3455789999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhh-----cCCCCCeeeeccCCCceEEcCCCceEEeccCC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-----RGCNTRILHFDIKPHNILLDEDFCPKISDFGL 126 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH-----~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~ 126 (291)
|+.+++|.+++.... .....+++..++.++.|++.||.+|| + .+++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~~~~L~~~l~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~---~~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 82 YCEGGDLAQLIQKCK--KERKYIEEEFIWRILTQLLLALYECHNRSDPG---NTVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred hccCCCHHHHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHhcCcccc---CcceecCCCHHHEEEecCCCEEEecccc
Confidence 999999999997642 23468999999999999999999999 7 9999999999999999999999999999
Q ss_pred ccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh
Q 022826 127 AKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
+......... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..|+..... .. ..
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~-~~----- 219 (265)
T cd08217 157 AKILGHDSSF--AKTYVGTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPFTARNQ-------LQ-LA----- 219 (265)
T ss_pred cccccCCccc--ccccccCCCccChhhhcCC--CCCchhHHHHHHHHHHHHHHCCCcccCcCH-------HH-HH-----
Confidence 8876543321 1234568899999999775 688999999999999999999988865421 00 00
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..+.. ......+..++..+.+++.+||+.+|++||++.++++
T Consensus 220 -~~~~~-~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 220 -SKIKE-GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred -HHHhc-CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00111 1111223456778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=256.11 Aligned_cols=217 Identities=28% Similarity=0.401 Sum_probs=179.9
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehhh
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~ 53 (291)
...++||+|+||+||-++.. +|+.+|+|.+.+++ .-.......|+|+..+
T Consensus 188 ~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlM 267 (591)
T KOG0986|consen 188 RVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLM 267 (591)
T ss_pred eeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEee
Confidence 44588999999999999765 49999999987665 3445678899999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
+||+|.-++.+. ....|+++.+..++.+|+.||++||+ .+||.||+||+||++|+.|.++|+|+|++..+..+
T Consensus 268 NGGDLkfHiyn~----g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 268 NGGDLKFHIYNH----GNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred cCCceeEEeecc----CCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999998888765 33789999999999999999999999 99999999999999999999999999999988777
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
.. .....||.+|||||++.+. .|+...|.|||||++|+|+.|..||........ ..+..+.+ .
T Consensus 341 ~~---~~~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----------~eEvdrr~--~ 403 (591)
T KOG0986|consen 341 KP---IRGRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----------REEVDRRT--L 403 (591)
T ss_pred Cc---cccccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchhhhhhhhh----------HHHHHHHH--h
Confidence 64 3445789999999999987 699999999999999999999999986543321 11111111 1
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCC
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPA 244 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps 244 (291)
....+.+..+++++.+|++..|.+||++|..
T Consensus 404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred cchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 1223445678999999999999999999953
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=245.01 Aligned_cols=215 Identities=23% Similarity=0.361 Sum_probs=160.8
Q ss_pred cccccCCceeEEEEEecC-------------CCeEEEEEeccCc--------------------------ceeecCCcce
Q 022826 7 NKLGQGGYGGVYKGKLLD-------------GRNVAIKVLNETK--------------------------GFCFEGHRRA 47 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~--------------------------~~~~~~~~~~ 47 (291)
+.||+|+||.||+|.... ...+++|++.... +++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997421 2358899876433 5666677889
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCc-------eE
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC-------PK 120 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~-------~k 120 (291)
++|||+.+++|..++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++. ++
T Consensus 81 lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK-----SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred EEEecccCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeE
Confidence 999999999999887543 2568999999999999999999999 99999999999999987664 89
Q ss_pred EeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhh
Q 022826 121 ISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHW 199 (291)
Q Consensus 121 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~ 199 (291)
++|||++...... ....++..|+|||.+.+. ..++.++||||||+++|+|++ |..|+...... ..
T Consensus 153 l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~ 218 (262)
T cd05077 153 LSDPGIPITVLSR------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-------EK 218 (262)
T ss_pred eCCCCCCccccCc------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-------HH
Confidence 9999988654322 123357789999988642 378899999999999999984 66554432110 00
Q ss_pred hhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 200 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
........ . . .......+.+++.+||+.||.+||++.++++.|+
T Consensus 219 ---~~~~~~~~--~-~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 219 ---ERFYEGQC--M-L----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred ---HHHHhcCc--c-C----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00000000 0 0 1112456889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=247.78 Aligned_cols=235 Identities=26% Similarity=0.268 Sum_probs=171.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||+|.+. +++.|++|.+.... +.+......++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 466789999999999999875 48999999986532 4555567788999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
||+ +++|.+++.... ..+++..+..++.||++||.|||+ .+++|+||+|+||+++.++.++|+|||++...
T Consensus 82 e~~-~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 82 EFM-ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred ccc-CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 999 889999996531 369999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhh--------hhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHW--------VYK 202 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~--------~~~ 202 (291)
...... .....++..|+|||.+.+. ..++.++|||||||++|+|++|..+|....... ....... .+.
T Consensus 153 ~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 153 GSPNRK--MTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWP 228 (298)
T ss_pred cCCCcc--ccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhh
Confidence 443221 1223456789999988553 367889999999999999999966665432210 0000000 000
Q ss_pred hhhhh-hhhc----ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 203 RLELE-EDLG----LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 203 ~~~~~-~~~~----~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..... .... ............+..+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000 0000 000001112334678899999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=243.10 Aligned_cols=230 Identities=26% Similarity=0.366 Sum_probs=177.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||.|+||.||+|... ++..+++|++.... +.+..+...++++|++.
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 567899999999999999865 48899999986432 34556778889999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++.... ....+++..+..++.|++.||.+||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~l~~~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 83 GGSLLDIMKSSY---PRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred CCcHHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999997653 23578999999999999999999999 999999999999999999999999999987655432
Q ss_pred cee--eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 135 SIV--SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 135 ~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... ......++..|++||.+... ..++.++|+||||+++|+|++|..||....... ....... ...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--------~~~~~~~---~~~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMK--------VLMLTLQ---NDP 224 (267)
T ss_pred cccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhh--------hHHHHhc---CCC
Confidence 221 12333568899999998654 367899999999999999999999886442210 0000000 001
Q ss_pred cCCCCh-hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 213 QGIENE-EDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 213 ~~~~~~-~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
...... ....++..+.+++.+||..||++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111111 12356778899999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=255.66 Aligned_cols=222 Identities=22% Similarity=0.281 Sum_probs=170.6
Q ss_pred hhhcccccCCceeEEEEEecCCCeEEEEEeccCc-----------------------------ceeecCCcceeeehhhc
Q 022826 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~~ 54 (291)
.+.++||+|+.+.||++...+.+.||+|.+.... ++-..++..|+||||-+
T Consensus 364 eilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd 443 (677)
T KOG0596|consen 364 EILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGD 443 (677)
T ss_pred hHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeeccc
Confidence 3458899999999999988777888888765433 45556788999999775
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
. +|..+|+.+. .-.+.-.+..+..|++.++.+.|+ .+|||-||||.|+++- .|.+||+|||.+.....+.
T Consensus 444 ~-DL~kiL~k~~-----~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 444 I-DLNKILKKKK-----SIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred c-cHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 5 9999998764 222322788899999999999999 9999999999999984 5689999999999988877
Q ss_pred ceeeccCCCCCccccCcccccccC---------CCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhh
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNF---------GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLE 205 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~---------~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (291)
........+||..||+||.+.... -..+.++|||||||++|+|+.|+.||...... +.+..
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~----------~aKl~ 583 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ----------IAKLH 583 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH----------HHHHH
Confidence 777777788999999999984321 12677899999999999999999998754221 11111
Q ss_pred hhhhhcccCCC---ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 LEEDLGLQGIE---NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ~~~~~~~~~~~---~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. +..++.. ...+..+ ++.++++.||..||.+|||+.+||+
T Consensus 584 a---I~~P~~~Iefp~~~~~~--~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 584 A---ITDPNHEIEFPDIPEND--ELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred h---hcCCCccccccCCCCch--HHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1 1111110 0111111 2889999999999999999999975
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=248.22 Aligned_cols=220 Identities=25% Similarity=0.350 Sum_probs=171.6
Q ss_pred hhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCCC
Q 022826 5 FKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
....||+|+||.||++.+. +++.|++|.+.... +.+..+...++++||+.+++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999875 58999999986432 45666788999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|..++.. ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 105 L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-- 172 (297)
T cd06659 105 LTDIVSQ-------TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-- 172 (297)
T ss_pred HHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--
Confidence 9988743 468899999999999999999999 9999999999999999999999999999875543221
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
......++..|+|||.+.+. .++.++||||||+++|+|++|..||....... ..... .. ......
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~---~~--~~~~~~ 237 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--------AMKRL---RD--SPPPKL 237 (297)
T ss_pred cccceecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHH---hc--cCCCCc
Confidence 11234568899999999765 68899999999999999999999886432110 00000 00 000001
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.....++..+.+++.+||+.+|.+||++.++++.
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1122355678899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=241.30 Aligned_cols=221 Identities=26% Similarity=0.421 Sum_probs=171.5
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||++... +++.+++|.+.... +....+...++|+||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 456789999999999999775 48999999986542 3445567789999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC-CceEEeccCCccccCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICHG 132 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~ 132 (291)
.+++|.+++... ....+++..+..++.+++.+|.|||+ ++++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 82 PGGTLAEYIQKR----CNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCHHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 999999999764 23568999999999999999999999 999999999999999865 4679999999876543
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... .....++..|+|||.+.+. .++.++||||||+++|+|++|..++..... +.... .. ..
T Consensus 155 ~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-------~~~~~-~~---~~--- 215 (256)
T cd08220 155 KSK---AYTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAANL-------PALVL-KI---MS--- 215 (256)
T ss_pred Ccc---ccccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCch-------HHHHH-HH---Hh---
Confidence 321 1224468899999999765 678899999999999999999988754321 11000 00 00
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.........++..+.+++.+||+.+|.+|||+.|+++
T Consensus 216 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 216 -GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0011112235667899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=243.25 Aligned_cols=215 Identities=21% Similarity=0.381 Sum_probs=162.5
Q ss_pred cccccCCceeEEEEEecC-C----------CeEEEEEeccCc-------------------------ceeecCCcceeee
Q 022826 7 NKLGQGGYGGVYKGKLLD-G----------RNVAIKVLNETK-------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~-------------------------~~~~~~~~~~lv~ 50 (291)
+.||+|+||.||+|.+.+ + ..+++|.+.... +.+.. ...++|+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 478999999999998754 3 257888766433 44444 6778999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC-------ceEEec
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-------CPKISD 123 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-------~~kl~D 123 (291)
||+.+++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++ .++|+|
T Consensus 80 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 80 EYVKFGPLDVFLHREK-----NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EcCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCC
Confidence 9999999999997642 378999999999999999999999 9999999999999999887 799999
Q ss_pred cCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCC-CCCCccccCCCccccchhhhhh
Q 022826 124 FGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGV-KNNANVAVDRSSEIYFPHWVYK 202 (291)
Q Consensus 124 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g-~~~~~~~~~~~~~~~~~~~~~~ 202 (291)
||++...... ....++..|+|||.+.+....++.++||||||+++|+|+++ ..|+....... . ..
T Consensus 152 fg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~------~--~~ 217 (259)
T cd05037 152 PGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE------K--ER 217 (259)
T ss_pred CCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh------H--HH
Confidence 9998764331 12334678999999876434788999999999999999985 44443331100 0 00
Q ss_pred hhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 203 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
.. . ........ ....+.+++.+||..+|.+|||+.++++.|+
T Consensus 218 ~~--~---~~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 218 FY--Q---DQHRLPMP----DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HH--h---cCCCCCCC----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0 00000011 1167889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=248.84 Aligned_cols=230 Identities=21% Similarity=0.280 Sum_probs=174.1
Q ss_pred cchhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeeh
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e 51 (291)
.+.+.+.||+|+||.||++.+.. ++.|++|.+.... +.+..+...++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 35667899999999999998754 8899999986532 34455667899999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 82 ~~~g~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 82 YVEGGDCATLLKNI------GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred cCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 99999999999654 468999999999999999999999 999999999999999999999999999876321
Q ss_pred CCC-------------ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchh
Q 022826 132 GRE-------------SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPH 198 (291)
Q Consensus 132 ~~~-------------~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~ 198 (291)
... .........++..|+|||.+.+. .++.++||||||+++|+|++|..||..... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~vl~el~~g~~pf~~~~~--------~ 222 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------E 222 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------H
Confidence 100 00011123467789999998765 788999999999999999999998864321 1
Q ss_pred hhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 199 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
...... .......+ . ....++..+.+++.+||+.||++||+..++++.|+.-
T Consensus 223 ~~~~~~-~~~~~~~~---~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 223 ELFGQV-ISDDIEWP---E-GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHHHHH-HhcccCCC---C-ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 011111 00001111 1 1124567789999999999999999987777777663
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=242.67 Aligned_cols=228 Identities=26% Similarity=0.369 Sum_probs=172.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeec------CCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFE------GHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~------~~~~~lv 49 (291)
+.+.+.||+|++|.||+|.+. +++.+++|++.... +.+.. ....++|
T Consensus 8 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv 87 (275)
T cd06608 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV 87 (275)
T ss_pred eeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence 456789999999999999875 48899999987543 22222 3347899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
|||+.+++|.+++.... .....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 88 MELCGGGSVTDLVKGLR--KKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEcCCCCcHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 99999999999986532 124678999999999999999999999 9999999999999999999999999999875
Q ss_pred cCCCCceeeccCCCCCccccCccccccc---CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh
Q 022826 130 CHGRESIVSMTGARGTVGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
...... ......++..|+|||.+... ...++.++||||||+++|+|++|..||....... .....
T Consensus 163 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~-- 230 (275)
T cd06608 163 LDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--------ALFKI-- 230 (275)
T ss_pred cccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--------HHHHh--
Confidence 433221 12334578899999987542 2356789999999999999999999886432110 00000
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.............++..+.+++.+||..||++|||+.++++
T Consensus 231 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 ---PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ---hccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00111111223346778999999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=241.66 Aligned_cols=223 Identities=25% Similarity=0.291 Sum_probs=168.1
Q ss_pred cchhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------------ceeec--CCcce
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------------GFCFE--GHRRA 47 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------------~~~~~--~~~~~ 47 (291)
++.+.+.||+|+||.||++.+. +++.|++|++.... +.+.. +...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 4567799999999999999875 48999999875321 22222 35678
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+++||+.+++|.+++... ..+++...+.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++
T Consensus 83 l~~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAY------GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 899999999999999654 468899999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCc-eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh
Q 022826 128 KICHGRES-IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 128 ~~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
........ ........++..|+|||.+.+. .++.++||||||+++|+|++|..||...... . ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-------~----~~-- 218 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-------A----AI-- 218 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCC--CCCchhhhHHHHHHHHHHHHCCCCccccchH-------H----HH--
Confidence 75532111 1112234468899999999765 7889999999999999999999888643110 0 00
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
............+......+.+++ +||..+|++||+++|+++
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 219 -FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 011111111122334556667777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=240.94 Aligned_cols=223 Identities=25% Similarity=0.267 Sum_probs=169.6
Q ss_pred cchhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-------------------------------ceeec--CCcce
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------------GFCFE--GHRRA 47 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------------------------------~~~~~--~~~~~ 47 (291)
.+.+++.||+|+||.||++.+.+ ++.|++|.+.... +.+.. ....+
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 35678999999999999998754 8999999875321 22222 24567
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+++||+.+++|.+++... ..+++.....++.|++.+|.|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 83 ~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSY------GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 899999999999998654 357888899999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCce-eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh
Q 022826 128 KICHGRESI-VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 128 ~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
......... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||...... . ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~---~~-- 218 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--------A---AI-- 218 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccchH--------H---HH--
Confidence 765432111 112334578899999998765 7889999999999999999999887533110 0 00
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
............+......+.+++.+||. +|++||+++++++
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 219 -FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 01111111122345567778899999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=273.27 Aligned_cols=185 Identities=26% Similarity=0.393 Sum_probs=133.0
Q ss_pred CcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEec
Q 022826 44 HRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISD 123 (291)
Q Consensus 44 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~D 123 (291)
...||-||||+...+.+++.+++... ....+|+++++|++||.|+|+ ++++||||||.|||++++..|||+|
T Consensus 669 ~~LYIQMEyCE~~ll~~iI~~N~~~~-----~~d~~wrLFreIlEGLaYIH~---~giIHRDLKP~NIFLd~~~~VKIGD 740 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTLLRDIIRRNHFNS-----QRDEAWRLFREILEGLAYIHD---QGIIHRDLKPRNIFLDSRNSVKIGD 740 (1351)
T ss_pred eEEEEEHhhhhhhHHHHHHHhcccch-----hhHHHHHHHHHHHHHHHHHHh---CceeeccCCcceeEEcCCCCeeecc
Confidence 34668899999977777776553211 467799999999999999999 9999999999999999999999999
Q ss_pred cCCccccC----------------CCCceeeccCCCCCccccCcccccccCC-CccccccchhHHHHHHHHhCCCCCCcc
Q 022826 124 FGLAKICH----------------GRESIVSMTGARGTVGYIAPEVFCRNFG-EVSYKSDVYSYGMMVFEMTGVKNNANV 186 (291)
Q Consensus 124 fg~~~~~~----------------~~~~~~~~~~~~~~~~y~aPE~l~~~~~-~~~~~~DiwslG~~l~~ll~g~~~~~~ 186 (291)
||++.... .+......+...||..|.|||++.+... .|+.|+|+||||++|+||+ .||..
T Consensus 741 FGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~T 817 (1351)
T KOG1035|consen 741 FGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGT 817 (1351)
T ss_pred cccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCc
Confidence 99997621 0111112345668999999999987632 6999999999999999998 23433
Q ss_pred ccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 187 AVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.++. .......+...++.......+..+. -.++|++||++||++||||.|||.
T Consensus 818 sMER----------a~iL~~LR~g~iP~~~~f~~~~~~~-e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 818 SMER----------ASILTNLRKGSIPEPADFFDPEHPE-EASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred hHHH----------HHHHHhcccCCCCCCcccccccchH-HHHHHHHHhcCCCccCCCHHHHhh
Confidence 3221 1111111222222211113333443 356999999999999999999874
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=245.86 Aligned_cols=237 Identities=20% Similarity=0.263 Sum_probs=173.1
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|.+. +++.|++|++.... +.+..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 467789999999999999875 58999999987542 4555677888999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
+++|.+++.... ..+++..++.++.|++.+|.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 82 -~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 82 -PSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred -CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 999999986542 579999999999999999999999 99999999999999999999999999998876543
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhh-------hhhhhh-
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHW-------VYKRLE- 205 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~-------~~~~~~- 205 (291)
.. .......++..|+|||.+.+. ..++.++||||+|+++|+|++|..++............... .+....
T Consensus 153 ~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 153 EP-RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CC-CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 22 112334578899999998654 35688999999999999999996666433211000000000 000000
Q ss_pred --hhhhhcccCCC----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 --LEEDLGLQGIE----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 --~~~~~~~~~~~----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.-..+...... .....+....+.+++.+||+.||++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 0111234578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=242.47 Aligned_cols=217 Identities=21% Similarity=0.246 Sum_probs=169.7
Q ss_pred hhcc--cccCCceeEEEEEec-CCCeEEEEEeccCc----------------------ceeecCCcceeeehhhcCCCHH
Q 022826 5 FKNK--LGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------GFCFEGHRRALIYEFVSNGSLE 59 (291)
Q Consensus 5 ~~~~--lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------~~~~~~~~~~lv~e~~~~g~L~ 59 (291)
+.+. ||+|+||.||++... ++..+++|.+.... +.+......++||||+++++|.
T Consensus 18 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~ 97 (267)
T PHA03390 18 IVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF 97 (267)
T ss_pred cccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHH
Confidence 4444 499999999999764 48899999987643 3445566788999999999999
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC-ceEEeccCCccccCCCCceee
Q 022826 60 KFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-CPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 60 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
+++... ..+++..+..++.|+++||.|||+ .+++|+||||+||+++.++ .++|+|||++......
T Consensus 98 ~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~----- 163 (267)
T PHA03390 98 DLLKKE------GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP----- 163 (267)
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----
Confidence 999654 388999999999999999999999 9999999999999999988 9999999988754322
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCCh
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 218 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (291)
....++..|+|||.+.+. .++.++||||||+++|+|++|..||....... .....+ . ... .....
T Consensus 164 -~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~-----~--~~~---~~~~~ 228 (267)
T PHA03390 164 -SCYDGTLDYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESL-----L--KRQ---QKKLP 228 (267)
T ss_pred -ccCCCCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHH-----H--Hhh---cccCC
Confidence 223468899999999765 77899999999999999999999987443221 100110 0 000 01112
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 022826 219 EDKEYARKMILVSLWCIQNNPSDRPA-MNRVVE 250 (291)
Q Consensus 219 ~~~~~~~~l~~l~~~~l~~dP~~Rps-~~ell~ 250 (291)
.....+..+.+++.+||+.+|.+||+ ++++++
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 229 FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 22357778999999999999999996 588874
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=281.53 Aligned_cols=223 Identities=26% Similarity=0.327 Sum_probs=178.2
Q ss_pred hcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehhhcCC
Q 022826 6 KNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+..||.|.||.||.|.+.+ |.-.|+|-++... ++-...+..+|.||||.+|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 5789999999999997654 8888988876543 5666677788999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+|.+.+... +-.++.....+..|++.|+.|||+ .||||+||||+||+++.+|.+|++|||.+....+....
T Consensus 1320 sLa~ll~~g------ri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1320 SLASLLEHG------RIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred cHHHHHHhc------chhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 999999554 456677777888999999999999 99999999999999999999999999999887654322
Q ss_pred e--eccCCCCCccccCcccccccC-CCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 137 V--SMTGARGTVGYIAPEVFCRNF-GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 137 ~--~~~~~~~~~~y~aPE~l~~~~-~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
. .....-||+.|||||++.|.. .+...++||||||||..||+||++||....++..-.+.. .. .
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V-------~~------g 1457 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV-------AA------G 1457 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH-------hc------c
Confidence 2 234556999999999998754 366789999999999999999999998765543222111 11 1
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.. ...+..++.+-.+++..||..||++|.++.||++.
T Consensus 1458 h~-Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 HK-PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CC-CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11 12233488899999999999999999999887764
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=244.16 Aligned_cols=228 Identities=24% Similarity=0.333 Sum_probs=170.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeec-----CCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFE-----GHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~-----~~~~~lv~ 50 (291)
+.+.+.||+|+||.||++... +++.+++|++.... +.+.. ....++|+
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ 103 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVL 103 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEE
Confidence 445678999999999999875 48999999986432 22221 23578999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
||+.+++|.++++... .....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 104 ey~~~~sL~~~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 104 ELCNGGSVTELVKGLL--ICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred EECCCCcHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 9999999999886531 234578999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeccCCCCCccccCcccccccC---CCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNF---GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~---~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
...... .....++..|+|||.+.... ..++.++|||||||++|+|++|+.|+...... ....
T Consensus 179 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-------~~~~------ 243 (291)
T cd06639 179 TSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-------KTLF------ 243 (291)
T ss_pred cccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-------HHHH------
Confidence 432211 12335688999999975431 24688999999999999999999887643210 0000
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
...............+...+.+++.+||+.+|++||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 KIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0000000001112335567999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=240.71 Aligned_cols=221 Identities=29% Similarity=0.359 Sum_probs=173.5
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------------~~~~~~~~~~lv~ 50 (291)
+...+.||+|+||.||+|... +++.|++|.+.... +.+..+...++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 456788999999999999876 68999999875421 4556667889999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++...
T Consensus 82 e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 82 ELVPGGSLAKLLKKY------GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 999999999998653 468899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
.... ......++..|++||.+.... .++.++|+||||+++|+|++|..||...... ..... ...
T Consensus 153 ~~~~---~~~~~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-------~~~~~----~~~- 216 (258)
T cd06632 153 VEFS---FAKSFKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQLEGV-------AAVFK----IGR- 216 (258)
T ss_pred cccc---cccccCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccCcHH-------HHHHH----HHh-
Confidence 4433 123345688899999986651 3889999999999999999999988654210 00000 000
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.......+..+...+.+++.+||+.+|++||++.++++
T Consensus 217 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 217 --SKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --cccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 00011122345677889999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=243.53 Aligned_cols=221 Identities=26% Similarity=0.427 Sum_probs=171.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|.+. +++.+++|.+.... +.+..+...+++||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 456788999999999999874 58999999875431 34456677889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++.. ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~~~~~~L~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 83 YAEGGSVRTLMKA-------GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred cCCCCcHHHHHHc-------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 9999999999843 378899999999999999999999 999999999999999999999999999988765
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
..... .....++..|+|||.+.+. ..++.++|+||||+++|+|++|..||........ ........
T Consensus 153 ~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-----------~~~~~~~~ 218 (277)
T cd06917 153 QNSSK--RSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-----------MMLIPKSK 218 (277)
T ss_pred CCccc--cccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-----------hhccccCC
Confidence 43321 2234578899999988653 3578899999999999999999998864321100 00000000
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.+.. ....+...+.+++.+||+.||++||++.++++
T Consensus 219 ~~~~---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRL---EDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCC---CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111 11125667899999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=239.86 Aligned_cols=226 Identities=24% Similarity=0.378 Sum_probs=173.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------------~~~~~~~~~~lv 49 (291)
+..++.||+|++|.||++... +++.+++|++.... +.+......++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 456789999999999999864 58999999986421 555667788999
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC-ceEEeccCCcc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-CPKISDFGLAK 128 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-~~kl~Dfg~~~ 128 (291)
+||+.+++|.+++.+. ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||.+.
T Consensus 82 ~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 82 VEWMAGGSVSHLLSKY------GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EeccCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 9999999999998654 468899999999999999999999 9999999999999998776 59999999987
Q ss_pred ccCCCCce--eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh
Q 022826 129 ICHGRESI--VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 129 ~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
........ .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........ .. ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~----~~-- 220 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH----LA----LI-- 220 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcch----HH----HH--
Confidence 65432110 011223467899999998765 778999999999999999999988864322110 00 00
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
............+..++..+.+++.+||..+|.+||++.++++
T Consensus 221 -~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 221 -FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0000011112234457788999999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=247.24 Aligned_cols=237 Identities=25% Similarity=0.323 Sum_probs=172.0
Q ss_pred cchhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehh
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~ 52 (291)
++.+.+.||+|+||.||+|.+.+ ++.||+|.+.... +.+..+...++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 35677899999999999998764 8999999875432 455566778999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|..+.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 82 VDHTVLDDLEKYP------NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred CCccHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9998888776432 458999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccch-------hhhhhh--
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFP-------HWVYKR-- 203 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~-------~~~~~~-- 203 (291)
... ......++..|+|||.+.+. ..++.++||||||+++|+|++|..+|............. ......
T Consensus 153 ~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 153 PGE--VYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred Ccc--ccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence 322 12334467899999998653 357789999999999999999987775432110000000 000000
Q ss_pred -hhhhhhhcccCCC-----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 204 -LELEEDLGLQGIE-----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 204 -~~~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.........+... ....+.++..+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000000000 0112245678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=241.39 Aligned_cols=219 Identities=25% Similarity=0.307 Sum_probs=178.1
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
.++-+.||+|.||.|-+++.+. ++.+|+|++++.. ..+...++.|+||||
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey 249 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY 249 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence 4567899999999999998754 9999999998765 455678899999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
.+||.|.-+|.+ ...+++...+.+-.+|++||.|||+ .+||.||+|.+|++++.+|.+||.|||++..--.
T Consensus 250 anGGeLf~HLsr------er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 250 ANGGELFFHLSR------ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred ccCceEeeehhh------hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 999999888854 3688999999999999999999999 9999999999999999999999999999874222
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
.. ...+..||||.|+|||++..+ .|..++|.|.+|+++|+|+.|+.||........ + .......+
T Consensus 321 ~g--~t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL---F------eLIl~ed~-- 385 (516)
T KOG0690|consen 321 YG--DTTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL---F------ELILMEDL-- 385 (516)
T ss_pred cc--ceeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccchhHH---H------HHHHhhhc--
Confidence 11 134678999999999999877 899999999999999999999999986644210 0 11111111
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~ 250 (291)
..+..++.+...|+..+|.+||.+|. .++|+.+
T Consensus 386 -----kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 386 -----KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred -----cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 23455677888999999999999993 4555543
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=240.50 Aligned_cols=226 Identities=26% Similarity=0.402 Sum_probs=175.0
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||++.+. +++.+++|.+.... +.+......++++||+.
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 456789999999999999876 48999999887553 35556678889999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++.... ..+++..+..++.|++.++.+||+ ..+++|+||||+||+++.++.++|+|||.+.......
T Consensus 83 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 83 GGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 999999987642 578999999999999999999997 4789999999999999999999999999887553222
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
. ....++..|+|||.+.+. .++.++||||||+++|+|++|..|+......... .. ... .......
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~---~~~---~~~~~~~ 220 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG---IF---ELL---QYIVNEP 220 (265)
T ss_pred h----hcccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccccccc---HH---HHH---HHHhcCC
Confidence 1 115568899999999776 7889999999999999999999988654321100 00 000 0000011
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
........++..+.+++.+||..||++|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 111111126778999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=245.22 Aligned_cols=214 Identities=23% Similarity=0.398 Sum_probs=160.2
Q ss_pred ccccCCceeEEEEEecC-------------------------CCeEEEEEeccCc-------------------------
Q 022826 8 KLGQGGYGGVYKGKLLD-------------------------GRNVAIKVLNETK------------------------- 37 (291)
Q Consensus 8 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~------------------------- 37 (291)
.||+|+||.||+|.... ...|++|++....
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999996421 2358899886432
Q ss_pred -ceeecCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC
Q 022826 38 -GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 116 (291)
Q Consensus 38 -~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~ 116 (291)
+++......++||||+++++|..++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++..
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-----KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEecc
Confidence 5666777889999999999999988642 3578999999999999999999999 999999999999999754
Q ss_pred C-------ceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHh-CCCCCCcccc
Q 022826 117 F-------CPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT-GVKNNANVAV 188 (291)
Q Consensus 117 ~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll-~g~~~~~~~~ 188 (291)
+ .++++|||++...... ....++..|+|||.+.+. ..++.++||||||+++|+|+ +|..|+....
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred CcccCccceeeecCCccccccccc------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3 4799999987543221 122357789999988653 46899999999999999995 5776665432
Q ss_pred CCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 189 DRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
... ... . .... ..... .....+.+++.+||+.+|++|||+.++++.|+
T Consensus 227 ~~~--------~~~-~-~~~~---~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 227 PSE--------KER-F-YEKK---HRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred hHH--------HHH-H-HHhc---cCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 110 000 0 0000 00111 12346889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=242.07 Aligned_cols=231 Identities=25% Similarity=0.361 Sum_probs=171.5
Q ss_pred hhhcccccCCceeEEEEEec------CCCeEEEEEeccCc---------------------------ceeecCCcceeee
Q 022826 4 SFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK---------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~ 50 (291)
.+...||+|+||.||+|+.+ +.+.+++|.+.... +.+......++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 87 (275)
T cd05046 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMIL 87 (275)
T ss_pred eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEE
Confidence 45678999999999999864 24679999886432 4555667789999
Q ss_pred hhhcCCCHHHHHhhcCCCC---CCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 51 EFVSNGSLEKFIYEKHPLE---TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
||+.+++|.+++....... ....+++..+..++.|++.+|.|||+ .+++|+||||+||+++.++.++++|||++
T Consensus 88 e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 88 EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcccccc
Confidence 9999999999997643111 12368999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
....... ........++..|+|||.+.+. .++.++||||||+++|+|++ |..||...... .. ... ..
T Consensus 165 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-------~~-~~~-~~ 232 (275)
T cd05046 165 KDVYNSE-YYKLRNALIPLRWLAPEAVQED--DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-------EV-LNR-LQ 232 (275)
T ss_pred cccCccc-ccccCCceeEEeecChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccchH-------HH-HHH-HH
Confidence 6543221 1112223446779999998765 67889999999999999998 56666432110 00 000 00
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
..... ......++..+.+++.+||+.+|.+||++.++++.|++
T Consensus 233 ~~~~~-----~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 233 AGKLE-----LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred cCCcC-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 00100 11122355678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=244.53 Aligned_cols=216 Identities=26% Similarity=0.360 Sum_probs=172.3
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||++.+.. ++.+++|++.... +.+..+...++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 4567899999999999998754 8999999986421 455667788999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|.||+++.++.++|+|||++.....
T Consensus 83 ~~~~~L~~~~~~~------~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 83 VPGGELFSHLRKS------GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999998654 578999999999999999999999 9999999999999999999999999999887544
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
. .....+++.|+|||.+.+. ..+.++||||||+++|+|++|..||..... ........ ...
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~--- 214 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKIL-EGK--- 214 (290)
T ss_pred C-----CCCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHh-cCC---
Confidence 3 2334578899999998765 678899999999999999999988764431 00011110 111
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~ 250 (291)
...+..++..+.+++.+||..||.+|+ ++.|+++
T Consensus 215 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 ----VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ----ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 111223467788999999999999998 7777763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=242.93 Aligned_cols=237 Identities=21% Similarity=0.277 Sum_probs=170.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|++|.||+|++. +++.|+||.+.... +.+..+...+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 467789999999999999875 48999999886432 4556677889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
. ++|..++... ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~-~~l~~~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 82 H-QDLKKFMDAS----PLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred c-cCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 6 5898888653 34678999999999999999999999 99999999999999999999999999998755332
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchh-------hhhhhhhh
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPH-------WVYKRLEL 206 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~ 206 (291)
.. ......++..|+|||.+.+. ..++.++||||||+++|+|++|..||.............. ..+.....
T Consensus 154 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 154 VR--TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred cc--ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH
Confidence 21 11223457789999988664 3568899999999999999999988865422110000000 00000000
Q ss_pred h--hhhcccCCC----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 E--EDLGLQGIE----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~--~~~~~~~~~----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. ......... ......++..+.+++.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0 000000000 0011234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=238.34 Aligned_cols=227 Identities=25% Similarity=0.387 Sum_probs=174.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||++... +++.|++|.++... +.+......++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 467789999999999999765 58999999987543 4555677889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+++|.+++... ..+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 82 SGGTLEELLEHG------RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCcHHHHHhhc------CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999998653 457889999999999999999999 99999999999999999999999999998776443
Q ss_pred Cceee--ccCCCCCccccCcccccccC-CCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 134 ESIVS--MTGARGTVGYIAPEVFCRNF-GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 134 ~~~~~--~~~~~~~~~y~aPE~l~~~~-~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
..... .....++..|+|||.+.+.. ...+.++||||||+++|++++|..||....... .... .. ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~------~~~~-~~---~~- 221 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF------QIMF-HV---GA- 221 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH------HHHH-HH---hc-
Confidence 22111 12345688999999987653 247889999999999999999999886432110 0000 00 00
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
...........+...+.+++.+||+.+|.+||++.+++.
T Consensus 222 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 -GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 001011112234667889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=242.73 Aligned_cols=218 Identities=27% Similarity=0.397 Sum_probs=168.2
Q ss_pred cccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehhhcCCCH
Q 022826 9 LGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 9 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
||+|+||+||++.+. +++.+++|++.... +.+......++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999765 48999999986422 345556778999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
.+++.... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--- 150 (277)
T cd05577 81 KYHIYNVG----EPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--- 150 (277)
T ss_pred HHHHHHcC----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---
Confidence 99987642 2478999999999999999999999 9999999999999999999999999999876543211
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCCh
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 218 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (291)
.....++..|+|||.+.+. .++.++||||||+++|+|++|..||........ .. .. .... ......
T Consensus 151 ~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~----~~--~~~~--~~~~~~ 216 (277)
T cd05577 151 IKGRAGTPGYMAPEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE----KE----EL--KRRT--LEMAVE 216 (277)
T ss_pred cccccCCCCcCCHHHhcCC--CCCchhhhHHHHHHHHHHhhCCCCCCCCccccc----HH----HH--Hhcc--cccccc
Confidence 1233467899999998765 588999999999999999999998865432111 00 00 0000 001112
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 022826 219 EDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVE 250 (291)
Q Consensus 219 ~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~ 250 (291)
.+..++..+.+++.+||+.||.+|| ++.++++
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 217 YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 2234567789999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=242.52 Aligned_cols=233 Identities=21% Similarity=0.294 Sum_probs=168.9
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecC--Ccceeeehh
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEG--HRRALIYEF 52 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~--~~~~lv~e~ 52 (291)
.+.+.||+|+||.||++... +++.+|+|+++... +.+... +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 56788999999999999875 48999999987532 344444 778999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+ +|.+.+.... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++. +.++|+|||++.....
T Consensus 82 ~~~-~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 82 MDM-NLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred CCc-cHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 975 8888876532 478999999999999999999999 99999999999999999 9999999999876543
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc-------hhhhhhhhh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF-------PHWVYKRLE 205 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~-------~~~~~~~~~ 205 (291)
.... ....++..|+|||.+.+. ..++.++|||||||++|+|++|..||........-... +........
T Consensus 152 ~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 152 KPPY---TEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CCCc---CCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence 3221 223467899999987543 35788999999999999999998888654221100000 000000000
Q ss_pred hhh--hhcccCCC----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 LEE--DLGLQGIE----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ~~~--~~~~~~~~----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
... ....+... ......++..+.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000 00000000 0011245788999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=241.87 Aligned_cols=218 Identities=23% Similarity=0.327 Sum_probs=169.5
Q ss_pred hcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCCCH
Q 022826 6 KNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
.+.||+|++|.||++.+. +++.+++|.+.... +.+......++++||+.+++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 368999999999999864 58999999875332 345567788999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
.+++.. .++++..+..++.|++.+|.+||+ .+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 104 ~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~ 171 (285)
T cd06648 104 TDIVTH-------TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R 171 (285)
T ss_pred HHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence 999854 368899999999999999999999 9999999999999999999999999998775443221 1
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCCh
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 218 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (291)
.....+++.|+|||.+.+. .++.++||||||+++|+|++|..||..... .......... .... ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--------~~~~~~~~~~---~~~~--~~ 236 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--------LQAMKRIRDN---LPPK--LK 236 (285)
T ss_pred cccccCCccccCHHHhcCC--CCCCcccHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHhc---CCCC--Cc
Confidence 1234468899999998765 688999999999999999999988764321 0001111000 0000 11
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 219 EDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 219 ~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
....++..+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 12235668999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=240.15 Aligned_cols=220 Identities=25% Similarity=0.315 Sum_probs=174.1
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||.|+||.||++++. +++.+++|++.... ..+..+...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 467789999999999999875 48999999987532 344566778999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ..+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 ~~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 82 LLGGDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 9999999998653 478899999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
.. ......++..|+|||.+.+. .++.++|+||||+++|+|++|..|+....... ...... ....
T Consensus 153 ~~---~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~------~~~~ 216 (258)
T cd05578 153 DT---LTTSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-----RDQIRA------KQET 216 (258)
T ss_pred Cc---cccccCCChhhcCHHHHccc--CCCCcccchhhHHHHHHHHhCCCCCCCCCccH-----HHHHHH------Hhcc
Confidence 32 12334567899999999775 68899999999999999999999887554321 110000 0000
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCH--HHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAM--NRVV 249 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~--~ell 249 (291)
.....+..++..+.+++.+||+.||.+||++ +|++
T Consensus 217 --~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 --ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1112233456889999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=242.97 Aligned_cols=222 Identities=24% Similarity=0.328 Sum_probs=172.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||+|+||.||++... +++.|++|.+.... +.+......++|+||+.+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 100 (293)
T cd06647 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG 100 (293)
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCC
Confidence 456688999999999999764 58899999986432 455566788999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++.+ ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 101 ~~L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 101 GSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CcHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999854 367888999999999999999999 9999999999999999999999999998875543222
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
......+++.|++||.+.+. .++.++|+||||+++|++++|..||............ . .....
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-----------~--~~~~~ 233 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-----------A--TNGTP 233 (293)
T ss_pred --ccccccCChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-----------h--cCCCC
Confidence 11233567889999998765 6789999999999999999999988654321110000 0 00000
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
........+..+.+++.+||..+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122356678899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=240.45 Aligned_cols=220 Identities=25% Similarity=0.367 Sum_probs=172.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||+|.+. +++.+|+|++.... +.+..+...++|+||+.
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 456788999999999999764 58999999976432 45566778899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++.. ..+++..+..++.+++.++.+||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~~l~~~i~~-------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 86 GGSALDLLEP-------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 9999999843 468999999999999999999999 999999999999999999999999999987654322
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
. ......++..|+|||.+.+. .++.++|+||||+++|+|++|..|+...... .... .... .
T Consensus 156 ~--~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~---~~~~----~ 216 (277)
T cd06641 156 I--KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPHSELHPM--------KVLF---LIPK----N 216 (277)
T ss_pred h--hhccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCccchH--------HHHH---HHhc----C
Confidence 1 11223467889999998764 7788999999999999999999887532110 0000 0000 0
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
........++..+.+++.+||+.+|.+||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 217 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0111223456778899999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=269.10 Aligned_cols=224 Identities=21% Similarity=0.282 Sum_probs=177.7
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.|..++.+. ++.||+|++.+-. .-+.++.+.|+||+|
T Consensus 77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY 156 (1317)
T KOG0612|consen 77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDY 156 (1317)
T ss_pred hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEec
Confidence 3466899999999999998755 9999999988622 345667889999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.||+|..++.+. .++++.-++.++.+|+.||.-+|+ .|+|||||||+||+++.+|.+||+|||.|-.+..
T Consensus 157 ~pGGDlltLlSk~------~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 157 MPGGDLLTLLSKF------DRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred ccCchHHHHHhhc------CCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 9999999999543 379999999999999999999999 9999999999999999999999999999987764
Q ss_pred CCceeeccCCCCCccccCcccccc--c-CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh-h
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCR--N-FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE-E 208 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~--~-~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 208 (291)
+... ......|||-|++||+++. . .+.|+..+|.||+||++|||+.|..||+.+.- ...+.++... .
T Consensus 228 dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl--------veTY~KIm~hk~ 298 (1317)
T KOG0612|consen 228 DGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL--------VETYGKIMNHKE 298 (1317)
T ss_pred CCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH--------HHHHHHHhchhh
Confidence 4332 2356779999999999843 2 26799999999999999999999999986532 1122222221 1
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPA---MNRVVE 250 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps---~~ell~ 250 (291)
.+..+ ....++....+||++.+ -+|+.|.. ++++..
T Consensus 299 ~l~FP-----~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 299 SLSFP-----DETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN 337 (1317)
T ss_pred hcCCC-----cccccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence 12222 22347888888888665 58889987 887754
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=244.38 Aligned_cols=238 Identities=21% Similarity=0.283 Sum_probs=172.0
Q ss_pred cchhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehh
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~ 52 (291)
.+.+.+.||+|+||.||+|.+.+ ++.|++|+++... +.+..+...++++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 35678899999999999998764 8899999876432 555667788999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.++.+..+... ...+++..+..++.||+.|+.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~l~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 82 VERTLLELLEAS------PGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred CCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 998666655533 2468999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhh-------hhhhhh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHW-------VYKRLE 205 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~-------~~~~~~ 205 (291)
.... ......++..|+|||.+.+. ..++.++||||||+++|+|++|..+|............... ......
T Consensus 153 ~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 153 RPAS-PLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred Cccc-cccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 4321 12234467889999998764 36788999999999999999999887643221100000000 000000
Q ss_pred hhhhh---cccCCCC------hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 LEEDL---GLQGIEN------EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ~~~~~---~~~~~~~------~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..... ....... ..+..++..+.+++++||+.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 0000000 011224778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=240.45 Aligned_cols=220 Identities=26% Similarity=0.356 Sum_probs=169.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|... +++.|++|++.... +.+......++|+||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 445688999999999999875 48999999986322 456667788999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+ ++.+++... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 97 ~~g-~l~~~~~~~-----~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 97 CLG-SASDILEVH-----KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred hCC-CHHHHHHHc-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 974 887777542 2468999999999999999999999 9999999999999999999999999998865432
Q ss_pred CCceeeccCCCCCccccCcccccc-cCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCR-NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
. ....+++.|+|||.+.+ ....++.++||||||+++|+|++|..|+....... . ...+.
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--------~------~~~~~ 227 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------A------LYHIA 227 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--------H------HHHHh
Confidence 2 22346788999998753 22468889999999999999999998875432100 0 00000
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
...........++..+.+++.+||+.||++||++.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 228 QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred cCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1111112233467789999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=244.19 Aligned_cols=236 Identities=22% Similarity=0.330 Sum_probs=168.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|++|.||++... +++.|++|.+.... +.+..+...++||||+.
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 456788999999999999875 58999999986432 45566778899999998
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+ +|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++......
T Consensus 87 ~-~L~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 87 T-DLKQYMDDCG-----GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred C-CHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 5 9999886532 478999999999999999999999 999999999999999999999999999986532211
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccch--------hhhhhhhhh
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFP--------HWVYKRLEL 206 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 206 (291)
. ......++..|+|||.+.+. ..++.++||||+|+++|+|++|..+|............. ...+.....
T Consensus 158 ~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 158 K--TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred c--cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 1 11223357889999988653 357889999999999999999998886443111000000 000000000
Q ss_pred hhh---hcccCC-CCh---hhHHH--HHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 EED---LGLQGI-ENE---EDKEY--ARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~~~---~~~~~~-~~~---~~~~~--~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
... ...... ... ..... ...+.+++.+||+.+|.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 000000 000 00011 266789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=240.91 Aligned_cols=237 Identities=25% Similarity=0.364 Sum_probs=175.9
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc---------------------------ceee--cCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK---------------------------GFCF--EGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---------------------------~~~~--~~~~~~lv~e~ 52 (291)
+...++||.|++|.||++.+.+ ++.+++|.+.... +.+. .....++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 4456899999999999998754 8999999987532 2222 23467899999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+++++|.+++.... .....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 83 CEGGSLDSIYKKVK--KRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred cCCCCHHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999876532 134678999999999999999999999 9999999999999999999999999999875433
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... ....++..|++||.+.+. .++.++||||||+++|+|++|..|+........ .+..... .......
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~---~~~~~~~ 225 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGK--PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL---GPIELLS---YIVNMPN 225 (287)
T ss_pred ccc----ccccCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC---ChHHHHH---HHhcCCc
Confidence 221 223457889999998765 788999999999999999999999875532100 0100000 0011011
Q ss_pred cCCCCh--hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHhhh
Q 022826 213 QGIENE--EDKEYARKMILVSLWCIQNNPSDRPAMNRVVE--MLEGSL 256 (291)
Q Consensus 213 ~~~~~~--~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~--~L~~~~ 256 (291)
...... ....++..+.+++.+||..+|++|||+.|+++ ++.+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 226 PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 111111 11235678999999999999999999999988 444433
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=237.78 Aligned_cols=216 Identities=21% Similarity=0.305 Sum_probs=169.8
Q ss_pred cccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehhhcCCCH
Q 022826 9 LGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 9 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
||.|+||.||++.+.. ++.+++|++.... +.+..+...++++||+.+++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999998754 8999999986532 455667788999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~--- 148 (262)
T cd05572 81 WTILRDR------GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--- 148 (262)
T ss_pred HHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---
Confidence 9999654 358899999999999999999999 9999999999999999999999999999887654321
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCCh
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 218 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (291)
.....+++.|++||.+.+. .++.++|+||||+++|+|++|..|+....... ...... .........
T Consensus 149 ~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~------~~~~~~~~~ 214 (262)
T cd05572 149 TWTFCGTPEYVAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDDEDP------MEIYND------ILKGNGKLE 214 (262)
T ss_pred cccccCCcCccChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH------HHHHHH------HhccCCCCC
Confidence 1223568899999998765 68899999999999999999999887554210 000010 000001111
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 022826 219 EDKEYARKMILVSLWCIQNNPSDRPA-----MNRVVE 250 (291)
Q Consensus 219 ~~~~~~~~l~~l~~~~l~~dP~~Rps-----~~ell~ 250 (291)
.+...+..+.+++.+||+.+|++||+ +.|+++
T Consensus 215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 215 FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 22233678999999999999999999 777766
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=234.87 Aligned_cols=222 Identities=30% Similarity=0.459 Sum_probs=174.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||+|++|.||++.+. +++.+++|++.... +.+......++++||+.+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 356789999999999999875 58999999986553 455556788899999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++.... ..+++..+..++.+++.+|.+||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 82 GSLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CcHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 99999986532 578999999999999999999999 9999999999999999999999999999876654332
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
.....++..|++||.+.+. ..+.++|+||||+++|+|++|..|+....... . ...........
T Consensus 154 ---~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~-----~~~~~~~~~~~- 216 (253)
T cd05122 154 ---RNTMVGTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGKPPYSELPPMK------A-----LFKIATNGPPG- 216 (253)
T ss_pred ---ccceecCCcccCHHHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCchHH------H-----HHHHHhcCCCC-
Confidence 2334567899999998775 58899999999999999999998876442100 0 00000000111
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......++..+.+++.+||+.||++|||+.++++
T Consensus 217 -~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 217 -LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -cCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112223678999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=242.60 Aligned_cols=242 Identities=24% Similarity=0.350 Sum_probs=184.1
Q ss_pred hhhcccccCCceeEEEEEecCCCeEEEEEeccCcc----------------------eee---c----CCcceeeehhhc
Q 022826 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG----------------------FCF---E----GHRRALIYEFVS 54 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~---~----~~~~~lv~e~~~ 54 (291)
-+.+.||+|.||+||+|++ .|+.||||++..... +.- . -...+||.+|.+
T Consensus 214 ~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe 292 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE 292 (513)
T ss_pred EEEEEecCccccceeeccc-cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence 3568999999999999998 899999999987651 100 0 124668999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcC-----CCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG-----CNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~-----~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
.|||.|+|++ .+++...+++++..+++||+|||-. ....|.|||||..||+|-.+|...|+|+|++..
T Consensus 293 ~GSL~DyL~r-------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 293 HGSLYDYLNR-------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred CCcHHHHHhh-------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 9999999965 5899999999999999999999951 124599999999999999999999999999987
Q ss_pred cCCCCce--eeccCCCCCccccCcccccccC----CCccccccchhHHHHHHHHhC----C------CCCCccccCCCcc
Q 022826 130 CHGRESI--VSMTGARGTVGYIAPEVFCRNF----GEVSYKSDVYSYGMMVFEMTG----V------KNNANVAVDRSSE 193 (291)
Q Consensus 130 ~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~----~~~~~~~DiwslG~~l~~ll~----g------~~~~~~~~~~~~~ 193 (291)
+...... .......||..|||||++...- ...-..+||||||.++||+.. | ..||.+....+.
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP- 444 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP- 444 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC-
Confidence 7655332 2235567999999999985421 112236899999999999962 2 234433333322
Q ss_pred ccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 194 IYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
....+++.--.+.+.......+........+.++++.||..||.-|.|+-.+-+.|.++.+
T Consensus 445 ---s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 445 ---SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ---CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 2333444444444444444455556778889999999999999999999999999998765
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=235.99 Aligned_cols=222 Identities=28% Similarity=0.440 Sum_probs=176.1
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||++... +++.+++|.+.... +.+......++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 467789999999999999765 58899999987532 3455567888999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
++++|.+++.... .....+++..++.++.+++.||.+||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 82 PFGDLSKAISKRK--KKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred CCCCHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999987642 223678999999999999999999999 99999999999999999999999999998776544
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
. .....+++.|++||.+.+. .++.++|+||||+++|+|++|..||...... .. ..... .
T Consensus 157 ~----~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------~~-------~~~~~-~ 215 (256)
T cd08530 157 M----AKTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-------DL-------RYKVQ-R 215 (256)
T ss_pred C----cccccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HH-------HHHHh-c
Confidence 2 2234568899999998765 7788999999999999999999887543210 00 00001 1
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.........+..++.+++.+||+.+|++||++.++++
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 216 GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111223357788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=245.28 Aligned_cols=249 Identities=21% Similarity=0.290 Sum_probs=173.2
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceee--cCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCF--EGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~--~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|.+.. ++.||+|+++... +.+. .....++|+|
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 4567889999999999998754 9999999986432 2222 2245789999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+ +|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 89 ~~~~-~l~~~l~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 89 YCEQ-DLASLLDNM-----PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred cCCC-CHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9975 898888653 2578999999999999999999999 999999999999999999999999999988664
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhh-------hhhhh
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHW-------VYKRL 204 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~-------~~~~~ 204 (291)
..... ......+..|+|||.+.+. ..++.++||||||+++|+|++|..||............... .+...
T Consensus 160 ~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 160 LPAKP--MTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CccCC--CCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 33211 1222346789999998653 36789999999999999999999888643221100000000 00000
Q ss_pred h---hhhhhcccCCC----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCCCC
Q 022826 205 E---LEEDLGLQGIE----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRP 265 (291)
Q Consensus 205 ~---~~~~~~~~~~~----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 265 (291)
. ........... .......+..+.+++.+||+.||++|||+.++++. ...+....+..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h--~~f~~~~~~~~~ 302 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES--SYFKEKPLPCEP 302 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC--hhhccCCCCCCC
Confidence 0 00000000000 00112246678899999999999999999999863 334433444333
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=241.16 Aligned_cols=236 Identities=22% Similarity=0.288 Sum_probs=170.8
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhc
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~ 54 (291)
.+.+.||.|++|.||+|.+. +|+.|++|++.... +.+..+...++++||+.
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 56788999999999999875 59999999886432 45666788899999995
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 -~~l~~~~~~~----~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 82 -LDLKKYMDSS----PLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred -cCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 5899988654 22478999999999999999999999 999999999999999999999999999987543221
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchh-------hhhhhhhhh
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPH-------WVYKRLELE 207 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 207 (291)
.. .....++..|+|||.+.+. ..++.++||||||+++|+|++|..||.............. ..+......
T Consensus 154 ~~--~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 154 RT--YTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred cc--cCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc
Confidence 11 1222457889999987653 3568899999999999999999988864422110000000 000000000
Q ss_pred hh--hccc----CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 208 ED--LGLQ----GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 208 ~~--~~~~----~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. .... .........++..+.+++.+||+.||.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 0000 0001112235567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=242.13 Aligned_cols=241 Identities=21% Similarity=0.279 Sum_probs=168.6
Q ss_pred cchhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCc-----c
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHR-----R 46 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~-----~ 46 (291)
++.+.+.||+|+||.||+|.+. +++.||+|.++... +.+..... .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 3567789999999999999875 48999999876432 22222223 6
Q ss_pred eeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC-CCceEEeccC
Q 022826 47 ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-DFCPKISDFG 125 (291)
Q Consensus 47 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~-~~~~kl~Dfg 125 (291)
+++|||+.+ +|.+++..... .....+++..++.++.||+.||.|||+ .+++|+||+|+||+++. ++.++|+|||
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGR-GPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcc-cCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 899999986 89888865431 123578999999999999999999999 99999999999999998 8899999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchh-------
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPH------- 198 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~------- 198 (291)
++........ ......+++.|+|||.+.+. ..++.++||||||+++|+|++|..||...........+..
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9875432211 11222357789999988653 3578999999999999999999988864321100000000
Q ss_pred hhhhhhh-hhhhhcccCCC----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 199 WVYKRLE-LEEDLGLQGIE----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 199 ~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..+.... .......+... ....+.++..+.+++.+||+.||.+||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000 00000000000 0111236677899999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=242.70 Aligned_cols=231 Identities=25% Similarity=0.312 Sum_probs=174.9
Q ss_pred chhhcccccCCceeEEEEEec----CCCeEEEEEeccCc-------------------------------ceeecCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL----DGRNVAIKVLNETK-------------------------------GFCFEGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-------------------------------~~~~~~~~~~ 47 (291)
+.+.+.||+|+||.||+++.. +++.+++|+++... +.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 456789999999999999753 47889999986421 3444556788
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+||||+.+++|.+++... ..+++..+..++.|++.+|.|||+ .+++|+||+|.||+++.++.++|+|||++
T Consensus 82 lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 82 LILDYVNGGELFTHLYQR------EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEecCCCCcHHHHHhhc------CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccc
Confidence 999999999999998643 468899999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
.......... .....++..|++||.+.+.....+.++||||||+++|+|++|..|+........ .......
T Consensus 153 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----~~~~~~~---- 223 (288)
T cd05583 153 KEFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS----QSEISRR---- 223 (288)
T ss_pred cccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch----HHHHHHH----
Confidence 7654432211 123456889999999876533578899999999999999999998864321110 0000000
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
.... ....+..+...+.+++.+||+.||++|||+.++.+.|+..
T Consensus 224 --~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 224 --ILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --HHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0000 0112233556788999999999999999999888777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=249.11 Aligned_cols=243 Identities=23% Similarity=0.248 Sum_probs=170.1
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceee-----cCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCF-----EGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~-----~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +.+. .....+++
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 456789999999999999764 58999999986321 1111 12346899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
+||+.+ +|..++.. ..+++..+..++.|++.||.+||+ .+++|+||||+||+++.++.++|+|||++..
T Consensus 87 ~e~~~~-~l~~~~~~-------~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 87 QELMET-DLYKLIKT-------QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred ehhccc-CHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 999965 88887743 479999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCcee-eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc-------hhhhh
Q 022826 130 CHGRESIV-SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF-------PHWVY 201 (291)
Q Consensus 130 ~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~-------~~~~~ 201 (291)
........ ......+++.|+|||.+.+. ..++.++||||||+++|+|++|+.||............ .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 54322111 11234568899999987543 36789999999999999999999888643211000000 00000
Q ss_pred hhhh---hhhhhc-ccCCCC----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhhhc
Q 022826 202 KRLE---LEEDLG-LQGIEN----EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM--LEGSLD 257 (291)
Q Consensus 202 ~~~~---~~~~~~-~~~~~~----~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~--L~~~~~ 257 (291)
.... ....+. .+.... ...+..+..+.+++.+||+.||++|||+.++++. ++...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0000 000000 000000 0112346778999999999999999999999886 555433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=241.73 Aligned_cols=231 Identities=26% Similarity=0.345 Sum_probs=167.6
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehhhc
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~ 54 (291)
...+.||+|+||.||++.+.. ++.+|+|.+.... +.+..+...++++||+.
T Consensus 7 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~ 86 (288)
T cd06616 7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86 (288)
T ss_pred HHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence 345789999999999998754 8999999986532 34455667788999986
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
. ++.++...... .....+++..+..++.+++.||.|||+ ..+++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~-~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 87 I-SLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred C-CHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 5 66554432110 123579999999999999999999997 1499999999999999999999999999987654322
Q ss_pred ceeeccCCCCCccccCcccccccC-CCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNF-GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~-~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
. .....++..|+|||.+.+.. ..++.++||||||+++|+|++|..||..... .. ...........+
T Consensus 163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~---~~~~~~~~~~~~ 229 (288)
T cd06616 163 A---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VF---DQLTQVVKGDPP 229 (288)
T ss_pred c---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HH---HHHhhhcCCCCC
Confidence 1 12234688999999986532 3678899999999999999999998864321 00 000000000011
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.........++..+.+|+.+||+.||++|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111123467789999999999999999999998863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=236.57 Aligned_cols=222 Identities=25% Similarity=0.405 Sum_probs=172.5
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||++.... +..+++|.+.... +.+......++++||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 4567899999999999998754 8999999986531 4556667888999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC-ceEEeccCCccccCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-CPKISDFGLAKICHG 132 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~ 132 (291)
.+++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++ .++|+|||.+.....
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 82 DGGDLMKRINRQ----RGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCcHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 999999999754 23467999999999999999999999 9999999999999998886 469999999876543
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
.... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..|+..... ..... .. .
T Consensus 155 ~~~~--~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~-~~-----~-- 215 (257)
T cd08225 155 SMEL--AYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVL-KI-----C-- 215 (257)
T ss_pred Cccc--ccccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHH-HH-----h--
Confidence 3221 1223468899999998765 688999999999999999999988754321 00000 00 0
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..........++..+.+++.+||..+|++|||+.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 216 QGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred cccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 01111122345667999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=238.69 Aligned_cols=236 Identities=21% Similarity=0.241 Sum_probs=169.8
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecC--Ccceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEG--HRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~--~~~~lv~e 51 (291)
+.+.+.||.|+||.||+|.+.. ++.+++|.++... +.+... ...++|+|
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e 86 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME 86 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence 4566899999999999998764 8899999986432 233334 78999999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+ +|.+++.... ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++..+.
T Consensus 87 ~~~~-~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 87 YVEH-DLKSLMETMK-----QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred hcCc-CHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 9975 9999886542 368999999999999999999999 999999999999999999999999999988665
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc-hhh------hhhhh
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF-PHW------VYKRL 204 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~-~~~------~~~~~ 204 (291)
.... ......+++.|+|||.+.+. ..++.++||||||+++|+|++|..||............ ... .+...
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 158 SPLK--PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred CCcc--ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence 4321 11233457889999998654 24688999999999999999999888644221000000 000 00000
Q ss_pred ---hhhhhhc-----ccCCCChhhHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 205 ---ELEEDLG-----LQGIENEEDKE-YARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 205 ---~~~~~~~-----~~~~~~~~~~~-~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
....... ........... ++..+.+++++||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000 00000011111 3677889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=237.58 Aligned_cols=223 Identities=27% Similarity=0.410 Sum_probs=173.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.+.+.||+|.||.||++.+. +++.+++|++.... +.+......++++||+.++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 455688999999999999876 58999999987543 3555678889999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+|.+++.... ..+++..+..++.|++.||.+||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 101 ~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 101 SLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred cHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 9999997642 478999999999999999999999 9999999999999999999999999998765433221
Q ss_pred eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 137 VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
......++..|++||.+.+. .++.++|+||||+++|+|++|..|+...... ... ......... .
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--------~~~---~~~~~~~~~--~ 235 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--------RAL---FLITTKGIP--P 235 (286)
T ss_pred -hhccccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCHH--------HHH---HHHHhcCCC--C
Confidence 11223457889999998765 6889999999999999999999887533111 000 000000011 1
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......++..+.+++.+||+.+|.+||++.++++
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1122336678999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=241.12 Aligned_cols=226 Identities=23% Similarity=0.313 Sum_probs=170.7
Q ss_pred chhhcccccCCceeEEEEEec----CCCeEEEEEeccCc-------------------------------ceeecCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL----DGRNVAIKVLNETK-------------------------------GFCFEGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-------------------------------~~~~~~~~~~ 47 (291)
+.+.+.||+|+||.||+++.. +|+.||+|+++... ..+..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 457789999999999999763 58899999986421 2344456678
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+|+||+.+++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++
T Consensus 82 lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 82 LILDYINGGELFTHLSQR------ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 999999999999998654 468899999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
......... ......++..|+|||.+.+....++.++||||||+++|+|++|..|+........ .... .
T Consensus 153 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~----~~~~------~ 221 (290)
T cd05613 153 KEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS----QAEI------S 221 (290)
T ss_pred eeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc----HHHH------H
Confidence 765432211 1123446889999999876544678899999999999999999988864321110 0000 0
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVE 250 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~ 250 (291)
....... ...+..+...+.+++.+||+.||++|| ++.++++
T Consensus 222 ~~~~~~~--~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 222 RRILKSE--PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHhhccC--CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0000000 111233566788999999999999997 6677665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=240.16 Aligned_cols=224 Identities=26% Similarity=0.355 Sum_probs=171.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+...+.||+|+||.||++++. +++.+++|++.... +.+..+...++|+||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 355678999999999999875 48999999986432 455667788899999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+ +|.+++... ...+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 107 ~~g-~l~~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 107 CLG-SASDLLEVH-----KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCC-CHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 975 887777543 2568999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCceeeccCCCCCccccCcccccc-cCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCR-NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
. ....++..|+|||.+.+ ..+.++.++||||||+++|+|++|..||....... ... .+.
T Consensus 178 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~------~~~ 237 (317)
T cd06635 178 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALY------HIA 237 (317)
T ss_pred c------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--------HHH------HHH
Confidence 2 23456789999999743 22367889999999999999999998875431100 000 000
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
...........++..+.+++.+||+.+|.+||++.++++.+-.+
T Consensus 238 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 238 QNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred hccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 01111112234566789999999999999999999999866443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=234.30 Aligned_cols=224 Identities=29% Similarity=0.369 Sum_probs=176.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecC--Ccceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEG--HRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~--~~~~lv~e 51 (291)
+.+.+.||+|++|.||+|... +++.+++|++.... +.+... ...++++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 456789999999999999876 58999999986543 344445 67889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
++.+++|.+++... ..+++..++.++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||.+....
T Consensus 82 ~~~~~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 82 YVSGGSLSSLLKKF------GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred ecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 99999999999654 389999999999999999999999 999999999999999999999999999988765
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
............++..|++||.+.+. ..+.++||||||+++|+|++|..||...... ... ...+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~-------~~~~~ 217 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSELGNP------MAA-------LYKIG 217 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HHH-------HHhcc
Confidence 54321112334568899999998775 5899999999999999999999988765410 000 00111
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
........+...+..+.+++.+||+.||.+||++.++++
T Consensus 218 ~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 218 SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 011112223344778999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=240.93 Aligned_cols=236 Identities=22% Similarity=0.268 Sum_probs=166.1
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||+|... +++.|++|.+.... +.+..+...++|+||+.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 456788999999999999775 48999999986432 44556677889999996
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 87 -~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 87 -TDLAQYMIQH-----PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred -CCHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 5887776442 2457788899999999999999999 999999999999999999999999999987543221
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc-------hhh-hhhhhhh
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF-------PHW-VYKRLEL 206 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~-------~~~-~~~~~~~ 206 (291)
. ......+++.|+|||.+.+. ..++.++||||||+++|+|++|..||............ +.. .......
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 158 Q--TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred C--CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 1 11233458899999998653 35788999999999999999999988644321000000 000 0000000
Q ss_pred hh----hh---cccCCCCh--hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 EE----DL---GLQGIENE--EDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~~----~~---~~~~~~~~--~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. .. ........ ........+.+++.+||+.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 00 00000000 00012456789999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=234.78 Aligned_cols=224 Identities=24% Similarity=0.415 Sum_probs=176.3
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||.|+||.||++.+. +++.+++|++.... +....+...++++|++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 456788999999999999875 48999999987542 3444567888999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
++++|.+++.... .....+++..+..++.+++.||.+||+ .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 82 DGGDLSQKIKKQK--KEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred CCCcHHHHHHHhh--ccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 9999999997652 134689999999999999999999999 99999999999999999999999999998765443
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
.. ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..|+..... .. ..... ..
T Consensus 157 ~~--~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~-~~~~~---~~---- 217 (258)
T cd08215 157 VD--LAKTVVGTPYYLSPELCQNK--PYNYKSDIWSLGCVLYELCTLKHPFEGENL-------LE-LALKI---LK---- 217 (258)
T ss_pred cc--eecceeeeecccChhHhccC--CCCccccHHHHHHHHHHHHcCCCCCCCCcH-------HH-HHHHH---hc----
Confidence 31 22334578899999998765 688999999999999999999988754321 00 00000 00
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......+..++..+.+++.+||+.+|.+||++.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 218 GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0011112245677899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=231.75 Aligned_cols=224 Identities=21% Similarity=0.237 Sum_probs=176.6
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCCCHH
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNGSLE 59 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g~L~ 59 (291)
++||-|--|.|-.+..+ +|+.+|+|++.... ..........+|||+++||.|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLf 147 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELF 147 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHH
Confidence 78999999999999765 49999999987543 1222244566899999999999
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc---CCCceEEeccCCccccCCCCce
Q 022826 60 KFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---EDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 60 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
..+.++ ....|.+..+..|++||..|+.|||+ .+|.||||||+|+++. .+..+||+|||.+..... .
T Consensus 148 sriq~~----g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~---~ 217 (400)
T KOG0604|consen 148 SRIQDR----GDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE---P 217 (400)
T ss_pred HHHHHc----ccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCC---C
Confidence 999886 45679999999999999999999999 9999999999999995 456799999999986442 2
Q ss_pred eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 137 VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
......+.||.|.|||++... .++...|+||+||++|-|+.|-.||.......- .+. ++........ ..+
T Consensus 218 ~~L~TPc~TPyYvaPevlg~e--KydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spg--Mk~rI~~gqy---~FP 287 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPG--MKRRIRTGQY---EFP 287 (400)
T ss_pred ccccCCcccccccCHHHhCch--hcCCCCCccchhHHHHHhhcCCCcccccCCccC---Chh--HHhHhhccCc---cCC
Confidence 234556779999999999876 799999999999999999999999987755221 111 1111111111 112
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.+.=..+++...++|+.+|+.+|.+|.|+.++++
T Consensus 288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 2222458889999999999999999999999875
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=239.82 Aligned_cols=226 Identities=23% Similarity=0.374 Sum_probs=170.2
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|.+.+ ++.||||.++... +.+......++++||+
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 3567899999999999998865 8999999987532 4566677888999998
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+ +|.+++... ...+++..+..++.|++.||.|||+ ..+++|+||+|+||+++.++.++|+|||++......
T Consensus 97 ~~-~l~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 97 ST-CLDKLLKRI-----QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred Cc-CHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 54 787777553 2478999999999999999999996 148999999999999999999999999998765432
Q ss_pred CceeeccCCCCCccccCcccccccC--CCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNF--GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~--~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
... ....++..|+|||.+.+.. +.++.++||||||+++|+|++|..||...... ...........
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~--- 235 (296)
T cd06618 169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEE--- 235 (296)
T ss_pred Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCC---
Confidence 211 2234578899999987652 35788999999999999999999887542111 00000000000
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
... ......+...+.+++.+||+.||.+||++.++++.
T Consensus 236 ~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 236 PPS--LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCC--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 01111356678999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=242.42 Aligned_cols=238 Identities=18% Similarity=0.294 Sum_probs=169.3
Q ss_pred hcccccC--CceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhc
Q 022826 6 KNKLGQG--GYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 6 ~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~ 54 (291)
.+.||+| +||.||++++. .++.||+|++.... +++..+...++|+||+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3567777 89999999875 59999999987432 45566778889999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++++||+.+.......
T Consensus 83 ~~~l~~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~ 155 (328)
T cd08226 83 YGSANSLLKTYF----PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG 155 (328)
T ss_pred CCCHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence 999999987642 2468999999999999999999999 999999999999999999999999997554322111
Q ss_pred ce----ee-ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcc-------c-------c
Q 022826 135 SI----VS-MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSE-------I-------Y 195 (291)
Q Consensus 135 ~~----~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~-------~-------~ 195 (291)
.. .. .....++..|+|||.+.+....++.++|||||||++|+|++|..||......... . .
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence 00 00 0112235679999999765446789999999999999999999988654211000 0 0
Q ss_pred chhhhhhh----hhhh-----h--------hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 196 FPHWVYKR----LELE-----E--------DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 196 ~~~~~~~~----~~~~-----~--------~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
++...... .... . ..............++..+.+|+++||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000000 0000 0 000001112223457788999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=239.87 Aligned_cols=238 Identities=16% Similarity=0.200 Sum_probs=167.9
Q ss_pred hhcccccCCceeEEEEEecCCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhcCC
Q 022826 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+++.+|.|+++.|+++.. +++.||+|++.... +.+......+++|||+.++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 445555555555555443 69999999987541 4566677889999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc-
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES- 135 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 135 (291)
+|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+||+.+........
T Consensus 85 ~l~~~l~~~----~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 85 SCEDLLKTH----FPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred CHHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 999999764 23468899999999999999999999 9999999999999999999999999998875432211
Q ss_pred ----eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccc--------------cch
Q 022826 136 ----IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEI--------------YFP 197 (291)
Q Consensus 136 ----~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~--------------~~~ 197 (291)
........++..|+|||.+.+....++.++|+||||+++|+|++|..||.......... ..+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence 11112334567899999987643468899999999999999999999987543211000 000
Q ss_pred hhhhhhhh----hhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 198 HWVYKRLE----LEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 198 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
........ .................++..+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000000 000000001111223456778999999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=238.94 Aligned_cols=242 Identities=22% Similarity=0.313 Sum_probs=172.0
Q ss_pred chhhcccccCCceeEEEEEec---CCCeEEEEEeccCc-----------------------------ceeecC--Cccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL---DGRNVAIKVLNETK-----------------------------GFCFEG--HRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-----------------------------~~~~~~--~~~~l 48 (291)
+.+.+.||+|+||.||+|... .++.||+|.+.... +.+... ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 567788999999999999874 47899999998721 344444 77899
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC----CCceEEecc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE----DFCPKISDF 124 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~----~~~~kl~Df 124 (291)
|+||+++ +|.+++..... .....+++..++.++.|++.||.|||+ .+++|+||||+||+++. ++.++|+||
T Consensus 82 v~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQ-AKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEeCCCc-CHHHHHHhhcc-CCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999975 78777754321 122478999999999999999999999 99999999999999999 999999999
Q ss_pred CCccccCCCCc-eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc-chhhhhh
Q 022826 125 GLAKICHGRES-IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY-FPHWVYK 202 (291)
Q Consensus 125 g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~-~~~~~~~ 202 (291)
|++........ ........++..|+|||.+.+. ..++.++||||||+++|+|++|..||........... +......
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 99886543222 1122334567889999988653 3678899999999999999999988875544321000 0000000
Q ss_pred hhhh-------------------hh---hhcccCCC-ChhhH------HHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 203 RLEL-------------------EE---DLGLQGIE-NEEDK------EYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 203 ~~~~-------------------~~---~~~~~~~~-~~~~~------~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.... .. ........ ..... ..+..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 00 00000000 00001 34456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=236.52 Aligned_cols=231 Identities=25% Similarity=0.351 Sum_probs=169.9
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-------------------------------ceeecCCc-----
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------------GFCFEGHR----- 45 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------------------------------~~~~~~~~----- 45 (291)
+++.+.||+|+||.||++.+.. ++.+++|++.... +.+.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 3567899999999999998865 8999999997321 33333333
Q ss_pred ceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccC
Q 022826 46 RALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 46 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
.+++||++.+ +|.+++... ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~----~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg 152 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC----PKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFG 152 (287)
T ss_pred eEEEehhccc-CHHHHHHHc----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccC
Confidence 8899999975 898888654 22468999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLE 205 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (291)
++......... ....++..|+|||.+.+. .++.++|+||||+++|+|++|..+|........ .... .....
T Consensus 153 ~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~--~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~~~~-~~~~~ 223 (287)
T cd07838 153 LARIYSFEMAL---TSVVVTLWYRAPEVLLQS--SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---LDKI-FDVIG 223 (287)
T ss_pred cceeccCCccc---ccccccccccChHHhccC--CCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---HHHH-HHHcC
Confidence 98765433221 223357889999999775 788999999999999999999877764322110 0000 00000
Q ss_pred h-------------hh--hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 L-------------EE--DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ~-------------~~--~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. .. ..................+.+++.+||+.||.+||++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 224 LPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 00 000000011122345677889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=273.25 Aligned_cols=232 Identities=25% Similarity=0.472 Sum_probs=173.1
Q ss_pred hcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------ceeecCCcceeeehhhcCCCHHHHH
Q 022826 6 KNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------GFCFEGHRRALIYEFVSNGSLEKFI 62 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------~~~~~~~~~~lv~e~~~~g~L~~~l 62 (291)
.+.||+|+||.||+|... +++.||+|.+.... +++......++||||+++|+|.+++
T Consensus 695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l 774 (968)
T PLN00113 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL 774 (968)
T ss_pred ccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHH
Confidence 467999999999999874 58999999986432 6667778889999999999999998
Q ss_pred hhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeeccCC
Q 022826 63 YEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGA 142 (291)
Q Consensus 63 ~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 142 (291)
+ .+++..+..++.|++.|++|||..+..+++|+||||+||+++.++..++. |+........ ...
T Consensus 775 ~---------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~ 838 (968)
T PLN00113 775 R---------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKC 838 (968)
T ss_pred h---------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCc
Confidence 3 47899999999999999999995333899999999999999998887775 5544332111 122
Q ss_pred CCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhh--hhhhhcccCC--CCh
Q 022826 143 RGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLE--LEEDLGLQGI--ENE 218 (291)
Q Consensus 143 ~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~--~~~ 218 (291)
.+++.|+|||.+.+. .++.++|||||||++|||++|+.|++........ ...+...... .......+.. ...
T Consensus 839 ~~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (968)
T PLN00113 839 FISSAYVAPETRETK--DITEKSDIYGFGLILIELLTGKSPADAEFGVHGS--IVEWARYCYSDCHLDMWIDPSIRGDVS 914 (968)
T ss_pred cccccccCcccccCC--CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCc--HHHHHHHhcCccchhheeCccccCCCC
Confidence 467899999998765 7899999999999999999999998654332211 1111110000 0000000111 111
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 219 EDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 219 ~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
.......++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 223455678899999999999999999999999998755
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=234.81 Aligned_cols=225 Identities=28% Similarity=0.405 Sum_probs=177.3
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|++|.||++.+.+ ++.|++|++.... +.+......++++||+.
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 4567899999999999998765 9999999987652 45566678899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++... ..+++..++.++.|++.++.+||+ ..+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 83 ~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 83 GGSLADLLKKV------GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999654 578999999999999999999997 3889999999999999999999999999988664433
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
... ....++..|+|||.+.+. .++.++|+||||+++|+|++|..|+....... ... ..... ....
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~----~~~-~~~~~------~~~~ 219 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQPS----FFE-LMQAI------CDGP 219 (264)
T ss_pred Ccc--cceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCccccccC----HHH-HHHHH------hcCC
Confidence 221 223457899999998765 78899999999999999999998886554210 000 00000 0111
Q ss_pred CCChhhHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 215 IENEEDKE-YARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 215 ~~~~~~~~-~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
....... ++..+.+++.+||+.+|++||++.++++.
T Consensus 220 -~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 220 -PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1112223 67789999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=240.96 Aligned_cols=211 Identities=26% Similarity=0.329 Sum_probs=175.8
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e 51 (291)
.++...||+|+||.|.+|.-+. .+.+|||++++.. .++..-++.|+|||
T Consensus 351 FnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVME 430 (683)
T KOG0696|consen 351 FNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVME 430 (683)
T ss_pred cceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEE
Confidence 3566789999999999996544 7889999998765 45666788999999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.||+|-..++.. .++.+..+..++.+|+.||-+||+ ++|+.||||.+|||++.+|.+||.|||++..--
T Consensus 431 yvnGGDLMyhiQQ~------GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 431 YVNGGDLMYHIQQV------GKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EecCchhhhHHHHh------cccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999888776 578888899999999999999999 999999999999999999999999999987421
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
.........+|||.|+|||++..+ .|+..+|.||+|+++|||+.|..||+...... .-+.+.
T Consensus 502 --~~~~TTkTFCGTPdYiAPEIi~Yq--PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--------------lF~aI~ 563 (683)
T KOG0696|consen 502 --FDGVTTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--------------LFQAIM 563 (683)
T ss_pred --cCCcceeeecCCCcccccceEEec--ccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--------------HHHHHH
Confidence 122234678899999999999877 99999999999999999999999998764321 111111
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCC
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDR 242 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~R 242 (291)
.. ....++.++.+...+++..|.+.|.+|
T Consensus 564 eh--nvsyPKslSkEAv~ickg~ltK~P~kR 592 (683)
T KOG0696|consen 564 EH--NVSYPKSLSKEAVAICKGLLTKHPGKR 592 (683)
T ss_pred Hc--cCcCcccccHHHHHHHHHHhhcCCccc
Confidence 11 133567789999999999999999999
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=235.27 Aligned_cols=220 Identities=26% Similarity=0.350 Sum_probs=168.8
Q ss_pred cccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehhhcCCCH
Q 022826 9 LGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 9 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
||+|+||.||++.+.+ ++.+++|++.... +....+...++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999998865 9999999986542 344556778899999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc---
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES--- 135 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 135 (291)
.+++... ..+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~------~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 81 ASLLENV------GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 9999654 378999999999999999999999 9999999999999999999999999999875433221
Q ss_pred ---eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 136 ---IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 136 ---~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
........++..|++||...+. ..+.++|+||||+++|++++|..|+...... ....... .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~-~~~~~- 219 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGETPE--------EIFQNIL-NGKIE- 219 (265)
T ss_pred ccccccccCcccCccccCHHHhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHh-cCCcC-
Confidence 1112334467889999998765 5888999999999999999999888644211 0000000 00010
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
.......+..+.+++.+||+.+|.+|||+..+.+.|+
T Consensus 220 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 ----WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ----CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 1111113678899999999999999999966665553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=233.17 Aligned_cols=220 Identities=27% Similarity=0.374 Sum_probs=174.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|++|.||++... +++.|++|.+.... +.+......+++++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 457789999999999999775 48899999986553 3455567788999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+++|.+++... ..+++..++.++.|++.+|.+||+ .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 82 ENGSLRQIIKKF------GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCcHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999998654 578999999999999999999999 99999999999999999999999999998876543
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
... .....++..|+|||.+.+. ..+.++|||+||+++|+|++|..|+...... .. .. ... .
T Consensus 153 ~~~--~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~-~~-~~~--~----- 213 (254)
T cd06627 153 SKD--DASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLNPM------AA-LF-RIV--Q----- 213 (254)
T ss_pred ccc--ccccccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HH-HH-HHh--c-----
Confidence 321 2234568899999998765 5788999999999999999999887643210 00 00 000 0
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......+...+..+.+++.+||+.+|++||++.+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 214 DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0111122345678889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=238.16 Aligned_cols=238 Identities=21% Similarity=0.300 Sum_probs=172.3
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||.|++|.||+|.+. +++.||+|+++... +.+......++|+||+.
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 567789999999999999875 48999999987542 45556677899999998
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+ +|.+++.... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~-~l~~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 82 K-DLKKYMDTHG---VRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred c-cHHHHHHhcC---CCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 5 8988886542 23568999999999999999999999 999999999999999999999999999987543321
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc------h-hhhhhhhhhh
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF------P-HWVYKRLELE 207 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~------~-~~~~~~~~~~ 207 (291)
. ......++..|++||.+.+. ..++.++||||||+++|+|++|..||............ + ...+......
T Consensus 155 ~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 155 N--TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred c--ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC
Confidence 1 11233457889999988653 35788999999999999999999887654321000000 0 0000000000
Q ss_pred hhhcc--cCCC----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 208 EDLGL--QGIE----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 208 ~~~~~--~~~~----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..... +... ....+..+..+.+++.+||+.||.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 0000 0112234677889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=237.31 Aligned_cols=234 Identities=23% Similarity=0.362 Sum_probs=170.2
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehhhc
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~ 54 (291)
.+.+.||+|+||+||+|...+ ++.|++|.+.... +.+..+...++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 467899999999999998864 8899999876532 3444567788999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++... ....+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 81 EGNLYQLMKDR----KGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred CCCHHHHHHhc----ccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 77999988664 23578999999999999999999999 999999999999999999999999999987654332
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccc---------cchhhhhhhhh
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEI---------YFPHWVYKRLE 205 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~---------~~~~~~~~~~~ 205 (291)
. .....++..|+|||.+.+. ..++.++|+||||+++|+|++|..+|.......... ....+... ..
T Consensus 154 ~---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 228 (283)
T cd07830 154 P---YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG-YK 228 (283)
T ss_pred C---cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhH-hh
Confidence 1 1223467889999988653 367899999999999999999998876443211000 00000000 00
Q ss_pred hhhhh--cccCCC----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 LEEDL--GLQGIE----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ~~~~~--~~~~~~----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..... ..+... ..........+.+++++||+.||++|||++|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000 000000 0001112467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=241.52 Aligned_cols=232 Identities=19% Similarity=0.275 Sum_probs=174.7
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-------------------------------ceeecCCcceeeeh
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------------------------------~~~~~~~~~~lv~e 51 (291)
.+...+|+|.||.|-.+.+.. +..||||+++.-. .++...+..|+|+|
T Consensus 92 ~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfe 171 (415)
T KOG0671|consen 92 EIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFE 171 (415)
T ss_pred ehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEe
Confidence 456789999999999998755 7899999987543 56777888999999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc-----------------
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD----------------- 114 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~----------------- 114 (291)
.+ |-|+.+++.++ +..+++..++.+|.+|+++++.+||+ .+++|.||||+||++.
T Consensus 172 ll-G~S~~dFlk~N----~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 172 LL-GLSTFDFLKEN----NYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred cc-ChhHHHHhccC----CccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCcccee
Confidence 99 44999999886 45789999999999999999999999 9999999999999982
Q ss_pred ---CCCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCC
Q 022826 115 ---EDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRS 191 (291)
Q Consensus 115 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~ 191 (291)
.+..++|+|||.+....... +....|-.|+|||++.|- +++.++||||+||+++|+.+|...|+.-.+..
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred ccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheecc--CcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 13358999999998644443 334458899999999998 99999999999999999999998877555332
Q ss_pred ccc-------cchhhhhhhhhh-----hhhhcccCCCC------------------hhhHHHHHHHHHHHHHhhhcCCCC
Q 022826 192 SEI-------YFPHWVYKRLEL-----EEDLGLQGIEN------------------EEDKEYARKMILVSLWCIQNNPSD 241 (291)
Q Consensus 192 ~~~-------~~~~~~~~~~~~-----~~~~~~~~~~~------------------~~~~~~~~~l~~l~~~~l~~dP~~ 241 (291)
..- .+|......... ...+.++.... .........|.+|+++||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 100 011111111100 00111110000 011235566999999999999999
Q ss_pred CCCHHHHHH
Q 022826 242 RPAMNRVVE 250 (291)
Q Consensus 242 Rps~~ell~ 250 (291)
|+|+.|++.
T Consensus 397 RiTl~EAL~ 405 (415)
T KOG0671|consen 397 RITLREALS 405 (415)
T ss_pred cccHHHHhc
Confidence 999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=259.44 Aligned_cols=237 Identities=19% Similarity=0.220 Sum_probs=158.5
Q ss_pred chhhcccccCCceeEEEEEec-C----CCeEEEEEeccCc-----------------------c----e-eecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-D----GRNVAIKVLNETK-----------------------G----F-CFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~-----------------------~----~-~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|.+. + +..||+|++.... . . ...+...++|
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV 213 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEYWLV 213 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCceEEE
Confidence 445689999999999999774 4 6899999876422 0 0 1355678999
Q ss_pred ehhhcCCCHHHHHhhcCCC--------------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC
Q 022826 50 YEFVSNGSLEKFIYEKHPL--------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE 115 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~--------------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~ 115 (291)
++|+.+++|.+++...... ..........+..++.||+.||.|||+ .+|+|+||||+|||++.
T Consensus 214 ~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NILl~~ 290 (566)
T PLN03225 214 WRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIFSE 290 (566)
T ss_pred EEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHEEEeC
Confidence 9999999999998754210 001112334567899999999999999 99999999999999985
Q ss_pred -CCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCC--------------------CccccccchhHHHHH
Q 022826 116 -DFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFG--------------------EVSYKSDVYSYGMMV 174 (291)
Q Consensus 116 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~--------------------~~~~~~DiwslG~~l 174 (291)
++.+||+|||++..+...... ......+++.|+|||.+..... .++.++|||||||++
T Consensus 291 ~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL 369 (566)
T PLN03225 291 GSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 369 (566)
T ss_pred CCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHH
Confidence 589999999999865433221 1234567899999997643211 234567999999999
Q ss_pred HHHhCCCCCCccccCCC------ccccchhhhhhhhhhhhhhcccCCCCh------hhHHHHHHHHHHHHHhhhcCCCCC
Q 022826 175 FEMTGVKNNANVAVDRS------SEIYFPHWVYKRLELEEDLGLQGIENE------EDKEYARKMILVSLWCIQNNPSDR 242 (291)
Q Consensus 175 ~~ll~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~l~~~~l~~dP~~R 242 (291)
|+|+++..++....... .......| . .......... ..........+|+.+||+.||++|
T Consensus 370 ~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~--~------~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 370 LQMAFPNLRSDSNLIQFNRQLKRNDYDLVAW--R------KLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHhCcCCCchHHHHHHHHHHhcCCcHHHH--H------HhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 99998665433210000 00000000 0 0000000000 000112235589999999999999
Q ss_pred CCHHHHHHH
Q 022826 243 PAMNRVVEM 251 (291)
Q Consensus 243 ps~~ell~~ 251 (291)
||+.++++.
T Consensus 442 ~ta~e~L~H 450 (566)
T PLN03225 442 ISAKAALAH 450 (566)
T ss_pred CCHHHHhCC
Confidence 999999873
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=237.51 Aligned_cols=217 Identities=23% Similarity=0.336 Sum_probs=167.7
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCCCHH
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNGSLE 59 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g~L~ 59 (291)
.+||+|+||.||++... +++.|++|++.... +.+..++..+++|||+.+++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 56999999999999774 58999999975422 4556678899999999999999
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeec
Q 022826 60 KFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSM 139 (291)
Q Consensus 60 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 139 (291)
+++.. ..+++..+..++.|++.++.|||+ .+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 106 ~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~ 173 (292)
T cd06657 106 DIVTH-------TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RR 173 (292)
T ss_pred HHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cc
Confidence 98743 368899999999999999999999 9999999999999999999999999998875543221 12
Q ss_pred cCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChh
Q 022826 140 TGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEE 219 (291)
Q Consensus 140 ~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (291)
....+++.|++||.+.+. .++.++|+||+|+++|+|++|..|+....... ..... .. ..+. ....
T Consensus 174 ~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--------~~~~~---~~-~~~~-~~~~ 238 (292)
T cd06657 174 KSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--------AMKMI---RD-NLPP-KLKN 238 (292)
T ss_pred cccccCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHH---Hh-hCCc-ccCC
Confidence 234568899999998664 67889999999999999999998876431100 00000 00 0000 0111
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 220 DKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 220 ~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
...++..+.+++.+||+.||.+||++.++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 1234556888999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=224.74 Aligned_cols=221 Identities=24% Similarity=0.362 Sum_probs=170.9
Q ss_pred cccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehhhcCCC
Q 022826 7 NKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
.-||.|+-|.||+++... |+.+|||...+.. +++..+....+-||.+.- .
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C 176 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-C 176 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-H
Confidence 569999999999998755 9999999998765 555666666677787744 6
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
++.+++. ...++++..+-++...+++||.||-. .++|+|||+||.||++|+.|++|+||||.+..+-...
T Consensus 177 ~ekLlkr-----ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--- 246 (391)
T KOG0983|consen 177 AEKLLKR-----IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--- 246 (391)
T ss_pred HHHHHHH-----hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc---
Confidence 6777755 34679999999999999999999997 3789999999999999999999999999986542211
Q ss_pred eccCCCCCccccCccccccc-CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~-~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
..+...|.+.|+|||.+... ...|+.++||||||+.++|+.||..|+..-.. ......++.. ..+ ..
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-------dFe~ltkvln----~eP-P~ 314 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-------DFEVLTKVLN----EEP-PL 314 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-------cHHHHHHHHh----cCC-CC
Confidence 23455689999999999765 35788999999999999999999998875322 1111111111 111 11
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......++..+.+++..||.+|+.+||...+|++
T Consensus 315 L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 315 LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1222338899999999999999999999998875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=232.85 Aligned_cols=198 Identities=20% Similarity=0.183 Sum_probs=157.5
Q ss_pred CCceeEEEEEec-CCCeEEEEEeccCc---------------------ceeecCCcceeeehhhcCCCHHHHHhhcCCCC
Q 022826 12 GGYGGVYKGKLL-DGRNVAIKVLNETK---------------------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLE 69 (291)
Q Consensus 12 G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~ 69 (291)
|.+|.||++++. +++.+|+|.+.... +.+......+++|||+.+++|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---- 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF---- 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh----
Confidence 899999999875 48999999998653 3445567889999999999999998654
Q ss_pred CCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeeccCCCCCcccc
Q 022826 70 TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYI 149 (291)
Q Consensus 70 ~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 149 (291)
..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++++|||.+....... ....++..|+
T Consensus 80 --~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~ 149 (237)
T cd05576 80 --LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYC 149 (237)
T ss_pred --cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcccc
Confidence 368999999999999999999999 999999999999999999999999999876543321 2233467799
Q ss_pred CcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHH
Q 022826 150 APEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMIL 229 (291)
Q Consensus 150 aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 229 (291)
|||.+.+. .++.++|+||+|+++|+|++|..++........ .... ...+..++..+.+
T Consensus 150 aPE~~~~~--~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------------~~~~-------~~~~~~~~~~~~~ 207 (237)
T cd05576 150 APEVGGIS--EETEACDWWSLGAILFELLTGKTLVECHPSGIN-------------THTT-------LNIPEWVSEEARS 207 (237)
T ss_pred CCcccCCC--CCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------------cccc-------cCCcccCCHHHHH
Confidence 99998665 678899999999999999999876542211000 0000 0112335667889
Q ss_pred HHHHhhhcCCCCCCCH
Q 022826 230 VSLWCIQNNPSDRPAM 245 (291)
Q Consensus 230 l~~~~l~~dP~~Rps~ 245 (291)
++.+||+.||++||++
T Consensus 208 li~~~l~~dp~~R~~~ 223 (237)
T cd05576 208 LLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHccCCHHHhcCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=242.63 Aligned_cols=240 Identities=24% Similarity=0.233 Sum_probs=170.3
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeec-----CCccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFE-----GHRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~-----~~~~~l 48 (291)
+.+.+.||+|+||.||++.+. +++.|++|.+.... +++.. ....++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 455688999999999999875 48999999986431 11111 134789
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
++||+. ++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.
T Consensus 87 v~e~~~-~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 87 VYELMD-TDLHQIIRSS------QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEeCCC-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 999996 5898888543 579999999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc--------chh-h
Q 022826 129 ICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY--------FPH-W 199 (291)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~--------~~~-~ 199 (291)
....... ......++..|+|||.+.+. ..++.++||||||+++|+|++|..||........... .+. +
T Consensus 157 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 157 TTSEKGD--FMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred ccCCCcc--cccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 6543321 11233467899999988653 2588999999999999999999998864321000000 000 0
Q ss_pred ---hhhh-hhhhhhhccc--CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhh
Q 022826 200 ---VYKR-LELEEDLGLQ--GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM--LEGS 255 (291)
Q Consensus 200 ---~~~~-~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~--L~~~ 255 (291)
.... .......... .........++..+.+++++||+.+|++|||+.++++. ++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000 0000000000 00011123456778999999999999999999999876 5554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=251.04 Aligned_cols=222 Identities=23% Similarity=0.360 Sum_probs=171.1
Q ss_pred hcccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCCCH
Q 022826 6 KNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
.-.||.|+||.||+|..+. +-..|.|++.... +-.+.....+++.|||.||-+
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV 116 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV 116 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence 4458999999999998755 5556677766544 233445667789999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
..++-+ -+..+.+.++.-++++++.+|.|||+ ++|+|+|||+.||++.-+|.++|+|||++...... ...
T Consensus 117 DaimlE-----L~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qk 186 (1187)
T KOG0579|consen 117 DAIMLE-----LGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQK 186 (1187)
T ss_pred hHHHHH-----hccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH--Hhh
Confidence 988865 34789999999999999999999999 99999999999999999999999999998643221 111
Q ss_pred ccCCCCCccccCcccccc---cCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 139 MTGARGTVGYIAPEVFCR---NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~---~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
.....|||.|+|||+... ....|+.++||||||+++.+|..+.+|-.... + ++.......-..+.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--------p---MRVllKiaKSePPT- 254 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--------P---MRVLLKIAKSEPPT- 254 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc--------h---HHHHHHHhhcCCCc-
Confidence 244678999999998643 33589999999999999999998886554331 1 11111122112222
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
...+..|+..|.+++.+||.+||..||++.+|++
T Consensus 255 -LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 255 -LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 2245679999999999999999999999999875
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=245.33 Aligned_cols=232 Identities=24% Similarity=0.235 Sum_probs=165.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceee------cCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCF------EGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~------~~~~~~ 47 (291)
+.+.+.||+|+||.||++.+. +++.||+|++.... +.+. +....+
T Consensus 18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 97 (353)
T cd07850 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY 97 (353)
T ss_pred eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence 345688999999999999875 59999999986421 1111 123468
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+|+||+.+ +|.+.+.. .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 98 lv~e~~~~-~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 98 LVMELMDA-NLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred EEEeccCC-CHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 99999965 88887732 38888999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCc------cccch-hhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSS------EIYFP-HWV 200 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~------~~~~~-~~~ 200 (291)
........ .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||........ ....+ ...
T Consensus 166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 166 RTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred eeCCCCCC---CCCCcccccccCHHHHhCC--CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 76543221 2233467899999999775 789999999999999999999988864421100 00000 000
Q ss_pred hhhhh--hhhhhc------------------ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 201 YKRLE--LEEDLG------------------LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 201 ~~~~~--~~~~~~------------------~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
..... ...... .+..........+..+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 000000 0000001122346678899999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=232.90 Aligned_cols=223 Identities=23% Similarity=0.255 Sum_probs=170.6
Q ss_pred cchhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------------ceeec--CCcce
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------------GFCFE--GHRRA 47 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------------~~~~~--~~~~~ 47 (291)
.+.+.+.||+|+||.||++.+. +++.+++|.+.... +.+.. ....+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 3567899999999999999875 48999999875321 22222 34577
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+++||+.+++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 83 ~v~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAY------GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEeCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 899999999999998654 358899999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCc-eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh
Q 022826 128 KICHGRES-IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 128 ~~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
+....... ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... . ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~----~~~-- 218 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYEA-------M----AAI-- 218 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccCH-------H----HHH--
Confidence 86533211 0111234568899999999775 688999999999999999999998764311 0 001
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
............+..+...+.+++.+||+ +|..||++.+++.
T Consensus 219 -~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 219 -FKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -HHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11111111223345677889999999999 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=237.43 Aligned_cols=221 Identities=25% Similarity=0.379 Sum_probs=172.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||++... +++.+++|++.... +.+..+...+++||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 456789999999999999875 59999999986521 34456678889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
++.+++|.+++... ..+++..++.++.|++.||.+||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~~~~~~L~~~l~~~------~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 83 YAPNGELLQYIRKY------GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999654 479999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCce------------------eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcc
Q 022826 132 GRESI------------------VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSE 193 (291)
Q Consensus 132 ~~~~~------------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~ 193 (291)
..... .......++..|+|||...+. .++.++||||||++++++++|..|+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--- 228 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--- 228 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCCccHH---
Confidence 33211 111223467899999988765 6888999999999999999999888754310
Q ss_pred ccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCH----HHHHH
Q 022826 194 IYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAM----NRVVE 250 (291)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~----~ell~ 250 (291)
...... .. .....+..++..+.+++.+||+.+|.+||++ +++++
T Consensus 229 -----~~~~~~---~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 -----LTFQKI---LK-----LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -----HHHHHH---Hh-----cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 000000 00 0111223446778999999999999999999 76654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=237.85 Aligned_cols=221 Identities=26% Similarity=0.351 Sum_probs=168.9
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+...+.||+|+||.||+|++.. ++.+++|.+.... +.+......++|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 3456789999999999998754 8899999986321 455566778899999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+. ++|.+++... ...+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 97 ~~-~~l~~~~~~~-----~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 97 CL-GSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred cC-CCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 96 5888877543 2468899999999999999999999 9999999999999999999999999998875432
Q ss_pred CCceeeccCCCCCccccCcccccc-cCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCR-NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
. ....+++.|+|||.+.+ ....++.++||||||+++|+|++|..|+....... ......
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------------~~~~~~ 227 (308)
T cd06634 168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------------ALYHIA 227 (308)
T ss_pred c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--------------HHHHHh
Confidence 2 23346789999999753 12357889999999999999999998875431100 000000
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L 252 (291)
...........++..+.+++.+||+.+|++||++.++++.-
T Consensus 228 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred hcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 01111112334667789999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=237.51 Aligned_cols=236 Identities=22% Similarity=0.263 Sum_probs=170.1
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecC--Ccceeeehh
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEG--HRRALIYEF 52 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~--~~~~lv~e~ 52 (291)
.+.+.||+|+||.||+|...+ ++.+++|.+.... +.+... ...++|++|
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 467889999999999998764 8999999997651 344444 788999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+ +|.+++... ...+++..++.++.||+.||.+||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 82 ~~~-~l~~~~~~~-----~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 82 MDH-DLTGLLDSP-----EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred ccc-cHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 975 898888543 2578999999999999999999999 9999999999999999999999999999886644
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccch-------hhhhhhhh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFP-------HWVYKRLE 205 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~-------~~~~~~~~ 205 (291)
... .......++..|+|||.+.+. ..++.++||||||+++|+|++|..|+............. ...+....
T Consensus 153 ~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 153 RNS-ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred CCc-ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccc
Confidence 321 112233457789999987654 357899999999999999999998876432210000000 00000000
Q ss_pred ---hhhhhcccC----CCChhhHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 ---LEEDLGLQG----IENEEDKE-YARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ---~~~~~~~~~----~~~~~~~~-~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......... ........ ++..+.+++++||+.+|.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000 00001111 2678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=241.71 Aligned_cols=238 Identities=23% Similarity=0.290 Sum_probs=164.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeec--------CCc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFE--------GHR 45 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~--------~~~ 45 (291)
+.+.+.||+|+||.||+|... +++.||+|++.... +++.. ...
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 445688999999999999875 48999999885432 22221 234
Q ss_pred ceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccC
Q 022826 46 RALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 46 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
.++|+||+.+ +|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||
T Consensus 94 ~~lv~e~~~~-~l~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 94 FYLVFEFCEH-DLAGLLSNK-----NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred EEEEEcCCCc-CHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCC
Confidence 5899999975 888887543 2478999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCce--eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc-------
Q 022826 126 LAKICHGRESI--VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF------- 196 (291)
Q Consensus 126 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~------- 196 (291)
++......... .......++..|+|||.+.+. ..++.++||||||+++|+|++|..++............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 98765432211 112233467889999988654 34688999999999999999999877544221000000
Q ss_pred hhhhhhhh---hhhhhhcccCCCC-hh-----hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 197 PHWVYKRL---ELEEDLGLQGIEN-EE-----DKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 197 ~~~~~~~~---~~~~~~~~~~~~~-~~-----~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
+....... ........+.... .. .......+.+++.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000 0000000000000 00 0012345778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=248.07 Aligned_cols=215 Identities=20% Similarity=0.301 Sum_probs=173.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------ceeecCCcceeeehhhcCCCH
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
+.+...+|.|+|+.|-++.+. +++..++|++.... +.+..+...++|||.+.|+-+
T Consensus 324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~el 403 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGEL 403 (612)
T ss_pred hccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHH
Confidence 345677999999999999764 48999999998773 567778889999999999988
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE-cCCCceEEeccCCccccCCCCcee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL-DEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill-~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
.+.+... +.....+..|+++|+.++.|||+ +|+||||+||+||++ +..|.++|+|||.+......
T Consensus 404 l~ri~~~-------~~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 404 LRRIRSK-------PEFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---- 469 (612)
T ss_pred HHHHHhc-------chhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence 7777543 22337788999999999999999 999999999999999 68899999999998876544
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
....+.|..|.|||++... .+++++||||||+++|+|++|..|+...... ......+..+
T Consensus 470 -~~tp~~t~~y~APEvl~~~--~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------------~ei~~~i~~~---- 529 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAIQ--EYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------------IEIHTRIQMP---- 529 (612)
T ss_pred -hcccchhhcccChhhhccC--CCCcchhhHHHHHHHHHHHhCCCccccCCch-------------HHHHHhhcCC----
Confidence 2334558899999999865 9999999999999999999999988765432 0111111111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.....++..+.+|+++||+.||.+|+++.++..-
T Consensus 530 ~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 530 KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1115678889999999999999999999998653
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=234.90 Aligned_cols=235 Identities=22% Similarity=0.286 Sum_probs=172.3
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhc
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~ 54 (291)
.+.+.||+|++|.||++... +++.+++|.+.... +.+..+...++++||+.
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 45688999999999999875 58999999986543 34555677889999997
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+ +|.+++... ...+++..+..++.|++.||.+||+ .+++|+||||+||+++.++.++|+|||.+.......
T Consensus 82 ~-~l~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 82 T-DLYKLIKDR-----QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred C-CHHHHHHhh-----cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 5 888888653 2578999999999999999999999 999999999999999999999999999987664433
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc------h-hhhhhhhhh-
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF------P-HWVYKRLEL- 206 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~------~-~~~~~~~~~- 206 (291)
. ......++..|+|||.+.+. ..++.++|+||||+++|+|++|..+|............ + .........
T Consensus 153 ~--~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 R--PYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred c--cccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh
Confidence 1 12233467889999998764 36889999999999999999999887544321100000 0 000000000
Q ss_pred --hhhhcccC----CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 --EEDLGLQG----IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 --~~~~~~~~----~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......+. ........++..+.+++.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000000 001123356788999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=253.86 Aligned_cols=205 Identities=17% Similarity=0.195 Sum_probs=139.1
Q ss_pred ceeecCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC
Q 022826 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 117 (291)
Q Consensus 38 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~ 117 (291)
+++......+++++++.+ +|.+++..... ..........+..++.||+.||.|||+ ++|+|+||||+|||++.++
T Consensus 230 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~-~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 230 EILRSEANTYMITQKYDF-DLYSFMYDEAF-DWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred EEEEECCeeEEEEecccc-CHHHHHhhccc-cccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCC
Confidence 455666778899999854 78777754321 112334567788999999999999999 9999999999999999999
Q ss_pred ceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc--
Q 022826 118 CPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY-- 195 (291)
Q Consensus 118 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~-- 195 (291)
.+||+|||++..+....... .....|+..|+|||++.+. .++.++|||||||++|+|+++..++...........
T Consensus 305 ~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999998765432211 1234679999999999876 789999999999999999998755433222110000
Q ss_pred ------------chhhhhhhhhhhhhhcccCCCCh-----hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 196 ------------FPHWVYKRLELEEDLGLQGIENE-----EDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 196 ------------~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
++..................... ........+.+++.+||+.||++|||+.|+++
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000000000000000000000 01123445778899999999999999999986
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=240.20 Aligned_cols=238 Identities=22% Similarity=0.276 Sum_probs=169.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------cee----ecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFC----FEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~----~~~~~~~lv 49 (291)
+.+.+.||+|+||.||++... +++.|++|++.... +.+ ......++|
T Consensus 7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 86 (334)
T cd07855 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86 (334)
T ss_pred eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence 345688999999999999875 49999999987542 111 123457899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
+||+. ++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++..
T Consensus 87 ~e~~~-~~l~~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 87 MDLME-SDLHHIIHSD------QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred Eehhh-hhHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99996 5898888543 468999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCce--eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccc------c-chhhh
Q 022826 130 CHGRESI--VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEI------Y-FPHWV 200 (291)
Q Consensus 130 ~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~------~-~~~~~ 200 (291)
....... .......++..|+|||.+.+. ..++.++||||||+++|+|++|+.||.......... . .+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 5432211 111234568899999998653 357899999999999999999999986542210000 0 00000
Q ss_pred hhhh---hhhhhh-cccCCC----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 201 YKRL---ELEEDL-GLQGIE----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 201 ~~~~---~~~~~~-~~~~~~----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.... ...... ...... ....+..+..+.+++++||+.+|.+||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000 000000 000000 11123457789999999999999999999998773
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=250.04 Aligned_cols=243 Identities=26% Similarity=0.377 Sum_probs=183.0
Q ss_pred hcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------ceeec--------CCcceeeeh
Q 022826 6 KNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------GFCFE--------GHRRALIYE 51 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------~~~~~--------~~~~~lv~e 51 (291)
.+.||+|+||.||+|+++ .|+.||||++.... .+..+ ...-+++||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 478999999999999865 49999999988733 22222 234568999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc--CCC--ceEEeccCCc
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD--EDF--CPKISDFGLA 127 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~--~~~--~~kl~Dfg~~ 127 (291)
||.+|||...+.+- ++..++++...+.++.++..||.|||+ ++|+||||||.||++- .+| ..||+|||.|
T Consensus 98 yC~gGsL~~~L~~P---EN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSP---ENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ecCCCcHHHHhcCc---ccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999764 467899999999999999999999999 9999999999999993 334 4699999999
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCc--cccchhhhhhhhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSS--EIYFPHWVYKRLE 205 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~--~~~~~~~~~~~~~ 205 (291)
+.++.+. ......||+.|++||++..+ ..++..+|.|||||++|+.+||..||.+...... +..+.....+...
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 9887665 34667889999999999752 3889999999999999999999999976644321 1111111100000
Q ss_pred --------hhhhhccc-CC--CChhhHHHHHHHHHHHHHhhhcCCCCCC--CHHHHHHHHHhhhcc
Q 022826 206 --------LEEDLGLQ-GI--ENEEDKEYARKMILVSLWCIQNNPSDRP--AMNRVVEMLEGSLDS 258 (291)
Q Consensus 206 --------~~~~~~~~-~~--~~~~~~~~~~~l~~l~~~~l~~dP~~Rp--s~~ell~~L~~~~~~ 258 (291)
..+.+.+. .+ .......+...+-+++..+|..+|.+|. ...+....++++++.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 00001110 00 1122345667788899999999999998 888888888887764
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=239.10 Aligned_cols=237 Identities=22% Similarity=0.254 Sum_probs=166.8
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeec----------C
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFE----------G 43 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~----------~ 43 (291)
+.+.+.||+|+||.||+|.+.. ++.|++|+++... +.+.. .
T Consensus 9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 88 (302)
T cd07864 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDK 88 (302)
T ss_pred hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccC
Confidence 4567899999999999998754 8999999996432 12221 2
Q ss_pred CcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEec
Q 022826 44 HRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISD 123 (291)
Q Consensus 44 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~D 123 (291)
...++++||+++ ++...+... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|
T Consensus 89 ~~~~lv~e~~~~-~l~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 89 GAFYLVFEYMDH-DLMGLLESG-----LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred CcEEEEEcccCc-cHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCc
Confidence 368899999976 777777543 2578999999999999999999999 9999999999999999999999999
Q ss_pred cCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhh-
Q 022826 124 FGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYK- 202 (291)
Q Consensus 124 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~- 202 (291)
||++........ ........+..|+|||.+.+. ..++.++||||||+++|+|++|..||...........+......
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999876543322 111223346789999988653 35788999999999999999999887643221000000000000
Q ss_pred ------hhhhhhhh---c-ccC---CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 203 ------RLELEEDL---G-LQG---IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 203 ------~~~~~~~~---~-~~~---~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
........ . ... ........++..+.+++.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000 0 000 000011124677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=240.30 Aligned_cols=237 Identities=23% Similarity=0.236 Sum_probs=168.3
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceee--cCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCF--EGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~--~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||+|.+. +++.+++|++.... +++. +....++|+
T Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07852 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF 88 (337)
T ss_pred HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence 456689999999999999875 48899999874311 2222 234578999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
||+.+ +|..++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 89 e~~~~-~L~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 89 EYMET-DLHAVIRA-------NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred ccccc-CHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99975 99888843 267888999999999999999999 99999999999999999999999999998866
Q ss_pred CCCCce---eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc-------hhhh
Q 022826 131 HGRESI---VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF-------PHWV 200 (291)
Q Consensus 131 ~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~-------~~~~ 200 (291)
...... .......++..|+|||.+.+. ..++.++||||||+++|+|++|+.||............ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred ccccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 443221 122233468899999987653 36788999999999999999999888643221100000 0000
Q ss_pred hhhh--hhhh----hhcccC--CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 201 YKRL--ELEE----DLGLQG--IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 201 ~~~~--~~~~----~~~~~~--~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.... .... ...... ......+.++..+.+++.+||+.||.+|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000 0000 000000 0011122256788999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=235.41 Aligned_cols=217 Identities=27% Similarity=0.392 Sum_probs=166.5
Q ss_pred hcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehhhcC
Q 022826 6 KNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
.+.||+|+||.||+|+.. +++.|++|++.... +.+......++|+||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 367999999999999874 48999999986432 45566778899999996
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++... ...+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 105 ~~l~~~l~~~-----~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 105 GSASDLLEVH-----KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 4888877543 2568999999999999999999999 9999999999999999999999999998764321
Q ss_pred eeeccCCCCCccccCcccccc-cCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 136 IVSMTGARGTVGYIAPEVFCR-NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
.....++..|+|||.+.+ ....++.++||||||+++|+|++|..|+........ . .. .....
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-------~-~~------~~~~~ 236 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------L-YH------IAQND 236 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-------H-HH------HHhcC
Confidence 123456789999999853 123678899999999999999999988765422110 0 00 00011
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
........++..+.+++.+||+.+|.+||++.++++.
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 237 SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111223355678899999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=235.92 Aligned_cols=237 Identities=22% Similarity=0.298 Sum_probs=168.0
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|++|.||+|.+. +++.|++|.+.... +.+..+...++|+||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 456789999999999999875 58999999886431 4566677889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC-CCceEEeccCCccccCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-DFCPKISDFGLAKICHG 132 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~-~~~~kl~Dfg~~~~~~~ 132 (291)
.+ +|.+++... ....+++..++.++.||+.||.|||+ .+++|+||+|+||+++. ++.+||+|||++.....
T Consensus 84 ~~-~l~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 84 DL-DLKKHMDSS----PDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred cc-cHHHHHHhC----CCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 64 888887553 22346888899999999999999999 99999999999999985 55799999999875433
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc------h-hhhhhhhh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF------P-HWVYKRLE 205 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~------~-~~~~~~~~ 205 (291)
... ......+++.|+|||.+.+. ..++.++||||||+++|+|++|..||............ + ...+....
T Consensus 156 ~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 156 PVR--TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred Ccc--ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 211 11233457899999998653 36788999999999999999999888653221000000 0 00000000
Q ss_pred h--hhhhcccCCCC----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 L--EEDLGLQGIEN----EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ~--~~~~~~~~~~~----~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. ......+.... ......+..+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000000000 011235667889999999999999999999986
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=240.78 Aligned_cols=236 Identities=22% Similarity=0.229 Sum_probs=168.2
Q ss_pred hhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------------------ceeecC
Q 022826 5 FKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------------------GFCFEG 43 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------------------~~~~~~ 43 (291)
+.+.||.|+||.||+|.+. .++.||||++.... +.+..+
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 4577999999999999875 48999999875321 344556
Q ss_pred CcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEec
Q 022826 44 HRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISD 123 (291)
Q Consensus 44 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~D 123 (291)
...+++|||+. ++|.+++... ..+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRK------IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECC
Confidence 67889999997 5999988543 468999999999999999999999 9999999999999999999999999
Q ss_pred cCCccccCCCC------------ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCC
Q 022826 124 FGLAKICHGRE------------SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRS 191 (291)
Q Consensus 124 fg~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~ 191 (291)
||++....... .........++..|+|||.+.+. ..++.++||||||+++|+|++|..||.......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99987654111 01111223357789999998764 357889999999999999999998886543211
Q ss_pred ccccchhhh-------hhhhhhhh---h--hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 192 SEIYFPHWV-------YKRLELEE---D--LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 192 ~~~~~~~~~-------~~~~~~~~---~--~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
......... +....... . ...+..........+..+.+++.+||+.+|++||++.|++..
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 000000000 00000000 0 000000001112345678899999999999999999999863
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=229.72 Aligned_cols=223 Identities=26% Similarity=0.386 Sum_probs=168.0
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-------------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||++++.. +..+++|+++... +.+......++++
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 5677899999999999998754 4555555544211 3444556788999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
||+.+++|.+++.... .....+++..++.++.|++.|+.|||+ .+++|+||+|+||+++. +.++|+|||++...
T Consensus 82 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 82 EYCEGRDLDCKLEELK--HTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EeCCCCCHHHHHHHHh--hcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeec
Confidence 9999999999886532 234679999999999999999999999 99999999999999975 57999999998765
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
..... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..++..... ... ... .
T Consensus 156 ~~~~~--~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~~-~~~------~ 217 (260)
T cd08222 156 MGSCD--LATTFTGTPYYMSPEALKHQ--GYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------LSV-VLR------I 217 (260)
T ss_pred CCCcc--cccCCCCCcCccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHH-HHH------H
Confidence 43222 12234467899999998664 678899999999999999999988753211 000 000 0
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
........+..++..+.+++.+||+.+|++||++.++++
T Consensus 218 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 218 -VEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -HcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 011111223456778999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=237.75 Aligned_cols=238 Identities=22% Similarity=0.270 Sum_probs=165.3
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------cee--------ecCCc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFC--------FEGHR 45 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~--------~~~~~ 45 (291)
+.+.+.||+|+||.||+|.+. +++.+++|++.... +.+ .....
T Consensus 10 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 89 (311)
T cd07866 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS 89 (311)
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCce
Confidence 456788999999999999875 48999999885322 111 12234
Q ss_pred ceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccC
Q 022826 46 RALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 46 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
.+++++|+.+ +|...+... ...+++..+..++.|+++||.|||+ .+++|+||||+||+++.++.++|+|||
T Consensus 90 ~~lv~~~~~~-~l~~~~~~~-----~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 90 VYMVTPYMDH-DLSGLLENP-----SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred EEEEEecCCc-CHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCc
Confidence 6889999865 787777542 3579999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCcee---------eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc
Q 022826 126 LAKICHGRESIV---------SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF 196 (291)
Q Consensus 126 ~~~~~~~~~~~~---------~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~ 196 (291)
++.......... ......+++.|+|||.+.+. ..++.++||||||+++|+|++|..+|............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 987654322111 11223457789999988653 35788999999999999999999887643321100000
Q ss_pred h-------hhhhhhhhhhhh----hcccCCC---ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 197 P-------HWVYKRLELEED----LGLQGIE---NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 197 ~-------~~~~~~~~~~~~----~~~~~~~---~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. ...+........ ....... ......+...+.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0 000000000000 0000000 0011223467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=245.23 Aligned_cols=230 Identities=30% Similarity=0.503 Sum_probs=185.8
Q ss_pred hhcccccCCceeEEEEEecC-CCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCCH
Q 022826 5 FKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
+.++||.|-||.||.|.+++ .-.||||.++.+. ++|..+--+|||.||+..|+|
T Consensus 271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNL 350 (1157)
T KOG4278|consen 271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNL 350 (1157)
T ss_pred eeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccH
Confidence 46899999999999999877 7789999998765 889999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
.+||.+. +..-++...++.++.||.+|+.||.. ++++||||-+.|.++.++..+|++|||+++.+..+....
T Consensus 351 LdYLRec----nr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA- 422 (1157)
T KOG4278|consen 351 LDYLREC----NRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA- 422 (1157)
T ss_pred HHHHHHh----chhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec-
Confidence 9999887 44567777788999999999999999 999999999999999999999999999999876553221
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCCh
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 218 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (291)
.-...-..-|.|||.+..+ .++.++|||+|||++|||.|..+-+....+... +. .+-..+.+-+
T Consensus 423 HAGAKFPIKWTAPEsLAyN--tFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY-------~LLEkgyRM~ 486 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYN--TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VY-------GLLEKGYRMD 486 (1157)
T ss_pred ccCccCcccccCccccccc--ccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HH-------HHHhcccccc
Confidence 1122235689999999876 899999999999999999986665544433221 11 1111122223
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 219 EDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 219 ~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
.+..++..+.+|++.||+++|.+||++.|+-+.+|.+...
T Consensus 487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 3455777889999999999999999999999999877643
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=241.91 Aligned_cols=246 Identities=21% Similarity=0.211 Sum_probs=168.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceee--------------
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCF-------------- 41 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~-------------- 41 (291)
+.+.+.||.|+||.||+|... +++.|++|++.... +...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT 86 (342)
T ss_pred eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccc
Confidence 456789999999999999875 48999999986543 1111
Q ss_pred cCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc-CCCceE
Q 022826 42 EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD-EDFCPK 120 (291)
Q Consensus 42 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~-~~~~~k 120 (291)
+....++++||+.+ +|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++ .++.++
T Consensus 87 ~~~~~~lv~e~~~~-~L~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 87 ELNSVYIVQEYMET-DLANVLEQ-------GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccceEEEEeecccc-cHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEE
Confidence 11346899999974 89888743 468999999999999999999999 9999999999999997 456789
Q ss_pred EeccCCccccCCCCceee-ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc----
Q 022826 121 ISDFGLAKICHGRESIVS-MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY---- 195 (291)
Q Consensus 121 l~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~---- 195 (291)
++|||.+........... .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...........
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999876533221111 1223457889999987542 3678899999999999999999999864422110000
Q ss_pred --------chhhhhhhhhhhh-hhcccCC-CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCC
Q 022826 196 --------FPHWVYKRLELEE-DLGLQGI-ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262 (291)
Q Consensus 196 --------~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 262 (291)
............. ....... ........+.++.+++.+||+.||.+|||+.++++ ...++.+..|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~--h~~~~~~~~~ 309 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM--HPYMSCYSCP 309 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC--CCccccccCC
Confidence 0000000000000 0000000 00111235677889999999999999999999985 3444444433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=236.88 Aligned_cols=242 Identities=23% Similarity=0.215 Sum_probs=173.3
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecC-----Cccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEG-----HRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~-----~~~~l 48 (291)
+.+.+.||.|+||.||+|+..+ ++.+++|++.... +.+... ...++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 5678999999999999998765 8999999887532 222222 36789
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
+++|+.+ +|.+++... ..+++..++.++.+++.||.+||+ .+++|+||||+||+++.++.++|+|||++.
T Consensus 82 v~e~~~~-~l~~~l~~~------~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 82 VTELMET-DLHKVIKSP------QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred Eecchhh-hHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999975 898888543 489999999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCce-eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCc---------cccchh
Q 022826 129 ICHGRESI-VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSS---------EIYFPH 198 (291)
Q Consensus 129 ~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~---------~~~~~~ 198 (291)
........ .......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||........ ......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred eecccccccccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 76543210 112233467889999998764 2678999999999999999999988865432100 000000
Q ss_pred hh-hhhhhhhhhhc---ccC--CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhh
Q 022826 199 WV-YKRLELEEDLG---LQG--IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM--LEGS 255 (291)
Q Consensus 199 ~~-~~~~~~~~~~~---~~~--~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~--L~~~ 255 (291)
+. ........... ... .........+..+.+++.+||+.+|.+||++.++++. +++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 00 00000000000 000 0000112356778999999999999999999999873 5553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=243.41 Aligned_cols=226 Identities=23% Similarity=0.396 Sum_probs=183.3
Q ss_pred hhcccccCCceeEEEEEec---CCC--eEEEEEeccCc---------------------------ceeecCCcceeeehh
Q 022826 5 FKNKLGQGGYGGVYKGKLL---DGR--NVAIKVLNETK---------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~---~~~--~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~ 52 (291)
++++||.|-||.||+|... +|+ .||||+.+.+. ++|. ..-.++|||.
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~WivmEL 471 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWIVMEL 471 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeEEEec
Confidence 4689999999999999653 233 58888877643 4443 3557799999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+..|-|..||..+ ...++......++.||+.+|.|||+ +..|||||-+.||++.....+||+|||+++....
T Consensus 472 ~~~GELr~yLq~n-----k~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 472 APLGELREYLQQN-----KDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred ccchhHHHHHHhc-----cccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 9999999999875 3789999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHh-CCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT-GVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll-~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
...... +...-..-|+|||.+.-. .++.++|||-|||.+||++ .|..||....+.+.-. ..
T Consensus 544 ~~yYka-S~~kLPIKWmaPESINfR--rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~--------~i------- 605 (974)
T KOG4257|consen 544 DAYYKA-SRGKLPIKWMAPESINFR--RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG--------HI------- 605 (974)
T ss_pred cchhhc-cccccceeecCccccchh--cccchhhHHHHHHHHHHHHHhcCCccccccccceEE--------Ee-------
Confidence 543322 223346689999999765 8999999999999999986 5888887665543211 11
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
..+-+.+.+++++..+..|+.+||..||.+||...++...|++++.
T Consensus 606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1233345567788899999999999999999999999999988777
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=223.88 Aligned_cols=243 Identities=19% Similarity=0.255 Sum_probs=185.7
Q ss_pred hcccccCCceeEEEEEe-cCCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcCCC
Q 022826 6 KNKLGQGGYGGVYKGKL-LDGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
.+.||+|+++.|-.+.. .++.+||||++.+.. .++.++.+.|||||-+.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 47899999999999954 579999999998755 68888999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC---ceEEeccCCccccCCCC
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF---CPKISDFGLAKICHGRE 134 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~---~~kl~Dfg~~~~~~~~~ 134 (291)
|...+.++ ..|++..+..+.++|+.||.+||. +||.|||+||+||+..... -+||+||.+.....-..
T Consensus 163 lLshI~~~------~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 163 LLSHIQKR------KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred HHHHHHHh------hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 99999876 589999999999999999999999 9999999999999995443 58999998876543211
Q ss_pred --c---eeeccCCCCCccccCcccc---cccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc--hhhhhhhh
Q 022826 135 --S---IVSMTGARGTVGYIAPEVF---CRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF--PHWVYKRL 204 (291)
Q Consensus 135 --~---~~~~~~~~~~~~y~aPE~l---~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~--~~~~~~~~ 204 (291)
+ .......+|+..|||||+. .+....|+.+.|.|||||++|-|+.|-.||....+..=.|.- +....+..
T Consensus 234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~ 313 (463)
T KOG0607|consen 234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK 313 (463)
T ss_pred CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH
Confidence 1 1223445688999999975 455457899999999999999999999999877664433321 11122222
Q ss_pred hhhhhhcc--cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHhhhcc
Q 022826 205 ELEEDLGL--QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE--MLEGSLDS 258 (291)
Q Consensus 205 ~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~--~L~~~~~~ 258 (291)
..+ ++.. -..++..=..++.+..+++..+|..|+.+|.++.++++ ++.....+
T Consensus 314 LFe-sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 314 LFE-SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHH-HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 221 1111 11222233467888999999999999999999999887 34444333
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=226.51 Aligned_cols=243 Identities=22% Similarity=0.283 Sum_probs=173.5
Q ss_pred hhhcccccCCceeEEEEEecC-----CCeEEEEEeccCc----------------------------ceeec-CCcceee
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-----GRNVAIKVLNETK----------------------------GFCFE-GHRRALI 49 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~----------------------------~~~~~-~~~~~lv 49 (291)
.+...||+|.||.||+|.-.+ ...+|+|.++.++ .++.+ +...+++
T Consensus 27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~ 106 (438)
T KOG0666|consen 27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL 106 (438)
T ss_pred hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence 455779999999999994322 3489999998774 23333 7788899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC----CceEEeccC
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED----FCPKISDFG 125 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~----~~~kl~Dfg 125 (291)
+||.+. +|..+++-.... ....++...+..|+.||+.|+.|||+ +=|+||||||.||++..+ |.+||+|||
T Consensus 107 fdYAEh-DL~~II~fHr~~-~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 107 FDYAEH-DLWHIIKFHRAS-KAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred ehhhhh-hHHHHHHHhccc-hhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 999987 999998765433 33678999999999999999999999 999999999999999877 899999999
Q ss_pred CccccCCCCcee-eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc-chh-hhhh
Q 022826 126 LAKICHGRESIV-SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY-FPH-WVYK 202 (291)
Q Consensus 126 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~-~~~-~~~~ 202 (291)
+++.+.+.-... ......-|.-|+|||++.|. ..|+.+.|||++||+|.||++....|........... ++. ...+
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 999886543322 11222346789999999986 5899999999999999999988877765444332211 110 0000
Q ss_pred hhhhhhhh------------------------cccCCCC--hhh--HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 022826 203 RLELEEDL------------------------GLQGIEN--EED--KEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252 (291)
Q Consensus 203 ~~~~~~~~------------------------~~~~~~~--~~~--~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L 252 (291)
..+..+.. ...+... ... +.-+...++|+..+|..||-+|+|+++.++..
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 00000000 0000000 000 00122377899999999999999999998865
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=226.37 Aligned_cols=210 Identities=28% Similarity=0.350 Sum_probs=166.1
Q ss_pred cccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehhhcCCCH
Q 022826 9 LGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 9 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
||+|+||.||++...+ ++.+++|++.... ..+..+...+++||++.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999998754 8999999986532 345567788999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
.+++... ..+++..+..++.|++.|+.+||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~ 149 (250)
T cd05123 81 FSHLSKE------GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--R 149 (250)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--c
Confidence 9999654 368999999999999999999999 9999999999999999999999999999876544321 1
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCCh
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 218 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (291)
.....++..|++||.+.+. ..+.++|+||||+++|++++|..||..... .. ....... . ...
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~-~~~~~~~-~-------~~~ 211 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KE-IYEKILK-D-------PLR 211 (250)
T ss_pred ccCCcCCccccChHHhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HH-HHHHHhc-C-------CCC
Confidence 2334567899999998765 678899999999999999999988864422 00 0001100 0 111
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 022826 219 EDKEYARKMILVSLWCIQNNPSDRPAMNR 247 (291)
Q Consensus 219 ~~~~~~~~l~~l~~~~l~~dP~~Rps~~e 247 (291)
.+...+..+.+++++||..||++||++.+
T Consensus 212 ~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 212 FPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 22233677889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=225.48 Aligned_cols=232 Identities=22% Similarity=0.365 Sum_probs=170.6
Q ss_pred cccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------------ceeecCCcceee
Q 022826 7 NKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------------GFCFEGHRRALI 49 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------------~~~~~~~~~~lv 49 (291)
.+||+|.||+||+|+..+ |+.|++|++-.+. ....+....++|
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 579999999999998765 8889998876533 122234458899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
|++|+. +|..++.+. ..+++...+.++++++++||.|+|. ..|+|||+||+||+|+.+|.++|+|||+++.
T Consensus 103 f~~ceh-DLaGlLsn~-----~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNR-----KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred HHHhhh-hHHHHhcCc-----cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 999988 999999654 3789999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCc--eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccc------------c
Q 022826 130 CHGRES--IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEI------------Y 195 (291)
Q Consensus 130 ~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~------------~ 195 (291)
+..... ...+++..-|.-|++||.+.|. ..++++.|||+.||++.+|.++...+....+..... .
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 754322 2224455568899999999886 689999999999999999999887665443321100 0
Q ss_pred chhhhhhhhhhhhhhcccCCCChhh---HHH------HHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 196 FPHWVYKRLELEEDLGLQGIENEED---KEY------ARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~------~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
+|... ....-.++..+.+..... ++. ..+.++|+..+|..||.+|+++++++.
T Consensus 253 WP~~d--~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 253 WPNVD--NLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CCCcc--cchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 01000 000111111111111111 111 226789999999999999999998774
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=229.85 Aligned_cols=235 Identities=25% Similarity=0.298 Sum_probs=170.6
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehhhc
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~ 54 (291)
.+.+.||+|.||.||+|...+ ++.+++|++.... +.+......++|+|++.
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 356789999999999998765 9999999988642 34455678889999997
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+ +|.+++.... ..+++..+..++.+++.||.+||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~-~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 82 M-DLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred c-CHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 5 9999997642 478999999999999999999999 999999999999999999999999999987654332
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccch-------hhhhhhhhhh
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFP-------HWVYKRLELE 207 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 207 (291)
. .......+..|+|||.+.+. ..++.++||||||+++|+|++|..+|............. ...+......
T Consensus 153 ~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 153 R--TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred c--ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccc
Confidence 2 12223346789999998654 367889999999999999999987775433110000000 0000000000
Q ss_pred --hhhcccC----CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 208 --EDLGLQG----IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 208 --~~~~~~~----~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.....+. ......+.....+.+++.+||..||++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 000111234667999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=245.49 Aligned_cols=224 Identities=26% Similarity=0.435 Sum_probs=179.2
Q ss_pred hhhcccccCCceeEEEEEecC--C--CeEEEEEeccCc---------------------------ceeecCCcceeeehh
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD--G--RNVAIKVLNETK---------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~ 52 (291)
.+.|.||+|.||.|++|.+.. | -.||||++.... ++..+ .-..+|+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 456899999999999997743 3 478999998765 23332 556689999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+..|+|.+.|+.. ....|-....-.++.||+.|+.||.+ +++|||||-+.|+++.....+||+|||+.+.+..
T Consensus 192 aplGSLldrLrka----~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 192 APLGSLLDRLRKA----KKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred cccchHHHHHhhc----cccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 9999999999873 45678888899999999999999999 9999999999999999888999999999999876
Q ss_pred CCceeecc-CCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCC-CCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 133 RESIVSMT-GARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVK-NNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 133 ~~~~~~~~-~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
......+. ...-...|+|||.+... .++.++|+|++||++|||.++. .||..... ......+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~--kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------------~qIL~~i 328 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHR--KFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------------IQILKNI 328 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccc--cccccchhhhhhhhHHhhhccCCCCCCCCCH--------------HHHHHhc
Confidence 65554432 33346789999999765 8999999999999999998744 45543311 1111122
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L 252 (291)
+ .+.+...++.+++++.+++.+||.++|++|||+..|.+.+
T Consensus 329 D-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 329 D-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred c-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 2 3444566778999999999999999999999999997544
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=239.64 Aligned_cols=231 Identities=25% Similarity=0.266 Sum_probs=165.6
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecC------Ccce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEG------HRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~------~~~~ 47 (291)
+.+.+.||+|++|.||+|++.. ++.||+|++.... +..... ...+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 3456889999999999998754 8899999986421 112112 2378
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+|++|+ +++|.+++.. .++++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 97 lv~e~~-~~~L~~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 97 LVTHLM-GADLNNIVKC-------QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred EEEecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 999998 5599998843 478999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc--------chhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY--------FPHW 199 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~--------~~~~ 199 (291)
...... .....++..|+|||.+.+. ..++.++||||||+++|++++|..||........... .+.+
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 865432 1233467889999998653 3678899999999999999999988864322100000 0000
Q ss_pred hhhhhh-hhhh--hcccCCC----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 200 VYKRLE-LEED--LGLQGIE----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 200 ~~~~~~-~~~~--~~~~~~~----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..+... .... ....... ......++..+.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000 0000 0000000 0011224678999999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=240.24 Aligned_cols=232 Identities=22% Similarity=0.366 Sum_probs=182.6
Q ss_pred hhhcccccCCceeEEEEEecCCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcCC
Q 022826 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
-++++||+|-||+|.++....+..||+|+++... ++|..++-+++|+||++.|
T Consensus 541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG 620 (807)
T ss_pred ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence 4679999999999999998778999999998765 8899999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+|.+++.... -..+.-+...+|+.||++|++||.+ .++|||||.+.|++++.++++||+|||.++-+-.++..
T Consensus 621 DLnqFl~ahe----apt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 621 DLNQFLSAHE----LPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred cHHHHHHhcc----CcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999997752 2235566677899999999999999 99999999999999999999999999999976665544
Q ss_pred eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCC--CCCccccCCCccccchhhhhhhhhhhhhh---c
Q 022826 137 VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVK--NNANVAVDRSSEIYFPHWVYKRLELEEDL---G 211 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 211 (291)
..-....-...|+|+|.|... .++.++|+|+||+++||+++.. .|+....+.. ..+..... .
T Consensus 694 ~vqgr~vlpiRwmawEsillg--kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~-----------vven~~~~~~~~ 760 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ-----------VVENAGEFFRDQ 760 (807)
T ss_pred eeecceeeeeeehhHHHHHhc--cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH-----------HHHhhhhhcCCC
Confidence 433333346799999998765 8999999999999999986533 3333221110 11111111 1
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
........+..++..+.+++.+||+.|-.+||+.+++...|.+.
T Consensus 761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11122334556788899999999999999999999999888653
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=236.61 Aligned_cols=247 Identities=23% Similarity=0.215 Sum_probs=168.9
Q ss_pred chhhcccccCCceeEEEEEec-C--CCeEEEEEeccCc-----------------------------cee----ecCCcc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-D--GRNVAIKVLNETK-----------------------------GFC----FEGHRR 46 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~-----------------------------~~~----~~~~~~ 46 (291)
+.+.+.||+|+||.||++... . ++.||+|.+.... +.+ ......
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 467789999999999999864 3 7799999876421 110 112345
Q ss_pred eeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCC
Q 022826 47 ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL 126 (291)
Q Consensus 47 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~ 126 (291)
+++++++. ++|.+++... ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||+
T Consensus 82 ~~~~e~~~-~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 82 YLYEELME-ADLHQIIRSG------QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEeccc-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 67788886 5898888543 578999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcee--eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccc-------cch
Q 022826 127 AKICHGRESIV--SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEI-------YFP 197 (291)
Q Consensus 127 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~-------~~~ 197 (291)
+.......... ......++..|+|||.+.+. ..++.++||||||+++|+|++|..||........-. ..+
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD 230 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCC
Confidence 98654322111 11234578899999987653 367899999999999999999998876432110000 000
Q ss_pred hhhhhhhh------hhhhhc-ccCC-CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCC
Q 022826 198 HWVYKRLE------LEEDLG-LQGI-ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262 (291)
Q Consensus 198 ~~~~~~~~------~~~~~~-~~~~-~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 262 (291)
........ ...... .... ...........+.+++.+||+.||.+|||+.++++. ..+.+.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~--~~~~~~~~~ 301 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH--PYLAIWHDP 301 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC--hhhhhhcCc
Confidence 00000000 000000 0000 000111235678899999999999999999998643 444444443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=233.03 Aligned_cols=236 Identities=24% Similarity=0.238 Sum_probs=166.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecC------Ccce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEG------HRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~------~~~~ 47 (291)
+.+.+.||+|+||.||++.+. +++.||+|.+.... +.+... ...+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY 96 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence 456688999999999999764 59999999985421 111111 2358
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+|++++ +++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 97 lv~e~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 97 LVMPFM-GTDLGKLMKH-------EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred EEEecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 999998 6699888743 478999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccc-------cchhhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEI-------YFPHWV 200 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~-------~~~~~~ 200 (291)
....... ....+++.|++||.+.+. ..++.++|+||||+++|++++|..||.......... ..+...
T Consensus 166 ~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 166 RQTDSEM-----TGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccCc-----cccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 7643321 223457889999998653 357889999999999999999999886432210000 000000
Q ss_pred hhhhh----hhhhhcccCCCC----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHH--HHHHhh
Q 022826 201 YKRLE----LEEDLGLQGIEN----EEDKEYARKMILVSLWCIQNNPSDRPAMNRVV--EMLEGS 255 (291)
Q Consensus 201 ~~~~~----~~~~~~~~~~~~----~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell--~~L~~~ 255 (291)
..... .......+.... .....++..+.+++.+||+.||++|||+.+++ ..++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00000 000000000000 01123456788999999999999999999998 344443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=232.66 Aligned_cols=230 Identities=24% Similarity=0.345 Sum_probs=179.1
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------------ceeecCCccee
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------------GFCFEGHRRAL 48 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------------~~~~~~~~~~l 48 (291)
-+-+.||+|+|++||+|.+.. +++||||+-...+ .+..+.+.+|-
T Consensus 466 LlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCT 545 (775)
T KOG1151|consen 466 LLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCT 545 (775)
T ss_pred HHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccccee
Confidence 346889999999999997654 8999999966544 34556778889
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE---cCCCceEEeccC
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFG 125 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill---~~~~~~kl~Dfg 125 (291)
|+|||+|.+|.-||+.. .-.+++.++.|++||+.+|.||.. ...+|+|-||||.||++ +..|.+||.|||
T Consensus 546 VLEYceGNDLDFYLKQh------klmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 546 VLEYCEGNDLDFYLKQH------KLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred eeeecCCCchhHHHHhh------hhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 99999999999999776 478999999999999999999997 33679999999999999 456899999999
Q ss_pred CccccCCCCce-----eeccCCCCCccccCccccc-c-cCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchh
Q 022826 126 LAKICHGRESI-----VSMTGARGTVGYIAPEVFC-R-NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPH 198 (291)
Q Consensus 126 ~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~-~-~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~ 198 (291)
++..+..+... ...+...||.-|++||.+. + .+..++.++||||+||+||..+.|+.||........
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd------ 692 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD------ 692 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH------
Confidence 99988754332 1234456899999999753 3 235789999999999999999999999987654221
Q ss_pred hhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 199 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.......+....+..+.-+.++.+...+|++||+..-++|....+|..
T Consensus 693 ----ILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 ----ILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ----HHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 011111122223333444567888999999999999999988777643
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=245.06 Aligned_cols=226 Identities=27% Similarity=0.379 Sum_probs=181.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------cee-----ecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFC-----FEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~-----~~~~~~~lv~ 50 (291)
..|.+.||.|.+|.||+++.. +++..|+|+..... +++ ..++.++|||
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM 100 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM 100 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence 346789999999999999765 48999999987765 111 2345678999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
|||.+||..+++++. .+.++.|+.++-|++.++.|+.|||. ..++|+|||-.||+++.+|.+||+|||++.++
T Consensus 101 EfC~gGSVTDLVKn~----~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 101 EFCGGGSVTDLVKNT----KGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred eccCCccHHHHHhhh----cccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 999999999999887 37899999999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCceeeccCCCCCccccCcccccc---cCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCR---NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~---~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
...... .....|||.|+|||++.- ....|+.++|+||||++..||.-|..|+-+-..... ..
T Consensus 174 dsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-------------LF 238 (953)
T KOG0587|consen 174 DSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-------------LF 238 (953)
T ss_pred eccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-------------hc
Confidence 544322 234568999999999843 224677899999999999999999887765432111 11
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..+..+..-...+.++++++-++|..||.+|-++||++.++++
T Consensus 239 ~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 239 LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111222223457789999999999999999999999998764
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=236.01 Aligned_cols=231 Identities=23% Similarity=0.249 Sum_probs=162.1
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceee------cCCccee
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCF------EGHRRAL 48 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~------~~~~~~l 48 (291)
.+.+.||+|+||.||++.+. +++.||+|++.... +.+. .....++
T Consensus 20 ~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 99 (345)
T cd07877 20 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 99 (345)
T ss_pred EEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEE
Confidence 45678999999999999764 58999999986432 1111 1133567
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
+++++ +++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.
T Consensus 100 v~~~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 100 VTHLM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred Eehhc-ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEecccccc
Confidence 77776 6799888743 368999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc-------hhhhh
Q 022826 129 ICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF-------PHWVY 201 (291)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~-------~~~~~ 201 (291)
..... .....++..|+|||.+.+. ..++.++||||||+++|+|++|..||............ +....
T Consensus 169 ~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T cd07877 169 HTDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 242 (345)
T ss_pred ccccc-----ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 54322 1233467889999988653 36788999999999999999999888643221100000 00000
Q ss_pred hhhh---hhhhhc-ccCCCC----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 202 KRLE---LEEDLG-LQGIEN----EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 202 ~~~~---~~~~~~-~~~~~~----~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.... ....+. ...... ......+..+.+++.+||+.||.+||++.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 000000 000000 0001235568899999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=240.24 Aligned_cols=220 Identities=22% Similarity=0.300 Sum_probs=179.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+++...||+|.|+.|.++.+. ++..||+|++.+.. .+.......|+||||+
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 456789999999999999764 59999999998876 4556678899999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+|.+++++.+. .+..+..+..++.|++++++|||+ ++|||+|||++||+++.+-++||+|||++..+...
T Consensus 138 ~~ge~~~yl~~~------gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 138 SGGELFDYLVKH------GRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred cCchhHHHHHhc------ccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc
Confidence 999999999776 355668899999999999999999 99999999999999999999999999999887643
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
. .....+|++.|.|||+..|. ....+++|+||+|+++|.|+.|..||+...-.... .......+.++
T Consensus 209 ~---~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr---------~rvl~gk~rIp 275 (596)
T KOG0586|consen 209 L---MLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR---------PRVLRGKYRIP 275 (596)
T ss_pred c---cccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCccccccc---------chheeeeeccc
Confidence 3 23567899999999999987 36789999999999999999999999865332110 00111111111
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.-.+.+..++++++|..+|.+|++.+++.+-
T Consensus 276 -------~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 276 -------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -------ceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 2244556789999999999999999997653
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=234.02 Aligned_cols=231 Identities=25% Similarity=0.279 Sum_probs=164.9
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceee-cCCcceeeehhh
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCF-EGHRRALIYEFV 53 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~-~~~~~~lv~e~~ 53 (291)
.+.+.||.|+||.||++.+. +++.|++|++.... +.+. .....++++||+
T Consensus 13 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~ 92 (328)
T cd07856 13 VDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL 92 (328)
T ss_pred EEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh
Confidence 35688999999999999865 59999999875321 2332 345678999998
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
. ++|.+++.. ..+++..+..++.|+++||.|||+ .+++|+||+|.||+++.++.++|+|||.+......
T Consensus 93 ~-~~L~~~~~~-------~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 93 G-TDLHRLLTS-------RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred c-cCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 4 589888743 468888899999999999999999 99999999999999999999999999998754322
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc-------chhhhhhh---
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY-------FPHWVYKR--- 203 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~-------~~~~~~~~--- 203 (291)
. ....++..|+|||.+.+. ..++.++||||||+++|+|++|..+|........... .+......
T Consensus 162 ~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 162 M-----TGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred c-----CCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 1 223457789999987652 3678999999999999999999988865422100000 00000000
Q ss_pred ---hhhhhhhcccCC--CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 204 ---LELEEDLGLQGI--ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 204 ---~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
............ .....+.++..+.+++++||+.+|++||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 001112345789999999999999999999998664
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=235.03 Aligned_cols=234 Identities=23% Similarity=0.252 Sum_probs=163.7
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeec------CCccee
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFE------GHRRAL 48 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~------~~~~~l 48 (291)
.+.+.||+|+||.||+|.+. +++.||+|++.... +.+.. ....++
T Consensus 18 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 97 (342)
T cd07879 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYL 97 (342)
T ss_pred EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEE
Confidence 35688999999999999875 59999999986431 12111 124588
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
+++|+.. +|..+. +..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.
T Consensus 98 v~e~~~~-~l~~~~--------~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 98 VMPYMQT-DLQKIM--------GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred Eeccccc-CHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 9999864 776654 1368899999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccc--------cchhhh
Q 022826 129 ICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEI--------YFPHWV 200 (291)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~--------~~~~~~ 200 (291)
...... ....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||........-. ..+...
T Consensus 166 ~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 166 HADAEM-----TGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCCCC-----CCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 543221 223457889999998653 257889999999999999999999987532110000 000000
Q ss_pred hhh-h-hhhhhh-cccCCCC----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHhh
Q 022826 201 YKR-L-ELEEDL-GLQGIEN----EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE--MLEGS 255 (291)
Q Consensus 201 ~~~-~-~~~~~~-~~~~~~~----~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~--~L~~~ 255 (291)
... . ...... ..+.... ...+.....+.+++.+||+.||++||++.++++ .+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000 0 000000 0000000 001124566889999999999999999999984 46654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=215.46 Aligned_cols=247 Identities=17% Similarity=0.257 Sum_probs=182.6
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+++.+.+|+|-||.+-+++++. +..+++|.++... .-+...+.+++++||++
T Consensus 26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP 105 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAP 105 (378)
T ss_pred hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCc
Confidence 4678899999999999998865 8899999998765 23344567788999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc--CCCceEEeccCCccccCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD--EDFCPKISDFGLAKICHG 132 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~--~~~~~kl~Dfg~~~~~~~ 132 (291)
-|+|.+-+. ..++.+....+++.|+++||.|||+ +++||||||.+||+|- +.-++||+|||+++..+.
T Consensus 106 ~gdL~snv~-------~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 106 RGDLRSNVE-------AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cchhhhhcC-------cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999998883 3688899999999999999999999 9999999999999992 334899999999876443
Q ss_pred CCceeeccCCCCCccccCccccccc---CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
.. ........|.+||++... .-...+.+|||+||+++|.+++|..||+.....+. +.+.+........
T Consensus 176 tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~----~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 176 TV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK----PYWEWEQWLKRKN 246 (378)
T ss_pred ee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc----hHHHHHHHhcccC
Confidence 32 223346789999986321 12457789999999999999999999995544443 2222222222222
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCC---CCHHHHHHH--HHhhhccCCCCCCCcccCCCC
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDR---PAMNRVVEM--LEGSLDSLRIPPRPFLLSSGS 272 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~R---ps~~ell~~--L~~~~~~~~~~~~~~~~~~~~ 272 (291)
...+ ...+.+++.++++.++-|..+|++| -++.+.... .|.+++....+.-.++.++.+
T Consensus 247 ~~~P----~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~k~~ee~~~tn~d~ 310 (378)
T KOG1345|consen 247 PALP----KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTVKRPEEDYYTNIDT 310 (378)
T ss_pred ccCc----hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccccChhhccccccCC
Confidence 2222 2344577788899999999999999 555555443 366676666665555444433
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=239.39 Aligned_cols=218 Identities=24% Similarity=0.394 Sum_probs=164.8
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------------------ceeecCCcceeee
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------------------~~~~~~~~~~lv~ 50 (291)
++.+.||+|+|-+||+|.+.. |-.||.=.++... -....++...+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 456889999999999998743 6666543322211 1223345677899
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC-CceEEeccCCccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKI 129 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~-~~~kl~Dfg~~~~ 129 (291)
|.+..|+|..|+++. .+.+.+.+..|++||+.||.|||+ -..+|+|||||-+||||+.+ |.|||+|+|+|..
T Consensus 123 EL~TSGtLr~Y~kk~------~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH------RRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred ecccCCcHHHHHHHh------ccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 999999999999876 588899999999999999999998 23579999999999999865 8999999999987
Q ss_pred cCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 130 CHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
..... .....|||.|||||++. ..|++.+||||||+.++||+|+..|...=. .+...+++..
T Consensus 196 ~r~s~----aksvIGTPEFMAPEmYE---E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-------n~AQIYKKV~---- 257 (632)
T KOG0584|consen 196 LRKSH----AKSVIGTPEFMAPEMYE---ENYNELVDVYAFGMCMLEMVTSEYPYSECT-------NPAQIYKKVT---- 257 (632)
T ss_pred hhccc----cceeccCccccChHHHh---hhcchhhhhhhhhHHHHHHHhccCChhhhC-------CHHHHHHHHH----
Confidence 54332 13356899999999986 389999999999999999999996554211 1222233332
Q ss_pred hcccCCCChh-hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 210 LGLQGIENEE-DKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 210 ~~~~~~~~~~-~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.+..... .+--..++++||.+||.. .++|+|+.|||+
T Consensus 258 ---SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 258 ---SGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ---cCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 2222211 111244688999999999 999999999986
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=248.44 Aligned_cols=117 Identities=27% Similarity=0.461 Sum_probs=103.1
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.++||+|+||.||+|.+. .++.||||+++... ..+......|+||||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 456789999999999999876 48999999987532 344556778999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
+.+++|.+++... ..+++..++.++.||+.||.|||+ .+|+|+||||+|||++.++.++|+|||+++
T Consensus 86 ~~g~~L~~li~~~------~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHIY------GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999998653 468899999999999999999999 999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=222.52 Aligned_cols=218 Identities=23% Similarity=0.351 Sum_probs=171.7
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e 51 (291)
.++-..||+|+|+.|..+++++ .+-+|+|+++++- .++..+.+.++|.|
T Consensus 252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie 331 (593)
T KOG0695|consen 252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE 331 (593)
T ss_pred ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence 3566889999999999998765 8899999998754 46667888999999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc-
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC- 130 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~- 130 (291)
|++||+|--++.+. .+++++.++.+..+|+.+|.|||+ .||+.+|+|.+||+++..|.+||.|||.+..-
T Consensus 332 yv~ggdlmfhmqrq------rklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 332 YVNGGDLMFHMQRQ------RKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EecCcceeeehhhh------hcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999996666443 699999999999999999999999 99999999999999999999999999998742
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
..++ ..+..+|||.|+|||++.|. .|...+|.|+||++++||+.|+.||+..-....+....... -+...+..+
T Consensus 403 ~~gd---~tstfcgtpnyiapeilrge--eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl-fqvilekqi 476 (593)
T KOG0695|consen 403 GPGD---TTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL-FQVILEKQI 476 (593)
T ss_pred CCCc---ccccccCCCcccchhhhccc--ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH-HHHHhhhcc
Confidence 2222 35778999999999999998 99999999999999999999999997543221111111111 123333334
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCC
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDR 242 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~R 242 (291)
.++. ..+-....+++.-|++||.+|
T Consensus 477 ripr-------slsvkas~vlkgflnkdp~er 501 (593)
T KOG0695|consen 477 RIPR-------SLSVKASHVLKGFLNKDPKER 501 (593)
T ss_pred cccc-------eeehhhHHHHHHhhcCCcHHh
Confidence 4432 233334456777889999999
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=243.33 Aligned_cols=237 Identities=26% Similarity=0.447 Sum_probs=183.6
Q ss_pred hhhcccccCCceeEEEEEecC--------CCeEEEEEeccCc----------------------------ceeecCCcce
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD--------GRNVAIKVLNETK----------------------------GFCFEGHRRA 47 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~----------------------------~~~~~~~~~~ 47 (291)
.+.+.||+|.||.|++|.... ...||||.++... +.|..+...+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 456799999999999997431 3479999988654 6777788999
Q ss_pred eeehhhcCCCHHHHHhhcC---CCCCC-------CCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC
Q 022826 48 LIYEFVSNGSLEKFIYEKH---PLETN-------QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 117 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~---~~~~~-------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~ 117 (291)
+|.||+..|+|.++++... ..+.. ..++....+.++.||+.|++||++ .++|||||-+.||++..+.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecCCC
Confidence 9999999999999998875 11111 248999999999999999999999 9999999999999999999
Q ss_pred ceEEeccCCccccCCCCceeec-cCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc
Q 022826 118 CPKISDFGLAKICHGRESIVSM-TGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF 196 (291)
Q Consensus 118 ~~kl~Dfg~~~~~~~~~~~~~~-~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~ 196 (291)
.+||+|||+++........... ....-...|+|||.+... .++.++||||||+++|||.+....+......
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~--~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~------ 527 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR--VFTSKSDVWSFGILLWEIFTLGGTPYPGIPP------ 527 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC--cccccchhhHHHHHHHHHhhCCCCCCCCCCc------
Confidence 9999999999965544332211 111124569999999875 9999999999999999998855444432110
Q ss_pred hhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 197 PHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
...... ....+.+.+.+..+..++.++++.||+.+|++||+..++.+.|+..+..
T Consensus 528 ~~~l~~-------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 528 TEELLE-------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred HHHHHH-------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 111111 1223334455666788999999999999999999999999999996653
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=199.49 Aligned_cols=236 Identities=20% Similarity=0.280 Sum_probs=170.4
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
++=.|+||+|.||+||+|+..+ ++-||+|.++... .+...++..-+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 4556899999999999998765 8899999987655 3334456667899999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.. +|..++.... +.++.+.++.++-|+++|+.++|+ +++.|+|+||.|.+|+.+|++|++|||+++.+.-.
T Consensus 84 dq-dlkkyfdsln-----g~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 84 DQ-DLKKYFDSLN-----GDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred hH-HHHHHHHhcC-----CcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 76 9998886643 678999999999999999999999 99999999999999999999999999999987544
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
... ++...-|.-|++|.++.|. .-|+...|+||.||++.|+..-.+|.....+-..+..-..+.........-....
T Consensus 155 vrc--ysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 155 VRC--YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred eEe--eeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc
Confidence 332 2333347789999999886 4788899999999999999864444433333222111111111000000000000
Q ss_pred CCC--------------ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 214 GIE--------------NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 214 ~~~--------------~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.++ ...-+.+...-+++++..|.-+|.+|+++++.++
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 000 0112334555678999999999999999998765
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-33 Score=220.08 Aligned_cols=228 Identities=25% Similarity=0.340 Sum_probs=173.5
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhcCCC
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
..||.|+||+|++-.++ .|+..|||.++... +.++.+...++-||.+.- |
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-S 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-h
Confidence 46999999999999765 49999999998765 445556666788999855 8
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|..+.+..... ....+++..+-+|....+.||.||-. ..+|+|||+||+||+++..|.+||||||.+.++.+ ..
T Consensus 149 lDklYk~vy~v-q~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---Si 222 (361)
T KOG1006|consen 149 LDKLYKRVYSV-QKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---SI 222 (361)
T ss_pred HHHHHHHHHHH-HhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH---HH
Confidence 87766553322 23689999999999999999999997 48899999999999999999999999999876532 22
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC-
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE- 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 216 (291)
..+.-.|...|+|||.+......++.++|+||||+++||+.||+.|...-.+ ...+......-..+.+.
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----------vfeql~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----------VFEQLCQVVIGDPPILLF 292 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----------HHHHHHHHHcCCCCeecC
Confidence 2345567889999999987656799999999999999999999976553221 01111111111111111
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.....+++..+..++-.||.+|-+.||+..+|++.
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 12234588899999999999999999999998753
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=235.08 Aligned_cols=182 Identities=23% Similarity=0.331 Sum_probs=151.9
Q ss_pred hcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehhhcC
Q 022826 6 KNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
.+.||-|+||+|.+++..+ ...||.|.+.+.+ ..+.++...|+||+|+.|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 3679999999999997655 7899999998765 455677889999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC---
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG--- 132 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~--- 132 (291)
|++-.+|.+. +-|++..++.++.+|..+|++.|. .|.+||||||+|||||.+|.+||.|||+|.-+.=
T Consensus 714 GDmMSLLIrm------gIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 714 GDMMSLLIRM------GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred ccHHHHHHHh------ccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceeccc
Confidence 9999999776 578899999999999999999999 9999999999999999999999999999965520
Q ss_pred ------C-----C-----------ce---------------eeccCCCCCccccCcccccccCCCccccccchhHHHHHH
Q 022826 133 ------R-----E-----------SI---------------VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 175 (291)
Q Consensus 133 ------~-----~-----------~~---------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~ 175 (291)
+ + +. ...-...||+.|+|||++... .++..+|.||.||++|
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--CccccchhhHhhHHHH
Confidence 0 0 00 000112479999999999876 8999999999999999
Q ss_pred HHhCCCCCCccccCCCccccchh
Q 022826 176 EMTGVKNNANVAVDRSSEIYFPH 198 (291)
Q Consensus 176 ~ll~g~~~~~~~~~~~~~~~~~~ 198 (291)
+|+.|+.||........++....
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~n 885 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVIN 885 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeee
Confidence 99999999988877655444333
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=219.90 Aligned_cols=104 Identities=30% Similarity=0.488 Sum_probs=89.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------------------ceeecCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------------------GFCFEGH 44 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------------------~~~~~~~ 44 (291)
+-+.++||.|.|++||++.+. ..+.||+|+.+... .-..++.
T Consensus 80 Y~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~ 159 (590)
T KOG1290|consen 80 YHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQ 159 (590)
T ss_pred EEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCc
Confidence 346789999999999999875 48899999998765 2344577
Q ss_pred cceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE
Q 022826 45 RRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL 113 (291)
Q Consensus 45 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill 113 (291)
+.|+|+|++.. +|..++... .-+.++...+..|++||+.||.|||. ..+|+|.||||+|||+
T Consensus 160 HVCMVfEvLGd-nLLklI~~s----~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 160 HVCMVFEVLGD-NLLKLIKYS----NYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred EEEEEehhhhh-HHHHHHHHh----CCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 89999999966 888888775 44789999999999999999999998 4899999999999997
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=228.82 Aligned_cols=241 Identities=21% Similarity=0.217 Sum_probs=159.7
Q ss_pred chhhcccccCCceeEEEEEe-----------------cCCCeEEEEEeccCc----------------------------
Q 022826 3 NSFKNKLGQGGYGGVYKGKL-----------------LDGRNVAIKVLNETK---------------------------- 37 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~---------------------------- 37 (291)
+.+.++||+|+||.||+|.. .+++.||||.+....
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 45678999999999999953 235689999976421
Q ss_pred -----------------cee--------ecCCcceeeehhhcCCCHHHHHhhcCC------------------CCCCCCC
Q 022826 38 -----------------GFC--------FEGHRRALIYEFVSNGSLEKFIYEKHP------------------LETNQKL 74 (291)
Q Consensus 38 -----------------~~~--------~~~~~~~lv~e~~~~g~L~~~l~~~~~------------------~~~~~~~ 74 (291)
+++ ......++||||+.+++|.+++..... ......+
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 011 123457899999999999999875311 0012345
Q ss_pred CHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeeccCCCCCccccCcccc
Q 022826 75 KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF 154 (291)
Q Consensus 75 ~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l 154 (291)
++..++.++.|++.+|.|||+ .+++|+||||+||+++.++.++|+|||++......... .......++.|+|||.+
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEEL 382 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhhh
Confidence 778899999999999999999 99999999999999999999999999998765432211 11122347899999987
Q ss_pred cccCC--------------------CccccccchhHHHHHHHHhCCCC-CCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 155 CRNFG--------------------EVSYKSDVYSYGMMVFEMTGVKN-NANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 155 ~~~~~--------------------~~~~~~DiwslG~~l~~ll~g~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
..... ....+.||||+||++|+|+++.. ++........+. ..... ....-......
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~--~~~~~-~~~~~r~~~~~ 459 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL--RQYDN-DLNRWRMYKGQ 459 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHH--hhccc-hHHHHHhhccc
Confidence 54211 11234799999999999999874 333211100000 00000 00000000111
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCC---CCCCCHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNP---SDRPAMNRVVE 250 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP---~~Rps~~ell~ 250 (291)
..........+....+|+.+||..+| .+|+|+.|+++
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 11111233456778899999999766 68999999875
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=233.26 Aligned_cols=226 Identities=26% Similarity=0.401 Sum_probs=180.6
Q ss_pred hcccccCCceeEEEEEec-C----CCeEEEEEeccCc---------------------------ceeecCCcceeeehhh
Q 022826 6 KNKLGQGGYGGVYKGKLL-D----GRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~ 53 (291)
..+||+|+||+||+|.+. + .-+||+|++.... ++|.... .-||++|+
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 478999999999999663 3 3478999987654 3444333 55899999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
+.|+|.++++.. +..+..+.++.|+.||++|+.|||. +.+|||||-+.||+|.....+|+.|||+++....+
T Consensus 780 P~G~LlDyvr~h-----r~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 780 PLGCLLDYVREH-----RDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred ccchHHHHHHHh-----hccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999874 3788999999999999999999999 99999999999999999889999999999988776
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
............+.|+|=|.+... .++.++|||||||+.||++| |..|.+... .. .+..+-.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~--~~thqSDVWsfGVtiWElmTFGa~Py~gi~---------~~------eI~dlle 914 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIR--KYTHQSDVWSFGVTIWELMTFGAKPYDGIP---------AE------EIPDLLE 914 (1177)
T ss_pred cccccccccccCcHHHHHHHhhcc--CCCchhhhhhhhhhHHHHHhcCCCccCCCC---------HH------HhhHHHh
Confidence 655555555567789999998766 89999999999999999987 444443321 11 1111112
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
.+.+...++.++.++..++.+||..|+..||+++++...+..+.+
T Consensus 915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 222355667788899999999999999999999999999877655
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=228.88 Aligned_cols=216 Identities=25% Similarity=0.348 Sum_probs=173.3
Q ss_pred hcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhcCC
Q 022826 6 KNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
.+.||+|-||+||-|+++ +|+.||||++.+.+ ..+...++.+.|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 378999999999999775 49999999998765 466678899999999976
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC---CceEEeccCCccccCCC
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED---FCPKISDFGLAKICHGR 133 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~---~~~kl~Dfg~~~~~~~~ 133 (291)
+..+.+-.. +..++++..-..+..||+.||.|||- ++|||.||||+||++... ..+||||||.++.....
T Consensus 648 DMLEMILSs----EkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 648 DMLEMILSS----EKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred hHHHHHHHh----hcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 555555443 56899999999999999999999999 999999999999999543 47999999999987654
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
.- .....|||.|+|||+++.+ .|+..-|+||.|+++|--+.|..||..+.+...++.- ..+..+
T Consensus 721 sF---RrsVVGTPAYLaPEVLrnk--GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQN-----------AaFMyP 784 (888)
T KOG4236|consen 721 SF---RRSVVGTPAYLAPEVLRNK--GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQN-----------AAFMYP 784 (888)
T ss_pred hh---hhhhcCCccccCHHHHhhc--cccccccceeeeEEEEEEecccccCCCccchhHHhhc-----------cccccC
Confidence 32 3455689999999999987 8999999999999999999999999877654332211 111111
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRV 248 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~el 248 (291)
...=.+.+....+||..+|+..-.+|-|.++-
T Consensus 785 ---p~PW~eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 785 ---PNPWSEISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred ---CCchhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 11224577788999999999999999877663
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=208.58 Aligned_cols=211 Identities=27% Similarity=0.357 Sum_probs=164.3
Q ss_pred CceeEEEEEecC-CCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcCCCHHHHHhh
Q 022826 13 GYGGVYKGKLLD-GRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSNGSLEKFIYE 64 (291)
Q Consensus 13 ~~g~V~~~~~~~-~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~g~L~~~l~~ 64 (291)
+||.||++...+ ++.+++|++.... +.+......++++|++.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999998865 8999999987542 455556788899999999999999865
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeeccCCCC
Q 022826 65 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARG 144 (291)
Q Consensus 65 ~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 144 (291)
. ..+++..++.++.+++.++.+||+ .+++|+||+|.||+++.++.++|+|||.+....... ......+
T Consensus 81 ~------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~ 148 (244)
T smart00220 81 R------GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVG 148 (244)
T ss_pred c------cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccC
Confidence 4 238999999999999999999999 999999999999999999999999999988755432 2233456
Q ss_pred CccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhH-HH
Q 022826 145 TVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDK-EY 223 (291)
Q Consensus 145 ~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 223 (291)
+..|++||.+.+. .++.++|||+||+++++|++|..|+...... ... ............... .+
T Consensus 149 ~~~~~~pE~~~~~--~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-------~~~------~~~~~~~~~~~~~~~~~~ 213 (244)
T smart00220 149 TPEYMAPEVLLGK--GYGKAVDVWSLGVILYELLTGKPPFPGDDQL-------LEL------FKKIGKPKPPFPPPEWKI 213 (244)
T ss_pred CcCCCCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-------HHH------HHHHhccCCCCccccccC
Confidence 7899999998754 7788999999999999999999877553110 000 000001111011111 15
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 224 ARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 224 ~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
+..+.+++.+||..+|++||++.++++
T Consensus 214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 214 SPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CHHHHHHHHHHccCCchhccCHHHHhh
Confidence 678999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=223.15 Aligned_cols=211 Identities=22% Similarity=0.286 Sum_probs=172.4
Q ss_pred hcccccCCceeEEEEEecCCC-eEEEEEeccCc-----------------------------ceeecCCcceeeehhhcC
Q 022826 6 KNKLGQGGYGGVYKGKLLDGR-NVAIKVLNETK-----------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
.-.||-|+||.|=+++..... .+|+|++++.+ ..+.+.+..|++||-|-|
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 456999999999999875433 48999988766 344567788899999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
|.|...+..+ +.|+..+...++..+++|++|||+ ++||.|||||+|.+++.+|-+||.|||.+....++..
T Consensus 505 GElWTiLrdR------g~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 505 GELWTILRDR------GSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred chhhhhhhhc------CCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 9999999776 578888899999999999999999 9999999999999999999999999999998877664
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
....||||.|.|||++.+. ..+.++|.|+||+++||+++|..||..... ......+......
T Consensus 576 ---TwTFcGTpEYVAPEIILnK--GHD~avDyWaLGIli~ELL~G~pPFs~~dp--------mktYn~ILkGid~----- 637 (732)
T KOG0614|consen 576 ---TWTFCGTPEYVAPEIILNK--GHDRAVDYWALGILIYELLTGSPPFSGVDP--------MKTYNLILKGIDK----- 637 (732)
T ss_pred ---eeeecCCcccccchhhhcc--CcchhhHHHHHHHHHHHHHcCCCCCCCCch--------HHHHHHHHhhhhh-----
Confidence 3568899999999999887 889999999999999999999999986542 1111111111100
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCC
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPA 244 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps 244 (291)
-..+....+...+|++++-..+|.+|..
T Consensus 638 -i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 638 -IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 1234556777888888888999999965
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-30 Score=219.55 Aligned_cols=233 Identities=21% Similarity=0.291 Sum_probs=173.8
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-------------------------------ceeecCCcceeeeh
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------------------------------~~~~~~~~~~lv~e 51 (291)
.+.-..|+|-|++|.+|.+.. |..||||++.... ..+...++.|+|||
T Consensus 435 ~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE 514 (752)
T KOG0670|consen 435 EVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFE 514 (752)
T ss_pred EEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEeh
Confidence 345568999999999998865 8899999998665 45667789999999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC-CceEEeccCCcccc
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKIC 130 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~-~~~kl~Dfg~~~~~ 130 (291)
.+.- +|.++|+.-+ ..-++....+..++.||..||.+|-. .+|+|.||||+|||+++. ..+||||||.+...
T Consensus 515 ~Lsl-NLRevLKKyG---~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 515 PLSL-NLREVLKKYG---RNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILKLCDFGSASFA 587 (752)
T ss_pred hhhc-hHHHHHHHhC---cccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceeeeccCcccccc
Confidence 9955 9999998864 45678889999999999999999999 999999999999999876 46799999998764
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccc-------cchhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEI-------YFPHWVYKR 203 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~-------~~~~~~~~~ 203 (291)
....- .++ .-+-.|.|||++.|. .|+...|+||.||++|||-||+..|+...++.-.. .+|.....+
T Consensus 588 ~enei-tPY---LVSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 588 SENEI-TPY---LVSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred ccccc-cHH---HHHHhccCcceeecC--cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 43221 111 125589999999998 99999999999999999999987776443322000 000000000
Q ss_pred ------------------------------------hhhhhh--hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 022826 204 ------------------------------------LELEED--LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAM 245 (291)
Q Consensus 204 ------------------------------------~~~~~~--~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~ 245 (291)
.....+ +....+ ..........|.+|+..||..||++|.|.
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~-~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRL-PDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCC-CchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 000001 111112 22234577789999999999999999999
Q ss_pred HHHHH
Q 022826 246 NRVVE 250 (291)
Q Consensus 246 ~ell~ 250 (291)
.+.|+
T Consensus 741 nqAL~ 745 (752)
T KOG0670|consen 741 NQALK 745 (752)
T ss_pred HHHhc
Confidence 98774
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=197.88 Aligned_cols=232 Identities=22% Similarity=0.301 Sum_probs=172.5
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+++|+|.+++||.|... +++.++||++++.+ -.+...+...+|+|+.+.
T Consensus 40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n 119 (338)
T KOG0668|consen 40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNN 119 (338)
T ss_pred HHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcc
Confidence 346789999999999999754 58899999998765 122234455688888888
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC-CceEEeccCCccccCCCC
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICHGRE 134 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 134 (291)
.+...+. ++++...+.-++.+++.||.|+|+ .||.|||+||.||||+.. ..++|+|||++...-.+.
T Consensus 120 ~Dfk~ly---------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 120 TDFKQLY---------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred ccHHHHh---------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 7777666 577888899999999999999999 999999999999999864 579999999998765544
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhh-----
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEED----- 209 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 209 (291)
. ......+..|.-||++..- +.++..-|+|||||++..|++.+.||....++..+..-...+.........
T Consensus 188 e---YnVRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 188 E---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred e---eeeeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 3 3344457788999998764 588999999999999999999999999887766543322211111111100
Q ss_pred hccc-----------------CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 210 LGLQ-----------------GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 210 ~~~~-----------------~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
+... ....+...-++.+..+|+...|..|..+|+|++|.+.
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0000 0001111224577899999999999999999999754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=231.59 Aligned_cols=220 Identities=29% Similarity=0.418 Sum_probs=161.3
Q ss_pred hcccccCCce-eEEEEEecCCCeEEEEEeccCc----------------------ceee--cCCcceeeehhhcCCCHHH
Q 022826 6 KNKLGQGGYG-GVYKGKLLDGRNVAIKVLNETK----------------------GFCF--EGHRRALIYEFVSNGSLEK 60 (291)
Q Consensus 6 ~~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~----------------------~~~~--~~~~~~lv~e~~~~g~L~~ 60 (291)
.+.+|.|+-| .||+|.. .++.||||.+-... .+|. ..+..|+..|.|.. +|.+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~d 591 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQD 591 (903)
T ss_pred HHHcccCCCCcEEEEEee-CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHH
Confidence 4778898875 5899987 88899999987654 3444 34567789999987 9999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC---C--CceEEeccCCccccCCCCc
Q 022826 61 FIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---D--FCPKISDFGLAKICHGRES 135 (291)
Q Consensus 61 ~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~---~--~~~kl~Dfg~~~~~~~~~~ 135 (291)
++... . ...........+..+.|+++||+|||+ .+||||||||.||+|+. + .+++|+|||++.....+..
T Consensus 592 lie~~-~-~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 592 LIESS-G-LDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHhcc-c-cchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 99773 1 111222224567889999999999999 99999999999999965 3 4789999999998876655
Q ss_pred eee-ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCC-CCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 136 IVS-MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGV-KNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 136 ~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
... .....||.+|+|||++... .-+.++|||||||++|++++| .-||.+.......+ ........
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI-----------l~~~~~L~ 733 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI-----------LTGNYTLV 733 (903)
T ss_pred hhhcccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHhhhhh-----------hcCcccee
Confidence 433 3556799999999999876 556699999999999999987 45565543221100 00000111
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVV 249 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell 249 (291)
.+ ....++ +..+||.+|++++|..||++.+++
T Consensus 734 ~L--~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 734 HL--EPLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred ee--ccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 11 111112 788999999999999999999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=207.68 Aligned_cols=234 Identities=24% Similarity=0.267 Sum_probs=159.7
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc-------c--------------------------eeecCCcceeeehh
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------G--------------------------FCFEGHRRALIYEF 52 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------~--------------------------~~~~~~~~~lv~e~ 52 (291)
+.||.|+||.||.+.+. +|+.|++|++..-. . ....-++.|.+.|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 67999999999999774 59999999976433 0 11111234456666
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.. +|..++- ..+.++...+.-++.||++||.|||+ .+|.||||||.|.+++.+-.+||+|||+++.-..
T Consensus 139 mQS-DLHKIIV------SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 139 MQS-DLHKIIV------SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHh-hhhheec------cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence 644 6666663 44788889999999999999999999 9999999999999999999999999999987554
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCc------cccchh-hhhhhhh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSS------EIYFPH-WVYKRLE 205 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~------~~~~~~-~~~~~~~ 205 (291)
++.... +...-|-.|+|||++.|. ..|+.+.||||.||+|.|++..+-.|........ ....+. +.++...
T Consensus 209 d~~~hM-TqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 209 RDRLNM-THEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhhhhh-HHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 433221 112236789999999986 6899999999999999999976665553322111 000000 0111111
Q ss_pred hh-------hhhcccCCCC----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 022826 206 LE-------EDLGLQGIEN----EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252 (291)
Q Consensus 206 ~~-------~~~~~~~~~~----~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L 252 (291)
.. ...+.+.... .....-..+...++..++.+||..|.+..+.+.-+
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 00 0001111000 01112334566788889999999999998877655
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-28 Score=190.35 Aligned_cols=168 Identities=21% Similarity=0.218 Sum_probs=125.8
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
|+|.+++..+ +..+++..++.++.|++.||.|||+ .+ ||+||+++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~- 63 (176)
T smart00750 1 VSLADILEVR-----GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ- 63 (176)
T ss_pred CcHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc-
Confidence 6899999653 2579999999999999999999999 66 999999999999999 99887643321
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
..+++.|+|||++.+. .++.++|||||||++|+|++|..|+........ . ..... .........
T Consensus 64 ------~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~------~-~~~~~-~~~~~~~~~ 127 (176)
T smart00750 64 ------SRVDPYFMAPEVIQGQ--SYTEKADIYSLGITLYEALDYELPYNEERELSA------I-LEILL-NGMPADDPR 127 (176)
T ss_pred ------CCCcccccChHHhcCC--CCcchhhHHHHHHHHHHHHhCCCCccccchhcH------H-HHHHH-HHhccCCcc
Confidence 2568999999999876 788999999999999999999998864322110 0 00000 000001011
Q ss_pred CChhhHHHHH--HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 022826 216 ENEEDKEYAR--KMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256 (291)
Q Consensus 216 ~~~~~~~~~~--~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~ 256 (291)
.......+.. .+.+++.+||+.||.+||++.++++.+....
T Consensus 128 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 128 DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 1112333444 6999999999999999999999999886653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=190.63 Aligned_cols=172 Identities=33% Similarity=0.467 Sum_probs=139.7
Q ss_pred hcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhcCC
Q 022826 6 KNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
++.||+|++|.|=+.++. +|...|+|.+...- +--......++-||.+.-
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t- 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT- 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence 478999999999999774 59999999987543 222234456678898866
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
||..+..+. +..+..+++..+-+|+..+++||.|||+ ...++|||+||.||+++.+|.+|+||||.+..+.+.-
T Consensus 130 Sldkfy~~v--~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi-- 203 (282)
T KOG0984|consen 130 SLDKFYRKV--LKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI-- 203 (282)
T ss_pred hHHHHHHHH--HhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh--
Confidence 888777664 3466899999999999999999999998 4789999999999999999999999999987653321
Q ss_pred eeccCCCCCccccCcccccccC--CCccccccchhHHHHHHHHhCCCCCCc
Q 022826 137 VSMTGARGTVGYIAPEVFCRNF--GEVSYKSDVYSYGMMVFEMTGVKNNAN 185 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~~--~~~~~~~DiwslG~~l~~ll~g~~~~~ 185 (291)
..+...|...|+|||.+.... ..|+.++||||||+.+.||.+++.|.+
T Consensus 204 -Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 204 -AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred -HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 234456788999999986532 378999999999999999999997665
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-29 Score=215.63 Aligned_cols=166 Identities=25% Similarity=0.335 Sum_probs=145.8
Q ss_pred hcccccCCceeEEEEEecC-CCeEEEEEeccCc-------------------------------------ceeecCCcce
Q 022826 6 KNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------------------GFCFEGHRRA 47 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------------------------------------~~~~~~~~~~ 47 (291)
.+.+|.|+||.|++|.++. ...|+||.+.+++ .++.+++.+|
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 4789999999999997754 7899999999877 7888999999
Q ss_pred eeehhhc-CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCC
Q 022826 48 LIYEFVS-NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL 126 (291)
Q Consensus 48 lv~e~~~-~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~ 126 (291)
|++|-.. +-+|++++.. ...+++..+.-|++||+.|+++||+ .+|||||||-+||+++.+|-+||+|||.
T Consensus 646 l~te~hg~gIDLFd~IE~------kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIEF------KPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred EEecCCCCCcchhhhhhc------cCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccc
Confidence 9999874 4488888854 3789999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCc
Q 022826 127 AKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNAN 185 (291)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~ 185 (291)
+....++. .....||..|.|||++.|. ...+..-|||+||+++|.++....|+.
T Consensus 717 aa~~ksgp----fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSGP----FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCCC----cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98876653 4566789999999999987 355778899999999999998777654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-29 Score=207.78 Aligned_cols=234 Identities=21% Similarity=0.313 Sum_probs=180.6
Q ss_pred hcccccCCceeEEEEEec------CCCeEEEEEeccCc---------------------------ceeecC-Ccceeeeh
Q 022826 6 KNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK---------------------------GFCFEG-HRRALIYE 51 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~---------------------------~~~~~~-~~~~lv~e 51 (291)
...+-+|.||.||+|.+. +.+.|.+|+++... +++.+. ..-+.++.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 345678999999999653 24667888877654 344443 34456789
Q ss_pred hhcCCCHHHHHhhcCCCC--CCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 52 FVSNGSLEKFIYEKHPLE--TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
+.+-|+|..++...+.-+ ..+.+...+...++.|++.|+.|||. .++||.||-+.|.+|++.-.+||+|=.+++.
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALSRD 445 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhccc
Confidence 999999999998433222 33667778899999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCC-CCCCccccCCCccccchhhhhhhhhhhh
Q 022826 130 CHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGV-KNNANVAVDRSSEIYFPHWVYKRLELEE 208 (291)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (291)
+-..+..+...+...+..|++||.++.. .++.++|+||||+++|||++. +.|..... |++.....
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~n~--~yssasDvWsfGVllWELmtlg~~PyaeID--------PfEm~~yl---- 511 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQNS--HYSSASDVWSFGVLLWELMTLGKLPYAEID--------PFEMEHYL---- 511 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHhhh--hhcchhhhHHHHHHHHHHHhcCCCCccccC--------HHHHHHHH----
Confidence 7666555544444456789999999887 899999999999999999874 44333221 22222111
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccC
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSL 259 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~ 259 (291)
..+.+...+.+++.++..++.-||...|++||+.+++...|.++-.++
T Consensus 512 ---kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 512 ---KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred ---hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 233344556778899999999999999999999999999998876544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=206.73 Aligned_cols=235 Identities=22% Similarity=0.334 Sum_probs=171.6
Q ss_pred chhhcccccCCceeEEEEEec----CCCeEEEEEeccCc-------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL----DGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.++||+|+|++||++.+. .++.||+|.+.... +...+++..++|+||+
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 346789999999999999653 47899999987655 6677788999999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC-CCceEEeccCCccccCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-DFCPKISDFGLAKICHG 132 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~-~~~~kl~Dfg~~~~~~~ 132 (291)
++-...+++ ..++...+..+++.++.||.++|. .||||+||||.|++.+. .++-.|+|||++.....
T Consensus 118 ~H~~f~~l~---------~~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 118 EHDRFRDLY---------RSLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred CccCHHHHH---------hcCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 999999998 467788999999999999999999 99999999999999975 47889999999872210
Q ss_pred ------------------------------------------CCceeeccCCCCCccccCcccccccCCCccccccchhH
Q 022826 133 ------------------------------------------RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSY 170 (291)
Q Consensus 133 ------------------------------------------~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~Diwsl 170 (291)
+......-...||++|+|||++... +..+.++||||.
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiws~ 264 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccceeec
Confidence 0000001123489999999999775 577899999999
Q ss_pred HHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh--------------------------------hhhhcccC----
Q 022826 171 GMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL--------------------------------EEDLGLQG---- 214 (291)
Q Consensus 171 G~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~---- 214 (291)
|++++.+++++.||....+......-.......... ........
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 999999999999987554443311100000000000 00000000
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
........++..+++|+.+||..||.+|.|+++.|+
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 001111224447899999999999999999999875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-27 Score=188.91 Aligned_cols=185 Identities=36% Similarity=0.624 Sum_probs=155.9
Q ss_pred cccCCceeEEEEEecC-CCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcCCCHHH
Q 022826 9 LGQGGYGGVYKGKLLD-GRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSNGSLEK 60 (291)
Q Consensus 9 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~g~L~~ 60 (291)
||+|.+|.||++...+ ++.+++|++.... +........++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998754 8999999998662 34444567889999999899999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC-CCceEEeccCCccccCCCCceeec
Q 022826 61 FIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-DFCPKISDFGLAKICHGRESIVSM 139 (291)
Q Consensus 61 ~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~ 139 (291)
++.... ..+++..++.++.+++.++.+||+ .+++|+||+|.||+++. ++.++|+||+.+........ ..
T Consensus 81 ~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~ 150 (215)
T cd00180 81 LLKENE-----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LL 150 (215)
T ss_pred HHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hh
Confidence 986532 478999999999999999999999 99999999999999999 89999999999876544321 12
Q ss_pred cCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChh
Q 022826 140 TGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEE 219 (291)
Q Consensus 140 ~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (291)
....+...|.+||.+... ...+.+.|+|++|+++++|
T Consensus 151 ~~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l------------------------------------------ 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL------------------------------------------ 187 (215)
T ss_pred hcccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH------------------------------------------
Confidence 234457899999998653 3678899999999999998
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 220 DKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 220 ~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
..+.+++.+|++.||++||++.++++.
T Consensus 188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 568889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=216.20 Aligned_cols=239 Identities=23% Similarity=0.331 Sum_probs=180.3
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+++|+|.+|.||++++.. ++..|+|+++... +-....+...+.||||.+
T Consensus 17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg 96 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG 96 (829)
T ss_pred hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence 3456899999999999998865 9999999998665 222234556689999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
|+|.+..+.. ..+++-++...+++.+.|++|||+ ++-+|||||-.||++++.|.+|+.|||.+.+....-.
T Consensus 97 gslQdiy~~T------gplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 97 GSLQDIYHVT------GPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred Ccccceeeec------ccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhhh
Confidence 9999998665 689999999999999999999999 9999999999999999999999999999876543211
Q ss_pred eeeccCCCCCccccCcccc-cccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 136 IVSMTGARGTVGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l-~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
......||+.|+|||+. .+..+.|...+|||++|+...++--...|..+... . +.......-....
T Consensus 168 --KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--------m---r~l~LmTkS~~qp 234 (829)
T KOG0576|consen 168 --KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--------M---RALFLMTKSGFQP 234 (829)
T ss_pred --hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--------H---HHHHHhhccCCCC
Confidence 12456789999999986 33446899999999999999988644444333221 1 1111111111111
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH-----------HHHhhhccCCCCC
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE-----------MLEGSLDSLRIPP 263 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~-----------~L~~~~~~~~~~~ 263 (291)
.-......+...|.+|++.||-++|.+||+++.+|. ..-++|++...|.
T Consensus 235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~ 294 (829)
T KOG0576|consen 235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPN 294 (829)
T ss_pred CcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCC
Confidence 112234568899999999999999999999998753 3345666666666
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=192.58 Aligned_cols=226 Identities=24% Similarity=0.210 Sum_probs=158.1
Q ss_pred cccccCCceeEEEEEe-cCCCeEEEEEeccCc----------------------------------ceeecCCcceeeeh
Q 022826 7 NKLGQGGYGGVYKGKL-LDGRNVAIKVLNETK----------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----------------------------------~~~~~~~~~~lv~e 51 (291)
..++.|+. .|..+.+ ..+++|++|+..... ....+-...|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 35677777 6666654 348899999876543 11122335668999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
++.. +|...+. ..++.+.+..|+.|++.|+.|||+ .+|+||||||+||++..+..+||.|||+++.-.
T Consensus 102 ~m~~-nl~~vi~--------~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 102 LMDA-NLCQVIL--------MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred hhhh-HHHHHHH--------HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccC
Confidence 9965 8877774 357788999999999999999999 999999999999999999999999999998543
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc-------chhhh-hhh
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY-------FPHWV-YKR 203 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~-------~~~~~-~~~ 203 (291)
.. ...+....+..|+|||++.+. .+.+.+||||+||++.||++|.-.|......+. +. .+... ..+
T Consensus 170 ~~---~~mtpyVvtRyyrapevil~~--~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ-~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 170 TD---FMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQ-WNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cc---cccCchhheeeccCchheecc--CCcccchhhhhhhHHHHHhhceEEecCchHHHH-HHHHHHHhcCCCHHHHHH
Confidence 33 233445557899999999987 599999999999999999999877764332221 00 00000 000
Q ss_pred hh-----------hhhhhccc------CCC--ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 204 LE-----------LEEDLGLQ------GIE--NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 204 ~~-----------~~~~~~~~------~~~--~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.. ....+... ..+ .+..+.-...+.+++.+||..||++|.|++++|+-
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 00000000 000 01112234557899999999999999999999863
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-27 Score=223.12 Aligned_cols=179 Identities=17% Similarity=0.200 Sum_probs=123.1
Q ss_pred CcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCc-----
Q 022826 44 HRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC----- 118 (291)
Q Consensus 44 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~----- 118 (291)
...++++|++ +++|.+++... ...+++..++.+++||+.||.|||+ ++|+||||||+||||+..+.
T Consensus 53 ~~~~~~~e~~-~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~gIvHrDlKP~NiLl~~~~~~k~~d 123 (793)
T PLN00181 53 DSIVRALECE-DVSLRQWLDNP-----DRSVDAFECFHVFRQIVEIVNAAHS---QGIVVHNVRPSCFVMSSFNHVSFIE 123 (793)
T ss_pred chhhhhhccC-CccHHHHHhcc-----cccccHHHHHHHHHHHHHHHHHHHh---CCeeeccCCchhEEEcccCcEEEee
Confidence 4566778877 55999999642 3569999999999999999999999 99999999999999965444
Q ss_pred --------------eEEeccCCccccCCCCc--------e------eeccCCCCCccccCcccccccCCCccccccchhH
Q 022826 119 --------------PKISDFGLAKICHGRES--------I------VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSY 170 (291)
Q Consensus 119 --------------~kl~Dfg~~~~~~~~~~--------~------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~Diwsl 170 (291)
+|++|||+++....... . .......+|+.|+|||++.+. .++.++|||||
T Consensus 124 ~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~sDVwSl 201 (793)
T PLN00181 124 SASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGS--SSNCASDVYRL 201 (793)
T ss_pred ccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccC--CCCchhhhhhH
Confidence 55555555543210000 0 000113467889999999876 78999999999
Q ss_pred HHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 171 GMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 171 G~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
||++|||+++..++..... ...... .. ..+ ..... ......+++.+||+.||.+||++.|+++
T Consensus 202 GviL~ELl~~~~~~~~~~~----------~~~~~~-~~--~~~---~~~~~-~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 202 GVLLFELFCPVSSREEKSR----------TMSSLR-HR--VLP---PQILL-NWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHhhCCCchhhHHH----------HHHHHH-Hh--hcC---hhhhh-cCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 9999999987765432110 000000 00 001 10111 1233567888999999999999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-24 Score=177.17 Aligned_cols=244 Identities=18% Similarity=0.235 Sum_probs=194.4
Q ss_pred cchhhcccccCCceeEEEEEe-cCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcC
Q 022826 2 TNSFKNKLGQGGYGGVYKGKL-LDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
.+.++++||.|+||++|.|.. -+++.||||.-+.+. .+..++...+||+|.+ |
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 467899999999999999964 579999999987665 5667788889999999 4
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC-----ceEEeccCCcccc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-----CPKISDFGLAKIC 130 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-----~~kl~Dfg~~~~~ 130 (291)
-||++++.-.+ .+|+.++++.++.|++.-++++|+ +.+|.|||||+|++|...+ .+-++|||++...
T Consensus 108 PSLEDLFD~Cg-----R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 108 PSLEDLFDLCG-----RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred cCHHHHHHHhc-----CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 59999986654 799999999999999999999999 9999999999999996443 5789999999876
Q ss_pred CCCCc-----eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhh
Q 022826 131 HGRES-----IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLE 205 (291)
Q Consensus 131 ~~~~~-----~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (291)
..... ........||..||+-.-..|. +.+.+-|+-+||-+|++++.|..||...........+.
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe-------- 249 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE-------- 249 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH--------
Confidence 54221 2223556799999999888876 78999999999999999999999998764432211111
Q ss_pred hhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCCC
Q 022826 206 LEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPR 264 (291)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 264 (291)
.+............+..++.+|...++-.-+.+-.+-|..+-+..++.++++.+....-
T Consensus 250 KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~D 308 (449)
T KOG1165|consen 250 KIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDD 308 (449)
T ss_pred HhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccc
Confidence 12222223333445667888888888888899999999999999999999888776543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=176.21 Aligned_cols=172 Identities=33% Similarity=0.459 Sum_probs=143.3
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcC
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
.+.+.||+|++|.||++...+ ++.+++|.+.... +.+......++++|++.+
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 567899999999999998865 8999999998641 344555778899999999
Q ss_pred CCHHHHHhhcCCCCCCCC-CCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 56 GSLEKFIYEKHPLETNQK-LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~-~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
++|.+++.... . +++..+..++.+++.++.+||+ .+++|+||+|.||+++.++.++|+|||.+.......
T Consensus 82 ~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 82 GDLFDYLRKKG------GKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred CCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 99999986542 3 8899999999999999999999 999999999999999999999999999988765432
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCcc
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANV 186 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~ 186 (291)
.. ......++..|++||... ....++.++|+|+||+++++|++|+.||..
T Consensus 153 ~~-~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AA-LLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cc-cccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 10 122334577899999984 224777899999999999999999998865
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=170.46 Aligned_cols=243 Identities=19% Similarity=0.248 Sum_probs=189.9
Q ss_pred cchhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcC
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
++.+.++||+|+||.+|.|... +|..||||+-+.+. .+..++....+||+.+ |
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-G 94 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-G 94 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-C
Confidence 3567899999999999999764 59999999977654 5777888899999999 5
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC---CCceEEeccCCccccCC
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---DFCPKISDFGLAKICHG 132 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~---~~~~kl~Dfg~~~~~~~ 132 (291)
.+|+++++-.. ..++.++++.++-|++.-++|+|. ++.+|+||||+|++..- ...+.++|||++..+..
T Consensus 95 PsLEdLfnfC~-----R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 95 PSLEDLFNFCS-----RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ccHHHHHHHHh-----hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 59999987653 689999999999999999999999 99999999999999853 34789999999987643
Q ss_pred CC-----ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 133 RE-----SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 133 ~~-----~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
.. +.....+..||..|.+-....|. ..+.+-|+-|+|.++.++..|..||+......... +-+.+
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q--------KyEkI 236 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ--------KYEKI 236 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCcccccchhhHHH--------HHHHH
Confidence 21 11223556789999998888776 67888999999999999999999998775543322 11222
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCC
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPP 263 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 263 (291)
............+..++.++...+.-|-..--++-|...-+.+.+.-+...+.-..
T Consensus 237 ~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~ 292 (341)
T KOG1163|consen 237 SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQY 292 (341)
T ss_pred HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccC
Confidence 22223333344566778888888888999999999998888888777776665543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.2e-25 Score=200.36 Aligned_cols=227 Identities=23% Similarity=0.251 Sum_probs=168.0
Q ss_pred hhcccccCCceeEEEEEec-CCCeEEEEEec----cCc----------------------------ceeecCCcceeeeh
Q 022826 5 FKNKLGQGGYGGVYKGKLL-DGRNVAIKVLN----ETK----------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~----~~~----------------------------~~~~~~~~~~lv~e 51 (291)
-++.+|.|++|.|+.+... .......|.+. ... ....+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3578999999988888543 24434444332 111 11111122223589
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
||+. +|..++... ..+....+..+++|++.|+.|+|. .|+.|+|+|++|+++..+|.+||+|||.+..+.
T Consensus 402 ~~~~-Dlf~~~~~~------~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN------GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred cccH-HHHHHHhcc------cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeec
Confidence 9999 999999654 478888899999999999999999 999999999999999999999999999999887
Q ss_pred CCCce--eeccCCCCCccccCcccccccCCCcc-ccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhh
Q 022826 132 GRESI--VSMTGARGTVGYIAPEVFCRNFGEVS-YKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEE 208 (291)
Q Consensus 132 ~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~-~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (291)
...+. .......|+..|+|||++.+. .|. ...||||.|+++..|++|+.||........... ......
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~--~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-------~~~~~~ 542 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGK--EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-------TNNYSD 542 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCccccccc--ccCcchhhhhhccceEEEEecCCCccccccccccchh-------hhcccc
Confidence 66655 556778899999999999886 554 578999999999999999998876655443320 000011
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..............++.....++.+||+.||.+|.|++++++
T Consensus 543 ~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 543 QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 111111122334567788889999999999999999999875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-22 Score=172.24 Aligned_cols=239 Identities=20% Similarity=0.227 Sum_probs=173.5
Q ss_pred chhhcccccCCceeEEEEEecC--CCeEEEEEeccCc------------------------------cee-ecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD--GRNVAIKVLNETK------------------------------GFC-FEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~------------------------------~~~-~~~~~~~lv 49 (291)
+.+.+.||+|+||.||.+.+.+ ...+|+|+..... ... ......++|
T Consensus 20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iV 99 (322)
T KOG1164|consen 20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIV 99 (322)
T ss_pred eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEE
Confidence 5678999999999999998755 3588999876532 111 244567899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC-----CceEEecc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-----FCPKISDF 124 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~-----~~~kl~Df 124 (291)
|+.+ |.+|.++.... ....++..++..++.|++.+|.++|+ .|++||||||.|+.+... ..+.|.||
T Consensus 100 M~l~-G~sL~dl~~~~----~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 100 MSLL-GPSLEDLRKRN----PPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred Eecc-CccHHHHHHhC----CCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 9988 45999987654 35789999999999999999999999 999999999999999754 46899999
Q ss_pred CCcc--ccCCCCce--ee----ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc
Q 022826 125 GLAK--ICHGRESI--VS----MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF 196 (291)
Q Consensus 125 g~~~--~~~~~~~~--~~----~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~ 196 (291)
|+++ .+...... .. .....||..|+++....+. ..+.+.|+||++.++.++..|..||...........+
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~--e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI--EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC--ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 9998 33222211 11 1234589999999998886 8899999999999999999999888554432221100
Q ss_pred hhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCC
Q 022826 197 PHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262 (291)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 262 (291)
. .. ........ .....+..+.++...+-..+...+|....+...|.+........
T Consensus 250 ~-----~~--~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~ 304 (322)
T KOG1164|consen 250 E-----KD--PRKLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSK 304 (322)
T ss_pred H-----HH--hhhhcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCC
Confidence 0 00 00000000 11223345555666666799999999999999998887766443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=174.96 Aligned_cols=212 Identities=20% Similarity=0.293 Sum_probs=138.0
Q ss_pred cchhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-------------------------------------------
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------------------- 37 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------------------- 37 (291)
|...++.||.|+|+.||.+.+.. ++.++||++....
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 34567899999999999999865 9999999976543
Q ss_pred -----ceeecC-----C---cceeeehhhcCCCHHHHHhhcCCCCC-CCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeee
Q 022826 38 -----GFCFEG-----H---RRALIYEFVSNGSLEKFIYEKHPLET-NQKLKWEVLYKIAVGIARGLEYLHRGCNTRILH 103 (291)
Q Consensus 38 -----~~~~~~-----~---~~~lv~e~~~~g~L~~~l~~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH 103 (291)
.+.... . ..+++|+-. .++|.+++..-..... ...+.......+..|++..+++||+ .|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence 011111 1 335677777 4488777543110011 1234455566777999999999999 99999
Q ss_pred eccCCCceEEcCCCceEEeccCCccccCCCCceeeccCCCCCccccCccccccc------CCCccccccchhHHHHHHHH
Q 022826 104 FDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN------FGEVSYKSDVYSYGMMVFEM 177 (291)
Q Consensus 104 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~------~~~~~~~~DiwslG~~l~~l 177 (291)
+||+|+|++++.+|.+.|+||+......... . . ...+..|.|||..... .-.++++.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~--~-~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY--R-C--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEE--E-G--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCcee--e-c--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999999999999997655432211 1 1 2235679999976332 12578899999999999999
Q ss_pred hCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCC
Q 022826 178 TGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDR 242 (291)
Q Consensus 178 l~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~R 242 (291)
..++.||........... ....+.+.++.+..||+.+|+.||.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~--------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW--------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG--------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc--------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999999886543322110 111233788899999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.6e-22 Score=184.94 Aligned_cols=222 Identities=19% Similarity=0.192 Sum_probs=164.0
Q ss_pred hhhcccccCCceeEEEEEecCCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCCC
Q 022826 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
-|...||+|+||.||+|...+|+.||||+-++.. ......+..++|++|.+.|+
T Consensus 701 ~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gt 780 (974)
T KOG1166|consen 701 CISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGT 780 (974)
T ss_pred EEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccccc
Confidence 4568899999999999988789999999988766 22233455678999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc-------CCCceEEeccCCcccc
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD-------EDFCPKISDFGLAKIC 130 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~-------~~~~~kl~Dfg~~~~~ 130 (291)
|.++++.. ...++.....+..|++..|++||. .+||||||||+|.||. +...++|+|||.+..+
T Consensus 781 lld~~N~~------~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 781 LLDLINTN------KVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred HHHhhccC------CCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 99999743 577888899999999999999999 9999999999999992 3446999999998765
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
.--..........+|-.+-.+|...|. .|++.+|.|.|+.+++-|++|+...... + ...
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLFG~y~q~~~-g------------------~~~ 910 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLFGKYMEVKN-G------------------SSW 910 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHHHHHHHhcC-C------------------cce
Confidence 422222334556678899999999987 9999999999999999999998533000 0 000
Q ss_pred cccCCCChhhHHH-HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 211 GLQGIENEEDKEY-ARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 211 ~~~~~~~~~~~~~-~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
... ......+ ..-.-+++..+|+.|-..=|.+.+|...|+..+.+
T Consensus 911 ~~~---~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 911 MVK---TNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred ecc---ccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 000 0011111 12233566667773333337888888888776543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-21 Score=164.96 Aligned_cols=150 Identities=19% Similarity=0.189 Sum_probs=109.5
Q ss_pred chhhcccccCCceeEEEEEec--CCCeEEEEEeccC------c----------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL--DGRNVAIKVLNET------K----------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~------~----------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|.+. +++.+|||++... . .........++||||
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~~LVmE~ 99 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKDGLVRGW 99 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCcEEEEEc
Confidence 567899999999999999764 4778899986422 0 011223567899999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeecc-CCCceEEcCCCceEEeccCCccccC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDI-KPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~di-kp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
+.+++|... . ... ...++.+++++|.|||+ .+|+|||| ||+||+++.++.++|+|||+++.+.
T Consensus 100 ~~G~~L~~~-~------~~~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 100 TEGVPLHLA-R------PHG------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred cCCCCHHHh-C------ccc------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 999999632 1 101 14678999999999999 99999999 9999999999999999999998765
Q ss_pred CCCcee------eccCCCCCccccCcccccccCCC----ccccccch
Q 022826 132 GRESIV------SMTGARGTVGYIAPEVFCRNFGE----VSYKSDVY 168 (291)
Q Consensus 132 ~~~~~~------~~~~~~~~~~y~aPE~l~~~~~~----~~~~~Diw 168 (291)
...... ......++..|.+||.+...... .+..+|-|
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 432111 12345567889999998654322 22345666
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-21 Score=155.95 Aligned_cols=225 Identities=22% Similarity=0.419 Sum_probs=169.7
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~ 54 (291)
.++.-+|.+...|+.|+|++ .|..+++|++.... +-|.......++..|++
T Consensus 192 lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 45667899999999999998 44455667665332 44555567778999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEe--ccCCccccCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS--DFGLAKICHG 132 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~--Dfg~~~~~~~ 132 (291)
-|+|...+++. .+--++..++.+++-++++|+.|||+ ...-|.---++...|+|+++-+++|. |-..+.+.
T Consensus 271 ~gslynvlhe~----t~vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedltarismad~kfsfqe-- 343 (448)
T KOG0195|consen 271 FGSLYNVLHEQ----TSVVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-- 343 (448)
T ss_pred chHHHHHHhcC----ccEEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchhhhheecccceeeeec--
Confidence 99999999876 33456777899999999999999998 11224455688899999998776664 54433322
Q ss_pred CCceeeccCCCCCccccCcccccccCCCc-cccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEV-SYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~-~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
......|.|++||.++...... -.++|+|||++++||+.|...||.+...- +....+.
T Consensus 344 -------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm--------------ecgmkia 402 (448)
T KOG0195|consen 344 -------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM--------------ECGMKIA 402 (448)
T ss_pred -------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch--------------hhhhhhh
Confidence 3344578999999998764433 35789999999999999999888765321 1223344
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~ 256 (291)
..+++...++..+..+.+|+.-|++.||.+||....++-.||++.
T Consensus 403 leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 555666667778888999999999999999999999999998864
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=149.73 Aligned_cols=116 Identities=17% Similarity=0.192 Sum_probs=92.9
Q ss_pred hhcccccCCceeEEEEEecCCCeEEEEEeccCcc----------------------------------------------
Q 022826 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG---------------------------------------------- 38 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---------------------------------------------- 38 (291)
+...||+|+||.||+|...+|+.||||+++....
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 1 INGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 3568999999999999887899999999864310
Q ss_pred ----eeecCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHh-hcCCCCCeeeeccCCCceEE
Q 022826 39 ----FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL-HRGCNTRILHFDIKPHNILL 113 (291)
Q Consensus 39 ----~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~L-H~~~~~~ivH~dikp~Nill 113 (291)
........++||||++++++...... ...++...+..++.|++.+|.++ |+ .+++|+||||+||++
T Consensus 81 v~~p~~~~~~~~~iVmE~i~g~~l~~~~~~------~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILLKSHVLVMEFIGDDGWAAPRLK------DAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEecCCEEEEEEeCCCCCcchhhh------cCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEE
Confidence 00001223799999998777654322 24788999999999999999999 68 999999999999999
Q ss_pred cCCCceEEeccCCcccc
Q 022826 114 DEDFCPKISDFGLAKIC 130 (291)
Q Consensus 114 ~~~~~~kl~Dfg~~~~~ 130 (291)
+ ++.++|+|||++...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 478999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-19 Score=153.83 Aligned_cols=236 Identities=28% Similarity=0.333 Sum_probs=168.1
Q ss_pred hhhcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------------ceeecCCcceeeehhh
Q 022826 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~~ 53 (291)
.+.+.||.|+|+.||++.+. ..+++|.+.... .........+++++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 45678999999999999876 788888876543 1223333468999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC-ceEEeccCCccccCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-CPKISDFGLAKICHG 132 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~ 132 (291)
.++++.+++...... ..++......++.|++.++.++|+ .+++|+|+||+||+++..+ .++++|||.+.....
T Consensus 81 ~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 81 DGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 999999776543100 378899999999999999999999 9999999999999999988 799999999986554
Q ss_pred CCcee----eccCCCCCccccCcccccccC-CCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 133 RESIV----SMTGARGTVGYIAPEVFCRNF-GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 133 ~~~~~----~~~~~~~~~~y~aPE~l~~~~-~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
..... ......++..|++||.+.+.. .......|+|++|+++++++++..|+........ ...........
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~----~~~~~~~~~~~ 230 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA----TSQTLKIILEL 230 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcccc----HHHHHHHHHhc
Confidence 33221 235667899999999997732 3788899999999999999999988554432100 00000000000
Q ss_pred hhh-cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 208 EDL-GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 208 ~~~-~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
... ................+.+++..|+..+|..|.+..+....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000 00000000002223568889999999999999998887764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-21 Score=178.64 Aligned_cols=234 Identities=21% Similarity=0.197 Sum_probs=165.6
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||++.|=.|.++++..|. |+||++-+.. ......+..|+|-+|+
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 345688999999999999987777 8999987655 2334456677888998
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC--
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH-- 131 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~-- 131 (291)
.+ +|.|.+..+ ..+......-|+=||+.||.-+|. .+|+|||||.+||||+.=.=+.|.||..-+..-
T Consensus 104 kh-nLyDRlSTR------PFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 104 KH-NLYDRLSTR------PFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred hh-hhhhhhccc------hHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 77 999988544 567778888899999999999999 999999999999999887678999998765432
Q ss_pred C---CCceeeccCCCCCccccCcccccc--------cCC-CccccccchhHHHHHHHHhCC-CCCCccccCCCccccchh
Q 022826 132 G---RESIVSMTGARGTVGYIAPEVFCR--------NFG-EVSYKSDVYSYGMMVFEMTGV-KNNANVAVDRSSEIYFPH 198 (291)
Q Consensus 132 ~---~~~~~~~~~~~~~~~y~aPE~l~~--------~~~-~~~~~~DiwslG~~l~~ll~g-~~~~~~~~~~~~~~~~~~ 198 (291)
. .+-.+.+......-+|+|||.... +.. ..+++-||||+||+++|+++. +.+|.-.+-
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL--------- 244 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL--------- 244 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH---------
Confidence 1 122223344445679999997633 111 267889999999999999875 444432100
Q ss_pred hhhhhh-hhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH-------------HHhhhccCCCCC
Q 022826 199 WVYKRL-ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM-------------LEGSLDSLRIPP 263 (291)
Q Consensus 199 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~-------------L~~~~~~~~~~~ 263 (291)
...+.. ..... .-...-....+++++..|++.||.+|.++++.|+. |...+..+...+
T Consensus 245 ~aYr~~~~~~~e-------~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy~FL~~Y~~~~~~~~ 316 (1431)
T KOG1240|consen 245 LAYRSGNADDPE-------QLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFYSFLYDYLDRFVPLT 316 (1431)
T ss_pred HhHhccCccCHH-------HHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHHHHHHHHHHhcCCcc
Confidence 000000 00000 00001112257889999999999999999999987 555666666554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.2e-20 Score=160.78 Aligned_cols=206 Identities=22% Similarity=0.368 Sum_probs=152.1
Q ss_pred ceeecCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCe-eeeccCCCceEEcCC
Q 022826 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRI-LHFDIKPHNILLDED 116 (291)
Q Consensus 38 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~i-vH~dikp~Nill~~~ 116 (291)
+.+.++...+.|++||..|+|.+.+.. ....+++.+...++++++.|+.|+|. ..| +|+.++..|.+++..
T Consensus 14 g~~~~~~~~~~i~~~c~rGsl~D~i~~-----~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~s~nClvd~~ 85 (484)
T KOG1023|consen 14 GASVDGPEMIVIWEYCSRGSLLDILSN-----EDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALKSSNCLVDSR 85 (484)
T ss_pred eeEecCCceEEEEeeecCccHHhHHhc-----cccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeeccccceeeee
Confidence 667777899999999999999999976 34788999999999999999999999 444 999999999999999
Q ss_pred CceEEeccCCccccCCCCceeeccCCCCCccccCcccccccC--CC---ccccccchhHHHHHHHHhCCCCCCccccCCC
Q 022826 117 FCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF--GE---VSYKSDVYSYGMMVFEMTGVKNNANVAVDRS 191 (291)
Q Consensus 117 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~--~~---~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~ 191 (291)
..+||.|||+.................-...|.|||.+.+.. .. .+.++||||||++++|+++...||+......
T Consensus 86 w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~ 165 (484)
T KOG1023|consen 86 WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVE 165 (484)
T ss_pred EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccC
Confidence 999999999987654311111112222356899999997631 11 4678999999999999999999988765443
Q ss_pred ccccchhhhhhhhhhhhhhcccCCCChh-hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 192 SEIYFPHWVYKRLELEEDLGLQGIENEE-DKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
.. ............ ....+... ..+....+..++.+||..+|++||+++++-..++.+..
T Consensus 166 ~~----~eii~~~~~~~~--~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 166 DP----DEIILRVKKGGS--NPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred Ch----HHHHHHHHhcCC--CCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 31 111111111000 01111111 12455579999999999999999999999999887655
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-19 Score=142.61 Aligned_cols=116 Identities=20% Similarity=0.234 Sum_probs=92.0
Q ss_pred hcccccCCceeEEEEEecCCCeEEEEEeccCccee---------------------------------------------
Q 022826 6 KNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKGFC--------------------------------------------- 40 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------------------------------- 40 (291)
...||+|+||.||+|.+.+|+.||||+++......
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999987789999999988642100
Q ss_pred -----ecCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC
Q 022826 41 -----FEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE 115 (291)
Q Consensus 41 -----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~ 115 (291)
......++||||++++++...... ...++......++.+++.++.++|+ ..+++|+||||+||+++
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~------~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLK------DVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhh------hccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence 000123799999998755433211 1357788899999999999999997 37999999999999999
Q ss_pred CCceEEeccCCcccc
Q 022826 116 DFCPKISDFGLAKIC 130 (291)
Q Consensus 116 ~~~~kl~Dfg~~~~~ 130 (291)
++.++|+|||++...
T Consensus 153 ~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 DGKPYIIDVSQAVEL 167 (190)
T ss_pred CCCEEEEEcccceec
Confidence 889999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-20 Score=167.16 Aligned_cols=199 Identities=26% Similarity=0.276 Sum_probs=158.2
Q ss_pred ccccCCceeEEEEEec----CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehhhc
Q 022826 8 KLGQGGYGGVYKGKLL----DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 8 ~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~~ 54 (291)
.+|+|+||.|++++.. .++.+++|++.+.. ..+..+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3789999999999532 27788888887655 23344556778899999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+|.|...+... ..+.+.....+...++-+++++|+ .+++++|+|++||+++.+|.+++.|||+++..-...
T Consensus 81 gg~lft~l~~~------~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 81 GGDLFTRLSKE------VMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cchhhhccccC------CchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 99998877543 677888888899999999999999 999999999999999999999999999987643322
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
..|||..|+|||++.| ...++|.||||+++++|++|..||... ... .+..
T Consensus 152 ------~~cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~~------------~~~--------~Il~ 201 (612)
T KOG0603|consen 152 ------IACGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGGD------------TMK--------RILK 201 (612)
T ss_pred ------hcccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCchH------------HHH--------HHhh
Confidence 2288999999999973 478999999999999999999888761 111 1111
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAM 245 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~ 245 (291)
.....+......+.+++..++..+|..|.-.
T Consensus 202 ~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1234566778888899999999999999544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=150.13 Aligned_cols=187 Identities=19% Similarity=0.236 Sum_probs=134.3
Q ss_pred cCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE--cCCC--
Q 022826 42 EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL--DEDF-- 117 (291)
Q Consensus 42 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill--~~~~-- 117 (291)
++...|+||..+.. +|.+++..+ ..+.....-|+.|+++|+.|||+ ++|.|+|+|.+||++ ++|+
T Consensus 314 ~~~tlylvMkrY~~-tLr~yl~~~-------~~s~r~~~~~laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P 382 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQ-TLREYLWTR-------HRSYRTGRVILAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIP 382 (598)
T ss_pred CCceEEEehhcchh-hHHHHHhcC-------CCchHHHHHHHHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCc
Confidence 35678899999977 999999775 56777888999999999999999 999999999999999 3443
Q ss_pred ceEEeccCCccccCCCCceee----ccCCCCCccccCcccccccCCC----ccccccchhHHHHHHHHhCCCCCCccccC
Q 022826 118 CPKISDFGLAKICHGRESIVS----MTGARGTVGYIAPEVFCRNFGE----VSYKSDVYSYGMMVFEMTGVKNNANVAVD 189 (291)
Q Consensus 118 ~~kl~Dfg~~~~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~----~~~~~DiwslG~~l~~ll~g~~~~~~~~~ 189 (291)
.++|+|||++-...+..-... .-+.-|+...+|||+...-.+. .-.++|.|+.|.+.||+++...||...-.
T Consensus 383 ~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe 462 (598)
T KOG4158|consen 383 QLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE 462 (598)
T ss_pred EEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch
Confidence 578899999876554222211 1234578899999997543222 23589999999999999999999886311
Q ss_pred CCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 190 RSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
-.. .... -+.-..+. .+..++..+.+++...|+.||++|++..-....|+
T Consensus 463 m~L----~~r~------Yqe~qLPa----lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 463 MLL----DTRT------YQESQLPA----LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hee----chhh------hhhhhCCC----CcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 110 0000 01111222 23345566888999999999999998876555553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-19 Score=165.93 Aligned_cols=202 Identities=22% Similarity=0.282 Sum_probs=139.7
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc---ceeecCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHH
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK---GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVL 79 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 79 (291)
+-++.|..|++|.||.++++. .+.+|+|+-+.+. .+....+.-+.| |+-...++.. .+++..
T Consensus 86 ~~IklisngAygavylvrh~~trqrfa~kiNkq~lilRnilt~a~npfvv------gDc~tllk~~------g~lPvd-- 151 (1205)
T KOG0606|consen 86 NTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLILRNILTFAGNPFVV------GDCATLLKNI------GPLPVD-- 151 (1205)
T ss_pred ceeEeeccCCCCceeeeeccccccchhhcccccchhhhccccccCCccee------chhhhhcccC------CCCcch--
Confidence 446789999999999998865 6778885444332 111112222222 3444445432 344433
Q ss_pred HHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC-------------CCceeeccCCCCCc
Q 022826 80 YKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG-------------RESIVSMTGARGTV 146 (291)
Q Consensus 80 ~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~-------------~~~~~~~~~~~~~~ 146 (291)
++.+++|||+ -+|||+|+||+|++|..-|.+|+.|||++..-.. ....+.....++||
T Consensus 152 ------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTP 222 (1205)
T KOG0606|consen 152 ------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTP 222 (1205)
T ss_pred ------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCc
Confidence 2788999999 9999999999999999999999999999864210 00011123457999
Q ss_pred cccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHH
Q 022826 147 GYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 226 (291)
Q Consensus 147 ~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (291)
.|+|||++..+ .|...+|.|++|+++|+++-|..||+.+. +++........ .+.++.. ...+..+
T Consensus 223 eyiaPeVilrq--gygkpvdwwamGiIlyeFLVgcvpffGdt--------peelfg~visd-~i~wpE~----dea~p~E 287 (1205)
T KOG0606|consen 223 EYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDT--------PEELFGQVISD-DIEWPEE----DEALPPE 287 (1205)
T ss_pred cccChhhhhhh--ccCCCccHHHHHHHHHHHheeeeeccCCC--------HHHHHhhhhhh-hcccccc----CcCCCHH
Confidence 99999999876 89999999999999999999999988762 23222222211 1122211 2335667
Q ss_pred HHHHHHHhhhcCCCCCC
Q 022826 227 MILVSLWCIQNNPSDRP 243 (291)
Q Consensus 227 l~~l~~~~l~~dP~~Rp 243 (291)
+.+++.++|+.+|..|-
T Consensus 288 a~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 288 AQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred HHHHHHHHHHhChHhhc
Confidence 88899999999999993
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5e-19 Score=142.95 Aligned_cols=141 Identities=14% Similarity=0.154 Sum_probs=104.0
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-----------------------------------ce-e-ec---
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-----------------------------------GF-C-FE--- 42 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------------------------------~~-~-~~--- 42 (291)
+.+.+.||+|+||.||++.. ++..+++|++.... .+ . ..
T Consensus 33 y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~ 111 (232)
T PRK10359 33 IKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKT 111 (232)
T ss_pred eEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccc
Confidence 34568899999999999765 67789999997432 11 1 11
Q ss_pred ---CCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCce
Q 022826 43 ---GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 119 (291)
Q Consensus 43 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~ 119 (291)
....+++|||++|.+|.++. .++. ....+++.+|..+|+ .+++|+|+||.||+++++| +
T Consensus 112 ~~~~~~~~lvmEyi~G~tL~~~~----------~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 112 LRYAHTYIMLIEYIEGVELNDMP----------EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccCCeEEEEEEECCccHHHhh----------hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-E
Confidence 23578999999999998873 1222 246699999999999 9999999999999999998 9
Q ss_pred EEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHh
Q 022826 120 KISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 178 (291)
Q Consensus 120 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll 178 (291)
+|+|||.......... -+.+.-. ..+..++|||+||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~a---------------~d~~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKA---------------KDRIDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhh---------------HHHHHHH-hHhcccccccceeEeehHHH
Confidence 9999998765422111 0111111 24557999999999988664
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.4e-19 Score=154.17 Aligned_cols=173 Identities=24% Similarity=0.338 Sum_probs=128.5
Q ss_pred CcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEec
Q 022826 44 HRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISD 123 (291)
Q Consensus 44 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~D 123 (291)
...++.|++|...+|.+++..+. .....++...+.++.|++.++.| ++.+|+|+||.||++..+..+||+|
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~---~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRR---TGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCC---cccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhh
Confidence 35778999999999999997653 55677888899999999999998 5789999999999999999999999
Q ss_pred cCCccccCCCC----ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchh
Q 022826 124 FGLAKICHGRE----SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPH 198 (291)
Q Consensus 124 fg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~ 198 (291)
||+........ .....+...+|.-|++||.|.|+ .|+.++|||+||++++|++. -.. +.
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~--~y~~kvdIyaLGlil~EL~~~f~T--------------~~ 463 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ--QYSEKVDIYALGLILAELLIQFST--------------QF 463 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhh--hhhhhcchhhHHHHHHHHHHHhcc--------------HH
Confidence 99988766544 12223455689999999999987 99999999999999999984 111 11
Q ss_pred hhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 022826 199 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAM 245 (291)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~ 245 (291)
.........+.-.++ .....+++. -..|++++|...|.+||++
T Consensus 464 er~~t~~d~r~g~ip---~~~~~d~p~-e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 464 ERIATLTDIRDGIIP---PEFLQDYPE-EYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred HHHHhhhhhhcCCCC---hHHhhcCcH-HHHHHHHhcCCCcccCchH
Confidence 111111112211111 112222232 2358899999999999943
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.6e-17 Score=136.60 Aligned_cols=117 Identities=19% Similarity=0.195 Sum_probs=93.1
Q ss_pred chhhcccccCCceeEEEEE--ecCCCeEEEEEeccCcc------------------------------------------
Q 022826 3 NSFKNKLGQGGYGGVYKGK--LLDGRNVAIKVLNETKG------------------------------------------ 38 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~------------------------------------------ 38 (291)
+.+.+.||+|+||.||+|. ..+|+.||+|+++....
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3467899999999999998 45699999999874310
Q ss_pred --e----eecCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCC-eeeeccCCCce
Q 022826 39 --F----CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR-ILHFDIKPHNI 111 (291)
Q Consensus 39 --~----~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~-ivH~dikp~Ni 111 (291)
. .......++||||+++.+|....... ..+.......++.|++.++.+||+ .+ ++|+||||+||
T Consensus 110 ~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NI 180 (237)
T smart00090 110 AGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKD------VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNI 180 (237)
T ss_pred cCCCCCeeeEecCceEEEEEecCCccccccccc------CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhE
Confidence 0 01122457999999998887654221 345566678999999999999999 99 99999999999
Q ss_pred EEcCCCceEEeccCCccc
Q 022826 112 LLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 112 ll~~~~~~kl~Dfg~~~~ 129 (291)
+++ +++++|+|||.+..
T Consensus 181 li~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EEE-CCCEEEEEChhhhc
Confidence 999 88999999998764
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.3e-17 Score=129.85 Aligned_cols=168 Identities=16% Similarity=0.089 Sum_probs=117.5
Q ss_pred hhhcccccCCceeEEEEEecCCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcCC
Q 022826 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
.+...|++|.||+|+.+.. .++.++.+.+.... -....-...+++|+|+.|.
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~ 83 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGA 83 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCc
Confidence 4567899999999998765 67777766554332 0111124468999999998
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeecc-CCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDI-KPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~di-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
+|...+.. . ...++.|++.+|.++|+ .||+|+|| ||+||+++.++.++|+|||++........
T Consensus 84 ~L~~~~~~-------~------~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 84 AMYQRPPR-------G------DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cHHhhhhh-------h------hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 88654311 1 13578899999999999 99999999 79999999999999999999986543321
Q ss_pred e----e--e-----ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCcccc
Q 022826 136 I----V--S-----MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAV 188 (291)
Q Consensus 136 ~----~--~-----~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~ 188 (291)
. . . .--...++.|+.|+........--.+.+.++.|.-+|.++|++-+...+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0 0 00112577788887643321122356677889999999999887655443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.4e-17 Score=129.70 Aligned_cols=114 Identities=24% Similarity=0.236 Sum_probs=91.7
Q ss_pred cchhhcccccCCceeEEEEEecCCCeEEEEEeccCc----------------------------------------ce--
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------------------GF-- 39 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------------------------~~-- 39 (291)
++.+.+.||+|+||.||++...+|+.|+||+++... ..
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 356678999999999999988789999999865321 00
Q ss_pred ----eecCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC
Q 022826 40 ----CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE 115 (291)
Q Consensus 40 ----~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~ 115 (291)
.......+++|||+++++|..+... .....++.+++.++.++|+ .+++|+||||+||+++.
T Consensus 96 ~v~~~~~~~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 96 PVPKPIDWNRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCCceeecCCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcC
Confidence 0112356789999999998765420 2356788999999999999 99999999999999999
Q ss_pred CCceEEeccCCcccc
Q 022826 116 DFCPKISDFGLAKIC 130 (291)
Q Consensus 116 ~~~~kl~Dfg~~~~~ 130 (291)
++.++|+|||.+..+
T Consensus 161 ~~~~~liDfg~~~~~ 175 (198)
T cd05144 161 DEKIYIIDWPQMVST 175 (198)
T ss_pred CCcEEEEECCccccC
Confidence 999999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.2e-16 Score=126.01 Aligned_cols=108 Identities=21% Similarity=0.332 Sum_probs=90.2
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEeccCc----------------------------------ceeecCCcceeeehh
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------------------~~~~~~~~~~lv~e~ 52 (291)
+.||+|++|.||+|.. .+..+++|+..... .++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 77788999754321 233456677899999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
++|++|.+++.... . ....++.+++.+|.++|+ .+++|+|++|.||+++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~---------~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG---------M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc---------H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999985431 1 788999999999999999 9999999999999999 78999999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.8e-16 Score=123.51 Aligned_cols=104 Identities=24% Similarity=0.376 Sum_probs=85.6
Q ss_pred ccccCCceeEEEEEecCCCeEEEEEeccCc----------------------------------ceeecCCcceeeehhh
Q 022826 8 KLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 8 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------------------~~~~~~~~~~lv~e~~ 53 (291)
.||+|+||.||++.. +++.+++|+..... .+.......+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 67889999854321 2233455668999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
+|++|.+++.... . .++.+++.+|.+||+ .+++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~------~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH------H-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999874421 0 789999999999999 9999999999999999 78999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.6e-16 Score=123.38 Aligned_cols=115 Identities=24% Similarity=0.260 Sum_probs=87.0
Q ss_pred hhcccccCCceeEEEEEecCCCeEEEEEeccCccee--------------------------------------------
Q 022826 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKGFC-------------------------------------------- 40 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------------------------------- 40 (291)
+.+.||+|+||.||+|.+.+++.||||++.......
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 357899999999999988779999999987532100
Q ss_pred ----ecCCcceeeehhhcCCCHHH-HHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC
Q 022826 41 ----FEGHRRALIYEFVSNGSLEK-FIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE 115 (291)
Q Consensus 41 ----~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~ 115 (291)
..-...+++|||++++.+.. .+... ... .....++.+++.++.++|+ ..+++|+||||+||+++
T Consensus 81 ~~~~~~~~~~~lv~e~~~g~~~~~~~l~~~-------~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 81 VPKPIDLNRHVLVMEFIGGDGIPAPRLKDV-------RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CCceEecCCCEEEEEEeCCCCccChhhhhh-------hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence 00123568999999854321 11111 001 5578899999999999997 47899999999999999
Q ss_pred CCceEEeccCCcccc
Q 022826 116 DFCPKISDFGLAKIC 130 (291)
Q Consensus 116 ~~~~kl~Dfg~~~~~ 130 (291)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 889999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=6e-15 Score=135.80 Aligned_cols=106 Identities=20% Similarity=0.316 Sum_probs=83.2
Q ss_pred hhcccccCCceeEEEEEecCCCeEEEEEe-ccCc---------------------------------ceeecCCcceeee
Q 022826 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVL-NETK---------------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~~---------------------------------~~~~~~~~~~lv~ 50 (291)
..+.||+|+||.||++.+.... +++|+. .... .++......++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 4678999999999999874433 333332 1100 2233445678999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
||+++++|.+++. ....++.+++.+|.+||+ .+++||||||+||++ .++.++|+|||+++.
T Consensus 416 E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 416 EYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999884 246789999999999999 999999999999999 677999999998764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.2e-16 Score=144.26 Aligned_cols=229 Identities=20% Similarity=0.210 Sum_probs=167.6
Q ss_pred chhhcccccCCceeEEEEEecC--CCeEEEEEeccCc-----------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD--GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+|+.|-...... ...++.|.+.... +........+++++
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 4566789999999999886543 3445555554332 23333455668899
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhh-cCCCCCeeeeccCCCceEEcCCC-ceEEeccCCccc
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RGCNTRILHFDIKPHNILLDEDF-CPKISDFGLAKI 129 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH-~~~~~~ivH~dikp~Nill~~~~-~~kl~Dfg~~~~ 129 (291)
+..++++.+-+... .....+......++.|+..++.|+| . .++.|+||||+|.+++..+ .+++.|||++..
T Consensus 102 ~s~g~~~f~~i~~~----~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 102 YSDGGSLFSKISHP----DSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cccccccccccccC----CccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999998887421 1125566678889999999999999 8 9999999999999999999 999999999998
Q ss_pred cCC-CCceeeccCCCC-CccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 130 CHG-RESIVSMTGARG-TVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 130 ~~~-~~~~~~~~~~~~-~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
+.. ..........+| ++.|.|||...+. ....+..|+||.|+++..+++|..|+.........+.... ...
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~--~~~---- 247 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWK--SNK---- 247 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccccceeec--ccc----
Confidence 776 444444556677 9999999998774 3557889999999999999999999887765543221110 000
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
... .............+++.+++..+|+.|.+.+++-.
T Consensus 248 ~~~-----~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 GRF-----TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccc-----ccCccccCChhhhhcccccccCCchhccccccccc
Confidence 000 01123445666788999999999999999888643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=2e-14 Score=115.69 Aligned_cols=106 Identities=23% Similarity=0.340 Sum_probs=77.1
Q ss_pred hcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------------ceeecCC---c-ceeee
Q 022826 6 KNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------------GFCFEGH---R-RALIY 50 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------------~~~~~~~---~-~~lv~ 50 (291)
.+.||+|+||.||. +-.++.. +||++.... ++..++. . ..+|+
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 37899999999996 3223444 699877541 2223321 2 23689
Q ss_pred hh--hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh-HHhhcCCCCCeeeeccCCCceEEcC----CCceEEec
Q 022826 51 EF--VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGL-EYLHRGCNTRILHFDIKPHNILLDE----DFCPKISD 123 (291)
Q Consensus 51 e~--~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l-~~LH~~~~~~ivH~dikp~Nill~~----~~~~kl~D 123 (291)
|| +.+++|.+++.+. .+++. ..++.+++.++ .|||+ .+|+|+||||+||+++. ++.++|+|
T Consensus 85 e~~G~~~~tL~~~l~~~-------~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC-------RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred cCCCCcchhHHHHHHcc-------cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 99 5578999999542 35554 35678888777 99999 99999999999999963 34799999
Q ss_pred cC
Q 022826 124 FG 125 (291)
Q Consensus 124 fg 125 (291)
|+
T Consensus 153 g~ 154 (210)
T PRK10345 153 NI 154 (210)
T ss_pred CC
Confidence 54
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=5.1e-13 Score=119.44 Aligned_cols=113 Identities=26% Similarity=0.322 Sum_probs=86.9
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------------------------------
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------------------------------- 37 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------------------------------- 37 (291)
+.||+|++|.||+|+..+|+.||||+.++..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999999899999999987653
Q ss_pred ----------------------ceeecCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH-HhHHhh
Q 022826 38 ----------------------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIAR-GLEYLH 94 (291)
Q Consensus 38 ----------------------~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~-~l~~LH 94 (291)
-+.......++||||++|++|.++..... ...+ ...++..++. .+..+|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-----~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-----AGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-----cCCC---HHHHHHHHHHHHHHHHH
Confidence 00011234569999999999988764321 1122 3445555555 467889
Q ss_pred cCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 95 ~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
. .|++|+|++|.||+++.+++++++|||++..+
T Consensus 275 ~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 R---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred h---CCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 9 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.1e-13 Score=111.52 Aligned_cols=108 Identities=23% Similarity=0.290 Sum_probs=82.1
Q ss_pred cccc-cCCceeEEEEEecCCCeEEEEEeccCc---------------------------------c--------eee-cC
Q 022826 7 NKLG-QGGYGGVYKGKLLDGRNVAIKVLNETK---------------------------------G--------FCF-EG 43 (291)
Q Consensus 7 ~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------------------~--------~~~-~~ 43 (291)
..|| .|+.|+||.+.. .+..++||.+.... + ... ..
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4677 899999999977 47788888774311 1 111 11
Q ss_pred C---cceeeehhhcC-CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCce
Q 022826 44 H---RRALIYEFVSN-GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 119 (291)
Q Consensus 44 ~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~ 119 (291)
. ..++|+|++++ .+|.+++.. ..++.. .+.+++.+|.+||+ .||+|+||||+||+++.++.+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-------~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-------APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKF 181 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-------CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCE
Confidence 1 22489999987 689888743 234443 36789999999999 999999999999999998999
Q ss_pred EEeccCCccc
Q 022826 120 KISDFGLAKI 129 (291)
Q Consensus 120 kl~Dfg~~~~ 129 (291)
+|+|||.+..
T Consensus 182 ~LIDfg~~~~ 191 (239)
T PRK01723 182 WLIDFDRGEL 191 (239)
T ss_pred EEEECCCccc
Confidence 9999998764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.9e-12 Score=110.68 Aligned_cols=250 Identities=13% Similarity=0.067 Sum_probs=166.2
Q ss_pred hhcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------------ceeecCC-cceeeehhh
Q 022826 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------------GFCFEGH-RRALIYEFV 53 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------------~~~~~~~-~~~lv~e~~ 53 (291)
++..||+|+-+.+|-.-.. ...+.|++.... -+.-++. ..-++|+.+
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v 92 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV 92 (637)
T ss_pred CCccccCCccceeeecchh--hchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence 4678999999999987432 233467765433 1222222 255777776
Q ss_pred cCC-CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 54 SNG-SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 54 ~~g-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
.+. .+..++.-..+........|...++..+.++.+..-||. .|.+-||++++|+|+++++.+.|.|=..-....+
T Consensus 93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n 169 (637)
T COG4248 93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN 169 (637)
T ss_pred CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeeccC
Confidence 554 445555555555666778999999999999999999999 9999999999999999999999998665554444
Q ss_pred CCceeeccCCCCCccccCccccc-cc--CCCccccccchhHHHHHHHHhCC-CCCCccccCCCccccchhhhhhhhh---
Q 022826 133 RESIVSMTGARGTVGYIAPEVFC-RN--FGEVSYKSDVYSYGMMVFEMTGV-KNNANVAVDRSSEIYFPHWVYKRLE--- 205 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~-~~--~~~~~~~~DiwslG~~l~~ll~g-~~~~~~~~~~~~~~~~~~~~~~~~~--- 205 (291)
+.. .....+.+.|.+||... +. ...-+..+|.|.||+++|+++.| +-|+...........--+.......
T Consensus 170 g~~---~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y 246 (637)
T COG4248 170 GTL---HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY 246 (637)
T ss_pred Cce---EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence 332 23344688999999864 11 12456788999999999999887 5555544333322211110111111
Q ss_pred --hhhhhcccCCCChhhHHHHHHHHHHHHHhhhc--CCCCCCCHHHHHHHHHhhhccCCCC
Q 022826 206 --LEEDLGLQGIENEEDKEYARKMILVSLWCIQN--NPSDRPAMNRVVEMLEGSLDSLRIP 262 (291)
Q Consensus 206 --~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~--dP~~Rps~~ell~~L~~~~~~~~~~ 262 (291)
..+.-..+.........++..+..|..+|... ++.-|||++.|+..|..+.++|..=
T Consensus 247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C 307 (637)
T COG4248 247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKC 307 (637)
T ss_pred chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhh
Confidence 01111112222334455677788888889854 3668999999999998877776554
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.4e-12 Score=99.59 Aligned_cols=111 Identities=23% Similarity=0.164 Sum_probs=86.2
Q ss_pred hhcccccCCceeEEEEEecCCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCCCH
Q 022826 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
+.+.||+|.++.||++... ++.+++|...... .........++++||+.++.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 3578999999999999874 4789999987652 111222357788888887666
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
..+ +......++.+++.++..+|.....+++|+|++|+||+++..+.++++||+.+..
T Consensus 81 ~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 432 4456677899999999999983334699999999999999989999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.6e-12 Score=114.38 Aligned_cols=114 Identities=19% Similarity=0.156 Sum_probs=81.6
Q ss_pred cccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------------------------
Q 022826 7 NKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------------------------ 37 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------------------------ 37 (291)
+.||+|++|.||+|+.++ |+.||||+.++..
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999887 9999999998542
Q ss_pred ----------cee-------------ecCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhh
Q 022826 38 ----------GFC-------------FEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94 (291)
Q Consensus 38 ----------~~~-------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH 94 (291)
..+ ......++||||+.|+.+.++-.-...-.....+....+..++.|+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------- 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------- 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 011 11234559999999999987532110000011244444555555554
Q ss_pred cCCCCCeeeeccCCCceEEcCCC----ceEEeccCCcccc
Q 022826 95 RGCNTRILHFDIKPHNILLDEDF----CPKISDFGLAKIC 130 (291)
Q Consensus 95 ~~~~~~ivH~dikp~Nill~~~~----~~kl~Dfg~~~~~ 130 (291)
. .|++|+|+||.||+++.+| .++++|||+...+
T Consensus 278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 4 8999999999999999888 9999999987644
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.9e-13 Score=112.94 Aligned_cols=186 Identities=22% Similarity=0.294 Sum_probs=123.9
Q ss_pred cCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEE
Q 022826 42 EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 121 (291)
Q Consensus 42 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl 121 (291)
+..+..++.||+..|++..+|++.. .....+......+|+-||++||.|||+ +...++|+++.-+-|++..+|-+|+
T Consensus 143 e~~rviFiteymssgs~~~fLkrt~--~~~~a~~~~~wkkw~tqIlsal~yLhs-~~PpiihgnlTc~tifiq~ngLIki 219 (458)
T KOG1266|consen 143 EKPRVIFITEYMSSGSLKQFLKRTK--KNQKALFQKAWKKWCTQILSALSYLHS-CDPPIIHGNLTCDTIFIQHNGLIKI 219 (458)
T ss_pred cccceEEEEecccchhHHHHHHHHH--HhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCccccCCcchhheeecCCceEEe
Confidence 4456789999999999999998864 244678888999999999999999998 5678999999999999999998888
Q ss_pred eccCCc--cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhh
Q 022826 122 SDFGLA--KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHW 199 (291)
Q Consensus 122 ~Dfg~~--~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~ 199 (291)
+--.-. ...-+...........+.+.|.+||.=... ..+.++|||+||+...+|..+.--.. +....+.++.
T Consensus 220 g~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t--n~~~a~dIy~fgmcAlemailEiq~t----nseS~~~~ee 293 (458)
T KOG1266|consen 220 GSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT--NTTGASDIYKFGMCALEMAILEIQST----NSESKVEVEE 293 (458)
T ss_pred cccCccccchhhhhhhHhhhhccccCCccccCCcCccc--ccccchhhhhhhHHHHHHHHheeccC----CCcceeehhh
Confidence 633211 111111111122344567889999874332 56778999999999999965442110 0000000110
Q ss_pred hhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 200 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.....+-.+... .-..++..|++-.|..||+|++++.
T Consensus 294 -------~ia~~i~~len~-------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 294 -------NIANVIIGLENG-------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred -------hhhhheeeccCc-------cccCcCcccccCCCCCCcchhhhhc
Confidence 000111111111 1234678899999999999998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.2e-12 Score=116.32 Aligned_cols=219 Identities=21% Similarity=0.208 Sum_probs=156.5
Q ss_pred hhccccc--CCceeEEEEEe---cCCCeEEEEEeccCc-----------------------------ceeecCCcceeee
Q 022826 5 FKNKLGQ--GGYGGVYKGKL---LDGRNVAIKVLNETK-----------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 5 ~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+|. |.+|.||.+.. .+++.+|+|.-+... ......+..++-+
T Consensus 118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqt 197 (524)
T KOG0601|consen 118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQT 197 (524)
T ss_pred cccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeee
Confidence 3467889 99999999976 348888888833211 2333456677888
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH----HhHHhhcCCCCCeeeeccCCCceEEcCC-CceEEeccC
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIAR----GLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFG 125 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~----~l~~LH~~~~~~ivH~dikp~Nill~~~-~~~kl~Dfg 125 (291)
|.|. .+|..+..... ..++...++..+.+... |+.++|+ .+++|.|+||+||+...+ ...+++|||
T Consensus 198 E~~~-~sl~~~~~~~~-----~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 198 ELCG-ESLQSYCHTPC-----NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred cccc-chhHHhhhccc-----ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcc
Confidence 9996 58888876543 45778888999999999 9999999 999999999999999999 788999999
Q ss_pred CccccCCCCceee---ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhh
Q 022826 126 LAKICHGRESIVS---MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYK 202 (291)
Q Consensus 126 ~~~~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~ 202 (291)
+...+....-... .....+...|++||++.+ -++...|||++|.++.+...+-..+..........
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-------- 337 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-------- 337 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--------
Confidence 9887765432111 122256789999999976 67899999999999999987665554432211100
Q ss_pred hhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 203 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. +... ...+.+..-+.++...+.+|++.+|-.|++...+..
T Consensus 338 -~---r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 -L---RQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -c---cccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 0000 112233333445555888899999999988887654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.1e-11 Score=98.09 Aligned_cols=113 Identities=17% Similarity=0.145 Sum_probs=83.7
Q ss_pred hcccccCCceeEEEEEecC-------CCeEEEEEeccCccee--------------------------------------
Q 022826 6 KNKLGQGGYGGVYKGKLLD-------GRNVAIKVLNETKGFC-------------------------------------- 40 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~-------------------------------------- 40 (291)
.-.||.|.-+.||.|...+ +..+|||+++.....+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999997543 4799999988654000
Q ss_pred ------------ecCCcceeeehhhcCCCHHH-HHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHh-hcCCCCCeeeecc
Q 022826 41 ------------FEGHRRALIYEFVSNGSLEK-FIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL-HRGCNTRILHFDI 106 (291)
Q Consensus 41 ------------~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~L-H~~~~~~ivH~di 106 (291)
..-...++||||+.+..+.. .+.+ ..++......++.+++.+|..| |. .++|||||
T Consensus 82 rl~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd-------~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKD-------AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhc-------cccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence 00133458999997754422 2321 2345556778889999999999 89 99999999
Q ss_pred CCCceEEcCCCceEEeccCCccc
Q 022826 107 KPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 107 kp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
++.||++. ++.+.|+||+.+..
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCcee
Confidence 99999997 46899999997764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.1e-11 Score=94.34 Aligned_cols=103 Identities=23% Similarity=0.235 Sum_probs=78.8
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEeccCc------------------------ceeecCCcceeeehhhcCCCHHHHH
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------GFCFEGHRRALIYEFVSNGSLEKFI 62 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------~~~~~~~~~~lv~e~~~~g~L~~~l 62 (291)
+.|+.|.++.||++.. .++.+++|+..... -........++|||++++.++...-
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~~ 82 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTED 82 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccccc
Confidence 5688999999999986 47889999976542 1222233467899999998775420
Q ss_pred hhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCC-----eeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 63 YEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR-----ILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 63 ~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~-----ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
.....++.+++.+|..||+ .+ ++|+|++|.||+++ ++.++++||+.+.
T Consensus 83 --------------~~~~~~~~~l~~~l~~LH~---~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 83 --------------FSDPENLEKIAKLLKKLHS---SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred --------------ccCHHHHHHHHHHHHHHhC---CCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 0123457899999999999 66 59999999999999 6689999999765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.2e-10 Score=85.36 Aligned_cols=105 Identities=20% Similarity=0.294 Sum_probs=84.1
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEeccCc----------------------------------ceeecCCcceeeehh
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------------------~~~~~~~~~~lv~e~ 52 (291)
..+++|+-+.|+.+.+.+ ..+++|.=.++. -++.+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 457899999999996643 345555532222 466677788899999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
.+|-.|.+.+... ...+++.+-.-+.-||. .+|+||||.+.||++...+ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999898543 25678889999999999 9999999999999998775 99999999863
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.3e-10 Score=84.79 Aligned_cols=116 Identities=26% Similarity=0.365 Sum_probs=88.3
Q ss_pred hcccccCCceeEEEEEecCCCeEEEEEeccCc----------------------------------ceeecCCcceeeeh
Q 022826 6 KNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------------------~~~~~~~~~~lv~e 51 (291)
...+-+|+-+.|+++.+ .|+...||.=..+. -++.+.....++||
T Consensus 12 l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 46678899999999977 67776676533332 35556677889999
Q ss_pred hhcC-CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC---ceEEeccCCc
Q 022826 52 FVSN-GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF---CPKISDFGLA 127 (291)
Q Consensus 52 ~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~---~~kl~Dfg~~ 127 (291)
|+++ .++.+++.... . .....+....+++.+-+.|.-||. .+++||||..+||++.+++ .+.++|||++
T Consensus 91 ~~~g~~~vk~~i~~~~---~-~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTM---E-DESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred eccchhHHHHHHHHHc---c-CcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecch
Confidence 9977 47788887653 2 222333347889999999999999 9999999999999996655 4589999998
Q ss_pred cc
Q 022826 128 KI 129 (291)
Q Consensus 128 ~~ 129 (291)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 65
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.1e-09 Score=89.40 Aligned_cols=111 Identities=27% Similarity=0.317 Sum_probs=83.9
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------------------------ce-
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------------------------GF- 39 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------------------------~~- 39 (291)
+.++++||-|.-|.||.|...+|..++||.=+... +.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 35689999999999999999889999999854332 00
Q ss_pred ---eecCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC
Q 022826 40 ---CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 116 (291)
Q Consensus 40 ---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~ 116 (291)
-..-++-++|||+++|--|... +++.+....++..|+.-+..+-. .|+||||+++-||+++++
T Consensus 173 VP~P~~~nRHaVvMe~ieG~eL~~~-----------r~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAWNRHAVVMEYIEGVELYRL-----------RLDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCccccccceeeeehcccceeecc-----------cCcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecC
Confidence 1112455689999988555333 22344566677777777776667 999999999999999999
Q ss_pred CceEEeccCCc
Q 022826 117 FCPKISDFGLA 127 (291)
Q Consensus 117 ~~~kl~Dfg~~ 127 (291)
|.+.++||--+
T Consensus 239 g~~~vIDwPQ~ 249 (304)
T COG0478 239 GDIVVIDWPQA 249 (304)
T ss_pred CCEEEEeCccc
Confidence 99999999533
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=8.5e-10 Score=103.92 Aligned_cols=181 Identities=20% Similarity=0.215 Sum_probs=129.6
Q ss_pred cCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEE
Q 022826 42 EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 121 (291)
Q Consensus 42 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl 121 (291)
.....+++++|.++++|...+++. ...+.+-.+.....+..+.++||+ ..+.|+|++|.|.++..+|..++
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~~~------~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l 945 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLHNS------GCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPL 945 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhhcC------CCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCccc
Confidence 345567899999999999998664 355555566677788899999999 88999999999999999999999
Q ss_pred eccCCccccCC---------------------CCc--e------eeccCCCCCccccCcccccccCCCccccccchhHHH
Q 022826 122 SDFGLAKICHG---------------------RES--I------VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGM 172 (291)
Q Consensus 122 ~Dfg~~~~~~~---------------------~~~--~------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~ 172 (291)
.||+......- ... . .......+|+.|.+||.+.+. .....+|+|+.|+
T Consensus 946 ~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~--~hgs~ad~~~~g~ 1023 (1205)
T KOG0606|consen 946 TDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR--RHGSAADWWSSGV 1023 (1205)
T ss_pred CccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc--cCCCcchhhhhhh
Confidence 99984322110 000 0 001223478999999999886 7788999999999
Q ss_pred HHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 022826 173 MVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMN 246 (291)
Q Consensus 173 ~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ 246 (291)
++++.++|..||........ . .......+.++. .+...+..+.+++...+..+|.+|..+.
T Consensus 1024 ~l~e~l~g~pp~na~tpq~~--------f-~ni~~~~~~~p~----g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1024 CLFEVLTGIPPFNAETPQQI--------F-ENILNRDIPWPE----GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhcCCCCCCCcchhhh--------h-hccccCCCCCCC----CccccChhhhhhhhhhhccCchhccCcc
Confidence 99999999998886643211 1 011111122222 2233556677888889999999997766
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.2e-09 Score=97.47 Aligned_cols=213 Identities=20% Similarity=0.219 Sum_probs=143.4
Q ss_pred hhcccccCCceeEEEEEe--cCCCeEEEEEeccCc------------------------------ceeecCCcceeeehh
Q 022826 5 FKNKLGQGGYGGVYKGKL--LDGRNVAIKVLNETK------------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~ 52 (291)
+...||.|.|+.|+.... .++..|++|.+.... .+. .....++-.||
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~-~~r~~~ip~e~ 347 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS-QLRQGYIPLEF 347 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc-ccccccCchhh
Confidence 457799999999999854 347788888876544 111 12234467799
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC-CceEEeccCCccccC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICH 131 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~-~~~kl~Dfg~~~~~~ 131 (291)
|+++++...... ...+.+...+++..|++.++.++|+ +..+|+|+||.||++..+ +.-+++||++...+.
T Consensus 348 ~~~~s~~l~~~~------~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 348 CEGGSSSLRSVT------SQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred hcCcchhhhhHH------HHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccc
Confidence 999888666522 2567777889999999999999999 999999999999999876 788999999875421
Q ss_pred CCCceeeccCCCCCcccc-CcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 132 GRESIVSMTGARGTVGYI-APEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~-aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
-.. ....+...+. ..|++... ..+..++|+++||..+.+.+++......... . .
T Consensus 419 ~~~-----~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-~------------------~ 473 (524)
T KOG0601|consen 419 FSS-----GVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQ-S------------------L 473 (524)
T ss_pred eec-----ccccccccccccchhhccc-cccccccccccccccccccccCcccCccccc-c------------------e
Confidence 111 1112223333 24444332 3778899999999999998877643222110 0 0
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L 252 (291)
.+........+.....+..+.+.++..++..||.+.++....
T Consensus 474 ~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 474 TIRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred eeecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 000001112222336677788889999999999988875543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.2e-09 Score=84.81 Aligned_cols=102 Identities=27% Similarity=0.368 Sum_probs=67.4
Q ss_pred eEEEEEecCCCeEEEEEeccCc----------------------------------------------c----eeecCCc
Q 022826 16 GVYKGKLLDGRNVAIKVLNETK----------------------------------------------G----FCFEGHR 45 (291)
Q Consensus 16 ~V~~~~~~~~~~vavK~~~~~~----------------------------------------------~----~~~~~~~ 45 (291)
.||.|...++..+|||+.+... + ....-..
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 4899998889999999988654 0 0011124
Q ss_pred ceeeehhhc--CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHH-hhcCCCCCeeeeccCCCceEEcCCCceEEe
Q 022826 46 RALIYEFVS--NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEY-LHRGCNTRILHFDIKPHNILLDEDFCPKIS 122 (291)
Q Consensus 46 ~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~-LH~~~~~~ivH~dikp~Nill~~~~~~kl~ 122 (291)
.++||||++ |..+..+... .++......++.+++..+.. +|. .|++|||+++.||+++++ .+.|+
T Consensus 81 ~~ivME~I~~~G~~~~~l~~~--------~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPRLKDV--------DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp TEEEEE--EETTEEGGCHHHC--------GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE-
T ss_pred CEEEEEecCCCccchhhHHhc--------cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEE
Confidence 558999998 6555444322 11133456778888886665 578 999999999999999888 89999
Q ss_pred ccCCccc
Q 022826 123 DFGLAKI 129 (291)
Q Consensus 123 Dfg~~~~ 129 (291)
|||.+..
T Consensus 149 Df~qav~ 155 (188)
T PF01163_consen 149 DFGQAVD 155 (188)
T ss_dssp -GTTEEE
T ss_pred ecCccee
Confidence 9997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.91 E-value=9.2e-09 Score=83.82 Aligned_cols=115 Identities=20% Similarity=0.202 Sum_probs=84.2
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEeccCc-----------------------------ceeecC---Ccceeeehhhc
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-----------------------------GFCFEG---HRRALIYEFVS 54 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~---~~~~lv~e~~~ 54 (291)
+.|+.|..+.||++...+|+.+++|+..... ...... ...++||+++.
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 5689999999999987666899999976532 111111 24589999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCC-------------------------------------
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC------------------------------------- 97 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~------------------------------------- 97 (291)
|.++.+.+.. ..++......++.+++..|..||+..
T Consensus 84 G~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 84 GRVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CEecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 9887665421 24666667777777777777777511
Q ss_pred ----------------CCCeeeeccCCCceEEcC--CCceEEeccCCcc
Q 022826 98 ----------------NTRILHFDIKPHNILLDE--DFCPKISDFGLAK 128 (291)
Q Consensus 98 ----------------~~~ivH~dikp~Nill~~--~~~~kl~Dfg~~~ 128 (291)
...++|+|+++.||+++. ++.+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 245799999999999988 5668999998765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=5.3e-10 Score=101.26 Aligned_cols=151 Identities=17% Similarity=0.262 Sum_probs=100.7
Q ss_pred HHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc-eee------ccCCCCCccccCccccc
Q 022826 83 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES-IVS------MTGARGTVGYIAPEVFC 155 (291)
Q Consensus 83 ~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~------~~~~~~~~~y~aPE~l~ 155 (291)
+.+++.|+.++|. +.++||++|.|++|+++..|..||+.|+.+....+... .+. .....-...|.|||.+.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 4556689999998 58899999999999999999999999988765433111 000 01112346899999998
Q ss_pred ccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHh
Q 022826 156 RNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWC 234 (291)
Q Consensus 156 ~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~ 234 (291)
+. ..+.++|+||+|+++|.+.. |...+..... .... .. .+... .........+++.++++=+.++
T Consensus 183 ~~--~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~--~~--------~~~~~-~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 183 GT--TNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSY--SF--------SRNLL-NAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred cc--cccccccceeeeeEEEEEecCCcchhhccCC-cchh--hh--------hhccc-ccccccccccCcHHHHHHHHHH
Confidence 75 77899999999999999974 4433332211 1000 00 00000 0000112255777888888899
Q ss_pred hhcCCCCCCCHHHHH
Q 022826 235 IQNNPSDRPAMNRVV 249 (291)
Q Consensus 235 l~~dP~~Rps~~ell 249 (291)
+..++.-||++..+.
T Consensus 249 l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLL 263 (700)
T ss_pred hcCCcccCcchhhhh
Confidence 999999999776654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.9e-08 Score=83.02 Aligned_cols=78 Identities=19% Similarity=0.137 Sum_probs=64.6
Q ss_pred CcceeeehhhcCC-CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC-------
Q 022826 44 HRRALIYEFVSNG-SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE------- 115 (291)
Q Consensus 44 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~------- 115 (291)
...++|+|++++. +|.+++.... ....+......++.+++..+..||. .|++|+|+++.||+++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~----~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA----TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCC
Confidence 3577999999886 7988885321 1345667788999999999999999 99999999999999975
Q ss_pred CCceEEeccCCcc
Q 022826 116 DFCPKISDFGLAK 128 (291)
Q Consensus 116 ~~~~kl~Dfg~~~ 128 (291)
++.+.++||+.+.
T Consensus 181 ~~~~~LIDl~r~~ 193 (268)
T PRK15123 181 DLKLSVIDLHRAQ 193 (268)
T ss_pred CceEEEEECCccc
Confidence 4689999999765
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.1e-08 Score=89.68 Aligned_cols=109 Identities=21% Similarity=0.261 Sum_probs=83.3
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------------------------------
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------------------------------- 37 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------------------------------- 37 (291)
+.|+.++-|-||+|+.++|+.||||+.++.-
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6789999999999999999999999998765
Q ss_pred ---------------------ceee-cCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCC-----HHHHHHHHHHHHHHh
Q 022826 38 ---------------------GFCF-EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLK-----WEVLYKIAVGIARGL 90 (291)
Q Consensus 38 ---------------------~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~-----~~~~~~i~~~l~~~l 90 (291)
.++. .....+++|||++|-.+.+..... ...++ ......++.|+..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~-----~~g~d~k~ia~~~~~~f~~q~~~-- 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK-----SAGIDRKELAELLVRAFLRQLLR-- 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH-----hcCCCHHHHHHHHHHHHHHHHHh--
Confidence 1221 245667999999999998874222 13344 2333344444444
Q ss_pred HHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 91 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 91 ~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
.|++|.|.+|.||+++.+|++.+.|||+....
T Consensus 284 --------dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 284 --------DGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred --------cCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 88999999999999999999999999987643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.4e-07 Score=85.56 Aligned_cols=125 Identities=17% Similarity=0.156 Sum_probs=90.5
Q ss_pred eeecCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCc
Q 022826 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 118 (291)
Q Consensus 39 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~ 118 (291)
....+...|+|+|-+. .|..++++. +.....-.+.||+.||.|||. ..+++|++|....|+|+..|.
T Consensus 77 t~e~~~~~ylvTErV~--Pl~~~lk~l---------~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~Ge 143 (690)
T KOG1243|consen 77 TTEEEGTLYLVTERVR--PLETVLKEL---------GKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGE 143 (690)
T ss_pred hhcccCceEEEeeccc--cHHHHHHHh---------HHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCc
Confidence 3344568899999884 488888653 245566678999999999985 389999999999999999999
Q ss_pred eEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCC
Q 022826 119 PKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKN 182 (291)
Q Consensus 119 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~ 182 (291)
-||++|.++.....-.. .......-..|..|+.+... .-..|.|.||+++++++.|..
T Consensus 144 WkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s----~~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 144 WKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS----EWSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred EEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc----ccchhhhhHHHHHHHHhCccc
Confidence 99999988764432221 01111112356677665433 245799999999999998843
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.69 E-value=7.1e-07 Score=78.96 Aligned_cols=193 Identities=18% Similarity=0.292 Sum_probs=129.3
Q ss_pred ceeEEEEEe-cCCCeEEEEEeccCc------------------------------ceeecCCcceeeehhhcC-CCHHHH
Q 022826 14 YGGVYKGKL-LDGRNVAIKVLNETK------------------------------GFCFEGHRRALIYEFVSN-GSLEKF 61 (291)
Q Consensus 14 ~g~V~~~~~-~~~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~~~~-g~L~~~ 61 (291)
-.+.|++.. .+|..|++|.++..+ ..-..+...++|++|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 367788854 579999999994433 122234567789999865 467666
Q ss_pred HhhcCC---------CCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 62 IYEKHP---------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 62 l~~~~~---------~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
...... ...+.+.++..+|.++.||..||.++|+ .|+.-+-+.+.+|+++.+-+++|...|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 554322 2345678899999999999999999999 9999999999999999998999998887654333
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
+.. |-+ .-..+-|.--||.+++.|.+|...-..... .... ..
T Consensus 446 d~~----------------~~l-----e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~-------~~~s--~~-------- 487 (655)
T KOG3741|consen 446 DPT----------------EPL-----ESQQQNDLRDLGLLLLALATGTENSNRTDS-------TQSS--HL-------- 487 (655)
T ss_pred CCC----------------cch-----hHHhhhhHHHHHHHHHHHhhcccccccccc-------hHHH--HH--------
Confidence 220 111 123466888899999999998642111100 0000 00
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L 252 (291)
......++.++.+++.-....++++ -++.+++..+
T Consensus 488 ----~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 488 ----TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred ----HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 1123446666777777777777776 5666666544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.4e-07 Score=73.02 Aligned_cols=112 Identities=15% Similarity=0.122 Sum_probs=83.9
Q ss_pred ccCCceeEEEEEecCCCeEEEEEeccCc---------------------------------ceee-----cCCcceeeeh
Q 022826 10 GQGGYGGVYKGKLLDGRNVAIKVLNETK---------------------------------GFCF-----EGHRRALIYE 51 (291)
Q Consensus 10 g~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------------------~~~~-----~~~~~~lv~e 51 (291)
|+|+++.|++... +|+.+-+|.-.... .++. .....+||+|
T Consensus 27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 5699999999866 45568888754111 1110 1234668888
Q ss_pred hhcC-CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCc--eEEeccCCcc
Q 022826 52 FVSN-GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC--PKISDFGLAK 128 (291)
Q Consensus 52 ~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~--~kl~Dfg~~~ 128 (291)
-+++ .+|.+++.+. .....+......+..+++..+.-||+ .++.|+|+.+.||+++.+|. +.++||..++
T Consensus 106 ~L~g~~~L~~~l~~~----~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 106 DMAGFISIADWYAQH----AVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred eCCCCccHHHHHhcC----CcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 6653 4888888553 22466778888999999999999999 99999999999999986667 9999998765
Q ss_pred c
Q 022826 129 I 129 (291)
Q Consensus 129 ~ 129 (291)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.2e-07 Score=74.30 Aligned_cols=114 Identities=24% Similarity=0.304 Sum_probs=82.1
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEeccCc--------------------------------------------cee--
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK--------------------------------------------GFC-- 40 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------------------------------------~~~-- 40 (291)
-.|++|.-+.||+|...++..+|+|+++... ++.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 3688999999999988789999999998765 111
Q ss_pred --ecCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCc
Q 022826 41 --FEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 118 (291)
Q Consensus 41 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~ 118 (291)
..-....|||||+.... ...+.-..-.+.......+..+++..+.-|-. ..++||+||+.-||++. ++.
T Consensus 134 ~Pi~~~~nVLvMEfIg~~g------~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 134 EPIAFRNNVLVMEFIGDDG------LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CceeecCCeEEEEeccCCC------CCCCCcccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCe
Confidence 11223458999986631 11111112233333577788888888887775 37899999999999999 789
Q ss_pred eEEeccCCccc
Q 022826 119 PKISDFGLAKI 129 (291)
Q Consensus 119 ~kl~Dfg~~~~ 129 (291)
+.|+||+-+..
T Consensus 205 p~iID~~QaV~ 215 (268)
T COG1718 205 PYIIDVSQAVT 215 (268)
T ss_pred EEEEECccccc
Confidence 99999987653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.4e-07 Score=76.12 Aligned_cols=76 Identities=26% Similarity=0.315 Sum_probs=65.0
Q ss_pred cceeeehhhcCC-CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC---ceE
Q 022826 45 RRALIYEFVSNG-SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF---CPK 120 (291)
Q Consensus 45 ~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~---~~k 120 (291)
..++|+|++++. +|.+++.... ..+......++.+++..+.-||. .|++|+|+++.|||++.++ .+.
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~~------~~~~~~~~~ll~~l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~ 161 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQWE------QLDPSQRRELLRALARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFY 161 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhhc------ccchhhHHHHHHHHHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEE
Confidence 457899999874 7999986532 26667788999999999999999 9999999999999998887 899
Q ss_pred EeccCCccc
Q 022826 121 ISDFGLAKI 129 (291)
Q Consensus 121 l~Dfg~~~~ 129 (291)
++||+.++.
T Consensus 162 lIDld~~~~ 170 (206)
T PF06293_consen 162 LIDLDRMRF 170 (206)
T ss_pred EEcchhcee
Confidence 999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.48 E-value=6.6e-07 Score=71.67 Aligned_cols=66 Identities=21% Similarity=0.305 Sum_probs=52.0
Q ss_pred cceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEecc
Q 022826 45 RRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 124 (291)
Q Consensus 45 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Df 124 (291)
..+++|||++|..|.++. .++. .+...+..++.-+|+ .|++|||.+|.|++++.++ ++++||
T Consensus 117 ~~~ll~EYIeG~~l~d~~----------~i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIE----------DIDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred EEEEEEEEecCeecccch----------hcCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-EEEEEC
Confidence 445899999998886653 1222 245667788999999 9999999999999998664 999999
Q ss_pred CCcc
Q 022826 125 GLAK 128 (291)
Q Consensus 125 g~~~ 128 (291)
+..+
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.5e-06 Score=78.67 Aligned_cols=115 Identities=19% Similarity=0.193 Sum_probs=79.2
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------------------------------
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------------------------------- 37 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------------------------------- 37 (291)
+.||.-+.|-||+|+.++|+.||||+-++.-
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999988754
Q ss_pred ------ce----------------eecCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhc
Q 022826 38 ------GF----------------CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95 (291)
Q Consensus 38 ------~~----------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~ 95 (291)
.. -......+|+|||++|..+.+.-.- ...+++...+ +..+.++...+==
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i-----~~~gi~~~~i---~~~l~~~~~~qIf 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI-----DKRGISPHDI---LNKLVEAYLEQIF 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH-----HHcCCCHHHH---HHHHHHHHHHHHH
Confidence 00 0112255689999999877555221 1234554433 3333332222110
Q ss_pred CCCCCeeeeccCCCceEEcC----CCceEEeccCCccccC
Q 022826 96 GCNTRILHFDIKPHNILLDE----DFCPKISDFGLAKICH 131 (291)
Q Consensus 96 ~~~~~ivH~dikp~Nill~~----~~~~kl~Dfg~~~~~~ 131 (291)
..|.+|+|=+|.||++.. ++.+.+-|||+.....
T Consensus 319 --~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 --KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 167999999999999983 6789999999976543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.1e-05 Score=66.01 Aligned_cols=29 Identities=21% Similarity=0.135 Sum_probs=25.4
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
..++|||+.|.||++++++ +.|+||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 4578999999999999888 9999998654
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.7e-06 Score=71.61 Aligned_cols=110 Identities=20% Similarity=0.255 Sum_probs=82.2
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------------------------ce-
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------------------------GF- 39 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------------------------~~- 39 (291)
..++++||-|.-+.||.+-+.+|.+.++|.=...+ ++
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 35789999999999999999889999998743222 11
Q ss_pred ---eecCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC
Q 022826 40 ---CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 116 (291)
Q Consensus 40 ---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~ 116 (291)
..+..+-++||+++.+..|...-+. .....+...++.-|--|-. .|++|||.+--||++.++
T Consensus 174 VPkpiD~~RH~Vvmelv~g~Pl~~v~~v------------~d~~~ly~~lm~~Iv~la~---~GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 174 VPKPIDHNRHCVVMELVDGYPLRQVRHV------------EDPPTLYDDLMGLIVRLAN---HGLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCcccccceeeHHHhhcccceeeeeec------------CChHHHHHHHHHHHHHHHH---cCceecccchheeEEecC
Confidence 1123455678888888776544311 1234566677777778888 999999999999999999
Q ss_pred CceEEeccCCc
Q 022826 117 FCPKISDFGLA 127 (291)
Q Consensus 117 ~~~kl~Dfg~~ 127 (291)
+.++++||--+
T Consensus 239 ~~i~vIDFPQm 249 (465)
T KOG2268|consen 239 DKIVVIDFPQM 249 (465)
T ss_pred CCEEEeechHh
Confidence 99999999543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=6e-05 Score=58.15 Aligned_cols=106 Identities=23% Similarity=0.262 Sum_probs=73.8
Q ss_pred hhcccccCCceeEEEEEecCCCeEEEEEeccCc---------------------ceeecCCcceeeehhhcCCCHHHHHh
Q 022826 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK---------------------GFCFEGHRRALIYEFVSNGSLEKFIY 63 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------~~~~~~~~~~lv~e~~~~g~L~~~l~ 63 (291)
+.+.|++|.+|.||++.+ .|..+++|+=..+. .....-+..++.|||..|.+|.+...
T Consensus 26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~~~~~ 104 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLGKLEI 104 (201)
T ss_pred hhhhhhcccccEEEEeec-cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchhhhhh
Confidence 457899999999999988 66789999877655 12222234445699999988877753
Q ss_pred hcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCC--CceEEcCCCceEEeccCCcc
Q 022826 64 EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKP--HNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 64 ~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp--~Nill~~~~~~kl~Dfg~~~ 128 (291)
.. . .+-...+++.-.-|-. .||-|+.|.- .||++.+. .+.|+||..++
T Consensus 105 ~~---------~----rk~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~-~~~iIDFd~At 154 (201)
T COG2112 105 GG---------D----RKHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDR-DVYIIDFDSAT 154 (201)
T ss_pred cc---------c----HHHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCC-cEEEEEccchh
Confidence 21 1 1223445555566667 8899998874 55655554 89999999776
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.0001 Score=60.21 Aligned_cols=121 Identities=21% Similarity=0.147 Sum_probs=66.9
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEeccCc--------------------------c---eeecCCcceeeehhhcCCC
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK--------------------------G---FCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------------------~---~~~~~~~~~lv~e~~~~g~ 57 (291)
+.|+.|..+.||+....+ ..+++|...... . ........+++|+++.+..
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~ 81 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP 81 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence 578899999999998856 699999987762 1 1112223578999999987
Q ss_pred HHH----------------HHhhcCCCC-CCCCCCHHH---------HHHH------------HHHHHH-HhHHhhc---
Q 022826 58 LEK----------------FIYEKHPLE-TNQKLKWEV---------LYKI------------AVGIAR-GLEYLHR--- 95 (291)
Q Consensus 58 L~~----------------~l~~~~~~~-~~~~~~~~~---------~~~i------------~~~l~~-~l~~LH~--- 95 (291)
+.. .+...+... ....+.... .... ...+.. .+..+++
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (239)
T PF01636_consen 82 LDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLP 161 (239)
T ss_dssp HHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhc
Confidence 777 121111110 001111100 0000 111222 2233331
Q ss_pred -CCCCCeeeeccCCCceEEc-CCCceEEeccCCcc
Q 022826 96 -GCNTRILHFDIKPHNILLD-EDFCPKISDFGLAK 128 (291)
Q Consensus 96 -~~~~~ivH~dikp~Nill~-~~~~~kl~Dfg~~~ 128 (291)
.....++|+|+.|.||+++ .++.+-|+||+.+.
T Consensus 162 ~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 162 KPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp CCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1236799999999999999 56666799998643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.78 E-value=9e-05 Score=63.68 Aligned_cols=116 Identities=20% Similarity=0.242 Sum_probs=84.2
Q ss_pred hhhcccccCCceeEEEEEecCCCeEEEEEeccCcceeecCCc--------------------------------------
Q 022826 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKGFCFEGHR-------------------------------------- 45 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~-------------------------------------- 45 (291)
++.-+|..|.-+.||.|...+|..+|||+++.+.-++.+..+
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 345678999999999998888999999999977622222221
Q ss_pred ------------ceeeehhhcCCCH-HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceE
Q 022826 46 ------------RALIYEFVSNGSL-EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 112 (291)
Q Consensus 46 ------------~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nil 112 (291)
.+|||+|+....- .-.| ....++...+..+-.+++.-+.-|-+ ..++||.||+--|++
T Consensus 227 GIP~PePIlLk~hVLVM~FlGrdgw~aPkL-------Kd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~L 297 (520)
T KOG2270|consen 227 GIPCPEPILLKNHVLVMEFLGRDGWAAPKL-------KDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLL 297 (520)
T ss_pred CCCCCCceeeecceEeeeeccCCCCcCccc-------ccccCChHHHHHHHHHHHHHHHHHHH--Hhceeccchhhhhhe
Confidence 1278888853221 1112 23456667788888888888888876 488999999999998
Q ss_pred EcCCCceEEeccCCccc
Q 022826 113 LDEDFCPKISDFGLAKI 129 (291)
Q Consensus 113 l~~~~~~kl~Dfg~~~~ 129 (291)
+ .+|.+.|+|.+-+..
T Consensus 298 y-hdG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 298 Y-HDGKLYIIDVSQSVE 313 (520)
T ss_pred E-ECCEEEEEEcccccc
Confidence 8 456899999876543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00069 Score=56.10 Aligned_cols=30 Identities=23% Similarity=0.190 Sum_probs=26.1
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
..++|+|+.|.||++++++.+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 558999999999999998777899998654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00032 Score=68.26 Aligned_cols=168 Identities=17% Similarity=0.183 Sum_probs=110.9
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCC---ceEEcCCCceEEe--
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPH---NILLDEDFCPKIS-- 122 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~---Nill~~~~~~kl~-- 122 (291)
+..++|.+.++...+... ..++....+.+..++.+|+.++|+ ....|.-+... +.-.+..+...++
T Consensus 263 v~~~~~s~~~~~~~~q~v------~~i~~~~~r~~~~~~~~GL~~~h~---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~ 333 (1351)
T KOG1035|consen 263 VLQEICSKVELRSLLQSV------GSIPLETLRILHQKLLEGLAYLHS---LSLEHVVLSASSSKESTVDGEGVVAISLS 333 (1351)
T ss_pred HHHhhcCccchHHHHhhc------cccCHHHHHHHHHHHhhhHHHHHH---hccceeEEecccccccccCccceeecchh
Confidence 345777777887777544 688999999999999999999999 65555544444 3333455566666
Q ss_pred ccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhh
Q 022826 123 DFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYK 202 (291)
Q Consensus 123 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~ 202 (291)
||+.+..+........ ......+.++|.............|+|.+|..+..+..+.........
T Consensus 334 ~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~------------- 397 (1351)
T KOG1035|consen 334 DFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV------------- 397 (1351)
T ss_pred hhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc-------------
Confidence 8887766543322111 122557788888766644445567999999999999876642221100
Q ss_pred hhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 022826 203 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252 (291)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L 252 (291)
.. ...+......+.+.+..|+..++++|+++.+++...
T Consensus 398 ---------~~---~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 398 ---------PV---SLLDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred ---------hh---hhhccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 00 000111111577788899999999999999998765
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00039 Score=55.13 Aligned_cols=80 Identities=28% Similarity=0.322 Sum_probs=62.2
Q ss_pred eeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCC
Q 022826 47 ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL 126 (291)
Q Consensus 47 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~ 126 (291)
+++.|+...+++.... ..+..-...+|..+.+|+.++++.+.+++.+....+.-.|++++|+-++++|++|++|...
T Consensus 32 ~~v~E~~~~~~~~~~~---~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~ 108 (188)
T PF12260_consen 32 FYVVEYVGAGSLYGIY---RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDD 108 (188)
T ss_pred EEEEEeecCccccccc---cccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechh
Confidence 5677888766553220 0011224678999999999999999999987766788999999999999999999999986
Q ss_pred ccc
Q 022826 127 AKI 129 (291)
Q Consensus 127 ~~~ 129 (291)
...
T Consensus 109 v~~ 111 (188)
T PF12260_consen 109 VFV 111 (188)
T ss_pred cch
Confidence 543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.001 Score=54.75 Aligned_cols=30 Identities=27% Similarity=0.441 Sum_probs=25.1
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
..++|||+.+.||+++.++..-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 558999999999999876555799998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0022 Score=53.50 Aligned_cols=29 Identities=24% Similarity=0.356 Sum_probs=25.4
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
..++|+|+.|.||++++++ +.|+||+.+.
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 4589999999999999877 7899998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.004 Score=60.85 Aligned_cols=31 Identities=26% Similarity=0.341 Sum_probs=24.8
Q ss_pred CCeeeeccCCCceEEcCC-Cc-eEEeccCCccc
Q 022826 99 TRILHFDIKPHNILLDED-FC-PKISDFGLAKI 129 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~-~~-~kl~Dfg~~~~ 129 (291)
..+||||+++.||+++.+ ++ +-|.||+.+..
T Consensus 225 ~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 225 TGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred cceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 359999999999999853 33 57899998754
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0017 Score=55.46 Aligned_cols=37 Identities=38% Similarity=0.476 Sum_probs=24.5
Q ss_pred HHHHHHHHHHHHHhHHhhc-CCCCCeeeeccCCCceEE
Q 022826 77 EVLYKIAVGIARGLEYLHR-GCNTRILHFDIKPHNILL 113 (291)
Q Consensus 77 ~~~~~i~~~l~~~l~~LH~-~~~~~ivH~dikp~Nill 113 (291)
+-++.++-|++.-.-..-+ ++-.+.+|.||||+||++
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILi 312 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILI 312 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEE
Confidence 3455666777654422322 223679999999999998
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.007 Score=49.70 Aligned_cols=30 Identities=27% Similarity=0.324 Sum_probs=26.2
Q ss_pred CCeeeeccCCCceEEcC-CCceEEeccCCcc
Q 022826 99 TRILHFDIKPHNILLDE-DFCPKISDFGLAK 128 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~-~~~~kl~Dfg~~~ 128 (291)
..++|+|+.+.||+++. ++.+.|+||..+.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 56999999999999998 5789999998654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0074 Score=52.10 Aligned_cols=31 Identities=26% Similarity=0.365 Sum_probs=26.0
Q ss_pred CCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 98 ~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
..+++|+|+.+.||+++.+...-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 3689999999999999876556899998654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0061 Score=51.96 Aligned_cols=30 Identities=30% Similarity=0.424 Sum_probs=26.3
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 579999999999999988777899998654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.00019 Score=65.56 Aligned_cols=158 Identities=20% Similarity=0.073 Sum_probs=104.7
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEeccCc----------------------ceeecCCcceeeehhhcCC-CHHHHHh
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------GFCFEGHRRALIYEFVSNG-SLEKFIY 63 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~~lv~e~~~~g-~L~~~l~ 63 (291)
+-+++|+++.+++.+....+....+.+...- +.+..+....+.++++..+ +......
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~ 327 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMT 327 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCC
Confidence 4467899999999986555555555554332 1122233444567777665 2211111
Q ss_pred hcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeeccCCC
Q 022826 64 EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR 143 (291)
Q Consensus 64 ~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 143 (291)
. ..-.+...+...+++.-.++++++|+ ..-+|+| ||+..+ +..+..||+....+.... ..+...
T Consensus 328 ~-----se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~ 391 (829)
T KOG0576|consen 328 V-----SEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAI 391 (829)
T ss_pred h-----hhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---ccccCC
Confidence 0 11234444566677888899999998 6568888 666655 578999999887765544 345567
Q ss_pred CCccccCcccccccCCCccccccchhHHHHHHHHhCCCC
Q 022826 144 GTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKN 182 (291)
Q Consensus 144 ~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~ 182 (291)
+++.|+|||+.... .+....|.|++|.-..++.-|-.
T Consensus 392 ~~~~~~~pev~~~~--~~~~~p~~~~~~~~~~~~ap~~p 428 (829)
T KOG0576|consen 392 GTPEPLAPEVIQEN--TIDGCPDSGSLAVSAIQMAPGLP 428 (829)
T ss_pred CCCCCCCchhhccc--ccccCCCccCCCcchhhcCCCCC
Confidence 89999999998876 88899999999987666654443
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0097 Score=50.87 Aligned_cols=51 Identities=12% Similarity=0.075 Sum_probs=35.7
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEeccC-c--------------------------ceee---cCCcceeeehhhcCC
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNET-K--------------------------GFCF---EGHRRALIYEFVSNG 56 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~--------------------------~~~~---~~~~~~lv~e~~~~g 56 (291)
+.||+|..+.||+....+++ +++|..+.. . +.+. .....++|||++++.
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~ 98 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGV 98 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCE
Confidence 56999999999999765554 666775542 1 2222 235689999999987
Q ss_pred CH
Q 022826 57 SL 58 (291)
Q Consensus 57 ~L 58 (291)
++
T Consensus 99 ~~ 100 (297)
T PRK10593 99 SV 100 (297)
T ss_pred ec
Confidence 54
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.013 Score=50.24 Aligned_cols=31 Identities=32% Similarity=0.509 Sum_probs=27.0
Q ss_pred CCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 98 ~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
..+++|+|+++.||+++.++...|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3789999999999999988767899998653
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0097 Score=47.43 Aligned_cols=41 Identities=29% Similarity=0.392 Sum_probs=33.8
Q ss_pred HHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 79 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 79 ~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
...-+.++.+-+..+|. .+|+-+|+++.|.. .-+|+|||.+
T Consensus 166 ~~~~~~~~~~dl~~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 166 QIRDIPQMLRDLKILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred chhHHHHHHHHHHHHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 33456778888899999 99999999999986 5699999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.02 Score=45.75 Aligned_cols=103 Identities=26% Similarity=0.371 Sum_probs=65.4
Q ss_pred hhcccccCCceeEEEEEecCCCeEEEEEeccCc-----------------------------------------------
Q 022826 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------------------------- 37 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------------------------------- 37 (291)
=...||+|+...||. +.+....+||+.....
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346899999999997 4456677888876554
Q ss_pred -ceeecCCcceeeehhhcC------CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCc
Q 022826 38 -GFCFEGHRRALIYEFVSN------GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHN 110 (291)
Q Consensus 38 -~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~N 110 (291)
++..++.-.-+|+|...+ .+|.+++.+ ..++. ... ..+-.-..+|-+ .+|+.+|++|.|
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-------~~~~~-~~~---~~L~~f~~~l~~---~~Iv~~dl~~~N 148 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-------GGLTE-ELR---QALDEFKRYLLD---HHIVIRDLNPHN 148 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-------CCccH-HHH---HHHHHHHHHHHH---cCCeecCCCccc
Confidence 222233333356655422 267777743 24444 333 333444567777 899999999999
Q ss_pred eEEcCC--C--ceEEec
Q 022826 111 ILLDED--F--CPKISD 123 (291)
Q Consensus 111 ill~~~--~--~~kl~D 123 (291)
|++... + .+.|+|
T Consensus 149 Iv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 149 IVVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEEecCCCceEEEEEe
Confidence 999432 2 466665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.029 Score=49.83 Aligned_cols=30 Identities=27% Similarity=0.343 Sum_probs=26.0
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
..++|||+.+.|||+..+ .++++||..+..
T Consensus 223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~~ 252 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAFY 252 (401)
T ss_pred CceeeccCCcccEEeeCC-CcEEEecccccc
Confidence 669999999999999776 599999987653
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.018 Score=49.25 Aligned_cols=39 Identities=33% Similarity=0.423 Sum_probs=27.9
Q ss_pred HHHHHHHHHHHHHhHHh-hcCCCCCeeeeccCCCceEEcC
Q 022826 77 EVLYKIAVGIARGLEYL-HRGCNTRILHFDIKPHNILLDE 115 (291)
Q Consensus 77 ~~~~~i~~~l~~~l~~L-H~~~~~~ivH~dikp~Nill~~ 115 (291)
+-++.++-|++.-.... .-++-.+.+|.||||+||++=+
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd 318 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFD 318 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEec
Confidence 45667788887765444 3333477999999999999933
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.028 Score=48.26 Aligned_cols=31 Identities=26% Similarity=0.468 Sum_probs=27.8
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
..++|||+++.|+++++.+.+-|.||+++..
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 4589999999999999988899999998765
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.086 Score=45.71 Aligned_cols=29 Identities=38% Similarity=0.452 Sum_probs=24.0
Q ss_pred CCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 98 ~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
..+++|+|+.+.||+++ + .+.|+||+-+.
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 36789999999999995 4 57899998653
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.077 Score=46.35 Aligned_cols=30 Identities=27% Similarity=0.321 Sum_probs=25.4
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
..++|||+.+.||++++++ ++++|+..+..
T Consensus 192 ~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~ 221 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEHE-TKVIDPEFAFY 221 (370)
T ss_pred ceeeeccCCcccEEEcCCC-CEEEcCccccc
Confidence 6789999999999998764 88999986653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.019 Score=50.48 Aligned_cols=59 Identities=19% Similarity=0.186 Sum_probs=42.4
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE 115 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~ 115 (291)
++=+|..|-++..++.. ...+++...+++.-.+.++.-|-- ..+.+|.|+.|.||++-.
T Consensus 322 l~E~~~~Gl~v~~~v~~-------~~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 322 LVETYERGLSVLRFVKW-------KSQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRF 380 (565)
T ss_pred eeeeccccccHHhhhhc-------ccChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEe
Confidence 44466677778777743 355666777777777777665554 378999999999999943
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.0039 Score=62.94 Aligned_cols=136 Identities=12% Similarity=0.023 Sum_probs=98.4
Q ss_pred CCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhc--CCCCCeeeeccCCCceEEcCCCceE
Q 022826 43 GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR--GCNTRILHFDIKPHNILLDEDFCPK 120 (291)
Q Consensus 43 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~--~~~~~ivH~dikp~Nill~~~~~~k 120 (291)
....+..++++.+|.+.+.+.+.. ++.+.+....+.....+.+....-.|+ ....-.+|.++|+.|.+|..+-+++
T Consensus 1303 s~ee~~r~~~~~~g~~f~iIikg~--ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~ 1380 (2724)
T KOG1826|consen 1303 STEEYIRSLYVEFGKLFSIIIKGL--EESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVK 1380 (2724)
T ss_pred ChHHHHHHHHHHHhHHHHHHHhcc--ccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccc
Confidence 345567899999999999998763 455666666666666665666666665 2234478999999999999999999
Q ss_pred EeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCC
Q 022826 121 ISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNA 184 (291)
Q Consensus 121 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~ 184 (291)
++++|+.+....... ......+++.|+.|++-..- .++.++|||..|+.+|....|..++
T Consensus 1381 ~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1381 LGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEI--KFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred ccccccccccCchHh--hhhhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHHHHHHHhcccHHH
Confidence 999999873221111 12333456778888876543 6777899999999999988777544
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.082 Score=45.94 Aligned_cols=30 Identities=23% Similarity=0.275 Sum_probs=25.2
Q ss_pred CeeeeccCCCceEEcC-CCceEEeccCCccc
Q 022826 100 RILHFDIKPHNILLDE-DFCPKISDFGLAKI 129 (291)
Q Consensus 100 ~ivH~dikp~Nill~~-~~~~kl~Dfg~~~~ 129 (291)
-.+|+|+.+.||++++ ++.++++||..+..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 3789999999999975 47899999987643
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.054 Score=45.97 Aligned_cols=49 Identities=22% Similarity=0.331 Sum_probs=30.5
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCC
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.++.|....+|+.. .+++.+.||+-.... .+.......+||+||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 568889999999987 468899999987432 4444456678999999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.13 Score=51.44 Aligned_cols=31 Identities=35% Similarity=0.434 Sum_probs=25.8
Q ss_pred CCeeeeccCCCceEEcCCC--ceE-EeccCCccc
Q 022826 99 TRILHFDIKPHNILLDEDF--CPK-ISDFGLAKI 129 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~--~~k-l~Dfg~~~~ 129 (291)
.+++|+|+++.||+++.++ ++. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 6799999999999998875 555 999997643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.046 Score=46.76 Aligned_cols=31 Identities=29% Similarity=0.248 Sum_probs=26.9
Q ss_pred CCCeeeeccCCCceEEcCC----CceEEeccCCcc
Q 022826 98 NTRILHFDIKPHNILLDED----FCPKISDFGLAK 128 (291)
Q Consensus 98 ~~~ivH~dikp~Nill~~~----~~~kl~Dfg~~~ 128 (291)
...++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 3678999999999999885 889999998654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.32 Score=43.34 Aligned_cols=29 Identities=17% Similarity=0.297 Sum_probs=24.5
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
..++|||+.+.|||+++++ .+++|...+.
T Consensus 230 ~~L~HGDl~~g~i~~~~~~-~~~id~ef~~ 258 (418)
T PLN02756 230 QALVHGDLHTGSVMVTPDS-TQVIDPEFAF 258 (418)
T ss_pred cceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence 6689999999999999875 8888876554
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.04 Score=47.84 Aligned_cols=55 Identities=20% Similarity=0.211 Sum_probs=47.2
Q ss_pred CCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 73 KLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 73 ~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
...++++..++++.+..++-+.. .-..=|+++.-.||+|+ .|.+.|+||.+++.-
T Consensus 317 ~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 317 ADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred cccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 44677899999999988888886 35578999999999999 999999999999853
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.028 Score=44.33 Aligned_cols=30 Identities=20% Similarity=0.258 Sum_probs=25.7
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
.-.+|+|+.|.|+++.++| ++++||+.+..
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 3469999999999998887 99999997653
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.39 E-value=0.1 Score=44.78 Aligned_cols=29 Identities=31% Similarity=0.356 Sum_probs=25.2
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
.+++|||+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 67999999999999987 678999998543
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.38 E-value=0.29 Score=43.43 Aligned_cols=30 Identities=20% Similarity=0.353 Sum_probs=25.9
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
..++|||++|.|||++++ ..|++|...+..
T Consensus 227 ~aLlHGDlHtGSI~v~~~-~~kvIDpEFAfy 256 (409)
T PRK12396 227 QALIHGDLHTGSVFVKND-STKVIDPEFAFY 256 (409)
T ss_pred hhhccCcCCCCCEEecCC-ceEEEccccccc
Confidence 668999999999999987 589999887754
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.36 E-value=0.31 Score=40.54 Aligned_cols=57 Identities=19% Similarity=0.206 Sum_probs=40.8
Q ss_pred hcccccCCceeEEEEEecCCCeEEEEEeccCcc----------------------eeecCCcceeeehhh-cCCCHHHHH
Q 022826 6 KNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG----------------------FCFEGHRRALIYEFV-SNGSLEKFI 62 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~~lv~e~~-~~g~L~~~l 62 (291)
...+..|+.+.|+.++..+|.+.++|+...... ...+.....+++|.+ ++.+|.+..
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g~~~L~~w~G~GaVrll~~d~~~~AlLLErl~~g~~L~~~~ 86 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARGEAALRWWNGRGAVRLLAADPERGALLLERLDPGRSLASLP 86 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhHHhHhheeCCCCceeeeccccccchhhhhhccCCCchhhcc
Confidence 345677999999999988999999999985431 112223556888998 445776555
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.34 E-value=0.095 Score=44.08 Aligned_cols=48 Identities=25% Similarity=0.300 Sum_probs=35.1
Q ss_pred HHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 81 KIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 81 ~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
+.+..+-..+.-.+.. ..-++|+|+.|+|++.++.+.+.|+||.-+..
T Consensus 136 ~~~~~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 136 KKLKELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 3444455555555541 13589999999999999999999999986653
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.32 E-value=0.046 Score=44.21 Aligned_cols=72 Identities=19% Similarity=0.210 Sum_probs=48.5
Q ss_pred HHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCcccccc
Q 022826 87 ARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSD 166 (291)
Q Consensus 87 ~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~D 166 (291)
+..|.-.|++ +.+.+|||..|+|||-+..|.+||.|=+.-.. .+..|.- +.. ...+.++.
T Consensus 151 i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN-~~Y----~~lT~~aE 210 (308)
T PF07387_consen 151 IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVN-IEY----ESLTQEAE 210 (308)
T ss_pred HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEe-eec----cccChHHH
Confidence 4667788852 47899999999999999999999999764210 0122222 111 24567777
Q ss_pred chhHHHHHHHHh
Q 022826 167 VYSYGMMVFEMT 178 (291)
Q Consensus 167 iwslG~~l~~ll 178 (291)
+-+|=..+++++
T Consensus 211 ~~~fv~s~l~~v 222 (308)
T PF07387_consen 211 VKVFVKSCLKLV 222 (308)
T ss_pred HHHHHHHHHHHH
Confidence 767666666665
|
The function of this family is unknown. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.08 E-value=0.043 Score=46.39 Aligned_cols=30 Identities=40% Similarity=0.543 Sum_probs=24.9
Q ss_pred CCeeeeccCCCceEEcCCCce-EEeccCCcc
Q 022826 99 TRILHFDIKPHNILLDEDFCP-KISDFGLAK 128 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~-kl~Dfg~~~ 128 (291)
..++|+|+++.||++++++++ -|+||+.+.
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 458999999999999975654 699999765
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.73 E-value=0.045 Score=44.15 Aligned_cols=30 Identities=37% Similarity=0.475 Sum_probs=20.9
Q ss_pred CCeeeeccCCCceEE-cCCCceEEeccCCcc
Q 022826 99 TRILHFDIKPHNILL-DEDFCPKISDFGLAK 128 (291)
Q Consensus 99 ~~ivH~dikp~Nill-~~~~~~kl~Dfg~~~ 128 (291)
..+.|+|+.+.||++ +.++.++++||..+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 457899999999999 888999999998654
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=93.43 E-value=0.14 Score=44.83 Aligned_cols=30 Identities=30% Similarity=0.396 Sum_probs=25.9
Q ss_pred CCeeeeccCCCceEEcC-CCceEEeccCCcc
Q 022826 99 TRILHFDIKPHNILLDE-DFCPKISDFGLAK 128 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~-~~~~kl~Dfg~~~ 128 (291)
..++|+|+++.||++++ ++.+.++||..+.
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 46899999999999976 4689999998764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 291 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-35 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-25 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-20 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-05 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-05 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-05 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-05 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-05 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-05 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-05 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-05 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-05 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-05 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-05 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-05 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 6e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 7e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 7e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 7e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 7e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-05 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-04 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-04 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 2e-93
Identities = 101/285 (35%), Positives = 154/285 (54%), Gaps = 37/285 (12%)
Query: 2 TNSF--KNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK---------------------- 37
+++F KN LG+GG+G VYKG+L DG VA+K L E +
Sbjct: 29 SDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 38 -----GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEY 92
GFC R L+Y +++NGS+ + E+ + L W +IA+G ARGL Y
Sbjct: 89 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE--SQPPLDWPKRQRIALGSARGLAY 146
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPE 152
LH C+ +I+H D+K NILLDE+F + DFGLAK+ +++ V+ T RGT+G+IAPE
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPE 205
Query: 153 VFCRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211
G+ S K+DV+ YG+M+ E+ TG + + ++ WV L+ ++
Sbjct: 206 YLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263
Query: 212 L--QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254
L ++ E ++I V+L C Q++P +RP M+ VV MLEG
Sbjct: 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 2e-78
Identities = 96/295 (32%), Positives = 143/295 (48%), Gaps = 54/295 (18%)
Query: 1 MTNSF--KNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK--------------------- 37
TN+F K +G G +G VYKG L DG VA+K
Sbjct: 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 38 -----GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEY 92
GFC E + LIY+++ NG+L++ +Y + WE +I +G ARGL Y
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL--PTMSMSWEQRLEICIGAARGLHY 154
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC-HGRESIVSMTGARGTVGYIAP 151
LH I+H D+K NILLDE+F PKI+DFG++K ++ +S T +GT+GYI P
Sbjct: 155 LHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS-TVVKGTLGYIDP 210
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRS---SEIYFPHWVYKRLE-- 205
E F + G ++ KSDVYS+G+++FE+ A+ +S + W +
Sbjct: 211 EYFIK--GRLTEKSDVYSFGVVLFEVLCARS-----AIVQSLPREMVNLAEWAVESHNNG 263
Query: 206 -LEE--DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257
LE+ D L + E RK ++ C+ + DRP+M V+ LE +L
Sbjct: 264 QLEQIVDPNLAD---KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 238 bits (611), Expect = 3e-78
Identities = 86/302 (28%), Positives = 134/302 (44%), Gaps = 63/302 (20%)
Query: 2 TNSFK--------NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK---------------- 37
TN+F NK+G+GG+G VYKG ++ VA+K L
Sbjct: 24 TNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIK 82
Query: 38 --------------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIA 83
GF +G L+Y ++ NGSL + L+ L W + KIA
Sbjct: 83 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL---SCLDGTPPLSWHMRCKIA 139
Query: 84 VGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC-HGRESIVSMTGA 142
G A G+ +LH +H DIK NILLDE F KISDFGLA+ +++++ +
Sbjct: 140 QGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT-SRI 195
Query: 143 RGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRS-SEIYFPHWV 200
GT Y+APE GE++ KSD+YS+G+++ E+ TG+ VD
Sbjct: 196 VGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPA-----VDEHREPQLLLDIK 247
Query: 201 YKRLELEEDLGLQGIE----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256
+ +E+ ++ N+ D M V+ C+ + RP + +V ++L+
Sbjct: 248 EEI--EDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
Query: 257 DS 258
S
Sbjct: 306 AS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-58
Identities = 69/297 (23%), Positives = 107/297 (36%), Gaps = 56/297 (18%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVL---------NETK----------------G 38
+G +G V+K +L VA+K+ NE + G
Sbjct: 27 QLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIG 85
Query: 39 FCFEGHRRA----LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
G LI F GSL F+ + W L IA +ARGL YLH
Sbjct: 86 AEKRGTSVDVDLWLITAFHEKGSLSDFL-------KANVVSWNELCHIAETMARGLAYLH 138
Query: 95 -------RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVG 147
G I H DIK N+LL + I+DFGLA +S G GT
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 148 YIAPEVF---CRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRL 204
Y+APEV + + D+Y+ G++++E+ A+ VD + F + +
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD-EYMLPFEEEIGQHP 257
Query: 205 ELEE---DLGLQGIENEEDKEYARKMILVSLW-----CIQNNPSDRPAMNRVVEMLE 253
LE+ + + + + + L C ++ R + V E +
Sbjct: 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 9e-56
Identities = 73/293 (24%), Positives = 130/293 (44%), Gaps = 63/293 (21%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK--------------------------- 37
K K+G G +G V++ + G +VA+K+L E
Sbjct: 41 IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 38 -GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
G + +++ E++S GSL + + H ++L +A +A+G+ YLH
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLL---HKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156
N I+H ++K N+L+D+ + K+ DFGL+++ + +S A GT ++APEV
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVLRD 213
Query: 157 NFGEVSYKSDVYSYGMMVFEM-TGVK-----NNANVAVDRSSEIYFPHWVYKRLELEEDL 210
+ KSDVYS+G++++E+ T + N A V + KRLE+ +L
Sbjct: 214 E--PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-------CKRLEIPRNL 264
Query: 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPP 263
+ + A + C N P RP+ ++++L + S PP
Sbjct: 265 ---------NPQVAAII----EGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-52
Identities = 66/304 (21%), Positives = 110/304 (36%), Gaps = 69/304 (22%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------GFC 40
+ +G+G +G V K K ++VAIK + G C
Sbjct: 12 VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 41 FEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
L+ E+ GSL ++ PL + ++G+ YLH
Sbjct: 71 LNPV--CLVMEYAEGGSLYNVLHGAEPLP---YYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 101 ILHFDIKPHNILLDEDF-CPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFG 159
++H D+KP N+LL KI DFG A + MT +G+ ++APEVF +
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGS-- 178
Query: 160 EVSYKSDVYSYGMMVFEM-------TGVKNNANVAVDRSSEIYFPHWVYK--RLELEEDL 210
S K DV+S+G++++E+ + A + V+ R L ++L
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA---------VHNGTRPPLIKNL 229
Query: 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLSS 270
K M C +PS RP+M +V+++ + P
Sbjct: 230 ---------PKPIESLM----TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPC 276
Query: 271 GSQP 274
Sbjct: 277 QHSL 280
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-51
Identities = 67/292 (22%), Positives = 116/292 (39%), Gaps = 72/292 (24%)
Query: 5 FKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------- 37
++ ++G+GG+G V+KG+L+ D VAIK L
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 38 -------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGL 90
G ++ EFV G L + +K +KW V ++ + IA G+
Sbjct: 83 PNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDK-----AHPIKWSVKLRLMLDIALGI 135
Query: 91 EYLHRGCNTRILHFDIKPHNILLDE-----DFCPKISDFGLAKICHGRESIVSMTGARGT 145
EY+ N I+H D++ NI L C K++DFGL+ ++S+ S++G G
Sbjct: 136 EYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVHSVSGLLGN 189
Query: 146 VGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYK-- 202
++APE + K+D YS+ M+++ + TG +I F + + +
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY---SYGKIKFINMIREEG 246
Query: 203 -RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
R + ED + C +P RP + +V+ L
Sbjct: 247 LRPTIPEDC---------PPRLRNVI----ELCWSGDPKKRPHFSYIVKELS 285
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 7e-51
Identities = 68/319 (21%), Positives = 103/319 (32%), Gaps = 65/319 (20%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVL---------NETK----------------G 38
+G+G YG VYKG L D R VA+KV NE
Sbjct: 16 KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 39 FCFEGHRRA-----LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
L+ E+ NGSL K++ W ++A + RGL YL
Sbjct: 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLS-------LHTSDWVSSCRLAHSVTRGLAYL 127
Query: 94 H------RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG------RESIVSMTG 141
H I H D+ N+L+ D ISDFGL+ G E +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 142 ARGTVGYIAPEVF-----CRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIY 195
GT+ Y+APEV R+ + D+Y+ G++ +E+ + ++
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247
Query: 196 FPHWVYKRLELEEDLGLQGIENE---------EDKEYARKMILVSLWCIQNNPSDRPAMN 246
F V E+ L E + E+ R + C + R
Sbjct: 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQ 307
Query: 247 RVVEMLEGSLDSLRIPPRP 265
E + +
Sbjct: 308 XAEERMAELMMIWERNKSV 326
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-47
Identities = 55/286 (19%), Positives = 105/286 (36%), Gaps = 68/286 (23%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------- 37
+F KL + G ++KG+ G ++ +KVL
Sbjct: 13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 38 --GFCFE--GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
G C LI ++ GSL ++E TN + K A+ +ARG+ +L
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEG----TNFVVDQSQAVKFALDMARGMAFL 127
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEV 153
H I + ++++DED +IS + G ++APE
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEA 179
Query: 154 FC-RNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211
+ +D++S+ ++++E+ T E+ F +E+ +
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTR-------------EVPFAD--LSNMEIGMKVA 224
Query: 212 LQG----IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
L+G I ++ M + C+ +P+ RP + +V +LE
Sbjct: 225 LEGLRPTIPPGISPHVSKLMKI----CMNEDPAKRPKFDMIVPILE 266
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-47
Identities = 68/293 (23%), Positives = 109/293 (37%), Gaps = 78/293 (26%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK--------------------------- 37
+ +G GG+G VY+ G VA+K
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 38 ---GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
G C + L+ EF G L + + + +++ ++L AV IARG+ YLH
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL-------SGKRIPPDILVNWAVQIARGMNYLH 122
Query: 95 RGCNTRILHFDIKPHNILLDEDFCP--------KISDFGLAKICHGRESIVSMTGARGTV 146
I+H D+K NIL+ + KI+DFGLA+ H A G
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAY 178
Query: 147 GYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGVK-----NNANVAVDRSSEIYFPHWV 200
++APEV S SDV+SYG++++E+ TG + VA +
Sbjct: 179 AWMAPEVI--RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL----- 231
Query: 201 YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
L + + +A+ M C +P RP+ +++ L
Sbjct: 232 --ALPIPSTC---------PEPFAKLM----EDCWNPDPHSRPSFTNILDQLT 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-46
Identities = 68/287 (23%), Positives = 117/287 (40%), Gaps = 68/287 (23%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK--------------------------- 37
++G G +G VYKGK +VA+K+LN T
Sbjct: 28 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 38 -GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
G+ A++ ++ SL ++ K + + L IA ARG++YLH
Sbjct: 86 MGYSTAPQL-AIVTQWCEGSSLYHHLHASET-----KFEMKKLIDIARQTARGMDYLHA- 138
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC- 155
+ I+H D+K +NI L ED KI DFGLA G++ ++APEV
Sbjct: 139 KS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 156 RNFGEVSYKSDVYSYGMMVFEMT-------GVKNNANV--AVDRSSEIYFPHWVYKRLEL 206
++ S++SDVY++G++++E+ + N + V R +L
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG---------SLSPDL 247
Query: 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
+ + + K R M C++ +RP+ R++ +E
Sbjct: 248 SK------VRSNCPKRMKRLM----AECLKKKRDERPSFPRILAEIE 284
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-46
Identities = 65/298 (21%), Positives = 110/298 (36%), Gaps = 60/298 (20%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLN--ETKGFCFE-------------------- 42
++G+G YG V+ GK G VA+KV E + E
Sbjct: 41 MVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 43 -------GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH- 94
+ LI ++ NGSL ++ + L + + K+A GL +LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL-------KSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 95 ----RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV--SMTGARGTVGY 148
I H D+K NIL+ ++ I+D GLA + V GT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 149 IAPEVF----CRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKR 203
+ PEV RN + +D+YS+G++++E+ + V ++ + V
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV---EEYQLPYHDLVPSD 269
Query: 204 LELEEDLGLQGIEN---EEDKEYARKMILVSLW-----CIQNNPSDRPAMNRVVEMLE 253
E+ + I+ ++ L + C +NP+ R RV + L
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 8e-46
Identities = 60/311 (19%), Positives = 105/311 (33%), Gaps = 71/311 (22%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK--------------------------- 37
+G+G +G VY G+ VAI++++ +
Sbjct: 37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 38 -GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
G C A+I +L + + L +IA I +G+ YLH
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKI-----VLDVNKTRQIAQEIVKGMGYLH-- 147
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKI---CHGRESIVSMTGARGTVGYIAPEV 153
ILH D+K N+ D I+DFGL I + G + ++APE+
Sbjct: 148 -AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 154 FCRNFGEV-------SYKSDVYSYGMMVFEM-TGV---KNNANVAVDRSSEIYFPHWVYK 202
+ + S SDV++ G + +E+ K A+ I+ K
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-----IWQMGTGMK 260
Query: 203 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262
+ + KE + + L+C +RP ++++MLE R
Sbjct: 261 PNLSQIGM---------GKEISDIL----LFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307
Query: 263 PRPFLLSSGSQ 273
P ++
Sbjct: 308 SHPGHFWKSAE 318
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-45
Identities = 63/298 (21%), Positives = 108/298 (36%), Gaps = 60/298 (20%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLN--ETKGFCFE-------------------- 42
+G+G YG V++G G NVA+K+ + + K + E
Sbjct: 12 LLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 43 -------GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH- 94
+ LI + GSL ++ L +I + IA GL +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYL-------QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 95 ----RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV--SMTGARGTVGY 148
I H D+K NIL+ ++ I+D GLA + + + GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 149 IAPEVFCR--NFGEVSY--KSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKR 203
+APEV + D++++G++++E+ + +N V + F V
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV---EDYKPPFYDVVPND 240
Query: 204 LELEEDLGLQGIEN---EEDKEYARKMILVSLW-----CIQNNPSDRPAMNRVVEMLE 253
E+ + ++ + L SL C NPS R R+ + L
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 9e-45
Identities = 59/298 (19%), Positives = 109/298 (36%), Gaps = 60/298 (20%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLN--ETKGFCFE-------------------- 42
+ +G+G +G V++GK G VA+K+ + E + + E
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 43 -------GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH- 94
+ L+ ++ +GSL ++ + E + K+A+ A GL +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL-------NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 95 ----RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV--SMTGARGTVGY 148
I H D+K NIL+ ++ I+D GLA + + GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 149 IAPEVF----CRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKR 203
+APEV E ++D+Y+ G++ +E+ ++ + V
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH---EDYQLPYYDLVPSD 274
Query: 204 LELEEDLGLQGIENE--------EDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
+EE + + + E R M + C N + R R+ + L
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-41
Identities = 57/310 (18%), Positives = 100/310 (32%), Gaps = 80/310 (25%)
Query: 5 FKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------- 37
LG+G +G K + G + +K L
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
G ++ R I E++ G+L I + + W A IA G+ YLH
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSM-----DSQYPWSQRVSFAKDIASGMAYLHS-M 127
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKI------------CHGRESIVSMTGARGT 145
N I+H D+ HN L+ E+ ++DFGLA++ + G
Sbjct: 128 N--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 146 VGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGVK-------NNANVAVDRSSEIYFP 197
++APE+ N K DV+S+G+++ E + V + ++
Sbjct: 186 PYWMAPEMI--NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-------- 235
Query: 198 HWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257
+ + + + C +P RP+ ++ LE
Sbjct: 236 VRGFLDRYCPPNC---------PPSFFPIT----VRCCDLDPEKRPSFVKLEHWLETLRM 282
Query: 258 SL--RIPPRP 265
L +P P
Sbjct: 283 HLAGHLPLGP 292
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 60/280 (21%), Positives = 103/280 (36%), Gaps = 75/280 (26%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETK-------------------------- 37
F ++G+G + VYKG VA L + K
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 38 --GFCFEGHRRA----LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLE 91
+ L+ E +++G+L+ + L+ + +K +VL I +GL+
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTY------LKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 92 YLHRGCNTRILHFDIKPHNILLD-EDFCPKISDFGLAKICHG--RESIVSMTGARGTVGY 148
+LH I+H D+K NI + KI D GLA + ++++ GT +
Sbjct: 144 FLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI------GTPEF 196
Query: 149 IAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVK----NNANVAVDRSSEIYFPHWVYKRL 204
+APE++ + E DVY++GM + EM + N A +Y+R+
Sbjct: 197 MAPEMYEEKYDE---SVDVYAFGMCMLEMATSEYPYSECQNAAQ-----------IYRRV 242
Query: 205 ELEE-DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRP 243
+ E KE CI+ N +R
Sbjct: 243 TSGVKPASFDKVAIPEVKEIIEG-------CIRQNKDERY 275
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-30
Identities = 76/296 (25%), Positives = 107/296 (36%), Gaps = 86/296 (29%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKG------------------------F 39
LGQG +G V K + LD R AIK + T+
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 40 CFEGHRRAL-----------IY---EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVG 85
+ R + ++ E+ NG+L I L + W + +I
Sbjct: 70 AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQRDEYWRLFRQIL-- 126
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS------- 138
L Y+H + I+H D+KP NI +DE KI DFGLAK H I+
Sbjct: 127 --EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 139 -----MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-----TGVKNNANVAV 188
+T A GT Y+A EV G + K D+YS G++ FEM TG N+
Sbjct: 182 GSSDNLTSAIGTAMYVATEV-LDGTGHYNEKIDMYSLGIIFFEMIYPFSTG-MERVNILK 239
Query: 189 D-RSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRP 243
RS I FP +K+I I ++P+ RP
Sbjct: 240 KLRSVSIEFPPDFDDNKMKV----------------EKKII---RLLIDHDPNKRP 276
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-29
Identities = 68/295 (23%), Positives = 111/295 (37%), Gaps = 70/295 (23%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVLNE--------TKGFCFE---------------- 42
KLG GG VY + + VAIK + K F E
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 43 --GHRRALIY---EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
Y E++ +L ++I PL + + I G+++ H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN------FTNQILDGIKHAHD-- 129
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR-GTVGYIAPEVFCR 156
RI+H DIKP NIL+D + KI DFG+AK E+ ++ T GTV Y +PE
Sbjct: 130 -MRIVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 157 NFGEVSYKSDVYSYGMMVFEM-TGVK-----NNANVAVDRSSEIYFPHWVYKRLELEEDL 210
+D+YS G++++EM G ++A+ + ++ +D+
Sbjct: 187 --EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN----VTTDVRKDI 240
Query: 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRP 265
Q + N V L + + ++R + EM + L S+ R
Sbjct: 241 P-QSLSN------------VILRATEKDKANRYK--TIQEMKD-DLSSVLHENRA 279
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 68/323 (21%), Positives = 114/323 (35%), Gaps = 73/323 (22%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVLNE--------TKGFCFE---------------- 42
LG GG V+ + L D R+VA+KVL F E
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 43 ------GHRRALIY---EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
L Y E+V +L ++ + P+ + ++ + + L +
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNFS 132
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR-GTVGYIAPE 152
H+ I+H D+KP NI++ K+ DFG+A+ + V+ T A GT Y++PE
Sbjct: 133 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 153 VFCRNFGEVSYKSDVYSYGMMVFEM-TGVK-----NNANVAVDRSSEIYFPHWVYKRLEL 206
V +SDVYS G +++E+ TG + +VA Y+ +
Sbjct: 190 QARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-------------YQH--V 232
Query: 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPF 266
ED +E ++ L + NP +R EM L + P
Sbjct: 233 REDPIPPSARHEGLSADLDAVV---LKALAKNPENRYQ--TAAEMRA-DLVRVHNGEPPE 286
Query: 267 LLSSGSQPDSSGTLVRQTEPSMA 289
+ + + L
Sbjct: 287 APKVLTDAERTSLLSSAAGNLSG 309
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 46/206 (22%), Positives = 78/206 (37%), Gaps = 57/206 (27%)
Query: 8 KLGQGGYGGVYKGK--LLDGRNVAIKVLNETK--GFC--FEGHRRAL----------IY- 50
+ GG G +Y ++GR V +K L + R+ L I+
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 51 -----------------EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
E+V SL++ +K P+ E + + I L YL
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVA-------EAI-AYLLEILPALSYL 198
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR-GTVGYIAPE 152
H +++ D+KP NI+L E+ K+ D G ++ G GT G+ APE
Sbjct: 199 HS---IGLVYNDLKPENIMLTEEQ-LKLIDLGAVS-------RINSFGYLYGTPGFQAPE 247
Query: 153 VFCRNFGEVSYKSDVYSYGMMVFEMT 178
+ R + +D+Y+ G + +T
Sbjct: 248 I-VR--TGPTVATDIYTVGRTLAALT 270
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-28
Identities = 63/314 (20%), Positives = 112/314 (35%), Gaps = 85/314 (27%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIK-------------VLNETK-----------GF--C 40
LG+GG+G V++ K +D N AIK V+ E K +
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 41 FEG----------HRRALIY---EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIA 87
+ + +Y + +L+ ++ + T ++ + V I + IA
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR---CTIEERERSVCLHIFLQIA 128
Query: 88 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI----------CHGRESIV 137
+E+LH + ++H D+KP NI D K+ DFGL +
Sbjct: 129 EAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM----TGVKNNANVAVDRSSE 193
TG GT Y++PE N S+K D++S G+++FE+ + D +
Sbjct: 186 RHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNL 243
Query: 194 IYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
+ P + K M+ + +P +RP ++E
Sbjct: 244 KFPPLFTQKYPCE------------------YVMV---QDMLSPSPMERPEAINIIEN-- 280
Query: 254 GSLDSLRIPPRPFL 267
+ L P + L
Sbjct: 281 AVFEDLDFPGKTVL 294
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 49/207 (23%), Positives = 85/207 (41%), Gaps = 51/207 (24%)
Query: 8 KLGQGGYGGVYKGK--LLDGRNVAIKVLNET----KGFC--FEGHRRAL----------- 48
+G+GG G VY+ + + + R VA+K+++ET F + R A
Sbjct: 41 LVGRGGMGDVYEAEDTVRE-RIVALKLMSETLSSDPVFRTRMQ--REARTAGRLQEPHVV 97
Query: 49 -IY-------------EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
I+ ++ L + + PL + + I I L+ H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA------IVRQIGSALDAAH 151
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR-GTVGYIAPEV 153
H D+KP NIL+ D + DFG+A + ++ G GT+ Y+APE
Sbjct: 152 A---AGATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPER 206
Query: 154 FCRNFGEVSYKSDVYSYGMMVFEM-TG 179
F +Y++D+Y+ +++E TG
Sbjct: 207 FSE--SHATYRADIYALTCVLYECLTG 231
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-28
Identities = 64/296 (21%), Positives = 106/296 (35%), Gaps = 88/296 (29%)
Query: 4 SFKNKLGQGGYGGVYKGKL-LDGRNVAIKVLNETK------------------------- 37
++G+G +G V+ G+L D VA+K ET
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 38 --GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETN-QKLKWEVLYKIAVGIARGLEYLH 94
G C + ++ E V G F L T +L+ + L ++ A G+EYL
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTF------LRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF 154
+H D+ N L+ E KISDFG+++ S + V + APE
Sbjct: 231 S---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 155 CRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214
N+G S +SDV+S+G++++E S P Y
Sbjct: 288 --NYGRYSSESDVWSFGILLWETF-------------SLGASP---Y-----------PN 318
Query: 215 IENEEDKEYARK-----------------MILVSLWCIQNNPSDRPAMNRVVEMLE 253
+ N++ +E+ K M C P RP+ + + + L+
Sbjct: 319 LSNQQTREFVEKGGRLPCPELCPDAVFRLM----EQCWAYEPGQRPSFSTIYQELQ 370
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-28
Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 40/205 (19%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG----------------------FCF 41
K+ LG G G + + D R+VA+K + FC
Sbjct: 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCT 86
Query: 42 EGHRRA--LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
E R+ + E + +L++++ +K + + GL +LH +
Sbjct: 87 EKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-----TLLQQTTSGLAHLH---SL 137
Query: 100 RILHFDIKPHNILLDE-----DFCPKISDFGLAKIC-HGRESIVSMTGARGTVGYIAPEV 153
I+H D+KPHNIL+ ISDFGL K GR S +G GT G+IAPE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 154 FCRNFGE-VSYKSDVYSYGMMVFEM 177
+ E +Y D++S G + + +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYV 222
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-27
Identities = 49/210 (23%), Positives = 93/210 (44%), Gaps = 51/210 (24%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIK--------VLNETK-----------GF--CFEGH 44
+G GG+G V+K K +DG+ IK E K + C++G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGF 76
Query: 45 RRA-----------------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIA 87
+ EF G+LE++I ++ +KL + ++ I
Sbjct: 77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR----GEKLDKVLALELFEQIT 132
Query: 88 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVG 147
+G++Y+H + ++++ D+KP NI L + KI DFGL ++ T ++GT+
Sbjct: 133 KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSKGTLR 186
Query: 148 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
Y++PE + + D+Y+ G+++ E+
Sbjct: 187 YMSPEQISSQ--DYGKEVDLYALGLILAEL 214
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 42/209 (20%), Positives = 76/209 (36%), Gaps = 48/209 (22%)
Query: 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLN-------ETKGFCFE-------GHRRALI--- 49
++G GG V++ + AIK +N + E I
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 50 YEFV------------SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
Y++ N L ++ +K + + + + +H+
Sbjct: 75 YDYEITDQYIYMVMECGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ-- 126
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF--- 154
I+H D+KP N L+ + K+ DFG+A + V GTV Y+ PE
Sbjct: 127 -HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 155 ------CRNFGEVSYKSDVYSYGMMVFEM 177
++ ++S KSDV+S G +++ M
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYM 213
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 42/209 (20%), Positives = 73/209 (34%), Gaps = 48/209 (22%)
Query: 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLN-------ETKGFCFE-------GHRRALI--- 49
++G GG V++ + AIK +N + E I
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 50 YEFV------------SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
Y++ N L ++ +K + + + + +H+
Sbjct: 94 YDYEITDQYIYMVMECGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ-- 145
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
I+H D+KP N L+ + K+ DFG+A + V GTV Y+ PE
Sbjct: 146 -HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 158 FGE---------VSYKSDVYSYGMMVFEM 177
+S KSDV+S G +++ M
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYM 232
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 53/206 (25%), Positives = 81/206 (39%), Gaps = 43/206 (20%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN-----VAIKVLNETK--------------------- 37
LG G +G VYKG + VAIK L E
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 38 ------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLE 91
G C LI + + G L ++ E + + L V IA+G+
Sbjct: 78 HVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMN 131
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAP 151
YL R++H D+ N+L+ KI+DFGLAK+ E G + + ++A
Sbjct: 132 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEM 177
E +++SDV+SYG+ V+E+
Sbjct: 189 ESI--LHRIYTHQSDVWSYGVTVWEL 212
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 52/218 (23%), Positives = 84/218 (38%), Gaps = 49/218 (22%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG----------------------FCFE 42
+ LG G G V GR VA+K + +C E
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE 78
Query: 43 GHRRA--LIYEFVSNGSLEKFIYEKHPLETNQKLKWEV-LYKIAVGIARGLEYLHRGCNT 99
R + E N +L+ + K+ + N KL+ E + IA G+ +LH +
Sbjct: 79 TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SL 134
Query: 100 RILHFDIKPHNILLD-------------EDFCPKISDFGLAKICHGRES--IVSMTGARG 144
+I+H D+KP NIL+ E+ ISDFGL K +S ++ G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 145 TVGYIAPEVFCRNFGEV-----SYKSDVYSYGMMVFEM 177
T G+ APE+ + + D++S G + + +
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-26
Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 45/203 (22%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIK---------------VLNET--------------K 37
K+G+G + VY+ LLDG VA+K + E
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
E + ++ E G L + I KH + + + ++K V + LE++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTVWKYFVQLCSALEHMH--- 153
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVG---YIAPEVF 154
+ R++H DIKP N+ + K+ D GL + T A VG Y++PE
Sbjct: 154 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-----KTTAAHSLVGTPYYMSPER- 207
Query: 155 CRNFGEVSYKSDVYSYGMMVFEM 177
G ++KSD++S G +++EM
Sbjct: 208 IHENG-YNFKSDIWSLGCLLYEM 229
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 52/203 (25%), Positives = 78/203 (38%), Gaps = 42/203 (20%)
Query: 6 KNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK---------------------GFCFEG 43
+ ++G+G +G V++ K G A+K + G EG
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREG 122
Query: 44 HRRALIYEFVSNGSLEKFIYEKHPLETNQKLKW--EVLYKIAVGIARGLEYLHRGCNTRI 101
+ E + GSL + I + L ++ L + + L GLEYLH RI
Sbjct: 123 PWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL--------EGLEYLH---TRRI 171
Query: 102 LHFDIKPHNILLDEDFCP-KISDFGLAKICHGRESIVSMTGA---RGTVGYIAPEVFCRN 157
LH D+K N+LL D + DFG A S+ GT ++APEV
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV-VMG 230
Query: 158 FGEVSYKSDVYSYGMMVFEM-TG 179
K D++S M+ M G
Sbjct: 231 KP-CDAKVDIWSSCCMMLHMLNG 252
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 41/209 (19%), Positives = 75/209 (35%), Gaps = 48/209 (22%)
Query: 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLN-------ETKGFCFE-------GHRRALI--- 49
++G GG V++ + AIK +N + E I
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 50 YEFV------------SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
Y++ N L ++ +K + + + + +H+
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ-- 173
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF--- 154
I+H D+KP N L+ + K+ DFG+A + V G V Y+ PE
Sbjct: 174 -HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 155 ------CRNFGEVSYKSDVYSYGMMVFEM 177
++ ++S KSDV+S G +++ M
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYM 260
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 36/199 (18%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------G 38
+ +LG G +G V GK +VA+K++ E G
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
C + + ++ E++SNG L ++ L+ L ++ + G+ +L
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFLES--- 122
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
+ +H D+ N L+D D C K+SDFG+ + + + S G + V + APEVF ++
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS-VGTKFPVKWSAPEVF--HY 179
Query: 159 GEVSYKSDVYSYGMMVFEM 177
+ S KSDV+++G++++E+
Sbjct: 180 FKYSSKSDVWAFGILMWEV 198
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 43/203 (21%), Positives = 81/203 (39%), Gaps = 35/203 (17%)
Query: 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHN 110
+ +L+ ++ + LE + V I + IA +E+LH + ++H D+KP N
Sbjct: 141 QLCRKENLKDWMNRRCSLED---REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSN 194
Query: 111 ILLDEDFCPKISDFGLAKI----------CHGRESIVSMTGARGTVGYIAPEVFCRNFGE 160
I D K+ DFGL + + TG GT Y++PE N
Sbjct: 195 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN--N 252
Query: 161 VSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEED 220
S+K D++S G+++FE+ + V +++ + L+ +
Sbjct: 253 YSHKVDIFSLGLILFELLYSFSTQMERVRIITDV-------RNLKFPLLF-------TQK 298
Query: 221 KEYARKMILVSLWCIQNNPSDRP 243
M+ + +P++RP
Sbjct: 299 YPQEHMMV---QDMLSPSPTERP 318
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 52/197 (26%), Positives = 85/197 (43%), Gaps = 34/197 (17%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNET----KGFCFEG-------HRRA------ 47
+ KLG G +G V+ VA+K + + F E H +
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 48 -------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
+I EF++ GSL F+ K L + IA G+ ++ +
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQ---RN 304
Query: 101 ILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGE 160
+H D++ NIL+ KI+DFGLA++ E GA+ + + APE NFG
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR-EGAKFPIKWTAPEAI--NFGS 361
Query: 161 VSYKSDVYSYGMMVFEM 177
+ KSDV+S+G+++ E+
Sbjct: 362 FTIKSDVWSFGILLMEI 378
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-25
Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 36/199 (18%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------G 38
+F ++G G +G V+ G L+ VAIK + E G
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
C E L+ EF+ +G L ++ + E L + + + G+ YL
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEE--- 122
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
++H D+ N L+ E+ K+SDFG+ + + S TG + V + +PEVF +F
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPEVF--SF 179
Query: 159 GEVSYKSDVYSYGMMVFEM 177
S KSDV+S+G++++E+
Sbjct: 180 SRYSSKSDVWSFGVLMWEV 198
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 36/199 (18%)
Query: 5 FKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------G 38
K+KLG G YG VY+G VA+K L E G
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
C +I EF++ G+L ++ E + Q++ VL +A I+ +EYL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEK--- 336
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
+H ++ N L+ E+ K++DFGL+++ G GA+ + + APE +
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESL--AY 393
Query: 159 GEVSYKSDVYSYGMMVFEM 177
+ S KSDV+++G++++E+
Sbjct: 394 NKFSIKSDVWAFGVLLWEI 412
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 46/214 (21%), Positives = 71/214 (33%), Gaps = 49/214 (22%)
Query: 4 SFKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGF----------------------- 39
+ LGQG V++G+ G AIKV N
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 40 ---CFEGHRRALIY---EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
E EF GSL + E L + + G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP---SNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 94 HRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYI 149
I+H +IKP NI+ D K++DFG A+ E VS+ GT Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYL 182
Query: 150 APEVFCRNFGEVSY------KSDVYSYGMMVFEM 177
P+++ R + D++S G+ +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 45/201 (22%), Positives = 73/201 (36%), Gaps = 47/201 (23%)
Query: 8 KLGQGGYGGVYKG-KLLDGRNVAIKVLNETKGFCFEGHRRALIYE--------------- 51
+LG G YG V+K DGR A+K F R + E
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSM--SPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121
Query: 52 ----FVSNGSLEKFIY--------EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
+ G L ++ ++H L ++ L +LH +
Sbjct: 122 LEQAWEEGGIL--YLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQ 176
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR---GTVGYIAPEVFCR 156
++H D+KP NI L K+ DFGL + + G Y+APE+
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVE------LGTAGAGEVQEGDPRYMAPELLQG 230
Query: 157 NFGEVSYKSDVYSYGMMVFEM 177
++G +DV+S G+ + E+
Sbjct: 231 SYG---TAADVFSLGLTILEV 248
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 58/295 (19%), Positives = 101/295 (34%), Gaps = 77/295 (26%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIK------------VLNETK---------------GF 39
KLG+GG+ V + L DG A+K E
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 40 CFEGHRRALIY---EFVSNGSLEKFIYEKHPLETNQKLK-WEVLYKIAVGIARGLEYLHR 95
E + + F G+L I + + L ++L + +GI RGLE +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEI--ERLKDKGNFLTEDQIL-WLLLGICRGLEAIHA 152
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGA-------RGTVGY 148
H D+KP NILL ++ P + D G R T+ Y
Sbjct: 153 ---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 149 IAPEVF-CRNFGEVSYKSDVYS-----YGMMV----FEMTGVKNNANVAVDRSSEIYFPH 198
APE+F ++ + ++DV+S Y MM ++M K ++ +++ P
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA-VQNQLSIP- 267
Query: 199 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
+ ++ + + + +P RP + ++ LE
Sbjct: 268 --------------------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 5e-25
Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 34/198 (17%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNET----KGFCFEG-------HRRAL---- 48
+LG G +G V+ G VA+K L + F E H+R +
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 49 ------IY---EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
IY E++ NGSL F+ KL L +A IA G+ ++
Sbjct: 76 VVTQEPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE---R 128
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFG 159
+H D++ NIL+ + KI+DFGLA++ E GA+ + + APE N+G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAI--NYG 185
Query: 160 EVSYKSDVYSYGMMVFEM 177
+ KSDV+S+G+++ E+
Sbjct: 186 TFTIKSDVWSFGILLTEI 203
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 37/216 (17%), Positives = 66/216 (30%), Gaps = 49/216 (22%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRN------VAIKVLNETKGFCFEGHRRA----------- 47
+ LG+G + VY+ D + +KV + F +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 48 ---------------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEY 92
L+ E S G+L I + + + ++ A+ + +E
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAI-NLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCP-----------KISDFGLAKICHGRESIVSMTG 141
+H I+H DIKP N +L F + D G + T
Sbjct: 188 VHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
Query: 142 ARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
T G+ E+ +Y+ D + V+ M
Sbjct: 245 KCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCM 278
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 6e-25
Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 36/199 (18%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------G 38
+F +LG G +G V GK +VAIK++ E G
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
C + +I E+++NG L ++ E + + + L ++ + +EYL
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLES--- 138
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
+ LH D+ N L+++ K+SDFGL++ E S G++ V + PEV +
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVL--MY 195
Query: 159 GEVSYKSDVYSYGMMVFEM 177
+ S KSD++++G++++E+
Sbjct: 196 SKFSSKSDIWAFGVLMWEI 214
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-25
Identities = 69/301 (22%), Positives = 109/301 (36%), Gaps = 67/301 (22%)
Query: 5 FKNKLGQGGYGGVYKGKLLD-----GRNVAIKVLNET----------------------- 36
LG+G +G V G VA+K L
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 37 ----KGFCFEGHRRA--LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGL 90
KG C + + L+ E+V GSL ++ +H + Q L A I G+
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQ------LLLFAQQICEGM 147
Query: 91 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICHGRESIVSMTGARGTVGYI 149
YLH +H D+ N+LLD D KI DFGLAK + G E V +
Sbjct: 148 AYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204
Query: 150 APEVFCRNFGEVSYKSDVYSYGMMVFE-MTGVKNNANVAVDRSSEIYFPHWVYKRLELEE 208
APE C + Y SDV+S+G+ ++E +T ++ + I L L
Sbjct: 205 APE--CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL-- 260
Query: 209 DLGLQGIENEE---------DKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSL 259
+ +E E + Y ++ + W + S RP ++ +L+ +
Sbjct: 261 ---TELLERGERLPRPDKCPAEVY---HLMKNCW--ETEASFRPTFENLIPILKTVHEKY 312
Query: 260 R 260
+
Sbjct: 313 Q 313
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 6e-25
Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 34/197 (17%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNET----KGFCFEG-------HRRA------ 47
+ KLGQG +G V+ G VAIK L + F E H +
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 48 -------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
++ E++S GSL F+ + + L+ L +A IA G+ Y+ R
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MN 383
Query: 101 ILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGE 160
+H D++ NIL+ E+ K++DFGLA++ E GA+ + + APE +G
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAA--LYGR 440
Query: 161 VSYKSDVYSYGMMVFEM 177
+ KSDV+S+G+++ E+
Sbjct: 441 FTIKSDVWSFGILLTEL 457
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-25
Identities = 53/206 (25%), Positives = 82/206 (39%), Gaps = 43/206 (20%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN-----VAIKVLNETK--------------------- 37
LG G +G VYKG + VAIK L E
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 38 ------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLE 91
G C LI + + G L ++ E + + L V IA+G+
Sbjct: 78 HVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMN 131
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAP 151
YL + R++H D+ N+L+ KI+DFGLAK+ E G + + ++A
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEM 177
E +++SDV+SYG+ V+E+
Sbjct: 189 ESI--LHRIYTHQSDVWSYGVTVWEL 212
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-25
Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 41/204 (20%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRN-----VAIKVLNETKG------FCFEG-------HRR 46
LG G +G V+KG + V IKV+ + G H
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 47 A-------------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
L+ +++ GSL + + L ++L V IA+G+ YL
Sbjct: 77 IVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRG-----ALGPQLLLNWGVQIAKGMYYL 131
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEV 153
++H ++ N+LL +++DFG+A + + + + A+ + ++A E
Sbjct: 132 EE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 154 FCRNFGEVSYKSDVYSYGMMVFEM 177
+FG+ +++SDV+SYG+ V+E+
Sbjct: 189 I--HFGKYTHQSDVWSYGVTVWEL 210
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-25
Identities = 59/202 (29%), Positives = 86/202 (42%), Gaps = 41/202 (20%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------GFCF 41
LG+G YG VY G+ L +AIK + E G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 42 EGHRRALIYEFVSNGSLEKFIYEKH-PLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
E + E V GSL + K PL+ N+ + + I GL+YLH + +
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE----QTIGFYTKQILEGLKYLH---DNQ 142
Query: 101 ILHFDIKPHNILLD-EDFCPKISDFGLAKICHGRESIV-SMTGARGTVGYIAPEVFCRNF 158
I+H DIK N+L++ KISDFG +K G + TG T+ Y+APE+ +
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTG---TLQYMAPEIIDKGP 199
Query: 159 GEVSYKSDVYSYGMMVFEM-TG 179
+D++S G + EM TG
Sbjct: 200 RGYGKAADIWSLGCTIIEMATG 221
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 34/197 (17%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNET----KGFCFEG-------HRRA------ 47
+ KLGQG +G V+ G VAIK L + F E H +
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 48 -------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
++ E++S GSL F+ + + L+ L +A IA G+ Y+ R
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MN 300
Query: 101 ILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGE 160
+H D++ NIL+ E+ K++DFGLA++ E GA+ + + APE +G
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAA--LYGR 357
Query: 161 VSYKSDVYSYGMMVFEM 177
+ KSDV+S+G+++ E+
Sbjct: 358 FTIKSDVWSFGILLTEL 374
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-24
Identities = 50/223 (22%), Positives = 75/223 (33%), Gaps = 61/223 (27%)
Query: 8 KLGQGGYGGVYKG-KLLDGRNVAIK--------------VLNET---------------K 37
K+G G +G V+K K LDG AIK L E
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
E + E+ + GSL I E + K L + + + RGL Y+H
Sbjct: 78 SAWAEDDHMLIQNEYCNGGSLADAISENY--RIMSYFKEAELKDLLLQVGRGLRYIH--- 132
Query: 98 NTRILHFDIKPHNILLDEDFCP-------------------KISDFGLAKICHGRESIVS 138
+ ++H DIKP NI + P KI D G +
Sbjct: 133 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE- 191
Query: 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVK 181
G ++A EV N+ K+D+++ + V G +
Sbjct: 192 -----GDSRFLANEVLQENYTH-LPKADIFALALTVVCAAGAE 228
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 46/198 (23%), Positives = 82/198 (41%), Gaps = 40/198 (20%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------GFC 40
+G+G +G V G G VA+K + G
Sbjct: 197 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 41 FEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
E ++ E+++ GSL ++ + L + L K ++ + +EYL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG---N 308
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFG 159
+H D+ N+L+ ED K+SDFGL +E+ + + V + APE
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEAL--REK 361
Query: 160 EVSYKSDVYSYGMMVFEM 177
+ S KSDV+S+G++++E+
Sbjct: 362 KFSTKSDVWSFGILLWEI 379
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-24
Identities = 47/199 (23%), Positives = 81/199 (40%), Gaps = 40/199 (20%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------GF 39
+G+G +G V G G VA+K + G
Sbjct: 24 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 40 CFEGHRRALI-YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
E I E+++ GSL ++ + L + L K ++ + +EYL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG--- 135
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
+H D+ N+L+ ED K+SDFGL +E+ + + V + APE
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEAL--RE 188
Query: 159 GEVSYKSDVYSYGMMVFEM 177
+ S KSDV+S+G++++E+
Sbjct: 189 KKFSTKSDVWSFGILLWEI 207
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-24
Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 36/200 (18%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGR-NVAIKVLNETK------------------------- 37
+ K+KLG G YG VY+G VA+K L E
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
G C +I EF++ G+L ++ E + Q++ VL +A I+ +EYL +
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEK-- 129
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
+H D+ N L+ E+ K++DFGL+++ G GA+ + + APE
Sbjct: 130 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESL--A 185
Query: 158 FGEVSYKSDVYSYGMMVFEM 177
+ + S KSDV+++G++++E+
Sbjct: 186 YNKFSIKSDVWAFGVLLWEI 205
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-24
Identities = 67/302 (22%), Positives = 117/302 (38%), Gaps = 67/302 (22%)
Query: 5 FKNKLGQGGYGGVYKGKLL-----DGRNVAIKVLNET----------------------- 36
F +LG+G +G V + G VA+K L +
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 37 ---KGFCFEGHRRA--LIYEFVSNGSLEKFIYEKHPLETNQ-KLKWEVLYKIAVGIARGL 90
KG C+ RR LI E++ GSL + L+ ++ ++ L + I +G+
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDY------LQKHKERIDHIKLLQYTSQICKGM 127
Query: 91 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICHGRESIVSMTGARGTVGYI 149
EYL R +H D+ NIL++ + KI DFGL K + +E + +
Sbjct: 128 EYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 150 APEVFCRNFGEVSYKSDVYSYGMMVFEMT--GVKNNANVAVDRSSEIYFPHWVYKRLELE 207
APE + S SDV+S+G++++E+ K+ + A L
Sbjct: 185 APE--SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL- 241
Query: 208 EDLGLQGIENEE---------DKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258
++ ++N D+ Y MI+ W NN + RP+ + ++ D+
Sbjct: 242 ----IELLKNNGRLPRPDGCPDEIY---MIMTECW--NNNVNQRPSFRDLALRVDQIRDN 292
Query: 259 LR 260
+
Sbjct: 293 MA 294
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-24
Identities = 50/206 (24%), Positives = 82/206 (39%), Gaps = 44/206 (21%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRN----VAIKVLNETK----------------------- 37
+ +G G G V G+L VAIK L
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 38 ----GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQ-KLKWEVLYKIAVGIARGLEY 92
G G ++ E++ NGSL+ F L T+ + L + G+ G+ Y
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTF------LRTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMT-GARGTVGYIAP 151
L +H D+ N+L+D + K+SDFGL+++ T G + + + AP
Sbjct: 167 LSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEM 177
E F S SDV+S+G++++E+
Sbjct: 224 EAI--AFRTFSSASDVWSFGVVMWEV 247
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-24
Identities = 57/300 (19%), Positives = 106/300 (35%), Gaps = 78/300 (26%)
Query: 5 FKNKLGQGGYGGVYKGKLL-----DGRNVAIKVLNET----------------------- 36
+ ++LG+G +G V + G VA+K L +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 37 ---KGFCFEGHRRA--LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLE 91
+G + R++ L+ E++ +G L F+ +L L + I +G+E
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGME 141
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI-VSMTGARGTVGYIA 150
YL R +H D+ NIL++ + KI+DFGLAK+ + V + + + A
Sbjct: 142 YLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVFEMT--GVKNNANVAVDRSSEIYFPHWVYKRLELEE 208
PE + S +SDV+S+G++++E+ K
Sbjct: 199 PE--SLSDNIFSRQSDVWSFGVVLYELFTYCDK---------------SCSPSAEFLRMM 241
Query: 209 DLGLQGIENEEDKEYARK---------------MILVSLWCIQNNPSDRPAMNRVVEMLE 253
E + ++ W +P DRP+ + + L+
Sbjct: 242 GCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCW--APSPQDRPSFSALGPQLD 299
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-24
Identities = 65/295 (22%), Positives = 110/295 (37%), Gaps = 67/295 (22%)
Query: 5 FKNKLGQGGYGGVYKGKLL-----DGRNVAIKVLNET----------------------- 36
LG+G +G V + G VA+K L
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 37 ----KGFCFEGHRRA--LIYEFVSNGSLEKFIYEKHPLETN-QKLKWEVLYKIAVGIARG 89
KG C E LI EF+ +GSL+++ L N K+ + K AV I +G
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEY------LPKNKNKINLKQQLKYAVQICKG 138
Query: 90 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI-VSMTGARGTVGY 148
++YL + +H D+ N+L++ + KI DFGL K + V +
Sbjct: 139 MDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 149 IAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207
APE C + SDV+S+G+ + E +T ++++ I H L
Sbjct: 196 YAPE--CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL- 252
Query: 208 EDLGLQGIENEE---------DKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
+ ++ + D+ Y ++ W + PS+R + ++E E
Sbjct: 253 ----VNTLKEGKRLPCPPNCPDEVY---QLMRKCW--EFQPSNRTSFQNLIEGFE 298
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-24
Identities = 66/301 (21%), Positives = 114/301 (37%), Gaps = 65/301 (21%)
Query: 5 FKNKLGQGGYGGVYKGKLL-----DGRNVAIKVLNET----------------------- 36
F +LG+G +G V + G VA+K L +
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 37 ---KGFCFEGHRRA--LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLE 91
KG C+ RR LI E++ GSL ++ + ++ L + I +G+E
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGME 159
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICHGRESIVSMTGARGTVGYIA 150
YL R +H D+ NIL++ + KI DFGL K + +E + + A
Sbjct: 160 YLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 216
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVFEMT--GVKNNANVAVDRSSEIYFPHWVYKRLELEE 208
PE + S SDV+S+G++++E+ K+ + A L
Sbjct: 217 PE--SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL-- 272
Query: 209 DLGLQGIENEE---------DKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSL 259
++ ++N D+ Y MI+ W NN + RP+ + ++ D +
Sbjct: 273 ---IELLKNNGRLPRPDGCPDEIY---MIMTECW--NNNVNQRPSFRDLALRVDQIRDQM 324
Query: 260 R 260
Sbjct: 325 A 325
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-24
Identities = 64/334 (19%), Positives = 107/334 (32%), Gaps = 98/334 (29%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN----VAIKVLNET-----------------KGF--- 39
+ LG+G +G V + +L VA+K+L K F
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85
Query: 40 --------CFEGHRRA------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVG 85
+ +I F+ +G L F+ E L + L + V
Sbjct: 86 HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT 145
IA G+EYL + +H D+ N +L ED ++DFGL++ + + ++
Sbjct: 146 IACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 146 VGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGVKNNANVAVDRSSEIYFPHWVYKRL 204
V ++A E + SDV+++G+ ++E MT
Sbjct: 203 VKWLALESL--ADNLYTVHSDVWAFGVTMWEIMT-------------------------- 234
Query: 205 ELEEDLGLQ---GIENEEDKEYARK---------------MILVSLWCIQNNPSDRPAMN 246
G GIEN E Y ++ W +P RP+
Sbjct: 235 -----RGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCW--SADPKQRPSFT 287
Query: 247 RVVEMLE---GSLDSLRIPPRPFLLSSGSQPDSS 277
+ LE G L L P ++
Sbjct: 288 CLRMELENILGHLSVLSTSQDPLYINIERAHHHH 321
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-24
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 43/206 (20%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRN-----VAIKVLNETK---------------------- 37
+ +G G +G VYKG L VAIK L
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 38 -----GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEY 92
G + +I E++ NG+L+KF+ EK + L + GIA G++Y
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKY 162
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR-ESIVSMTGARGTVGYIAP 151
L +H D+ NIL++ + K+SDFGL+++ E+ + +G + + + AP
Sbjct: 163 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEM 177
E ++ + + SDV+S+G++++E+
Sbjct: 220 EAI--SYRKFTSASDVWSFGIVMWEV 243
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-24
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 52/205 (25%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIK--------------VLNETKGF------------- 39
K+G+G +G K DGR IK E
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 40 CFEGHRRALIY-EFVSNGSLEKFI--YEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
FE + I ++ G L K I + + +Q L W V I L+++H
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLALKHVHD- 143
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE----SIVSMTGARGTVGYIAPE 152
+ILH DIK NI L +D ++ DFG+A++ + + + GT Y++PE
Sbjct: 144 --RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI------GTPYYLSPE 195
Query: 153 VFCRNFGEVSYKSDVYSYGMMVFEM 177
+ C N + KSD+++ G +++E+
Sbjct: 196 I-CENKP-YNNKSDIWALGCVLYEL 218
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 5e-24
Identities = 48/217 (22%), Positives = 73/217 (33%), Gaps = 50/217 (23%)
Query: 4 SFKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGF----------------------- 39
+ LGQG V++G+ G AIKV N
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 40 ---CFEGHRRALIY---EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
E EF GSL + E L + + G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP---SNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 94 HRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYI 149
I+H +IKP NI+ D K++DFG A+ E VS+ GT Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEYL 182
Query: 150 APEVFCRNFGEVSY------KSDVYSYGMMVFEM-TG 179
P+++ R + D++S G+ + TG
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-24
Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 42/203 (20%)
Query: 6 KNKLGQGGYGGVYKGKLLDGRN---VAIKVLNETK------------------------- 37
+LG G +G V +G + VAIKVL +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 38 --GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
G C + L+ E G L KF+ K +++ + ++ ++ G++YL
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEE 128
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI-VSMTGARGTVGYIAPEVF 154
+H D+ N+LL KISDFGL+K +S + + + + + APE
Sbjct: 129 ---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 155 CRNFGEVSYKSDVYSYGMMVFEM 177
NF + S +SDV+SYG+ ++E
Sbjct: 186 --NFRKFSSRSDVWSYGVTMWEA 206
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-23
Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 43/204 (21%)
Query: 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETKGFCFEGHRRALIYE-------------- 51
+LG+G YG V K + + G+ +A+K + T ++ L+ +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN---SQEQKRLLMDLDISMRTVDCPFTV 69
Query: 52 -----FVSN-----------GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
SL+KF K ++ Q + ++L KIAV I + LE+LH
Sbjct: 70 TFYGALFREGDVWICMELMDTSLDKFY--KQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
++H D+KP N+L++ K+ DFG++ + + A G Y+APE
Sbjct: 128 --KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDA-GCKPYMAPERIN 182
Query: 156 RNFGEVSY--KSDVYSYGMMVFEM 177
+ Y KSD++S G+ + E+
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIEL 206
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-23
Identities = 48/205 (23%), Positives = 79/205 (38%), Gaps = 43/205 (20%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIK--------------VLNETK-----------GF-- 39
+G G YG K + DG+ + K +++E +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 40 CFEGHRRALIY---EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-- 94
+Y E+ G L I + Q L E + ++ + L+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF 154
+LH D+KP N+ LD K+ DFGLA+I + S GT Y++PE
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQ- 187
Query: 155 CRNFGEVSY--KSDVYSYGMMVFEM 177
+SY KSD++S G +++E+
Sbjct: 188 MNR---MSYNEKSDIWSLGCLLYEL 209
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-23
Identities = 44/205 (21%), Positives = 77/205 (37%), Gaps = 43/205 (20%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN----VAIKVLNETK---------------------- 37
+G+G +G V++G + N VAIK
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 77
Query: 38 -----GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEY 92
G + +I E + G L F+ + L L A ++ L Y
Sbjct: 78 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAY 131
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPE 152
L R +H DI N+L+ + C K+ DFGL++ + + + + ++APE
Sbjct: 132 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 187
Query: 153 VFCRNFGEVSYKSDVYSYGMMVFEM 177
NF + SDV+ +G+ ++E+
Sbjct: 188 SI--NFRRFTSASDVWMFGVCMWEI 210
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-23
Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 42/201 (20%)
Query: 8 KLGQGGYGGVYKGKLLDGR---NVAIKVL-------NETKGFCFEG-------HRRA--- 47
+LG G +G V KG + VA+K+L E +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 48 ----------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
L+ E G L K+ L+ N+ +K + + ++ ++ G++YL
Sbjct: 84 IGICEAESWMLVMEMAELGPLNKY------LQQNRHVKDKNIIELVHQVSMGMKYLEE-- 135
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI-VSMTGARGTVGYIAPEVFCR 156
+ +H D+ N+LL KISDFGL+K E+ + T + V + APE
Sbjct: 136 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI-- 192
Query: 157 NFGEVSYKSDVYSYGMMVFEM 177
N+ + S KSDV+S+G++++E
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEA 213
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-23
Identities = 67/312 (21%), Positives = 108/312 (34%), Gaps = 94/312 (30%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN----VAIKVLNETK---------------------- 37
LG+G +G V +G L VA+K +
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 38 ------GFCFEGHRRA-----LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGI 86
G C E + +I F+ G L ++ + + + L K V I
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 87 ARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTV 146
A G+EYL N LH D+ N +L +D ++DFGL+K + + A+ V
Sbjct: 157 ALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 147 GYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGVKNNANVAVDRSSEIYFPHWVYKRLE 205
+IA E + KSDV+++G+ ++E T
Sbjct: 214 KWIAIESL--ADRVYTSKSDVWAFGVTMWEIAT--------------------------- 244
Query: 206 LEEDLGLQ---GIENEEDKEYARK---------------MILVSLWCIQNNPSDRPAMNR 247
G+ G++N E +Y I+ S W + +P DRP +
Sbjct: 245 ----RGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCW--RTDPLDRPTFSV 298
Query: 248 VVEMLEGSLDSL 259
+ LE L+SL
Sbjct: 299 LRLQLEKLLESL 310
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-23
Identities = 52/206 (25%), Positives = 82/206 (39%), Gaps = 57/206 (27%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVLNETKGF---------------------------- 39
LG+GG+ ++ D A K++ ++
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 40 CFEGHRRALIY---EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
FE + ++ E SL + + L + E Y + I G +YLHR
Sbjct: 109 FFEDNDF--VFVVLELCRRRSLLELHKRRKALT-----EPEARYYL-RQIVLGCQYLHR- 159
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR-----GTVGYIAP 151
R++H D+K N+ L+ED KI DFGLA + V G R GT YIAP
Sbjct: 160 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKVLCGTPNYIAP 210
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEM 177
EV + S++ DV+S G +++ +
Sbjct: 211 EVLSKK--GHSFEVDVWSIGCIMYTL 234
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 4e-23
Identities = 54/206 (26%), Positives = 83/206 (40%), Gaps = 57/206 (27%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------GF-- 39
LG+GG+ ++ D A K++ ++ GF
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 40 CFEGHRRALIY---EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
FE + ++ E SL + + L E Y + I G +YLHR
Sbjct: 83 FFEDNDF--VFVVLELCRRRSLLELHKRRKALTEP-----EARYYL-RQIVLGCQYLHR- 133
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR-----GTVGYIAP 151
R++H D+K N+ L+ED KI DFGLA + V G R GT YIAP
Sbjct: 134 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKVLCGTPNYIAP 184
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEM 177
EV + S++ DV+S G +++ +
Sbjct: 185 EVLSKK--GHSFEVDVWSIGCIMYTL 208
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 5e-23
Identities = 53/211 (25%), Positives = 76/211 (36%), Gaps = 50/211 (23%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLN----------------------------- 34
K +LG GG+G V + G VAIK
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 35 ----ETKGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGL 90
+ L E+ G L K++ + E LK + + I+ L
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF---ENCCGLKEGPIRTLLSDISSAL 134
Query: 91 EYLHRGCNTRILHFDIKPHNILLD---EDFCPKISDFGLAKICHGRESIVSMTGARGTVG 147
YLH RI+H D+KP NI+L + KI D G AK E T GT+
Sbjct: 135 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQ 188
Query: 148 YIAPEVF-CRNFGEVSYKSDVYSYGMMVFEM 177
Y+APE+ + + D +S+G + FE
Sbjct: 189 YLAPELLEQKKYTV---TVDYWSFGTLAFEC 216
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-23
Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 44/207 (21%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRN----VAIKVLNET----------------KGF----- 39
+G+G +G VY G+ +D AIK L+ +G
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 40 ------CFEGHRRAL-IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEY 92
+ ++ +G L +FI + L + +ARG+EY
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR-----NPTVKDLISFGLQVARGMEY 139
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE--SIVSMTGARGTVGYIA 150
L + +H D+ N +LDE F K++DFGLA+ RE S+ AR V + A
Sbjct: 140 LAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVFEM 177
E + KSDV+S+G++++E+
Sbjct: 197 LESL--QTYRFTTKSDVWSFGVLLWEL 221
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-23
Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 42/206 (20%)
Query: 4 SFKNKLGQGGYGGVYKGKL-LDGRN---VAIKVLNETK---------------------- 37
S +G G +G V G+L L + VAIK L
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 38 -----GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEY 92
G + ++ E++ NGSL+ F+ + + L + GIA G++Y
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-----QFTVIQLVGMLRGIASGMKY 162
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR-ESIVSMTGARGTVGYIAP 151
L +H D+ NIL++ + K+SDFGL ++ E+ + G + + + +P
Sbjct: 163 LSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEM 177
E + + + SDV+SYG++++E+
Sbjct: 220 EAI--AYRKFTSASDVWSYGIVLWEV 243
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 7e-23
Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 44/204 (21%)
Query: 8 KLGQGGYGGVYKGKLL-DGRNVAIKVLNETKGFCFEGHRRALIYE--------------- 51
++G+G YG V K G+ +A+K + T E ++ L+ +
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMRSSDCPYIVQ 85
Query: 52 ----FVSN-----------GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
S +K Y+ + + E+L KI + + L +L
Sbjct: 86 FYGALFREGDCWICMELMSTSFDK-FYKYVYSVLDDVIPEEILGKITLATVKALNHLKE- 143
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR-ESIVSMTGARGTVGYIAPEVFC 155
N +I+H DIKP NILLD K+ DFG++ G+ ++ T G Y+APE
Sbjct: 144 -NLKIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAKTRDAGCRPYMAPERID 198
Query: 156 RNFGEVSY--KSDVYSYGMMVFEM 177
+ Y +SDV+S G+ ++E+
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYEL 222
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 9e-23
Identities = 63/329 (19%), Positives = 113/329 (34%), Gaps = 94/329 (28%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRN------VAIKVLNET----------------KGF--- 39
+LGQG +G VY+G VAIK +NE K F
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 40 --------CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQK----LKWEVLYKIAVGIA 87
+G +I E ++ G L+ ++ P N + ++A IA
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 88 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVG 147
G+ YL+ + +H D+ N ++ EDF KI DFG+ + + + V
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 148 YIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206
+++PE G + SDV+S+G++++E T
Sbjct: 206 WMSPESL--KDGVFTTYSDVWSFGVVLWEIAT---------------------------- 235
Query: 207 EEDLGLQ---GIENEEDKEYARK---------------MILVSLWCIQNNPSDRPAMNRV 248
L Q G+ NE+ + + ++ W Q NP RP+ +
Sbjct: 236 ---LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCW--QYNPKMRPSFLEI 290
Query: 249 VEMLEGSLDSLRIPPRPFLLSSGSQPDSS 277
+ ++ ++ + P+
Sbjct: 291 ISSIKEEMEPGFREVSFYYSEENKLPEPE 319
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-22
Identities = 46/215 (21%), Positives = 83/215 (38%), Gaps = 52/215 (24%)
Query: 8 KLGQGGYGGVYKGKLLDGRNVAIKVLN-----ETKGFCFEGHRRA--------------- 47
L QG + + + D + A+K + + F + +
Sbjct: 38 TLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 48 -----------------------LIYEFVSNGSLEKFIYEKHPLE--TNQKLKWEVLYKI 82
+IYE++ N S+ KF L+ + +V+ I
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 83 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGA 142
+ Y+H N I H D+KP NIL+D++ K+SDFG ++ ++ + G+
Sbjct: 157 IKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGS 210
Query: 143 RGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
RGT ++ PE F K D++S G+ ++ M
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM 245
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 96.2 bits (239), Expect = 2e-22
Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 42/203 (20%)
Query: 6 KNKLGQGGYGGVYKGKLLDGRN---VAIKVLNETK------------------------- 37
+LG G +G V +G + VAIKVL +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 38 --GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
G C + L+ E G L KF+ + +++ + ++ ++ G++YL
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFL-----VGKREEIPVSNVAELLHQVSMGMKYLEE 454
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI-VSMTGARGTVGYIAPEVF 154
+H ++ N+LL KISDFGL+K +S + + + + + APE
Sbjct: 455 ---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 155 CRNFGEVSYKSDVYSYGMMVFEM 177
NF + S +SDV+SYG+ ++E
Sbjct: 512 --NFRKFSSRSDVWSYGVTMWEA 532
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-22
Identities = 65/311 (20%), Positives = 111/311 (35%), Gaps = 100/311 (32%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN----VAIKVLNET----------------KGF---- 39
F +G+G +G VY G LLD A+K LN K F
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 40 -------CFEGHRRAL-IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLE 91
C L + ++ +G L FI + + L + +A+G++
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMK 142
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE--SIVSMTGARGTVGYI 149
YL + + +H D+ N +LDE F K++DFGLA+ + +E S+ + TGA+ V ++
Sbjct: 143 YLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199
Query: 150 APEVFCRNFGEVSYKSDVYSYGMMVFE-MTGVKNNANVAVDRSSEIYFPHWVYKRLELEE 208
A E + + KSDV+S+G++++E MT
Sbjct: 200 ALESL--QTQKFTTKSDVWSFGVLLWELMT------------------------------ 227
Query: 209 DLGLQ---GIENEEDKEYARK-----------------MILVSLWCIQNNPSDRPAMNRV 248
G + + Y + M L C RP+ + +
Sbjct: 228 -RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVM----LKCWHPKAEMRPSFSEL 282
Query: 249 VEMLEGSLDSL 259
V + +
Sbjct: 283 VSRISAIFSTF 293
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 2e-22
Identities = 61/331 (18%), Positives = 110/331 (33%), Gaps = 80/331 (24%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVLN-------------------------------- 34
L +GG+ VY+ + + GR A+K L
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 35 --ETKGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEY 92
K G L+ + G L +F+ + E+ L + + KI R +++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM---ESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR--------- 143
+HR I+H D+K N+LL K+ DFG A R
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 144 -GTVGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVY 201
T Y PE+ + + K D+++ G +++ + +
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL----------------------CF 248
Query: 202 KRLELEEDLGLQGIEN------EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255
++ E+ L+ I N D +Y L+ +Q NP +R ++ VV L+
Sbjct: 249 RQHPFEDGAKLR-IVNGKYSIPPHDTQYTVFHSLIR-AMLQVNPEERLSIAEVVHQLQEI 306
Query: 256 LDSLRIPPRPFLLSSGSQPDSSGTLVRQTEP 286
+ + P+ + Q G+ P
Sbjct: 307 AAARNVNPKSPITELLEQNGGYGSATLSRGP 337
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-22
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 51/215 (23%)
Query: 5 FKNKLGQGGYGGVYKGKLLDG---RNVAIKVLNET------------------------- 36
F++ +G+G +G V K ++ + AIK + E
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 37 ---KGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQ----------KLKWEVLYKIA 83
G C L E+ +G+L F+ + LET+ L + L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 84 VGIARGLEYL-HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGA 142
+ARG++YL + +H D+ NIL+ E++ KI+DFGL++ G+E V T
Sbjct: 149 ADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMG 201
Query: 143 RGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
R V ++A E N+ + SDV+SYG++++E+
Sbjct: 202 RLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEI 234
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 3e-22
Identities = 44/205 (21%), Positives = 77/205 (37%), Gaps = 43/205 (20%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN----VAIKVLNETK---------------------- 37
+G+G +G V++G + N VAIK
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 38 -----GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEY 92
G + +I E + G L F+ + L L A ++ L Y
Sbjct: 453 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKF-----SLDLASLILYAYQLSTALAY 506
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPE 152
L R +H DI N+L+ + C K+ DFGL++ + + + + ++APE
Sbjct: 507 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 562
Query: 153 VFCRNFGEVSYKSDVYSYGMMVFEM 177
NF + SDV+ +G+ ++E+
Sbjct: 563 SI--NFRRFTSASDVWMFGVCMWEI 585
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 3e-22
Identities = 45/204 (22%), Positives = 77/204 (37%), Gaps = 41/204 (20%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN----VAIKVLNET------KGFCFEG-------HRR 46
LG+G +G VY+G + + VA+K + + F E H
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74
Query: 47 A-------------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
+I E G L ++ LK L ++ I + + YL
Sbjct: 75 IVKLIGIIEEEPTWIIMELYPYGELGHYLERNKN-----SLKVLTLVLYSLQICKAMAYL 129
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEV 153
+H DI NIL+ C K+ DFGL++ E + R + +++PE
Sbjct: 130 ES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED-EDYYKASVTRLPIKWMSPES 185
Query: 154 FCRNFGEVSYKSDVYSYGMMVFEM 177
NF + SDV+ + + ++E+
Sbjct: 186 I--NFRRFTTASDVWMFAVCMWEI 207
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 94.4 bits (234), Expect = 4e-22
Identities = 31/250 (12%), Positives = 80/250 (32%), Gaps = 43/250 (17%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107
+Y + + T++ L ++ + + R L LH ++H ++
Sbjct: 182 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLR 238
Query: 108 PHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR---NFGEVSYK 164
P +I+LD+ ++ F G ++ + A + + +++
Sbjct: 239 PVDIVLDQRGGVFLTGFEHLVR-DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFA 297
Query: 165 SDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY 223
D ++ G+ ++ + + + + W+++ + +
Sbjct: 298 FDTWTLGLAIYWIWCAD-----LPNTDDAALGGSEWIFR-------------SCKNIPQP 339
Query: 224 ARKMILVSLWCIQNNPSDR---------PAMNRVVEMLEGSLDSLRIPPRP-----FLLS 269
R ++ ++ DR P ++ L +L + P S
Sbjct: 340 VRALL---EGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPS 396
Query: 270 SGSQPDSSGT 279
SQPD +G
Sbjct: 397 GTSQPDEAGA 406
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 4e-22
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 54/205 (26%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIKVLNETK--------------------------GF-- 39
LG+G + GVY+ + + G VAIK++++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 40 CFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLK-WEVLYKIAVGIARGLEYLHRGC 97
FE L+ E NG + +++ + + E + + I G+ YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNR-----VKPFSENEARHFMH-QIITGMLYLHS-- 130
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR-----GTVGYIAPE 152
ILH D+ N+LL + KI+DFGLA + + M + GT YI+PE
Sbjct: 131 -HGILHRDLTLSNLLLTRNMNIKIADFGLA-------TQLKMPHEKHYTLCGTPNYISPE 182
Query: 153 VFCRNFGEVSYKSDVYSYGMMVFEM 177
+ R+ +SDV+S G M + +
Sbjct: 183 IATRS--AHGLESDVWSLGCMFYTL 205
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-22
Identities = 52/233 (22%), Positives = 83/233 (35%), Gaps = 55/233 (23%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN------VAIKVLNETK-------------------- 37
F LG G +G V + VA+K+L T
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 38 --------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLE--------TNQKLKWEVLYK 81
G C G +I E+ G L F+ K + N L
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 82 IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTG 141
+ +A+G+ +L +H D+ N+LL KI DFGLA+ + +
Sbjct: 169 FSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 142 ARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT--------GVKNNANV 186
AR V ++APE + +SDV+SYG++++E+ G+ N+
Sbjct: 226 ARLPVKWMAPESI--FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 5e-22
Identities = 53/237 (22%), Positives = 83/237 (35%), Gaps = 59/237 (24%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN------VAIKVLNETK-------------------- 37
SF LG G +G V + VA+K+L +
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 38 --------GFCFEGHRRALIYEFVSNGSLEKF------------IYEKHPLETNQKLKWE 77
G C G +I E+ G L F + L E
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 78 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137
L + +A+G+ +L +H D+ NILL KI DFGLA+ + V
Sbjct: 146 DLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM--------TGVKNNANV 186
AR V ++APE +++SDV+SYG+ ++E+ G+ ++
Sbjct: 203 VKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 7e-22
Identities = 47/200 (23%), Positives = 86/200 (43%), Gaps = 44/200 (22%)
Query: 7 NKLGQGGYGGVYKGKLL-DGRNVAIKV----LNETK-----------------------G 38
++LG G G V+K G +A K+ + G
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
+ ++ E + GSL++ + + + ++L K+++ + +GL YL
Sbjct: 99 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPE------QILGKVSIAVIKGLTYLRE--K 150
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR-GTVGYIAPEVFCRN 157
+I+H D+KP NIL++ K+ DFG++ + I SM + GT Y++PE
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGT 205
Query: 158 FGEVSYKSDVYSYGMMVFEM 177
S +SD++S G+ + EM
Sbjct: 206 --HYSVQSDIWSMGLSLVEM 223
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 8e-22
Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 44/208 (21%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN----VAIKVLNET----------------KGF---- 39
F +G+G +G VY G LLD A+K LN K F
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 40 -------CFEGHR-RALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLE 91
C ++ ++ +G L FI + + L + +A+G++
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMK 206
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE--SIVSMTGARGTVGYI 149
+L + + +H D+ N +LDE F K++DFGLA+ + +E S+ + TGA+ V ++
Sbjct: 207 FLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 150 APEVFCRNFGEVSYKSDVYSYGMMVFEM 177
A E + + KSDV+S+G++++E+
Sbjct: 264 ALESL--QTQKFTTKSDVWSFGVLLWEL 289
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-21
Identities = 49/207 (23%), Positives = 74/207 (35%), Gaps = 43/207 (20%)
Query: 4 SFKNKLGQGGYGGVYKGKLL--DGRN--VAIKVLNE--------TKGFCFEG-------H 44
KLG G +G V +G+ G+ VA+K L F E H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 45 RR-------------ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLE 91
R ++ E GSL + + L + AV +A G+
Sbjct: 81 RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMG 135
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMT-GARGTVGYIA 150
YL R +H D+ N+LL KI DFGL + + M + + A
Sbjct: 136 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 192
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVFEM 177
PE S+ SD + +G+ ++EM
Sbjct: 193 PESL--KTRTFSHASDTWMFGVTLWEM 217
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 2e-21
Identities = 23/210 (10%), Positives = 50/210 (23%), Gaps = 29/210 (13%)
Query: 48 LIYEFVSNGSLEKFIYE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDI 106
L+ S LE L+ + + R L ++H
Sbjct: 165 LLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHF 220
Query: 107 KPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSD 166
P N+ + D + D R S V Y E + ++ +
Sbjct: 221 TPDNLFIMPDGRLMLGDVSALWKVGTRGPASS-----VPVTYAPREFLNASTATFTHALN 275
Query: 167 VYSYGMMVFEM-TGV-----KNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEED 220
+ G+ ++ + + + P L
Sbjct: 276 AWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP--------- 326
Query: 221 KEYARKMILVSLWCIQNNPSDRPAMNRVVE 250
++ + +I + + R +E
Sbjct: 327 -DFVKTLI---GRFLNFDRRRRLLPLEAME 352
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 67/330 (20%), Positives = 108/330 (32%), Gaps = 96/330 (29%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN------VAIKVLNETK-------------------- 37
+ LG G +G VY+G++ N VA+K L E
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 38 -------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETN-QKLKWEVLYKIAVGIARG 89
G + R ++ E ++ G L+ F+ E P + L L +A IA G
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 90 LEYLHRGCNTRILHFDIKPHNILLD---EDFCPKISDFGLAKICHGRESIVSMTGARGTV 146
+YL +H DI N LL KI DFG+A+ + A V
Sbjct: 153 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 147 GYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGVKNNANVAVDRSSEIYFPHWVYKRLE 205
++ PE F G + K+D +S+G++++E +
Sbjct: 210 KWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFS--------------------------- 240
Query: 206 LEEDLGLQ---GIENEEDKEYARK---------------MILVSLWCIQNNPSDRPAMNR 247
LG N+E E+ I+ W Q+ P DRP
Sbjct: 241 ----LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCW--QHQPEDRPNFAI 294
Query: 248 VVEMLEGSLDSLRI--PPRPFLLSSGSQPD 275
++E +E + P + +
Sbjct: 295 ILERIEYCTQDPDVINTALPIEYGPLVEEE 324
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 2e-21
Identities = 49/223 (21%), Positives = 87/223 (39%), Gaps = 60/223 (26%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN------VAIKVLNET--------------------- 36
F +LG+ +G VYKG L VAIK L +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 37 ------KGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETN----------QKLKWEVLY 80
G + ++I+ + S+G L +F+ + P L+
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 81 KIAVGIARGLEYL------HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134
+ IA G+EYL H+ D+ N+L+ + KISD GL + + +
Sbjct: 132 HLVAQIAAGMEYLSSHHVVHK---------DLATRNVLVYDKLNVKISDLGLFREVYAAD 182
Query: 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
+ + + ++APE +G+ S SD++SYG++++E+
Sbjct: 183 YYKLLGNSLLPIRWMAPEAI--MYGKFSIDSDIWSYGVVLWEV 223
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-21
Identities = 44/216 (20%), Positives = 88/216 (40%), Gaps = 47/216 (21%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN------VAIKVLNETK-------------------- 37
K +LG+G +G V+ + + VA+K L +
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77
Query: 38 ------GFCFEGHRRALIYEFVSNGSLEKF----------IYEKHPLETNQKLKWEVLYK 81
G C +G +++E++ +G L KF + + P + +L +
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 82 IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTG 141
IA IA G+ YL +H D+ N L+ + KI DFG+++ + +
Sbjct: 138 IASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 142 ARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
+ ++ PE + + + +SDV+S+G++++E+
Sbjct: 195 TMLPIRWMPPESI--MYRKFTTESDVWSFGVILWEI 228
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 5e-21
Identities = 48/201 (23%), Positives = 75/201 (37%), Gaps = 45/201 (22%)
Query: 7 NKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--GFCFEGHRRA---------------- 47
LG+G +G VY + +A+KVL + + E R
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 48 -----------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
LI E+ G++ Y + L+ K + +A L Y H
Sbjct: 75 YGYFHDATRVYLILEYAPLGTV----YRE--LQKLSKFDEQRTATYITELANALSYCHS- 127
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156
R++H DIKP N+LL KI+DFG + S GT+ Y+ PE+
Sbjct: 128 --KRVIHRDIKPENLLLGSAGELKIADFGWSVH---APSSRRTDLC-GTLDYLPPEMIEG 181
Query: 157 NFGEVSYKSDVYSYGMMVFEM 177
K D++S G++ +E
Sbjct: 182 R--MHDEKVDLWSLGVLCYEF 200
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-21
Identities = 67/339 (19%), Positives = 117/339 (34%), Gaps = 103/339 (30%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN--------VAIKVLNETK------------------ 37
LG+G +G V + + VA+K+L
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 38 ----------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETN----------QKLKWE 77
G C + +I E+ S G+L +++ + P ++L +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 78 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137
L A +ARG+EYL + + +H D+ N+L+ ED KI+DFGLA+ H +
Sbjct: 192 DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGVKNNANVAVDRSSEIYF 196
T R V ++APE +++SDV+S+G++++E T
Sbjct: 249 KTTNGRLPVKWMAPEAL--FDRIYTHQSDVWSFGVLLWEIFT------------------ 288
Query: 197 PHWVYKRLELEEDLGLQ---GIENEEDKEYARK---------------MILVSLWCIQNN 238
LG G+ EE + ++ M++ W
Sbjct: 289 -------------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCW--HAV 333
Query: 239 PSDRPAMNRVVEMLEGSLDSLRIPPRPFLLSSGSQPDSS 277
PS RP ++VE L+ + +
Sbjct: 334 PSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHHHHDYDI 372
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-21
Identities = 45/221 (20%), Positives = 84/221 (38%), Gaps = 58/221 (26%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN------VAIKVLNETK-------------------- 37
K +LG+G +G V+ + + VA+K L E
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103
Query: 38 ------GFCFEGHRRALIYEFVSNGSLEKF---------IYEKHPLETNQKLKWEVLYKI 82
G C EG +++E++ +G L +F + L L +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 83 AVGIARGLEYL------HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136
A +A G+ YL HR TR N L+ + KI DFG+++ + +
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATR---------NCLVGQGLVVKIGDFGMSRDIYSTDYY 214
Query: 137 VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
+ ++ PE + + + +SDV+S+G++++E+
Sbjct: 215 RVGGRTMLPIRWMPPESI--LYRKFTTESDVWSFGVVLWEI 253
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-21
Identities = 57/242 (23%), Positives = 85/242 (35%), Gaps = 64/242 (26%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN------VAIKVLNETK-------------------- 37
F LG G +G V VA+K+L E
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 38 --------GFCFEGHRRALIYEFVSNGSLEKF-----------------IYEKHPLETNQ 72
G C LI+E+ G L + E
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 73 KLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132
L +E L A +A+G+E+L +H D+ N+L+ KI DFGLA+
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM--------TGVKNNA 184
+ V AR V ++APE G + KSDV+SYG++++E+ G+ +A
Sbjct: 225 DSNYVVRGNARLPVKWMAPE--SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282
Query: 185 NV 186
N
Sbjct: 283 NF 284
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-20
Identities = 48/220 (21%), Positives = 94/220 (42%), Gaps = 51/220 (23%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN--------VAIKVLNET----------------KGF 39
+ LG+G +G V + + VA+K+L + K
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 40 ------------CFEGHRRALIYEFVSNGSLEKFIYEKHPLETN----------QKLKWE 77
C + +I E+ S G+L +++ + P +++ ++
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 78 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137
L +ARG+EYL + + +H D+ N+L+ E+ KI+DFGLA+ + +
Sbjct: 158 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
T R V ++APE +++SDV+S+G++++E+
Sbjct: 215 KTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLMWEI 252
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 48/219 (21%), Positives = 93/219 (42%), Gaps = 51/219 (23%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRN--------VAIKVLNET----------------KGF- 39
LG+G +G V + + VA+K+L + K
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 40 -----------CFEGHRRALIYEFVSNGSLEKFIYEKHPLETN----------QKLKWEV 78
C + +I E+ S G+L +++ + P +++ ++
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 79 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138
L +ARG+EYL + + +H D+ N+L+ E+ KI+DFGLA+ + +
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
T R V ++APE +++SDV+S+G++++E+
Sbjct: 262 TTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLMWEI 298
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 67/331 (20%), Positives = 107/331 (32%), Gaps = 96/331 (29%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN------VAIKVLNETK-------------------- 37
+ LG G +G VY+G++ N VA+K L E
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 38 -------GFCFEGHRRALIYEFVSNGSLEKFIYEKHP-LETNQKLKWEVLYKIAVGIARG 89
G + R ++ E ++ G L+ F+ E P L L +A IA G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 90 LEYLHRGCNTRILHFDIKPHNILLD---EDFCPKISDFGLAKICHGRESIVSMTGARGTV 146
+YL +H DI N LL KI DFG+A+ + A V
Sbjct: 194 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250
Query: 147 GYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGVKNNANVAVDRSSEIYFPHWVYKRLE 205
++ PE F G + K+D +S+G++++E +
Sbjct: 251 KWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFS--------------------------- 281
Query: 206 LEEDLGLQ---GIENEEDKEYARK---------------MILVSLWCIQNNPSDRPAMNR 247
LG N+E E+ I+ W Q+ P DRP
Sbjct: 282 ----LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCW--QHQPEDRPNFAI 335
Query: 248 VVEMLEGSLDSLRI--PPRPFLLSSGSQPDS 276
++E +E + P + +
Sbjct: 336 ILERIEYCTQDPDVINTALPIEYGPLVEEEE 366
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-20
Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 50/208 (24%)
Query: 4 SFKNKLGQGGYGGVYKGK-LLDGRNVAIK---------------VLNET----------- 36
+ LG+G +G V K + G+ A+K +L E
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 37 ---KGFCFEGHRRALIYEFVSNGSL-EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEY 92
F + L+ E + G L ++ I K E + +I + G+ Y
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIRQVLSGITY 141
Query: 93 LHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYI 149
+H +I+H D+KP N+LL +D +I DFGL+ + M GT YI
Sbjct: 142 MH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYI 195
Query: 150 APEVFCRNFGEVSYKSDVYSYGMMVFEM 177
APEV + E K DV+S G++++ +
Sbjct: 196 APEVLHGTYDE---KCDVWSTGVILYIL 220
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-20
Identities = 67/328 (20%), Positives = 105/328 (32%), Gaps = 112/328 (34%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRN------VAIKVLNET----------------KGF--- 39
LG+G +G V K + VA+K+L E K
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 40 --------CFEGHRRALIYEFVSNGSLEKF------------------IYEKHPLETNQK 73
C + LI E+ GSL F +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 74 LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133
L L A I++G++YL +++H D+ NIL+ E KISDFGL++ +
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGVKNNANVAVDRSS 192
+S V + R V ++A E + +SDV+S+G++++E +T
Sbjct: 204 DSYVKRSQGRIPVKWMAIESL--FDHIYTTQSDVWSFGVLLWEIVT-------------- 247
Query: 193 EIYFPHWVYKRLELEEDLGLQ---GIENEEDKEYARK-----------------MILVSL 232
LG GI E + M L
Sbjct: 248 -----------------LGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLM----L 286
Query: 233 WCIQNNPSDRPAMNRVVEMLEGSLDSLR 260
C + P RP + + LE + R
Sbjct: 287 QCWKQEPDKRPVFADISKDLEKMMVKRR 314
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-20
Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 49/207 (23%)
Query: 4 SFKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETK------------------------- 37
KLG G YG V + + AIK++ +T
Sbjct: 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 38 ---GFCFEGHRRALIYEFVSNGSL-EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
F + L+ E G L ++ I+ E + I + G+ YL
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA-------VIIKQVLSGVTYL 152
Query: 94 HRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIA 150
H I+H D+KP N+LL ++D KI DFGL+ + ++ M GT YIA
Sbjct: 153 H---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIA 206
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVFEM 177
PEV + + E K DV+S G+++F +
Sbjct: 207 PEVLRKKYDE---KCDVWSIGVILFIL 230
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-20
Identities = 56/236 (23%), Positives = 89/236 (37%), Gaps = 58/236 (24%)
Query: 4 SFKNKLGQGGYGGVYKGKLLD------GRNVAIKVLNETK-------------------- 37
LG+G +G V + R VA+K+L E
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 38 --------GFCF-EGHRRALIYEFVSNGSLEKFIYEKHPLETN----------QKLKWEV 78
G C G +I EF G+L ++ K L E
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 79 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138
L + +A+G+E+L + + +H D+ NILL E KI DFGLA+ + V
Sbjct: 150 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MT-------GVKNNANV 186
AR + ++APE + +SDV+S+G++++E + GVK +
Sbjct: 207 KGDARLPLKWMAPETI--FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 8e-20
Identities = 56/218 (25%), Positives = 76/218 (34%), Gaps = 60/218 (27%)
Query: 4 SFKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRA--------------- 47
KLG G YG V K AIKV+ +++
Sbjct: 39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 48 ------------------------LIYEFVSNGSL-EKFIYEKHPLETNQKLKWEVLYKI 82
L+ EF G L E+ I E + I
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA-------NI 151
Query: 83 AVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSM 139
I G+ YLH I+H DIKP NILL + KI DFGL+ +
Sbjct: 152 MKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---L 205
Query: 140 TGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
GT YIAPEV + + E K DV+S G++++ +
Sbjct: 206 RDRLGTAYYIAPEVLKKKYNE---KCDVWSCGVIMYIL 240
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-20
Identities = 52/207 (25%), Positives = 83/207 (40%), Gaps = 49/207 (23%)
Query: 4 SFKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETK------------------------- 37
+ LG+G +G V K K + + A+KV+N+
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 38 ---GFCFEGHRRALIYEFVSNGSL-EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
+ ++ E + G L ++ I K E + +I + G+ Y+
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGITYM 137
Query: 94 HRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIA 150
H I+H D+KP NILL ++D KI DFGL+ M GT YIA
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIA 191
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVFEM 177
PEV + E K DV+S G++++ +
Sbjct: 192 PEVLRGTYDE---KCDVWSAGVILYIL 215
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-19
Identities = 46/199 (23%), Positives = 78/199 (39%), Gaps = 45/199 (22%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVLNETK--GFCFEGHRRA------------------ 47
LG+G +G VY + +A+KVL +++ E R
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 48 ---------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
L+ EF G L Y++ L+ + + + +A L Y H
Sbjct: 82 YFHDRKRIYLMLEFAPRGEL----YKE--LQKHGRFDEQRSATFMEELADALHYCHE--- 132
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
+++H DIKP N+L+ KI+DFG + S+ T GT+ Y+ PE+
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRTMC-GTLDYLPPEMIEGK- 187
Query: 159 GEVSYKSDVYSYGMMVFEM 177
K D++ G++ +E
Sbjct: 188 -THDEKVDLWCAGVLCYEF 205
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-19
Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 56/209 (26%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKVLN--------------------------ETKGF 39
+LG G +G VYK K G A KV+ + G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 40 CFEGHRRALIYEFVSNGSLEKFIYE-KHPLETNQKLKWEVLYKIAV---GIARGLEYLHR 95
+ + ++ EF G+++ + E L Q I V + L +LH
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---------IQVVCRQMLEALNFLH- 134
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFG----LAKICHGRESIVSMTGARGTVGYIAP 151
+ RI+H D+K N+L+ + +++DFG K R+S + GT ++AP
Sbjct: 135 --SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAP 186
Query: 152 EV-FCRNFGEVSY--KSDVYSYGMMVFEM 177
EV C + Y K+D++S G+ + EM
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEM 215
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-19
Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 57/212 (26%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRALIYE--FVSNGSLEKFI-- 62
+G G YG VYKG+ + G+ AIKV++ T + E + S + I
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----GDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 63 -----YEKHPLETNQKLKWEV-----------LYK-----------IAV---GIARGLEY 92
+K+P + +L W V L K IA I RGL +
Sbjct: 86 YYGAFIKKNPPGMDDQL-WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT-VG---Y 148
LH +++H DIK N+LL E+ K+ DFG++ + G R T +G +
Sbjct: 145 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA------QLDRTVGRRNTFIGTPYW 195
Query: 149 IAPEVF-CRNFGEVSY--KSDVYSYGMMVFEM 177
+APEV C + +Y KSD++S G+ EM
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-19
Identities = 40/216 (18%), Positives = 81/216 (37%), Gaps = 57/216 (26%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN--------VAIKVLNETK------------------ 37
F LGQG + ++KG + + V +KVL++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 38 --------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARG 89
G C G L+ EFV GSL+ ++ + + ++A +A
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAAA 125
Query: 90 LEYLHRGCNTRILHFDIKPHNILLDEDFCP--------KISDFGLAKICHGRESIVSMTG 141
+ +L ++H ++ NILL + K+SD G++ ++
Sbjct: 126 MHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------VLPKDI 176
Query: 142 ARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
+ + ++ PE N ++ +D +S+G ++E+
Sbjct: 177 LQERIPWVPPECI-ENPKNLNLATDKWSFGTTLWEI 211
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-19
Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT 145
+ L+YL RI+H D+KP NILLDE I+DF +A + I +M GT
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GT 177
Query: 146 VGYIAPEVFCRNFGEVSYKS-DVYSYGMMVFEM 177
Y+APE+F G + D +S G+ +E+
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYEL 210
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-19
Identities = 54/205 (26%), Positives = 84/205 (40%), Gaps = 55/205 (26%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKV------------LNETK--------------GF 39
K+GQG G VY + G+ VAI+ +NE
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 40 CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAV---GIARGLEYLHRG 96
G ++ E+++ GSL + + ++ Q IA + LE+LH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQ---------IAAVCRECLQALEFLH-- 133
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFG----LAKICHGRESIVSMTGARGTVGYIAPE 152
+ +++H DIK NILL D K++DFG + R ++V GT ++APE
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV------GTPYWMAPE 186
Query: 153 VFCRNFGEVSYKSDVYSYGMMVFEM 177
V R K D++S G+M EM
Sbjct: 187 VVTRK--AYGPKVDIWSLGIMAIEM 209
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-19
Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 56/205 (27%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVL-------------------------NETKGFC- 40
K+G+G +G V+KG + VAIK++ TK +
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 41 -FEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAV---GIARGLEYLHRG 96
+ + +I E++ GS + E PL+ Q IA I +GL+YLH
Sbjct: 89 YLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQ---------IATILREILKGLDYLH-- 136
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT-VG---YIAPE 152
+ + +H DIK N+LL E K++DFG+A + R T VG ++APE
Sbjct: 137 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAG------QLTDTQIKRNTFVGTPFWMAPE 189
Query: 153 VFCRNFGEVSYKSDVYSYGMMVFEM 177
V + K+D++S G+ E+
Sbjct: 190 VIKQ--SAYDSKADIWSLGITAIEL 212
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-19
Identities = 44/204 (21%), Positives = 80/204 (39%), Gaps = 47/204 (23%)
Query: 8 KLGQGGYGGVYKGKLL-DGRNVAIKVLNETKGFCFEGHRRALIYE--------------- 51
++G G G V+K + G +A+K + + + + ++ +
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN---KEENKRILMDLDVVLKSHDCPYIVQ 88
Query: 52 ----FVSN-----------GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
F++N EK + +L K+ V I + L YL
Sbjct: 89 CFGTFITNTDVFIAMELMGTCAEKLKKRMQ-----GPIPERILGKMTVAIVKALYYLKE- 142
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF-C 155
++H D+KP NILLDE K+ DFG++ + + G Y+APE
Sbjct: 143 -KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL---VDDKAKDRSAGCAAYMAPERIDP 198
Query: 156 RNFGEVSY--KSDVYSYGMMVFEM 177
+ + Y ++DV+S G+ + E+
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVEL 222
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-19
Identities = 51/206 (24%), Positives = 82/206 (39%), Gaps = 43/206 (20%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVLN-------------E------------TKGFC- 40
+G G V VAIK +N E +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 41 -FEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAV---GIARGLEYLHRG 96
L+ + +S GS+ I ++ + IA + GLEYLH+
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST-IATILREVLEGLEYLHK- 139
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGL-AKICHGRESIVSMTGARGT-VG---YIAP 151
+H D+K NILL ED +I+DFG+ A + G + ++ R T VG ++AP
Sbjct: 140 --NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD--ITRNKVRKTFVGTPCWMAP 195
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEM 177
EV + G +K+D++S+G+ E+
Sbjct: 196 EVMEQVRG-YDFKADIWSFGITAIEL 220
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 6e-19
Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 55/205 (26%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKVLNETK--------------------------GF 39
K+G+G G V + GR VA+K+++ K
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 40 CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAV---GIARGLEYLHRG 96
G ++ EF+ G+L I + L Q IA + + L YLH
Sbjct: 111 YLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQ---------IATVCEAVLQALAYLH-- 158
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFG----LAKICHGRESIVSMTGARGTVGYIAPE 152
++H DIK +ILL D K+SDFG ++K R+S+V GT ++APE
Sbjct: 159 -AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPE 211
Query: 153 VFCRNFGEVSYKSDVYSYGMMVFEM 177
V R+ + + D++S G+MV EM
Sbjct: 212 VISRS--LYATEVDIWSLGIMVIEM 234
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 7e-19
Identities = 53/205 (25%), Positives = 81/205 (39%), Gaps = 52/205 (25%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKVLNETK---------------------------- 37
++G G +G VY + + + VAIK ++ +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 38 -GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAV---GIARGLEYL 93
G H L+ E+ + + K PL+ + IA G +GL YL
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE---------IAAVTHGALQGLAYL 170
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEV 153
H + ++H D+K NILL E K+ DFG A I S V GT ++APEV
Sbjct: 171 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEV 221
Query: 154 -FCRNFGEVSYKSDVYSYGMMVFEM 177
+ G+ K DV+S G+ E+
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIEL 246
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 9e-19
Identities = 52/243 (21%), Positives = 73/243 (30%), Gaps = 73/243 (30%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRA---------------- 47
K +GQG YG V AIK++N+ K
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 48 ---------------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVG------- 85
L+ E G L + T + V +I
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 86 ---------------------------IARGLEYLHRGCNTRILHFDIKPHNILL--DED 116
I L YLH N I H DIKP N L ++
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKS 206
Query: 117 FCPKISDFGLAKICHGRES--IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMV 174
F K+ DFGL+K + + MT GT ++APEV K D +S G+++
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 175 FEM 177
+
Sbjct: 267 HLL 269
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 58/327 (17%), Positives = 108/327 (33%), Gaps = 112/327 (34%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDGRN------VAIKVLNET----------------KGF-- 39
+ +G+G +G V++ + VA+K+L E F
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 40 ---------CFEGHRRALIYEFVSNGSLEKF------------------IYEKHPLETNQ 72
C G L++E+++ G L +F +
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 73 KLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132
L IA +A G+ YL + +H D+ N L+ E+ KI+DFGL++ +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGVKNNANVAVDRS 191
+ + + ++ PE + + +SDV++YG++++E +
Sbjct: 227 ADYYKADGNDAIPIRWMPPESI--FYNRYTTESDVWAYGVVLWEIFS------------- 271
Query: 192 SEIYFPHWVYKRLELEEDLGLQ---GIENEEDKEYARK-----------------MILVS 231
GLQ G+ +EE Y R M
Sbjct: 272 ------------------YGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLM---- 309
Query: 232 LWCIQNNPSDRPAMNRVVEMLEGSLDS 258
C P+DRP+ + +L+ +
Sbjct: 310 RLCWSKLPADRPSFCSIHRILQRMCER 336
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 20/139 (14%), Positives = 54/139 (38%), Gaps = 18/139 (12%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107
+Y + + T++ L ++ + + R L LH ++H ++
Sbjct: 177 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLR 233
Query: 108 PHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGE------- 160
P +I+LD+ ++ F R+ ++ + G+ PE+ R
Sbjct: 234 PVDIVLDQRGGVFLTGFEHLV----RDGARVVS--SVSRGFEPPELEARRATISYHRDRR 287
Query: 161 --VSYKSDVYSYGMMVFEM 177
+++ D ++ G++++ +
Sbjct: 288 TLMTFSFDAWALGLVIYWI 306
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 45/203 (22%), Positives = 82/203 (40%), Gaps = 44/203 (21%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKVLN---------ETKGFC-FEGH----------- 44
KLG+G Y V++ + + V +K+L E K G
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVK 101
Query: 45 -----RRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
AL++E V+N ++ +Y+ + +E+L + L+Y H
Sbjct: 102 DPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRFYMYEIL--------KALDYCHSM--- 149
Query: 100 RILHFDIKPHNILLDEDFCP-KISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
I+H D+KPHN+++D + ++ D+GLA+ H + + PE+ ++
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH---PGQEYNVRVASRYFKGPELLV-DY 205
Query: 159 GEVSYKSDVYSYGMMVFEMTGVK 181
Y D++S G M+ M K
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRK 228
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 38/212 (17%), Positives = 71/212 (33%), Gaps = 53/212 (25%)
Query: 7 NKLGQG--GYGGVYKGK-LLDGRNVAIKVLNETK-------------------------- 37
+G+G V + G V ++ +N
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 38 --GFCFEGHRRALIYEFVSNGSLEKFI--YEKHPLETNQKLKWEVLYKIAV---GIARGL 90
+ ++ F++ GS + I + + IA G+ + L
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA---------IAYILQGVLKAL 141
Query: 91 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICHGRESIVSMTGARGTVG- 147
+Y+H +H +K +IL+ D +S I HG+ V + +V
Sbjct: 142 DYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 148 --YIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
+++PEV +N KSD+YS G+ E+
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 230
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-18
Identities = 55/204 (26%), Positives = 84/204 (41%), Gaps = 53/204 (25%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKVLN------------------------ETKGFCF 41
KLG+G YG VYK G+ VAIK + + G F
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 42 EGHRRALIYEFVSNGSLEKFIYEKH-PLETNQKLKWEVLYKIAV---GIARGLEYLHRGC 97
+ ++ E+ GS+ I ++ L ++ IA +GLEYLH
Sbjct: 95 KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE---------IATILQSTLKGLEYLH--- 142
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFG----LAKICHGRESIVSMTGARGTVGYIAPEV 153
R +H DIK NILL+ + K++DFG L R +++ GT ++APEV
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI------GTPFWMAPEV 196
Query: 154 FCRNFGEVSYKSDVYSYGMMVFEM 177
+ +D++S G+ EM
Sbjct: 197 IQE--IGYNCVADIWSLGITAIEM 218
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-18
Identities = 47/218 (21%), Positives = 82/218 (37%), Gaps = 54/218 (24%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIKVLNETK--------GFCFEGHRRALIYEFVSNGSLE 59
+G+G YG V D A+KVL++ K R +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 60 KFIYE--------KHP--------LETNQKLKW----------EVLYKIAVG-------- 85
+ +Y+ HP L+ + V+ +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 86 -----IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMT 140
+ +G+EYLH +I+H DIKP N+L+ ED KI+DFG++ G +++ ++
Sbjct: 141 FYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LS 195
Query: 141 GARGTVGYIAPEVFCRNFGEVS-YKSDVYSYGMMVFEM 177
GT ++APE S DV++ G+ ++
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-18
Identities = 51/209 (24%), Positives = 77/209 (36%), Gaps = 54/209 (25%)
Query: 4 SFKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGF----------------------- 39
FK KLG G +G V+ + G IK +N+ +
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 40 ---CFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLY--KIAVGIAR----G 89
FE + ++ E G L + I + +
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA--------LSEGYVAELMKQMMNA 136
Query: 90 LEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTGARGTV 146
L Y H + ++H D+KP NIL KI DFGLA++ E T A GT
Sbjct: 137 LAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTA 190
Query: 147 GYIAPEVFCRNFGEVSYKSDVYSYGMMVF 175
Y+APEVF R+ K D++S G++++
Sbjct: 191 LYMAPEVFKRDVTF---KCDIWSAGVVMY 216
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 7e-18
Identities = 41/206 (19%), Positives = 72/206 (34%), Gaps = 55/206 (26%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRR----------------- 46
+N +G+G +G V A K + + + ++
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 47 ---------ALIYEFVSNGSL-EKFIYEKHPLETNQKLKWEVLYKIAVGIAR----GLEY 92
L+ E + G L E+ ++++ E A I + + Y
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVVHKRVFRE-----------SDAARIMKDVLSAVAY 121
Query: 93 LHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYI 149
H + H D+KP N L D K+ DFGLA + M GT Y+
Sbjct: 122 CH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYV 175
Query: 150 APEVFCRNFGEVSYKSDVYSYGMMVF 175
+P+V +G + D +S G+M++
Sbjct: 176 SPQVLEGLYGP---ECDEWSAGVMMY 198
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-17
Identities = 52/201 (25%), Positives = 79/201 (39%), Gaps = 54/201 (26%)
Query: 6 KNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETKGFCFE------------GHRR------ 46
LG G +G V+K + G +A K++ E H
Sbjct: 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153
Query: 47 --------ALIYEFVSNGSL-EKFIYEKHPL-ETNQKLKWEVLYKIAVGIAR----GLEY 92
L+ E+V G L ++ I E + L E + + G+ +
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRIIDESYNLTE-----------LDTILFMKQICEGIRH 202
Query: 93 LHRGCNTRILHFDIKPHNILL--DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIA 150
+H ILH D+KP NIL + KI DFGLA+ RE + GT ++A
Sbjct: 203 MH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLA 256
Query: 151 PEVFCRNFGEVSYKSDVYSYG 171
PEV +F VS+ +D++S G
Sbjct: 257 PEVVNYDF--VSFPTDMWSVG 275
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-17
Identities = 42/208 (20%), Positives = 72/208 (34%), Gaps = 53/208 (25%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIKVLN--------------------------------- 34
LG+G YG V + A+K+L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 35 -----ETKGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARG 89
E K + ++ E+ G E ++ + + G
Sbjct: 73 DVLYNEEKQKMY------MVMEYCVCGMQEMLDSVPE-----KRFPVCQAHGYFCQLIDG 121
Query: 90 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYI 149
LEYLH I+H DIKP N+LL KIS G+A+ H + + ++G+ +
Sbjct: 122 LEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 150 APEVFCRNFGEVSYKSDVYSYGMMVFEM 177
PE+ +K D++S G+ ++ +
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNI 206
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-17
Identities = 53/204 (25%), Positives = 81/204 (39%), Gaps = 49/204 (24%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGF------------------------ 39
LG+G +G V K K + + A+KV+N+
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 40 ---CFEGHRRA-LIYEFVSNGSL-EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
E ++ E + G L ++ I K E + +I + G+ Y+H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGITYMH 138
Query: 95 RGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAP 151
I+H D+KP NILL ++D KI DFGL+ M GT YIAP
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAP 192
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVF 175
EV + E K DV+S G++++
Sbjct: 193 EVLRGTYDE---KCDVWSAGVILY 213
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 53/205 (25%), Positives = 82/205 (40%), Gaps = 53/205 (25%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVLN-----ETKG------------------------ 38
+G+GG+G VY + D G+ A+K L+ +G
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 39 --FCFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
+ F + I + ++ G L + + Y A I GLE++H
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD----MRFY--AAEIILGLEHMHN 310
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR-GTVGYIAPEVF 154
+++ D+KP NILLDE +ISD GLA + A GT GY+APEV
Sbjct: 311 ---RFVVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGYMAPEVL 362
Query: 155 CRNFGEVSYKSDV--YSYGMMVFEM 177
+ Y S +S G M+F++
Sbjct: 363 QKGVA---YDSSADWFSLGCMLFKL 384
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-17
Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 63/211 (29%)
Query: 8 KLGQGGYGGVYKGKLLDGRNVAIK-VLNETKGFCFEG----------HR--RALIYEFVS 54
+G G +G V++ KL++ VAIK VL + + F+ H L F S
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYS 103
Query: 55 NGSLEKFIY---------------EKHPLETNQKLKWEV----LYKIAVGIARGLEYLHR 95
NG + ++ +H + Q + + +Y+ + R L Y+H
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ----LLRSLAYIH- 158
Query: 96 GCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICHGRESIVSMTGARGTVGYI----- 149
+ I H DIKP N+LLD K+ DFG AKI E VS YI
Sbjct: 159 --SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS---------YICSRYY 207
Query: 150 -APEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
APE+ FG +Y + D++S G ++ E+
Sbjct: 208 RAPELI---FGATNYTTNIDIWSTGCVMAEL 235
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-17
Identities = 47/208 (22%), Positives = 75/208 (36%), Gaps = 53/208 (25%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRA---------------- 47
K LG+G V + + A+K+++ T G F
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 48 --------------------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIA 87
L+++ + G L ++ EK L + KI +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALL 134
Query: 88 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVG 147
+ LH I+H D+KP NILLD+D K++DFG + E + GT
Sbjct: 135 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 188
Query: 148 YIAPEVF--CRNFGEVSY--KSDVYSYG 171
Y+APE+ N Y + D++S G
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTG 216
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 4e-17
Identities = 46/203 (22%), Positives = 73/203 (35%), Gaps = 54/203 (26%)
Query: 4 SFKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRR---------------- 46
+LG G +G V++ GR K +N +
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 47 ----------ALIYEFVSNGSL-EKFIYEKHPL-ETNQKLKWEVLYKIAVGIAR----GL 90
LI EF+S G L ++ E + + E + R GL
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE-----------AEVINYMRQACEGL 162
Query: 91 EYLHRGCNTRILHFDIKPHNILL--DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGY 148
+++H I+H DIKP NI+ + KI DFGLA + E + T +
Sbjct: 163 KHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEF 216
Query: 149 IAPEVFCRNFGEVSYKSDVYSYG 171
APE+ R V + +D+++ G
Sbjct: 217 AAPEIVDREP--VGFYTDMWAIG 237
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-17
Identities = 43/205 (20%), Positives = 73/205 (35%), Gaps = 49/205 (23%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRAL------------------- 48
LG G +G V+ + V +K + + K
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 49 --IYEFVSNGSLEKFIY---EKHP--------LETNQKLKWEVLYKIAVGIARGLEYLHR 95
+ + N + F EKH ++ + +L + I + + YL
Sbjct: 92 IKVLDIFEN---QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL 148
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
I+H DIK NI++ EDF K+ DFG A + GT+ Y APEV
Sbjct: 149 K---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLM 202
Query: 156 RNFGEVSY---KSDVYSYGMMVFEM 177
N Y + +++S G+ ++ +
Sbjct: 203 GN----PYRGPELEMWSLGVTLYTL 223
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 5e-17
Identities = 52/204 (25%), Positives = 83/204 (40%), Gaps = 49/204 (24%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVL--------NETKG--------------------F 39
LG+GG+G V+ ++ G+ A K L +G +
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 40 CFE-GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
FE L+ ++ G + IY + + Y I GLE+LH+
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY--TAQIVSGLEHLHQ--- 307
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR---GTVGYIAPEVFC 155
I++ D+KP N+LLD+D +ISD GLA E T + GT G++APE+
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAV-----ELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 156 RNFGEVSYKSDV--YSYGMMVFEM 177
Y V ++ G+ ++EM
Sbjct: 363 GE----EYDFSVDYFALGVTLYEM 382
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 6e-17
Identities = 48/212 (22%), Positives = 75/212 (35%), Gaps = 52/212 (24%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRA---------------- 47
LG G G V + VAI+++++ K
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 48 -----------------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGL 90
++ E + G L + ++LK + +
Sbjct: 199 HPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAV 252
Query: 91 EYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTGARGTVG 147
+YLH I+H D+KP N+LL +ED KI+DFG +KI M GT
Sbjct: 253 QYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPT 306
Query: 148 YIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM 177
Y+APEV + G Y D +S G+++F
Sbjct: 307 YLAPEVL-VSVGTAGYNRAVDCWSLGVILFIC 337
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-17
Identities = 45/214 (21%), Positives = 76/214 (35%), Gaps = 60/214 (28%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRA---------------- 47
+G+G + V + G+ A+K+++ K G
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 48 ---------------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLY--KIAVGIAR-- 88
+++EF+ L I ++ +Y +A R
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA--------DAGFVYSEAVASHYMRQI 139
Query: 89 --GLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTGAR 143
L Y H + I+H D+KPH +LL + K+ FG+A ES + G
Sbjct: 140 LEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGGRV 194
Query: 144 GTVGYIAPEVFCRNFGEVSY--KSDVYSYGMMVF 175
GT ++APEV R Y DV+ G+++F
Sbjct: 195 GTPHFMAPEVVKRE----PYGKPVDVWGCGVILF 224
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 8e-17
Identities = 48/205 (23%), Positives = 78/205 (38%), Gaps = 50/205 (24%)
Query: 4 SFKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRR---------------- 46
+LG G +G V++ G N A K + E R+
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 47 ----------ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIAR----GLEY 92
+IYEF+S G L + + ++H + + AV R GL +
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE---------AVEYMRQVCKGLCH 270
Query: 93 LHRGCNTRILHFDIKPHNILL--DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIA 150
+H +H D+KP NI+ K+ DFGL ++ S+ GT + A
Sbjct: 271 MH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAA 324
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVF 175
PEV V Y +D++S G++ +
Sbjct: 325 PEVA--EGKPVGYYTDMWSVGVLSY 347
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 65/212 (30%), Positives = 86/212 (40%), Gaps = 64/212 (30%)
Query: 8 KLGQGGYGGVYKGKLLD-GRNVAIK-VLNETKGFCFEG----------HRR--ALIYEFV 53
+G G +G VY+ KL D G VAIK VL + + F+ H L Y F
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 54 SNGSLEKFIY---------------EKHPLETNQKLKWEV----LYKIAVGIARGLEYLH 94
S+G + +Y +H Q L +Y+ + R L Y+H
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ----LFRSLAYIH 173
Query: 95 RGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICHGRESIVSMTGARGTVGYI---- 149
I H DIKP N+LLD D K+ DFG AK E VS YI
Sbjct: 174 SF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---------YICSRY 221
Query: 150 --APEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
APE+ FG Y S DV+S G ++ E+
Sbjct: 222 YRAPELI---FGATDYTSSIDVWSAGCVLAEL 250
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 52/213 (24%), Positives = 77/213 (36%), Gaps = 60/213 (28%)
Query: 8 KLGQGGYGGVYKGKLLD-GRNVAIK-----------VLNETKGFCFEGHRR--ALIYEFV 53
GQG +G V GK G +VAIK L + H L F
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFY 89
Query: 54 SNGSLEK------FIYE----------KHPLETNQKLKWEV----LYKIAVGIARGLEYL 93
+ G ++ + E ++ + L+++ R + L
Sbjct: 90 TLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI----RSIGCL 145
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICHGRESIVSMTGARGTVGYI--- 149
H + H DIKPHN+L++E K+ DFG AK E V+ YI
Sbjct: 146 HLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA---------YICSR 195
Query: 150 ---APEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
APE+ FG Y + D++S G + EM
Sbjct: 196 YYRAPELI---FGNQHYTTAVDIWSVGCIFAEM 225
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 57/201 (28%), Positives = 83/201 (41%), Gaps = 46/201 (22%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVLN-----ETKG-----------------------F 39
LG+GG+G V ++ G+ A K L + KG +
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 40 CFE-GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
+E L+ ++ G L + H + V Y A I GLE LHR
Sbjct: 252 AYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEARAVFY--AAEICCGLEDLHR--- 304
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
RI++ D+KP NILLD+ +ISD GLA ++I GTVGY+APEV
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAPEVVKNE- 360
Query: 159 GEVSYKSDV--YSYGMMVFEM 177
Y ++ G +++EM
Sbjct: 361 ---RYTFSPDWWALGCLLYEM 378
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-16
Identities = 42/203 (20%), Positives = 67/203 (33%), Gaps = 55/203 (27%)
Query: 4 SFKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFE------------GHRR---- 46
LG+G +G V++ + K + KG HR
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHL 66
Query: 47 ----------ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLY--KIAVGIAR----GL 90
+I+EF+S + + I + V L
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTS-----------AFELNEREIVSYVHQVCEAL 115
Query: 91 EYLHRGCNTRILHFDIKPHNILL--DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGY 148
++LH + I HFDI+P NI+ KI +FG A+ + + Y
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEY 169
Query: 149 IAPEVFCRNFGEVSYKSDVYSYG 171
APEV + VS +D++S G
Sbjct: 170 YAPEVHQHDV--VSTATDMWSLG 190
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-16
Identities = 45/210 (21%), Positives = 70/210 (33%), Gaps = 61/210 (29%)
Query: 4 SFKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEG------------------H 44
+LG G + V K + G A K + + + H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 45 RR--------------ALIYEFVSNGSL-EKFIYEKHPLETNQKLKWEVLYKIAVGIAR- 88
LI E VS G L + ++ E + A +
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE-----------EEATSFIKQ 123
Query: 89 ---GLEYLHRGCNTRILHFDIKPHNILL---DEDFCP-KISDFGLAKICHGRESIVSMTG 141
G+ YLH +I HFD+KP NI+L + K+ DFGLA
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKN 177
Query: 142 ARGTVGYIAPEVFCRNFGEVSYKSDVYSYG 171
GT ++APE+ + ++D++S G
Sbjct: 178 IFGTPEFVAPEIVNYEP--LGLEADMWSIG 205
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-16
Identities = 53/200 (26%), Positives = 80/200 (40%), Gaps = 44/200 (22%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIKVLNETKGF-CFEGHRR-------------------- 46
LG+G YG V + VA+K+++ + C E ++
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 47 ------ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
L E+ S G L F +E + + + + G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL--FDR----IEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 125
Query: 101 ILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGE 160
I H DIKP N+LLDE KISDFGLA + + GT+ Y+APE+ R
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR--- 182
Query: 161 VSY---KSDVYSYGMMVFEM 177
+ DV+S G+++ M
Sbjct: 183 -EFHAEPVDVWSCGIVLTAM 201
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-16
Identities = 45/210 (21%), Positives = 70/210 (33%), Gaps = 61/210 (29%)
Query: 4 SFKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEG------------------H 44
+LG G + V K + G+ A K + + + H
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 45 RR--------------ALIYEFVSNGSL-EKFIYEKHPLETNQKLKWEVLYKIAVGIAR- 88
LI E VS G L + ++ E A +
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE-----------DEATQFLKQ 116
Query: 89 ---GLEYLHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAKICHGRESIVSMTG 141
G+ YLH RI HFD+KP NI+L + K+ DFG+A
Sbjct: 117 ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKN 170
Query: 142 ARGTVGYIAPEVFCRNFGEVSYKSDVYSYG 171
GT ++APE+ + ++D++S G
Sbjct: 171 IFGTPEFVAPEIVNYEP--LGLEADMWSIG 198
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-16
Identities = 43/207 (20%), Positives = 77/207 (37%), Gaps = 62/207 (29%)
Query: 5 FKNKLGQGGYGGVYKG-KLLDGRNVAIKVLN----------------------------- 34
K +LG+G + V + G A K++N
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 35 -----ETKGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARG 89
+ + F + L+++ V+ G L + I + + I
Sbjct: 70 LHDSIQEESFHY------LVFDLVTGGELFEDIVAR------EFYSEADASHCIQQILES 117
Query: 90 LEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTGARGTV 146
+ Y H + I+H ++KP N+LL + K++DFGLA + E + G GT
Sbjct: 118 IAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTP 171
Query: 147 GYIAPEVFCRNFGEVSY--KSDVYSYG 171
GY++PEV ++ Y D+++ G
Sbjct: 172 GYLSPEVLKKD----PYSKPVDIWACG 194
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-16
Identities = 46/210 (21%), Positives = 71/210 (33%), Gaps = 61/210 (29%)
Query: 4 SFKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEG------------------H 44
+LG G + V K + G A K + + + H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 45 RR--------------ALIYEFVSNGSL-EKFIYEKHPLETNQKLKWEVLYKIAVGIAR- 88
LI E VS G L + ++ E + A +
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE-----------EEATSFIKQ 123
Query: 89 ---GLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLAKICHGRESIVSMTG 141
G+ YLH +I HFD+KP NI+L + P K+ DFGLA
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKN 177
Query: 142 ARGTVGYIAPEVFCRNFGEVSYKSDVYSYG 171
GT ++APE+ + ++D++S G
Sbjct: 178 IFGTPEFVAPEIVNYEP--LGLEADMWSIG 205
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-16
Identities = 49/210 (23%), Positives = 75/210 (35%), Gaps = 52/210 (24%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRA---------------- 47
LG G G V + VAIK++++ K
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 48 -----------------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGL 90
++ E + G L + ++LK + +
Sbjct: 74 HPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAV 127
Query: 91 EYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTGARGTVG 147
+YLH I+H D+KP N+LL +ED KI+DFG +KI M GT
Sbjct: 128 QYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPT 181
Query: 148 YIAPEVFCRNFGEVSY--KSDVYSYGMMVF 175
Y+APEV + G Y D +S G+++F
Sbjct: 182 YLAPEVL-VSVGTAGYNRAVDCWSLGVILF 210
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-16
Identities = 49/199 (24%), Positives = 76/199 (38%), Gaps = 49/199 (24%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRR----------------- 46
F LG G + V+ K L G+ A+K + ++ F
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 47 ---------ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
L+ + VS G L I E+ + + + ++YLH
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILER------GVYTEKDASLVIQQVLSAVKYLH--- 123
Query: 98 NTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF 154
I+H D+KP N+L +E+ I+DFGL+K+ M+ A GT GY+APEV
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVL 179
Query: 155 CRNFGEVSY--KSDVYSYG 171
+ Y D +S G
Sbjct: 180 AQK----PYSKAVDCWSIG 194
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-16
Identities = 43/207 (20%), Positives = 77/207 (37%), Gaps = 59/207 (28%)
Query: 4 SFKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFE--------------GH---- 44
+LG+G + V + +L G+ A ++N K + H
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 45 --------RRA--LIYEFVSNGSL-EKFIYEKHPLETNQKLKWEVLYKIAVGIAR----G 89
LI++ V+ G L E + ++ E A +
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE-----------ADASHCIQQILEA 122
Query: 90 LEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTGARGTV 146
+ + H ++H ++KP N+LL + K++DFGLA G + G GT
Sbjct: 123 VLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTP 177
Query: 147 GYIAPEVFCRNFGEVSY--KSDVYSYG 171
GY++PEV ++ Y D+++ G
Sbjct: 178 GYLSPEVLRKD----PYGKPVDLWACG 200
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-16
Identities = 53/200 (26%), Positives = 80/200 (40%), Gaps = 44/200 (22%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIKVLNETKGF-CFEGHRR-------------------- 46
LG+G YG V + VA+K+++ + C E ++
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 47 ------ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
L E+ S G L F +E + + + + G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL--FDR----IEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 125
Query: 101 ILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGE 160
I H DIKP N+LLDE KISDFGLA + + GT+ Y+APE+ R
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR--- 182
Query: 161 VSY---KSDVYSYGMMVFEM 177
+ DV+S G+++ M
Sbjct: 183 -EFHAEPVDVWSCGIVLTAM 201
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-16
Identities = 45/210 (21%), Positives = 70/210 (33%), Gaps = 61/210 (29%)
Query: 4 SFKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEG------------------H 44
+LG G + V K + G A K + + + H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 45 RR--------------ALIYEFVSNGSL-EKFIYEKHPLETNQKLKWEVLYKIAVGIAR- 88
LI E V+ G L + ++ E + A +
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-----------EEATEFLKQ 122
Query: 89 ---GLEYLHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAKICHGRESIVSMTG 141
G+ YLH + +I HFD+KP NI+L KI DFGLA
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKN 176
Query: 142 ARGTVGYIAPEVFCRNFGEVSYKSDVYSYG 171
GT ++APE+ + ++D++S G
Sbjct: 177 IFGTPEFVAPEIVNYEP--LGLEADMWSIG 204
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 27/90 (30%), Positives = 45/90 (50%), Gaps = 10/90 (11%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT 145
+ + +LH I+H D+KP NILLD++ ++SDFG + E + GT
Sbjct: 209 LLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGT 262
Query: 146 VGYIAPEVFCRNFGEV----SYKSDVYSYG 171
GY+APE+ + E + D+++ G
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACG 292
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-15
Identities = 42/204 (20%), Positives = 73/204 (35%), Gaps = 55/204 (26%)
Query: 6 KNKLGQGGYGGVYKGK-LLDGRNVAIK--------------------VLNETKGF----- 39
+LG+G + V + G+ A K VL K
Sbjct: 34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 40 ---CFEGHRR-ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLY-KIAVGIAR----GL 90
+E LI E+ + G + + E++ + + + G+
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLPE---------LAEMVSENDVIRLIKQILEGV 144
Query: 91 EYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTGARGTVG 147
YLH I+H D+KP NILL KI DFG+++ + GT
Sbjct: 145 YYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPE 198
Query: 148 YIAPEVFCRNFGEVSYKSDVYSYG 171
Y+APE+ + ++ +D+++ G
Sbjct: 199 YLAPEILNYDP--ITTATDMWNIG 220
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-15
Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 32/149 (21%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKV--LNETKGF------------------------ 39
KLG G Y VYKG G VA+K L+ +G
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 40 -CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
++ L++EF+ N L+K++ + T + L+ ++ + +GL + H
Sbjct: 71 VIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-- 127
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLA 127
+ILH D+KP N+L+++ K+ DFGLA
Sbjct: 128 -KILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 44/212 (20%), Positives = 78/212 (36%), Gaps = 72/212 (33%)
Query: 5 FKNKLGQGGYGGVYKG-KLLDGRNVAIKVLN----------------------------- 34
K +LG+G + V + G A K++N
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 35 -----ETKGFCFEGHRRALIYEFVSNGSLEKFIYEKHPL-ETNQKLKWEVLYKIAVGIAR 88
+ + F + L+++ V+ G L + I + E A +
Sbjct: 93 LHDSIQEESFHY------LVFDLVTGGELFEDIVAREFYSE-----------ADASHCIQ 135
Query: 89 ----GLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTG 141
+ Y H + I+H ++KP N+LL + K++DFGLA + E+ G
Sbjct: 136 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHG 189
Query: 142 ARGTVGYIAPEVFCRNFGEVSY--KSDVYSYG 171
GT GY++PEV ++ Y D+++ G
Sbjct: 190 FAGTPGYLSPEVLKKD----PYSKPVDIWACG 217
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 44/208 (21%), Positives = 71/208 (34%), Gaps = 55/208 (26%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRA-------------------- 47
LG GG+G VY G + D VAIK + + + +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 48 --------------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
LI E + F + + L+ E+ + + +
Sbjct: 111 IRLLDWFERPDSFVLILERPE-PVQDLFDF----ITERGALQEELARSFFWQVLEAVRHC 165
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICHGRESIVSMTGARGTVGYIAPE 152
H +LH DIK NIL+D + K+ DFG + T GT Y PE
Sbjct: 166 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPE 218
Query: 153 VFCRNFGEVSY---KSDVYSYGMMVFEM 177
+ Y + V+S G+++++M
Sbjct: 219 WIRYH----RYHGRSAAVWSLGILLYDM 242
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 39/186 (20%), Positives = 62/186 (33%), Gaps = 49/186 (26%)
Query: 5 FKNKLGQGGYGGVYKG-KLLDGRNVAIKVLNETKGFCFE---------GHR--------- 45
K +G G Y + A+K+++++K E H
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY 85
Query: 46 --RALIY---EFVSNGSLEKFIYEKHPL-ETNQKLKWEVLYKIAVGIAR----GLEYLHR 95
+Y E + G L I + E + A + +EYLH
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKFFSE-----------REASAVLFTITKTVEYLH- 133
Query: 96 GCNTRILHFDIKPHNILL---DEDFCP-KISDFGLAKICHGRESIVSMTGARGTVGYIAP 151
++H D+KP NIL + +I DFG AK + + T ++AP
Sbjct: 134 --AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL--LMTPCYTANFVAP 189
Query: 152 EVFCRN 157
EV R
Sbjct: 190 EVLERQ 195
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-15
Identities = 45/210 (21%), Positives = 72/210 (34%), Gaps = 57/210 (27%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRA-------------------- 47
LG+GG+G V+ G L D VAIKV+ + + +
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 48 ----------------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLE 91
L+ E + F Y + L + ++
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQ-DLFDY----ITEKGPLGEGPSRCFFGQVVAAIQ 153
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICHGRESIVSMTGARGTVGYIA 150
+ H ++H DIK NIL+D K+ DFG + H T GT Y
Sbjct: 154 HCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSP 206
Query: 151 PEVFCRNFGEVSY---KSDVYSYGMMVFEM 177
PE R+ Y + V+S G+++++M
Sbjct: 207 PEWISRH----QYHALPATVWSLGILLYDM 232
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-15
Identities = 57/203 (28%), Positives = 87/203 (42%), Gaps = 48/203 (23%)
Query: 7 NKLGQGGYGGVYKGKLLDGRNVAIKVL---NETKGF------------------------ 39
K+G+G YG VYK K GR VA+K + E +G
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 40 -CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
L++EF+ L+K + E + ++K + RG+ + H+
Sbjct: 87 VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIK-----IYLYQLLRGVAHCHQ--- 137
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKI--CHGRESIVSMTGARGTVGYIAPEVFCR 156
RILH D+KP N+L++ D K++DFGLA+ R S T T+ Y AP+V
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR----SYTHEVVTLWYRAPDVL-- 191
Query: 157 NFGEVSYKS--DVYSYGMMVFEM 177
G Y + D++S G + EM
Sbjct: 192 -MGSKKYSTSVDIWSIGCIFAEM 213
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-15
Identities = 49/207 (23%), Positives = 82/207 (39%), Gaps = 60/207 (28%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIKVLN--------------------------------- 34
+G+G + V + +L GR VAIK+++
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 35 -ETKGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
ET+ + LI E+ S G + F Y L + ++K + I ++Y
Sbjct: 83 IETEKTLY------LIMEYASGGEV--FDY----LVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEV 153
H+ I+H D+K N+LLD D KI+DFG + + G Y APE+
Sbjct: 131 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPEL 184
Query: 154 FCRNFGEVSY---KSDVYSYGMMVFEM 177
F Y + DV+S G++++ +
Sbjct: 185 FQGK----KYDGPEVDVWSLGVILYTL 207
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 8e-15
Identities = 44/202 (21%), Positives = 86/202 (42%), Gaps = 45/202 (22%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKVL---NETKGF----------------------- 39
K+G+G YG V+K K VA+K + ++ +G
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 40 --CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
+ L++EF L+K+ + + + ++ L+++ +GL + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQ-DLKKYF-DSCNGDLDPEIVKSFLFQLL----KGLGFCHS-- 119
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
+LH D+KP N+L++ + K+++FGLA+ + + T+ Y P+V
Sbjct: 120 -RNVLHRDLKPQNLLINRNGELKLANFGLARAFG--IPVRCYSAEVVTLWYRPPDVL--- 173
Query: 158 FGEVSYKS--DVYSYGMMVFEM 177
FG Y + D++S G + E+
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAEL 195
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 1e-14
Identities = 50/201 (24%), Positives = 81/201 (40%), Gaps = 44/201 (21%)
Query: 7 NKLGQGGYGGVYKGKLLDGRNVAIKVL---NETKGF------------------------ 39
K+G+G YG VYK + G A+K + E +G
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 40 -CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
R L++E + L+K + + L+ + + G+ Y H
Sbjct: 68 VIHTKKRLVLVFEHLDQ-DLKKLL-DVCE----GGLESVTAKSFLLQLLNGIAYCHD--- 118
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
R+LH D+KP N+L++ + KI+DFGLA+ + T T+ Y AP+V
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEIVTLWYRAPDVL---M 173
Query: 159 GEVSYKS--DVYSYGMMVFEM 177
G Y + D++S G + EM
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEM 194
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 49/206 (23%), Positives = 74/206 (35%), Gaps = 59/206 (28%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRR--------------------- 46
+G G +G + L VA+K + E +R
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 47 -----ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRI 101
A+I E+ S G L + + + + + G+ Y H +I
Sbjct: 87 TPTHLAIIMEYASGGEL--YER----ICNAGRFSEDEARFFFQQLLSGVSYCHS---MQI 137
Query: 102 LHFDIKPHNILLDEDFCP--KISDFGLAKICHGRESIVSMTGAR-----GTVGYIAPEVF 154
H D+K N LLD P KI DFG +K S+ ++ GT YIAPEV
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKS--------SVLHSQPKSTVGTPAYIAPEVL 189
Query: 155 CRNFGEVSY---KSDVYSYGMMVFEM 177
R Y +DV+S G+ ++ M
Sbjct: 190 LRQ----EYDGKIADVWSCGVTLYVM 211
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 49/201 (24%), Positives = 75/201 (37%), Gaps = 45/201 (22%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVL--------NETK--------------------GF 39
LG+G + V + L R AIK+L N+ F
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 40 CFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEV--LYKIAVGIARGLEYLHRG 96
F+ + + NG L Y + Y I LEYLH
Sbjct: 98 TFQDDEKLYFGLSYAKNGEL--LKY----IRKIGSFDETCTRFY--TAEIVSALEYLH-- 147
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156
I+H D+KP NILL+ED +I+DFG AK+ GT Y++PE+
Sbjct: 148 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206
Query: 157 NFGEVSYKSDVYSYGMMVFEM 177
SD+++ G +++++
Sbjct: 207 K--SACKSSDLWALGCIIYQL 225
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-14
Identities = 45/198 (22%), Positives = 74/198 (37%), Gaps = 47/198 (23%)
Query: 6 KNKLGQGGYGGVYKG-KLLDGRNVAIKVLNETKGF---------------------CFE- 42
K LG G G V + G+ A+K+L ++ +E
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYEN 93
Query: 43 -GHRRALIY---EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
H + + E + G L I E+ ++ E++ I +++LH +
Sbjct: 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG----TAIQFLH---S 146
Query: 99 TRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
I H D+KP N+L ++D K++DFG AK + T Y+APEV
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLG 202
Query: 156 RNFGEVSY--KSDVYSYG 171
Y D++S G
Sbjct: 203 PE----KYDKSCDMWSLG 216
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-14
Identities = 32/91 (35%), Positives = 44/91 (48%), Gaps = 15/91 (16%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTGA 142
I + YLH I+H D+KP N+L D KI+DFGL+KI + M
Sbjct: 157 ILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTV 210
Query: 143 RGTVGYIAPEVFCRNFGEVSY--KSDVYSYG 171
GT GY APE+ +Y + D++S G
Sbjct: 211 CGTPGYCAPEILRGC----AYGPEVDMWSVG 237
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-14
Identities = 56/201 (27%), Positives = 80/201 (39%), Gaps = 35/201 (17%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIK--------------VLNETKGFCFEGHRR--ALI 49
+G G YG V G VAIK E H L+
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 50 YEFVSNGSLEKF--IYEKHPL-ETN------QKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
F SL F Y P +T+ K E + + + +GL+Y+H
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA---G 146
Query: 101 ILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGE 160
++H D+KP N+ ++ED KI DFGLA R + MTG T Y APEV ++
Sbjct: 147 VVHRDLKPGNLAVNEDCELKILDFGLA-----RHADAEMTGYVVTRWYRAPEVIL-SWMH 200
Query: 161 VSYKSDVYSYGMMVFEMTGVK 181
+ D++S G ++ EM K
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGK 221
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT 145
+ L+ +H + +H D+KP N+LLD+ K++DFG + + T A GT
Sbjct: 177 VVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGT 232
Query: 146 VGYIAPEVFCRNFGEVSYKSDV--YSYGMMVFEM 177
YI+PEV G+ Y + +S G+ ++EM
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 55/207 (26%), Positives = 80/207 (38%), Gaps = 51/207 (24%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKVL---NETKGF----------------------- 39
KLG+G YG VYK + VAIK + +E +G
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 40 --CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
HR LI+E+ N L+K++ + N + V+ + G+ + H
Sbjct: 100 SVIHHNHRLHLIFEYAEN-DLKKYM------DKNPDVSMRVIKSFLYQLINGVNFCHSR- 151
Query: 98 NTRILHFDIKPHNILLDEDFCP-----KISDFGLAKICHGRESIVSMTGARGTVGYIAPE 152
R LH D+KP N+LL KI DFGLA+ I T T+ Y PE
Sbjct: 152 --RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG--IPIRQFTHEIITLWYRPPE 207
Query: 153 VFCRNFGEVSYKS--DVYSYGMMVFEM 177
+ G Y + D++S + EM
Sbjct: 208 IL---LGSRHYSTSVDIWSIACIWAEM 231
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 5e-14
Identities = 55/202 (27%), Positives = 82/202 (40%), Gaps = 45/202 (22%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKVL---NETKGF----------------------- 39
+G+G YG V K + GR VAIK ++ K
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 40 --CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
C + R L++EFV + ++ + E P L ++V+ K I G+ + H
Sbjct: 91 EVCKKKKRWYLVFEFVDH-TILDDL-ELFP----NGLDYQVVQKYLFQIINGIGFCHS-- 142
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
I+H DIKP NIL+ + K+ DFG A+ T Y APE+
Sbjct: 143 -HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVYDDEVATRWYRAPELL--- 196
Query: 158 FGEVSYKS--DVYSYGMMVFEM 177
G+V Y DV++ G +V EM
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEM 218
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 7e-14
Identities = 40/202 (19%), Positives = 78/202 (38%), Gaps = 45/202 (22%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKVL---NETKGF----------------------- 39
K+G+G YG V+K + G+ VAIK +
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 40 --CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
R L++E+ + ++ + +++ + + ++ I + + + H+
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHEL-DRYQ----RGVPEHLVKSITWQTLQAVNFCHK-- 120
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
+H D+KP NIL+ + K+ DFG A++ G T Y +PE+
Sbjct: 121 -HNCIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSDYYDDEVATRWYRSPELL--- 174
Query: 158 FGEVSYKS--DVYSYGMMVFEM 177
G+ Y DV++ G + E+
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAEL 196
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-14
Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 62/220 (28%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRAL----IYEFVSNGS----- 57
KLG G + V+ K +++ +VA+K++ K + A + + V++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKED 81
Query: 58 ----------LEKFIY----EKH------PLETN----------QKLKWEVLYKIAVGIA 87
L+ F + H L N + + + +I+ +
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 141
Query: 88 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCP------KISDFGLAKICHGRESIVSMTG 141
GL+Y+HR C I+H DIKP N+L++ P KI+D G A C E +
Sbjct: 142 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSIQ 197
Query: 142 ARGTVGYIAPEVFCRNFG-EVSYKSDVYSYGMMVFEM-TG 179
R Y +PEV G +D++S ++FE+ TG
Sbjct: 198 TR---EYRSPEVL---LGAPWGCGADIWSTACLIFELITG 231
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-13
Identities = 51/214 (23%), Positives = 84/214 (39%), Gaps = 73/214 (34%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIKVLN--------------------------------- 34
LG G +G V G+ L G VA+K+LN
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 35 --ETKGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEY 92
T F ++ E+VS G E F Y + + +++ ++ I ++Y
Sbjct: 79 VISTPTDFF------MVMEYVSGG--ELFDY----ICKHGRVEEMEARRLFQQILSAVDY 126
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR------GTV 146
HR ++H D+KP N+LLD KI+DFGL+ + M+ G+
Sbjct: 127 CHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM---------MSDGEFLRTSCGSP 174
Query: 147 GYIAPEVFCRNFGEVSY---KSDVYSYGMMVFEM 177
Y APEV Y + D++S G++++ +
Sbjct: 175 NYAAPEVISGR----LYAGPEVDIWSCGVILYAL 204
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 53/206 (25%), Positives = 83/206 (40%), Gaps = 38/206 (18%)
Query: 63 YEKHPLETNQKLKWEVLYKIAVGIARGLEYL-HRGCNTRILHFDIKPHNILLDEDFCPKI 121
E L E L + +A+G+E+L R C +H D+ NILL E KI
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKI 234
Query: 122 SDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT--- 178
DFGLA+ + V AR + ++APE + +SDV+S+G++++E+
Sbjct: 235 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETI--FDRVYTIQSDVWSFGVLLWEIFSLG 292
Query: 179 -----GVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMI-LVSL 232
GVK + +RL+ +G +Y + L
Sbjct: 293 ASPYPGVKIDEE--------------FCRRLK-------EGTRMRA-PDYTTPEMYQTML 330
Query: 233 WCIQNNPSDRPAMNRVVEMLEGSLDS 258
C PS RP + +VE L L +
Sbjct: 331 DCWHGEPSQRPTFSELVEHLGNLLQA 356
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 41/206 (19%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKVL---NETKGFCFEGHR-----RAL-------IY 50
K+GQG +G V+K + G+ VA+K + NE +GF R + L +
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 82
Query: 51 EFVSNGSLEK----------FIYEKHPLET-----NQKLKWEVLYKIAVGIARGLEYLHR 95
E + F + +H L K + ++ + GL Y+HR
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 142
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH--GRESIVSMTGARGTVGYIAPEV 153
+ILH D+K N+L+ D K++DFGLA+ T T+ Y PE+
Sbjct: 143 ---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 199
Query: 154 FCRNFGEVSYKS--DVYSYGMMVFEM 177
GE Y D++ G ++ EM
Sbjct: 200 L---LGERDYGPPIDLWGAGCIMAEM 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 58/204 (28%), Positives = 86/204 (42%), Gaps = 44/204 (21%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIK--------------VLNETKGFCFEGHRR--ALIYE 51
+G G YG V G VAIK E + H L+
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 52 FVSNGSLEKF--IYEKHPL-ETN-------QKLKWE----VLYKIAVGIARGLEYLHRGC 97
F + +L+ F Y P T+ +KL + ++Y++ +GL Y+H
Sbjct: 93 FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML----KGLRYIHAA- 147
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
I+H D+KP N+ ++ED KI DFGLA R++ MTG T Y APEV N
Sbjct: 148 --GIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEMTGYVVTRWYRAPEVIL-N 199
Query: 158 FGEVSYKSDVYSYGMMVFEMTGVK 181
+ + D++S G ++ EM K
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 2e-13
Identities = 62/216 (28%), Positives = 91/216 (42%), Gaps = 70/216 (32%)
Query: 9 LGQGGYGGVYKGKLLDGRNV----AIKVLN----------ETKG---------------- 38
LGQG +G V+ K + G + A+KVL TK
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 39 -FCFEGHRRA-LIYEFVSNGSL-------EKFIYEKHPLETNQKLKWEVLYKIAVGIARG 89
+ F+ + LI +F+ G L F + Y +A
Sbjct: 92 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF-----------TEEDVKFY--LAELALA 138
Query: 90 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR---GTV 146
L++LH + I++ D+KP NILLDE+ K++DFGL+K ESI A GTV
Sbjct: 139 LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-----ESIDHEKKAYSFCGTV 190
Query: 147 GYIAPEVFCRNFGEVSYKSDV--YSYGMMVFEM-TG 179
Y+APEV R + +S+G+++FEM TG
Sbjct: 191 EYMAPEVVNRR----GHTQSADWWSFGVLMFEMLTG 222
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 27/95 (28%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT 145
+ ++ +H +H DIKP NIL+D + +++DFG ++ S A GT
Sbjct: 184 MVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGT 239
Query: 146 VGYIAPEVF-CRNFGEVSYKSDV--YSYGMMVFEM 177
YI+PE+ G+ Y + +S G+ ++EM
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEM 274
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 40/201 (19%), Positives = 73/201 (36%), Gaps = 55/201 (27%)
Query: 6 KNKLGQGGYGGVYKG-KLLDGRNVAIKVLNETK------------------------GFC 40
LG+G + K + A+K++++
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 41 FEGHRRALIYEFVSNGSL-EKFIYEKHPLETNQKLKWEVLYKIAVGIAR----GLEYLHR 95
+ L+ E ++ G L E+ +KH E A I R + ++H
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSE-----------TEASYIMRKLVSAVSHMH- 123
Query: 96 GCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPE 152
+ ++H D+KP N+L +++ KI DFG A++ + T+ Y APE
Sbjct: 124 --DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTPCFTLHYAAPE 179
Query: 153 VFCRNFGEVSY--KSDVYSYG 171
+ +N Y D++S G
Sbjct: 180 LLNQN----GYDESCDLWSLG 196
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-13
Identities = 46/210 (21%), Positives = 75/210 (35%), Gaps = 58/210 (27%)
Query: 6 KNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFE-------------GH------- 44
++ LG+G + V L+ + A+K++ + G GH
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 45 -------RRALIYEFVSNGSL-EKFIYEKHPLETNQKLKWEVLYKIAVGIAR----GLEY 92
R L++E + GS+ +H E A + + L++
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE-----------LEASVVVQDVASALDF 126
Query: 93 LHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTGAR-----G 144
LH N I H D+KP NIL ++ KI DF L ++ G
Sbjct: 127 LH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 145 TVGYIAPEVFCRNFGEV-SY--KSDVYSYG 171
+ Y+APEV E Y + D++S G
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 28/97 (28%), Positives = 45/97 (46%), Gaps = 9/97 (9%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT 145
I ++ +H +H DIKP NILLD +++DFG ++ S+ A GT
Sbjct: 171 IVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGT 226
Query: 146 VGYIAPEVFCRNFGEVSYKS-----DVYSYGMMVFEM 177
Y++PE+ G S D ++ G+ +EM
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 4e-13
Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 44/201 (21%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKV--LNETKGF------------------------ 39
+KLG+G Y VYKGK L VA+K L +G
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 40 -CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
L++E++ L++++ + + +K + RGL Y HR
Sbjct: 68 IIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVK-----LFLFQLLRGLAYCHR--- 118
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
++LH D+KP N+L++E K++DFGLA+ + T+ Y P++
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPPDIL---L 173
Query: 159 GEVSYKS--DVYSYGMMVFEM 177
G Y + D++ G + +EM
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEM 194
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 4e-13
Identities = 55/214 (25%), Positives = 85/214 (39%), Gaps = 73/214 (34%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIKVLN--------------------------------- 34
LG G +G V GK L G VA+K+LN
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 35 --ETKGFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEY 92
T F ++ E+VS G E F Y + N +L + ++ I G++Y
Sbjct: 84 VISTPSDIF------MVMEYVSGG--ELFDY----ICKNGRLDEKESRRLFQQILSGVDY 131
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR------GTV 146
HR ++H D+KP N+LLD KI+DFGL+ + M+ G+
Sbjct: 132 CHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM---------MSDGEFLRTSCGSP 179
Query: 147 GYIAPEVFCRNFGEVSY---KSDVYSYGMMVFEM 177
Y APEV Y + D++S G++++ +
Sbjct: 180 NYAAPEVISGR----LYAGPEVDIWSSGVILYAL 209
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-13
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 46/209 (22%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKVLN--ETKGFCFEGHRRAL--------------- 48
+ +G+G YG V L+ VAIK ++ E + +C +R L
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC----QRTLREIKILLRFRHENII 88
Query: 49 -IYEFVSNGSLEKF--IYEKHPL-ETN-------QKLKWE----VLYKIAVGIARGLEYL 93
I + + ++E+ +Y L ET+ Q L + LY+I RGL+Y+
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL----RGLKYI 144
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC-HGRESIVSMTGARGTVGYIAPE 152
H +LH D+KP N+LL+ KI DFGLA++ + +T T Y APE
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 153 VFCRNFGEVSYKSDVYSYGMMVFEMTGVK 181
+ N + D++S G ++ EM +
Sbjct: 202 IML-NSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-13
Identities = 54/204 (26%), Positives = 84/204 (41%), Gaps = 52/204 (25%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVL--------NE---TKG-----------------F 39
LG+G +G V K GR A+K+L +E T +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 40 CFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
F+ H R + E+ + G L + + ++ Y I L+YLH N
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA----RFY--GAEIVSALDYLHSEKN 269
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR---GTVGYIAPEVFC 155
+++ D+K N++LD+D KI+DFGL K E I + GT Y+APEV
Sbjct: 270 --VVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYLAPEVLE 322
Query: 156 RNFGEVSYKSDV--YSYGMMVFEM 177
N Y V + G++++EM
Sbjct: 323 DN----DYGRAVDWWGLGVVMYEM 342
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-13
Identities = 57/200 (28%), Positives = 84/200 (42%), Gaps = 36/200 (18%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIK--------------VLNETKGFCFEGHRR--ALIYE 51
+G G YG V G VA+K E + H L+
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 52 FVSNGSLEKF--IYEKHPL-ETN-------QKLKWEVLYKIAVGIARGLEYLHRGCNTRI 101
F SLE+F +Y L + QKL + + + I RGL+Y+H I
Sbjct: 97 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DI 153
Query: 102 LHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEV 161
+H D+KP N+ ++ED KI DFGLA R + MTG T Y APE+ N+
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLA-----RHTADEMTGYVATRWYRAPEIML-NWMHY 207
Query: 162 SYKSDVYSYGMMVFEMTGVK 181
+ D++S G ++ E+ +
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 8e-13
Identities = 38/160 (23%), Positives = 65/160 (40%), Gaps = 46/160 (28%)
Query: 7 NKLGQGGYGGVYKGK--LLDGRNVAIKVL---NETKGF---------------------- 39
++G+G YG V+K + GR VA+K + +G
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 40 -----------CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIAR 88
+ L++E V L ++ +K P + E + + + R
Sbjct: 77 VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVP---EPGVPTETIKDMMFQLLR 131
Query: 89 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128
GL++LH R++H D+KP NIL+ K++DFGLA+
Sbjct: 132 GLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 9e-13
Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 41/154 (26%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAI-KVLNETKGFCFEG--------------------- 43
+ LG+G + VYK + + VAI K+ + +G
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 44 ------HRRA---LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
++ L+++F+ LE I + + T +K + +GLEYLH
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIK-----AYMLMTLQGLEYLH 129
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128
+ ILH D+KP+N+LLDE+ K++DFGLAK
Sbjct: 130 Q---HWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 9e-13
Identities = 43/199 (21%), Positives = 69/199 (34%), Gaps = 46/199 (23%)
Query: 5 FKNKLGQGGYGGVYKG-KLLDGRNVAIKVLNETKGF---------------------CFE 42
LG G G V + A+K+L + +E
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYE 125
Query: 43 GHRRA-----LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
++ E + G L I ++ ++ E++ I ++YLH
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG----EAIQYLH--- 178
Query: 98 NTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF 154
+ I H D+KP N+L + K++DFG AK S+T T Y+APEV
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVL 235
Query: 155 CRNFGEVSY--KSDVYSYG 171
Y D++S G
Sbjct: 236 GPE----KYDKSCDMWSLG 250
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-12
Identities = 54/204 (26%), Positives = 83/204 (40%), Gaps = 53/204 (25%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVL--------NE---TKG-----------------F 39
LG+G +G V + GR A+K+L +E T +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 40 CFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
F+ H R + E+ + G L + + + Y I LEYLH +
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA----RFY--GAEIVSALEYLH---S 123
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR---GTVGYIAPEVFC 155
+++ DIK N++LD+D KI+DFGL K E I + GT Y+APEV
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAPEVLE 178
Query: 156 RNFGEVSYKSDV--YSYGMMVFEM 177
N Y V + G++++EM
Sbjct: 179 DN----DYGRAVDWWGLGVVMYEM 198
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-12
Identities = 49/205 (23%), Positives = 81/205 (39%), Gaps = 54/205 (26%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVL--------NE---TKG------------------ 38
+G+G Y V +L R A+KV+ + +
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 39 FCFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
CF+ R + E+V+ G L + + L + Y + I+ L YLH
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKL----PEEHARFY--SAEISLALNYLH--- 127
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR---GTVGYIAPEVF 154
I++ D+K N+LLD + K++D+G+ K E + GT YIAPE+
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAPEIL 182
Query: 155 CRNFGEVSY-KS-DVYSYGMMVFEM 177
Y S D ++ G+++FEM
Sbjct: 183 RGE----DYGFSVDWWALGVLMFEM 203
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 45/216 (20%), Positives = 76/216 (35%), Gaps = 55/216 (25%)
Query: 8 KLGQGGYGGVYKGKLLDGRNVAIKVLNETKGFCFEGH--------RRAL----------- 48
+ G YG V G +G VAIK + T + +R L
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 49 -----IYEFVSNGSLEKF--IY----------------EKHPLETNQKLKWEVLYKIAVG 85
+ + + +Y ++ + + Q +++ +Y I
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVI-SPQHIQY-FMYHIL-- 144
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT 145
GL LH ++H D+ P NILL ++ I DF LA+ + + T
Sbjct: 145 --LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTH 196
Query: 146 VGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVK 181
Y APE+ F + D++S G ++ EM K
Sbjct: 197 RWYRAPELVM-QFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 2e-12
Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 62/213 (29%)
Query: 9 LGQGGYGGVYKGKLLDGRNV----AIKVL---------NE---TKG-------------- 38
LG+GGYG V++ + + G N A+KVL + TK
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 39 ---FCFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWE--VLYKIAVGIARGLEY 92
+ F+ + LI E++S G L F+ LE + Y I+ L +
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGEL--FMQ----LEREGIFMEDTACFY--LAEISMALGH 136
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR---GTVGYI 149
LH I++ D+KP NI+L+ K++DFGL K ESI T GT+ Y+
Sbjct: 137 LH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-----ESIHDGTVTHTFCGTIEYM 188
Query: 150 APEVFCRNFGEVSYKSDV--YSYGMMVFEM-TG 179
APE+ R+ + V +S G ++++M TG
Sbjct: 189 APEILMRS----GHNRAVDWWSLGALMYDMLTG 217
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 54/205 (26%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVL--------NE---TKG------------------ 38
LG+G +G V ++ + G A+KVL ++ T
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 39 FCFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
CF+ R + EFV+ G L I + Y A I L +LH
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF----DEARARFY--AAEIISALMFLHDK- 143
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR---GTVGYIAPEVF 154
I++ D+K N+LLD + K++DFG+ K E I + GT YIAPE+
Sbjct: 144 --GIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTTATFCGTPDYIAPEIL 196
Query: 155 CRNFGEVSY-KS-DVYSYGMMVFEM 177
Y + D ++ G++++EM
Sbjct: 197 QEM----LYGPAVDWWAMGVLLYEM 217
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-12
Identities = 41/162 (25%), Positives = 61/162 (37%), Gaps = 48/162 (29%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKVL---NETKGFC---------------------- 40
++G G YG VYK + G VA+K + N G
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 41 --------FEGHRRA------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGI 86
R L++E V L ++ +K P L E + +
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAP---PPGLPAETIKDLMRQF 129
Query: 87 ARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128
RGL++LH I+H D+KP NIL+ K++DFGLA+
Sbjct: 130 LRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 43/157 (27%), Positives = 64/157 (40%), Gaps = 46/157 (29%)
Query: 6 KNKLGQGGYGGVYKGK-LLDGRNVAIKVLN---ETKGFCFEGHRRAL------------- 48
++ +G G YG V + L+ R VAIK + E C +R L
Sbjct: 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDC----KRILREIAILNRLNHDH 113
Query: 49 ---IYEFVSNGSLEKF-----IYE------KHPLETNQKLKWE----VLYKIAVGIARGL 90
+ + V +EKF + E K T L +LY + G+
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLL----VGV 169
Query: 91 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127
+Y+H ILH D+KP N L+++D K+ DFGLA
Sbjct: 170 KYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 34/97 (35%), Positives = 48/97 (49%), Gaps = 17/97 (17%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR-- 143
IA L YLH + I++ D+KP NILLD ++DFGL K E+I +
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-----ENIEHNSTTSTF 199
Query: 144 -GTVGYIAPEVFCRNFGEVSYKSDV--YSYGMMVFEM 177
GT Y+APEV + Y V + G +++EM
Sbjct: 200 CGTPEYLAPEVLHKQ----PYDRTVDWWCLGAVLYEM 232
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 56/203 (27%), Positives = 80/203 (39%), Gaps = 42/203 (20%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIK--------------VLNETKGFCFEGHRR--ALIYE 51
+G G G V + RNVAIK E H+ L+
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 52 FVSNGSLEKF--IYEKHPL-ETN------QKLKWE----VLYKIAVGIARGLEYLHRGCN 98
F SLE+F +Y L + N +L E +LY++ G+++LH
Sbjct: 93 FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML----CGIKHLHSA-- 146
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
I+H D+KP NI++ D KI DFGLA+ + MT T Y APEV
Sbjct: 147 -GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGM- 201
Query: 159 GEVSYKSDVYSYGMMVFEMTGVK 181
D++S G ++ EM
Sbjct: 202 -GYKENVDIWSVGCIMGEMIKGG 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 48/205 (23%), Positives = 81/205 (39%), Gaps = 54/205 (26%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVL--------NE---TKG------------------ 38
+G+G Y V +L R A++V+ + +
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 39 FCFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
CF+ R + E+V+ G L + + L + Y + I+ L YLH
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKL----PEEHARFY--SAEISLALNYLH--- 170
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR---GTVGYIAPEVF 154
I++ D+K N+LLD + K++D+G+ K E + GT YIAPE+
Sbjct: 171 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 155 CRNFGEVSY-KS-DVYSYGMMVFEM 177
Y S D ++ G+++FEM
Sbjct: 226 RGE----DYGFSVDWWALGVLMFEM 246
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-12
Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 54/205 (26%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVL--------NE---TKG------------------ 38
LG+G +G V + A+K+L ++ T
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 39 FCFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
CF+ R + E+V+ G L I + K V Y A IA GL +L
Sbjct: 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF----KEPHAVFY--AAEIAIGLFFLQ--- 138
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR---GTVGYIAPEVF 154
+ I++ D+K N++LD + KI+DFG+ K E+I + GT YIAPE+
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTFCGTPDYIAPEII 193
Query: 155 CRNFGEVSYKSDV--YSYGMMVFEM 177
Y V +++G++++EM
Sbjct: 194 AYQ----PYGKSVDWWAFGVLLYEM 214
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-12
Identities = 30/310 (9%), Positives = 66/310 (21%), Gaps = 105/310 (33%)
Query: 8 KLGQGGYGGVYKGK--LLDGRNVAIKVL----NETKGFCFEGHRRAL------------I 49
G ++ LD R VA+ + E R L +
Sbjct: 38 FHGGVPPLQFWQALDTALD-RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 50 Y-------------EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR- 95
E++ GSL++ ++ +A + HR
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIR------AMQSLAAAADAAHRA 148
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
G + P + + D G + +
Sbjct: 149 G----VALSIDHPSRVRVSID--------GDVVL--------------AYPATMPD---- 178
Query: 156 RNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214
+ + D+ G ++ + W + L
Sbjct: 179 -----ANPQDDIRGIGASLYALLVN------------------RWPLPEAGVRSGLAPAE 215
Query: 215 IENEEDKEYARKMI--------LVSLWCIQNNPSDRPA--MNRVVEMLEGSLDSLRIPPR 264
+ + V+ +Q + R A + +++ D +
Sbjct: 216 RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGP 275
Query: 265 PFLLSSGSQP 274
+ P
Sbjct: 276 IDEAPVSAAP 285
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 6e-12
Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 17/97 (17%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR-- 143
IA GL +L + I++ D+K N++LD + KI+DFG+ K E+I +
Sbjct: 451 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTF 502
Query: 144 -GTVGYIAPEVFCRNFGEVSY-KS-DVYSYGMMVFEM 177
GT YIAPE+ Y KS D +++G++++EM
Sbjct: 503 CGTPDYIAPEIIAYQ----PYGKSVDWWAFGVLLYEM 535
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-12
Identities = 50/216 (23%), Positives = 79/216 (36%), Gaps = 60/216 (27%)
Query: 8 KLGQGGYGGVYKGKLLD---GRNVAIKVLNETKGFCFEGHRRALI------------YEF 52
K+G+G YG VYK K D ++ A+K + E G R + +
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACREIALLRELKHPNVISLQKV 86
Query: 53 VSNGSLEK----FIYEKHPLET-----NQKLKWEVLYKIAVG--------IARGLEYLHR 95
+ + K F Y +H L + ++ G I G+ YLH
Sbjct: 87 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146
Query: 96 GCNTRILHFDIKPHNILLDEDF----CPKISDFGLAKI--------CHGRESIVSMTGAR 143
+LH D+KP NIL+ + KI+D G A++ +V
Sbjct: 147 ---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV------ 197
Query: 144 GTVGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 177
T Y APE+ G Y D+++ G + E+
Sbjct: 198 -TFWYRAPELL---LGARHYTKAIDIWAIGCIFAEL 229
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 8e-12
Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 56/206 (27%)
Query: 9 LGQGGYGGVYKGKLLD-GRNVAIKVL--------NE---TKG------------------ 38
LG+G +G V+ + + AIK L ++ T
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 39 FCFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
F+ + E+++ G L I H + ++ Y A I GL++LH
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA----TFY--AAEIILGLQFLH--- 135
Query: 98 NTRILHFDIKPHNILLDED-FCPKISDFGLAKICHGRESIVSMTGAR---GTVGYIAPEV 153
+ I++ D+K NILLD+D KI+DFG+ K E+++ GT YIAPE+
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHI-KIADFGMCK-----ENMLGDAKTNTFCGTPDYIAPEI 189
Query: 154 FCRNFGEVSY-KS-DVYSYGMMVFEM 177
Y S D +S+G++++EM
Sbjct: 190 LLGQ----KYNHSVDWWSFGVLLYEM 211
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 9e-12
Identities = 35/141 (24%), Positives = 63/141 (44%), Gaps = 31/141 (21%)
Query: 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEV----LYKIAVGIARGLEYLHRGCNTRILH 103
+I E+V + +L K + K + + + + + +Y++ R + ++H + I H
Sbjct: 115 VIMEYVPD-TLHKVL--KSFIRSGRSIPMNLISIYIYQLF----RAVGFIH---SLGICH 164
Query: 104 FDIKPHNILLDEDFCP-KISDFGLAKICHGRESIVSMTGARGTVGYI------APEVFCR 156
DIKP N+L++ K+ DFG AK E V+ YI APE+
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA---------YICSRFYRAPELML- 214
Query: 157 NFGEVSYKSDVYSYGMMVFEM 177
E + D++S G + E+
Sbjct: 215 GATEYTPSIDLWSIGCVFGEL 235
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 55/214 (25%), Positives = 82/214 (38%), Gaps = 53/214 (24%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLN--ETKGFCFEGHRRAL------------- 48
K+ LG+G YG V G VAIK + + F R L
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA----LRTLREIKILKHFKHEN 70
Query: 49 ---IYEFVSNGSLEKF--IYEKHPL-ET-------NQKLKWE----VLYKIAVGIARGLE 91
I+ S E F +Y L +T Q L + +Y+ R ++
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL----RAVK 126
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS--------MTGAR 143
LH ++H D+KP N+L++ + K+ DFGLA+I + S M
Sbjct: 127 VLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 144 GTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
T Y APEV + S DV+S G ++ E+
Sbjct: 184 ATRWYRAPEVML-TSAKYSRAMDVWSCGCILAEL 216
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 58/207 (28%), Positives = 84/207 (40%), Gaps = 46/207 (22%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIK--------------VLNETKGFCFEGHRR--ALI 49
+G G G V + RNVAIK E H+ +L+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 50 YEFVSNGSLEKF--IYEKHPL-ETN------QKLKWE----VLYKIAVGIARGLEYLHRG 96
F +LE+F +Y L + N +L E +LY++ G+++LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML----CGIKHLHSA 183
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156
I+H D+KP NI++ D KI DFGLA+ + MT T Y APEV
Sbjct: 184 G---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 237
Query: 157 NFGEVSYKS--DVYSYGMMVFEMTGVK 181
YK D++S G ++ EM K
Sbjct: 238 M----GYKENVDIWSVGCIMGEMVRHK 260
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 49/216 (22%), Positives = 78/216 (36%), Gaps = 78/216 (36%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRALIYEFVSNGSLEKFIYE--- 64
LG+G +G V + VA+K ++ + + E
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQL--------------LKKSDMHMRVEREISY 62
Query: 65 ----KHP--------LETNQKLKWEVL---------YKIAVG-------------IARGL 90
+HP + T + V+ Y + I +
Sbjct: 63 LKLLRHPHIIKLYDVITTPTDI-VMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 91 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGAR------G 144
EY HR +I+H D+KP N+LLD++ KI+DFGL+ I MT G
Sbjct: 122 EYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNI---------MTDGNFLKTSCG 169
Query: 145 TVGYIAPEVFCRNFGEVSY---KSDVYSYGMMVFEM 177
+ Y APEV Y + DV+S G++++ M
Sbjct: 170 SPNYAAPEVINGK----LYAGPEVDVWSCGIVLYVM 201
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 5/95 (5%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT 145
I LE+LH I++ DIK NILLD + ++DFGL+K E+ + GT
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GT 223
Query: 146 VGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TG 179
+ Y+AP++ D +S G++++E+ TG
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-11
Identities = 49/213 (23%), Positives = 78/213 (36%), Gaps = 47/213 (22%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIK------------VLNETKGFCFEGH---------- 44
LG GG G V+ + VAIK L E K H
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEIL 77
Query: 45 RRALIYEFVSNGSLEKF--IYEKHPL-ETN-------QKLKWE----VLYKIAVGIARGL 90
+ GSL + +Y ET+ L E +Y++ RGL
Sbjct: 78 GPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL----RGL 133
Query: 91 EYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAK-ICHGRESIVSMTGARGTVGY 148
+Y+H +LH D+KP N+ ++ + KI DFGLA+ + ++ T Y
Sbjct: 134 KYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 149 IAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVK 181
+P + + + D+++ G + EM K
Sbjct: 191 RSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 52/207 (25%), Positives = 82/207 (39%), Gaps = 52/207 (25%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRALIYEFVSNG----------S 57
+G+G +G V K ++VA+K++ K F + I E +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 58 LEKFIYEKH------PLETN----------QKLKWEVLYKIAVGIARGLEYLHRGCNTRI 101
LE F + H L N Q ++ K A I + L+ LH+ RI
Sbjct: 165 LENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRI 221
Query: 102 LHFDIKPHNILLDEDFCP--KISDFGLAKICHGRESIVSMTGARGTVGYI------APEV 153
+H D+KP NILL + K+ DFG + C+ + + + YI APEV
Sbjct: 222 IHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYT---------YIQSRFYRAPEV 270
Query: 154 FCRNFGEVSYKSDVYSYGMMVFEM-TG 179
D++S G ++ E+ TG
Sbjct: 271 ILG--ARYGMPIDMWSLGCILAELLTG 295
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 5e-11
Identities = 38/94 (40%), Positives = 53/94 (56%), Gaps = 14/94 (14%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT 145
+ LEYLH + I++ D+KP NILLD++ KI+DFG AK + T GT
Sbjct: 115 VCLALEYLH-SKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYT-LCGT 166
Query: 146 VGYIAPEVFCRNFGEVSY-KS-DVYSYGMMVFEM 177
YIAPEV Y KS D +S+G++++EM
Sbjct: 167 PDYIAPEVVSTK----PYNKSIDWWSFGILIYEM 196
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-11
Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 14/94 (14%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT 145
I EYLH + +++ D+KP N+L+D+ +++DFG AK GR + T GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWT-LCGT 201
Query: 146 VGYIAPEVFCRNFGEVSY-KS-DVYSYGMMVFEM 177
+APE+ Y K+ D ++ G++++EM
Sbjct: 202 PEALAPEIILSK----GYNKAVDWWALGVLIYEM 231
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 5e-10
Identities = 49/204 (24%), Positives = 78/204 (38%), Gaps = 40/204 (19%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRALIYEFVSNGS-------- 57
+ +G+G +G V K ++ VAIK++ K F + + E ++
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 58 --LEKFIYEKH------PLETN----------QKLKWEVLYKIAVGIARGLEYLHRGCNT 99
F++ H L N + + + K A + L +L
Sbjct: 120 HLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-EL 178
Query: 100 RILHFDIKPHNILLDEDFCP--KISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
I+H D+KP NILL KI DFG + C + I +R Y +PEV
Sbjct: 179 SIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSR---FYRSPEVL--- 230
Query: 158 FG-EVSYKSDVYSYGMMVFEM-TG 179
G D++S G ++ EM TG
Sbjct: 231 LGMPYDLAIDMWSLGCILVEMHTG 254
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 6e-10
Identities = 45/157 (28%), Positives = 65/157 (41%), Gaps = 46/157 (29%)
Query: 6 KNKLGQGGYGGVYKGK-LLDGRNVAIKVLN---ETKGFCFEGHRRAL------------- 48
K+ +G+G YG VY +NVAIK +N E C +R L
Sbjct: 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC----KRILREITILNRLKSDY 86
Query: 49 ---IYEFVSNGSLEKF-----IYE------KHPLETNQKLKWE----VLYKIAVGIARGL 90
+Y+ + L KF + E K +T L E +LY + G
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLL----LGE 142
Query: 91 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127
++H I+H D+KP N LL++D K+ DFGLA
Sbjct: 143 NFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-09
Identities = 26/111 (23%), Positives = 48/111 (43%), Gaps = 23/111 (20%)
Query: 86 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGT 145
+ + ++YLH G +LH D+KP NILL+ + K++DFGL++ + +
Sbjct: 118 LIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 146 VG-------------------YIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
Y APE+ + + D++S G ++ E+
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILL-GSTKYTKGIDMWSLGCILGEI 224
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 5e-08
Identities = 51/252 (20%), Positives = 77/252 (30%), Gaps = 91/252 (36%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRALIYEFVSNGS--------- 57
KLG G + V+ + + VA+KV+ + + + + V N
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 58 ---LEKFIYE----KH------PLETN----------QKLKWEVLYKIAVGIARGLEYLH 94
L+ F H L + Q L + KI + +GL+YLH
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH 163
Query: 95 RGCNTRILHFDIKPHNILL----------------------------------------- 113
C I+H DIKP NILL
Sbjct: 164 TKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221
Query: 114 --------DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKS 165
E KI+D G A H + T Y + EV + + +
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGS--GYNTPA 274
Query: 166 DVYSYGMMVFEM 177
D++S M FE+
Sbjct: 275 DIWSTACMAFEL 286
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 37/155 (23%), Positives = 55/155 (35%), Gaps = 46/155 (29%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRALIYEFVSNG---------- 56
K+G G +G + GK L VAIK+ H Y+ + +G
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQL-HLEYRFYKQLGSGDGIPQVYYFG 74
Query: 57 ---------------SLE---KFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
SLE L+T VL IA+ + +EY+H +
Sbjct: 75 PCGKYNAMVLELLGPSLEDLFDLCDRTFSLKT-------VL-MIAIQLISRMEYVH---S 123
Query: 99 TRILHFDIKPHNILLDEDFCPK-----ISDFGLAK 128
+++ D+KP N L+ I DF LAK
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 7e-07
Identities = 32/154 (20%), Positives = 52/154 (33%), Gaps = 37/154 (24%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGF---------------------CFE 42
LG G G V + A+K+L + +E
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYE 81
Query: 43 GHRRA-----LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
++ E + G L I ++ ++ E++ I I YLH
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ----YLH--- 134
Query: 98 NTRILHFDIKPHNILL---DEDFCPKISDFGLAK 128
+ I H D+KP N+L + K++DFG AK
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 33/155 (21%), Positives = 58/155 (37%), Gaps = 46/155 (29%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIK-------------------VLNETKGFC------F 41
++G+G +G +++G LL+ + VAIK +L G
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76
Query: 42 EGHRRALIYEFVSNGSLE---KFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
EG L+ + + SLE K ++T V A + ++ +H
Sbjct: 77 EGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKT-------VA-MAAKQMLARVQSIH---E 124
Query: 99 TRILHFDIKPHNILLDEDFCPK-----ISDFGLAK 128
+++ DIKP N L+ + DFG+ K
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 41/153 (26%), Positives = 59/153 (38%), Gaps = 44/153 (28%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIK-------------------VLNETKGFC------F 41
K+G G +G +Y G + G VAIK ++ G
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75
Query: 42 EGHRRALIYEFVSNGSLE---KFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
EG ++ E + SLE F K L+T VL +A + +EY+H +
Sbjct: 76 EGDYNVMVMELLGP-SLEDLFNFCSRKFSLKT-------VL-LLADQMISRIEYIH---S 123
Query: 99 TRILHFDIKPHNILLDEDFCPK---ISDFGLAK 128
+H D+KP N L+ I DFGLAK
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 6e-06
Identities = 42/153 (27%), Positives = 58/153 (37%), Gaps = 44/153 (28%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIK-------------------VLNETKGFC------F 41
K+G G +G +Y G + VAIK +L G
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV 73
Query: 42 EGHRRALIYEFVSNGSLE---KFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
EG L+ + + SLE F K L+T VL +A + +E++H +
Sbjct: 74 EGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKT-------VL-MLADQMINRVEFVH---S 121
Query: 99 TRILHFDIKPHNILLDEDFCPK---ISDFGLAK 128
LH DIKP N L+ I DFGLAK
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 8e-06
Identities = 50/235 (21%), Positives = 79/235 (33%), Gaps = 84/235 (35%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRAL----IYEFVSNGS----- 57
K+G G +G V + + + + A+KV+ K + R A I + + N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY----TRSAKIEADILKKIQNDDINNNN 97
Query: 58 ----LEKFIYEKHP--------------LETNQK--LKWEVLYKIAVGIARGLEYLHRGC 97
KF+Y H + N E + + I + L YL +
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK-- 155
Query: 98 NTRILHFDIKPHNILLDEDFCP-------------------------KISDFGLAKICHG 132
+ H D+KP NILLD+ + K+ DFG A
Sbjct: 156 -MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFK 212
Query: 133 RESIVSMTGARGTVGYI------APEVFCRNFG-EVSYKSDVYSYGMMVFEM-TG 179
+ S I APEV SD++S+G ++ E+ TG
Sbjct: 213 SDYHGS---------IINTRQYRAPEVI---LNLGWDVSSDMWSFGCVLAELYTG 255
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 1e-05
Identities = 25/144 (17%), Positives = 45/144 (31%), Gaps = 27/144 (18%)
Query: 41 FEGHRRALIYEFVSNG-SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
F+ + ++ EF G LE+ + I + L
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQM--------RTKLSSLATAKSILHQLTASLAVAEASLR- 182
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKIC----HGRE-SIVSMTGARGTVG------- 147
H D+ N+LL + K+ K G + SI+ T +R
Sbjct: 183 -FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCD 241
Query: 148 -YIAPEVFCRNFGEVSYKSDVYSY 170
+ ++F G+ Y+ D+Y
Sbjct: 242 VSMDEDLFT---GDGDYQFDIYRL 262
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 2e-05
Identities = 16/86 (18%), Positives = 30/86 (34%), Gaps = 1/86 (1%)
Query: 8 KLGQGGYGGVYKGKLLDGRNVAIKVLNETKGFCFEGHRRALIYEFVSNGSLEKFIYEKHP 67
K+G+G +G V++ D VAIK++ G + E + + K +
Sbjct: 27 KIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 68 LETNQKLKWEVLYKIAVGIARGLEYL 93
N+ + L + L
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLL 111
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 41/233 (17%), Positives = 68/233 (29%), Gaps = 84/233 (36%)
Query: 8 KLGQGGYGGVYKG--KLLDGRNVAIKVLNETKGFCFEGHRRALI---------------- 49
LG+G +G V + VA+K++ + A +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY----REAARLEINVLKKIKEKDKENK 81
Query: 50 YEFVSNGSLEKFIYEKH------PLETN----------QKLKWEVLYKIAVGIARGLEYL 93
+ V + F + H L N Q + +A + L +L
Sbjct: 82 FLCVL--MSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCP-------------------KISDFGLAKICHGRE 134
H ++ H D+KP NIL +++DFG A E
Sbjct: 140 HE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHE 194
Query: 135 SIVSMTGARGTVGYI------APEVFCRNFG-EVSYKSDVYSYGMMVFEM-TG 179
+ + PEV + DV+S G ++FE G
Sbjct: 195 HHTT---------IVATRHYRPPEVI---LELGWAQPCDVWSIGCILFEYYRG 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 31/168 (18%), Positives = 52/168 (30%), Gaps = 57/168 (33%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKV-----------LNETK------------------ 37
K+G GG+G +Y A V +E K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 38 -----------GF----CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKI 82
G R ++ E + L+K N K + ++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKI------SGQNGTFKKSTVLQL 156
Query: 83 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI--SDFGLAK 128
+ + LEY+H +H DIK N+LL ++ +D+GL+
Sbjct: 157 GIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-05
Identities = 29/167 (17%), Positives = 52/167 (31%), Gaps = 52/167 (31%)
Query: 8 KLGQGGYGGVYKGKLLDGRNV------AIKVLNETKGFCFEGHRRALIYEFVSNGSLEKF 61
+GQGG+G +Y + +V +KV G F + Y+ + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELK---FYQRAAKPEQIQK 98
Query: 62 IYEKHPL-------------ETNQKLKWEVL-------------------------YKIA 83
L + + +++
Sbjct: 99 WIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLS 158
Query: 84 VGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI--SDFGLAK 128
+ I LEY+H +H DIK N+LL+ ++ D+GLA
Sbjct: 159 LRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 21/173 (12%), Positives = 45/173 (26%), Gaps = 62/173 (35%)
Query: 7 NKLGQGGYGGVYKGKLLDGRN---------VAIKV-------LNETKGFCFEGHRRALIY 50
+ + G +Y+ ++K+ NE F +
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 51 EFVSNG-----------------------------SLEKFIYEKH----PLETNQKLKWE 77
SL+ + +
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERS------- 160
Query: 78 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI--SDFGLAK 128
VL ++A + LE+LH +H ++ NI +D + ++ + +G A
Sbjct: 161 VL-QVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 5e-05
Identities = 46/233 (19%), Positives = 75/233 (32%), Gaps = 84/233 (36%)
Query: 8 KLGQGGYGGVYKGK--LLDGRNVAIKVLNETKGFCFEGHRRALI---------------- 49
LG+G +G V + GR+VA+K++ + A
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY----CEAARSEIQVLEHLNTTDPNST 76
Query: 50 YEFVSNGSLEKFIYEKH------PLETN----------QKLKWEVLYKIAVGIARGLEYL 93
+ V LE F + H L + + + + K+A I + + +L
Sbjct: 77 FRCVQ--MLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCP-------------------KISDFGLAKICHGRE 134
H ++ H D+KP NIL + K+ DFG A + E
Sbjct: 135 HS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDE 189
Query: 135 SIVSMTGARGTVGYI------APEVFCRNFG-EVSYKSDVYSYGMMVFEM-TG 179
+ + APEV S DV+S G ++ E G
Sbjct: 190 HHST---------LVSTRHYRAPEVI---LALGWSQPCDVWSIGCILIEYYLG 230
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 291 | |||
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.98 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.91 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.77 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.58 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.29 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.19 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.11 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.03 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.88 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.8 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.76 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.62 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.57 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.44 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.32 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.95 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.73 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.71 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.64 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.81 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.83 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.9 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 92.33 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 91.48 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 90.42 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 89.94 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.16 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.35 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 84.26 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.38 |
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-53 Score=361.17 Aligned_cols=238 Identities=23% Similarity=0.237 Sum_probs=190.4
Q ss_pred hhcccccCCceeEEEEEecC-CCeEEEEEeccCc---------------------ceeecCCcceeeehhhcCCCHHHHH
Q 022826 5 FKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK---------------------GFCFEGHRRALIYEFVSNGSLEKFI 62 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---------------------~~~~~~~~~~lv~e~~~~g~L~~~l 62 (291)
+.++||+|+||.||+|++.. |+.||||+++... +.+.++...|+|||||++|+|.+++
T Consensus 62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l 141 (336)
T 4g3f_A 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI 141 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHH
T ss_pred eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHH
Confidence 45789999999999998854 9999999998655 5677788899999999999999999
Q ss_pred hhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC-ceEEeccCCccccCCCCce---ee
Q 022826 63 YEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-CPKISDFGLAKICHGRESI---VS 138 (291)
Q Consensus 63 ~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~---~~ 138 (291)
.+. ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.+| .+||+|||+++........ ..
T Consensus 142 ~~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~ 212 (336)
T 4g3f_A 142 KQM------GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212 (336)
T ss_dssp HHH------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred HHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence 765 479999999999999999999999 9999999999999999988 6999999999876543221 12
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCCh
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 218 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (291)
....+||+.|+|||++.+. .++.++|||||||++|+|++|..||........ +. ..... ......
T Consensus 213 ~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~-----~i~~~-----~~~~~~ 277 (336)
T 4g3f_A 213 GDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CL-----KIASE-----PPPIRE 277 (336)
T ss_dssp -CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HH-----HHHHS-----CCGGGG
T ss_pred CCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HH-----HHHcC-----CCCchh
Confidence 2345799999999999886 789999999999999999999999975433211 00 11000 000011
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCCCCc
Q 022826 219 EDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPF 266 (291)
Q Consensus 219 ~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~ 266 (291)
.+..++..+.+|+.+||+.||++|||+.|+++.|...+..+..-..|.
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw 325 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW 325 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCS
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCC
Confidence 234567789999999999999999999999999999888776554443
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=352.00 Aligned_cols=236 Identities=28% Similarity=0.445 Sum_probs=180.1
Q ss_pred hhhcccccCCceeEEEEEecCCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhcC
Q 022826 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
.+.++||+|+||+||+|++.+ .||||+++... +++. ....++|||||++
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~g 115 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEG 115 (307)
T ss_dssp CEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSS
T ss_pred EEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCC
Confidence 467899999999999998643 69999987543 5544 4568999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
|+|.+++... ...+++..+..|+.|++.||.|||+ ++||||||||+||||+.++.+||+|||+|+.......
T Consensus 116 GsL~~~l~~~-----~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 116 SSLYKHLHVQ-----ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CBHHHHHHTS-----CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999754 2579999999999999999999999 9999999999999999999999999999987654433
Q ss_pred eeeccCCCCCccccCccccccc-CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~-~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
........||+.|+|||++.+. .+.++.++|||||||++|||++|+.||...... ....... ......+.
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-------~~~~~~~--~~~~~~p~ 258 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-------DQIIFMV--GRGYASPD 258 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHH--HTTCCCCC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-------HHHHHHH--hcCCCCCC
Confidence 3334556799999999999754 236899999999999999999999998754221 0001110 00111111
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCC
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLR 260 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 260 (291)
.......++..+.+|+.+||+.||++|||+.|+++.|+.+...+.
T Consensus 259 -~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 259 -LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp -STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred -cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 112234567789999999999999999999999999998766553
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=353.39 Aligned_cols=235 Identities=23% Similarity=0.402 Sum_probs=187.0
Q ss_pred hhhcccccCCceeEEEEEec------CCCeEEEEEeccCc--------------------------ceeecCCcceeeeh
Q 022826 4 SFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e 51 (291)
.+++.||+|+||.||+|++. ++..||||+++... +++.++...++|||
T Consensus 16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 95 (299)
T 4asz_A 16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 95 (299)
T ss_dssp EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 45689999999999999864 36789999997654 78888889999999
Q ss_pred hhcCCCHHHHHhhcCC-------CCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEecc
Q 022826 52 FVSNGSLEKFIYEKHP-------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 124 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Df 124 (291)
||++|+|.+++..... ......+++..++.|+.|++.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEECCc
Confidence 9999999999976421 1234679999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhh
Q 022826 125 GLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKR 203 (291)
Q Consensus 125 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~ 203 (291)
|+++...............+|+.|+|||.+.+. .++.++|||||||++|||+| |+.||..... ......
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~~~~ 242 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEVIEC 242 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHH
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHH
Confidence 999876554433333445689999999999876 89999999999999999998 8888865321 111111
Q ss_pred hhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 204 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
.... .....+..++.++.+|+.+||+.||++|||+.++.+.|+++.+.
T Consensus 243 i~~~-------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 243 ITQG-------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcC-------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111 11122334667899999999999999999999999999987653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-52 Score=352.05 Aligned_cols=233 Identities=24% Similarity=0.396 Sum_probs=186.2
Q ss_pred chhhcccccCCceeEEEEEec------CCCeEEEEEeccCc---------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK---------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv 49 (291)
..+.++||+|+||.||+|.+. +++.||||+++... +++.+....++|
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 456789999999999999863 36789999997543 778888899999
Q ss_pred ehhhcCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCce
Q 022826 50 YEFVSNGSLEKFIYEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 119 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~ 119 (291)
||||++|+|.++|...... .....+++..+..|+.||+.||.|||+ ++||||||||+||||+.++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCCE
Confidence 9999999999999764321 123568999999999999999999999 999999999999999999999
Q ss_pred EEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchh
Q 022826 120 KISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPH 198 (291)
Q Consensus 120 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~ 198 (291)
||+|||+++...............||+.|+|||.+.+. .++.++|||||||++|||++ |..||..... .
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--------~ 254 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------Q 254 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--------H
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCH--------H
Confidence 99999999876544333334556789999999999876 89999999999999999998 7777764321 1
Q ss_pred hhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 199 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
....... .+...+.+..++..+.+|+.+||+.||++|||+.||++.|+..
T Consensus 255 ~~~~~i~-------~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 255 DVVEMIR-------NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHH-------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHH-------cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111111 1111122344667899999999999999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=353.57 Aligned_cols=233 Identities=23% Similarity=0.384 Sum_probs=179.3
Q ss_pred hhcccccCCceeEEEEEec------CCCeEEEEEeccCc--------------------------ceeecCCcceeeehh
Q 022826 5 FKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~ 52 (291)
+.++||+|+||.||+|++. +++.||||+++... +++.+....++||||
T Consensus 45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4688999999999999864 37789999997654 778888899999999
Q ss_pred hcCCCHHHHHhhcCCC---------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEec
Q 022826 53 VSNGSLEKFIYEKHPL---------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISD 123 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~---------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~D 123 (291)
|++|+|.++++..... ....++++..++.|+.|++.||.|||+ ++|+||||||+||||+.++.+||+|
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEcc
Confidence 9999999999775321 123579999999999999999999999 9999999999999999999999999
Q ss_pred cCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhh
Q 022826 124 FGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYK 202 (291)
Q Consensus 124 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~ 202 (291)
||+++...............||+.|+|||++.+. .++.++|||||||++|||++ |+.||..... .....
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~~~ 271 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--------TEAID 271 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------HHHHH
T ss_pred cccceeccCCCcceecCcccccccccChhhhcCC--CCCccccccchHHHHHHHHcCCCCCCCCCCH--------HHHHH
Confidence 9999876544433333456789999999999876 89999999999999999998 8888865321 11111
Q ss_pred hhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 203 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
..... .....+..++.++.+|+.+||+.||++|||+.|+++.|+.+.+
T Consensus 272 ~i~~g-------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 272 CITQG-------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHT-------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHcC-------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11111 1112233466789999999999999999999999999999765
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=352.87 Aligned_cols=221 Identities=22% Similarity=0.291 Sum_probs=181.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.++||+|+||.||+|++. +|+.||||++.... +.+.+++..|+|||||++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 445688999999999999885 49999999996543 667778899999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
|+|.+++.+ .++++..++.++.||+.||.|||+ ++|+||||||+||||+.+|.+||+|||+++.+.....
T Consensus 156 g~L~~~l~~-------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 156 GALTDIVTH-------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp EEHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CcHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999964 369999999999999999999999 9999999999999999999999999999987654332
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ........ . ....
T Consensus 226 --~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~---~--~~~~ 288 (346)
T 4fih_A 226 --RRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIR---D--NLPP 288 (346)
T ss_dssp --CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHH---H--SSCC
T ss_pred --cccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHH---c--CCCC
Confidence 23456899999999999876 789999999999999999999999975321 11111111 1 0111
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.......++.++.+|+.+||+.||++|||+.|+++
T Consensus 289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 12223456788999999999999999999999876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=359.35 Aligned_cols=222 Identities=24% Similarity=0.368 Sum_probs=175.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|++. +|+.||||++.... +.+.++...|+|||||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~ 105 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC 105 (350)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 456688999999999999875 49999999997653 6677788999999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+|+|.+++... ....+++..++.++.||+.||.|||+ ++|+||||||+||||+.+|.+||+|||+++.....
T Consensus 106 ~gg~L~~~i~~~----~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 106 EGGDLFKRINAQ----KGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp TTCBHHHHHHHT----TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCcHHHHHHHc----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999764 33568999999999999999999999 99999999999999999999999999999865432
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
.. .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ........ .-..+
T Consensus 179 ~~--~~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~---~~~~~ 243 (350)
T 4b9d_A 179 VE--LARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSM--------KNLVLKII---SGSFP 243 (350)
T ss_dssp HH--HHHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHH---HTCCC
T ss_pred cc--cccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHH---cCCCC
Confidence 11 12345689999999999886 789999999999999999999999975421 11111111 11111
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.....++.++.+|+.+||+.||++|||+.|+++
T Consensus 244 ----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 ----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122346778999999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=351.22 Aligned_cols=220 Identities=22% Similarity=0.348 Sum_probs=182.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||+||+|++. +++.||||++.+.. +.+.++...|+||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 567799999999999999875 49999999997532 566778889999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
|.+|+|.+++.+. ..+++..++.+++||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+++.+..
T Consensus 114 ~~gG~L~~~i~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 114 AKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999765 579999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
..........+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ........ ...+.
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~-~~~~~- 252 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNE--------GLIFAKII-KLEYD- 252 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HTCCC-
T ss_pred CCCcccccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-cCCCC-
Confidence 4444445667899999999999886 789999999999999999999999975421 11111111 11111
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVV 249 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell 249 (291)
.+..++.++.+|+.+||+.||++|||++|++
T Consensus 253 ------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 ------FPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ------CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1234567889999999999999999999863
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=343.28 Aligned_cols=247 Identities=24% Similarity=0.338 Sum_probs=181.2
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCC----cceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGH----RRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~----~~~lv~e~~ 53 (291)
+.++++||+|+||+||+|++ +|+.||||+++... +++.... ..++|||||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 34679999999999999987 78999999997654 3444332 468999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCC-----CCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC-----NTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~-----~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
++|+|.++++. .+++++.+.+++.|++.||.|||+.. ..+|+||||||+|||++.++++||+|||+++
T Consensus 84 ~~gsL~~~l~~-------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 84 EHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp TTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCcHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999965 36899999999999999999999810 1299999999999999999999999999998
Q ss_pred ccCCCCceee--ccCCCCCccccCcccccccC----CCccccccchhHHHHHHHHhCCCCCCccccCCCccccc------
Q 022826 129 ICHGRESIVS--MTGARGTVGYIAPEVFCRNF----GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF------ 196 (291)
Q Consensus 129 ~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~----~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~------ 196 (291)
.......... .....||+.|+|||++.+.. ..++.++|||||||++|||++|..|+.........+.-
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 7654433222 23456899999999997541 24678999999999999999998776544332111100
Q ss_pred hhhhhhhhhhhhhhcccCCCC-hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 197 PHWVYKRLELEEDLGLQGIEN-EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
............... +..+. .........+.+|+.+||+.||++|||+.|+++.|+++.++
T Consensus 237 ~~~~~~~~~~~~~~r-p~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHTTSCCC-CCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhcccCC-CCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 000000000001111 11111 12335677899999999999999999999999999998664
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=337.98 Aligned_cols=218 Identities=25% Similarity=0.384 Sum_probs=172.1
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceee----cCCcceeee
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCF----EGHRRALIY 50 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~----~~~~~~lv~ 50 (291)
.+.+.||+|+||.||+|.+.. ++.||+|++.... +.+. .+...++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 456789999999999998754 8999999987543 2222 234578999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCC--eeeeccCCCceEEc-CCCceEEeccCCc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR--ILHFDIKPHNILLD-EDFCPKISDFGLA 127 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~dikp~Nill~-~~~~~kl~Dfg~~ 127 (291)
|||.+|+|.+++.+. ..+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||+|
T Consensus 109 Ey~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp ECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred eCCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 999999999999765 579999999999999999999999 88 99999999999997 4799999999999
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
+...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ......
T Consensus 180 ~~~~~~~----~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-------~~~~~~---- 241 (290)
T 3fpq_A 180 TLKRASF----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRR---- 241 (290)
T ss_dssp GGCCTTS----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHH----
T ss_pred EeCCCCc----cCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-------HHHHHH----
Confidence 8644332 234679999999999864 5899999999999999999999998643221 101111
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
+.....+...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 242 --i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 242 --VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --HHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111112223334567899999999999999999999976
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=354.01 Aligned_cols=221 Identities=22% Similarity=0.291 Sum_probs=180.9
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.++||+|+||.||+|++.. |+.||||++.... +.+..++..|+|||||.+
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 4456889999999999998854 9999999997544 567778899999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
|+|.+++.. .++++..++.+++||+.||.|||+ ++|+||||||+||||+.+|.+||+|||++..+.....
T Consensus 233 G~L~~~i~~-------~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 233 GALTDIVTH-------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp EEHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CcHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999964 369999999999999999999999 9999999999999999999999999999987654332
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
.....+||+.|+|||++.+. .|+.++|||||||++|+|++|..||..... ........ .. ...
T Consensus 303 --~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~---~~--~~~ 365 (423)
T 4fie_A 303 --RRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIR---DN--LPP 365 (423)
T ss_dssp --CBCCCEECTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHH---HS--CCC
T ss_pred --cccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHH---cC--CCC
Confidence 23456799999999999876 899999999999999999999999865321 11111111 10 011
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.......++..+.+||.+||..||++|||+.|+++
T Consensus 366 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 366 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11223346778999999999999999999999987
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=335.38 Aligned_cols=218 Identities=24% Similarity=0.368 Sum_probs=165.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||+||+|++. +|+.||||++++.. +.+......|+||||
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 94 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY 94 (275)
T ss_dssp CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 456789999999999999875 49999999997543 567778889999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
| +|+|.+++..+ ..+++..++.+++||+.||.|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 95 ~-~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 95 A-GNELFDYIVQR------DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp C-CEEHHHHHHHS------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred C-CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9 67999999765 579999999999999999999999 9999999999999999999999999999986544
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
.. .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||..... ........ ....
T Consensus 165 ~~---~~~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvily~lltg~~PF~~~~~--------~~~~~~i~-~~~~-- 229 (275)
T 3hyh_A 165 GN---FLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYVMLCRRLPFDDESI--------PVLFKNIS-NGVY-- 229 (275)
T ss_dssp -------------CTTSCHHHHSSS-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HTCC--
T ss_pred CC---ccCCeeECcccCChhhhcCC-CCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH-cCCC--
Confidence 32 22456799999999999876 2346899999999999999999999975321 11111111 1111
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..+..++.++.+|+.+||+.||++|||+.|+++
T Consensus 230 -----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 -----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 112335678899999999999999999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=345.57 Aligned_cols=236 Identities=28% Similarity=0.417 Sum_probs=186.2
Q ss_pred hhhcccccCCceeEEEEEecC------CCeEEEEEeccCc----------------------------ceeec-CCccee
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD------GRNVAIKVLNETK----------------------------GFCFE-GHRRAL 48 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~----------------------------~~~~~-~~~~~l 48 (291)
.+++.||+|+||.||+|.+.. ++.||||+++... +.+.+ +...++
T Consensus 67 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~i 146 (353)
T 4ase_A 67 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 146 (353)
T ss_dssp EEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred EEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEE
Confidence 467899999999999997643 3579999987543 44544 456899
Q ss_pred eehhhcCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCc
Q 022826 49 IYEFVSNGSLEKFIYEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 118 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~ 118 (291)
|||||++|+|.++|+..... .....+++..+..++.||+.||.|||+ ++||||||||+|||++.++.
T Consensus 147 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~ 223 (353)
T 4ase_A 147 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNV 223 (353)
T ss_dssp EEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeCCCCC
Confidence 99999999999999764210 113568999999999999999999999 99999999999999999999
Q ss_pred eEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccch
Q 022826 119 PKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFP 197 (291)
Q Consensus 119 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~ 197 (291)
+||+|||+|+...............+|+.|+|||++.+. .++.++|||||||++|||++ |..||......
T Consensus 224 vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~------- 294 (353)
T 4ase_A 224 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------- 294 (353)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-------
T ss_pred EEECcchhhhhcccCCCceeeccccccccccCHHHHhcC--CCCCcccEeehHHHHHHHHhCCCCCCCCCCHH-------
Confidence 999999999877655444444556789999999999876 89999999999999999998 88888654221
Q ss_pred hhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 198 HWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
........... ....+..++.++.+++.+||+.||++|||+.|+++.|+.+++.
T Consensus 295 ~~~~~~i~~g~-------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 295 EEFCRRLKEGT-------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HHHHHHHHHTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCC-------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 11111111111 1112234566789999999999999999999999999998764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=337.49 Aligned_cols=219 Identities=26% Similarity=0.301 Sum_probs=175.8
Q ss_pred chhhcccccCCceeEEEEEec----CCCeEEEEEeccCc----------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL----DGRNVAIKVLNETK----------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||+||+|++. .++.||||+++... +.+.++...|+||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 457789999999999999763 37899999987543 5667788899999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
|||.+|+|.+++.+. ..+++..++.+++||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+|+..
T Consensus 106 Ey~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp CCCTTCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EcCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999765 479999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ........ ...
T Consensus 177 ~~~~~--~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~-~~~- 242 (304)
T 3ubd_A 177 IDHEK--KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQGKDR--------KETMTMIL-KAK- 242 (304)
T ss_dssp ----C--CCCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HCC-
T ss_pred cCCCc--cccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCCcCH--------HHHHHHHH-cCC-
Confidence 43322 23456799999999999876 889999999999999999999999975421 11111111 011
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAM-----NRVVE 250 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~-----~ell~ 250 (291)
...+..++.++.+|+.+||+.||++|||+ +|+++
T Consensus 243 ------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 ------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11123466789999999999999999984 66664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=324.92 Aligned_cols=223 Identities=25% Similarity=0.326 Sum_probs=161.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeec------------
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFE------------ 42 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~------------ 42 (291)
+.+.+.||+|+||.||+|++. +|+.||||+++... +.+..
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 356789999999999999875 49999999987543 22221
Q ss_pred CCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEe
Q 022826 43 GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 122 (291)
Q Consensus 43 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~ 122 (291)
....|+|||||.+|+|.+++..+. .....++..++.++.||+.||.|||+ ++|+||||||+|||++.+|.+||+
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRC---TIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCC---SGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcC---CCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEc
Confidence 123689999999999999997653 22345677889999999999999999 999999999999999999999999
Q ss_pred ccCCccccCCCCcee----------eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCc
Q 022826 123 DFGLAKICHGRESIV----------SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSS 192 (291)
Q Consensus 123 Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~ 192 (291)
|||+++......... .....+||+.|+|||++.+. .++.++|||||||++|+|++ ||....+
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~~~~~--- 232 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFSTQME--- 232 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCSSHHH---
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCCCccH---
Confidence 999998765432211 12345699999999999876 89999999999999999996 4432110
Q ss_pred cccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 193 EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.......... .............+.+|+.+||+.||++|||+.|+++
T Consensus 233 -------~~~~~~~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 -------RVRTLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -------HHHHHHHHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------HHHHHHHHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0011111111 1112233445566788999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=327.31 Aligned_cols=174 Identities=22% Similarity=0.354 Sum_probs=144.9
Q ss_pred chhhcccccCCceeEEEEEec----CCCeEEEEEeccCc-------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL----DGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.++||+|+||.||+|+++ .++.||+|++.... .++......|+||||+
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~ 102 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYL 102 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECC
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCC
Confidence 456789999999999999763 36789999986554 5666778899999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC-CceEEeccCCccccCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICHG 132 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~ 132 (291)
++|+|.+++ ..+++..++.+++||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 103 ~g~~L~~~~---------~~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 103 EHESFLDIL---------NSLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp CCCCHHHHH---------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred CcccHHHHH---------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 999999998 358999999999999999999999 999999999999999876 8999999999976533
Q ss_pred CCc--------------------------eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCcc
Q 022826 133 RES--------------------------IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANV 186 (291)
Q Consensus 133 ~~~--------------------------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~ 186 (291)
... .......+||+.|+|||++.+. ..++.++||||+||++|+|++|+.||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 211 0112345699999999999764 3689999999999999999999999975
Q ss_pred ccC
Q 022826 187 AVD 189 (291)
Q Consensus 187 ~~~ 189 (291)
..+
T Consensus 250 ~~~ 252 (361)
T 4f9c_A 250 ASD 252 (361)
T ss_dssp CSS
T ss_pred CCC
Confidence 543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=329.61 Aligned_cols=237 Identities=22% Similarity=0.236 Sum_probs=173.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------cee------ecCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFC------FEGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~------~~~~~~~ 47 (291)
+.+.+.||+|+||.||+|++. +|+.||||+++... +++ .+....|
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 456789999999999999875 49999999997543 111 1335789
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+|||||+ |+|.+++... ..+++..+..+++||+.||.|||+ ++|+||||||+|||++.+|.+||+|||++
T Consensus 136 ivmE~~~-g~L~~~i~~~------~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 136 VVLDLME-SDLHQIIHSS------QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEECCS-EEHHHHHTSS------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEeCCC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeeccee
Confidence 9999996 5899999654 589999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCC--ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc-------hh
Q 022826 128 KICHGRE--SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF-------PH 198 (291)
Q Consensus 128 ~~~~~~~--~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~-------~~ 198 (291)
+.+.... ........+||+.|+|||++.+. ..++.++||||+||++|+|++|..||............ +.
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 8764322 12223556899999999998775 36799999999999999999999999754321100000 00
Q ss_pred hhhhh----hhhhhhhcccCCCC----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 199 WVYKR----LELEEDLGLQGIEN----EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 199 ~~~~~----~~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..... .........+.... ...+..+.++.+|+.+||..||++|||+.|+++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 00000000000000 011234677899999999999999999999886
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=342.68 Aligned_cols=221 Identities=25% Similarity=0.349 Sum_probs=179.0
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|++.. |+.||||++.+.. +.+.+....|+|
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 4567899999999999998764 9999999986432 456677889999
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
||||.||+|.+++... ..+++..++.+++||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|..
T Consensus 271 mEy~~GGdL~~~l~~~------~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp ECCCCSCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999765 579999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 130 CHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
+.... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||........ ...... .....
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-----~~i~~~-i~~~~ 410 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRM-TLTMA 410 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-----HHHHHH-HHHCC
T ss_pred cCCCC----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHh-hcCCC
Confidence 65433 2456899999999999642 2789999999999999999999999976433211 000000 00110
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPA-----MNRVVE 250 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps-----~~ell~ 250 (291)
...+..++.++.+||.+||+.||++|++ +.|+++
T Consensus 411 -------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 -------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1122346778999999999999999998 677664
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=333.52 Aligned_cols=223 Identities=21% Similarity=0.318 Sum_probs=181.9
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||+|+||.||+|.+.. |+.||+|++.... +.+.+....++|||||.+
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g 238 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 4567899999999999998754 9999999987654 566778899999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC--CceEEeccCCccccCCC
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED--FCPKISDFGLAKICHGR 133 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~--~~~kl~Dfg~~~~~~~~ 133 (291)
|+|.+++... ...+++..+..+++||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 239 g~L~~~i~~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 239 GELFEKVADE-----HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CBHHHHHTCT-----TSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred CcHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999998643 2579999999999999999999999 999999999999999754 89999999999987654
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
.. ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...... ...... .. ...
T Consensus 311 ~~---~~~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--------~~~~~i---~~-~~~ 373 (573)
T 3uto_A 311 QS---VKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------ETLRNV---KS-CDW 373 (573)
T ss_dssp SE---EEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHH---HT-TCC
T ss_pred Cc---eeeeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHH---Hh-CCC
Confidence 43 2345789999999999886 7899999999999999999999999754221 011111 10 011
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.........++..+.+||.+||+.||.+|||+.|+++
T Consensus 374 ~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 374 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1223334456788999999999999999999999987
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=303.14 Aligned_cols=245 Identities=26% Similarity=0.343 Sum_probs=184.6
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecC----Ccceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEG----HRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~----~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|++ .++.||||++.... +++... ...++||||+
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~ 104 (322)
T 3soc_A 26 LQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104 (322)
T ss_dssp EEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred chhhheecccCceEEEEEEE-CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecC
Confidence 45678999999999999987 48999999986543 333332 2368999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCC----------CeeeeccCCCceEEcCCCceEEec
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT----------RILHFDIKPHNILLDEDFCPKISD 123 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~----------~ivH~dikp~Nill~~~~~~kl~D 123 (291)
.+|+|.+++.. ..+++..++.++.|++.||.|||+ . +++|+||||+||+++.++.+||+|
T Consensus 105 ~~g~L~~~l~~-------~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 105 EKGSLSDFLKA-------NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp TTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred CCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 99999999965 369999999999999999999999 8 999999999999999999999999
Q ss_pred cCCccccCCCCceeeccCCCCCccccCcccccccC---CCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhh
Q 022826 124 FGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF---GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWV 200 (291)
Q Consensus 124 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~---~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~ 200 (291)
||++................+|+.|+|||.+.+.. ..++.++|||||||++|+|++|..||................
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 99998766544433344467899999999987631 256678999999999999999999987654432211110000
Q ss_pred h--hhhhhhhhh----cccCCCC-hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 201 Y--KRLELEEDL----GLQGIEN-EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 201 ~--~~~~~~~~~----~~~~~~~-~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
. ......... ..+.... .........+.+|+.+||+.||++|||+.++++.|+++.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0 000000000 0111111 12234567799999999999999999999999999997654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=300.56 Aligned_cols=249 Identities=35% Similarity=0.583 Sum_probs=193.4
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.+.+.||+|+||.||+|.+.+++.||+|++.... +++......++||||+.++
T Consensus 41 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 120 (321)
T 2qkw_B 41 FDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120 (321)
T ss_dssp CSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred cCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence 45668899999999999998789999999987543 5666778889999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+|.+++.... .....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 121 ~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 195 (321)
T 2qkw_B 121 NLKRHLYGSD--LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195 (321)
T ss_dssp BTGGGSSSSC--CCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC
T ss_pred cHHHHHhccC--CCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9999986542 123469999999999999999999999 99999999999999999999999999999765433322
Q ss_pred eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh--hhhhcccC
Q 022826 137 VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL--EEDLGLQG 214 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 214 (291)
.......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.......... ...+....... ......+.
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 272 (321)
T 2qkw_B 196 HLSTVVKGTLGYIDPEYFIKG--RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN-LAEWAVESHNNGQLEQIVDPN 272 (321)
T ss_dssp CCBCCCEEETTTCCHHHHHHC--BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCC-HHHHTHHHHTTTCCCSSSSSS
T ss_pred ccccccCCCccccCHHHhcCC--CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHH-HHHHhhhccccccHHHhcChh
Confidence 223344578999999999775 78999999999999999999999987654322111 11111100000 00111122
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccC
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSL 259 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~ 259 (291)
.........+..+.+++.+||+.||++|||+.|+++.|+.+++..
T Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 233445678899999999999999999999999999999987643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=303.14 Aligned_cols=236 Identities=27% Similarity=0.483 Sum_probs=176.4
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||+|++ +++.||||++.... +++......++||||+.
T Consensus 39 y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 3p86_A 39 LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS 117 (309)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCT
T ss_pred ceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCC
Confidence 45678999999999999987 68899999987543 56667778899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCC--eeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR--ILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+++|.+++.... ....+++..++.++.|++.||.|||+ .+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 118 ~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 118 RGSLYRLLHKSG---AREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp TCBHHHHHHSTT---HHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred CCcHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999999997642 22349999999999999999999999 99 99999999999999999999999999875433
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... ......+|+.|+|||.+.+. .++.++||||||+++|+|++|..||...... ... .....
T Consensus 192 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~--------~~~------~~~~~ 253 (309)
T 3p86_A 192 TFL--SSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNLNPA--------QVV------AAVGF 253 (309)
T ss_dssp ------------CCTTSCHHHHTTC--CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--------HHH------HHHHH
T ss_pred ccc--ccccCCCCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHH------HHHHh
Confidence 221 12345679999999999876 7899999999999999999999988643210 000 00101
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCC
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPP 263 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 263 (291)
.......+..++..+.+++.+||+.||.+|||+.++++.|+.+++....++
T Consensus 254 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 254 KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 111122233456778999999999999999999999999999988765544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=295.35 Aligned_cols=242 Identities=17% Similarity=0.244 Sum_probs=189.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +++......++||||+ ++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 90 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP 90 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CC
Confidence 456789999999999999874 59999999986543 4566677889999999 88
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCc-----eEEeccCCccccC
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC-----PKISDFGLAKICH 131 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~-----~kl~Dfg~~~~~~ 131 (291)
+|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++. ++|+|||++....
T Consensus 91 ~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 91 SLEDLLDLC-----GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp BHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CHHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 999999764 2469999999999999999999999 99999999999999987776 9999999998765
Q ss_pred CCCce-----eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh
Q 022826 132 GRESI-----VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 132 ~~~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
..... .......+|+.|+|||.+.+. .++.++||||||+++|+|++|..||........... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~-----~~~~~~ 235 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK-----YERIGE 235 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH-----HHHHHH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHH-----HHHHHh
Confidence 43221 112445689999999999876 789999999999999999999999976543221111 111110
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCC
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPP 263 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 263 (291)
.. ...........++..+.+++.+||+.||++|||+.++++.|+++++++....
T Consensus 236 ~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~ 289 (298)
T 1csn_A 236 KK---QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 289 (298)
T ss_dssp HH---HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred hc---cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence 00 0000011122456789999999999999999999999999999998877653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=307.27 Aligned_cols=238 Identities=25% Similarity=0.449 Sum_probs=186.1
Q ss_pred chhhcccccCCceeEEEEEec--------CCCeEEEEEeccCc----------------------------ceeecCCcc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL--------DGRNVAIKVLNETK----------------------------GFCFEGHRR 46 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~----------------------------~~~~~~~~~ 46 (291)
+.+.+.||+|+||.||+|++. ++..||||+++... +++......
T Consensus 83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 162 (370)
T 2psq_A 83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 162 (370)
T ss_dssp EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSC
T ss_pred CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCE
Confidence 346688999999999999763 24579999997543 556677889
Q ss_pred eeeehhhcCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC
Q 022826 47 ALIYEFVSNGSLEKFIYEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 116 (291)
Q Consensus 47 ~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~ 116 (291)
++||||+.+|+|.+++...... .....+++..++.++.||+.||.|||+ .+|+|+||||+||+++.+
T Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTEN 239 (370)
T ss_dssp EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTT
T ss_pred EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECCC
Confidence 9999999999999999875321 123468999999999999999999999 999999999999999999
Q ss_pred CceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCcccc
Q 022826 117 FCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIY 195 (291)
Q Consensus 117 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~ 195 (291)
+.+||+|||++................+++.|+|||++.+. .++.++|||||||++|+|++ |..||......
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~p~~~~~~~----- 312 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----- 312 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----
Confidence 99999999999876544332233444567899999999876 78999999999999999998 88877643211
Q ss_pred chhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCC
Q 022826 196 FPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLR 260 (291)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 260 (291)
. ...... .......+..++..+.+++.+||+.||++|||+.|+++.|++++....
T Consensus 313 --~-~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 313 --E-LFKLLK-------EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp --G-HHHHHH-------TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred --H-HHHHHh-------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 0 000000 011112223456789999999999999999999999999999876543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=297.78 Aligned_cols=240 Identities=20% Similarity=0.232 Sum_probs=186.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.+.+.||+|+||.||+|++. +++.||||++.... +++..+...++||||+ ++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GP 89 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CC
T ss_pred eEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CC
Confidence 456799999999999999874 58999999986543 4566677889999999 88
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCc-----eEEeccCCccccC
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC-----PKISDFGLAKICH 131 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~-----~kl~Dfg~~~~~~ 131 (291)
+|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++. ++|+|||++....
T Consensus 90 ~L~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 90 SLEDLFDLC-----DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp BHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred CHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 999999763 2589999999999999999999999 99999999999999998887 9999999998764
Q ss_pred CCCcee-----eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh
Q 022826 132 GRESIV-----SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 132 ~~~~~~-----~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
...... ......||+.|+|||.+.+. .++.++||||||+++|+|++|..||.......... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~-----~~~~i~~ 234 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE-----RYQKIGD 234 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH-----HHHHHHH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCC--CCCchhHHHHHHHHHHHHhcCCCCccccccccHHH-----HHHHHHh
Confidence 432211 12456689999999999876 78999999999999999999999997653222100 1111110
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCC
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 262 (291)
.. ...........++ .+.+++.+||+.||.+||++.++.+.|+++.+.++..
T Consensus 235 ~~---~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~ 286 (330)
T 2izr_A 235 TK---RATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM 286 (330)
T ss_dssp HH---HHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred hh---ccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 00 0000011112234 8999999999999999999999999999998877554
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=294.27 Aligned_cols=238 Identities=23% Similarity=0.324 Sum_probs=178.4
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------cee----ecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFC----FEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~----~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|++ +++.||||++.... +.+ ......++||||+
T Consensus 10 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~ 88 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred EEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhc
Confidence 45678999999999999987 78999999987554 111 1234578999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhh--------cCCCCCeeeeccCCCceEEcCCCceEEeccC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH--------RGCNTRILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH--------~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
.+|+|.+++.. ..+++..++.++.|++.||.||| + .+++|+||||+||+++.++.+||+|||
T Consensus 89 ~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 89 EMGSLYDYLQL-------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp TTCBHHHHHTT-------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred cCCCHHHHHhh-------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEeeCC
Confidence 99999999943 47999999999999999999999 8 999999999999999999999999999
Q ss_pred CccccCCCCceee--ccCCCCCccccCcccccccCC----CccccccchhHHHHHHHHhCC----------CCCCccccC
Q 022826 126 LAKICHGRESIVS--MTGARGTVGYIAPEVFCRNFG----EVSYKSDVYSYGMMVFEMTGV----------KNNANVAVD 189 (291)
Q Consensus 126 ~~~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~----~~~~~~DiwslG~~l~~ll~g----------~~~~~~~~~ 189 (291)
++........... .....+|+.|+|||.+.+... .++.++||||||+++|+|++| ..||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 9976554333221 233468999999999876422 345799999999999999999 555544332
Q ss_pred CCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 190 RSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
..... . ........................+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 239 ~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 239 NDPSF--E--DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SSCCH--H--HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcch--h--hhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 22111 0 00000000000011111112345788899999999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=305.36 Aligned_cols=251 Identities=25% Similarity=0.409 Sum_probs=190.7
Q ss_pred chhhcccccCCceeEEEEEec--------CCCeEEEEEeccCc----------------------------ceeecCCcc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL--------DGRNVAIKVLNETK----------------------------GFCFEGHRR 46 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~----------------------------~~~~~~~~~ 46 (291)
+.+.+.||+|+||.||+|++. ++..||+|+++... +.+......
T Consensus 71 y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 150 (382)
T 3tt0_A 71 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 150 (382)
T ss_dssp EEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred eEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCce
Confidence 345688999999999999863 23579999987543 566677888
Q ss_pred eeeehhhcCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC
Q 022826 47 ALIYEFVSNGSLEKFIYEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 116 (291)
Q Consensus 47 ~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~ 116 (291)
++||||+.+++|.+++...... .....+++..++.++.||+.||.|||+ .+|+|+||||+||+++.+
T Consensus 151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~ 227 (382)
T 3tt0_A 151 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTED 227 (382)
T ss_dssp EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTT
T ss_pred EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEcCC
Confidence 9999999999999999875421 123569999999999999999999999 999999999999999999
Q ss_pred CceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCcccc
Q 022826 117 FCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIY 195 (291)
Q Consensus 117 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~ 195 (291)
+.+||+|||++................+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.....
T Consensus 228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt~g~~p~~~~~~------ 299 (382)
T 3tt0_A 228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 299 (382)
T ss_dssp CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH------
Confidence 99999999999876544333333445568899999999875 78999999999999999999 8887764321
Q ss_pred chhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCCCCcccCCCCC
Q 022826 196 FPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLSSGSQ 273 (291)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~~~~ 273 (291)
........ .......+..++..+.+++.+||+.||++|||+.++++.|++++........+........
T Consensus 300 --~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~~~~ 368 (382)
T 3tt0_A 300 --EELFKLLK-------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHHHH 368 (382)
T ss_dssp --HHHHHHHH-------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----------
T ss_pred --HHHHHHHH-------cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCCCccccc
Confidence 10111111 0111112234566789999999999999999999999999999998888777766555433
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=292.89 Aligned_cols=242 Identities=20% Similarity=0.272 Sum_probs=188.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... .+.......++||||+ ++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 4hgt_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred eEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CC
Confidence 456789999999999999874 58999999865443 3345667788999999 88
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE---cCCCceEEeccCCccccCCC
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~ 133 (291)
+|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||++ +.++.+||+|||++......
T Consensus 90 ~L~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 90 SLEDLFNFC-----SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp BHHHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 999999753 2579999999999999999999999 999999999999999 78899999999999876543
Q ss_pred Cce-----eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhh
Q 022826 134 ESI-----VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEE 208 (291)
Q Consensus 134 ~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (291)
... .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||....................
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 235 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM---- 235 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH----
T ss_pred ccCccCCCCcccccCCCccccchHHhcCC--CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc----
Confidence 321 122345689999999999876 789999999999999999999999976544332221111111000
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCC
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPP 263 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 263 (291)
..........++..+.+++.+||+.||++|||+.++++.|+++++....+.
T Consensus 236 ----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 236 ----STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp ----HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred ----cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 000011112346789999999999999999999999999999998877654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=294.35 Aligned_cols=221 Identities=24% Similarity=0.322 Sum_probs=178.3
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +.+..+...++||||+.+
T Consensus 22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 101 (297)
T 3fxz_A 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (297)
T ss_dssp BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence 456789999999999999874 59999999986443 556677889999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++.. ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 102 ~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 102 GSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CBHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999965 368999999999999999999999 9999999999999999999999999999876654332
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
......+|+.|+|||.+.+. .++.++||||||+++|+|++|..||...... ..... .... ...
T Consensus 172 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~---~~~~--~~~ 234 (297)
T 3fxz_A 172 --KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYL---IATN--GTP 234 (297)
T ss_dssp --CBCCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHH---HHHH--CSC
T ss_pred --ccCCccCCcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH---HHhC--CCC
Confidence 12345689999999999876 7899999999999999999999998654211 00000 0000 111
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
....+..++..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 12223456778999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=297.01 Aligned_cols=244 Identities=41% Similarity=0.694 Sum_probs=188.7
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||+|+||.||+|+..+++.||||++.... +++......++||||+.+
T Consensus 32 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 111 (326)
T 3uim_A 32 FSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 111 (326)
T ss_dssp SCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTT
T ss_pred cccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccC
Confidence 45578999999999999988789999999987543 566677888999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCC---CeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT---RILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~---~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
++|.+++.... .....+++..++.++.|++.||.|||+ . +++|+||||+||+++.++.++|+|||++.....
T Consensus 112 ~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 186 (326)
T 3uim_A 112 GSVASCLRERP--ESQPPLDWPKRQRIALGSARGLAYLHD---HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186 (326)
T ss_dssp CBHHHHHHCCS--TTCCCCCHHHHHHHHHHHHHHHHHHHH---SSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCS
T ss_pred CCHHHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCeEeCCCchhhEEECCCCCEEeccCccccccCc
Confidence 99999997653 234569999999999999999999999 8 999999999999999999999999999987653
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCC-ccccchhhhhhhhh--hhhh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRS-SEIYFPHWVYKRLE--LEED 209 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~ 209 (291)
.... ......+|+.|+|||.+.+. .++.++||||||+++|+|++|..||....... .......+...... ....
T Consensus 187 ~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (326)
T 3uim_A 187 KDTH-VTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263 (326)
T ss_dssp SSSC-EECCCCSCGGGCCHHHHHHS--EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred cccc-ccccccCCcCccCHHHhccC--CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence 3322 22345589999999999776 78999999999999999999999986332111 11111111111000 0011
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
..............+..+.+++.+||+.||.+|||+.++++.|++
T Consensus 264 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 111222233456778899999999999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=298.13 Aligned_cols=234 Identities=25% Similarity=0.421 Sum_probs=182.0
Q ss_pred chhhcccccCCceeEEEEEecC----CCeEEEEEeccCc---------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD----GRNVAIKVLNETK---------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|.+.. +..||||+++... +++..+...++|||
T Consensus 51 y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 130 (325)
T 3kul_A 51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE 130 (325)
T ss_dssp EEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEE
T ss_pred eEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEee
Confidence 4467899999999999998742 4459999997642 56667788899999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++... ...+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++.++|+|||++....
T Consensus 131 ~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 131 YMENGSLDTFLRTH-----DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp CCTTCBHHHHHHTT-----TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CCCCCcHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999653 2579999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCc-eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 132 GRES-IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 132 ~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
.... ........+++.|+|||.+.+. .++.++||||||+++|+|++ |..||...... .......
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~~~~~~~---- 268 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--------DVISSVE---- 268 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHH----
T ss_pred cCccceeeccCCCCcccccCHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHH----
Confidence 4322 2222334457789999999776 78999999999999999998 88887543211 0001110
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCC
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRI 261 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 261 (291)
.......+..++..+.+++.+||+.||++|||+.++++.|+.+++....
T Consensus 269 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 269 ---EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp ---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred ---cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 0111122334567899999999999999999999999999998875443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=291.17 Aligned_cols=243 Identities=20% Similarity=0.266 Sum_probs=189.6
Q ss_pred chhhcccccCCceeEEEEEe-cCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKL-LDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.+.+.||+|+||.||+|++ .+++.||+|++.... .+.......++||||+ ++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CC
Confidence 45678999999999999987 459999999986543 2335566778999999 88
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE---cCCCceEEeccCCccccCCC
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~ 133 (291)
+|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||++ +.++.+||+|||++......
T Consensus 90 ~L~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 90 SLEDLFNFC-----SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp BHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CHHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 999999753 2579999999999999999999999 999999999999999 47889999999999876543
Q ss_pred Ccee-----eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhh
Q 022826 134 ESIV-----SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEE 208 (291)
Q Consensus 134 ~~~~-----~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (291)
.... ......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...........+.......
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----- 234 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK----- 234 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-----
T ss_pred ccccccccccccccccccccCChhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc-----
Confidence 3211 12345689999999999876 78999999999999999999999998654332222111111100
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCCC
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPR 264 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 264 (291)
... ........++..+.+++.+||+.||++|||+.++++.|++++.....+..
T Consensus 235 -~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 3uzp_A 235 -MST--PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp -HHS--CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSS
T ss_pred -cCC--chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccc
Confidence 000 00111233567799999999999999999999999999999988776543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=295.44 Aligned_cols=235 Identities=23% Similarity=0.390 Sum_probs=185.2
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+++.||+|+||.||+|.+.. ++.||+|++.... +++..+...++||||+.+
T Consensus 12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 91 (310)
T 3s95_A 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG 91 (310)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCC
Confidence 4567899999999999998754 9999999886533 566778889999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 92 ~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 92 GTLRGIIKSM-----DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CBHHHHHHHC-----CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred CcHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999764 2579999999999999999999999 9999999999999999999999999999987643322
Q ss_pred eee------------ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhh
Q 022826 136 IVS------------MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKR 203 (291)
Q Consensus 136 ~~~------------~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~ 203 (291)
... .....||+.|+|||.+.+. .++.++||||||+++|+|++|..++...............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~---- 237 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR--SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR---- 237 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH----
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh----
Confidence 110 1145689999999999875 7899999999999999999999887755433222211110
Q ss_pred hhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCC
Q 022826 204 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLR 260 (291)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 260 (291)
...... .+..++..+.+++.+||+.||++|||+.++++.|+++...+.
T Consensus 238 -~~~~~~--------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 238 -GFLDRY--------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp -HHHHHT--------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -cccccc--------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 000000 012244568899999999999999999999999999876654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=304.83 Aligned_cols=230 Identities=24% Similarity=0.375 Sum_probs=181.0
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcC
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
.+.+.||+|+||.||+|.+. +++.||||+++... +++......++||||+.+
T Consensus 117 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 196 (377)
T 3cbl_A 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 196 (377)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCC
Confidence 45689999999999999886 58999999987542 566677889999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
|+|.+++... +..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++.......
T Consensus 197 g~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 197 GDFLTFLRTE-----GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CBHHHHHHHH-----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred CCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 9999999764 2568999999999999999999999 9999999999999999999999999999876443221
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
........+++.|+|||.+.+. .++.++||||||+++|+|++ |..|+...... ....... ..
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--------~~~~~~~-------~~ 331 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQ--------QTREFVE-------KG 331 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--------HHHHHHH-------TT
T ss_pred eecCCCCCCCcCcCCHhHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHH-------cC
Confidence 1111122346789999999765 78999999999999999998 77777643210 0000000 01
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
.....+..++..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 11112233566788999999999999999999999999987654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=299.15 Aligned_cols=249 Identities=24% Similarity=0.334 Sum_probs=181.5
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------c-----eeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------G-----FCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~-----~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|+. +++.||||++.... + ........++||||
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 93 (336)
T 3g2f_A 15 LKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93 (336)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred hheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEec
Confidence 45678999999999999976 78999999986443 1 11122346799999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCC---------CeeeeccCCCceEEcCCCceEEec
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT---------RILHFDIKPHNILLDEDFCPKISD 123 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~---------~ivH~dikp~Nill~~~~~~kl~D 123 (291)
+.+|+|.+++... ..++..++.++.||+.||.|||+ . +|+|+||||+||+++.++.+||+|
T Consensus 94 ~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 94 YPNGSLXKYLSLH-------TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp CTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred CCCCcHHHHHhhc-------ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEee
Confidence 9999999999653 55899999999999999999999 8 999999999999999999999999
Q ss_pred cCCccccCCCCc------eeeccCCCCCccccCcccccccC-----CCccccccchhHHHHHHHHhCCCCCCccccCCCc
Q 022826 124 FGLAKICHGRES------IVSMTGARGTVGYIAPEVFCRNF-----GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSS 192 (291)
Q Consensus 124 fg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~l~~~~-----~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~ 192 (291)
||++........ ........+|+.|+|||++.+.. ..++.++|||||||++|+|++|..|+........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999986643211 11223456899999999987621 2567789999999999999999887755443222
Q ss_pred ccc-chhhhhh-------hhhhhhhhcccCCCC--hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCC
Q 022826 193 EIY-FPHWVYK-------RLELEEDLGLQGIEN--EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262 (291)
Q Consensus 193 ~~~-~~~~~~~-------~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 262 (291)
... +...... ..........+.... ......+..+.+|+.+||+.||++|||+.|+++.|++++......
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 111 1100000 000000000111111 112346778999999999999999999999999999999876655
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=308.42 Aligned_cols=239 Identities=21% Similarity=0.276 Sum_probs=188.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.+.++||+|+||.||+|.+. +++.||||++.... .++......++||||+ ++
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~ 87 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 87 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CC
Confidence 567899999999999999874 59999999876543 3455677788999999 88
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE---cCCCceEEeccCCccccCCC
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~ 133 (291)
+|.+++... ...+++..++.++.||+.||.|||+ .+|+|+||||+|||| +.++.+||+|||++......
T Consensus 88 sL~~ll~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 88 SLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp BHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 999999753 2579999999999999999999999 999999999999999 58899999999999876543
Q ss_pred Cce-----eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhh
Q 022826 134 ESI-----VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEE 208 (291)
Q Consensus 134 ~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (291)
... .......+|+.|+|||.+.+. .++.++|||||||++|+|++|..||...........+......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~------ 231 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK------ 231 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH------
T ss_pred ccccccccccccccCCCccccCHHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc------
Confidence 321 112356789999999999876 7899999999999999999999999765443221111111000
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCC
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLR 260 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 260 (291)
............++.++.+|+..||+.||++||++.+|++.|++++....
T Consensus 232 --~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 232 --KVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp --HHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --cccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 01111112223456789999999999999999999999999999877553
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=293.11 Aligned_cols=241 Identities=27% Similarity=0.342 Sum_probs=178.0
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecC----Ccceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEG----HRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~----~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|++ +++.||||++.... +.+... ...++||||+
T Consensus 39 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 117 (337)
T 3mdy_A 39 IQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYH 117 (337)
T ss_dssp CEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCC
T ss_pred eEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEecc
Confidence 45678999999999999987 48999999986543 233333 5688999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCC--------CeeeeccCCCceEEcCCCceEEeccC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT--------RILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~--------~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
.+++|.+++.. ..+++..++.++.|++.||.|||+ . +++|+||||+||+++.++.+||+|||
T Consensus 118 ~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 118 ENGSLYDYLKS-------TTLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp TTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred CCCcHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 99999999954 369999999999999999999999 7 99999999999999999999999999
Q ss_pred CccccCCCCcee--eccCCCCCccccCcccccccCCCccc------cccchhHHHHHHHHhCCCCCC----------ccc
Q 022826 126 LAKICHGRESIV--SMTGARGTVGYIAPEVFCRNFGEVSY------KSDVYSYGMMVFEMTGVKNNA----------NVA 187 (291)
Q Consensus 126 ~~~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~------~~DiwslG~~l~~ll~g~~~~----------~~~ 187 (291)
++.......... ......+|+.|+|||.+.+. .... ++|||||||++|+|++|..++ ...
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES--LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTC--CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccc--cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 997654432221 12345689999999999765 3333 489999999999999995443 322
Q ss_pred cCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCC
Q 022826 188 VDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLR 260 (291)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 260 (291)
....... ........................++..+.+++.+||+.||++|||+.++++.|+++.+...
T Consensus 266 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 266 VPSDPSY----EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp SCSSCCH----HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred cCCCCch----hhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 2111100 00000000001111111111234688889999999999999999999999999999887654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=287.44 Aligned_cols=230 Identities=25% Similarity=0.461 Sum_probs=183.8
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||+|+||.||++++.++..||+|++.... +++......++||||+.+++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (268)
T 3sxs_A 10 ITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGC 89 (268)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred eeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCc
Confidence 45678999999999999998888899999997654 56667778899999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 90 L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 160 (268)
T 3sxs_A 90 LLNYLRSH-----GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV- 160 (268)
T ss_dssp HHHHHHHH-----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-
T ss_pred HHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh-
Confidence 99999764 2469999999999999999999999 99999999999999999999999999999866544322
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
......+++.|+|||.+.+. .++.++||||||+++|+|++ |..||...... . ...... ....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~-~~~~~~-------~~~~ 223 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-------E-VVLKVS-------QGHR 223 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHS--EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-------H-HHHHHH-------TTCC
T ss_pred cccCCCcCcccCCHHHHhcc--CCchhhhhHHHHHHHHHHHcCCCCCccccChH-------H-HHHHHH-------cCCC
Confidence 23444567789999999876 78999999999999999998 88877543211 0 000000 0001
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
...+...+..+.+++.+||+.||++|||+.++++.|+.+.++
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 111223456788999999999999999999999999987654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=296.87 Aligned_cols=226 Identities=27% Similarity=0.306 Sum_probs=180.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +++..+...++||||+.
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 456789999999999999876 59999999986433 56667788899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++... ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 89 GGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp TEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999988543 579999999999999999999999 999999999999999999999999999998665443
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
.........+|+.|+|||++.+. ..++.++||||||+++|+|++|..||.......... .. .....
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~~-----------~~~~~ 225 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SD-----------WKEKK 225 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH--HH-----------HHTTC
T ss_pred cccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH--HH-----------Hhccc
Confidence 33334556789999999999765 234789999999999999999999997654322100 00 00011
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
........++..+.+|+.+||+.||++|||+.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1111223466778899999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=297.57 Aligned_cols=241 Identities=24% Similarity=0.394 Sum_probs=169.8
Q ss_pred chhhcccccCCceeEEEEEecC-C---CeEEEEEeccCc----------------------------ceeecCCcc----
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-G---RNVAIKVLNETK----------------------------GFCFEGHRR---- 46 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~----------------------------~~~~~~~~~---- 46 (291)
+.+.+.||+|+||.||+|.+.. + ..||||+++... +++......
T Consensus 25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (323)
T 3qup_A 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP 104 (323)
T ss_dssp CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence 4567899999999999998754 3 389999987542 333333333
Q ss_pred --eeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEecc
Q 022826 47 --ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 124 (291)
Q Consensus 47 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Df 124 (291)
++|+||+.+++|.+++...........+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+||
T Consensus 105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEeec
Confidence 8999999999999999765433334479999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhh
Q 022826 125 GLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKR 203 (291)
Q Consensus 125 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~ 203 (291)
|++................+++.|+|||.+.+. .++.++||||||+++|+|++ |..||....... ....
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~~ 251 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--------IYNY 251 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHH
T ss_pred cccccccccccccccccccCcccccCchhhcCC--CCCCccchhhHHHHHHHHHhCCCCCccccChHH--------HHHH
Confidence 999876544332223344467889999999876 78999999999999999999 787776432210 0000
Q ss_pred hhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCC
Q 022826 204 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPP 263 (291)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 263 (291)
.. .......+..++..+.+++.+||+.||++|||+.++++.|+++++......
T Consensus 252 ~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 252 LI-------GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp HH-------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred Hh-------cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 00 011111223456779999999999999999999999999999988665443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=299.46 Aligned_cols=248 Identities=17% Similarity=0.184 Sum_probs=185.0
Q ss_pred chhhcccccCCceeEEEEEecC------CCeEEEEEeccCc-------------------------------------ce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD------GRNVAIKVLNETK-------------------------------------GF 39 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-------------------------------------~~ 39 (291)
+.+.+.||+|+||.||+|.+.. ++.||||++.... ++
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 116 (364)
T 3op5_A 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS 116 (364)
T ss_dssp EEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred EEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence 4567899999999999998754 4789999976543 12
Q ss_pred eecC----CcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc-
Q 022826 40 CFEG----HRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD- 114 (291)
Q Consensus 40 ~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~- 114 (291)
+... ...++||||+ +++|.+++... ...+++..++.++.||+.||.|||+ .+|+|+||||+||+++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-----AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEETTEEEEEEEEECE-EEEHHHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEES
T ss_pred eeeccCCcceEEEEEeCC-CCCHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEec
Confidence 2221 4478999999 88999999764 2579999999999999999999999 9999999999999998
Q ss_pred -CCCceEEeccCCccccCCCCcee-----eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCcccc
Q 022826 115 -EDFCPKISDFGLAKICHGRESIV-----SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAV 188 (291)
Q Consensus 115 -~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~ 188 (291)
.++.+||+|||+++......... ......+|+.|+|||.+.+. .++.++|||||||++|+|++|..||....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV--APSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 88999999999997654322111 11334589999999999876 78999999999999999999999998643
Q ss_pred CCCccccchhhhhhhh-hhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCCCCcc
Q 022826 189 DRSSEIYFPHWVYKRL-ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFL 267 (291)
Q Consensus 189 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 267 (291)
.... ......... .....+..... ....++..+.+++..||+.||.+||++.++++.|+++++.+..+.....
T Consensus 266 ~~~~---~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~ 339 (364)
T 3op5_A 266 KDPK---YVRDSKIRYRENIASLMDKCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKL 339 (364)
T ss_dssp TCHH---HHHHHHHHHHHCHHHHHHHHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred cCHH---HHHHHHHHhhhhHHHHHHHhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCcc
Confidence 3211 000000000 00000000000 0022466789999999999999999999999999999998877654444
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=286.99 Aligned_cols=240 Identities=33% Similarity=0.532 Sum_probs=186.7
Q ss_pred hcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------------ceeecCCcceeeehhhcC
Q 022826 6 KNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
++.||+|+||.||+|.. +++.||+|++.... +++......++||||+.+
T Consensus 36 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 114 (307)
T 2nru_A 36 GNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN 114 (307)
T ss_dssp CCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred CCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCC
Confidence 47899999999999986 78999999986431 566667888999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++.... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 115 ~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 115 GSLLDRLSCLD---GTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp CBHHHHHHTGG---GCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred CcHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence 99999997542 34579999999999999999999999 9999999999999999999999999999987654433
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
........+++.|+|||.+.+ .++.++||||||+++|+|++|..||.......................... ....
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 264 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY-IDKK 264 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH-SCSS
T ss_pred cccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh-cccc
Confidence 333445568999999999865 478899999999999999999999876543221111111000000000000 1111
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~ 256 (291)
........+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 265 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 265 MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 22345667889999999999999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=293.26 Aligned_cols=237 Identities=27% Similarity=0.424 Sum_probs=187.0
Q ss_pred chhhcccccCCceeEEEEEec------CCCeEEEEEeccCc---------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK---------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +.+......++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 104 (314)
T 2ivs_A 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104 (314)
T ss_dssp EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence 345688999999999999762 35789999997543 566677889999
Q ss_pred ehhhcCCCHHHHHhhcCCCC------------------CCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCce
Q 022826 50 YEFVSNGSLEKFIYEKHPLE------------------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNI 111 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~------------------~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Ni 111 (291)
|||+.+++|.+++....... ....+++..++.++.||+.||.|||+ .+++|+||||+||
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~NI 181 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNI 181 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchheE
Confidence 99999999999998754211 12358999999999999999999999 9999999999999
Q ss_pred EEcCCCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCC
Q 022826 112 LLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDR 190 (291)
Q Consensus 112 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~ 190 (291)
+++.++.++|+|||++................+++.|+|||.+.+. .++.++||||||+++|+|++ |..||......
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC--CcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999876554444334445567899999999875 78999999999999999999 88887643221
Q ss_pred CccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccC
Q 022826 191 SSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSL 259 (291)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~ 259 (291)
. ...... .......+..++..+.+++.+||+.||++|||+.++++.|++++++.
T Consensus 260 ~--------~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 313 (314)
T 2ivs_A 260 R--------LFNLLK-------TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313 (314)
T ss_dssp G--------HHHHHH-------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred H--------HHHHhh-------cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence 0 001010 00111122345678999999999999999999999999999988754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=288.28 Aligned_cols=230 Identities=27% Similarity=0.484 Sum_probs=183.3
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||+|+||.||++.+.+++.||+|++.... +++......++||||+.+++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred ceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence 45678999999999999998888899999987653 56667778899999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ .
T Consensus 92 L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 162 (269)
T 4hcu_A 92 LSDYLRTQ-----RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 162 (269)
T ss_dssp HHHHHHTT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred HHHHHHhc-----CcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence 99999653 2568999999999999999999999 9999999999999999999999999999976543221 1
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
......+++.|+|||.+.+. .++.++||||||+++|+|++ |..||...... ........ ...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--------~~~~~~~~-------~~~ 225 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDIST-------GFR 225 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHT-------TCC
T ss_pred cccCcccccccCCHHHhcCC--CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHhc-------Ccc
Confidence 12334457789999999776 78999999999999999999 88777643210 00111100 011
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
...+...+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 112233466789999999999999999999999999997653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=294.81 Aligned_cols=245 Identities=24% Similarity=0.368 Sum_probs=181.3
Q ss_pred chhhcccccCCceeEEEEEe-----cCCCeEEEEEeccCc---------------------------ceeecC--Cccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKL-----LDGRNVAIKVLNETK---------------------------GFCFEG--HRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~---------------------------~~~~~~--~~~~l 48 (291)
+.+.+.||+|+||.||+|++ .+++.||+|++.... +++... ...++
T Consensus 23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence 34568899999999999983 348899999987542 333333 56789
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
||||+.+++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.
T Consensus 103 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPKNK-----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEECCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEeCCCCcHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccc
Confidence 999999999999996642 579999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCce-eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 129 ICHGRESI-VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 129 ~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
........ .......++..|+|||.+.+. .++.++||||||+++|+|++|..|+............+..........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQS--KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCC--CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 76654432 223445578889999999776 788999999999999999999887543311000000000000000000
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
............+..++..+.+++.+||+.||.+|||+.++++.|+.+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 01111111122234466789999999999999999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=298.51 Aligned_cols=223 Identities=22% Similarity=0.308 Sum_probs=173.8
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|++.. ++.||+|++++.. +.+......++|||
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E 133 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 133 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence 4567899999999999998765 8899999987542 45666778999999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+|+|..++... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.+|.+||+|||++....
T Consensus 134 ~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 134 YVNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp CCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred cCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999765 479999999999999999999999 999999999999999999999999999997532
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.........................
T Consensus 205 ~~~~--~~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-- 278 (396)
T 4dc2_A 205 RPGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-- 278 (396)
T ss_dssp CTTC--CBCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--
T ss_pred cCCC--ccccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--
Confidence 2211 23456789999999999876 78999999999999999999999996543221110000000001111111
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAM 245 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~ 245 (291)
...+..++..+.+|+.+||+.||.+||++
T Consensus 279 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 -----IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11223456778999999999999999996
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=299.01 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=183.6
Q ss_pred chhhcccccCCceeEEEEEe-----cCCCeEEEEEeccCc--------------------------ceee--cCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKL-----LDGRNVAIKVLNETK--------------------------GFCF--EGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~--------------------------~~~~--~~~~~~lv 49 (291)
+.+.+.||+|+||.||++++ .+++.||+|++.... +++. .....++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 104 (327)
T 3lxl_A 25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV 104 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEE
T ss_pred hhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEE
Confidence 45678999999999999984 348899999987653 2333 45668899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
|||+.+++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++..
T Consensus 105 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 105 MEYLPSGCLRDFLQRHR-----ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EECCTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EeecCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccccee
Confidence 99999999999997642 469999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcee-eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhh
Q 022826 130 CHGRESIV-SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEE 208 (291)
Q Consensus 130 ~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (291)
........ ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||........................
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccC--CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 65443322 22334578889999999776 7899999999999999999999887644221000000000000000001
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCC
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPP 263 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 263 (291)
...........+..++..+.+++.+||+.||++|||+.++++.|+.++.......
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 1111111222234567789999999999999999999999999999877665443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=297.19 Aligned_cols=230 Identities=26% Similarity=0.422 Sum_probs=170.7
Q ss_pred chhhcccccCCceeEEEEEecC-CCe----EEEEEeccCc---------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRN----VAIKVLNETK---------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~----vavK~~~~~~---------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||+|.+.. ++. |++|.+.... +++. ....++++
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~v~ 95 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIT 95 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEE-SSSEEEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEe-cCCceEEE
Confidence 4567899999999999998643 554 5777764322 3333 34578899
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
+++.+++|.+++... ...+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 96 ~~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 96 QLMPFGCLLDYVREH-----KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp CCCSSCBHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EecCCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999764 2579999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
.............+++.|+|||.+.+. .++.++||||||+++|+|++ |..||....... ......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~~~~---- 233 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILE---- 233 (327)
T ss_dssp ------------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHH----
T ss_pred cCccccccccCCCccccccCHHHHcCC--CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHH----
Confidence 544433333444567889999999876 78999999999999999999 888886542211 000000
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
.......+..++..+.+++.+||+.||.+|||+.|+++.|+++.+.
T Consensus 234 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 234 ---KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ---cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0111112233566789999999999999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=292.30 Aligned_cols=220 Identities=23% Similarity=0.333 Sum_probs=178.0
Q ss_pred chhhcccccCCceeEEEEEe-cCCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKL-LDGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|.+ .+|+.||||++.... +++......++||||+
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence 45678999999999999987 459999999986542 5666778899999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+++|.+++... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 97 SGGEVFDYLVAH------GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp TTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999765 479999999999999999999999 99999999999999999999999999999876543
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
.. ....++|+.|+|||++.+. ...+.++|||||||++|+|++|..||..... .. ..... .....
T Consensus 168 ~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~-~~~~i-~~~~~--- 231 (328)
T 3fe3_A 168 GK---LDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-------KE-LRERV-LRGKY--- 231 (328)
T ss_dssp CG---GGTTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHH-HHCCC---
T ss_pred Cc---cccccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-------HH-HHHHH-HhCCC---
Confidence 32 3456789999999999875 2345899999999999999999999875421 00 00000 01111
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
..+..++..+.+|+.+||+.||.+|||+.|+++.
T Consensus 232 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1112345678899999999999999999999863
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=289.69 Aligned_cols=237 Identities=25% Similarity=0.334 Sum_probs=181.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|++. +++.||+|++.... +++......++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 92 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY 92 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence 456789999999999999875 48999999985432 566677888999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 93 ~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 93 IEGPTLSEYIESH------GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp CCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999765 479999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... .......+|+.|+|||.+.+. .++.++||||||+++|+|++|..||....... ...... ....
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-------~~~~~~----~~~~ 229 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-------IAIKHI----QDSV 229 (294)
T ss_dssp ------------CCSSCCHHHHHTC--CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH-------HHHHHH----SSCC
T ss_pred ccc-cccCccccCccccCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHh----hccC
Confidence 321 112335689999999999876 78899999999999999999999987542110 000000 0000
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHhhhccCCCC
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRP-AMNRVVEMLEGSLDSLRIP 262 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-s~~ell~~L~~~~~~~~~~ 262 (291)
+.........++..+.+++.+||+.||++|| ++.++.+.|+.++..-+..
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~ 280 (294)
T 4eqm_A 230 PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN 280 (294)
T ss_dssp CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTT
T ss_pred CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCC
Confidence 0000111234567899999999999999998 9999999999987755443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=295.13 Aligned_cols=222 Identities=22% Similarity=0.303 Sum_probs=177.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||++.+. +|+.||+|+++... +++......++|
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 93 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI 93 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence 456789999999999999876 49999999987532 456667788999
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC----ceEEeccC
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF----CPKISDFG 125 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~----~~kl~Dfg 125 (291)
|||+.+|+|.+++... ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++ .+||+|||
T Consensus 94 ~e~~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 94 LELVSGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EECCCSCBHHHHHTTC------SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 9999999999999643 579999999999999999999999 9999999999999998776 79999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLE 205 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (291)
++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...... ......
T Consensus 165 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--------~~~~~i- 230 (361)
T 2yab_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANI- 230 (361)
T ss_dssp SCEECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHH-
T ss_pred CceEcCCCCc---cccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHH-
Confidence 9987654322 2445689999999999775 7899999999999999999999998654211 000000
Q ss_pred hhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 LEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
... ...........++..+.+|+.+||..||++|||+.|+++
T Consensus 231 --~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 231 --TAV-SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --HTT-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --Hhc-CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 011111222345678999999999999999999999884
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=288.42 Aligned_cols=229 Identities=25% Similarity=0.440 Sum_probs=180.1
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||+|+||.||++.+.+++.||+|+++... +++......++||||+.+++
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 105 (283)
T 3gen_A 26 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 105 (283)
T ss_dssp EEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCB
T ss_pred HHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCc
Confidence 34568999999999999998888899999998653 56667778899999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ .
T Consensus 106 L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 176 (283)
T 3gen_A 106 LLNYLREM-----RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T 176 (283)
T ss_dssp HHHHHHCG-----GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-H
T ss_pred HHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc-c
Confidence 99999763 2579999999999999999999999 9999999999999999999999999999976543221 1
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
......+++.|+|||.+.+. .++.++||||||+++|+|++ |..||...... ....... ....
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~-------~~~~ 239 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIA-------QGLR 239 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHH-------TTCC
T ss_pred cccCCccCcccCCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccChh--------HHHHHHh-------cccC
Confidence 12334457889999999876 78999999999999999998 88887643211 0001110 0011
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
...+...+..+.+++.+||+.||++|||+.++++.|+++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 11122345678899999999999999999999999998875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=288.19 Aligned_cols=243 Identities=23% Similarity=0.351 Sum_probs=181.2
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc----------------------ceeecCCcceeeehhhcCCCHHH
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------GFCFEGHRRALIYEFVSNGSLEK 60 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~~lv~e~~~~g~L~~ 60 (291)
+.+.+.||+|+||.||++++ .++.||+|++.... -+.......++||||+.+++|.+
T Consensus 10 ~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~L~~ 88 (307)
T 2eva_A 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYN 88 (307)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCBHHH
T ss_pred eeeeeEeecCCCceEEEEEE-CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCCHHH
Confidence 45678999999999999987 57899999997654 12222345789999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCc-eEEeccCCccccCCCCceeec
Q 022826 61 FIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC-PKISDFGLAKICHGRESIVSM 139 (291)
Q Consensus 61 ~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~~~ 139 (291)
++.... ....+++..++.++.|++.||.|||+....+++|+||||+||+++.++. +||+|||++.......
T Consensus 89 ~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~----- 160 (307)
T 2eva_A 89 VLHGAE---PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM----- 160 (307)
T ss_dssp HHHCSS---SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHhccC---CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-----
Confidence 997652 2345789999999999999999999833357999999999999998886 7999999987543321
Q ss_pred cCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChh
Q 022826 140 TGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEE 219 (291)
Q Consensus 140 ~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (291)
....+++.|+|||.+.+. .++.++||||||+++|+|++|..||........ . .... .. .......
T Consensus 161 ~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~-~~~~---~~----~~~~~~~ 225 (307)
T 2eva_A 161 TNNKGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-----R-IMWA---VH----NGTRPPL 225 (307)
T ss_dssp ----CCTTSSCHHHHTCC--CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-----H-HHHH---HH----TTCCCCC
T ss_pred ccCCCCCceEChhhhCCC--CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-----H-HHHH---Hh----cCCCCCc
Confidence 234579999999999875 789999999999999999999998864322110 0 0000 00 0111112
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCCCCcccC
Q 022826 220 DKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLS 269 (291)
Q Consensus 220 ~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~ 269 (291)
...++..+.+++.+||+.||++|||+.++++.|+.+.+.+.....+...+
T Consensus 226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~~ 275 (307)
T 2eva_A 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275 (307)
T ss_dssp BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCCCE
T ss_pred ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccccc
Confidence 23456678999999999999999999999999999988887766555443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=296.47 Aligned_cols=238 Identities=23% Similarity=0.393 Sum_probs=182.7
Q ss_pred chhhcccccCCceeEEEEEecC------CCeEEEEEeccCc---------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD------GRNVAIKVLNETK---------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~---------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|++.+ ++.||+|+++... +++......++|
T Consensus 49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 128 (343)
T 1luf_A 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 128 (343)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence 3456889999999999998742 4789999997643 566677889999
Q ss_pred ehhhcCCCHHHHHhhcCCCC------------------CCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCce
Q 022826 50 YEFVSNGSLEKFIYEKHPLE------------------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNI 111 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~------------------~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Ni 111 (291)
|||+.+++|.+++....... ....+++..++.++.||+.||.|||+ .+++|+||||+||
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NI 205 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNC 205 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceE
Confidence 99999999999998743110 12579999999999999999999999 9999999999999
Q ss_pred EEcCCCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCC
Q 022826 112 LLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDR 190 (291)
Q Consensus 112 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~ 190 (291)
+++.++.+||+|||++................+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.....
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~- 282 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH- 282 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-
T ss_pred EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC--CcCcccccHHHHHHHHHHHhcCCCcCCCCCh-
Confidence 9999999999999999765433222222344568899999999876 78999999999999999998 8877764321
Q ss_pred CccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCC
Q 022826 191 SSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLR 260 (291)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 260 (291)
........ . ......+..++..+.+++.+||+.||++|||+.++++.|+++.+...
T Consensus 283 -------~~~~~~~~---~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 283 -------EEVIYYVR---D----GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp -------HHHHHHHH---T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred -------HHHHHHHh---C----CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 00000000 0 01111223456789999999999999999999999999999877654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=295.42 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=184.7
Q ss_pred hhhcccccCCceeEEEEEec-----CCCeEEEEEeccCc---------------------------ceeec--CCcceee
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-----DGRNVAIKVLNETK---------------------------GFCFE--GHRRALI 49 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~---------------------------~~~~~--~~~~~lv 49 (291)
.+.+.||+|+||.||++... +++.||||+++... +++.. ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 46789999999999988642 47899999997643 33333 3567899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
|||+.+++|.+++.. ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++..
T Consensus 114 ~e~~~~~~L~~~l~~-------~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPR-------HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp ECCCTTCBHHHHGGG-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EecccCCcHHHHHhh-------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 999999999999954 359999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcee-eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc-chhhhhhhhhhh
Q 022826 130 CHGRESIV-SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY-FPHWVYKRLELE 207 (291)
Q Consensus 130 ~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 207 (291)
........ ......++..|+|||.+.+. .++.++||||||+++|+|++|..||........... .......... .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 260 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR-L 260 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH-H
T ss_pred ccccccccccccCCCCCceeeChHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH-H
Confidence 65543322 22344567889999999876 788999999999999999999988764421100000 0000000000 0
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCC
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPP 263 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 263 (291)
............+..++..+.+|+.+||+.||++|||+.++++.|+.+.+.++.+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 11111111222334566789999999999999999999999999999988776554
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=301.01 Aligned_cols=237 Identities=26% Similarity=0.385 Sum_probs=182.0
Q ss_pred chhhcccccCCceeEEEEEec------CCCeEEEEEeccCc---------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK---------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|... +++.||||+++... +++......++|
T Consensus 73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 152 (367)
T 3l9p_A 73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 152 (367)
T ss_dssp EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEE
Confidence 346788999999999999843 36789999986532 566677788999
Q ss_pred ehhhcCCCHHHHHhhcCCC-CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC---ceEEeccC
Q 022826 50 YEFVSNGSLEKFIYEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF---CPKISDFG 125 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~---~~kl~Dfg 125 (291)
|||+.+|+|.+++...... .....+++..++.++.||+.||.|||+ .+|+||||||+||+++.++ .+||+|||
T Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECCCc
Confidence 9999999999999876432 223569999999999999999999999 9999999999999998555 59999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRL 204 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~ 204 (291)
+++...............+|+.|+|||++.+. .++.++|||||||++|+|++ |..||...... ......
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--------~~~~~i 299 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------EVLEFV 299 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHHHH
T ss_pred cccccccccccccCCCcCCcccEECHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHH
Confidence 99754322211112334468899999999776 78999999999999999998 88777654210 000111
Q ss_pred hhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccC
Q 022826 205 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSL 259 (291)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~ 259 (291)
. .......+..++..+.+|+.+||+.||++|||+.++++.|+.+.+..
T Consensus 300 ~-------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 300 T-------SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp H-------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred H-------cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 0 01111122345667899999999999999999999999998876643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=291.98 Aligned_cols=230 Identities=23% Similarity=0.362 Sum_probs=176.6
Q ss_pred chhhcccccCCceeEEEEEecC-CCe----EEEEEeccCc---------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRN----VAIKVLNETK---------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~----vavK~~~~~~---------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||+|.+.. ++. |++|.+.... +++ .+...++|+
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~v~ 93 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVT 93 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEE-CBSSEEEEE
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-cCCccEEEE
Confidence 3456889999999999998754 554 7888775332 333 356688999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
+|+.+|+|.+++... ...+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 94 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 94 QYLPLGSLLDHVRQH-----RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp ECCTTCBSHHHHHSS-----GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EeCCCCCHHHHHHHc-----cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999653 2578899999999999999999999 99999999999999999999999999999877
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
.............++..|+|||.+.+. .++.++||||||+++|+|++ |..||....... .........
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~- 234 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--------VPDLLEKGE- 234 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--------HHHHHHTTC-
T ss_pred CcccccccccCCCCcccccChHHhccC--CCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--------HHHHHHcCC-
Confidence 655443334455677899999999876 78999999999999999999 888887542211 000010000
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
. ...+..++..+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus 235 --~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 235 --R----LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp --B----CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred --C----CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 111122445688899999999999999999999999987653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=283.57 Aligned_cols=228 Identities=25% Similarity=0.439 Sum_probs=177.3
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||+|++. +++.||+|++.... -+.......++||
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~lv~ 100 (287)
T 4f0f_A 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM 100 (287)
T ss_dssp EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTEEEE
T ss_pred ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCeEEE
Confidence 456789999999999999875 59999999985322 1222233447999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCC--eeeeccCCCceEEcCCCc-----eEEec
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR--ILHFDIKPHNILLDEDFC-----PKISD 123 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~dikp~Nill~~~~~-----~kl~D 123 (291)
||+.+++|.+++... ...+++..++.++.|++.||.|||+ .+ ++|+||||+||+++.++. ++|+|
T Consensus 101 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 101 EFVPCGDLYHRLLDK-----AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp ECCTTCBHHHHHHCT-----TSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred EecCCCCHHHHHhcc-----cCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 999999999988653 3579999999999999999999999 99 999999999999988776 99999
Q ss_pred cCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhh
Q 022826 124 FGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKR 203 (291)
Q Consensus 124 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~ 203 (291)
||++...... .....+++.|+|||.+.+....++.++||||||+++|+|++|..||........
T Consensus 173 fg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----------- 236 (287)
T 4f0f_A 173 FGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----------- 236 (287)
T ss_dssp CTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-----------
T ss_pred CCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-----------
Confidence 9998754332 234567999999999865445788999999999999999999999865432110
Q ss_pred hhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 204 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
...............+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 237 -KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -HHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 000111111111222334567899999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=288.66 Aligned_cols=215 Identities=23% Similarity=0.269 Sum_probs=171.4
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehhh
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~ 53 (291)
.+.++||+|+||+||+|++. +++.||||++.... +++.++...++||||+
T Consensus 60 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~ 139 (311)
T 3p1a_A 60 QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC 139 (311)
T ss_dssp EEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc
Confidence 45578999999999999886 59999999986532 5667788899999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
+++|.+++.... ..+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++......
T Consensus 140 -~~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 140 -GPSLQQHCEAWG-----ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp -CCBHHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred -CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 569999887652 579999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
.. .....||+.|+|||++.+ .++.++||||||+++|+|++|..++..... .. .+...
T Consensus 211 ~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~------~~~~~ 267 (311)
T 3p1a_A 211 GA---GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQ------QLRQG 267 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------HH------HHTTT
T ss_pred CC---CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HH------HHhcc
Confidence 22 234558999999999865 688999999999999999999766543211 00 00011
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.........++..+.+++.+||+.||++|||+.|+++
T Consensus 268 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 268 YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1112233446778999999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=290.33 Aligned_cols=219 Identities=24% Similarity=0.322 Sum_probs=176.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+++.. +++.||+|+++... +.+......++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~ 86 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence 456789999999999999876 49999999986531 456667889999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.+|.+||+|||++.....
T Consensus 87 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 87 ANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp CTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999765 478999999999999999999999 9999999999999999999999999999875432
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ........ ....
T Consensus 158 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~-~~~~-- 222 (337)
T 1o6l_A 158 DGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELIL-MEEI-- 222 (337)
T ss_dssp TTC--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HCCC--
T ss_pred CCC--cccccccChhhCChhhhcCC--CCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHHHHH-cCCC--
Confidence 221 12445689999999999876 789999999999999999999999865321 00111110 1111
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~ 250 (291)
..+..++..+.+++.+||+.||++|| ++.|+++
T Consensus 223 -----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 11224567889999999999999999 8999876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=293.80 Aligned_cols=241 Identities=26% Similarity=0.395 Sum_probs=181.9
Q ss_pred chhhcccccCCceeEEEEEec------CCCeEEEEEeccCc----------------------------ceeecCCccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK----------------------------GFCFEGHRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----------------------------~~~~~~~~~~l 48 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +.+......++
T Consensus 47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 126 (344)
T 1rjb_A 47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 126 (344)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEE
Confidence 345789999999999999862 35689999987532 55666778999
Q ss_pred eehhhcCCCHHHHHhhcCCC-----------------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCce
Q 022826 49 IYEFVSNGSLEKFIYEKHPL-----------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNI 111 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Ni 111 (291)
||||+.+|+|.+++...... .....+++..++.++.||+.||.|||+ .+++|+||||+||
T Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NI 203 (344)
T 1rjb_A 127 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNV 203 (344)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGE
T ss_pred EEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhE
Confidence 99999999999999765311 011348999999999999999999999 9999999999999
Q ss_pred EEcCCCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCC
Q 022826 112 LLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDR 190 (291)
Q Consensus 112 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~ 190 (291)
+++.++.++|+|||++................+++.|+|||.+.+. .++.++||||||+++|+|++ |..||......
T Consensus 204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC--CCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 9999999999999999876544433333445567899999999775 78999999999999999998 88888654321
Q ss_pred CccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCC
Q 022826 191 SSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262 (291)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 262 (291)
. ....... .......+..++..+.+++.+||+.||.+|||+.++++.|+.++...+..
T Consensus 282 ~-------~~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 339 (344)
T 1rjb_A 282 A-------NFYKLIQ-------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339 (344)
T ss_dssp H-------HHHHHHH-------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred H-------HHHHHHh-------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence 1 0000000 01111122335677999999999999999999999999999988766543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=287.06 Aligned_cols=235 Identities=27% Similarity=0.425 Sum_probs=169.5
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.++||+|+||.||+|++. ..+|+|+++... .........++||||+.+
T Consensus 26 y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~~~ 103 (289)
T 3og7_A 26 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEG 103 (289)
T ss_dssp CEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCCE
T ss_pred eeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEecCC
Confidence 456789999999999999853 369999987543 112345567899999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 104 ~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 104 SSLYHHLHAS-----ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp EEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred CcHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 9999999653 3679999999999999999999999 9999999999999999999999999999876544333
Q ss_pred eeeccCCCCCccccCccccccc-CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~-~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
........+++.|+|||.+... ...++.++||||||+++|+|++|..||....... ... ..........
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~---~~~~~~~~~~ 245 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-------QII---EMVGRGSLSP 245 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-------HHH---HHHHHTSCCC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-------HHH---HHhcccccCc
Confidence 3333445689999999998632 2367889999999999999999999986543211 000 0011111111
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
........++..+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1112233456789999999999999999999999999999865
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=290.38 Aligned_cols=232 Identities=22% Similarity=0.289 Sum_probs=168.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCc----cee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHR----RAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~----~~l 48 (291)
+.+.+.||+|+||.||+|++. +++.||||+++... +.+..... .++
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~l 93 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 93 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEE
Confidence 456789999999999999874 58999999997642 22222222 389
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
||||+.+++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.
T Consensus 94 v~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 94 VMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEECCCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred EEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 99999999999999765 479999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCce-eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 129 ICHGRESI-VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 129 ~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
........ .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||....... .... .
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-------~~~~-~--- 231 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQ-H--- 231 (311)
T ss_dssp -----------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHH-H---
T ss_pred cccccccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHH-H---
Confidence 65433221 122334579999999999876 78999999999999999999999986542110 0000 0
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHH-HHHHHHhhhc
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNR-VVEMLEGSLD 257 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~e-ll~~L~~~~~ 257 (291)
..............++..+.+++.+||+.||++||++.+ +.+.|.....
T Consensus 232 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 232 -VREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp -HHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred -hcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 000010001112236678999999999999999996554 5566666544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=288.80 Aligned_cols=222 Identities=23% Similarity=0.297 Sum_probs=177.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||++.+. +++.||+|++.... +++......++|
T Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 92 (326)
T 2y0a_A 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 92 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 456789999999999999875 49999999986532 556667788999
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC----ceEEeccC
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF----CPKISDFG 125 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~----~~kl~Dfg 125 (291)
|||+.+++|.+++... ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++ .+||+|||
T Consensus 93 ~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 93 LELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EECCCSCBHHHHHTTS------SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEcCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999643 579999999999999999999999 9999999999999998887 89999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLE 205 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (291)
++........ .....+|+.|+|||++.+. .++.++||||||+++|+|++|..||...... .....
T Consensus 164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~-- 228 (326)
T 2y0a_A 164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLAN-- 228 (326)
T ss_dssp TCEECCTTSC---CCCCCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHH--
T ss_pred CCeECCCCCc---cccccCCcCcCCceeecCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHH--
Confidence 9987654332 2345689999999999765 7899999999999999999999998643210 00000
Q ss_pred hhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 LEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.... ...........++..+.+|+.+||+.||++|||+.|+++
T Consensus 229 -~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 229 -VSAV-NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -HHHT-CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -HHhc-CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 111111222345677899999999999999999999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=289.93 Aligned_cols=238 Identities=26% Similarity=0.415 Sum_probs=172.6
Q ss_pred chhhcccccCCceeEEEEEecC----CCeEEEEEeccCc----------------------------ceeecCC-----c
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD----GRNVAIKVLNETK----------------------------GFCFEGH-----R 45 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~----------------------------~~~~~~~-----~ 45 (291)
+.+.+.||+|+||.||+|.... ++.||+|+++... +++.... .
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 115 (313)
T 3brb_A 36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK 115 (313)
T ss_dssp EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence 4567889999999999997642 4589999987542 2333222 3
Q ss_pred ceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccC
Q 022826 46 RALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 46 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
.++|+||+.+++|.+++...........+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||
T Consensus 116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEeecC
Confidence 48999999999999999654433345679999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRL 204 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~ 204 (291)
++................+++.|+|||.+.+. .++.++||||||+++|+|++ |..||....... .....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~ 262 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--------MYDYL 262 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHHHH
T ss_pred cceecccccccCcccccCCCccccCchhhcCC--CccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--------HHHHH
Confidence 99876543322223344567899999999775 78999999999999999999 777765432210 00000
Q ss_pred hhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCC
Q 022826 205 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLR 260 (291)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 260 (291)
. .......+..++..+.+++.+||+.||.+|||+.++++.|+++++.++
T Consensus 263 ~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 263 L-------HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp H-------TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred H-------cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 0 011112223456789999999999999999999999999999988764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=299.33 Aligned_cols=232 Identities=25% Similarity=0.439 Sum_probs=171.4
Q ss_pred chhhcccccCCceeEEEEEec----CCCeEEEEEeccCc---------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL----DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|++. ++..||||+++... +++......++|||
T Consensus 47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 126 (373)
T 2qol_A 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE 126 (373)
T ss_dssp CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEe
Confidence 456789999999999999865 47789999987542 56667788999999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++... ...+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||+++...
T Consensus 127 ~~~~~sL~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 127 YMENGSLDSFLRKH-----DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp CCTTCBHHHHHHTT-----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCCCCcHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999653 3579999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCce-eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 132 GRESI-VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 132 ~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
..... .......++..|+|||.+.+. .++.++||||||+++|+|++ |..||..... ........ ..
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~~~~~i~--~~ 266 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QDVIKAVD--EG 266 (373)
T ss_dssp ---------------CTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HHHHHHHH--TT
T ss_pred cCCccceeccCCCcCCCccChhhhccC--CcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH--cC
Confidence 43221 111223346789999999876 78999999999999999997 8888754321 00011110 00
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccC
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSL 259 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~ 259 (291)
.. ...+..++..+.+++.+||+.||++||++.++++.|+++++.-
T Consensus 267 ~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 267 YR-----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp EE-----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CC-----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 01 1112235667899999999999999999999999999987753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=291.54 Aligned_cols=239 Identities=25% Similarity=0.426 Sum_probs=185.3
Q ss_pred chhhcccccCCceeEEEEEec--------CCCeEEEEEeccCc----------------------------ceeecCCcc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL--------DGRNVAIKVLNETK----------------------------GFCFEGHRR 46 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~----------------------------~~~~~~~~~ 46 (291)
+.+.+.||+|+||.||+|++. +++.||+|++.... +++......
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 116 (334)
T 2pvf_A 37 LTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 116 (334)
T ss_dssp EEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCC
T ss_pred eEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCce
Confidence 456789999999999999863 36789999987542 556667788
Q ss_pred eeeehhhcCCCHHHHHhhcCCCC----------CCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC
Q 022826 47 ALIYEFVSNGSLEKFIYEKHPLE----------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 116 (291)
Q Consensus 47 ~lv~e~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~ 116 (291)
++||||+.+++|.+++....... ....+++..++.++.||+.||.|||+ .+++|+||||+||+++.+
T Consensus 117 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~ 193 (334)
T 2pvf_A 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTEN 193 (334)
T ss_dssp EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTT
T ss_pred EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEcCC
Confidence 99999999999999998753210 12458999999999999999999999 999999999999999999
Q ss_pred CceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCcccc
Q 022826 117 FCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIY 195 (291)
Q Consensus 117 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~ 195 (291)
+.+||+|||++................+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.....
T Consensus 194 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~------ 265 (334)
T 2pvf_A 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------ 265 (334)
T ss_dssp CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred CCEEEccccccccccccccccccCCCCcccceeChHHhcCC--CcChHHHHHHHHHHHHHHHhCCCCCcCcCCH------
Confidence 99999999999876654433333445567899999999775 78999999999999999999 8887764321
Q ss_pred chhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCC
Q 022826 196 FPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRI 261 (291)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 261 (291)
.......... .....+..++..+.+++.+||+.||.+|||+.++++.|++++.....
T Consensus 266 --~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 266 --EELFKLLKEG-------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp --HHHHHHHHHT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred --HHHHHHHhcC-------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 1011111000 01112234566789999999999999999999999999998876544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=287.40 Aligned_cols=220 Identities=25% Similarity=0.334 Sum_probs=176.2
Q ss_pred hhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCCC
Q 022826 5 FKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
..+.||+|+||.||+|++. +|+.||||++.... +.+......++||||+.+++
T Consensus 49 ~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 128 (321)
T 2c30_A 49 SYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128 (321)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred ccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCC
Confidence 4568999999999999886 59999999987543 45666778899999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++.. ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 129 L~~~l~~-------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 197 (321)
T 2c30_A 129 LTDIVSQ-------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK- 197 (321)
T ss_dssp HHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-
T ss_pred HHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc-
Confidence 9999843 469999999999999999999999 99999999999999999999999999998765443221
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
.....+|+.|+|||.+.+. .++.++||||||+++|+|++|..||..... ...... ... ......
T Consensus 198 -~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~pf~~~~~--------~~~~~~---~~~--~~~~~~ 261 (321)
T 2c30_A 198 -RKSLVGTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDGEPPYFSDSP--------VQAMKR---LRD--SPPPKL 261 (321)
T ss_dssp -BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHH---HHH--SSCCCC
T ss_pred -cccccCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH---Hhc--CCCCCc
Confidence 2345689999999999765 789999999999999999999998864321 101111 111 111111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.....++..+.+++.+||+.||++|||+.++++.
T Consensus 262 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 262 KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1233456778999999999999999999999873
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=292.64 Aligned_cols=245 Identities=23% Similarity=0.399 Sum_probs=178.3
Q ss_pred chhhcccccCCceeEEEEEe-----cCCCeEEEEEeccCc--------------------------ceee--cCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKL-----LDGRNVAIKVLNETK--------------------------GFCF--EGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~--------------------------~~~~--~~~~~~lv 49 (291)
+.+.+.||+|+||.||++++ .+++.||||++.... +++. .....++|
T Consensus 12 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 91 (295)
T 3ugc_A 12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 91 (295)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEE
T ss_pred hhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEE
Confidence 45678999999999999984 248899999987643 2322 23457899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
|||+.+++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++..
T Consensus 92 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 92 MEYLPYGSLRDYLQKH-----KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EECCTTCBHHHHHHHC-----GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEeCCCCCHHHHHHhc-----ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999764 2469999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcee-eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCc----cccchhhhhhhh
Q 022826 130 CHGRESIV-SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSS----EIYFPHWVYKRL 204 (291)
Q Consensus 130 ~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~----~~~~~~~~~~~~ 204 (291)
........ ......++..|+|||.+.+. .++.++||||||+++|+|++|..|+........ ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-- 239 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF-- 239 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH--
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCC--CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH--
Confidence 65433221 12333457789999999876 789999999999999999999887754321100 0000000000
Q ss_pred hhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCC
Q 022826 205 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLR 260 (291)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 260 (291)
...... ........+..++..+.+++.+||+.||++|||+.|+++.|+++.+.+.
T Consensus 240 ~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 240 HLIELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHHH-HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHHH-hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 000001 1111122234566789999999999999999999999999999987663
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=286.28 Aligned_cols=242 Identities=21% Similarity=0.262 Sum_probs=183.4
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc---------------------------ceeecC--Ccceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK---------------------------GFCFEG--HRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---------------------------~~~~~~--~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|.+.. ++.||||++.... +++... ...++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 4567999999999999998865 9999999987532 233333 367899999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE----cCCCceEEeccCCcc
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAK 128 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill----~~~~~~kl~Dfg~~~ 128 (291)
+.+++|.+++.... ....+++..++.++.||+.||.|||+ .+|+|+||||+||++ +.++.+||+|||++.
T Consensus 91 ~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 91 CPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp CTTCBHHHHHHSGG---GTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred CCCCCHHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999997652 33449999999999999999999999 999999999999999 778889999999998
Q ss_pred ccCCCCceeeccCCCCCccccCccccccc------CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhh
Q 022826 129 ICHGRESIVSMTGARGTVGYIAPEVFCRN------FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYK 202 (291)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~------~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~ 202 (291)
....... .....+++.|+|||++.+. ...++.++|||||||++|+|++|..||........... ....
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---~~~~ 238 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE---VMYK 238 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH---HHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH---HHHH
Confidence 7654432 2345679999999998531 24788999999999999999999999875433221110 0000
Q ss_pred hhhhhhh-------------hc---ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 022826 203 RLELEED-------------LG---LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256 (291)
Q Consensus 203 ~~~~~~~-------------~~---~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~ 256 (291)
....... .. ...........+...+.+++.+||+.||++|||+.|+++...+..
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 0000000 00 001112334678889999999999999999999999999987743
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=298.56 Aligned_cols=223 Identities=21% Similarity=0.303 Sum_probs=176.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||++.+. +++.+|+|++.... +.+......++||||+
T Consensus 13 Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 92 (444)
T 3soa_A 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLV 92 (444)
T ss_dssp EEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeC
Confidence 456789999999999999875 58999999987643 5667788899999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc---CCCceEEeccCCcccc
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---EDFCPKISDFGLAKIC 130 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~---~~~~~kl~Dfg~~~~~ 130 (291)
.+|+|.+.+... ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++ .++.+||+|||++...
T Consensus 93 ~gg~L~~~i~~~------~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 93 TGGELFEDIVAR------EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp BCCBHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 999999999765 579999999999999999999999 9999999999999998 5678999999999776
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ........ ...
T Consensus 164 ~~~~~--~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~-~~~- 229 (444)
T 3soa_A 164 EGEQQ--AWFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWDEDQ--------HRLYQQIK-AGA- 229 (444)
T ss_dssp CTTCC--BCCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHH-HTC-
T ss_pred cCCCc--eeecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHH-hCC-
Confidence 54332 22446789999999999775 789999999999999999999999865421 00111111 111
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..........++..+.+|+.+||+.||++|||+.|+++
T Consensus 230 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 230 --YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp --CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --CCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11111222345678999999999999999999999987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=297.40 Aligned_cols=219 Identities=22% Similarity=0.291 Sum_probs=172.9
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|++.. ++.||+|+++... +.+......++|||
T Consensus 25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E 104 (353)
T 3txo_A 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME 104 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence 4567899999999999998764 8999999987532 45666778999999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+|+|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.+|.+||+|||++....
T Consensus 105 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 105 FVNGGDLMFHIQKS------RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999765 479999999999999999999999 999999999999999999999999999987533
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...... ....... ...
T Consensus 176 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~-~~~-- 240 (353)
T 3txo_A 176 CNGV--TTATFCGTPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAIL-NDE-- 240 (353)
T ss_dssp C-----------CCGGGCCHHHHHHH--HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHH-HCC--
T ss_pred cCCc--cccccCCCcCeEChhhcCCC--CcCCccCCCcchHHHHHHHhCCCCCCCCCHH--------HHHHHHH-cCC--
Confidence 2221 23445789999999999876 7899999999999999999999998754211 0111110 111
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCH------HHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAM------NRVVE 250 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~------~ell~ 250 (291)
...+..++..+.+++.+||+.||.+||++ .++++
T Consensus 241 -----~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 -----VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11122356678899999999999999998 66664
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=289.50 Aligned_cols=239 Identities=27% Similarity=0.436 Sum_probs=186.8
Q ss_pred chhhcccccCCceeEEEEEe------cCCCeEEEEEeccCc----------------------------ceeecCCccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKL------LDGRNVAIKVLNETK----------------------------GFCFEGHRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~----------------------------~~~~~~~~~~l 48 (291)
+.+.+.||+|+||.||+|.+ .+++.||+|+++... +.+......++
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 104 (313)
T 1t46_A 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104 (313)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEE
Confidence 34678999999999999975 236799999987543 55666778899
Q ss_pred eehhhcCCCHHHHHhhcCCC------------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC
Q 022826 49 IYEFVSNGSLEKFIYEKHPL------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 116 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~ 116 (291)
||||+.+++|.+++...... .....+++..++.++.|++.||.|||+ .+++|+||||+||+++.+
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHG 181 (313)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETT
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEcCC
Confidence 99999999999999875311 112358999999999999999999999 999999999999999999
Q ss_pred CceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCcccc
Q 022826 117 FCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIY 195 (291)
Q Consensus 117 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~ 195 (291)
+.++|+|||++................+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.......
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---- 255 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---- 255 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH----
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCCcccchh----
Confidence 99999999999876655443333445567889999999775 78999999999999999998 888776543211
Q ss_pred chhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCC
Q 022826 196 FPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLR 260 (291)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 260 (291)
....... . ......+..++..+.+++.+||+.||.+|||+.++++.|++++++..
T Consensus 256 ---~~~~~~~--~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 256 ---KFYKMIK--E-----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp ---HHHHHHH--H-----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred ---HHHHHhc--c-----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 0000000 0 00111123356778999999999999999999999999999887654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=294.71 Aligned_cols=231 Identities=16% Similarity=0.143 Sum_probs=183.3
Q ss_pred chhhcccccCCceeEEEEE------ecCCCeEEEEEeccCc--------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGK------LLDGRNVAIKVLNETK--------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||+|. ...++.||+|++.... +.+......++||
T Consensus 67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~ 146 (365)
T 3e7e_A 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVG 146 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEE
T ss_pred EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEE
Confidence 3456789999999999994 3358999999987654 4556678889999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC-----------CCce
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-----------DFCP 119 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~-----------~~~~ 119 (291)
||+.+|+|.+++...... ....+++..++.++.||+.||.|||+ .+|+||||||+||+++. ++.+
T Consensus 147 e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~ 222 (365)
T 3e7e_A 147 ELYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222 (365)
T ss_dssp CCCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred eccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccccCCE
Confidence 999999999999764211 23579999999999999999999999 99999999999999988 8999
Q ss_pred EEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhh
Q 022826 120 KISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHW 199 (291)
Q Consensus 120 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~ 199 (291)
||+|||++................||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........
T Consensus 223 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---- 296 (365)
T 3e7e_A 223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE---- 296 (365)
T ss_dssp EECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEEC----
T ss_pred EEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC--CCCccccHHHHHHHHHHHHhCCCccccCCCCceeec----
Confidence 99999999765433333334566789999999999876 689999999999999999999999865543211100
Q ss_pred hhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHhhhccC
Q 022826 200 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDR-PAMNRVVEMLEGSLDSL 259 (291)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~R-ps~~ell~~L~~~~~~~ 259 (291)
. .... . .....+.+++..||+.+|.+| |++.++.+.|++.+...
T Consensus 297 --------~--~~~~--~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 297 --------G--LFRR--L----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp --------S--CCTT--C----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred --------h--hccc--c----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0 0000 0 124567789999999999999 68899999998887753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=297.67 Aligned_cols=237 Identities=28% Similarity=0.408 Sum_probs=182.0
Q ss_pred chhhcccccCCceeEEEEEec------CCCeEEEEEeccCc----------------------------ceeec-CCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK----------------------------GFCFE-GHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----------------------------~~~~~-~~~~~ 47 (291)
+.+.+.||+|+||.||+|++. +++.||||+++... +.+.. +...+
T Consensus 24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~ 103 (359)
T 3vhe_A 24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 103 (359)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceE
Confidence 346789999999999999742 36799999997643 33333 34588
Q ss_pred eeehhhcCCCHHHHHhhcCCCC----------------------------------------------------------
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLE---------------------------------------------------------- 69 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~---------------------------------------------------------- 69 (291)
+||||+.+|+|.+++.......
T Consensus 104 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (359)
T 3vhe_A 104 VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE 183 (359)
T ss_dssp EEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------
T ss_pred EEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccccc
Confidence 9999999999999998753100
Q ss_pred --CCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeeccCCCCCcc
Q 022826 70 --TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVG 147 (291)
Q Consensus 70 --~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 147 (291)
....+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++.++|+|||++................+|+.
T Consensus 184 ~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~ 260 (359)
T 3vhe_A 184 DLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260 (359)
T ss_dssp CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred chhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence 02238999999999999999999999 9999999999999999999999999999987654443333445567889
Q ss_pred ccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHH
Q 022826 148 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 226 (291)
Q Consensus 148 y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (291)
|+|||++.+. .++.++||||||+++|+|++ |..||....... ......... .....+..++..
T Consensus 261 y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~-------~~~~~~~~~~~~ 324 (359)
T 3vhe_A 261 WMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCRRLKEG-------TRMRAPDYTTPE 324 (359)
T ss_dssp GCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-------HHHHHHHHT-------CCCCCCTTCCHH
T ss_pred eEChhhhcCC--CCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-------HHHHHHHcC-------CCCCCCCCCCHH
Confidence 9999999875 78999999999999999998 888886543211 011111100 011112335567
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 227 MILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 227 l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
+.+++.+||+.||.+|||+.|+++.|+.+++.
T Consensus 325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 89999999999999999999999999998764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=294.60 Aligned_cols=245 Identities=16% Similarity=0.170 Sum_probs=186.2
Q ss_pred chhhcccccCCceeEEEEEecC---------CCeEEEEEeccCc------------------------------------
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD---------GRNVAIKVLNETK------------------------------------ 37 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~------------------------------------ 37 (291)
+.+.+.||+|+||.||+|++.. ++.||+|++....
T Consensus 44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~ 123 (352)
T 2jii_A 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCM 123 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCC
T ss_pred EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccchh
Confidence 4567899999999999998753 7899999997653
Q ss_pred ceee-cCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC
Q 022826 38 GFCF-EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 116 (291)
Q Consensus 38 ~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~ 116 (291)
+++. .+...++||||+ +++|.+++... ....+++..++.++.||+.||.|||+ .+++|+||||+||+++.+
T Consensus 124 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 124 GFGVHQDKYRFLVLPSL-GRSLQSALDVS----PKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPE 195 (352)
T ss_dssp EEEEETTTEEEEEEECC-CEEHHHHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEEETT
T ss_pred hccccCCcEEEEEecCC-CcCHHHHHHhC----CcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEEcCC
Confidence 1222 267789999999 88999999764 23679999999999999999999999 999999999999999999
Q ss_pred C--ceEEeccCCccccCCCCcee-----eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccC
Q 022826 117 F--CPKISDFGLAKICHGRESIV-----SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVD 189 (291)
Q Consensus 117 ~--~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~ 189 (291)
+ .++|+|||++.......... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.....
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 8 99999999997654322111 11334689999999999876 789999999999999999999999876542
Q ss_pred CCccccchhhhhhhhhhhhhhcccCCCC--hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCCC
Q 022826 190 RSSEIYFPHWVYKRLELEEDLGLQGIEN--EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPR 264 (291)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 264 (291)
.... ... .............. .....++..+.+++.+||+.||++|||+.++++.|+++++..+....
T Consensus 274 ~~~~------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~ 343 (352)
T 2jii_A 274 NTED------IMK-QKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPY 343 (352)
T ss_dssp CHHH------HHH-HHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTT
T ss_pred CHHH------HHH-HHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcC
Confidence 2110 000 00000000000000 00113467899999999999999999999999999999998876643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=289.56 Aligned_cols=223 Identities=20% Similarity=0.252 Sum_probs=179.1
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.+.+.||+|+||.||++.+.. ++.+|+|++.... +.+......++||||+.++
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~ 86 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCC
Confidence 4567899999999999998754 8899999987553 5666778899999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC--CCceEEeccCCccccCCCC
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE--DFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~--~~~~kl~Dfg~~~~~~~~~ 134 (291)
+|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++. ++.++|+|||++.......
T Consensus 87 ~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 87 DIFERINTS-----AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp BHHHHHTSS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 999999543 2579999999999999999999999 99999999999999987 7899999999998765543
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
. .....+++.|+|||++.+. .++.++||||||+++|+|++|..||...... ...... .. ....
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i---~~-~~~~ 221 (321)
T 1tki_A 159 N---FRLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENI---MN-AEYT 221 (321)
T ss_dssp E---EEEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHH---HH-TCCC
T ss_pred c---cccccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHHH---Hc-CCCC
Confidence 2 2334579999999999775 6889999999999999999999998654211 000000 00 0111
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
........++..+.+|+.+||..||.+|||+.|+++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111222346778999999999999999999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=304.27 Aligned_cols=232 Identities=24% Similarity=0.428 Sum_probs=183.0
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||+|+||.||+|.+.++..||||+++... +++ .....++||||+.+|+
T Consensus 190 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~-~~~~~~lv~e~~~~g~ 268 (454)
T 1qcf_A 190 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGS 268 (454)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEECCCTTCB
T ss_pred eEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEE-eCCccEEEEeecCCCc
Confidence 34678999999999999998788899999998643 333 3567899999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ....+++..++.++.||+.||.|||+ ++++|+||||+||+++.++.+||+|||+++....... .
T Consensus 269 L~~~l~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~ 340 (454)
T 1qcf_A 269 LLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T 340 (454)
T ss_dssp HHHHHHSH----HHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-H
T ss_pred HHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-e
Confidence 99999754 22468899999999999999999999 9999999999999999999999999999986543211 1
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
......++..|+|||.+.+. .++.++||||||+++|+|++ |..||..... ......... ...
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~-------~~~ 403 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRALER-------GYR 403 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHHHHH-------TCC
T ss_pred ccCCCcccccccCHHHhccC--CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHc-------CCC
Confidence 12233457789999999765 78999999999999999999 8888764321 111111110 011
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCC
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLR 260 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 260 (291)
...+..++..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 11223456789999999999999999999999999999876543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=292.33 Aligned_cols=225 Identities=23% Similarity=0.290 Sum_probs=169.0
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||++.+.+++.||||++.... +++......++|||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 89 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 89 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence 45678999999999999998889999999986442 45666778899999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++ ++.+||+|||++.....
T Consensus 90 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 90 CGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp CCSEEHHHHHHHS------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 5677999999764 578999999999999999999999 9999999999999997 67899999999987654
Q ss_pred CCceeeccCCCCCccccCccccccc---------CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRN---------FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKR 203 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~---------~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~ 203 (291)
...........||+.|+|||++.+. ...++.++|||||||++|+|++|..||....... . .
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~----~ 229 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------S----K 229 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH------H----H
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH------H----H
Confidence 4333333455789999999998641 1378899999999999999999999986432210 0 0
Q ss_pred hhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 204 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
. ............+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 230 ~---~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 230 L---HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp H---HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H---HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 0 00001111111122234568899999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=292.03 Aligned_cols=230 Identities=26% Similarity=0.429 Sum_probs=173.9
Q ss_pred chhhcccccCCceeEEEEEecC-CCe----EEEEEeccCc---------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRN----VAIKVLNETK---------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~----vavK~~~~~~---------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||+|++.. ++. |++|.+.... +++.. ...++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~v~ 95 (327)
T 3poz_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIT 95 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-SSEEEEE
T ss_pred cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEE
Confidence 4567899999999999998643 443 5888875332 33333 4577899
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
+++.+|+|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++..
T Consensus 96 e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 96 QLMPFGCLLDYVREH-----KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp ECCTTCBHHHHHHHS-----TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EecCCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999764 2579999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
.............+++.|+|||.+.+. .++.++||||||+++|+|++ |..||....... ......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~---- 233 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILE---- 233 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHH----
T ss_pred cCCcccccccCCCccccccChHHhccC--CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--------HHHHHH----
Confidence 554443333445568899999999876 88999999999999999999 888886432211 000000
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
.......+..++..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 234 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 234 ---KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ---cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 0111112233566788999999999999999999999999988653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=305.13 Aligned_cols=231 Identities=30% Similarity=0.491 Sum_probs=185.0
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.+.+.||+|+||.||+|.+.. +..||||+++... +++......++||||+.+|
T Consensus 222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g 301 (495)
T 1opk_A 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 301 (495)
T ss_dssp EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCC
Confidence 3456899999999999998865 8899999997653 5677778899999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+|.+++... ....+++..++.++.||+.||.|||+ ++|+|+||||+||+++.++.+||+|||+++.......
T Consensus 302 ~L~~~l~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 373 (495)
T 1opk_A 302 NLLDYLREC----NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY- 373 (495)
T ss_dssp BHHHHHHHS----CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-
T ss_pred CHHHHHHhc----CcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCce-
Confidence 999999764 33568999999999999999999999 9999999999999999999999999999987644322
Q ss_pred eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 137 VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
.......++..|+|||.+.+. .++.++||||||+++|+|++ |..|+...... . ...... ...
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-------~-~~~~~~-------~~~ 436 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------Q-VYELLE-------KDY 436 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------G-HHHHHH-------TTC
T ss_pred eecCCCcCCcceeCHhHHhcC--CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHH-------cCC
Confidence 222334457789999999775 78999999999999999998 77777643211 0 011110 111
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
....+..++..+.+|+.+||+.||++|||+.++++.|+.+++.
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 1122334567889999999999999999999999999987654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=283.65 Aligned_cols=234 Identities=26% Similarity=0.446 Sum_probs=182.6
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||+|+||.||+|.+.+++.||+|++.... +++ .....++||||+.+++
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~~~~ 93 (279)
T 1qpc_A 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGS 93 (279)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSCEEEEECCTTCB
T ss_pred hhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEE-cCCCcEEEEecCCCCC
Confidence 45678999999999999998778899999987643 232 3456889999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ .
T Consensus 94 L~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 165 (279)
T 1qpc_A 94 LVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T 165 (279)
T ss_dssp HHHHTTSH----HHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred HHHHHhcC----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-c
Confidence 99998653 22379999999999999999999999 9999999999999999999999999999987654322 1
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
......++..|+|||.+.+. .++.++||||||+++|+|++ |..||..... .. ....... ...
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~-~~~~~~~-------~~~ 228 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PE-VIQNLER-------GYR 228 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HH-HHHHHHT-------TCC
T ss_pred cccCCCCccCccChhhhccC--CCCchhhhHHHHHHHHHHHhCCCCCCcccCH-------HH-HHHHHhc-------ccC
Confidence 22334467789999999765 78899999999999999999 7877754321 00 0011100 011
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCC
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 262 (291)
...+..++..+.+++.+||+.||++|||+.++++.|++++......
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 1122345678999999999999999999999999999998876554
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=286.02 Aligned_cols=232 Identities=30% Similarity=0.488 Sum_probs=185.8
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.+.+.||+|+||.||+|.+.+ ++.||+|++.... +++......++||||+.++
T Consensus 15 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 94 (288)
T 3kfa_A 15 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 94 (288)
T ss_dssp EEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTE
T ss_pred eeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCC
Confidence 4567899999999999998865 8899999987654 5666777889999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 95 ~L~~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 95 NLLDYLREC----NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp EHHHHHHHC----CTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred cHHHHHHhc----ccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence 999999764 33579999999999999999999999 99999999999999999999999999999876543322
Q ss_pred eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 137 VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
......+++.|+|||.+.+. .++.++||||||+++|+|++ |..||....... ...... ...
T Consensus 168 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--------~~~~~~-------~~~ 229 (288)
T 3kfa_A 168 -AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLE-------KDY 229 (288)
T ss_dssp -EETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHHHHH-------TTC
T ss_pred -cccCCccccCcCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHh-------ccC
Confidence 22334457889999999876 78999999999999999999 777776432110 000000 011
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccC
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSL 259 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~ 259 (291)
....+..++..+.+++.+||+.||.+|||+.++++.|+.++.+.
T Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11222345678999999999999999999999999999887653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=291.48 Aligned_cols=219 Identities=22% Similarity=0.313 Sum_probs=176.0
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +++......++||||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 90 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence 567799999999999999874 59999999986431 566677888999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+ +|+|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 91 ~-~g~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 91 A-GGELFDYIVEK------KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp C-CEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred C-CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9 67999998765 479999999999999999999999 9999999999999999999999999999986554
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... ....+||+.|+|||++.+. ...+.++||||||+++|+|++|..||........... .
T Consensus 161 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~----------------i 220 (336)
T 3h4j_B 161 GNF---LKTSCGSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----------------V 220 (336)
T ss_dssp SBT---TCCCTTSTTTSCGGGSCCS-GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC----------------C
T ss_pred Ccc---cccccCCcCcCCHHHHcCC-CCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH----------------H
Confidence 332 2445689999999999875 2347899999999999999999999975432211000 0
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.......+..++..+.+|+.+||+.||.+|||+.|+++.
T Consensus 221 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 221 NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 000011122356678899999999999999999999863
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=290.38 Aligned_cols=226 Identities=20% Similarity=0.290 Sum_probs=177.5
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------ceeecCCcceeeehhhcCCCH
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
+.+.+.||+|+||.||++.+.. ++.||+|++.... +.+.++...++||||+.+|+|
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L 103 (342)
T 2qr7_A 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL 103 (342)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcH
Confidence 3467899999999999998754 8999999997654 566777889999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC----CceEEeccCCccccCCCC
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED----FCPKISDFGLAKICHGRE 134 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~----~~~kl~Dfg~~~~~~~~~ 134 (291)
.+++... ..+++..++.++.||+.||.|||+ .+|+|+||||+||++..+ +.+||+|||++.......
T Consensus 104 ~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 104 LDKILRQ------KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp HHHHHTC------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 9999654 479999999999999999999999 999999999999998443 359999999998765433
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
. .....++|+.|+|||++.+. .++.++|||||||++|+|++|..||........ ........ .. ...
T Consensus 175 ~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----~~~~~~i~-~~---~~~ 241 (342)
T 2qr7_A 175 G--LLMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-----EEILARIG-SG---KFS 241 (342)
T ss_dssp C--CBCCSSCCSSCCCHHHHHHH--HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH-----HHHHHHHH-HC---CCC
T ss_pred C--ceeccCCCccccCHHHhcCC--CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH-----HHHHHHHc-cC---Ccc
Confidence 2 12345689999999999875 688999999999999999999999875432211 11111110 00 111
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
........++..+.+|+.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111222346778999999999999999999999876
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=289.31 Aligned_cols=222 Identities=23% Similarity=0.344 Sum_probs=173.0
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|++.. ++.||+|++.... +.+......++|||
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e 90 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 90 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence 4567899999999999998864 8999999997542 45666788899999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+|+|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.+|.+||+|||++....
T Consensus 91 ~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 91 YVNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999765 479999999999999999999999 999999999999999999999999999997533
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccc-cchhhhhhhhhhhhhh
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEI-YFPHWVYKRLELEEDL 210 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 210 (291)
.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.......... .......... ....
T Consensus 162 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i-~~~~- 235 (345)
T 3a8x_A 162 RPGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-LEKQ- 235 (345)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH-HHCC-
T ss_pred CCCC--cccccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH-HcCC-
Confidence 2221 23456789999999999876 78999999999999999999999986432211100 0000000100 0111
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAM 245 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~ 245 (291)
...+..++..+.+++.+||+.||.+||++
T Consensus 236 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 ------IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ------CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11123456778999999999999999996
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=290.72 Aligned_cols=222 Identities=23% Similarity=0.321 Sum_probs=176.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +.+......++||||+
T Consensus 31 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 110 (362)
T 2bdw_A 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 110 (362)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 456789999999999999875 49999999997543 5666778889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC---CceEEeccCCcccc
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED---FCPKISDFGLAKIC 130 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~---~~~kl~Dfg~~~~~ 130 (291)
.+++|.+++... ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++.+ +.+||+|||++...
T Consensus 111 ~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 111 TGGELFEDIVAR------EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CSCBHHHHHTTC------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 999999998654 578999999999999999999999 999999999999999765 45999999999876
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
..... .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||..... ........ ..
T Consensus 182 ~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~~~~i~-~~-- 245 (362)
T 2bdw_A 182 NDSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQIK-AG-- 245 (362)
T ss_dssp TTCCS---CCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HT--
T ss_pred cCCcc---cccCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH-hC--
Confidence 53322 2345689999999999775 789999999999999999999999865421 00011110 00
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
...........++..+.+|+.+||+.||++|||+.++++
T Consensus 246 -~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 246 -AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp -CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111112222346778999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=280.88 Aligned_cols=229 Identities=27% Similarity=0.475 Sum_probs=182.4
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||+|+||.||++.+.+++.||+|++.... +++......++||||+.+++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred eeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence 45678999999999999998888899999998653 56666778999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....... ..
T Consensus 90 L~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 160 (267)
T 3t9t_A 90 LSDYLRTQ-----RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 160 (267)
T ss_dssp HHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred HHHHHhhC-----cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence 99999764 2568999999999999999999999 999999999999999999999999999987654321 11
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
......+++.|+|||.+.+. .++.++||||||+++|+|++ |..||..... ......... ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~i~~-------~~~ 223 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDIST-------GFR 223 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHT-------TCC
T ss_pred ccccccccccccChhhhcCC--CccchhchhhhHHHHHHHhccCCCCCCCCCH--------HHHHHHHhc-------CCc
Confidence 12334467789999999775 78899999999999999999 7877754321 000111100 001
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
...+..++..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11122346678999999999999999999999999999765
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=301.93 Aligned_cols=233 Identities=28% Similarity=0.444 Sum_probs=178.6
Q ss_pred hhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCCH
Q 022826 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
.+.+.||+|+||.||+|.+.++..||||+++... +++. ....++||||+.+|+|
T Consensus 187 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~iv~e~~~~gsL 265 (452)
T 1fmk_A 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 265 (452)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBH
T ss_pred eeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc-CCceEEEehhhcCCCH
Confidence 4568899999999999998777889999998643 3433 3678899999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
.+++... .+..+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||+++....... ..
T Consensus 266 ~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~ 337 (452)
T 1fmk_A 266 LDFLKGE----TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA 337 (452)
T ss_dssp HHHHSHH----HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred HHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCce-ec
Confidence 9999653 23468999999999999999999999 9999999999999999999999999999986543221 11
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
.....++..|+|||.+.+. .++.++||||||+++|+|++ |..||..... ........ .....
T Consensus 338 ~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~-------~~~~~ 400 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVE-------RGYRM 400 (452)
T ss_dssp -----CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHH-------TTCCC
T ss_pred ccCCcccccccCHhHHhcC--CCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH-------cCCCC
Confidence 2233457789999999775 78999999999999999999 7877754321 10111111 11111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCC
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 262 (291)
..+..++..+.+++.+||+.||++|||+.++++.|+.+......+
T Consensus 401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 223346678899999999999999999999999999988765443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=295.25 Aligned_cols=225 Identities=22% Similarity=0.288 Sum_probs=169.6
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||++.+.+++.||||++.... +++......++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 45678999999999999998779999999986432 44666777899999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++ ++.+||+|||++.....
T Consensus 137 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 137 CGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp CCSEEHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred cCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 5678999999764 478899999999999999999999 9999999999999995 57999999999987654
Q ss_pred CCceeeccCCCCCccccCccccccc---------CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRN---------FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKR 203 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~---------~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~ 203 (291)
...........||+.|+|||++.+. ...++.++|||||||++|+|++|..||....... . .
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~----~ 276 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------S----K 276 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------H----H
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH------H----H
Confidence 4333333456789999999998651 1368899999999999999999999986432210 0 0
Q ss_pred hhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 204 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
. ..+.........+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 277 ~---~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 277 L---HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp H---HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H---HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 0 00000111111111224578899999999999999999999863
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=283.86 Aligned_cols=236 Identities=25% Similarity=0.304 Sum_probs=175.0
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||+|++.+++.||+|++.... +++......++||||+.
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 102 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME 102 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred hHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence 45678999999999999998889999999987432 55667778899999998
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+ +|.+++... ...+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 103 ~-~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 103 K-DLKKVLDEN-----KTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp E-EHHHHHHTC-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred C-CHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 5 888888653 2569999999999999999999999 999999999999999999999999999998754332
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhh-------hhhhhhh
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWV-------YKRLELE 207 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~-------~~~~~~~ 207 (291)
. ......+|+.|+|||.+.+. ..++.++|||||||++|+|++|..||................ +......
T Consensus 174 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 174 R--SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp C-----CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred c--cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 2 22345679999999998763 368999999999999999999999987654332100000000 0000000
Q ss_pred ---hhhcccCCC----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 208 ---EDLGLQGIE----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 208 ---~~~~~~~~~----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......... ......++.++.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000000 0111234567899999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=283.63 Aligned_cols=236 Identities=26% Similarity=0.416 Sum_probs=181.6
Q ss_pred hhhcccccCCceeEEEEEecC-C---CeEEEEEeccCc---------------------------ceeecCCc-ceeeeh
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-G---RNVAIKVLNETK---------------------------GFCFEGHR-RALIYE 51 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~---------------------------~~~~~~~~-~~lv~e 51 (291)
.+++.||+|+||.||+|.+.+ + ..+|+|++.... +++..... .++|++
T Consensus 24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 103 (298)
T 3pls_A 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP 103 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence 456889999999999997643 3 379999987533 34433333 489999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 104 ~~~~~~L~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 104 YMCHGDLLQFIRSP-----QRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp CCTTCBHHHHHHCT-----TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred cccCCCHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999653 3678999999999999999999999 999999999999999999999999999997654
Q ss_pred CCCc--eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 132 GRES--IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 132 ~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
.... ........+++.|+|||.+.+. .++.++||||||+++|+|++|..|+........ ......
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-------~~~~~~---- 242 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-------LTHFLA---- 242 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-------HHHHHH----
T ss_pred CCcccccccCcCCCCCccccChhhhccC--CCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-------HHHHhh----
Confidence 3221 1122344568899999999776 789999999999999999997776554322110 000000
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCC
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPP 263 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 263 (291)
.......+..++..+.+++.+||+.||.+|||+.++++.|+++++.+....
T Consensus 243 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 243 ---QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp ---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred ---cCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 000111223355678999999999999999999999999999999876553
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=286.81 Aligned_cols=242 Identities=24% Similarity=0.361 Sum_probs=181.3
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCC----cceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGH----RRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~----~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|++ +++.||||++.... +.+.... ..++||||+
T Consensus 44 y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~ 122 (342)
T 1b6c_B 44 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 122 (342)
T ss_dssp CEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCC
T ss_pred EEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeec
Confidence 45678999999999999987 68999999986543 3333333 688999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhh--------cCCCCCeeeeccCCCceEEcCCCceEEeccC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH--------RGCNTRILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH--------~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
.+++|.+++.. ..+++..++.++.|++.||.||| + .+++|+||||+||+++.++.++|+|||
T Consensus 123 ~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 123 EHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp TTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CCCcHHHHHhc-------cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 99999999964 36899999999999999999999 8 999999999999999999999999999
Q ss_pred CccccCCCCcee--eccCCCCCccccCcccccccCC----CccccccchhHHHHHHHHhCC----------CCCCccccC
Q 022826 126 LAKICHGRESIV--SMTGARGTVGYIAPEVFCRNFG----EVSYKSDVYSYGMMVFEMTGV----------KNNANVAVD 189 (291)
Q Consensus 126 ~~~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~----~~~~~~DiwslG~~l~~ll~g----------~~~~~~~~~ 189 (291)
++.......... ......+++.|+|||.+.+... .++.++||||||+++|+|++| ..||.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 998765443322 2244568999999999876421 234789999999999999999 444443322
Q ss_pred CCccccchhhhhhhhhhhhhhcccCCCC-hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCC
Q 022826 190 RSSEIYFPHWVYKRLELEEDLGLQGIEN-EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLR 260 (291)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 260 (291)
..... .. .......... .+.... .........+.+|+.+||+.||++|||+.++++.|+++.++..
T Consensus 273 ~~~~~--~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 273 SDPSV--EE--MRKVVCEQKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp SSCCH--HH--HHHHHTTSCC-CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred CcccH--HH--HHHHHHHHHh-CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 11100 00 0000000001 111111 1234677889999999999999999999999999999877654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=289.06 Aligned_cols=224 Identities=19% Similarity=0.257 Sum_probs=158.9
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------ceeecCCcceeeehhhcCCCHHHH
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------GFCFEGHRRALIYEFVSNGSLEKF 61 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------~~~~~~~~~~lv~e~~~~g~L~~~ 61 (291)
+.||+|+||.||++.+. +++.||||++.... +++.+....++||||+.+++|.++
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 96 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFER 96 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHH
Confidence 77999999999999885 48999999987643 566777889999999999999999
Q ss_pred HhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC---ceEEeccCCccccCCCCceee
Q 022826 62 IYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF---CPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 62 l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
+... ..+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++ .++|+|||++........ .
T Consensus 97 l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~ 165 (325)
T 3kn6_A 97 IKKK------KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--P 165 (325)
T ss_dssp HHHC------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--c
Confidence 9764 579999999999999999999999 9999999999999997765 899999999986543322 2
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc--cCCC
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL--QGIE 216 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 216 (291)
.....+|+.|+|||.+.+. .++.++||||||+++|+|++|..||............. .....+.. ....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-------~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV-------EIMKKIKKGDFSFE 236 (325)
T ss_dssp ------------------C--CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH-------HHHHHHTTTCCCCC
T ss_pred ccccCCCcCccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH-------HHHHHHHcCCCCCC
Confidence 2345679999999999776 78999999999999999999999997654321111100 01111111 1112
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......++..+.+|+.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 2333456788999999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=286.66 Aligned_cols=216 Identities=27% Similarity=0.365 Sum_probs=176.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+++.. +++.||+|+++... +.+......++||||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~ 87 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 87 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence 456789999999999999875 49999999986532 556677889999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++... ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++.+|.+||+|||++.....
T Consensus 88 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 88 IEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCSCBHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999764 478999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
. ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ........ ....
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~-~~~~-- 220 (318)
T 1fot_A 159 V-----TYTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKIL-NAEL-- 220 (318)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH-HCCC--
T ss_pred c-----cccccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-hCCC--
Confidence 2 2345789999999999876 789999999999999999999999865321 00111110 0001
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~ 250 (291)
..+..++..+.+++.+||+.||++|| +++++++
T Consensus 221 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 -----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11233567789999999999999999 8898874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=292.64 Aligned_cols=236 Identities=17% Similarity=0.180 Sum_probs=173.0
Q ss_pred chhhcccccCCceeEEEEEec----CCCeEEEEEeccCc-------------------------------------ceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL----DGRNVAIKVLNETK-------------------------------------GFCF 41 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-------------------------------------~~~~ 41 (291)
+.+.+.||+|+||.||+|.+. ++..+|+|++.... +.+.
T Consensus 39 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~ 118 (345)
T 2v62_A 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL 118 (345)
T ss_dssp EEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEE
T ss_pred EEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccc
Confidence 456789999999999999875 57899999987542 2222
Q ss_pred c----CCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC
Q 022826 42 E----GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 117 (291)
Q Consensus 42 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~ 117 (291)
. ....++||||+ +++|.+++... ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++
T Consensus 119 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 119 TEFKGRSYRFMVMERL-GIDLQKISGQN------GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EESSSCEEEEEEEECE-EEEHHHHCBGG------GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSS
T ss_pred cccCCCcEEEEEEecc-CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCC
Confidence 3 56789999999 88999998654 389999999999999999999999 9999999999999998877
Q ss_pred --ceEEeccCCccccCCCCce-----eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCC
Q 022826 118 --CPKISDFGLAKICHGRESI-----VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDR 190 (291)
Q Consensus 118 --~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~ 190 (291)
.+||+|||+++........ .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 9999999999766432111 112445689999999999876 7899999999999999999999999653222
Q ss_pred CccccchhhhhhhhhhhhhhcccCCCChh--hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 191 SSEIYFPHWVYKRLELEEDLGLQGIENEE--DKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
.... ...........+...... ...++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 267 ~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 267 PVAV-------QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHH-------HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cHHH-------HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1100 000000000000000000 01356689999999999999999999999999988644
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=283.20 Aligned_cols=236 Identities=26% Similarity=0.432 Sum_probs=179.6
Q ss_pred chhhcccccCCceeEEEEEecC----CCeEEEEEeccCc---------------------------ce-eecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD----GRNVAIKVLNETK---------------------------GF-CFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~---------------------------~~-~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||+|.+.+ ...+++|.+.... ++ ...+...++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 4567899999999999998643 2368999987533 33 33456788999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
||+.+++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 107 e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 107 PYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp ECCTTCBHHHHHHCT-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred eCCCCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999653 3578999999999999999999999 99999999999999999999999999999866
Q ss_pred CCCCc--eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhh
Q 022826 131 HGRES--IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEE 208 (291)
Q Consensus 131 ~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (291)
..... ........+++.|+|||.+.+. .++.++||||||+++|+|++|..++........ .. ....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~----~~~~--- 246 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---IT----VYLL--- 246 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HH----HHHH---
T ss_pred cccchhccccccCCCCCccccChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HH----HHHh---
Confidence 43321 1122334567889999999776 789999999999999999996655443322111 00 0000
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCC
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 262 (291)
.......+..++..+.+++.+||+.||++|||+.++++.|+.+++.+...
T Consensus 247 ----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 247 ----QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp ----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred ----cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 00111112234567899999999999999999999999999998877654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=295.55 Aligned_cols=225 Identities=21% Similarity=0.271 Sum_probs=168.5
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------ceee----cCCcceeeehhhcCCCHH
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------GFCF----EGHRRALIYEFVSNGSLE 59 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------~~~~----~~~~~~lv~e~~~~g~L~ 59 (291)
+.||+|+||.||++.+. +++.||||++.... +++. .....++||||+.+|+|.
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~ 147 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF 147 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHH
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHH
Confidence 68999999999999875 48999999986433 2222 255688999999999999
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC---CCceEEeccCCccccCCCCce
Q 022826 60 KFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---DFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 60 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+++... ....+++..++.++.||+.||.|||+ .+|+|+||||+||+++. ++.+||+|||++.......
T Consensus 148 ~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~-- 218 (400)
T 1nxk_A 148 SRIQDR----GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-- 218 (400)
T ss_dssp HHHHCC-------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----
T ss_pred HHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCCC--
Confidence 999764 23569999999999999999999999 99999999999999987 7899999999998654332
Q ss_pred eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 137 VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
.....++|+.|+|||++.+. .++.++|||||||++|+|++|..||............. ... ...... ..
T Consensus 219 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~----~~i-~~~~~~---~~ 287 (400)
T 1nxk_A 219 -SLTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----TRI-RMGQYE---FP 287 (400)
T ss_dssp ---------CTTCCGGGSCCC--CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH----HHH-HHTCCC---CC
T ss_pred -ccccCCCCCCccCHhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH----HHH-HcCccc---CC
Confidence 12345679999999999765 78999999999999999999999997654322111100 000 011111 11
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
......++..+.+|+.+||+.||++|||+.|+++.
T Consensus 288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11123466789999999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=281.46 Aligned_cols=222 Identities=27% Similarity=0.476 Sum_probs=168.5
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|.+ .++.||+|++.... +++......++||||
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF 87 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred eeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence 45678999999999999987 58899999986432 566667788999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCC---eeeeccCCCceEEcC--------CCceEE
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR---ILHFDIKPHNILLDE--------DFCPKI 121 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~---ivH~dikp~Nill~~--------~~~~kl 121 (291)
+.+++|.+++. ...+++..++.++.|++.||.|||+ .+ ++|+||||+||+++. ++.++|
T Consensus 88 ~~~~~L~~~~~-------~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 88 ARGGPLNRVLS-------GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CTTEEHHHHHT-------SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred CCCCCHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 99999999984 3579999999999999999999999 88 899999999999986 678999
Q ss_pred eccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhh
Q 022826 122 SDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVY 201 (291)
Q Consensus 122 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~ 201 (291)
+|||++........ ....+++.|+|||.+.+. .++.++||||||+++|+|++|..||......
T Consensus 158 ~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------- 220 (271)
T 3dtc_A 158 TDFGLAREWHRTTK----MSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGL----------- 220 (271)
T ss_dssp CCCCC-----------------CCGGGSCHHHHHHC--CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-----------
T ss_pred ccCCcccccccccc----cCCCCccceeCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------
Confidence 99999876543322 234579999999999876 7899999999999999999999988653211
Q ss_pred hhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 202 KRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
...............+..++..+.+++.+||+.||.+|||+.|+++.|+++
T Consensus 221 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 221 ---AVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ---HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ---HHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 000011111111222334567799999999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=293.62 Aligned_cols=223 Identities=24% Similarity=0.370 Sum_probs=177.6
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||++.+.. ++.||+|++.... +.+......++||||
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 96 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL 96 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 4567899999999999998755 8999999986432 556677889999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++... ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++.+|.++|+|||++.....
T Consensus 97 ~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 97 LLGGDLRYHLQQN------VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CTTEEHHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999654 579999999999999999999999 9999999999999999999999999999987644
Q ss_pred CCceeeccCCCCCccccCccccccc-CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~-~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
.. ......||+.|+|||++.+. ...++.++|||||||++|+|++|..||......... . ..... . ..
T Consensus 168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~----~-~~~~~---~-~~ 235 (384)
T 4fr4_A 168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK----E-IVHTF---E-TT 235 (384)
T ss_dssp TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH----H-HHHHH---H-HC
T ss_pred CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH----H-HHHHH---h-hc
Confidence 33 23456789999999998753 236899999999999999999999999754332210 0 00000 0 00
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPA-MNRVVE 250 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps-~~ell~ 250 (291)
. ...+..++..+.+|+.+||+.||.+||+ +.++++
T Consensus 236 ~----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 V----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred c----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1 1122345678999999999999999998 677654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=290.58 Aligned_cols=226 Identities=19% Similarity=0.246 Sum_probs=176.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +.+......++||
T Consensus 26 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 105 (351)
T 3c0i_A 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVF 105 (351)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 456789999999999999875 49999999985321 5666778899999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCc---eEEeccCCc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC---PKISDFGLA 127 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~---~kl~Dfg~~ 127 (291)
||+.+++|.+++.... .....+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++. +||+|||++
T Consensus 106 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 106 EFMDGADLCFEIVKRA--DAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp ECCSSCBHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred eCCCCCCHHHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999988886542 123468999999999999999999999 99999999999999976654 999999999
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
........ ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||..... ....... .
T Consensus 181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~i~-~ 246 (351)
T 3c0i_A 181 IQLGESGL--VAGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGTKE---------RLFEGII-K 246 (351)
T ss_dssp EECCTTSC--BCCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---------HHHHHHH-H
T ss_pred eEecCCCe--eecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCcHH---------HHHHHHH-c
Confidence 87654322 12345689999999999876 789999999999999999999999875311 0000000 0
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. ...........++..+.+|+.+||+.||++|||+.++++
T Consensus 247 ~---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 247 G---KYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp T---CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C---CCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 001111112345678999999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=284.11 Aligned_cols=223 Identities=25% Similarity=0.348 Sum_probs=170.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeec------------
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFE------------ 42 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~------------ 42 (291)
+.+.+.||+|+||.||+|++. +++.||||++.... +.+.+
T Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~ 87 (332)
T 3qd2_B 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE 87 (332)
T ss_dssp EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence 456789999999999999886 59999999987432 22211
Q ss_pred ---------------------------------------------CCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHH
Q 022826 43 ---------------------------------------------GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWE 77 (291)
Q Consensus 43 ---------------------------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 77 (291)
....++||||+.+++|.+++.... .....++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~ 164 (332)
T 3qd2_B 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC---SLEDREHG 164 (332)
T ss_dssp --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC---SGGGSCHH
T ss_pred hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc---CccchhhH
Confidence 113789999999999999998764 33456778
Q ss_pred HHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce----------eeccCCCCCcc
Q 022826 78 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI----------VSMTGARGTVG 147 (291)
Q Consensus 78 ~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~~~ 147 (291)
.++.++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++......... .......+|+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 899999999999999999 99999999999999999999999999999876543211 11234568999
Q ss_pred ccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHH
Q 022826 148 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKM 227 (291)
Q Consensus 148 y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 227 (291)
|+|||.+.+. .++.++||||||+++|+|++|..++.... . ...... ..............+
T Consensus 242 y~aPE~~~~~--~~~~~~Di~slG~il~el~~~~~~~~~~~--------------~--~~~~~~-~~~~~~~~~~~~~~~ 302 (332)
T 3qd2_B 242 YMSPEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQMERV--------------R--IITDVR-NLKFPLLFTQKYPQE 302 (332)
T ss_dssp GSCHHHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHHHHH--------------H--HHHHHH-TTCCCHHHHHHCHHH
T ss_pred ccChHHhcCC--CCcchhhHHHHHHHHHHHHHcCCChhHHH--------------H--HHHHhh-ccCCCcccccCChhH
Confidence 9999999876 78999999999999999998764332110 0 000111 111223345566778
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 022826 228 ILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 228 ~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.+++.+||+.||++|||+.|+++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCCCcCCCHHHHhh
Confidence 99999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=298.79 Aligned_cols=224 Identities=25% Similarity=0.433 Sum_probs=177.3
Q ss_pred hhhcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------ceeecC-CcceeeehhhcCCCH
Q 022826 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------GFCFEG-HRRALIYEFVSNGSL 58 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------~~~~~~-~~~~lv~e~~~~g~L 58 (291)
.+.+.||+|+||.||+|.+ +++.||||+++... +++... ...++||||+.+|+|
T Consensus 196 ~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L 274 (450)
T 1k9a_A 196 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274 (450)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred EEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence 4568999999999999987 57899999998654 344433 378999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
.+++.... ...+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||+++......
T Consensus 275 ~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 343 (450)
T 1k9a_A 275 VDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 343 (450)
T ss_dssp HHHHHHHC----TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred HHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc----
Confidence 99998752 2357999999999999999999999 999999999999999999999999999988543221
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
....++..|+|||.+.+. .++.++||||||+++|+|++ |..||....... ....... +...
T Consensus 344 -~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~-------~~~~ 405 (450)
T 1k9a_A 344 -DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEK-------GYKM 405 (450)
T ss_dssp ----CCCTTTSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--------HHHHHHT-------TCCC
T ss_pred -cCCCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHc-------CCCC
Confidence 122457899999999775 78999999999999999998 888876543211 0111110 1111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
..+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 2233456788999999999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=281.95 Aligned_cols=235 Identities=26% Similarity=0.384 Sum_probs=186.1
Q ss_pred cccccCCceeEEEEEec---CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcCC
Q 022826 7 NKLGQGGYGGVYKGKLL---DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.||+|+||.||+|.+. +++.||+|+++... +++ .....++||||+.++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 48999999999999753 47789999998643 333 456689999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 95 ~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 95 PLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EHHHHHTTC-----TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred CHHHHHHhC-----CccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 999999643 3579999999999999999999999 99999999999999999999999999999876544332
Q ss_pred ee-ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 137 VS-MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 137 ~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
.. .....+++.|+|||.+.+. .++.++||||||+++|+|++ |..||...... . ....... .
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~-~~~~i~~-------~ 229 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------E-VMAFIEQ-------G 229 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------H-HHHHHHT-------T
T ss_pred eeccccccccccccCHHHhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-------H-HHHHHhc-------C
Confidence 22 2334467899999999765 78999999999999999998 88887653221 0 0000000 0
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCCCCcc
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFL 267 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 267 (291)
.....+..++..+.+++.+||+.||++||++.++++.|++++.+...+-++.-
T Consensus 230 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~ 282 (287)
T 1u59_A 230 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 282 (287)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCC
T ss_pred CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCc
Confidence 11122234667899999999999999999999999999999988877755543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=291.69 Aligned_cols=219 Identities=23% Similarity=0.314 Sum_probs=175.3
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|++.. ++.||+|+++... +.+......++|||
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E 101 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 101 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence 4566899999999999998865 8899999987532 45556678899999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+|+|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.+|.+||+|||++....
T Consensus 102 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 102 YVNGGDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999765 479999999999999999999999 999999999999999999999999999997543
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ........ ...
T Consensus 173 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~-~~~-- 237 (353)
T 2i0e_A 173 WDGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIM-EHN-- 237 (353)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HCC--
T ss_pred cCCc--ccccccCCccccChhhhcCC--CcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHHHHHH-hCC--
Confidence 2221 23456789999999999876 789999999999999999999999875321 11111111 111
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPA-----MNRVVE 250 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps-----~~ell~ 250 (291)
...+..++..+.+|+.+||..||.+||+ +.++++
T Consensus 238 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 238 -----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1112346678999999999999999995 567664
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=293.35 Aligned_cols=218 Identities=22% Similarity=0.305 Sum_probs=175.6
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|++.. ++.||+|+++... +.+......++|||
T Consensus 19 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E 98 (345)
T 1xjd_A 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 98 (345)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 4567899999999999998864 8999999987531 45666778999999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+|+|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.+|.+||+|||++....
T Consensus 99 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 99 YLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp CCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 99999999999765 478999999999999999999999 999999999999999999999999999997543
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ......... .
T Consensus 170 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~----~ 233 (345)
T 1xjd_A 170 LGDA--KTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRM----D 233 (345)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH----C
T ss_pred cCCC--cccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHh----C
Confidence 2221 13456789999999999876 789999999999999999999999875421 111111110 0
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHH-HHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMN-RVV 249 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~-ell 249 (291)
.. ..+..++..+.+|+.+||..||++||++. +++
T Consensus 234 ~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 234 NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11 11223567889999999999999999997 654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=287.63 Aligned_cols=232 Identities=26% Similarity=0.457 Sum_probs=174.9
Q ss_pred hhhcccccCCceeEEEEEecC-----CCeEEEEEeccCc---------------------------ceeecCCcceeeeh
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-----GRNVAIKVLNETK---------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e 51 (291)
.+.+.||+|+||.||+|.+.. +..||+|+++... +++......++|||
T Consensus 47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 126 (333)
T 1mqb_A 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 126 (333)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEe
Confidence 456889999999999997643 2359999987542 55666778899999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++... ...+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++....
T Consensus 127 ~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 127 YMENGALDKFLREK-----DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp CCTTEEHHHHHHHT-----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCCCCcHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 99999999999763 2579999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCce-eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 132 GRESI-VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 132 ~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
..... .......+++.|+|||.+.+. .++.++||||||+++|+|++ |..||..... ........
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~~~~~---- 264 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKAIN---- 264 (333)
T ss_dssp ------------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHH----
T ss_pred cccccccccCCCCccccccCchhcccC--CCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHH----
Confidence 33221 112233457789999999765 78999999999999999998 8888754321 00111110
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCC
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLR 260 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 260 (291)
.......+..++..+.+++.+||+.||++||++.++++.|+++++...
T Consensus 265 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 265 ---DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp ---TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ---CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 000111123456778999999999999999999999999999876543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=292.71 Aligned_cols=216 Identities=22% Similarity=0.255 Sum_probs=173.0
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|++.. ++.||+|+++... +.+......|+|||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E 119 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence 3467899999999999998865 8999999986532 45556678899999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+|+|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.+|.+||+|||++....
T Consensus 120 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 120 YINGGELFYHLQRE------RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred CCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999765 478999999999999999999999 999999999999999999999999999997643
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ........ ...
T Consensus 191 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~-~~~-- 255 (373)
T 2r5t_A 191 EHNS--TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNIL-NKP-- 255 (373)
T ss_dssp CCCC--CCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHHHHHHH-HSC--
T ss_pred cCCC--ccccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHH-hcc--
Confidence 2221 23456789999999999876 789999999999999999999999865321 11111110 000
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNR 247 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~e 247 (291)
...+..++..+.+|+.+||+.||.+||++.+
T Consensus 256 -----~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 256 -----LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp -----CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred -----cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 1112235667899999999999999999854
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=290.08 Aligned_cols=225 Identities=22% Similarity=0.270 Sum_probs=166.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.+.+.||+|+||.||++++. +++.||||++.... +++......++||||+.++
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 101 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG 101 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCC
Confidence 456789999999999999886 59999999997643 5666778899999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCc--eEEeccCCccccCCCC
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC--PKISDFGLAKICHGRE 134 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~ 134 (291)
+|.+++... ..+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++. +||+|||+++......
T Consensus 102 ~L~~~l~~~------~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 102 ELYERICNA------GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp BHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 999999765 479999999999999999999999 99999999999999987765 9999999987433222
Q ss_pred ceeeccCCCCCccccCcccccccCCCc-cccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEV-SYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~-~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
......+|+.|+|||++.+. .+ +.++|||||||++|+|++|..||........ +.. ....... .
T Consensus 173 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~----~~~~~~~---~ 237 (361)
T 3uc3_A 173 ---QPKSTVGTPAYIAPEVLLRQ--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD---YRK----TIQRILS---V 237 (361)
T ss_dssp -----------CTTSCHHHHHCS--SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC---HHH----HHHHHHT---T
T ss_pred ---CCCCCcCCCCcCChhhhcCC--CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH---HHH----HHHHHhc---C
Confidence 12334689999999999775 44 4558999999999999999999876433211 000 0000000 1
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.........++..+.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11111112345678899999999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=286.49 Aligned_cols=170 Identities=27% Similarity=0.354 Sum_probs=145.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e 51 (291)
+.+.++||+|+||.||+|++. +++.||||++.... +.+......++|||
T Consensus 37 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e 116 (360)
T 3llt_A 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116 (360)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEEC
T ss_pred EEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEc
Confidence 456789999999999999885 58999999987432 45556778899999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC----------------
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---------------- 115 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~---------------- 115 (291)
|+ +++|.+++... ....+++..++.++.||+.||.|||+ .+|+|+||||+||+++.
T Consensus 117 ~~-~~~L~~~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 117 PL-GPSLYEIITRN----NYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp CC-CCBHHHHHHHT----TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred CC-CCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhccccc
Confidence 99 88999999765 33469999999999999999999999 99999999999999975
Q ss_pred ---------CCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCcc
Q 022826 116 ---------DFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANV 186 (291)
Q Consensus 116 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~ 186 (291)
++.+||+|||++....... ....+|+.|+|||++.+. .++.++|||||||++|+|++|..||..
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNL--GWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCC--CCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 7899999999997643322 345679999999999876 789999999999999999999999865
Q ss_pred c
Q 022826 187 A 187 (291)
Q Consensus 187 ~ 187 (291)
.
T Consensus 262 ~ 262 (360)
T 3llt_A 262 H 262 (360)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=289.80 Aligned_cols=216 Identities=21% Similarity=0.303 Sum_probs=175.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||++++. +++.||+|++.... +.+......++||||
T Consensus 43 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 122 (350)
T 1rdq_E 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 355689999999999999876 49999999986432 455667788999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.+|.+||+|||++.....
T Consensus 123 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 123 VAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp CTTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999765 468999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
.. ...+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ........ ....
T Consensus 194 ~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~-~~~~-- 255 (350)
T 1rdq_E 194 RT-----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIV-SGKV-- 255 (350)
T ss_dssp CB-----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HCCC--
T ss_pred Cc-----ccccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHHHH-cCCC--
Confidence 32 345689999999999876 789999999999999999999999875421 11111111 0111
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPA-----MNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps-----~~ell~ 250 (291)
..+..++..+.+++.+||+.||.+||+ +.++++
T Consensus 256 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 112345678899999999999999998 888765
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=277.38 Aligned_cols=226 Identities=22% Similarity=0.400 Sum_probs=177.2
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc----------------------------ceeecC--Ccceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------GFCFEG--HRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------------~~~~~~--~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|++ +++.||+|++.... +++... ...++||||
T Consensus 12 y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 12 LNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp CEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred hHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence 45678999999999999988 58899999987543 344444 677999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCC--eeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR--ILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
+.+++|.+++... ....+++..++.++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+||+++...
T Consensus 91 ~~~~~L~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 91 MPYGSLYNVLHEG----TNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CTTCBHHHHHHSC----SSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred cCCCcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999764 23468999999999999999999999 89 999999999999999999999998876543
Q ss_pred CCCCceeeccCCCCCccccCcccccccC-CCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNF-GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~-~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
.. ....+|+.|+|||.+.+.. ..++.++||||||+++|+|++|..||...... . . ...
T Consensus 164 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~-~------~~~ 222 (271)
T 3kmu_A 164 QS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-------E-I------GMK 222 (271)
T ss_dssp SC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-------H-H------HHH
T ss_pred cc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-------H-H------HHH
Confidence 22 2345689999999987641 23345899999999999999999988643211 0 0 000
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
..........+..++..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 223 VALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111111112233456779999999999999999999999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=282.00 Aligned_cols=236 Identities=19% Similarity=0.211 Sum_probs=172.1
Q ss_pred hcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcCCC
Q 022826 6 KNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
.+.||+|+||.||+|.+. +++.||||++.... +++......++||||+.+++
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 367999999999999875 59999999986543 56667788999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCc---eEEeccCCccccCCCC
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC---PKISDFGLAKICHGRE 134 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~---~kl~Dfg~~~~~~~~~ 134 (291)
|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++. +||+|||++.......
T Consensus 98 L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 98 ILSHIHKR------RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp HHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred HHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 99999765 478999999999999999999999 99999999999999988776 9999999987654221
Q ss_pred c-----eeeccCCCCCccccCccccccc---CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhh-hhh
Q 022826 135 S-----IVSMTGARGTVGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYK-RLE 205 (291)
Q Consensus 135 ~-----~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~-~~~ 205 (291)
. ........+++.|+|||++.+. ...++.++|||||||++|+|++|..||.........+........ ...
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 1 1112234589999999998651 125788999999999999999999999766443322111100000 000
Q ss_pred hhhhhccc--CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 LEEDLGLQ--GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ~~~~~~~~--~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
....+... .........++..+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 01111111 1111112245678999999999999999999999987
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=280.96 Aligned_cols=229 Identities=23% Similarity=0.367 Sum_probs=169.2
Q ss_pred chhhcccccCCceeEEEEEecC----CCeEEEEEeccCc---------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD----GRNVAIKVLNETK---------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|.+.. +..||+|++.... +++ .....++|||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 95 (281)
T 1mp8_A 17 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIME 95 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred eEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEe
Confidence 4567899999999999998743 4579999986532 332 4567889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 96 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 96 LCTLGELRSFLQVR-----KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp CCTTEEHHHHHHHT-----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred cCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999754 2479999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
..... ......+++.|+|||.+.+. .++.++||||||+++|+|++ |..||....... .......
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--------~~~~i~~---- 232 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIEN---- 232 (281)
T ss_dssp ------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHT----
T ss_pred ccccc-ccccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--------HHHHHHc----
Confidence 33211 12233457789999999765 78999999999999999996 887776442211 0000000
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
......+..++..+.+++.+||+.||++|||+.++++.|++++++
T Consensus 233 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 233 ---GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 001112234567889999999999999999999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=292.84 Aligned_cols=247 Identities=19% Similarity=0.235 Sum_probs=184.9
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc---------------------------ceeecC--Ccceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK---------------------------GFCFEG--HRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---------------------------~~~~~~--~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|++.. ++.||||++.... +++... ...++||||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 4567999999999999998865 9999999987532 233333 367899999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE----cCCCceEEeccCCcc
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAK 128 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill----~~~~~~kl~Dfg~~~ 128 (291)
+.+++|.+++.... ....+++..++.++.|++.||.|||+ .+|+|+||||+||++ +.++.+||+|||++.
T Consensus 91 ~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 91 CPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CTTEEHHHHTTSGG---GTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred CCCCCHHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999997642 23449999999999999999999999 999999999999999 777889999999998
Q ss_pred ccCCCCceeeccCCCCCccccCccccccc------CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhh
Q 022826 129 ICHGRESIVSMTGARGTVGYIAPEVFCRN------FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYK 202 (291)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~------~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~ 202 (291)
....... .....+++.|+|||.+.+. ...++.++|||||||++|+|++|..||..................
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 7644322 2345689999999998641 126788999999999999999999998754332211110000000
Q ss_pred hhh----------hhhhhcc---cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 203 RLE----------LEEDLGL---QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 203 ~~~----------~~~~~~~---~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
... ....+.+ ..........+...+.+++.+||+.||++||++.++++.++++++.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 000 0000000 0111123467888899999999999999999999999999998875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=288.72 Aligned_cols=235 Identities=25% Similarity=0.424 Sum_probs=170.8
Q ss_pred hhhcccccCCceeEEEEEecC----CCeEEEEEeccCc---------------------------ceee-cCCcceeeeh
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD----GRNVAIKVLNETK---------------------------GFCF-EGHRRALIYE 51 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~---------------------------~~~~-~~~~~~lv~e 51 (291)
.+.+.||+|+||.||+|.+.+ ...||+|.+.... +++. .+...++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 456889999999999997642 2468999986432 3333 3457789999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++... ...+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||+++...
T Consensus 172 ~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 172 YMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp CCTTCBHHHHHHCT-----TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCCCCCHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999653 3568899999999999999999999 999999999999999999999999999998654
Q ss_pred CCCce--eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCC-CCCccccCCCccccchhhhhhhhhhhh
Q 022826 132 GRESI--VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVK-NNANVAVDRSSEIYFPHWVYKRLELEE 208 (291)
Q Consensus 132 ~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (291)
..... .......+++.|+|||.+.+. .++.++||||||+++|+|++|. .||....... ... ....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~----~~~----~~~~-- 311 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITV----YLLQ-- 311 (373)
T ss_dssp --------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC----HHH----HHHT--
T ss_pred ccccccccccCCCCCcccccChHHhcCC--CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH----HHH----HHHc--
Confidence 32211 112334467889999999876 7899999999999999999954 4444332111 000 0000
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCC
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPP 263 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 263 (291)
......+..++..+.+++.+||+.||++|||+.++++.|+.++..+....
T Consensus 312 -----~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 312 -----GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 00111123355678999999999999999999999999999998877554
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=287.55 Aligned_cols=221 Identities=20% Similarity=0.299 Sum_probs=172.8
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehhhcCC
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.||+|+||.||+|.+. +++.||+|++.... +++......++||||+.++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 78999999999999876 49999999987532 4566677889999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC---CCceEEeccCCccccCCC
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---DFCPKISDFGLAKICHGR 133 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~---~~~~kl~Dfg~~~~~~~~ 133 (291)
+|.+++... ....+++..++.++.||+.||.|||+ .+++|+||||+||+++. ++.++|+|||++......
T Consensus 115 ~L~~~~~~~----~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 115 EIFSLCLPE----LAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EGGGGGSSC----C-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred cHHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 999998543 34679999999999999999999999 99999999999999987 789999999999876433
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
.. .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||....... ... .... ...
T Consensus 188 ~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~---~i~~-~~~ 250 (327)
T 3lm5_A 188 CE---LREIMGTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--------TYL---NISQ-VNV 250 (327)
T ss_dssp ---------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHH---HHHH-TCC
T ss_pred cc---cccccCCcCccCCeeecCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--------HHH---HHHh-ccc
Confidence 22 2335679999999999776 78999999999999999999999886542110 000 0011 111
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.........++..+.+++.+||+.||++|||+.++++.
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 251 DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11222334567789999999999999999999999863
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=278.34 Aligned_cols=230 Identities=21% Similarity=0.280 Sum_probs=174.7
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|.+.. ++.||+|++.... +++..+...++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 5677899999999999998854 8999999987543 5666778899999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+ ++.+.+... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++......
T Consensus 84 ~~-~l~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 84 DQ-DLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp SE-EHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred CC-CHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 76 676666543 2579999999999999999999999 99999999999999999999999999999865432
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc--
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG-- 211 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 211 (291)
.. ......+|+.|+|||.+.+. ..++.++||||||+++|+|++|..|+.......... ...........
T Consensus 155 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~------~~i~~~~~~~~~~ 225 (292)
T 3o0g_A 155 VR--CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL------KRIFRLLGTPTEE 225 (292)
T ss_dssp CS--CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH------HHHHHHHCCCCTT
T ss_pred cc--cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHH------HHHHHHhCCCChh
Confidence 22 22445679999999998764 357999999999999999999988865433211100 00000000000
Q ss_pred ------------------ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 212 ------------------LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 212 ------------------~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
...........++..+.+|+.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000001112346678899999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=288.13 Aligned_cols=223 Identities=25% Similarity=0.285 Sum_probs=168.0
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||+|+||.||+|++.. ++.||||++.... +++......++||||+.+++
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 134 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE 134 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCC
Confidence 3456899999999999998864 8899999987543 56667788899999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC---CCceEEeccCCccccCCCC
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---DFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~---~~~~kl~Dfg~~~~~~~~~ 134 (291)
|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++. ++.+||+|||++.......
T Consensus 135 L~~~l~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 135 LFDRIVEK------GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp HHHHHTTC------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 99999654 468999999999999999999999 99999999999999975 8899999999988654322
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
......+|+.|+|||.+.+. .++.++|||||||++|+|++|..||....... ....... .. ...
T Consensus 206 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~~i~---~~-~~~ 269 (349)
T 2w4o_A 206 ---LMKTVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-------FMFRRIL---NC-EYY 269 (349)
T ss_dssp ----------CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-------HHHHHHH---TT-CCC
T ss_pred ---ccccccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCcccH-------HHHHHHH---hC-CCc
Confidence 12345679999999999875 78999999999999999999999986543210 0001100 00 001
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
........++..+.+|+.+||+.||++|||+.|+++
T Consensus 270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 270 FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111222346678899999999999999999999987
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=280.73 Aligned_cols=228 Identities=26% Similarity=0.338 Sum_probs=172.3
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------------ceeecCC---
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------------GFCFEGH--- 44 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------------~~~~~~~--- 44 (291)
+.+.+.||+|+||.||+|++. +++.||||++.... +++....
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~ 90 (308)
T 3g33_A 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR 90 (308)
T ss_dssp CEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSS
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCC
Confidence 456789999999999999874 59999999986321 2233222
Q ss_pred --cceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEe
Q 022826 45 --RRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 122 (291)
Q Consensus 45 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~ 122 (291)
..+++||++.+ +|.+++... ....+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.+||+
T Consensus 91 ~~~~~lv~e~~~~-~L~~~~~~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 91 EIKVTLVFEHVDQ-DLRTYLDKA----PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp EEEEEEEEECCCC-BHHHHHHTC----CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEEC
T ss_pred ceeEEEEehhhhc-CHHHHHhhc----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEe
Confidence 47899999975 999999765 23459999999999999999999999 999999999999999999999999
Q ss_pred ccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhh
Q 022826 123 DFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYK 202 (291)
Q Consensus 123 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~ 202 (291)
|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||........ ...
T Consensus 163 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-------~~~ 230 (308)
T 3g33_A 163 DFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-------LGK 230 (308)
T ss_dssp SCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTS--CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH-------HHH
T ss_pred eCccccccCCCcc---cCCccccccccCchHHcCC--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHH
Confidence 9999986543322 2345679999999999776 789999999999999999999999865432110 000
Q ss_pred hhhhhhhhc--------------ccCC----CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 203 RLELEEDLG--------------LQGI----ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 203 ~~~~~~~~~--------------~~~~----~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......... .... .......++..+.+|+.+||+.||++|||+.|+++
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 000000000 0000 00111235678899999999999999999999876
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=287.14 Aligned_cols=236 Identities=23% Similarity=0.387 Sum_probs=182.1
Q ss_pred chhhcccccCCceeEEEEEec------CCCeEEEEEeccCc---------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK---------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|.+. .++.||+|++.... +++......++|
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 106 (322)
T 1p4o_A 27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 106 (322)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEE
Confidence 456789999999999999764 37889999987543 566667788999
Q ss_pred ehhhcCCCHHHHHhhcCCC----CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccC
Q 022826 50 YEFVSNGSLEKFIYEKHPL----ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
|||+.+++|.+++...... .....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||
T Consensus 107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEECcCc
Confidence 9999999999999763210 012467999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRL 204 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~ 204 (291)
++................+++.|+|||.+.+. .++.++||||||+++|+|++ |..||..... .......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~ 253 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRFV 253 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------HHHHHHH
T ss_pred cccccccccccccccCCCCCCCccChhhhccC--CCCchhhHHHHHHHHHHHHhcCCCccccCCH--------HHHHHHH
Confidence 99865443332223334567889999999875 78999999999999999998 6776654311 0000000
Q ss_pred hhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 205 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
. .. .....+..++..+.+++.+||+.||++|||+.++++.|++++..
T Consensus 254 ---~---~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 254 ---M---EG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp ---H---TT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ---H---cC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 0 00 01112234567789999999999999999999999999887663
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=289.92 Aligned_cols=224 Identities=22% Similarity=0.284 Sum_probs=177.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +.+......++||||+.+
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g 132 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence 456788999999999999875 48999999987642 566677889999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC--CCceEEeccCCccccCCC
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE--DFCPKISDFGLAKICHGR 133 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~--~~~~kl~Dfg~~~~~~~~ 133 (291)
++|.+++... ...+++..++.++.||+.||.|||+ .+|+|+||||+||+++. ++.+||+|||++......
T Consensus 133 g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 133 GELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CBHHHHTTCT-----TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CcHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999998643 2579999999999999999999999 99999999999999974 578999999999876544
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
... ....+|+.|+|||++.+. .++.++|||||||++|+|++|..||...... ..... .... ..
T Consensus 205 ~~~---~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------~~~~~---i~~~-~~ 267 (387)
T 1kob_A 205 EIV---KVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--------ETLQN---VKRC-DW 267 (387)
T ss_dssp SCE---EEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHH---HHHC-CC
T ss_pred cce---eeeccCCCccCchhccCC--CCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--------HHHHH---HHhC-CC
Confidence 322 234679999999999875 7899999999999999999999998754210 00000 0000 01
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.........++..+.+|+.+||+.||++|||+.|+++.
T Consensus 268 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 268 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11122223466789999999999999999999999873
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=283.61 Aligned_cols=241 Identities=22% Similarity=0.383 Sum_probs=174.3
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +.+......++||||
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 113 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 113 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence 456789999999999999874 59999999987522 566677888999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++.... .....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 114 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 114 ADAGDLSRMIKHFK--KQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp CCSCBHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred CCCCCHHHHHHHhc--ccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999987531 123578999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||....... ..... .+..
T Consensus 189 ~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~------~~~~ 252 (310)
T 2wqm_A 189 KTT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------YSLCK------KIEQ 252 (310)
T ss_dssp ------------CCSSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTC---CCH------HHHHH------HHHT
T ss_pred CCc--cccccCCCeeEeChHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccchhH------HHHHH------Hhhc
Confidence 321 12334578999999999775 78999999999999999999999886542210 00000 0111
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCCC
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPR 264 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 264 (291)
..........++..+.+++.+||+.||++|||+.++++.|+++......++.
T Consensus 253 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 253 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 1111111234567899999999999999999999999999998776665543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=281.81 Aligned_cols=241 Identities=23% Similarity=0.307 Sum_probs=167.0
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||+|.+. +++.||+|+++... +++..+...++||||+.
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (317)
T 2pmi_A 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD 86 (317)
T ss_dssp ------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC
T ss_pred eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC
Confidence 456789999999999999875 48999999986432 56666778899999998
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
++|.+++...........+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 87 -~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 87 -NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp -CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred -CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 4999998775433344579999999999999999999999 999999999999999999999999999998654322
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchh-------hhhhhhhhh
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPH-------WVYKRLELE 207 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 207 (291)
. ......+|+.|+|||++.+. ..++.++|||||||++|+|++|..||.............. ..+......
T Consensus 163 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 163 N--TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp C--CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred c--cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 1 12345679999999998763 3688999999999999999999999875432110000000 000000000
Q ss_pred hhh--cccCCC-C--------hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 208 EDL--GLQGIE-N--------EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 208 ~~~--~~~~~~-~--------~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
... ...... . .....++..+.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000 000000 0 001124567999999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=294.38 Aligned_cols=225 Identities=19% Similarity=0.270 Sum_probs=178.0
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|++.. ++.||+|+++... +.+.+....++||||
T Consensus 71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 150 (410)
T 3v8s_A 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150 (410)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 3456889999999999998865 8999999986521 566677889999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++.. ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.+|.+||+|||++.....
T Consensus 151 ~~gg~L~~~l~~-------~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 151 MPGGDLVNLMSN-------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp CTTEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 999999999864 368999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCceeeccCCCCCccccCcccccccCC--CccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh-hhh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFG--EVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL-EED 209 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~--~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 209 (291)
... ......+||+.|+|||++.+... .++.++|||||||++|+|++|..||..... ......... ...
T Consensus 221 ~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~ 291 (410)
T 3v8s_A 221 EGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMNHKNS 291 (410)
T ss_dssp TSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTHHHH
T ss_pred CCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--------hhHHHHHHhcccc
Confidence 332 22345679999999999976521 278999999999999999999999975421 111111111 111
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSD--RPAMNRVVEM 251 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~--Rps~~ell~~ 251 (291)
+..+ ....++..+.+|+++||..+|.+ ||++.|+++.
T Consensus 292 ~~~p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 292 LTFP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCC-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccCC-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1111 11235678899999999999988 9999999863
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=291.24 Aligned_cols=242 Identities=17% Similarity=0.216 Sum_probs=178.2
Q ss_pred chhhcccccC--CceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQG--GYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+| +||.||+|++. +++.||||++.... +++......++|||
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 106 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 106 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence 4567899999 99999999886 49999999997543 56677888999999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++... ....+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++.++|+|||.+....
T Consensus 107 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 107 FMAYGSAKDLICTH----FMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp CCTTCBHHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred ccCCCCHHHHHhhh----cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999764 33569999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCce-----eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhh--
Q 022826 132 GRESI-----VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRL-- 204 (291)
Q Consensus 132 ~~~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~-- 204 (291)
..... .......+++.|+|||++.+....++.++|||||||++|+|++|..||....................
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 22111 11233467889999999987444789999999999999999999999975433211000000000000
Q ss_pred ---------hh-----------hhhh--------cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 205 ---------EL-----------EEDL--------GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 205 ---------~~-----------~~~~--------~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.. .... ............++..+.+|+.+||+.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 0000 00000011234466789999999999999999999999853
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=281.82 Aligned_cols=222 Identities=22% Similarity=0.293 Sum_probs=177.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +++......++|
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (321)
T 2a2a_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLI 93 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 456789999999999999876 48999999986532 556667788999
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC----ceEEeccC
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF----CPKISDFG 125 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~----~~kl~Dfg 125 (291)
|||+.+++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++ .++|+|||
T Consensus 94 ~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 94 LELVSGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp ECCCCSCBHHHHHHTC------SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 9999999999999653 578999999999999999999999 9999999999999999887 79999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLE 205 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (291)
++........ .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||...... . ....
T Consensus 165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~-~~~~-- 229 (321)
T 2a2a_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------E-TLAN-- 229 (321)
T ss_dssp TCEECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------H-HHHH--
T ss_pred cceecCcccc---ccccCCCCCccCcccccCC--CCCCccccHHHHHHHHHHHHCCCCCCCCCHH-------H-HHHH--
Confidence 9987654322 2345679999999999775 7899999999999999999999998643210 0 0000
Q ss_pred hhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 LEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
... ............++..+.+++.+||+.||++|||+.|+++
T Consensus 230 -i~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 230 -ITS-VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -HHT-TCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -HHh-cccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 0011111222345677899999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=290.03 Aligned_cols=228 Identities=23% Similarity=0.299 Sum_probs=176.1
Q ss_pred chhhcccccCCceeEEEEEec----CCCeEEEEEeccCc-------------------------------ceeecCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL----DGRNVAIKVLNETK-------------------------------GFCFEGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-------------------------------~~~~~~~~~~ 47 (291)
+.+.+.||+|+||.||+++.. +++.||||+++... +.+......+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 456688999999999999873 58999999986421 4455667788
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+||||+.+++|.+++... ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||++
T Consensus 136 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEECCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEeecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999765 478999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
+........ ......+|+.|+|||.+.+....++.++|||||||++|+|++|..||........ ........
T Consensus 207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~--- 278 (355)
T 1vzo_A 207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISRRI--- 278 (355)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHHHH---
T ss_pred eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch----HHHHHHHH---
Confidence 765432211 1233568999999999986544678999999999999999999999875433211 00000000
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVEML 252 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~~L 252 (291)
. ... ...+..++..+.+|+.+||+.||++|| ++.++++..
T Consensus 279 ~-~~~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 279 L-KSE----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp H-HCC----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred h-ccC----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0 001 112234566788999999999999999 999998743
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=282.85 Aligned_cols=238 Identities=20% Similarity=0.257 Sum_probs=174.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||++.+. +++.||+|++.... +++..+...++|+||
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL 115 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence 456789999999999999875 58999999987542 566667888999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 116 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 116 INGVDLAAMLRRQ------GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp CCCEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred cCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999765 478999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...... . ... ... ..
T Consensus 187 ~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~-~~~---~~~-~~ 250 (309)
T 2h34_A 187 EKL-TQLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQLS--------V-MGA---HIN-QA 250 (309)
T ss_dssp -----------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHH--------H-HHH---HHH-SC
T ss_pred ccc-ccccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCCchHH--------H-HHH---Hhc-cC
Confidence 321 112344578999999999775 7889999999999999999999988754210 0 000 000 00
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHhhhccCCCCCCC
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRP-AMNRVVEMLEGSLDSLRIPPRP 265 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-s~~ell~~L~~~~~~~~~~~~~ 265 (291)
..........++..+.+++.+||+.||++|| ++.++++.|++.+......+..
T Consensus 251 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~~~ 304 (309)
T 2h34_A 251 IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRAT 304 (309)
T ss_dssp CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--------
T ss_pred CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccchh
Confidence 0111122334566789999999999999999 9999999999988776655443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=277.25 Aligned_cols=225 Identities=27% Similarity=0.315 Sum_probs=178.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +++......++|+||+.
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (276)
T 2yex_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (276)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecC
Confidence 456789999999999999875 59999999986432 56666778899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 89 GGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp TEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999988543 579999999999999999999999 999999999999999999999999999998654433
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
.........+++.|+|||.+.+. ...+.++||||||+++|+|++|..||.......... .. .. ...
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~-----~~------~~~ 225 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SD-----WK------EKK 225 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH--HH-----HH------TTC
T ss_pred chhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH--HH-----hh------hcc
Confidence 32233456689999999999765 234789999999999999999999987654322100 00 00 000
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
........++..+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 011122345677889999999999999999999976
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=289.08 Aligned_cols=241 Identities=20% Similarity=0.277 Sum_probs=166.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------cee--------ecCCcc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFC--------FEGHRR 46 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~--------~~~~~~ 46 (291)
+.+.+.||+|+||.||++++. +++.||||++.... +.+ ......
T Consensus 30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 109 (337)
T 3ll6_A 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109 (337)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence 456789999999999999875 59999999885433 122 233447
Q ss_pred eeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCC--eeeeccCCCceEEcCCCceEEecc
Q 022826 47 ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR--ILHFDIKPHNILLDEDFCPKISDF 124 (291)
Q Consensus 47 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~dikp~Nill~~~~~~kl~Df 124 (291)
++++||+. |+|.+++.... ....+++..++.++.||+.||.|||+ .+ ++|+||||+||+++.++.+||+||
T Consensus 110 ~lv~e~~~-g~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 110 LLLTELCK-GQLVEFLKKME---SRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEECCS-EEHHHHHHHHH---TTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred EEEEEecC-CCHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecC
Confidence 89999996 59999887632 33579999999999999999999999 99 999999999999999999999999
Q ss_pred CCccccCCCCcee----------eccCCCCCccccCcccccc-cCCCccccccchhHHHHHHHHhCCCCCCccccCCCcc
Q 022826 125 GLAKICHGRESIV----------SMTGARGTVGYIAPEVFCR-NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSE 193 (291)
Q Consensus 125 g~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~ 193 (291)
|++.......... ......+++.|+|||++.. ....++.++||||||+++|+|++|..||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~- 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI- 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence 9998765432211 1123457899999999832 223788999999999999999999999864322110
Q ss_pred ccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCCCCccc
Q 022826 194 IYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLL 268 (291)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~ 268 (291)
....... .........+.+|+.+||+.||++|||+.|+++.|+.+.......+..+..
T Consensus 262 ------------~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~~ 319 (337)
T 3ll6_A 262 ------------VNGKYSI-----PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPIT 319 (337)
T ss_dssp ----------------CCC-----CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCCH
T ss_pred ------------hcCcccC-----CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccHH
Confidence 0000000 111122345788999999999999999999999999988876666555443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=275.81 Aligned_cols=222 Identities=23% Similarity=0.314 Sum_probs=176.7
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|.+.. ++.||+|++.... +.+......++||||+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 87 (284)
T 3kk8_A 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 87 (284)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence 4567899999999999998754 8999999986543 5666777889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCc---eEEeccCCcccc
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC---PKISDFGLAKIC 130 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~---~kl~Dfg~~~~~ 130 (291)
.+++|.+.+... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++. ++|+|||++...
T Consensus 88 ~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 88 TGGELFEDIVAR------EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred CCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999998765 479999999999999999999999 99999999999999976655 999999999765
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
..... .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||...... ...... ..
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------~~~~~~-~~--- 221 (284)
T 3kk8_A 159 NDSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYAQI-KA--- 221 (284)
T ss_dssp CSSCB---CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHH-HH---
T ss_pred ccCcc---ccCCCCCcCCcCchhhcCC--CCCcccchHHHHHHHHHHHHCCCCCCCCchh--------HHHHHH-Hh---
Confidence 44322 2345679999999999876 7899999999999999999999998653211 000000 00
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
............++..+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 222 GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1111111222345677899999999999999999999987
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=279.34 Aligned_cols=236 Identities=22% Similarity=0.260 Sum_probs=172.7
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||+|++.+++.||+|++.... +.+......++||||+.
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 56778999999999999998779999999986432 56666788899999998
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+ +|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~-~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 84 Q-DLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp E-EHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred C-CHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 6 999998653 2578999999999999999999999 999999999999999999999999999987654322
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhh-------hhhhhhhh
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHW-------VYKRLELE 207 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~ 207 (291)
. ......+|+.|+|||.+.+. ..++.++|||||||++|+|++|..||............... .+......
T Consensus 155 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 155 R--KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c--ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 1 12334578999999998764 36899999999999999999999988654221000000000 00000000
Q ss_pred hhhc--c----cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 208 EDLG--L----QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 208 ~~~~--~----~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.... . +.........++..+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 0 00000111235677889999999999999999999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=287.38 Aligned_cols=237 Identities=25% Similarity=0.429 Sum_probs=182.7
Q ss_pred chhhcccccCCceeEEEEEecC-C-----CeEEEEEeccCc----------------------------ceeecCCccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-G-----RNVAIKVLNETK----------------------------GFCFEGHRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~----------------------------~~~~~~~~~~l 48 (291)
+.+.+.||+|+||.||+|.+.. + ..||+|++.... +++......++
T Consensus 48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 127 (333)
T 2i1m_A 48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV 127 (333)
T ss_dssp EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEE
Confidence 4567899999999999998743 3 479999987642 56667788999
Q ss_pred eehhhcCCCHHHHHhhcCCC--------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceE
Q 022826 49 IYEFVSNGSLEKFIYEKHPL--------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 120 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~--------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~k 120 (291)
||||+.+|+|.+++...... .....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++
T Consensus 128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~k 204 (333)
T 2i1m_A 128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAK 204 (333)
T ss_dssp EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGEEE
T ss_pred EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCeEE
Confidence 99999999999999764210 013468999999999999999999999 9999999999999999999999
Q ss_pred EeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhh
Q 022826 121 ISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHW 199 (291)
Q Consensus 121 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~ 199 (291)
|+|||++................+++.|+|||.+.+. .++.++||||||+++|+|++ |..||........
T Consensus 205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------- 275 (333)
T 2i1m_A 205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------- 275 (333)
T ss_dssp BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-------
T ss_pred ECccccccccccccceeecCCCCCCccccCHHHhccC--CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-------
Confidence 9999999866544333333444567889999999875 78999999999999999998 7777765432110
Q ss_pred hhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 200 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
...... . . .....+...+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 276 ~~~~~~-~-~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 276 FYKLVK-D-G-----YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHH-H-T-----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHh-c-C-----CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 000000 0 0 00111222456788999999999999999999999999987654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=280.15 Aligned_cols=231 Identities=26% Similarity=0.406 Sum_probs=178.9
Q ss_pred hhhc-ccccCCceeEEEEEec---CCCeEEEEEeccCc----------------------------ceeecCCcceeeeh
Q 022826 4 SFKN-KLGQGGYGGVYKGKLL---DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 4 ~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e 51 (291)
.+.+ .||+|+||.||+|.+. .++.||||+++... +++ .....++|||
T Consensus 19 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 97 (291)
T 1xbb_A 19 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVME 97 (291)
T ss_dssp EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEE
Confidence 3445 8999999999999542 37889999987542 344 5667889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 98 ~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 98 MAELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp CCTTEEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHhC------cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 99999999999764 469999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCceee-ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 132 GRESIVS-MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 132 ~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
....... .....+++.|+|||.+.+. .++.++||||||+++|+|++ |..||...... ....... .
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~---~ 235 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLE---K 235 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHH---T
T ss_pred cCCCcccccccCCCCceeeChHHhccC--CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHH---c
Confidence 4433221 2333457889999999775 78899999999999999999 88887653210 0011110 0
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCC
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRI 261 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 261 (291)
......+..++..+.+++.+||+.||.+|||+.++++.|++++.+...
T Consensus 236 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 236 ----GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 011112234567899999999999999999999999999998875543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=285.55 Aligned_cols=238 Identities=28% Similarity=0.399 Sum_probs=182.4
Q ss_pred chhhcccccCCceeEEEEEe------cCCCeEEEEEeccCc----------------------------ceeec-CCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKL------LDGRNVAIKVLNETK----------------------------GFCFE-GHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~----------------------------~~~~~-~~~~~ 47 (291)
+.+.+.||+|+||.||+|.+ .+++.||||++.... +.+.. +...+
T Consensus 29 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~ 108 (316)
T 2xir_A 29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 108 (316)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred eeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceE
Confidence 45678999999999999974 236899999987643 23333 34588
Q ss_pred eeehhhcCCCHHHHHhhcCCCC----------CCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLE----------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 117 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~ 117 (291)
+||||+.+++|.+++....... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~ 185 (316)
T 2xir_A 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKN 185 (316)
T ss_dssp EEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCC
Confidence 9999999999999997653100 02238999999999999999999999 9999999999999999999
Q ss_pred ceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccc
Q 022826 118 CPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYF 196 (291)
Q Consensus 118 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~ 196 (291)
.++|+|||++................+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.......
T Consensus 186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----- 258 (316)
T 2xir_A 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----- 258 (316)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-----
T ss_pred CEEECCCccccccccCccceeccCCCcceeecCchhhccc--cccchhHHHHHHHHHHHHHhCCCCCCcccchhH-----
Confidence 9999999999876544433333445568899999999776 78999999999999999998 888876432211
Q ss_pred hhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccC
Q 022826 197 PHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSL 259 (291)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~ 259 (291)
.......... ....+..++..+.+++.+||+.||.+|||+.++++.|+.+++..
T Consensus 259 --~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 259 --EFCRRLKEGT-------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp --HHHHHHHHTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --HHHHHhccCc-------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 0111111000 01112234567899999999999999999999999999987643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=279.37 Aligned_cols=228 Identities=25% Similarity=0.407 Sum_probs=178.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------cee----------------ecC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------GFC----------------FEG 43 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------~~~----------------~~~ 43 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +++ ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (284)
T 2a19_B 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKT 92 (284)
T ss_dssp EEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEE
T ss_pred cceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCc
Confidence 346689999999999999886 59999999997653 121 124
Q ss_pred CcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEec
Q 022826 44 HRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISD 123 (291)
Q Consensus 44 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~D 123 (291)
...++||||+.+++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 93 KCLFIQMEFCDKGTLEQWIEKR----RGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp EEEEEEECCCCSCBHHHHHHHG----GGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECC
T ss_pred ceEEEEEeccCCCCHHHHHhhc----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEEECc
Confidence 4578999999999999999764 33579999999999999999999999 9999999999999999999999999
Q ss_pred cCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhh
Q 022826 124 FGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKR 203 (291)
Q Consensus 124 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~ 203 (291)
||++........ .....+++.|+|||.+.+. .++.++||||||+++|+|++|..++..... .
T Consensus 166 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~~-------------~ 227 (284)
T 2a19_B 166 FGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFETSK-------------F 227 (284)
T ss_dssp CTTCEESSCCSC---CCCCCSCCTTSCHHHHHCS--CCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-------------H
T ss_pred chhheecccccc---ccccCCcccccChhhhccC--CCcchhhhHHHHHHHHHHHhcCCcchhHHH-------------H
Confidence 999887654332 2334579999999999775 789999999999999999999876542210 0
Q ss_pred hhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCC
Q 022826 204 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262 (291)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 262 (291)
. ..+..... ...++..+.+++.+||+.||++|||+.|+++.|+.+.+..+..
T Consensus 228 ~---~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 228 F---TDLRDGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp H---HHHHTTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred H---HHhhcccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 0 00111111 1224556889999999999999999999999999886655443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=280.46 Aligned_cols=222 Identities=23% Similarity=0.348 Sum_probs=169.5
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------------------------
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------------------------- 37 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------------------------- 37 (291)
+.+.+.||+|+||.||+|.+. +++.||||++....
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 94 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD 94 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence 456789999999999999875 48999999985421
Q ss_pred --------ceeec--CCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccC
Q 022826 38 --------GFCFE--GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 107 (291)
Q Consensus 38 --------~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dik 107 (291)
+++.. ....++||||+.+++|.+++ ....+++..++.++.|++.||.|||+ .+++|+|||
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlk 164 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-------TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIK 164 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-------CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCC
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-------hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCC
Confidence 23332 56788999999999997754 33579999999999999999999999 999999999
Q ss_pred CCceEEcCCCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCC-ccccccchhHHHHHHHHhCCCCCCcc
Q 022826 108 PHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGE-VSYKSDVYSYGMMVFEMTGVKNNANV 186 (291)
Q Consensus 108 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~-~~~~~DiwslG~~l~~ll~g~~~~~~ 186 (291)
|+||+++.++.+||+|||++......... .....+|+.|+|||.+.+.... .+.++||||||+++|+|++|..||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999876543322 2445689999999999765222 47889999999999999999999864
Q ss_pred ccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 187 AVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
... ....... ............++..+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~--------~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERI--------MCLHSKI------KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSH--------HHHHHHH------HHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccH--------HHHHHHH------hcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 321 0000000 0011111112235667899999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=303.74 Aligned_cols=232 Identities=28% Similarity=0.448 Sum_probs=182.3
Q ss_pred hhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCCH
Q 022826 4 SFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
.+.+.||+|+||.||+|.+.++..||||+++... +++. ....++||||+.+|+|
T Consensus 270 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~lv~e~~~~gsL 348 (535)
T 2h8h_A 270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 348 (535)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTEEH
T ss_pred hhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEe-eccceEeeehhcCCcH
Confidence 4568899999999999998777889999998643 3333 3678899999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceee
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
.+++... ....+++..++.++.||+.||.|||+ ++|+|+||||+|||++.++.+||+|||+++...... ...
T Consensus 349 ~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~ 420 (535)
T 2h8h_A 349 LDFLKGE----TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTA 420 (535)
T ss_dssp HHHHSHH----HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHT
T ss_pred HHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eec
Confidence 9999753 23468999999999999999999999 999999999999999999999999999998654321 111
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
.....++..|+|||.+.+. .++.++||||||+++|+|++ |..||..... ........ .....
T Consensus 421 ~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~~~~i~-------~~~~~ 483 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVE-------RGYRM 483 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HHHHHHHH-------TTCCC
T ss_pred ccCCcCcccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH-------cCCCC
Confidence 2233457789999999775 78999999999999999999 7877754321 00111111 01111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCC
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRI 261 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 261 (291)
..+..++..+.+|+.+||+.||++|||+.+|++.|+.++.....
T Consensus 484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 12234567889999999999999999999999999998775544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=283.04 Aligned_cols=241 Identities=26% Similarity=0.411 Sum_probs=182.8
Q ss_pred chhhcccccCCceeEEEEEecC-CCe--EEEEEeccCc----------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRN--VAIKVLNETK----------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~--vavK~~~~~~----------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|++.. +.. +++|.++... +++......++|||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 106 (327)
T 1fvr_A 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 106 (327)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence 4567899999999999998754 554 4999886422 55666778899999
Q ss_pred hhcCCCHHHHHhhcCC----------CCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEE
Q 022826 52 FVSNGSLEKFIYEKHP----------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 121 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl 121 (291)
|+.+++|.+++..... ......+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.++|
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeEEE
Confidence 9999999999976421 0123579999999999999999999999 99999999999999999999999
Q ss_pred eccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhh
Q 022826 122 SDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWV 200 (291)
Q Consensus 122 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~ 200 (291)
+|||++....... ......+++.|+|||.+.+. .++.++||||||+++|+|++ |..||..... ...
T Consensus 184 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~ 250 (327)
T 1fvr_A 184 ADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AEL 250 (327)
T ss_dssp CCTTCEESSCEEC---CC----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHH
T ss_pred cccCcCccccccc---cccCCCCCccccChhhhccc--cCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------HHH
Confidence 9999987432111 11223457889999999775 78899999999999999998 8888864321 000
Q ss_pred hhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCCCCc
Q 022826 201 YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPF 266 (291)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~ 266 (291)
..... .......+..++..+.+++.+||+.||.+|||+.++++.|+++++.........
T Consensus 251 ~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 309 (327)
T 1fvr_A 251 YEKLP-------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTT 309 (327)
T ss_dssp HHHGG-------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCCB
T ss_pred HHHhh-------cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCccccc
Confidence 01110 011111223456778999999999999999999999999999988765544333
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=294.59 Aligned_cols=223 Identities=26% Similarity=0.404 Sum_probs=179.0
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|++. +|+.||||++.... +++......++||||
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 457789999999999999875 59999999986432 566677889999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||++.....
T Consensus 98 ~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 98 VSGGELFDYICKN------GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp CSSEEHHHHTTSS------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999998643 579999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... ....+||+.|+|||++.+. ...+.++|||||||++|+|++|..||..... .. ...... ...
T Consensus 169 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-------~~-~~~~i~-~~~--- 232 (476)
T 2y94_A 169 GEF---LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHV-------PT-LFKKIC-DGI--- 232 (476)
T ss_dssp TCC---BCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-------HH-HHHHHH-TTC---
T ss_pred ccc---ccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCH-------HH-HHHHHh-cCC---
Confidence 332 2445789999999999875 2347899999999999999999999875421 11 011110 000
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHh
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE--MLEG 254 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~--~L~~ 254 (291)
...+..++..+.+|+.+||+.||++|||+.++++ ++.+
T Consensus 233 ----~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 233 ----FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred ----cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 0112234567889999999999999999999987 4544
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=284.37 Aligned_cols=214 Identities=23% Similarity=0.291 Sum_probs=173.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------------ceeecCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------------GFCFEGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------------~~~~~~~~~~ 47 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +++......+
T Consensus 26 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 105 (335)
T 3dls_A 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQ 105 (335)
T ss_dssp EEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEE
Confidence 345688999999999999875 48999999987542 4666677888
Q ss_pred eeehhhcCC-CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCC
Q 022826 48 LIYEFVSNG-SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL 126 (291)
Q Consensus 48 lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~ 126 (291)
+||||+.+| +|.+++... ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||+
T Consensus 106 lv~e~~~~g~~l~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 106 LVMEKHGSGLDLFAFIDRH------PRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEECCTTSCBHHHHHHTC------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEeCCCCccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999776 999998654 479999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh
Q 022826 127 AKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
+........ .....+|+.|+|||.+.+. ...+.++||||||+++|+|++|..||........
T Consensus 177 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------- 238 (335)
T 3dls_A 177 AAYLERGKL---FYTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-------------- 238 (335)
T ss_dssp CEECCTTCC---BCEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT--------------
T ss_pred ceECCCCCc---eeccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh--------------
Confidence 987654432 2234579999999999775 2338899999999999999999999865322110
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.. ...+..++..+.+|+.+||+.||++|||+.++++.
T Consensus 239 -~~-------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 -AA-------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -TC-------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -hc-------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00111245678999999999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=292.60 Aligned_cols=226 Identities=19% Similarity=0.260 Sum_probs=177.8
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehhh
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~ 53 (291)
.+.+.||+|+||.||+|++.+ ++.||+|++.... +.+.+....++||||+
T Consensus 77 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~ 156 (437)
T 4aw2_A 77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYY 156 (437)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecC
Confidence 456899999999999998865 8899999986522 5566778899999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+|+|.+++... ...+++..++.++.||+.||.|||+ .+|+||||||+||+++.+|.+||+|||++......
T Consensus 157 ~gg~L~~~l~~~-----~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 157 VGGDLLTLLSKF-----EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp TTCBHHHHHHTT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHHc-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 999999999753 2579999999999999999999999 99999999999999999999999999999765443
Q ss_pred CceeeccCCCCCccccCcccccc---cCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhh-hhhh
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCR---NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLE-LEED 209 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~---~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 209 (291)
... .....+||+.|+|||++.+ ....++.++|||||||++|+|++|..||..... ........ ....
T Consensus 229 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 229 GTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHKER 299 (437)
T ss_dssp SCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTHHHH
T ss_pred CCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh--------hHHHHhhhhcccc
Confidence 322 2344678999999999862 124689999999999999999999999975421 11111111 1111
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSD--RPAMNRVVE 250 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~--Rps~~ell~ 250 (291)
...+.. ...++..+.+|+++||..+|++ ||+++|+++
T Consensus 300 ~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 300 FQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 112211 1235667889999999888888 999999886
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=293.58 Aligned_cols=220 Identities=23% Similarity=0.325 Sum_probs=174.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|++. +++.||||++.... +.+......++||||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 229 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence 345689999999999999875 49999999986431 456667788999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ..+++..+..++.||+.||.|||+ ..+|+|+||||+||+++.++.+||+|||++.....
T Consensus 230 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 230 ANGGELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp CSSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999999765 479999999999999999999994 17899999999999999999999999999875433
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...... . ..... .....
T Consensus 302 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~-~~~~i-~~~~~-- 366 (446)
T 4ejn_A 302 DGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------K-LFELI-LMEEI-- 366 (446)
T ss_dssp -------CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHH-HHCCC--
T ss_pred CCc--ccccccCCccccCHhhcCCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------H-HHHHH-HhCCC--
Confidence 221 23456789999999999776 7899999999999999999999998654211 0 00000 00001
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~ 250 (291)
..+..++..+.+|+.+||+.||.+|| ++.|+++
T Consensus 367 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 -----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11223567789999999999999999 9999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=286.46 Aligned_cols=220 Identities=25% Similarity=0.297 Sum_probs=171.2
Q ss_pred hcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCCCH
Q 022826 6 KNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
.+.||+|+||.||+|.+. +++.||+|+++... +++......++||||+.+++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 467999999999999875 49999999997643 566777889999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE--cCCCceEEeccCCccccCCCCce
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL--DEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
.+++... ...+++..++.++.||+.||.|||+ .+|+|+||||+||++ +.++.+||+|||++........
T Consensus 174 ~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 174 FDRIIDE-----SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp HHHHHHT-----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred HHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence 9988653 2578999999999999999999999 999999999999999 5678999999999987654332
Q ss_pred eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 137 VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
.....+|+.|+|||++.+. .++.++|||||||++|+|++|..||...... . .... .... .....
T Consensus 245 --~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~-~~~~---i~~~-~~~~~ 308 (373)
T 2x4f_A 245 --LKVNFGTPEFLAPEVVNYD--FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-------E-TLNN---ILAC-RWDLE 308 (373)
T ss_dssp --CCCCCSSCTTCCHHHHTTC--BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHHH---HHHT-CCCSC
T ss_pred --cccccCCCcEeChhhccCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHH---HHhc-cCCCC
Confidence 2334689999999999765 7899999999999999999999998654221 0 0000 0000 01111
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......++..+.+|+.+||+.||.+|||+.|+++
T Consensus 309 ~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 309 DEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2223446778999999999999999999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=307.12 Aligned_cols=219 Identities=22% Similarity=0.301 Sum_probs=176.6
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|++.. ++.||||+++... ..+......|+|||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E 422 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence 3456889999999999998764 8899999987432 34556678899999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+|+|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+||||+.+|.+||+|||++....
T Consensus 423 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 423 YVNGGDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred CcCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999765 479999999999999999999999 999999999999999999999999999998543
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
.... .....+||+.|+|||++.+. .++.++||||||+++|+|++|..||...... ..... +.
T Consensus 494 ~~~~--~~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--------~~~~~------i~ 555 (674)
T 3pfq_A 494 WDGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQS------IM 555 (674)
T ss_dssp CTTC--CBCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHH------HH
T ss_pred cCCc--ccccccCCCcccCHhhhcCC--CCCccceEechHHHHHHHHcCCCCCCCCCHH--------HHHHH------HH
Confidence 2221 23456789999999999776 8899999999999999999999999754211 01111 11
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAM-----NRVVE 250 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~-----~ell~ 250 (291)
... ...+..++.++.+|+.+||+.||++||++ +|+++
T Consensus 556 ~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 556 EHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred hCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111 11223467789999999999999999997 66654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=278.30 Aligned_cols=225 Identities=25% Similarity=0.425 Sum_probs=171.3
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------cee-ecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------GFC-FEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------~~~-~~~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||+|+||.||++.+ +++.||+|+++... +++ ......++||||+.+++
T Consensus 23 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~ 101 (278)
T 1byg_A 23 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101 (278)
T ss_dssp EEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred ceEEeEEecCCCceEEEEEE-cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCC
Confidence 45678999999999999987 58899999997654 332 23457899999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 102 L~~~l~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 171 (278)
T 1byg_A 102 LVDYLRSR----GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 171 (278)
T ss_dssp HHHHHHHH----HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred HHHHHHhc----ccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence 99999764 22348999999999999999999999 999999999999999999999999999987543322
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
....+++.|+|||.+.+. .++.++||||||+++|+|++ |..||....... ...... ....
T Consensus 172 --~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--------~~~~~~-------~~~~ 232 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVE-------KGYK 232 (278)
T ss_dssp ------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------HHHHHT-------TTCC
T ss_pred --cCCCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHh-------cCCC
Confidence 223457899999999775 78999999999999999998 888776432110 000000 0111
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
...+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 11223456789999999999999999999999999988643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=282.95 Aligned_cols=223 Identities=21% Similarity=0.320 Sum_probs=175.4
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------------ceeecCCcce
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------------GFCFEGHRRA 47 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------------~~~~~~~~~~ 47 (291)
.+.+.||+|+||.||+|.+. +|+.||||++.... +++......+
T Consensus 97 ~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 176 (365)
T 2y7j_A 97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF 176 (365)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEE
T ss_pred ccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEE
Confidence 45589999999999999885 59999999985431 4556677889
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+||||+.+++|.+++... ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.+|.++|+|||++
T Consensus 177 lv~e~~~g~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 177 LVFDLMRKGELFDYLTEK------VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp EEECCCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCcc
Confidence 999999999999999764 479999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeccCCCCCccccCccccccc----CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRN----FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKR 203 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~----~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~ 203 (291)
........ .....+|+.|+|||.+.+. ...++.++|||||||++|+|++|..||..... ......
T Consensus 248 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--------~~~~~~ 316 (365)
T 2y7j_A 248 CHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--------ILMLRM 316 (365)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred cccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--------HHHHHH
Confidence 87654332 2345689999999998643 23578899999999999999999999865321 000000
Q ss_pred hhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 204 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. ... ............+..+.+++.+||+.||++|||+.++++
T Consensus 317 i-~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 I-MEG---QYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp H-HHT---CCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H-HhC---CCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 000 000011111234667899999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=283.47 Aligned_cols=236 Identities=26% Similarity=0.394 Sum_probs=177.1
Q ss_pred chhhcccccCCceeEEEEEe------cCCCeEEEEEeccCc---------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKL------LDGRNVAIKVLNETK---------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|++ .+++.||||++.... +++......++|
T Consensus 32 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (327)
T 2yfx_A 32 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 111 (327)
T ss_dssp CEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEE
Confidence 45678999999999999983 237899999986432 566667788999
Q ss_pred ehhhcCCCHHHHHhhcCCC-CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC---CCceEEeccC
Q 022826 50 YEFVSNGSLEKFIYEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---DFCPKISDFG 125 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~---~~~~kl~Dfg 125 (291)
|||+.+++|.+++...... .....+++..++.++.|++.||.|||+ .+++|+||||+||+++. +..++|+|||
T Consensus 112 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 112 MELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEECccc
Confidence 9999999999999875422 122568999999999999999999999 99999999999999984 4469999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRL 204 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~ 204 (291)
++................+++.|+|||.+.+. .++.++||||||+++|+|++ |..||..... .......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~~~ 258 (327)
T 2yfx_A 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVLEFV 258 (327)
T ss_dssp HHHHHHC------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHHH
T ss_pred cccccccccccccCCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--------HHHHHHH
Confidence 98765433322222334568899999999775 78999999999999999998 7777754321 0000000
Q ss_pred hhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 205 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
. .......+..++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 259 ~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 259 T-------SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp H-------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred h-------cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 0 0001112234566789999999999999999999999999987653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=290.14 Aligned_cols=226 Identities=21% Similarity=0.260 Sum_probs=176.1
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||++++. +++.||+|++.+.. +.+.+....|+||||
T Consensus 63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~ 142 (412)
T 2vd5_A 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY 142 (412)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence 345688999999999999885 59999999986421 456677888999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++... +..+++..++.++.||+.||.|||+ .+|+||||||+||+++.+|.+||+|||++.....
T Consensus 143 ~~gg~L~~~l~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 143 YVGGDLLTLLSKF-----GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp CCSCBHHHHHHHH-----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 9999999999764 2479999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCceeeccCCCCCccccCccccccc-----CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh-
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRN-----FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL- 206 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~-----~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~- 206 (291)
.... .....+||+.|+|||++.+. ...++.++|||||||++|+|++|..||..... .........
T Consensus 215 ~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~ 285 (412)
T 2vd5_A 215 DGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST--------AETYGKIVHY 285 (412)
T ss_dssp TSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTH
T ss_pred CCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhc
Confidence 3321 22345789999999998631 23689999999999999999999999875421 111111111
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCC---CCHHHHHH
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDR---PAMNRVVE 250 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~R---ps~~ell~ 250 (291)
......+ .....++..+.+|+++||. +|.+| |+++|+++
T Consensus 286 ~~~~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 286 KEHLSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ccCcCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1111111 1123467789999999999 99998 58998875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=272.46 Aligned_cols=221 Identities=20% Similarity=0.244 Sum_probs=176.2
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||+|+||.||+|.+.. +..+|+|++.... +++......++||||+.+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (277)
T 3f3z_A 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90 (277)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCC
Confidence 4567899999999999998765 7899999987542 566677888999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE---cCCCceEEeccCCccccCC
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~ 132 (291)
++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||++ +.++.++|+|||++.....
T Consensus 91 ~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 91 GELFERVVHK------RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999998765 468999999999999999999999 999999999999999 7889999999999987654
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||...... ...... . ...
T Consensus 162 ~~~---~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~---~-~~~ 223 (277)
T 3f3z_A 162 GKM---MRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS--------EVMLKI---R-EGT 223 (277)
T ss_dssp TSC---BCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHH---H-HCC
T ss_pred ccc---hhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHH--------HHHHHH---H-hCC
Confidence 332 234567999999999865 4889999999999999999999998654211 000000 0 001
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..........++..+.+++.+||+.||++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 224 FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111112245778999999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=276.79 Aligned_cols=224 Identities=26% Similarity=0.374 Sum_probs=170.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||++.+. ++..+|+|++.... +++......++||||+.
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 103 (285)
T 3is5_A 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCE 103 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCC
Confidence 456789999999999999875 48999999987543 56667788899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE---cCCCceEEeccCCccccC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICH 131 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill---~~~~~~kl~Dfg~~~~~~ 131 (291)
+++|.+++.... .....+++..++.++.|++.||.|||+ .+++|+||||+||++ +.++.++|+|||++....
T Consensus 104 ~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 104 GGELLERIVSAQ--ARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CCBHHHHHHHHH--HHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCcHHHHHHhhh--hcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999986531 123679999999999999999999999 999999999999999 456789999999997654
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
.... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||...... . . .......
T Consensus 179 ~~~~---~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-------~-~----~~~~~~~ 240 (285)
T 3is5_A 179 SDEH---STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-------E-V----QQKATYK 240 (285)
T ss_dssp -----------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-H----HHHHHHC
T ss_pred Cccc---CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHH-------H-H----HhhhccC
Confidence 4322 234567999999999853 6789999999999999999999998653210 0 0 0000111
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.... ......++..+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 241 EPNY-AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCC-CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred Cccc-ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 1111124567889999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=280.30 Aligned_cols=242 Identities=20% Similarity=0.284 Sum_probs=174.2
Q ss_pred cchhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhh
Q 022826 2 TNSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 2 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~ 53 (291)
.+.+.+.||+|+||.||+|++. +++.||+|++.... +++......++||||+
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 3567799999999999999886 58999999986433 4566778889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+ +|.+++... ...+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~-~l~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 83 DK-DLKQYLDDC-----GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp SE-EHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred cc-CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 75 999998764 2579999999999999999999999 99999999999999999999999999998754432
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcc------------ccchhhhh
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSE------------IYFPHWVY 201 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~------------~~~~~~~~ 201 (291)
.. ......+++.|+|||.+.+. ..++.++||||||+++|+|++|..||......... ..++....
T Consensus 154 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 154 TK--TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp -----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cc--ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence 21 12334578999999998763 36899999999999999999999988654321100 00000000
Q ss_pred hhhhhhhhhcccCCC----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHhhhc
Q 022826 202 KRLELEEDLGLQGIE----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE--MLEGSLD 257 (291)
Q Consensus 202 ~~~~~~~~~~~~~~~----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~--~L~~~~~ 257 (291)
. ........+... ......++..+.+|+.+||+.||++|||+.|+++ ++.++.+
T Consensus 231 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 231 N--EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp C--HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred c--hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 0 000000000000 0111235667899999999999999999999987 4555443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=300.65 Aligned_cols=224 Identities=26% Similarity=0.381 Sum_probs=179.3
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|++. +|+.||+|++.... +.+......++||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 345689999999999999875 59999999986432 456677889999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++... ....+++..++.++.||+.||.|||+ .+|+|+||||+||+++.+|.+||+|||++.....
T Consensus 266 ~~gg~L~~~l~~~----~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 266 MNGGDLKFHIYHM----GQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp CCSCBHHHHHHSS----SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999764 23459999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ........ .. .
T Consensus 339 ~~~---~~~~~GT~~Y~APEvl~~~--~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~----~~~i~~~i---~~--~ 404 (576)
T 2acx_A 339 GQT---IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----REEVERLV---KE--V 404 (576)
T ss_dssp TCC---EECCCSCGGGCCHHHHTTC--EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC----HHHHHHHH---HH--C
T ss_pred Ccc---ccccCCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCcccccchh----HHHHHHHh---hc--c
Confidence 432 2345789999999999875 789999999999999999999999976543221 11011100 00 0
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~ 250 (291)
....+..++..+.+|+.+||+.||.+|| ++.|+++
T Consensus 405 ---~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 ---PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ---cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1112234667899999999999999999 7888875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=275.53 Aligned_cols=228 Identities=24% Similarity=0.370 Sum_probs=175.2
Q ss_pred chhhcccccCCceeEEEEEecC----CCeEEEEEeccCc---------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD----GRNVAIKVLNETK---------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|.+.+ +..||+|++.... +++ .....++|||
T Consensus 14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e 92 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII-EEEPTWIIME 92 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEE-cCCCCEEEEe
Confidence 4567899999999999997643 3469999987652 333 3456789999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 93 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 93 LYPYGELGHYLERN-----KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp CCTTCBHHHHHHHH-----TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred cCCCCCHHHHHHhc-----cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 99999999999764 2568999999999999999999999 999999999999999999999999999988654
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
..... ......+++.|+|||.+.+. .++.++||||||+++|+|++ |..||....... .........
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--------~~~~~~~~~-- 231 (281)
T 3cc6_A 165 DEDYY-KASVTRLPIKWMSPESINFR--RFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--------VIGVLEKGD-- 231 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--------HHHHHHHTC--
T ss_pred ccccc-ccccCCCCcceeCchhhccC--CCCchhccHHHHHHHHHHHhCCCCCcccCChHH--------HHHHHhcCC--
Confidence 43211 12334467889999999765 78999999999999999998 898886432211 000010000
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
....+..++..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 232 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 232 -----RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 011122355678999999999999999999999999998765
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=281.35 Aligned_cols=219 Identities=26% Similarity=0.365 Sum_probs=176.5
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||++.+.+ ++.+|+|++.... +++......++||||
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 122 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEec
Confidence 3467899999999999998865 8899999986542 566677889999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 123 ~~~~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 123 CRRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp CTTCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999998765 478999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...... . ...... ...
T Consensus 194 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~-~~~~~~-~~~--- 257 (335)
T 2owb_A 194 DGE--RKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------E-TYLRIK-KNE--- 257 (335)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHHHHH-HTC---
T ss_pred Ccc--cccccCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-------H-HHHHHh-cCC---
Confidence 222 12345679999999999775 7889999999999999999999988643210 0 000000 000
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. ..+..++..+.+++.+||+.||++|||+.|+++
T Consensus 258 ~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 258 Y----SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 111234567889999999999999999999987
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=281.59 Aligned_cols=219 Identities=23% Similarity=0.294 Sum_probs=171.2
Q ss_pred chhhcccccCCceeEEEEEe----cCCCeEEEEEeccCc------------------------------ceeecCCccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKL----LDGRNVAIKVLNETK------------------------------GFCFEGHRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~------------------------------~~~~~~~~~~l 48 (291)
+.+.+.||+|+||.||+++. .+++.||+|+++... +.+......++
T Consensus 19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 98 (327)
T 3a62_A 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL 98 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence 45678999999999999987 358999999987532 45666778899
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
||||+.+++|.+++... ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 99 ILEYLSGGELFMQLERE------GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEECCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEeCCCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999765 478999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhh
Q 022826 129 ICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEE 208 (291)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (291)
....... ......||+.|+|||.+.+. .++.++||||||+++|+|++|..||...... ....... ..
T Consensus 170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~-~~ 236 (327)
T 3a62_A 170 ESIHDGT--VTHTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPFTGENRK--------KTIDKIL-KC 236 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHH-HT
T ss_pred ccccCCc--cccccCCCcCccCHhhCcCC--CCCCcccchhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHH-hC
Confidence 5432221 12345689999999999775 7899999999999999999999998754210 0011110 00
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVE 250 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~ 250 (291)
.. ..+..++..+.+++.+||+.||++|| ++.++++
T Consensus 237 ~~-------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 KL-------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CC-------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CC-------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 01 11223567789999999999999999 7778765
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=276.05 Aligned_cols=218 Identities=26% Similarity=0.370 Sum_probs=172.9
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|.+.. ++.||+|++.... +++......++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence 4567899999999999998755 7899999985432 566677889999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 91 ~~~~~l~~~l~~~------~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 91 APLGTVYRELQKL------SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999765 478999999999999999999999 9999999999999999999999999998865433
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
.. .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||..... ....... ....
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~---~~~~- 223 (279)
T 3fdn_A 162 SR----RTDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRI---SRVE- 223 (279)
T ss_dssp ----------CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHH---HHTC-
T ss_pred cc----ccccCCCCCccCHhHhccC--CCCccchhHhHHHHHHHHHHCCCCCCCCcH--------HHHHHHH---HhCC-
Confidence 22 2344679999999999775 788999999999999999999998864321 0011111 0000
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
...+..++..+.+|+.+||+.||.+|||+.|+++.
T Consensus 224 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11122355678899999999999999999999974
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=283.20 Aligned_cols=240 Identities=23% Similarity=0.207 Sum_probs=177.5
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +++......++||
T Consensus 28 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 107 (345)
T 3hko_A 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107 (345)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEE
Confidence 456789999999999999875 48999999986431 5667778899999
Q ss_pred hhhcCCCHHHHHhhcCCC----------------------------------CCCCCCCHHHHHHHHHHHHHHhHHhhcC
Q 022826 51 EFVSNGSLEKFIYEKHPL----------------------------------ETNQKLKWEVLYKIAVGIARGLEYLHRG 96 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~----------------------------------~~~~~~~~~~~~~i~~~l~~~l~~LH~~ 96 (291)
||+.+++|.+++...... .....+++..++.++.||+.||.|||+
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~- 186 (345)
T 3hko_A 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN- 186 (345)
T ss_dssp ECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred eCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-
Confidence 999999999998531100 001234678899999999999999999
Q ss_pred CCCCeeeeccCCCceEEcCCC--ceEEeccCCccccCCC--CceeeccCCCCCccccCcccccccCCCccccccchhHHH
Q 022826 97 CNTRILHFDIKPHNILLDEDF--CPKISDFGLAKICHGR--ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGM 172 (291)
Q Consensus 97 ~~~~ivH~dikp~Nill~~~~--~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~ 172 (291)
.+++|+||||+||+++.++ .+||+|||++...... ..........+++.|+|||.+.+....++.++||||||+
T Consensus 187 --~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 187 --QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp --TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred --CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 9999999999999998776 8999999999865332 111223455689999999999765457899999999999
Q ss_pred HHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH--
Q 022826 173 MVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE-- 250 (291)
Q Consensus 173 ~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~-- 250 (291)
++|+|++|..||....... ..... . .............++..+.+|+.+||+.||.+|||+.++++
T Consensus 265 il~el~~g~~pf~~~~~~~--------~~~~~---~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDAD--------TISQV---L-NKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHH--------HHHHH---H-HCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred HHHHHHHCCCCCCCCChHH--------HHHHH---H-hcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence 9999999999986542210 00000 0 01111112223346778999999999999999999999987
Q ss_pred HHHhhhc
Q 022826 251 MLEGSLD 257 (291)
Q Consensus 251 ~L~~~~~ 257 (291)
+++++.+
T Consensus 333 ~~~~~~~ 339 (345)
T 3hko_A 333 WISQFSD 339 (345)
T ss_dssp HHHTTSS
T ss_pred hhccChH
Confidence 4555433
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=289.24 Aligned_cols=170 Identities=26% Similarity=0.325 Sum_probs=145.4
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-------------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||+|.+.. ++.||||++.... +.+......++||
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 178 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF 178 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEE
Confidence 4567899999999999998765 8999999997543 3445567889999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCc--eEEeccCCcc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC--PKISDFGLAK 128 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~--~kl~Dfg~~~ 128 (291)
|++. ++|.+++... ....+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++. +||+|||++.
T Consensus 179 e~~~-~~L~~~l~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 179 ELLS-MNLYELIKKN----KFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp CCCC-CBHHHHHHHT----TTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred eccC-CCHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 9996 5999998765 33569999999999999999999999 99999999999999999887 9999999987
Q ss_pred ccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccc
Q 022826 129 ICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVA 187 (291)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~ 187 (291)
..... .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 251 ~~~~~-----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 251 YEHQR-----VYTYIQSRFYRAPEVILGA--RYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp ETTCC-----CCSSCSCGGGCCHHHHHTB--CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCc-----ccccCCCCCccChHHHhCC--CCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 54332 2345679999999999876 7899999999999999999999888654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=276.59 Aligned_cols=225 Identities=20% Similarity=0.246 Sum_probs=173.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------------cee--ecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------------GFC--FEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------------~~~--~~~~~~~lv 49 (291)
+.+.+.||+|+||.||++.+. +++.||+|++.... +++ ......++|
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence 567899999999999999875 48999999986431 333 345678999
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
|||+.++ |.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++..
T Consensus 87 ~e~~~~~-l~~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSV----PEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EECCSEE-HHHHHHHS----TTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ehhccCC-HHHHHHhC----cccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999875 77777654 34679999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 130 CHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
..............+++.|+|||.+.+.....+.++||||||+++|+|++|..||..... ........ ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~i~-~~- 228 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--------YKLFENIG-KG- 228 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHH-HC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--------HHHHHHHh-cC-
Confidence 654333333345568999999999976534557899999999999999999998875321 00001000 00
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.. ..+..++..+.+++.+||+.||++|||+.++++.
T Consensus 229 --~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 229 --SY----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --CC----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --CC----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 1122345678899999999999999999999963
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=278.99 Aligned_cols=228 Identities=22% Similarity=0.403 Sum_probs=174.3
Q ss_pred chhhcccccCCceeEEEEEecC-C-------CeEEEEEeccCc--------------------------ceeecCCccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-G-------RNVAIKVLNETK--------------------------GFCFEGHRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~--------------------------~~~~~~~~~~l 48 (291)
+.+.+.||+|+||.||+|.+.. + ..||+|++.... +++......++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (289)
T 4fvq_A 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENIL 89 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEE
T ss_pred eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEE
Confidence 4567899999999999997654 3 479999986543 56667788899
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCc--------eE
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC--------PK 120 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~--------~k 120 (291)
||||+.+++|.+++... ...+++..++.++.||+.||.|||+ .+++|+||||+||+++.++. ++
T Consensus 90 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 90 VQEFVKFGSLDTYLKKN-----KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp EEECCTTCBHHHHHHHT-----GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EEECCCCCCHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999764 2459999999999999999999999 99999999999999988887 99
Q ss_pred EeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhh
Q 022826 121 ISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWV 200 (291)
Q Consensus 121 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~ 200 (291)
|+|||++...... ....+++.|+|||.+.+. ..++.++||||||+++|+|++|..++........
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-------- 226 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-------- 226 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHH--------
Confidence 9999998654322 123357889999999762 3789999999999999999997665554322110
Q ss_pred hhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCC
Q 022826 201 YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRI 261 (291)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 261 (291)
...... ..... +...+..+.+++.+||+.||++|||+.++++.|++++..-..
T Consensus 227 --~~~~~~--~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 227 --KLQFYE--DRHQL----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp --HHHHHH--TTCCC----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred --HHHHhh--ccCCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 000000 00111 111245688999999999999999999999999998764433
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=288.63 Aligned_cols=237 Identities=22% Similarity=0.267 Sum_probs=161.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceee--cCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCF--EGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~--~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +++. +....++||
T Consensus 11 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 90 (388)
T 3oz6_A 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVF 90 (388)
T ss_dssp EEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEE
T ss_pred eEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEe
Confidence 456789999999999999875 49999999985432 2332 234689999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
||+.+ +|..++.. ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 91 e~~~~-~L~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 91 DYMET-DLHAVIRA-------NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp ECCSE-EHHHHHHH-------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred cccCc-CHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99974 99999854 378999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCC-------------------ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCC
Q 022826 131 HGRE-------------------SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRS 191 (291)
Q Consensus 131 ~~~~-------------------~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~ 191 (291)
.... .........+|+.|+|||++.+. ..++.++|||||||++|+|++|..||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 3211 11112345689999999999763 378999999999999999999999987543211
Q ss_pred ccccc------hh-------------hhhhhhhhhhhhcccCCCChhh------------HHHHHHHHHHHHHhhhcCCC
Q 022826 192 SEIYF------PH-------------WVYKRLELEEDLGLQGIENEED------------KEYARKMILVSLWCIQNNPS 240 (291)
Q Consensus 192 ~~~~~------~~-------------~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~l~~l~~~~l~~dP~ 240 (291)
..... +. ...................... ..++..+.+|+.+||+.||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 00000 00 0000000000000000000000 02356789999999999999
Q ss_pred CCCCHHHHHHH
Q 022826 241 DRPAMNRVVEM 251 (291)
Q Consensus 241 ~Rps~~ell~~ 251 (291)
+|||+.|+++-
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=292.42 Aligned_cols=222 Identities=26% Similarity=0.338 Sum_probs=175.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +++......++||||+
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 103 (486)
T 3mwu_A 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELY 103 (486)
T ss_dssp EEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcC
Confidence 456789999999999999875 59999999985321 5667778899999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc---CCCceEEeccCCcccc
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---EDFCPKISDFGLAKIC 130 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~---~~~~~kl~Dfg~~~~~ 130 (291)
.+++|.+.+... ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++ .++.+||+|||++...
T Consensus 104 ~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 104 TGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999998765 479999999999999999999999 9999999999999995 4567999999999866
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
..... .....+|+.|+|||++.+ .++.++|||||||++|+|++|..||...... ....... .
T Consensus 175 ~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~----~ 236 (486)
T 3mwu_A 175 QQNTK---MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--------DILKRVE----T 236 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHH----H
T ss_pred CCCCc---cCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHH----h
Confidence 44322 244568999999999865 5889999999999999999999998654210 0011110 0
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
............++..+.+|+.+||+.||.+|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 237 GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp TCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01111122334567789999999999999999999999873
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=279.75 Aligned_cols=232 Identities=21% Similarity=0.305 Sum_probs=173.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------ceeec--CCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------GFCFE--GHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------~~~~~--~~~~~lv~e~~~~ 55 (291)
+.+.+.||+|+||.||+|.+. +++.||+|+++... +++.. ....++||||+.+
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 117 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred eEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence 456789999999999999874 59999999997543 33333 5667899999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC-ceEEeccCCccccCCCC
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-CPKISDFGLAKICHGRE 134 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 134 (291)
++|.+++ ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++ .++|+|||++.......
T Consensus 118 ~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 118 TDFKQLY---------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp CCHHHHG---------GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred hhHHHHH---------HhCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 9999988 358899999999999999999999 9999999999999999776 89999999998655433
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc-
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ- 213 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 213 (291)
. .....+++.|+|||.+.+. ..++.++|||||||++|+|++|..||.........................+...
T Consensus 186 ~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 186 E---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp C---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred c---cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 2 2345678999999998763 3789999999999999999999999865433211110000000000000000000
Q ss_pred ---------------------CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 214 ---------------------GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 214 ---------------------~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.........++..+.+|+.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0001112235778999999999999999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=284.21 Aligned_cols=244 Identities=23% Similarity=0.401 Sum_probs=181.5
Q ss_pred chhhcccccCCceeEEEEEe-----cCCCeEEEEEeccCc--------------------------ceeec--CCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKL-----LDGRNVAIKVLNETK--------------------------GFCFE--GHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~--------------------------~~~~~--~~~~~lv 49 (291)
+.+.+.||+|+||.||+++. .+++.||+|++.... +++.. ....++|
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 122 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence 35678999999999999983 348899999987643 22222 3367899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
|||+.+++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++..
T Consensus 123 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKH-----KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ECCCTTCBHHHHHHHS-----TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EECCCCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999764 2569999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCceee-ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCc----cccchhhhhhhh
Q 022826 130 CHGRESIVS-MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSS----EIYFPHWVYKRL 204 (291)
Q Consensus 130 ~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~----~~~~~~~~~~~~ 204 (291)
......... .....++..|+|||.+.+. .++.++||||||+++|+|++|..|+........ ............
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCC--CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 654433222 2334467789999999876 789999999999999999999887653311000 000000000000
Q ss_pred hhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccC
Q 022826 205 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSL 259 (291)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~ 259 (291)
...+. .......+..++..+.+++.+||+.||++|||+.++++.|+++.+++
T Consensus 273 --~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 273 --IELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp --HHHHH-TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --HHHhh-cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 00010 11111123345678999999999999999999999999999987654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=281.99 Aligned_cols=237 Identities=24% Similarity=0.347 Sum_probs=176.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceee----cCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCF----EGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~----~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||++++. +++.||||++.... +++. .....++|+|
T Consensus 31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 110 (317)
T 2buj_A 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110 (317)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEE
Confidence 456789999999999999874 59999999885433 2332 3447789999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+++|.+++.... .....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 111 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 111 FFKRGTLWNEIERLK--DKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp CCTTCBHHHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred eCCCCcHHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999997642 234679999999999999999999999 999999999999999999999999999887543
Q ss_pred CCCce-------eeccCCCCCccccCcccccccC-CCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhh
Q 022826 132 GRESI-------VSMTGARGTVGYIAPEVFCRNF-GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKR 203 (291)
Q Consensus 132 ~~~~~-------~~~~~~~~~~~y~aPE~l~~~~-~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~ 203 (291)
..... .......+++.|+|||.+.+.. ..++.++||||||+++|+|++|..||........... . .
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~--~----~ 259 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA--L----A 259 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH--H----H
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh--H----H
Confidence 21100 0011234688999999987542 2468899999999999999999998864322111000 0 0
Q ss_pred hhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 204 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
..... .......++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 260 --~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 --VQNQL-----SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp --HHCC-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred --hhccC-----CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00000 111123356679999999999999999999999999998644
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=291.46 Aligned_cols=227 Identities=12% Similarity=0.050 Sum_probs=168.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCcc------------------e---eec------------------
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETKG------------------F---CFE------------------ 42 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------------------~---~~~------------------ 42 (291)
+.+.+.||+|+||.||+|.+. +++.||||++..... . ..+
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 456789999999999999875 589999999987330 0 000
Q ss_pred ----------------CCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHH------HHHHHHHHHHhHHhhcCCCCC
Q 022826 43 ----------------GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVL------YKIAVGIARGLEYLHRGCNTR 100 (291)
Q Consensus 43 ----------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~------~~i~~~l~~~l~~LH~~~~~~ 100 (291)
....++||||+. ++|.+++.... ..+++..+ ..++.||+.||.|||+ .+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ 214 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-----FVYVFRGDEGILALHILTAQLIRLAANLQS---KG 214 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-----cccchhhhhhhhhHHHHHHHHHHHHHHHHH---CC
Confidence 023689999998 79999998742 23444445 6778999999999999 99
Q ss_pred eeeeccCCCceEEcCCCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCC
Q 022826 101 ILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGV 180 (291)
Q Consensus 101 ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g 180 (291)
|+|+||||+||+++.++.+||+|||++....... ....+++.|+|||.+.+....++.++|||||||++|+|++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998653221 13345699999999976334789999999999999999999
Q ss_pred CCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 181 KNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
+.||.............. .. ...............++..+.+|+.+||+.||++|||+.++++
T Consensus 290 ~~Pf~~~~~~~~~~~~~~------~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWKRP------SL-RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTCCCBC------CT-TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccchhhh------hh-hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999986643322111000 00 0000011111112345678999999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=291.99 Aligned_cols=221 Identities=27% Similarity=0.361 Sum_probs=172.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|++. +++.||+|++.... +++......++|||||
T Consensus 39 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 118 (494)
T 3lij_A 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118 (494)
T ss_dssp EEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 446789999999999999886 48999999987542 5667778899999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC---CceEEeccCCcccc
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED---FCPKISDFGLAKIC 130 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~---~~~kl~Dfg~~~~~ 130 (291)
.+|+|.+++... ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++.. +.+||+|||++...
T Consensus 119 ~~g~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 119 KGGELFDEIIHR------MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp CSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999998765 479999999999999999999999 999999999999999764 45999999999876
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
..... .....+|+.|+|||++.+ .++.++|||||||++|+|++|..||...... ........
T Consensus 190 ~~~~~---~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~---- 251 (494)
T 3lij_A 190 ENQKK---MKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--------EILRKVEK---- 251 (494)
T ss_dssp BTTBC---BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHH----
T ss_pred CCCcc---ccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh----
Confidence 54432 244568999999999863 6889999999999999999999998754221 01111100
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
............++..+.+|+.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 252 GKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp TCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0111112222346778999999999999999999999885
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=274.15 Aligned_cols=220 Identities=25% Similarity=0.389 Sum_probs=156.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +++......++||||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence 456789999999999999874 59999999986431 566667788999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 93 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 93 CHNGEMNRYLKNR-----VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp CTTEEHHHHHHTC-----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred CCCCcHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999753 2578999999999999999999999 9999999999999999999999999999886543
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
.... .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||......... . ....
T Consensus 165 ~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~-----------~~~~ 226 (278)
T 3cok_A 165 PHEK--HYTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---N-----------KVVL 226 (278)
T ss_dssp -------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------CCS
T ss_pred CCCc--ceeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---H-----------HHhh
Confidence 2211 1234578999999999775 7889999999999999999999998754321100 0 0000
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. ...+..++..+.+++.+||+.||++|||+.++++
T Consensus 227 ~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 227 AD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00 0112235567889999999999999999999876
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=278.56 Aligned_cols=233 Identities=20% Similarity=0.272 Sum_probs=173.9
Q ss_pred chhhcccccCCceeEEEEEe-c-CCCeEEEEEeccCc-------------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKL-L-DGRNVAIKVLNETK-------------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~-------------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|.+ . +++.||+|+++... +++......++|
T Consensus 16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv 95 (339)
T 1z57_A 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIV 95 (339)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEE
Confidence 55678999999999999987 3 48899999987532 344566788999
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC--------------
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-------------- 115 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~-------------- 115 (291)
|||+ +++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.
T Consensus 96 ~e~~-~~~l~~~l~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 96 FELL-GLSTYDFIKEN----GFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EECC-CCBHHHHHHHT----TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EcCC-CCCHHHHHHhc----CCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 9999 78999999765 23468999999999999999999999 99999999999999987
Q ss_pred -----CCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCC
Q 022826 116 -----DFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDR 190 (291)
Q Consensus 116 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~ 190 (291)
++.++|+|||++...... .....+|+.|+|||.+.+. .++.++||||||+++|+|++|..||......
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 678999999998764332 2345679999999999875 7899999999999999999999998754321
Q ss_pred Cccccc-------hhhhhhhhh---------------------hhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCC
Q 022826 191 SSEIYF-------PHWVYKRLE---------------------LEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDR 242 (291)
Q Consensus 191 ~~~~~~-------~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~R 242 (291)
...... +........ ..................+..+.+|+.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 100000 000000000 0000000000001123457789999999999999999
Q ss_pred CCHHHHHH
Q 022826 243 PAMNRVVE 250 (291)
Q Consensus 243 ps~~ell~ 250 (291)
||+.|+++
T Consensus 321 pt~~ell~ 328 (339)
T 1z57_A 321 ITLREALK 328 (339)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=272.16 Aligned_cols=227 Identities=22% Similarity=0.322 Sum_probs=177.0
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||++.+. +++.||+|+++... +++......++|
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 86 (283)
T 3bhy_A 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLI 86 (283)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEE
Confidence 456789999999999999886 49999999986532 556667788999
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC----ceEEeccC
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF----CPKISDFG 125 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~----~~kl~Dfg 125 (291)
|||+.+++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++ .++|+|||
T Consensus 87 ~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 87 LELVSGGELFDFLAEK------ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EeecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999764 478999999999999999999999 9999999999999998877 89999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLE 205 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (291)
++........ .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||...... .....
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~-- 222 (283)
T 3bhy_A 158 IAHKIEAGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGETKQ--------ETLTN-- 222 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHH--
T ss_pred cceeccCCCc---ccccCCCcCccCcceecCC--CCCcchhhhhHHHHHHHHHHCCCCCCCcchH--------HHHHH--
Confidence 9986544322 2334578999999999765 7899999999999999999999988654210 00000
Q ss_pred hhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHhh
Q 022826 206 LEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE--MLEGS 255 (291)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~--~L~~~ 255 (291)
... .............+..+.+++.+||+.||++|||+.++++ .++++
T Consensus 223 -~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 223 -ISA-VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp -HHT-TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred -hHh-cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 000 0111111222345677899999999999999999999997 45554
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=272.37 Aligned_cols=219 Identities=25% Similarity=0.377 Sum_probs=170.5
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceee----cCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCF----EGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~----~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|.+.. +..||+|++.... +.+. .....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 3456789999999999998754 8899999986543 2211 24557899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCC--eeeeccCCCceEEc-CCCceEEeccCC
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR--ILHFDIKPHNILLD-EDFCPKISDFGL 126 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~dikp~Nill~-~~~~~kl~Dfg~ 126 (291)
|||+.+++|.+++... ..+++..++.++.||+.||.|||+ .+ ++|+||||+||+++ .++.++|+|||+
T Consensus 108 ~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEecCCCCHHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999765 478999999999999999999999 88 99999999999997 789999999999
Q ss_pred ccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh
Q 022826 127 AKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
+........ ....+++.|+|||.+.+ .++.++||||||+++|+|++|..||........ ..
T Consensus 179 ~~~~~~~~~----~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-------~~----- 239 (290)
T 1t4h_A 179 ATLKRASFA----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-------IY----- 239 (290)
T ss_dssp GGGCCTTSB----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-------HH-----
T ss_pred ccccccccc----ccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-------HH-----
Confidence 875443322 23457999999998864 588999999999999999999999865322110 00
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
................+..+.+++.+||+.||.+|||+.++++
T Consensus 240 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 240 -RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0011111111222334467899999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=275.13 Aligned_cols=223 Identities=26% Similarity=0.363 Sum_probs=174.0
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||+|+||.||+|.+.. ++.||+|++.... +.+......++||||+.+++
T Consensus 31 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (314)
T 3com_A 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS 110 (314)
T ss_dssp EEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCC
Confidence 4567899999999999998754 9999999987543 55666778899999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 111 L~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 180 (314)
T 3com_A 111 VSDIIRLR-----NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-- 180 (314)
T ss_dssp HHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--
T ss_pred HHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--
Confidence 99999643 2579999999999999999999999 9999999999999999999999999999976543322
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
......+++.|+|||.+.+. .++.++||||||+++|+|++|..||....... ...... .......
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----------~~~~~~--~~~~~~~ 245 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHPMR-----------AIFMIP--TNPPPTF 245 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-----------HHHHHH--HSCCCCC
T ss_pred ccCccCCCCCccChhhcCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCChHH-----------HHHHHh--cCCCccc
Confidence 12344678999999999775 78999999999999999999999886432100 000000 0111111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..+..++..+.+++.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 123345678999999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=272.71 Aligned_cols=222 Identities=21% Similarity=0.297 Sum_probs=177.8
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|.+.. ++.||+|++.... +++......++||||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 95 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF 95 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence 4567899999999999998764 7899999985421 566677888999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 96 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 96 APRGELYKELQKH------GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999765 468999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
.. .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||...... ..... .....
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~---~~~~~- 228 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--------ETHRR---IVNVD- 228 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHH---HHTTC-
T ss_pred cc----cccccCCCCcCCHHHhccC--CCCcccchhhHHHHHHHHHHCCCCCCCCCHh--------HHHHH---Hhccc-
Confidence 22 2345679999999999875 7899999999999999999999988653211 00000 00000
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHhh
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE--MLEGS 255 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~--~L~~~ 255 (291)
...+..++..+.+++.+||+.||.+|||+.++++ .+...
T Consensus 229 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 229 ----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred ----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 1112335667889999999999999999999987 55543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=296.07 Aligned_cols=226 Identities=25% Similarity=0.379 Sum_probs=177.5
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehhh
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~ 53 (291)
.+.+.||+|+||.||+|++. +|+.||+|++.... +.+......|+||||+
T Consensus 188 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~ 267 (543)
T 3c4z_A 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIM 267 (543)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEec
Confidence 34578999999999999885 49999999986432 4556677899999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+|+|.+++.... .....+++..++.++.||+.||.|||+ .+|+|+||||+||+++.+|.+||+|||++......
T Consensus 268 ~gg~L~~~l~~~~--~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 268 NGGDIRYHIYNVD--EDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp TTCBHHHHHHTSS--TTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred cCCCHHHHHHHhh--cccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 9999999987642 124579999999999999999999999 99999999999999999999999999999876543
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
... ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ........ ....
T Consensus 343 ~~~--~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~----~~~~~~~i-~~~~---- 409 (543)
T 3c4z_A 343 QTK--TKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQRV-LEQA---- 409 (543)
T ss_dssp CCC--BCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC----HHHHHHHH-HHCC----
T ss_pred Ccc--cccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCCccchh----HHHHHHHH-hhcc----
Confidence 321 2345789999999999876 789999999999999999999999976532211 11111111 0000
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAM-----NRVVE 250 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~-----~ell~ 250 (291)
...+..++..+.+|+.+||+.||.+||++ .++++
T Consensus 410 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 ---VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ---cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11123456788999999999999999965 66653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=277.64 Aligned_cols=230 Identities=25% Similarity=0.371 Sum_probs=166.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|++. +++.||+|++.... +.+..+...++||||+
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (290)
T 3fme_A 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM 88 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECC
T ss_pred hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehh
Confidence 456789999999999999875 58999999987543 5666778899999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCC-CeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT-RILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
++ +|.+++.... .....+++..++.++.|++.||.|||+ . +++|+||||+||+++.++.++|+|||++.....
T Consensus 89 ~~-~l~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 89 DT-SLDKFYKQVI--DKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp SE-EHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred cc-chHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 75 8888876531 134689999999999999999999999 8 999999999999999999999999999876544
Q ss_pred CCceeeccCCCCCccccCcccccc--cCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCR--NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~--~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
... .....+++.|+|||.+.. ....++.++||||||+++|+|++|..||..... ........ .
T Consensus 163 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~-----~ 227 (290)
T 3fme_A 163 DVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-------PFQQLKQV-----V 227 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-------HHHHHHHH-----H
T ss_pred ccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-------hHHHHHHH-----h
Confidence 322 233457899999999732 123688999999999999999999998864321 11000100 0
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHh
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE--MLEG 254 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~--~L~~ 254 (291)
...........++..+.+++.+||+.||++|||+.|+++ .+..
T Consensus 228 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 228 -EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp -HSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -ccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 011111122345677999999999999999999999987 4543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=282.01 Aligned_cols=219 Identities=26% Similarity=0.372 Sum_probs=172.5
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehhh
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~ 53 (291)
.+.+.||+|+||.||+|++. +++.||||++.... +++......++||||+
T Consensus 57 ~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 136 (348)
T 1u5q_A 57 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 136 (348)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecC
Confidence 34578999999999999874 58999999986432 5666778899999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
. |+|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++......
T Consensus 137 ~-g~l~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 137 L-GSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp S-EEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred C-CCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 7 5888888653 2579999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeccCCCCCccccCcccccc-cCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCR-NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
....+|+.|+|||++.+ ....++.++|||||||++|+|++|..||...... . ..... ..
T Consensus 208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------~-~~~~~------~~ 267 (348)
T 1u5q_A 208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------S-ALYHI------AQ 267 (348)
T ss_dssp ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------H-HHHHH------HH
T ss_pred ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-------H-HHHHH------Hh
Confidence 23467999999999854 2247889999999999999999999988643210 0 00000 00
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
..........++..+.+++.+||+.||++|||+.++++.
T Consensus 268 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 268 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111111123456778899999999999999999998764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=274.74 Aligned_cols=221 Identities=23% Similarity=0.348 Sum_probs=175.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||+|+||.||++++. +++.||+|++.... +++......++||||+.+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (304)
T 2jam_A 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSG 90 (304)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred ceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCC
Confidence 456789999999999999875 59999999987543 556677788999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE---cCCCceEEeccCCccccCC
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~ 132 (291)
++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||++ +.++.++|+|||++.....
T Consensus 91 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 91 GELFDRILER------GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred ccHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999998765 478999999999999999999999 999999999999999 7788999999999875433
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
.. .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||...... ....... .. .
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~-~~---~ 223 (304)
T 2jam_A 162 GI----MSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEETES--------KLFEKIK-EG---Y 223 (304)
T ss_dssp BT----THHHHSCCCBCCTTTBSSC--SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHH-HC---C
T ss_pred Cc----cccccCCCCccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHH-cC---C
Confidence 21 1233578999999999775 7899999999999999999999988653210 0000000 00 0
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..........++..+.+++.+||+.||++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 224 YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111222345678999999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=287.64 Aligned_cols=224 Identities=24% Similarity=0.319 Sum_probs=166.1
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------------ceeecCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------------GFCFEGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------------~~~~~~~~~~ 47 (291)
+.+.+.||+|+||.||+|.+.. ++.||+|++.... ++ ......+
T Consensus 137 y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~-~~~~~~~ 215 (419)
T 3i6u_A 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYY 215 (419)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE-EESSEEE
T ss_pred EEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE-EecCceE
Confidence 4456889999999999998754 8999999986531 23 2445678
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC---ceEEecc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF---CPKISDF 124 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~---~~kl~Df 124 (291)
+||||+.+++|.+++... ..+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++ .+||+||
T Consensus 216 lv~e~~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 216 IVLELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp EEEECCTTCBGGGGTSSS------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred EEEEcCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeec
Confidence 999999999998888543 579999999999999999999999 9999999999999996544 5999999
Q ss_pred CCccccCCCCceeeccCCCCCccccCcccccc-cCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhh
Q 022826 125 GLAKICHGRESIVSMTGARGTVGYIAPEVFCR-NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKR 203 (291)
Q Consensus 125 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~ 203 (291)
|++....... ......+|+.|+|||++.+ ....++.++|||||||++|+|++|..||........ ... .
T Consensus 287 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~---~~~----~ 356 (419)
T 3i6u_A 287 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---LKD----Q 356 (419)
T ss_dssp STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC---HHH----H
T ss_pred ccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH---HHH----H
Confidence 9998764332 2234568999999999864 224788999999999999999999999875432211 000 0
Q ss_pred hhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 204 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. .. ............++..+.+|+.+||+.||++|||+.|+++
T Consensus 357 i-~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 I-TS---GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp H-HT---TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H-hc---CCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0 00 0001111122345778999999999999999999999886
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=289.35 Aligned_cols=172 Identities=27% Similarity=0.386 Sum_probs=137.6
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecC-----Cccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEG-----HRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~-----~~~~l 48 (291)
+.+.+.||+|+||.||+|.+.. ++.||||++.... +++... ...|+
T Consensus 28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 107 (432)
T 3n9x_A 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107 (432)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence 4567899999999999998754 8899999997532 222222 56899
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
||||+.+ +|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 108 v~e~~~~-~L~~~~~~~------~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 108 VLEIADS-DLKKLFKTP------IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEECCSE-EHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEecCCc-CHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 9999865 999999653 579999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCce--------------------eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCc
Q 022826 129 ICHGRESI--------------------VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNAN 185 (291)
Q Consensus 129 ~~~~~~~~--------------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~ 185 (291)
........ .......+|+.|+|||++.+. ..++.++|||||||++|+|++|..|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccc
Confidence 76543211 112455689999999987543 378999999999999999998655544
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=277.43 Aligned_cols=235 Identities=23% Similarity=0.341 Sum_probs=172.1
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||+|.+.+ .+++|+++... +++......++|+||+.
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 112 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence 4567999999999999998743 59999987532 55666778899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++... ...+++..++.++.||+.||.|||+ .+++|+||||+||+++ ++.++|+|||++.......
T Consensus 113 ~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 113 GRTLYSVVRDA-----KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp SEEHHHHTTSS-----CCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred CCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 99999999653 2578999999999999999999999 9999999999999998 6799999999987543211
Q ss_pred ---ceeeccCCCCCccccCccccccc-------CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhh
Q 022826 135 ---SIVSMTGARGTVGYIAPEVFCRN-------FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRL 204 (291)
Q Consensus 135 ---~~~~~~~~~~~~~y~aPE~l~~~-------~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~ 204 (291)
.........+++.|+|||.+.+. ...++.++||||||+++|+|++|..||...... ......
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~ 255 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--------AIIWQM 255 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--------HHHHHH
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHh
Confidence 11122334578999999998652 235788999999999999999999988643211 000010
Q ss_pred hhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCC
Q 022826 205 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262 (291)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 262 (291)
... ..+ ......++..+.+++.+||..||++|||+.++++.|+.+.+..+..
T Consensus 256 ~~~---~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~ 307 (319)
T 2y4i_B 256 GTG---MKP---NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307 (319)
T ss_dssp HTT---CCC---CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred ccC---CCC---CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 000 011 1111134556889999999999999999999999999987765443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=301.22 Aligned_cols=229 Identities=27% Similarity=0.401 Sum_probs=176.6
Q ss_pred ccccCCceeEEEEEec---CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcCCC
Q 022826 8 KLGQGGYGGVYKGKLL---DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 8 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
.||+|+||.||+|.+. ++..||||+++... +++. .+..++||||+.+|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~-~~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-SSSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEec-cCCeEEEEEeCCCCc
Confidence 7999999999999764 35679999997642 4443 356889999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ...+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||+++.........
T Consensus 422 L~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 422 LHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp HHHHHTTC-----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred HHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 99999653 3579999999999999999999999 999999999999999999999999999998764432211
Q ss_pred e-ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 138 S-MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 138 ~-~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
. .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||...... . ...... .+.
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~-~~~~i~-------~~~ 556 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------E-VMAFIE-------QGK 556 (613)
T ss_dssp --------CCTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-------H-HHHHHH-------TTC
T ss_pred eeccCCCCccceeCHhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-------H-HHHHHH-------cCC
Confidence 1 1223346789999999765 88999999999999999998 88888654221 0 111111 011
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCC
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 262 (291)
....+..++..+.+|+.+||+.||++||++.++++.|+.++..+...
T Consensus 557 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~ 603 (613)
T 2ozo_A 557 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603 (613)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence 11223346678999999999999999999999999999988776554
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=280.64 Aligned_cols=236 Identities=19% Similarity=0.295 Sum_probs=172.4
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|++.. ++.||+|++.... +++......++||||+
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence 4577899999999999998865 9999999986543 5666778889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~l~~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 85 DHTVLHELDRYQ------RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp SEEHHHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred CCchHHHHHhhh------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999998887543 579999999999999999999999 99999999999999999999999999999875433
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhh-------hhhhhh
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWV-------YKRLEL 206 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~-------~~~~~~ 206 (291)
.. ......+++.|+|||.+.+. ..++.++||||||+++|+|++|..||................ ......
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 156 SD--YYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp ------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred cc--ccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 22 12344678999999998763 367999999999999999999999986543211100000000 000000
Q ss_pred h---hhhcccCCCC-----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 E---EDLGLQGIEN-----EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~---~~~~~~~~~~-----~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. .....+.... .....++..+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0000000000 011245667899999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=275.80 Aligned_cols=220 Identities=25% Similarity=0.365 Sum_probs=175.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +.+......++||||+.
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 345688999999999999875 48999999986542 55666778899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+++|.+++.. ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 104 ~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 104 GGSALDLLEP-------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp TEEHHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999843 479999999999999999999999 999999999999999999999999999997654432
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
. ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...... .... .......
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~---~~~~~~~-- 236 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSELHPM--------KVLF---LIPKNNP-- 236 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHH---HHHHSCC--
T ss_pred c--ccCccCCCcCccCHHHHhcC--CCCchhhhHHHHHHHHHHccCCCCCCCcCHH--------HHHH---HhhcCCC--
Confidence 1 12345678999999999775 7889999999999999999999887643210 0000 0011111
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
......++..+.+++.+||+.||++|||+.++++.
T Consensus 237 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 237 --PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp --CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred --CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11122355678999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=282.27 Aligned_cols=228 Identities=22% Similarity=0.287 Sum_probs=154.5
Q ss_pred hcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------ceeec----CCcceeeehhhcCCCH
Q 022826 6 KNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------GFCFE----GHRRALIYEFVSNGSL 58 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------~~~~~----~~~~~lv~e~~~~g~L 58 (291)
.+.||+|+||.||+|.+. +++.||||++.... +++.. +...++||||+.+|+|
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L 113 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL 113 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEH
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCH
Confidence 356999999999999886 49999999986543 22222 4457899999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC---CCceEEeccCCccccCCCCc
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---DFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~---~~~~kl~Dfg~~~~~~~~~~ 135 (291)
.+++... ....+++..++.++.||+.||.|||+ .+++|+||||+||+++. ++.++|+|||++.......
T Consensus 114 ~~~l~~~----~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~- 185 (336)
T 3fhr_A 114 FSRIQER----GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA- 185 (336)
T ss_dssp HHHHHTC-----CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred HHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc-
Confidence 9999764 23579999999999999999999999 99999999999999976 4559999999997654322
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
.....+++.|+|||.+.+. .++.++||||||+++|+|++|..||............. ...... ....
T Consensus 186 ---~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-----~~~~~~---~~~~ 252 (336)
T 3fhr_A 186 ---LQTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK-----RRIRLG---QYGF 252 (336)
T ss_dssp ---------------------C--HHHHHHHHHHHHHHHHHHHHSSCCC-----------------------------CC
T ss_pred ---cccCCCCcCccChhhhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH-----Hhhhcc---cccc
Confidence 2344568999999999765 78999999999999999999999986554322100000 000000 0111
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHh
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE--MLEG 254 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~--~L~~ 254 (291)
.......++..+.+|+.+||+.||++|||+.|+++ ++.+
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 11122345678899999999999999999999998 4544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=272.12 Aligned_cols=220 Identities=25% Similarity=0.349 Sum_probs=176.8
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||++.+.+ ++.+|+|++.... +++......++||||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence 4567899999999999998865 8899999986542 566677888999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 97 ~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 97 CRRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp CTTCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999998765 478999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...... . ..... . .
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~-~~~~~---~---~ 229 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------E-TYLRI---K---K 229 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHHHH---H---T
T ss_pred Ccc--ccccccCCCCcCCcchhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHH---h---h
Confidence 222 12345678999999999775 7889999999999999999999988653211 0 00000 0 0
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.. ...+..++..+.+++.+||+.||++|||+.++++.
T Consensus 230 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 230 NE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp TC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cc--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 11122345678899999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=280.16 Aligned_cols=172 Identities=25% Similarity=0.323 Sum_probs=143.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||+|.+. +++.||||+++... +.+......++||
T Consensus 56 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 135 (382)
T 2vx3_A 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVF 135 (382)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEE
Confidence 345688999999999999875 48899999997543 3445567888999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc--CCCceEEeccCCcc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD--EDFCPKISDFGLAK 128 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~--~~~~~kl~Dfg~~~ 128 (291)
||+.+ +|.+++... ....+++..++.++.|++.||.|||+. ..+|+|+||||+||+++ .++.+||+|||++.
T Consensus 136 e~~~~-~L~~~l~~~----~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 136 EMLSY-NLYDLLRNT----NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp ECCCC-BHHHHHHHT----TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred ecCCC-CHHHHHhhc----CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 99965 999999765 235699999999999999999999930 17899999999999994 47789999999998
Q ss_pred ccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccc
Q 022826 129 ICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVA 187 (291)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~ 187 (291)
..... .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 210 ~~~~~-----~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 210 QLGQR-----IYQYIQSRFYRSPEVLLGM--PYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp ETTCC-----CCSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecccc-----cccccCCccccChHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 75432 2345679999999999876 7899999999999999999999998754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=276.20 Aligned_cols=225 Identities=22% Similarity=0.283 Sum_probs=167.3
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||++.+.+++.||+|++.... +++......++|||
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 108 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 108 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence 45678999999999999998889999999986432 45566778889999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||++++ +.+||+|||++.....
T Consensus 109 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 109 CGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp CCSEEHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 5677999999764 478999999999999999999999 99999999999999964 8999999999987654
Q ss_pred CCceeeccCCCCCccccCccccccc---------CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRN---------FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKR 203 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~---------~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~ 203 (291)
...........+++.|+|||.+.+. ...++.++||||||+++|+|++|..||....... . .
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-------~---~ 248 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------S---K 248 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------H---H
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-------H---H
Confidence 4333223445689999999998651 1367889999999999999999999886432210 0 0
Q ss_pred hhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 204 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
. ............+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 249 ~---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 249 L---HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp H---HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H---HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 0 00001111111112235678899999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=277.17 Aligned_cols=224 Identities=23% Similarity=0.295 Sum_probs=170.5
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------------ceeecCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------------GFCFEGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------------~~~~~~~~~~ 47 (291)
+.+.+.||+|+||.||+|.+.. ++.||||++.... +++ .....+
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 90 (322)
T 2ycf_A 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYY 90 (322)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred eeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE-cCCceE
Confidence 4567899999999999998754 8999999986421 233 334588
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCc---eEEecc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC---PKISDF 124 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~---~kl~Df 124 (291)
+||||+.+++|.+++... ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++. ++|+||
T Consensus 91 lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 91 IVLELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp EEEECCTTEETHHHHSTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred EEEecCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 999999999999998543 579999999999999999999999 99999999999999987664 999999
Q ss_pred CCccccCCCCceeeccCCCCCccccCcccccc-cCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhh
Q 022826 125 GLAKICHGRESIVSMTGARGTVGYIAPEVFCR-NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKR 203 (291)
Q Consensus 125 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~ 203 (291)
|++........ .....+++.|+|||.+.+ ....++.++||||||+++|+|++|..||........ ... .
T Consensus 162 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~----~ 231 (322)
T 2ycf_A 162 GHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---LKD----Q 231 (322)
T ss_dssp TTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC---HHH----H
T ss_pred ccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH---HHH----H
Confidence 99986543321 123457899999999753 124788999999999999999999999875433211 000 0
Q ss_pred hhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 204 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. ... ...........++..+.+++.+||+.||++|||+.++++
T Consensus 232 ~-~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 232 I-TSG---KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp H-HHT---CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred H-HhC---ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0 000 001111122345678999999999999999999999884
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=293.24 Aligned_cols=221 Identities=26% Similarity=0.340 Sum_probs=176.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|++. +++.||||++.... +++......++|+||
T Consensus 28 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 107 (484)
T 3nyv_A 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 107 (484)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 345688999999999999886 59999999986432 566677888999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE---cCCCceEEeccCCccc
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKI 129 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill---~~~~~~kl~Dfg~~~~ 129 (291)
+.+++|.+++... ..+++..++.++.||+.||.|||+ .+|+|+||||+||++ +.++.+||+|||++..
T Consensus 108 ~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 108 YTGGELFDEIISR------KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp CCSCBHHHHHHTC------SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999998654 579999999999999999999999 999999999999999 5678999999999987
Q ss_pred cCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 130 CHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
...... .....+|+.|+|||++.+ .++.++|||||||++|+|++|..||...... .......
T Consensus 179 ~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~---- 240 (484)
T 3nyv_A 179 FEASKK---MKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEY--------DILKKVE---- 240 (484)
T ss_dssp BCCCCS---HHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHH----
T ss_pred cccccc---cccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHH----
Confidence 654332 233457999999999865 5889999999999999999999998754211 0111110
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.............++..+.+|+.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 241 KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00111112233456778999999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=290.55 Aligned_cols=221 Identities=27% Similarity=0.334 Sum_probs=173.8
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc---------------------------------------ceeec
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK---------------------------------------GFCFE 42 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---------------------------------------~~~~~ 42 (291)
+.+.++||+|+||.||+|.+.. ++.||+|++.... +++..
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 117 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4467899999999999998864 8999999986421 56667
Q ss_pred CCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC---ce
Q 022826 43 GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF---CP 119 (291)
Q Consensus 43 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~---~~ 119 (291)
....++|||||.+|+|.+++... ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++ .+
T Consensus 118 ~~~~~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 118 KKYFYLVTEFYEGGELFEQIINR------HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSE
T ss_pred CCEEEEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccE
Confidence 78889999999999999999765 479999999999999999999999 9999999999999998776 69
Q ss_pred EEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhh
Q 022826 120 KISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHW 199 (291)
Q Consensus 120 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~ 199 (291)
||+|||++........ .....+|+.|+|||++.+ .++.++|||||||++|+|++|..||...... .
T Consensus 189 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~ 254 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--------D 254 (504)
T ss_dssp EECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------H
T ss_pred EEEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--------H
Confidence 9999999987654432 244568999999999864 6889999999999999999999998754211 0
Q ss_pred hhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 200 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
...... . ............++..+.+|+.+||+.||.+|||+.|+++
T Consensus 255 ~~~~i~---~-~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 255 IIKKVE---K-GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHH---H-CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHH---c-CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 011110 0 0011111122345778999999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=272.50 Aligned_cols=218 Identities=23% Similarity=0.327 Sum_probs=170.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +++......++||||
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 92 (289)
T 1x8b_A 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEY 92 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEe
Confidence 345689999999999999886 59999999987542 566677888999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC----------------
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED---------------- 116 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~---------------- 116 (291)
+.+++|.+++.... .....+++..++.++.||+.||.|||+ .+++|+||||+||+++.+
T Consensus 93 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 93 CNGGSLADAISENY--RIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp CTTCBHHHHHHHHH--HHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC------------------
T ss_pred cCCCcHHHHHHhhc--ccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999999997642 122578999999999999999999999 999999999999999844
Q ss_pred ---CceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcc
Q 022826 117 ---FCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSE 193 (291)
Q Consensus 117 ---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~ 193 (291)
..++|+|||++....... ...+++.|+|||.+.+. ..++.++||||||+++|+|++|..++.....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred CCceEEEEcccccccccCCcc------ccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 479999999988654332 23479999999998764 3667899999999999999988866532210
Q ss_pred ccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 194 IYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.... ..-..+ ..+..++..+.+++.+||+.||++|||+.++++
T Consensus 237 -------~~~~---~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 -------WHEI---RQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -------HHHH---HTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------HHHH---HcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 0000 000111 112235667899999999999999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=278.22 Aligned_cols=237 Identities=22% Similarity=0.310 Sum_probs=171.1
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeec--------CCc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFE--------GHR 45 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~--------~~~ 45 (291)
+.+.+.||+|+||.||+|++. +++.||+|++.... +++.. ...
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (351)
T 3mi9_A 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 98 (351)
T ss_dssp EEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CE
T ss_pred eeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCce
Confidence 456789999999999999884 59999999985443 22222 456
Q ss_pred ceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccC
Q 022826 46 RALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 46 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
.++||||+.+ +|.+.+... ...+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||
T Consensus 99 ~~lv~e~~~~-~l~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 99 IYLVFDFCEH-DLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp EEEEEECCSE-EHHHHHHCT-----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEeccCC-CHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 7899999976 888877553 2579999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCc--eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccc---------
Q 022826 126 LAKICHGRES--IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEI--------- 194 (291)
Q Consensus 126 ~~~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~--------- 194 (291)
++........ ........+|+.|+|||++.+. ..++.++|||||||++|+|++|..||..........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9987643221 1223445679999999998764 367999999999999999999999887542211000
Q ss_pred ---cchhhhhhhhhhhhhhcc-cCCCChhhH-----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 195 ---YFPHWVYKRLELEEDLGL-QGIENEEDK-----EYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 195 ---~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
.++.... ......... ......... ..+..+.+|+.+||+.||++|||+.|+++-
T Consensus 249 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDN--YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGG--CGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Chhhcccccc--chhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000000 000000000 000000111 124568899999999999999999999873
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=284.63 Aligned_cols=232 Identities=26% Similarity=0.288 Sum_probs=172.9
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc---------------------------------ceee----cCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK---------------------------------GFCF----EGH 44 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---------------------------------~~~~----~~~ 44 (291)
+.+.+.||+|+||.||+|++.. ++.||||++.... +.+. ...
T Consensus 39 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~ 118 (397)
T 1wak_A 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGT 118 (397)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEE
T ss_pred EEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCc
Confidence 4567899999999999998754 8899999987542 1111 455
Q ss_pred cceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCC-CeeeeccCCCceEEcCCC------
Q 022826 45 RRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT-RILHFDIKPHNILLDEDF------ 117 (291)
Q Consensus 45 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~ivH~dikp~Nill~~~~------ 117 (291)
..++||||+ +++|.+.+... ....+++..++.++.||+.||.|||+ + +|+|+||||+||+++.++
T Consensus 119 ~~~lv~e~~-~~~l~~~~~~~----~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 119 HICMVFEVL-GHHLLKWIIKS----NYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EEEEEECCC-CCBHHHHHHHT----TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred eEEEEEecc-CccHHHHHHhc----ccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhh
Confidence 788999999 55777776553 23579999999999999999999999 8 999999999999998775
Q ss_pred -------------------------------------------ceEEeccCCccccCCCCceeeccCCCCCccccCcccc
Q 022826 118 -------------------------------------------CPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF 154 (291)
Q Consensus 118 -------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l 154 (291)
.++|+|||++...... .....+|+.|+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence 7999999999865432 2344679999999999
Q ss_pred cccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhh----------h---------cccC-
Q 022826 155 CRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEED----------L---------GLQG- 214 (291)
Q Consensus 155 ~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~---------~~~~- 214 (291)
.+. .++.++|||||||++|+|++|..||............... ......... . ....
T Consensus 266 ~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 266 IGS--GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI-ALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHH-HHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred cCC--CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHH-HHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 876 7899999999999999999999999765433211000000 000000000 0 0000
Q ss_pred -------------CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 215 -------------IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 215 -------------~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.........+..+.+|+.+||+.||++|||+.|+++
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001124567788999999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=290.18 Aligned_cols=167 Identities=26% Similarity=0.356 Sum_probs=125.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------cee-----ecCCccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFC-----FEGHRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~-----~~~~~~~l 48 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +++ ......|+
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 134 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134 (458)
T ss_dssp EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence 456789999999999999875 49999999986532 222 22356899
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
|||++. ++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 135 v~e~~~-~~L~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 135 VLEIAD-SDFKKLFRTP------VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EECCCS-EEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEeccc-cchhhhcccC------CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccch
Confidence 999985 5999998653 579999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCce-------------------------eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCC
Q 022826 129 ICHGRESI-------------------------VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGV 180 (291)
Q Consensus 129 ~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g 180 (291)
........ .......+|+.|+|||++.+. ..++.++|||||||++|+|++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHh
Confidence 76422110 112344679999999987443 3789999999999999999984
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=278.01 Aligned_cols=230 Identities=24% Similarity=0.278 Sum_probs=172.3
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-------------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||.||+|.+.. ++.||||++.... +++......++||
T Consensus 12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 91 (346)
T 1ua2_A 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 91 (346)
T ss_dssp -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEE
Confidence 4567899999999999998754 8999999986421 4556677889999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
||+.+ +|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 92 e~~~~-~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 92 DFMET-DLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp ECCSE-EHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EcCCC-CHHHHHHhc-----CcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 99986 898888653 2568889999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
..... ......+|+.|+|||.+.+. ..++.++|||||||++|+|++|..+|........ ...........
T Consensus 163 ~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~-------~~~i~~~~~~~ 232 (346)
T 1ua2_A 163 GSPNR--AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-------LTRIFETLGTP 232 (346)
T ss_dssp TSCCC--CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHHHCCC
T ss_pred cCCcc--cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHHHcCCC
Confidence 43322 22345679999999998764 3578999999999999999999887765422100 00000000000
Q ss_pred ---------------cccCCCC----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 022826 211 ---------------GLQGIEN----EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251 (291)
Q Consensus 211 ---------------~~~~~~~----~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~ 251 (291)
....... .....++..+.+|+.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000 0112345789999999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=302.00 Aligned_cols=226 Identities=27% Similarity=0.415 Sum_probs=174.5
Q ss_pred cccccCCceeEEEEEec---CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLL---DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.||+|+||.||+|.+. .++.||||+++... +++ .....++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-ecCCEEEEEEccCC
Confidence 47999999999999653 36789999997532 344 34567899999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
|+|.+++... ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||+++.......
T Consensus 454 g~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 454 GPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 9999999654 578999999999999999999999 9999999999999999999999999999987654332
Q ss_pred e-eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 136 I-VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 136 ~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
. .......+++.|+|||++.+. .++.++|||||||++|+|++ |..||...... ....... .
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~-------~ 587 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLE-------K 587 (635)
T ss_dssp ----------CGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHH-------T
T ss_pred ccccccCCCCceeeeChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHH-------c
Confidence 1 112333457889999999776 78999999999999999998 88888654221 0111111 0
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccC
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSL 259 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~ 259 (291)
......+..++..+.+|+.+||+.||++||++.++++.|+++...+
T Consensus 588 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 588 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1111223346678999999999999999999999999999887654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=284.43 Aligned_cols=233 Identities=22% Similarity=0.343 Sum_probs=175.1
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||++.+. +++.||+|++.... +++..+...++||||+.
T Consensus 35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 114 (360)
T 3eqc_A 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 114 (360)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred ceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCC
Confidence 345688999999999999886 48999999987542 56667788999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCC-CeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT-RILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
+++|.+++... ..+++..+..++.|++.||.|||+ . +++|+||||+||+++.++.++|+|||++......
T Consensus 115 ~~~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 115 GGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp TCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999765 478999999999999999999998 7 8999999999999999999999999998654221
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchh---------------
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPH--------------- 198 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~--------------- 198 (291)
. .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||...........+..
T Consensus 186 ~----~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 186 M----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp C--------CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred c----ccCCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 1 2334679999999999876 789999999999999999999999875422110000000
Q ss_pred -------h-----h-hhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 199 -------W-----V-YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 199 -------~-----~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. . .........+............++..+.+|+.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0 0 00000000000011111112235667999999999999999999999886
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=271.57 Aligned_cols=223 Identities=27% Similarity=0.355 Sum_probs=173.1
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCCCHH
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNGSLE 59 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g~L~ 59 (291)
..||+|+||.||+|.+. +++.||+|++.... +.+......++||||+.+++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 38999999999999875 48999999987543 5666677889999999999999
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC-CCceEEeccCCccccCCCCceee
Q 022826 60 KFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-DFCPKISDFGLAKICHGRESIVS 138 (291)
Q Consensus 60 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~ 138 (291)
+++.... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++. ++.++|+|||++........ .
T Consensus 108 ~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~ 179 (295)
T 2clq_A 108 ALLRSKW---GPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--C 179 (295)
T ss_dssp HHHHHTT---CCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred HHHHhhc---cCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--c
Confidence 9997652 23467899999999999999999999 99999999999999987 89999999999876543221 1
Q ss_pred ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCCh
Q 022826 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 218 (291)
Q Consensus 139 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (291)
.....+++.|+|||.+.+....++.++||||||+++|+|++|..||....... ..... ..... ....
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~---~~~~~---~~~~ 246 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-------AAMFK---VGMFK---VHPE 246 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-------HHHHH---HHHHC---CCCC
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-------HHHHh---hcccc---cccc
Confidence 23456789999999997653357899999999999999999999886432110 00000 00001 1111
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 219 EDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 219 ~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.+..++..+.+++.+||+.||++|||+.++++
T Consensus 247 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 247 IPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22345678899999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=278.44 Aligned_cols=228 Identities=25% Similarity=0.316 Sum_probs=167.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +++..+...++||||+
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 115 (329)
T 3gbz_A 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA 115 (329)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecC
Confidence 456789999999999999875 58999999986443 5666778889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc-----CCCceEEeccCCcc
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD-----EDFCPKISDFGLAK 128 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~-----~~~~~kl~Dfg~~~ 128 (291)
.+ +|.+++... ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++ .++.+||+|||++.
T Consensus 116 ~~-~L~~~~~~~------~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 116 EN-DLKKYMDKN------PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp SE-EHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred CC-CHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 85 999999764 469999999999999999999999 9999999999999994 45569999999998
Q ss_pred ccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhh
Q 022826 129 ICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEE 208 (291)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (291)
....... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|..||........ .........
T Consensus 186 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~~~~~~~ 255 (329)
T 3gbz_A 186 AFGIPIR--QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ-------LFKIFEVLG 255 (329)
T ss_dssp HHC-------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHHHC
T ss_pred ccCCccc--ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH-------HHHHHHHhC
Confidence 6543221 12334568999999999764 3589999999999999999999999865432110 000000000
Q ss_pred hh----------------cccCCCC-----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 209 DL----------------GLQGIEN-----EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 209 ~~----------------~~~~~~~-----~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. ..+.... .....++..+.+|+.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 0000000 011124577899999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=288.57 Aligned_cols=218 Identities=14% Similarity=0.157 Sum_probs=162.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------------------ceeec
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------------------GFCFE 42 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------------------~~~~~ 42 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +++..
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~ 154 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence 345689999999999999874 59999999986321 01111
Q ss_pred CC-----------------cceeeehhhcCCCHHHHHhhcCCCCC-CCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeee
Q 022826 43 GH-----------------RRALIYEFVSNGSLEKFIYEKHPLET-NQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHF 104 (291)
Q Consensus 43 ~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~ 104 (291)
.. ..+++|||+ +|+|.+++.....+.. ...+++..++.++.||+.||.|||+ .+|+|+
T Consensus 155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHr 230 (377)
T 3byv_A 155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHT 230 (377)
T ss_dssp TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECS
T ss_pred cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 11 378999999 5799999987532111 2344568889999999999999999 999999
Q ss_pred ccCCCceEEcCCCceEEeccCCccccCCCCceeeccCCCCCccccCccccccc---------CCCccccccchhHHHHHH
Q 022826 105 DIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN---------FGEVSYKSDVYSYGMMVF 175 (291)
Q Consensus 105 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~---------~~~~~~~~DiwslG~~l~ 175 (291)
||||+||+++.++.+||+|||++..... ......| +.|+|||++.+. ...++.++|||||||++|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 9999999999999999999999985322 1234556 999999998763 125789999999999999
Q ss_pred HHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 176 EMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 176 ~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
+|++|..||.......... . + ... ...++..+.+|+.+||+.||++|||+.++++
T Consensus 305 elltg~~Pf~~~~~~~~~~---~-----------~-~~~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSE---W-----------I-FRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHSSCCC------CCSG---G-----------G-GSS-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHCCCCCcccccccchh---h-----------h-hhh-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999986543221100 0 0 000 0224567889999999999999999999886
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=271.98 Aligned_cols=230 Identities=23% Similarity=0.362 Sum_probs=168.6
Q ss_pred chhhcccccCCceeEEEEEec--CCC--eEEEEEeccCc-----------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL--DGR--NVAIKVLNETK-----------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~-----------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|.+. +++ .||+|+++... +++. ....++|
T Consensus 20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~v 98 (291)
T 1u46_A 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMV 98 (291)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc-cCCceee
Confidence 456789999999999999753 233 68999987532 3333 3347899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
+||+.+++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++..
T Consensus 99 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 99 TELAPLGSLLDRLRKH-----QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EECCTTCBHHHHHHHH-----GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EecccCCCHHHHHHhc-----cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 9999999999999764 2568999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcee-eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhh
Q 022826 130 CHGRESIV-SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 130 ~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
........ ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||...... . ..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~-~~------ 234 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------Q-IL------ 234 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------H-HH------
T ss_pred ccccccchhhhccCCCCceeeCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-------H-HH------
Confidence 65443322 22334567789999999775 78899999999999999999 88887643210 0 00
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
..+............++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 235 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 01111111112223466789999999999999999999999999988643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=288.73 Aligned_cols=231 Identities=24% Similarity=0.204 Sum_probs=164.8
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeec------CCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFE------GHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~------~~~~~ 47 (291)
+.+.+.||+|+||.||+|.+.. ++.||||++.... +++.. ....+
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 143 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 143 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence 3456889999999999998754 8999999997532 22222 23569
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+||||+.+ +|.+.+. ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 144 lv~E~~~~-~l~~~~~--------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 144 LVMELMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEECCSE-EHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred EEEeCCCC-CHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 99999976 5766663 248999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc--------chhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY--------FPHW 199 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~--------~~~~ 199 (291)
+...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||........... .+..
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eecCCCc---ccCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 8654332 22445679999999999876 789999999999999999999999975432110000 0000
Q ss_pred hhhhhhhhh-hhc-c----------------cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 200 VYKRLELEE-DLG-L----------------QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 200 ~~~~~~~~~-~~~-~----------------~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......... ... . ...........+..+.+|+.+||+.||++|||+.|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 000 0 00111222334778999999999999999999999886
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=276.72 Aligned_cols=233 Identities=21% Similarity=0.292 Sum_probs=171.1
Q ss_pred chhhcccccCCceeEEEEEecC-C-CeEEEEEeccCc-------------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-G-RNVAIKVLNETK-------------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~-~~vavK~~~~~~-------------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|.+.. + +.||+|+++... .++......++|
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv 100 (355)
T 2eu9_A 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIA 100 (355)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred EEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEE
Confidence 4567899999999999998753 4 689999987532 344556788899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE----------------
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---------------- 113 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill---------------- 113 (291)
|||+ +++|.+++... ....+++..++.++.||+.||.|||+ .+|+|+||||+||++
T Consensus 101 ~e~~-~~~l~~~l~~~----~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 101 FELL-GKNTFEFLKEN----NFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EECC-CCBHHHHHHHT----TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred Eecc-CCChHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccccc
Confidence 9999 56887777654 23579999999999999999999999 999999999999999
Q ss_pred ---cCCCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCC
Q 022826 114 ---DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDR 190 (291)
Q Consensus 114 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~ 190 (291)
+.++.++|+|||++....... ....+|+.|+|||++.+. .++.++||||||+++|+|++|..||......
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 567899999999997643322 345679999999999875 7899999999999999999999998754321
Q ss_pred Cccccc-------hhhhhhhhhhhh-----hhccc----------------CCCChhhHHHHHHHHHHHHHhhhcCCCCC
Q 022826 191 SSEIYF-------PHWVYKRLELEE-----DLGLQ----------------GIENEEDKEYARKMILVSLWCIQNNPSDR 242 (291)
Q Consensus 191 ~~~~~~-------~~~~~~~~~~~~-----~~~~~----------------~~~~~~~~~~~~~l~~l~~~~l~~dP~~R 242 (291)
...... +........... ..... ..........+..+.+|+.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 100000 000000000000 00000 00001122346689999999999999999
Q ss_pred CCHHHHHH
Q 022826 243 PAMNRVVE 250 (291)
Q Consensus 243 ps~~ell~ 250 (291)
||+.|+++
T Consensus 326 pt~~e~l~ 333 (355)
T 2eu9_A 326 ITLAEALL 333 (355)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=269.63 Aligned_cols=224 Identities=21% Similarity=0.291 Sum_probs=176.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------------------ceeecCCc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------------------GFCFEGHR 45 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------------------~~~~~~~~ 45 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +++.....
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (298)
T 1phk_A 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 98 (298)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred cceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCe
Confidence 456789999999999999885 48999999985421 45666778
Q ss_pred ceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccC
Q 022826 46 RALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 46 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
.++||||+.+++|.+++... ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||
T Consensus 99 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 99 FFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp EEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEeccCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEeccc
Confidence 89999999999999999765 478999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccc----cCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCR----NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVY 201 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~----~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~ 201 (291)
++........ .....+++.|+|||.+.+ ....++.++||||||+++|+|++|..||..... ....
T Consensus 170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~ 238 (298)
T 1phk_A 170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLML 238 (298)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH
T ss_pred chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--------HHHH
Confidence 9987654332 234567999999999853 123678899999999999999999998864321 0000
Q ss_pred hhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 202 KRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
... .... ..........++..+.+++.+||+.||++|||+.++++
T Consensus 239 ~~~-~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 RMI-MSGN---YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHH-HHTC---CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHH-hcCC---cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 000 0000 11111222356778999999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=281.14 Aligned_cols=236 Identities=26% Similarity=0.372 Sum_probs=171.5
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|++.. ++.||+|++.... +++......++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 106 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred heeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecC
Confidence 3456899999999999998865 9999999985443 5667778889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+++|.+++... ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 107 ~~~~l~~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 107 DHTILDDLELFP------NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp SEEHHHHHHHST------TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred CcchHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 998888886543 579999999999999999999999 99999999999999999999999999999765432
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc--------hhhh--hhh
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF--------PHWV--YKR 203 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~--------~~~~--~~~ 203 (291)
.. ......+++.|+|||.+.+. ..++.++||||||+++|+|++|..||............ +... ...
T Consensus 178 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 178 GE--VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp --------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cc--ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 22 12345678999999998764 36789999999999999999999988754321100000 0000 000
Q ss_pred hhhhhhhcccCCC-----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 204 LELEEDLGLQGIE-----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 204 ~~~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.........+... ......++..+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000000 0111245778999999999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=274.77 Aligned_cols=225 Identities=29% Similarity=0.416 Sum_probs=167.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeec------CCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFE------GHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~------~~~~~lv 49 (291)
+.+.+.||+|+||.||+|++. +++.||||++.... +++.. ....++|
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv 105 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 105 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEE
Confidence 356789999999999999875 59999999986542 23322 4578999
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
|||+.+++|.+++... ....+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++..
T Consensus 106 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 106 MEFCGAGSVTDLIKNT----KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp EECCTTEEHHHHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred EEcCCCCcHHHHHHhc----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 9999999999999764 33578999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCceeeccCCCCCccccCccccccc---CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh
Q 022826 130 CHGRESIVSMTGARGTVGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
...... ......+++.|+|||.+.+. ...++.++||||||+++|+|++|..||...... . . ...
T Consensus 179 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~-~---~~~ 245 (326)
T 2x7f_A 179 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------R-A---LFL 245 (326)
T ss_dssp --------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------H-H---HHH
T ss_pred cCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------H-H---HHH
Confidence 543221 12334578999999998632 236889999999999999999999988543210 0 0 000
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
... ..........++..+.+++.+||..||.+||++.++++
T Consensus 246 ~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 246 IPR---NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHH---SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhc---CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000 01111112335667899999999999999999999987
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=273.47 Aligned_cols=227 Identities=22% Similarity=0.331 Sum_probs=174.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------cee--ecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFC--FEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~--~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||++++. +++.||+|++.... +.+ ......++|||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 87 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence 456789999999999999875 48999999987532 222 34567899999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCC-----eeeeccCCCceEEcCCCceEEeccCC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR-----ILHFDIKPHNILLDEDFCPKISDFGL 126 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~-----ivH~dikp~Nill~~~~~~kl~Dfg~ 126 (291)
|+.+++|.+++.... .....+++..++.++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||+
T Consensus 88 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 88 YCEGGDLASVITKGT--KERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp CCTTEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred CCCCCCHHHHHHhhc--ccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999997642 123459999999999999999999999 88 99999999999999999999999999
Q ss_pred ccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh
Q 022826 127 AKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
+......... .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||..... ........
T Consensus 163 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~i~- 229 (279)
T 2w5a_A 163 ARILNHDTSF--AKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIR- 229 (279)
T ss_dssp HHHC---CHH--HHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-
T ss_pred heeecccccc--ccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCH--------HHHHHHHh-
Confidence 8765433211 1223568999999999875 788999999999999999999988865421 00011110
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
.-.. ...+..++..+.+++.+||+.||++|||+.|+++.+.
T Consensus 230 --~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 230 --EGKF----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp --HTCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred --hccc----ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 0011 1122345678999999999999999999999987653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=268.11 Aligned_cols=219 Identities=25% Similarity=0.419 Sum_probs=167.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +.+......++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence 456789999999999999886 59999999986432 556667888999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 93 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 93 VSGGELFDYICKH------GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp CCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred cCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999765 468999999999999999999999 9999999999999999999999999999887544
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... .....+++.|+|||.+.+. ...+.++||||||+++|+|++|..||..... .. ...... . ..
T Consensus 164 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~-~~~~~~-~---~~ 227 (276)
T 2h6d_A 164 GEF---LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------PT-LFKKIR-G---GV 227 (276)
T ss_dssp ----------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHH-H---CC
T ss_pred Ccc---eecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HH-HHHHhh-c---Cc
Confidence 321 2334578999999999765 2347899999999999999999998864311 00 011100 0 00
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. ..+..++..+.+++.+||+.||++|||+.++++
T Consensus 228 ~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 228 F----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1 112234567889999999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=275.65 Aligned_cols=231 Identities=25% Similarity=0.252 Sum_probs=164.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecC------Ccce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEG------HRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~------~~~~ 47 (291)
+.+.+.||+|+||.||+|.+. +|+.||||++.... +++... ...+
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence 456688999999999999875 49999999985432 222222 3458
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++
T Consensus 107 lv~e~~-~~~L~~~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp EEEECC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 999999 7799999864 368999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc-------chhhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY-------FPHWV 200 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~-------~~~~~ 200 (291)
+..... .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||........... .+...
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 865432 2345679999999998763 3789999999999999999999999875432110000 00000
Q ss_pred hhhh------hhhhhhc-cc-CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 201 YKRL------ELEEDLG-LQ-GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 201 ~~~~------~~~~~~~-~~-~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.... .....+. .. ..........+..+.+|+.+||..||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000 0000000 00 0001112234677899999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=274.36 Aligned_cols=232 Identities=23% Similarity=0.313 Sum_probs=169.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------------------ceeec---
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------------------GFCFE--- 42 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------------------~~~~~--- 42 (291)
+.+.+.||+|+||.||+|++. +++.||||++.... +++..
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 100 (373)
T 1q8y_A 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 100 (373)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred EEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCC
Confidence 456789999999999999874 58999999987432 11221
Q ss_pred -CCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCC-CeeeeccCCCceEEc------
Q 022826 43 -GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT-RILHFDIKPHNILLD------ 114 (291)
Q Consensus 43 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~ivH~dikp~Nill~------ 114 (291)
....+++||++ +++|.+++... ....+++..++.++.||+.||.|||+ . +|+|+||||+||+++
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 101 NGVHVVMVFEVL-GENLLALIKKY----EHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp TEEEEEEEECCC-CEEHHHHHHHT----TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTT
T ss_pred CCceEEEEEecC-CCCHHHHHHHh----hccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCc
Confidence 22678999999 78999999764 23569999999999999999999999 8 999999999999994
Q ss_pred CCCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccc
Q 022826 115 EDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEI 194 (291)
Q Consensus 115 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~ 194 (291)
..+.++|+|||++...... .....+|+.|+|||++.+. .++.++||||||+++|+|++|..||..........
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4448999999999765432 2334679999999999876 78999999999999999999999987554321100
Q ss_pred cchhhhhhhhhhhhh---------------hc-------cc-----------CCCChhhHHHHHHHHHHHHHhhhcCCCC
Q 022826 195 YFPHWVYKRLELEED---------------LG-------LQ-----------GIENEEDKEYARKMILVSLWCIQNNPSD 241 (291)
Q Consensus 195 ~~~~~~~~~~~~~~~---------------~~-------~~-----------~~~~~~~~~~~~~l~~l~~~~l~~dP~~ 241 (291)
.... .......... .. .. ......+...+..+.+|+.+||+.||++
T Consensus 246 ~~~~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 246 DDDH-IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp HHHH-HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred hHHH-HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 0000 0000000000 00 00 0001123567889999999999999999
Q ss_pred CCCHHHHHH
Q 022826 242 RPAMNRVVE 250 (291)
Q Consensus 242 Rps~~ell~ 250 (291)
|||+.|+++
T Consensus 325 Rpt~~ell~ 333 (373)
T 1q8y_A 325 RADAGGLVN 333 (373)
T ss_dssp CBCHHHHHT
T ss_pred cCCHHHHhh
Confidence 999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=273.01 Aligned_cols=237 Identities=24% Similarity=0.326 Sum_probs=166.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +.+......++||||+.
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 96 (303)
T 2vwi_A 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS 96 (303)
T ss_dssp CEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCT
T ss_pred hhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhcc
Confidence 456799999999999999865 58999999886432 45566778899999999
Q ss_pred CCCHHHHHhhcCC--CCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 55 NGSLEKFIYEKHP--LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 55 ~g~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+++|.+++..... ......+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 173 (303)
T 2vwi_A 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173 (303)
T ss_dssp TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence 9999999875211 1123569999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCce---eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh-h
Q 022826 133 RESI---VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE-E 208 (291)
Q Consensus 133 ~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 208 (291)
.... .......+++.|+|||.+.+. ..++.++||||||+++|+|++|..||........ ........ .
T Consensus 174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~ 245 (303)
T 2vwi_A 174 GGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-------LMLTLQNDPP 245 (303)
T ss_dssp --------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-------HHHHHTSSCC
T ss_pred CCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-------HHHHhccCCC
Confidence 2211 112334578999999998652 2678999999999999999999998865432110 00000000 0
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..............++..+.+++.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000000000111234567899999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=283.63 Aligned_cols=238 Identities=21% Similarity=0.259 Sum_probs=168.7
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc----------------------ceeec------CCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------GFCFE------GHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------~~~~~------~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||.||+|++..+..+|+|++.... +++.. ....++||||+.
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~ 121 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCS
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccC
Confidence 55678999999999999998776678888876543 22221 223779999998
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc-CCCceEEeccCCccccCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD-EDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~ 133 (291)
+ ++...+.... .....+++..++.++.||+.||.|||+ .+|+||||||+||+++ .++.+||+|||+++.....
T Consensus 122 ~-~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 122 E-TVYRASRHYA--KLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp E-EHHHHHHHHH--HTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred c-cHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 7 4444433211 134689999999999999999999999 9999999999999998 7999999999999876443
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhh----hhh-hhhh
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVY----KRL-ELEE 208 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~----~~~-~~~~ 208 (291)
... ....+|+.|+|||++.+. ..++.++|||||||++|+|++|..||................. ... ....
T Consensus 196 ~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 196 EPN---VSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp CCC---CSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred CCC---cccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 322 334578999999998764 3689999999999999999999999876432110000000000 000 0000
Q ss_pred hh---cccCCCC-----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 209 DL---GLQGIEN-----EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 209 ~~---~~~~~~~-----~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. ..+.... ......+..+.+|+.+||+.||.+|||+.|+++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00 0000000 011225568999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=280.74 Aligned_cols=238 Identities=19% Similarity=0.214 Sum_probs=170.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------cee-------------------
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------GFC------------------- 40 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------~~~------------------- 40 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +++
T Consensus 9 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (383)
T 3eb0_A 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNK 88 (383)
T ss_dssp EEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC----------------
T ss_pred EEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccccccc
Confidence 556799999999999999874 59999999986553 222
Q ss_pred -------------------ecCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCe
Q 022826 41 -------------------FEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRI 101 (291)
Q Consensus 41 -------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~i 101 (291)
......++||||+.+ +|.+.+.... .....+++..++.++.||+.||.|||+ .+|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~---~gi 162 (383)
T 3eb0_A 89 LGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFI--RSGRSIPMNLISIYIYQLFRAVGFIHS---LGI 162 (383)
T ss_dssp ---------------------CCEEEEEECCCSE-EHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHT---TTE
T ss_pred ccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH---CcC
Confidence 223347899999985 8887776421 134689999999999999999999999 999
Q ss_pred eeeccCCCceEEc-CCCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCC
Q 022826 102 LHFDIKPHNILLD-EDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGV 180 (291)
Q Consensus 102 vH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g 180 (291)
+|+||||+||+++ .++.+||+|||++........ .....+++.|+|||.+.+. ..++.++|||||||++|+|++|
T Consensus 163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g 238 (383)
T 3eb0_A 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGELILG 238 (383)
T ss_dssp ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHS
T ss_pred ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHHHHhC
Confidence 9999999999997 688999999999987644332 2334568999999998764 3589999999999999999999
Q ss_pred CCCCccccCCCccccchhhhh-hhhhhh-------hhhcccCCCC-----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 022826 181 KNNANVAVDRSSEIYFPHWVY-KRLELE-------EDLGLQGIEN-----EEDKEYARKMILVSLWCIQNNPSDRPAMNR 247 (291)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~-------~~~~~~~~~~-----~~~~~~~~~l~~l~~~~l~~dP~~Rps~~e 247 (291)
..||................. ...... .....+.... ..+...+..+.+|+.+||+.||.+|||+.|
T Consensus 239 ~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 318 (383)
T 3eb0_A 239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE 318 (383)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 999875432110000000000 000000 0000000000 012235667899999999999999999999
Q ss_pred HHH
Q 022826 248 VVE 250 (291)
Q Consensus 248 ll~ 250 (291)
+++
T Consensus 319 ~l~ 321 (383)
T 3eb0_A 319 AMA 321 (383)
T ss_dssp HHT
T ss_pred Hhc
Confidence 984
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=272.37 Aligned_cols=225 Identities=22% Similarity=0.342 Sum_probs=170.4
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||+|+||.||+|.+.. ++.||+|++.... +.+......++||||+.+
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG 100 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence 4567889999999999998864 8999999986543 556667788999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 101 ~~l~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 101 GAVDAIMLELD-----RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred CcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 99999987642 579999999999999999999999 999999999999999999999999999875322110
Q ss_pred eeeccCCCCCccccCcccccc---cCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 136 IVSMTGARGTVGYIAPEVFCR---NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~---~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
.......+++.|+|||.+.. ....++.++||||||+++|+|++|..|+...... ..... .. ..
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~---~~--~~ 237 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLK---IA--KS 237 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHH---HH--HS
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--------HHHHH---Hh--cc
Confidence 01123457899999999842 1236789999999999999999999888653210 00000 00 01
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.......+..++..+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 238 DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11111223446678999999999999999999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=274.81 Aligned_cols=212 Identities=25% Similarity=0.348 Sum_probs=171.5
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------------ceeecCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------------GFCFEGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------------~~~~~~~~~~ 47 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +++......+
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~ 124 (320)
T 3a99_A 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 124 (320)
T ss_dssp EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEE
Confidence 456789999999999999875 58999999986532 4455567788
Q ss_pred eeehhhcC-CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc-CCCceEEeccC
Q 022826 48 LIYEFVSN-GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD-EDFCPKISDFG 125 (291)
Q Consensus 48 lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~-~~~~~kl~Dfg 125 (291)
+|+|++.+ ++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++ .++.+||+|||
T Consensus 125 lv~e~~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 125 LILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEcCCCCccHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999976 8999999765 478999999999999999999999 9999999999999998 78999999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLE 205 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (291)
++....... .....+++.|+|||.+.+. ...+.++||||||+++|+|++|..||......
T Consensus 196 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------------- 255 (320)
T 3a99_A 196 SGALLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------------- 255 (320)
T ss_dssp TCEECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---------------
T ss_pred ccccccccc----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhhh---------------
Confidence 998765332 2345679999999998765 24478999999999999999999988643110
Q ss_pred hhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 LEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..... .....++..+.+++.+||+.||++|||+.++++
T Consensus 256 ~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 IRGQV-------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHCCC-------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hcccc-------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 011224567889999999999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=279.32 Aligned_cols=240 Identities=21% Similarity=0.291 Sum_probs=157.3
Q ss_pred hcccccCCceeEEEEEec---CCCeEEEEEeccCc------------------------cee--ecCCcceeeehhhcCC
Q 022826 6 KNKLGQGGYGGVYKGKLL---DGRNVAIKVLNETK------------------------GFC--FEGHRRALIYEFVSNG 56 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~------------------------~~~--~~~~~~~lv~e~~~~g 56 (291)
+++||+|+||.||+|++. +++.||||++.... +++ ......++||||+.+
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~- 104 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 104 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-
Confidence 568999999999999865 47899999987653 333 346678999999975
Q ss_pred CHHHHHhhcCC---CCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEE----cCCCceEEeccCCccc
Q 022826 57 SLEKFIYEKHP---LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAKI 129 (291)
Q Consensus 57 ~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill----~~~~~~kl~Dfg~~~~ 129 (291)
+|.+++..... ......+++..++.++.||+.||.|||+ .+|+|+||||+||++ +.++.+||+|||++..
T Consensus 105 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 181 (405)
T 3rgf_A 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181 (405)
T ss_dssp EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-
T ss_pred CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCcee
Confidence 88888764311 1122359999999999999999999999 999999999999999 6778999999999987
Q ss_pred cCCCCc-eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc--chhhhhhhhhh
Q 022826 130 CHGRES-IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY--FPHWVYKRLEL 206 (291)
Q Consensus 130 ~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~--~~~~~~~~~~~ 206 (291)
...... ........+|+.|+|||++.+. ..++.++|||||||++|+|++|..||........... ...........
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~ 260 (405)
T 3rgf_A 182 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260 (405)
T ss_dssp ---------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHH
T ss_pred cCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHh
Confidence 653221 1223445689999999998764 3689999999999999999999999975543211000 00000000000
Q ss_pred h---------------------hhhcccCCCC-hhhH-------HHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 E---------------------EDLGLQGIEN-EEDK-------EYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~---------------------~~~~~~~~~~-~~~~-------~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. .......... .... ..+..+.+|+.+||+.||.+|||+.|+++
T Consensus 261 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 261 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 0000000000 0000 01456889999999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=274.33 Aligned_cols=231 Identities=24% Similarity=0.222 Sum_probs=162.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecC------Ccce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEG------HRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~------~~~~ 47 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +++... ...+
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 106 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 106 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence 456788999999999999875 48999999987532 222222 2679
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+||||+.+ +|.+.+. ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++
T Consensus 107 lv~e~~~~-~l~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 107 IVMELMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEECCSE-EHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred EEEEcCCC-CHHHHHh--------hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 99999975 7888874 258899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCc--------cccchhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSS--------EIYFPHW 199 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~--------~~~~~~~ 199 (291)
....... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||........ ....+..
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp ------------------CTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHH
T ss_pred ccccccc---ccCCceecCCccCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 7654322 12345679999999999875 789999999999999999999999875432100 0000000
Q ss_pred hhhhh-hh----hhhhc-------------ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 200 VYKRL-EL----EEDLG-------------LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 200 ~~~~~-~~----~~~~~-------------~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..... .. ..... ............+..+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000 00 00000 000111223445788999999999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=270.24 Aligned_cols=231 Identities=25% Similarity=0.373 Sum_probs=173.0
Q ss_pred chhhcccccCCceeEEEEEec--CCCeEEEEEeccCc-------------------------------ceee-----cCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL--DGRNVAIKVLNETK-------------------------------GFCF-----EGH 44 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-------------------------------~~~~-----~~~ 44 (291)
+.+.+.||+|+||.||+|++. +++.||+|++.... +++. ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 456789999999999999874 48899999986322 2222 456
Q ss_pred cceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEecc
Q 022826 45 RRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 124 (291)
Q Consensus 45 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Df 124 (291)
..++||||+. ++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+||
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred eEEEEEecCC-CCHHHHHHhc----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecC
Confidence 6789999998 5999999765 23469999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhh
Q 022826 125 GLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRL 204 (291)
Q Consensus 125 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~ 204 (291)
|++....... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||........ .... ....
T Consensus 165 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i-~~~~ 235 (326)
T 1blx_A 165 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKI-LDVI 235 (326)
T ss_dssp CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHH-HHHH
T ss_pred cccccccCCC---CccccccccceeCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHH-HHHc
Confidence 9987654322 23445679999999999775 789999999999999999999998875432100 0000 0000
Q ss_pred hh-------------hhhhc--ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 205 EL-------------EEDLG--LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 205 ~~-------------~~~~~--~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. ..... ...........++..+.+|+.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 00000 000001112345677899999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=266.18 Aligned_cols=225 Identities=28% Similarity=0.386 Sum_probs=164.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------cee-------------ecC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------GFC-------------FEG 43 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------~~~-------------~~~ 43 (291)
+.+.+.||+|+||.||+|++. +++.||||++.... +.+ ...
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (303)
T 1zy4_A 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKK 87 (303)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CE
T ss_pred chhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccC
Confidence 456789999999999999875 59999999986532 111 124
Q ss_pred CcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEec
Q 022826 44 HRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISD 123 (291)
Q Consensus 44 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~D 123 (291)
...++||||+.+++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 88 STLFIQMEYCENGTLYDLIHSE-----NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp EEEEEEEECCCSCBHHHHHHHS-----CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred CceEEEEecCCCCCHHHhhhcc-----ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence 5678999999999999999753 2568889999999999999999999 9999999999999999999999999
Q ss_pred cCCccccCCCCc------------eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCC
Q 022826 124 FGLAKICHGRES------------IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRS 191 (291)
Q Consensus 124 fg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~ 191 (291)
||++........ ........+++.|+|||.+.+. ..++.++||||||+++|+|++ |+.....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~-- 233 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGME-- 233 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence 999986543211 1112344578999999998754 368899999999999999997 3321110
Q ss_pred ccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 192 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. ........ .....+.......+..+.+++.+||+.||.+|||+.++++
T Consensus 234 -----~~---~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 -----RV---NILKKLRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -----HH---HHHHHHHS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----HH---HHHHhccc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 00 00000010 0111112223345567889999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=275.08 Aligned_cols=235 Identities=23% Similarity=0.238 Sum_probs=159.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------ceeecCC-------cceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------GFCFEGH-------RRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------~~~~~~~-------~~~lv 49 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +++.... ..++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv 104 (360)
T 3e3p_A 25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVV 104 (360)
T ss_dssp EEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEE
Confidence 456789999999999999885 49999999986543 2222211 27799
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhh--cCCCCCeeeeccCCCceEEcC-CCceEEeccCC
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH--RGCNTRILHFDIKPHNILLDE-DFCPKISDFGL 126 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH--~~~~~~ivH~dikp~Nill~~-~~~~kl~Dfg~ 126 (291)
|||+.+ +|...+.... .....+++..++.++.|++.||.||| + .+|+|+||||+||+++. ++.+||+|||+
T Consensus 105 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 105 MEYVPD-TLHRCCRNYY--RRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EECCSC-BHHHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eecccc-cHHHHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 999987 6655444321 23467899999999999999999999 8 99999999999999996 89999999999
Q ss_pred ccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhh----
Q 022826 127 AKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYK---- 202 (291)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~---- 202 (291)
+........ .....+|+.|+|||++.+. ..++.++|||||||++|+|++|..||........ .......
T Consensus 179 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~ 251 (360)
T 3e3p_A 179 AKKLSPSEP---NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ---LHEIVRVLGCP 251 (360)
T ss_dssp CBCCCTTSC---CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCC
T ss_pred ceecCCCCC---cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH---HHHHHHHcCCC
Confidence 987654332 2344579999999998664 3589999999999999999999998875432110 0000000
Q ss_pred hhhhhhhhc-------ccCC-C-------ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 203 RLELEEDLG-------LQGI-E-------NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 203 ~~~~~~~~~-------~~~~-~-------~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......... .... . .......+..+.+|+.+||+.||.+|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000 0000 0 0011124678999999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=294.40 Aligned_cols=229 Identities=22% Similarity=0.347 Sum_probs=175.5
Q ss_pred chhhcccccCCceeEEEEEecC----CCeEEEEEeccCc---------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD----GRNVAIKVLNETK---------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|.+.. +..||+|+++... +++ .....++|||
T Consensus 392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~lv~E 470 (656)
T 2j0j_A 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIME 470 (656)
T ss_dssp EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-ecCceEEEEE
Confidence 3456889999999999998743 4579999986532 333 3456889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+|+|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....
T Consensus 471 ~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 471 LCTLGELRSFLQVR-----KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp CCTTCBHHHHHHHT-----TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred cCCCCcHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 99999999999754 2468999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
..... ......+++.|+|||.+.+. .++.++||||||+++|+|++ |..||...... .........
T Consensus 543 ~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--------~~~~~i~~~--- 608 (656)
T 2j0j_A 543 DSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIENG--- 608 (656)
T ss_dssp C-----------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHHT---
T ss_pred CCcce-eccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHcC---
Confidence 43221 12233457899999999776 78999999999999999997 77777643211 011111100
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
.....+..++..+.+++.+||+.||++|||+.++++.|+++++.
T Consensus 609 ----~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 609 ----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 01112234567889999999999999999999999999998754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=281.87 Aligned_cols=230 Identities=23% Similarity=0.294 Sum_probs=163.8
Q ss_pred hcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------ceeecCCcceeeehhhcCCCHHHH
Q 022826 6 KNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------GFCFEGHRRALIYEFVSNGSLEKF 61 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------~~~~~~~~~~lv~e~~~~g~L~~~ 61 (291)
.+.||+|+||+||.+...+|+.||||++.... +.+..+...++||||+. |+|.++
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~ 98 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDL 98 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHH
Confidence 57899999999988766679999999986543 45566778899999996 599999
Q ss_pred HhhcCCCCCC-CCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC-------------CceEEeccCCc
Q 022826 62 IYEKHPLETN-QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-------------FCPKISDFGLA 127 (291)
Q Consensus 62 l~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~-------------~~~kl~Dfg~~ 127 (291)
+......... ...++..++.++.||+.||.|||+ .+|+|+||||+||+++.+ +.+||+|||++
T Consensus 99 l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a 175 (434)
T 2rio_A 99 VESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175 (434)
T ss_dssp HHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTC
T ss_pred HhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEcccccc
Confidence 9765321111 112334567899999999999999 999999999999999654 48999999999
Q ss_pred cccCCCCcee--eccCCCCCccccCccccccc-----CCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhh
Q 022826 128 KICHGRESIV--SMTGARGTVGYIAPEVFCRN-----FGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHW 199 (291)
Q Consensus 128 ~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~-----~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~ 199 (291)
.......... ......||+.|+|||++.+. ...++.++|||||||++|+|++ |..||.......
T Consensus 176 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-------- 247 (434)
T 2rio_A 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-------- 247 (434)
T ss_dssp EECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--------
T ss_pred eecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--------
Confidence 8765443221 12345689999999998652 2468899999999999999998 888775432110
Q ss_pred hhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 200 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
....................++..+.+++.+||+.||.+|||+.++++
T Consensus 248 ---~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ---SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 000111111122222234567889999999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=282.89 Aligned_cols=235 Identities=23% Similarity=0.272 Sum_probs=169.1
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc----------------------ceee------cCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------GFCF------EGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----------------------~~~~------~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|++.. ++.||||++.... +++. .....++||||+
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~ 135 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 135 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECC
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcc
Confidence 4567899999999999998864 9999999986543 1221 112356899999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC-CceEEeccCCccccCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICHG 132 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~ 132 (291)
.+ +|.+.+.... .....+++..++.++.||+.||.|||+ .+|+|+||||+||+++.+ +.+||+|||+++....
T Consensus 136 ~~-~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 136 PE-TVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp CE-EHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred cc-cHHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 76 6766665321 134689999999999999999999999 999999999999999965 5789999999987644
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhh----hhhhhh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYK----RLELEE 208 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 208 (291)
... .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||........ +...... ......
T Consensus 210 ~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~---l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 210 GEP---NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ---LVEIIKVLGTPTREQIR 282 (420)
T ss_dssp TCC---CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCSCCHHHHH
T ss_pred CCC---ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHH
Confidence 332 2334579999999998764 3689999999999999999999999876432110 0000000 000000
Q ss_pred h-------hcccCCCC-h----hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 209 D-------LGLQGIEN-E----EDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 209 ~-------~~~~~~~~-~----~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. ...+.... . .....+..+.+|+.+||..||.+|||+.|+++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0 00000000 0 11234578999999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=264.18 Aligned_cols=225 Identities=25% Similarity=0.333 Sum_probs=175.3
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|.+. +++.||+|++.... +++......++|+|++
T Consensus 24 y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (287)
T 2wei_A 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELY 103 (287)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEcc
Confidence 456789999999999999886 59999999986432 5566677889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC---CceEEeccCCcccc
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED---FCPKISDFGLAKIC 130 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~---~~~kl~Dfg~~~~~ 130 (291)
.+++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.+ +.++|+|||++...
T Consensus 104 ~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 104 TGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp CSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred CCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 999999998765 478999999999999999999999 999999999999999654 47999999998865
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
..... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||...... ....... .
T Consensus 175 ~~~~~---~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~-~--- 236 (287)
T 2wei_A 175 QQNTK---MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--------DILKRVE-T--- 236 (287)
T ss_dssp CCCSS---CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHH-H---
T ss_pred cCCCc---cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHH-c---
Confidence 43322 122346889999999865 4789999999999999999999988653210 0000000 0
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHh
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE--MLEG 254 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~--~L~~ 254 (291)
............++..+.+++.+||+.||++|||+.++++ .+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 237 GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp CCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred CCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 0111111222345678999999999999999999999987 4444
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=272.07 Aligned_cols=236 Identities=22% Similarity=0.226 Sum_probs=171.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeec-----CCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFE-----GHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~-----~~~~~lv 49 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +++.. ....++|
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence 456789999999999999875 48899999987432 22222 2467899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
+|++.+ +|.+++.. ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++.++|+|||++..
T Consensus 109 ~e~~~~-~L~~~l~~-------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 109 QDLMET-DLYKLLKT-------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EECCSE-EHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EcccCc-CHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 999975 99999854 369999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCcee-eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhh-------hh
Q 022826 130 CHGRESIV-SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHW-------VY 201 (291)
Q Consensus 130 ~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~-------~~ 201 (291)
........ ......+|+.|+|||++.+. ..++.++|||||||++|+|++|..||............... ..
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 54332211 12445689999999987654 36899999999999999999999988654322110000000 00
Q ss_pred h------hhhhhhhhcccCCC--ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 202 K------RLELEEDLGLQGIE--NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 202 ~------~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. .............. ......++..+.+|+.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00000000000000 0011234677899999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=281.89 Aligned_cols=217 Identities=14% Similarity=0.113 Sum_probs=159.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCcce------------------------------------------
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETKGF------------------------------------------ 39 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------------------------------------------ 39 (291)
+.+++.||+|+||.||+|.+. +|+.||||++......
T Consensus 80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence 345688999999999999875 4999999998832200
Q ss_pred --------------eecCCcceeeehhhcCCCHHHHHhhcCC-CCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeee
Q 022826 40 --------------CFEGHRRALIYEFVSNGSLEKFIYEKHP-LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHF 104 (291)
Q Consensus 40 --------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~ 104 (291)
.......+++|+++ +++|.+++..... ......+++..++.++.||+.||.|||+ .+|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHr 235 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHT 235 (413)
T ss_dssp CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECS
T ss_pred CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccC
Confidence 00012345566655 5699888853210 0123568888999999999999999999 999999
Q ss_pred ccCCCceEEcCCCceEEeccCCccccCCCCceeeccCCCCCccccCccccccc--------CCCccccccchhHHHHHHH
Q 022826 105 DIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN--------FGEVSYKSDVYSYGMMVFE 176 (291)
Q Consensus 105 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--------~~~~~~~~DiwslG~~l~~ 176 (291)
||||+||+++.++.+||+|||+++..... .....| +.|+|||++.+. ...++.++|||||||++|+
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 99999999999999999999998764322 344566 999999998321 1267889999999999999
Q ss_pred HhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 022826 177 MTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVV 249 (291)
Q Consensus 177 ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell 249 (291)
|++|+.||......... . .. .... ..++..+.+|+.+||+.||++||++.+++
T Consensus 310 lltg~~Pf~~~~~~~~~---~----------~~--~~~~-----~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGS---E----------WI--FRSC-----KNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHSSCCCCTTGGGSCS---G----------GG--GSSC-----CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHCCCCCCCcchhhhH---H----------HH--Hhhc-----ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999998754321110 0 00 0000 12346789999999999999999976653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=272.83 Aligned_cols=236 Identities=23% Similarity=0.247 Sum_probs=169.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceee-----cCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCF-----EGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~-----~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +++. .....++|
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence 456789999999999999875 48999999986432 2222 12567899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
+||+. ++|.+++.. ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++..
T Consensus 93 ~e~~~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 93 QELMQ-TDLHRVIST-------QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp ECCCS-EEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EeccC-ccHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99997 499999864 368999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcee--------eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc------
Q 022826 130 CHGRESIV--------SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY------ 195 (291)
Q Consensus 130 ~~~~~~~~--------~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~------ 195 (291)
........ ......+|+.|+|||++.+. ..++.++||||||+++|+|++|..||...........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 64322111 12234679999999987653 3789999999999999999999998875431100000
Q ss_pred -------chhhh-hhhhhhhhhhcc-c-CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 196 -------FPHWV-YKRLELEEDLGL-Q-GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 196 -------~~~~~-~~~~~~~~~~~~-~-~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..... ............ . .........++..+.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 000000000000 0 0000111245678899999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=274.70 Aligned_cols=231 Identities=23% Similarity=0.248 Sum_probs=153.0
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceee------cCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCF------EGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~------~~~~~~ 47 (291)
+.+.+.||+|+||.||+|.+. +|+.||||++.... +++. .....+
T Consensus 31 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~ 110 (367)
T 2fst_X 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110 (367)
T ss_dssp EEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred eEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEE
Confidence 456789999999999999875 48999999986532 2222 225578
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
++++++ +++|.+++.. ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++
T Consensus 111 lv~e~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 111 LVTHLM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp EEEECC-CEECC------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred EEeccc-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 999998 6799888843 479999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccch-------hhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFP-------HWV 200 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~-------~~~ 200 (291)
+..... .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||............. ...
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp ----------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred cccccc-----CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 764432 2334678999999998763 378999999999999999999999987543211000000 000
Q ss_pred hhhhh---hhhhh-cccCCCC----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 201 YKRLE---LEEDL-GLQGIEN----EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 201 ~~~~~---~~~~~-~~~~~~~----~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..... ....+ ....... ......+..+.+|+.+||..||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000 00000 0000000 011123567899999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=267.64 Aligned_cols=223 Identities=22% Similarity=0.332 Sum_probs=156.4
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhc
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~ 54 (291)
.+.+.||+|+||.||+|.+. +++.||||++.... +++......++||||+
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 106 (318)
T 2dyl_A 28 ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM- 106 (318)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred cccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence 45688999999999999885 59999999987543 5666778889999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCC-CeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT-RILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
++.+..+.... ...+++..++.++.|++.||.|||+ . +++|+||||+||+++.++.++|+|||++......
T Consensus 107 ~~~~~~l~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 107 GTCAEKLKKRM-----QGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp SEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred CCcHHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 54666555432 3579999999999999999999998 7 9999999999999999999999999998765433
Q ss_pred CceeeccCCCCCccccCcccccc---cCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCR---NFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~---~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
.. .....+++.|+|||.+.+ ....++.++||||||+++|+|++|..||...... ..........
T Consensus 179 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~--- 245 (318)
T 2dyl_A 179 KA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-------FEVLTKVLQE--- 245 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHHHHHHS---
T ss_pred cc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-------HHHHHHHhcc---
Confidence 21 233457899999999853 1236788999999999999999999888643211 0011111000
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.... ......++..+.+++.+||+.||.+|||+.++++
T Consensus 246 ~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 246 EPPL--LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCC--CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCC--CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0111 1111235667889999999999999999999876
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=271.61 Aligned_cols=230 Identities=25% Similarity=0.351 Sum_probs=156.0
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +++......++||||+
T Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~ 103 (327)
T 3aln_A 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM 103 (327)
T ss_dssp EEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeec
Confidence 456788999999999999885 58999999987643 5666677889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCC-CeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT-RILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
.+ +|.+++..... .....+++..++.++.|++.||.|||+ . +++|+||||+||+++.++.+||+|||++.....
T Consensus 104 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 104 ST-SFDKFYKYVYS-VLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp SE-EHHHHHHHHHH-TTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred CC-ChHHHHHHHHh-hhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 86 88888764210 123678999999999999999999999 8 999999999999999999999999999976543
Q ss_pred CCceeeccCCCCCccccCccccccc--CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRN--FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~--~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
... .....+++.|+|||.+.+. ...++.++||||||+++|+|++|..||........... .. ...
T Consensus 179 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------~~---~~~ 245 (327)
T 3aln_A 179 SIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT-------QV---VKG 245 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C-------CC---CCS
T ss_pred ccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH-------HH---hcC
Confidence 321 2233578999999998421 13688999999999999999999999875322111000 00 000
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
............++..+.+|+.+||+.||++|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0011111112235667999999999999999999999876
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=270.10 Aligned_cols=230 Identities=23% Similarity=0.253 Sum_probs=165.0
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCc------ce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHR------RA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~------~~ 47 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +++..... .+
T Consensus 44 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 123 (371)
T 4exu_A 44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 123 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred EEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEE
Confidence 445688999999999999875 48999999997532 33333333 38
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+||||+. ++|.+++. ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 124 lv~e~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 124 LVMPFMQ-TDLQKIMG--------MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp EEEECCC-EEHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred EEEcccc-ccHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 9999997 48888762 359999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc--------hhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF--------PHW 199 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~--------~~~ 199 (291)
...... .....+|+.|+|||.+.+. ..++.++||||||+++|+|++|..||............ ...
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccC-----cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 764332 2345679999999998763 37899999999999999999999998754211000000 000
Q ss_pred hh----h-hhhhhhhhcccCCCC--hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 200 VY----K-RLELEEDLGLQGIEN--EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 200 ~~----~-~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. . .......+....... .....++..+.+|+.+||+.||++|||+.|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00 0 000000000000000 011234678999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=268.79 Aligned_cols=212 Identities=26% Similarity=0.393 Sum_probs=168.1
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------------------ceeecCCc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------------------GFCFEGHR 45 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------------------~~~~~~~~ 45 (291)
+.+.+.||+|+||.||+|++. +++.||||++.... +++.....
T Consensus 33 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~ 112 (312)
T 2iwi_A 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEG 112 (312)
T ss_dssp CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----
T ss_pred eEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCe
Confidence 456789999999999999875 48999999986431 34445667
Q ss_pred ceeeehh-hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc-CCCceEEec
Q 022826 46 RALIYEF-VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD-EDFCPKISD 123 (291)
Q Consensus 46 ~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~-~~~~~kl~D 123 (291)
.++|+|+ +.+++|.+++... ..+++..++.++.||+.||.|||+ .+++|+||||+||+++ .++.++|+|
T Consensus 113 ~~~v~e~~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 113 FMLVLERPLPAQDLFDYITEK------GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp CEEEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEEE
Confidence 7899999 7889999999765 468999999999999999999999 9999999999999998 889999999
Q ss_pred cCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhh
Q 022826 124 FGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKR 203 (291)
Q Consensus 124 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~ 203 (291)
||++....... .....+++.|+|||.+.+. ...+.++||||||+++|+|++|..||.....
T Consensus 184 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------------- 244 (312)
T 2iwi_A 184 FGSGALLHDEP----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQE-------------- 244 (312)
T ss_dssp CSSCEECCSSC----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------
T ss_pred cchhhhcccCc----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHH--------------
Confidence 99988765432 2345679999999998764 2345689999999999999999988864311
Q ss_pred hhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 204 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. ..... .....++..+.+++.+||+.||++|||+.|+++
T Consensus 245 ~-~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 I-LEAEL-------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp H-HHTCC-------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred H-hhhcc-------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000 111234567889999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=272.38 Aligned_cols=235 Identities=21% Similarity=0.207 Sum_probs=164.2
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------------------cee-----
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------------------GFC----- 40 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------------------~~~----- 40 (291)
+.+.+.||+|+||.||+|.+.+++.||||++.... +++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 103 (362)
T 3pg1_A 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEE 103 (362)
T ss_dssp CEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCT
T ss_pred eEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccC
Confidence 45678999999999999998789999999885321 222
Q ss_pred ecCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceE
Q 022826 41 FEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 120 (291)
Q Consensus 41 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~k 120 (291)
......++||||+. |+|.+++... ...+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.++
T Consensus 104 ~~~~~~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 104 PAMHKLYLVTELMR-TDLAQVIHDQ-----RIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp TTCCEEEEEEECCS-EEHHHHHHCT-----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEE
T ss_pred CCcceEEEEEccCC-CCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEE
Confidence 22335789999998 5888888643 3579999999999999999999999 9999999999999999999999
Q ss_pred EeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccch---
Q 022826 121 ISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFP--- 197 (291)
Q Consensus 121 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~--- 197 (291)
|+|||++........ .....+++.|+|||.+.+. ..++.++|||||||++|+|++|..||.............
T Consensus 175 l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 250 (362)
T 3pg1_A 175 ICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250 (362)
T ss_dssp ECCTTC------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEecCcccccccccc---cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 999999975433221 2334578899999998763 378999999999999999999999987542110000000
Q ss_pred ------hhhh-hhhhhhhhh--cccCCC----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 198 ------HWVY-KRLELEEDL--GLQGIE----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 198 ------~~~~-~~~~~~~~~--~~~~~~----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.... ......... ...... .......+..+.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 0000 000000000 000000 0112234567899999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=270.19 Aligned_cols=232 Identities=21% Similarity=0.342 Sum_probs=175.0
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccC----------------------c---------------------ce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNET----------------------K---------------------GF 39 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----------------------~---------------------~~ 39 (291)
+.+.+.||+|+||.||+|.+ +++.||+|++... . ++
T Consensus 33 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 33 YRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp EEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred eEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 45678999999999999998 9999999998632 1 55
Q ss_pred eecCCcceeeehhhcCCCHHHHHhhcCCCCC--CCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC
Q 022826 40 CFEGHRRALIYEFVSNGSLEKFIYEKHPLET--NQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 117 (291)
Q Consensus 40 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~ 117 (291)
+......++||||+.+++|.+++........ ...+++..++.++.|++.||.|||+ ..+++|+||||+||+++.++
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~~~ 189 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNG 189 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECTTS
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcCCC
Confidence 6667888999999999999998332111112 5789999999999999999999995 37999999999999999999
Q ss_pred ceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccc-cccchhHHHHHHHHhCCCCCCccccCCCccccc
Q 022826 118 CPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSY-KSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF 196 (291)
Q Consensus 118 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~-~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~ 196 (291)
.++|+|||++...... ......+++.|+|||.+.+. ..++. ++||||||+++|+|++|..||........
T Consensus 190 ~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---- 260 (348)
T 2pml_X 190 RVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE---- 260 (348)
T ss_dssp CEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH----
T ss_pred cEEEeccccccccccc----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH----
Confidence 9999999999875443 23445679999999999764 24444 99999999999999999999875433100
Q ss_pred hhhhhhhhhhhhhhcccC------------CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 197 PHWVYKRLELEEDLGLQG------------IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
...... ......+. ........++..+.+|+.+||+.||.+|||+.|+++
T Consensus 261 ---~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 ---LFNNIR-TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ---HHHHHT-SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---HHHHHh-ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000 00000000 000111446678999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=273.40 Aligned_cols=226 Identities=23% Similarity=0.283 Sum_probs=161.8
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------ceeecCCcceeeehhhcCCCH
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
+.+.+.||+|+||+|+.....+++.||||++.... +.+......++|||++.+ +|
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g-~L 104 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TL 104 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSE-EH
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCC-CH
Confidence 44568999999999776655679999999986543 455667778999999964 99
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC---C--CceEEeccCCccccCCC
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---D--FCPKISDFGLAKICHGR 133 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~---~--~~~kl~Dfg~~~~~~~~ 133 (291)
.+++.... ..++...++.++.||+.||.|||+ .+|+||||||+||+++. + ..++|+|||++......
T Consensus 105 ~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 105 QEYVEQKD-----FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp HHHHHSSS-----CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred HHHHHhcC-----CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 99997643 234444567899999999999999 99999999999999953 2 35789999999876543
Q ss_pred Cce-eeccCCCCCccccCccccccc-CCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 134 ESI-VSMTGARGTVGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 134 ~~~-~~~~~~~~~~~y~aPE~l~~~-~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
... .......||+.|+|||++.+. ...++.++|||||||++|+|++ |..||....... .......
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-----------~~~~~~~- 244 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-----------ANILLGA- 244 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-----------HHHHTTC-
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-----------HHHHhcc-
Confidence 221 223445689999999999743 2367889999999999999999 777764321100 0000000
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
...............+.+|+.+||+.||++|||+.++++
T Consensus 245 -~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 -CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000111122345667889999999999999999999983
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=262.42 Aligned_cols=236 Identities=23% Similarity=0.246 Sum_probs=163.6
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc--------------------------cee--------------e
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK--------------------------GFC--------------F 41 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------------------~~~--------------~ 41 (291)
+.+.+.||+|+||.||+|.+.. ++.||+|++.... +++ .
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 92 (320)
T 2i6l_A 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92 (320)
T ss_dssp EEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred eeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence 4567899999999999998865 8999999986543 111 3
Q ss_pred cCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc-CCCceE
Q 022826 42 EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD-EDFCPK 120 (291)
Q Consensus 42 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~-~~~~~k 120 (291)
.....++||||+. ++|.+++.. ..+++..++.++.|++.||.|||+ .+++|+||||+||+++ .++.+|
T Consensus 93 ~~~~~~lv~e~~~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 93 ELNSVYIVQEYME-TDLANVLEQ-------GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp SCSEEEEEEECCS-EEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEE
T ss_pred ccCceeEEeeccC-CCHHHHhhc-------CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEE
Confidence 3467789999997 599999843 478999999999999999999999 9999999999999997 567999
Q ss_pred EeccCCccccCCCCce-eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccch--
Q 022826 121 ISDFGLAKICHGRESI-VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFP-- 197 (291)
Q Consensus 121 l~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~-- 197 (291)
|+|||++......... .......+++.|+|||.+.+. ..++.++||||||+++|+|++|..||.............
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999865432211 112334468899999988653 378899999999999999999999987543211000000
Q ss_pred -----hhhhhhhh------hhhhhcccCC-CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 198 -----HWVYKRLE------LEEDLGLQGI-ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 198 -----~~~~~~~~------~~~~~~~~~~-~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
........ .......... .......++..+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000000 0000000000 00112235778999999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=266.80 Aligned_cols=230 Identities=23% Similarity=0.251 Sum_probs=165.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCC------cce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGH------RRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~------~~~ 47 (291)
+.+.+.||+|+||.||+|.+. +|+.||||++.... +++.... ..+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 456788999999999999875 48999999986532 2333332 348
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+||||+. ++|.+++. ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 106 lv~e~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMG--------LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp EEEECCS-EEGGGTTT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred EEecccc-CCHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccc
Confidence 9999997 48877652 358999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc--------hhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF--------PHW 199 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~--------~~~ 199 (291)
...... .....+++.|+|||.+.+. ..++.++||||||+++|+|++|..||............ ..+
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 764332 2334578999999998763 37889999999999999999999998754321000000 000
Q ss_pred hhh---h--hhhhhhhcc--cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 200 VYK---R--LELEEDLGL--QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 200 ~~~---~--~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
... . ......+.. ..........++..+.+|+.+||+.||++|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 0 000000000 00001112345778999999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=281.10 Aligned_cols=245 Identities=24% Similarity=0.267 Sum_probs=177.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------cee------ecCCccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFC------FEGHRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~------~~~~~~~l 48 (291)
+.+.+.||+|+||.||+|.+. +++.||||++.... +++ ..+...++
T Consensus 16 Y~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~L 95 (676)
T 3qa8_A 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLL 95 (676)
T ss_dssp -CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEE
Confidence 457799999999999999875 49999999987542 111 22667789
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCc---eEEeccC
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC---PKISDFG 125 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~---~kl~Dfg 125 (291)
||||+.+++|.+++.... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++. ++|+|||
T Consensus 96 VmEy~~ggsL~~~L~~~~---~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 96 AMEYCEGGDLRKYLNQFE---NCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp EEECCSSCBHHHHHHSSS---CTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEeCCCCCHHHHHHhcc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 999999999999997642 33468999999999999999999999 99999999999999987765 8999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccc-cchhhhhhh-
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEI-YFPHWVYKR- 203 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~-~~~~~~~~~- 203 (291)
++........ .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||........-. .........
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELLEQK--KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSSCCS--CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred cccccccccc---cccccCCcccCChHHhccC--CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 9987654332 2345679999999999765 78999999999999999999999986531100000 000000000
Q ss_pred ---hhhhhhhcc---cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHH-----HHHHHHhhhcc
Q 022826 204 ---LELEEDLGL---QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNR-----VVEMLEGSLDS 258 (291)
Q Consensus 204 ---~~~~~~~~~---~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~e-----ll~~L~~~~~~ 258 (291)
......... ..........++..+.+++.+||..||++|||+.+ +++.++.+++.
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 000000000 01112233457788999999999999999999988 67777776653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=256.79 Aligned_cols=203 Identities=20% Similarity=0.270 Sum_probs=155.5
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------ceeec----CCcceeeehhhcCCCHH
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------GFCFE----GHRRALIYEFVSNGSLE 59 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------~~~~~----~~~~~lv~e~~~~g~L~ 59 (291)
+.||+|+||.||++.+. +++.||+|++.... +.+.. ....++||||+.+++|.
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF 103 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHH
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHH
Confidence 67999999999999875 58999999987543 23333 56788999999999999
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC---CCceEEeccCCccccCCCCce
Q 022826 60 KFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---DFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 60 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++. ++.++|+|||++.....
T Consensus 104 ~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---- 172 (299)
T 3m2w_A 104 SRIQDR----GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG---- 172 (299)
T ss_dssp HHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT----
T ss_pred HHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccccccc----
Confidence 999875 33579999999999999999999999 99999999999999987 78999999998764211
Q ss_pred eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 137 VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
..++.++||||||+++|+|++|..||.............. ..........
T Consensus 173 ----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~--------~~~~~~~~~~ 222 (299)
T 3m2w_A 173 ----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--------RIRMGQYEFP 222 (299)
T ss_dssp ----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC--------SSCTTCCSSC
T ss_pred ----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH--------HHhhccccCC
Confidence 2578899999999999999999999865432211000000 0000000011
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......++..+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1111346778999999999999999999999997
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=252.75 Aligned_cols=205 Identities=11% Similarity=0.036 Sum_probs=158.1
Q ss_pred chhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|.+.. ++.||||++.... +++......++||||
T Consensus 33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 112 (286)
T 3uqc_A 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW 112 (286)
T ss_dssp EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEe
Confidence 4567899999999999998865 8999999997642 456667789999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+++|.+++.. ......+..++.||+.||.|||+ .+|+|+||||+||+++.+|.++|++++.
T Consensus 113 ~~g~~L~~~l~~--------~~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~~------ 175 (286)
T 3uqc_A 113 IRGGSLQEVADT--------SPSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPAT------ 175 (286)
T ss_dssp CCEEEHHHHHTT--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCCC------
T ss_pred cCCCCHHHHHhc--------CCChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEeccc------
Confidence 999999999843 23555788999999999999999 9999999999999999999999985432
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
++ .++.++||||||+++|+|++|+.||.................. .
T Consensus 176 ----------------~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~---------~ 221 (286)
T 3uqc_A 176 ----------------MP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAG---------Q 221 (286)
T ss_dssp ----------------CT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTS---------C
T ss_pred ----------------cC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhcc---------C
Confidence 22 4688999999999999999999999865432211000000000 0
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccC
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSL 259 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~ 259 (291)
..........++..+.+++.+||+.||++| |+.|+++.|+++...-
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 000011123456778999999999999999 9999999999976543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=280.79 Aligned_cols=213 Identities=25% Similarity=0.306 Sum_probs=167.0
Q ss_pred chhhcccccCCceeEEEEEec--CCCeEEEEEeccCc---------------------------ceeecCCc-----cee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL--DGRNVAIKVLNETK---------------------------GFCFEGHR-----RAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~---------------------------~~~~~~~~-----~~l 48 (291)
+.+.+.||+|+||.||++.+. +++.||||++.... +++..... .|+
T Consensus 82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l 161 (681)
T 2pzi_A 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI 161 (681)
T ss_dssp EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence 456788999999999999875 58999999986432 34443333 699
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
||||+.+++|.+++. ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++.+ .+||+|||++.
T Consensus 162 v~E~~~g~~L~~~~~--------~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 162 VMEYVGGQSLKRSKG--------QKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEECCCCEECC------------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred EEEeCCCCcHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccch
Confidence 999999999988762 278999999999999999999999 999999999999999885 89999999998
Q ss_pred ccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhh
Q 022826 129 ICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEE 208 (291)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (291)
..... ....||+.|+|||++.+. .+.++|||||||++|+|++|..++........ +
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~---~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----~----------- 285 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----P----------- 285 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHC---SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----C-----------
T ss_pred hcccC------CccCCCccccCHHHHcCC---CCCceehhhhHHHHHHHHhCCCCCcccccccc----c-----------
Confidence 65433 345689999999998764 38899999999999999999876654321110 0
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHhhhcc
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRP-AMNRVVEMLEGSLDS 258 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-s~~ell~~L~~~~~~ 258 (291)
........+..+.+++.+||+.||++|| +++++.+.|.++++.
T Consensus 286 -------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 286 -------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp -------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred -------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 0112223456788999999999999999 577788888776643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=247.75 Aligned_cols=211 Identities=16% Similarity=0.170 Sum_probs=160.6
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCcc-----------------------ee-------------------
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG-----------------------FC------------------- 40 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------------------~~------------------- 40 (291)
+.+.+.||+|+||.||+|++ +++.||||++..... ..
T Consensus 22 y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~ 100 (336)
T 2vuw_A 22 LQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSV 100 (336)
T ss_dssp HHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEE
T ss_pred chheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcce
Confidence 45678999999999999988 789999999975410 00
Q ss_pred -------------------------------ecCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 022826 41 -------------------------------FEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARG 89 (291)
Q Consensus 41 -------------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~ 89 (291)
......++||||+.+|++.+.+.. ..+++..++.++.||+.|
T Consensus 101 ~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 101 HCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHHHHHHH
T ss_pred eEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHHHHHHH
Confidence 026789999999999977666632 468999999999999999
Q ss_pred hHHhh-cCCCCCeeeeccCCCceEEcCCC--------------------ceEEeccCCccccCCCCceeeccCCCCCccc
Q 022826 90 LEYLH-RGCNTRILHFDIKPHNILLDEDF--------------------CPKISDFGLAKICHGRESIVSMTGARGTVGY 148 (291)
Q Consensus 90 l~~LH-~~~~~~ivH~dikp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y 148 (291)
|.||| + .+|+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 174 L~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 9 9999999999999999887 8999999999865432 23579999
Q ss_pred cCcccccccCCCccccccchhHHHH-HHHHhCCCCCCccccCCCccccchhhhh-hhhhhhhhhcc-cCCCChhhHHHHH
Q 022826 149 IAPEVFCRNFGEVSYKSDVYSYGMM-VFEMTGVKNNANVAVDRSSEIYFPHWVY-KRLELEEDLGL-QGIENEEDKEYAR 225 (291)
Q Consensus 149 ~aPE~l~~~~~~~~~~~DiwslG~~-l~~ll~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~ 225 (291)
+|||++.+. . +.++|||||+++ .++++.|..||... .+.. ........... ..........++.
T Consensus 244 ~aPE~~~g~--~-~~~~Diwsl~~~~~~~~~~g~~p~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 244 MDEDLFTGD--G-DYQFDIYRLMKKENNNRWGEYHPYSNV----------LWLHYLTDKMLKQMTFKTKCNTPAMKQIKR 310 (336)
T ss_dssp TCSGGGCCC--S-SHHHHHHHHHHHHHTTCTTSCCTHHHH----------HHHHHHHHHHHHTCCCSSCCCSHHHHHHHH
T ss_pred cChhhhcCC--C-ccceehhhhhCCCCcccccccCCCcch----------hhhhHHHHhhhhhhccCcccchhhhhhcCH
Confidence 999999875 3 889999998777 66677787766421 0000 00000101111 1222334567899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHH
Q 022826 226 KMILVSLWCIQNNPSDRPAMNRVV 249 (291)
Q Consensus 226 ~l~~l~~~~l~~dP~~Rps~~ell 249 (291)
++.+|+.+||+.| |+.|++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHhccC-----CHHHHH
Confidence 9999999999977 898887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-29 Score=229.69 Aligned_cols=159 Identities=18% Similarity=0.172 Sum_probs=107.3
Q ss_pred ccccCCceeEEEEE-ecCCCeEEEEEeccCc-------------------------------------ceeecCCcceee
Q 022826 8 KLGQGGYGGVYKGK-LLDGRNVAIKVLNETK-------------------------------------GFCFEGHRRALI 49 (291)
Q Consensus 8 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-------------------------------------~~~~~~~~~~lv 49 (291)
....|..|.+..++ ..-|+.+++|++.... +++.++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 34566677666663 3348999999997642 677788899999
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
|||++|++|.+++... ..++.. +|++||+.||.|+|+ +|||||||||+|||++.+|.+||+|||+++.
T Consensus 321 MEyv~G~~L~d~i~~~------~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG------EEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp EECCCSEEHHHHHHTT------CCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred EecCCCCcHHHHHHhC------CCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCee
Confidence 9999999999999765 355553 589999999999999 9999999999999999999999999999987
Q ss_pred cCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCC
Q 022826 130 CHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNN 183 (291)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~ 183 (291)
...... .....+||+.|+|||++.+ .+..++|+|++|++++.+.++..+
T Consensus 389 ~~~~~~--~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 389 TPQDCS--WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CC---C--CSHHHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred CCCCCc--cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccch
Confidence 644322 1234568999999999976 456789999999999888765544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-24 Score=197.93 Aligned_cols=156 Identities=18% Similarity=0.210 Sum_probs=119.3
Q ss_pred hcccccCCceeEEEEEecCCCeEEEEEeccCc----------------------------------ceeecCCcceeeeh
Q 022826 6 KNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------------------~~~~~~~~~~lv~e 51 (291)
.+.||+|+||.||++.. .++.+++|+..... .++......++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 46899999999999944 67888999854322 34456677899999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+++++|.+++.. +..++.|++.||.|||+ ++|+|+||||+||+++. .+||+|||+++...
T Consensus 420 ~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 420 YINGKLAKDVIED--------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp CCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 9999999999843 55899999999999999 99999999999999998 99999999998765
Q ss_pred CCCcee-----eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCC
Q 022826 132 GRESIV-----SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVK 181 (291)
Q Consensus 132 ~~~~~~-----~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~ 181 (291)
...... ......||+.|+|||++.+....|+...|+|+..+-..+-+..+
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r 535 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERR 535 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhc
Confidence 432211 11345689999999999874347888899999888777766443
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.9e-22 Score=169.81 Aligned_cols=120 Identities=16% Similarity=0.109 Sum_probs=97.1
Q ss_pred hhcccccCCceeEEEEEecCCCeEEEEEeccCcc----------------------------------------eeecCC
Q 022826 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG----------------------------------------FCFEGH 44 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------------------------~~~~~~ 44 (291)
+++.||+|+||.||+|.+.+|+.||+|+++.... ......
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~~~~~~ 173 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 173 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCeEEecc
Confidence 4589999999999999886699999999963210 012335
Q ss_pred cceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEecc
Q 022826 45 RRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 124 (291)
Q Consensus 45 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Df 124 (291)
..++||||+++++|.+ +.. .....++.|++.||.|||+ .+++|+||||+||+++ ++.++|+||
T Consensus 174 ~~~lvmE~~~g~~L~~-l~~------------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 174 GNAVLMELIDAKELYR-VRV------------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp TTEEEEECCCCEEGGG-CCC------------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred ceEEEEEecCCCcHHH-cch------------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 6789999999999988 421 1245799999999999999 9999999999999999 999999999
Q ss_pred CCccccCCCCceeeccCCCCCccccCcccccc
Q 022826 125 GLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156 (291)
Q Consensus 125 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~ 156 (291)
|++.. +..+.|||.+.+
T Consensus 237 G~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 237 PQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp TTCEE---------------TTSTTHHHHHHH
T ss_pred CCCeE---------------CCCCCHHHHHHH
Confidence 99863 345788888743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-18 Score=144.86 Aligned_cols=112 Identities=20% Similarity=0.265 Sum_probs=87.2
Q ss_pred hhhcccccCCceeEEEEEe-cCCCe--EEEEEeccCcc------------------------------------------
Q 022826 4 SFKNKLGQGGYGGVYKGKL-LDGRN--VAIKVLNETKG------------------------------------------ 38 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~------------------------------------------ 38 (291)
.+.+.||+|+||.||+|.+ .+|+. ||||+++....
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 3568899999999999987 67888 99998643210
Q ss_pred ------eeecCCcceeeehhhcC-C----CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhh-cCCCCCeeeecc
Q 022826 39 ------FCFEGHRRALIYEFVSN-G----SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RGCNTRILHFDI 106 (291)
Q Consensus 39 ------~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH-~~~~~~ivH~di 106 (291)
........++||||+.+ | +|.++... .++..+..++.|++.+|.+|| + .+++|+||
T Consensus 130 ~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~---~givHrDl 197 (258)
T 1zth_A 130 AGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQE---AELVHADL 197 (258)
T ss_dssp TTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHT---SCEECSSC
T ss_pred CCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHH---CCEEeCCC
Confidence 00112345799999953 3 67766432 223457889999999999999 9 99999999
Q ss_pred CCCceEEcCCCceEEeccCCccc
Q 022826 107 KPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 107 kp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
||+|||++. .++|+|||++..
T Consensus 198 kp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEE
T ss_pred CHHHEEEcC--cEEEEECccccc
Confidence 999999988 899999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=4.6e-18 Score=147.40 Aligned_cols=111 Identities=16% Similarity=0.203 Sum_probs=86.9
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCcc------------------------------------------e-
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG------------------------------------------F- 39 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------------------------------~- 39 (291)
+.++.+||+|+||.||+|.+.+|+.||||+++.... +
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 456789999999999999988899999999764320 0
Q ss_pred ---eecCCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC
Q 022826 40 ---CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 116 (291)
Q Consensus 40 ---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~ 116 (291)
.......++||||+++++|..+.. . .....++.||+.+|.+||+ .+||||||||.|||++++
T Consensus 177 vp~p~~~~~~~LVME~i~G~~L~~l~~----------~--~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 177 VPEPIAQSRHTIVMSLVDALPMRQVSS----------V--PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREE 241 (397)
T ss_dssp CCCEEEEETTEEEEECCSCEEGGGCCC----------C--SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEE
T ss_pred CCeeeeccCceEEEEecCCccHhhhcc----------c--HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCC
Confidence 011123468999999988855431 1 1246788999999999999 999999999999999877
Q ss_pred C----------ceEEeccCCcc
Q 022826 117 F----------CPKISDFGLAK 128 (291)
Q Consensus 117 ~----------~~kl~Dfg~~~ 128 (291)
| .+.|+||+-+.
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCE
T ss_pred CCcccccccccceEEEEeCCcc
Confidence 6 38999998654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.98 E-value=1.2e-09 Score=90.04 Aligned_cols=105 Identities=16% Similarity=0.039 Sum_probs=74.8
Q ss_pred ccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCCHHHHHhh
Q 022826 10 GQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGSLEKFIYE 64 (291)
Q Consensus 10 g~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~L~~~l~~ 64 (291)
+.|..+.||++...+|+.+++|+..... .....+...++|||+++|.+|. ..
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~- 105 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS- 105 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS-
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC-
Confidence 4566799999987668889999976542 2333445678999999998884 21
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCC-----------------------------------------------
Q 022826 65 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC----------------------------------------------- 97 (291)
Q Consensus 65 ~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~----------------------------------------------- 97 (291)
..+ ...++.+++..+..||+-.
T Consensus 106 --------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 106 --------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp --------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred --------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 111 2356677777777777611
Q ss_pred --------CCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 98 --------NTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 98 --------~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0129999999999999877656799999754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=3.2e-09 Score=87.71 Aligned_cols=112 Identities=15% Similarity=0.054 Sum_probs=83.4
Q ss_pred hhcccccCCceeEEEEEecCCCeEEEEEeccC---c------------------------ceeecCCcceeeehhhcCCC
Q 022826 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNET---K------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 5 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~---~------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+...++.|+.+.||++.. .++.+++|+.+.. . .++......++|||+++|.+
T Consensus 18 ~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 96 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL 96 (263)
T ss_dssp EEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred eEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence 455677888899999975 4789999998641 1 34455667889999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCC----------------------------------------
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC---------------------------------------- 97 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~---------------------------------------- 97 (291)
|.+.+.. ......++.+++.++..||+-+
T Consensus 97 l~~~~~~-----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 97 CSEEYED-----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp HHHHCCT-----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred hhhccCC-----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 9876311 1123477889999999999710
Q ss_pred ----------------CCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 98 ----------------NTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 98 ----------------~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
...++|||+++.||++++++.+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999876556799998653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.77 E-value=1.7e-08 Score=87.40 Aligned_cols=114 Identities=19% Similarity=0.195 Sum_probs=84.3
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEec--cCc-----------------------------ceeecC---Ccceeeehh
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLN--ETK-----------------------------GFCFEG---HRRALIYEF 52 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-----------------------------~~~~~~---~~~~lv~e~ 52 (291)
+.|+.|.++.||+.... +..+++|+.. ... ..+... ...++|||+
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 57899999999999764 5688899887 221 222222 347899999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCC-----------------------------------
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC----------------------------------- 97 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~----------------------------------- 97 (291)
++|..+.+.. ...++......++.+++..|..||+-.
T Consensus 123 v~G~~l~~~~--------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 123 VSGRVLWDQS--------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp CCCBCCCCTT--------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred cCCeecCCCc--------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9997774321 135678888899999999999999710
Q ss_pred --------------------CCCeeeeccCCCceEEcCCCc--eEEeccCCccc
Q 022826 98 --------------------NTRILHFDIKPHNILLDEDFC--PKISDFGLAKI 129 (291)
Q Consensus 98 --------------------~~~ivH~dikp~Nill~~~~~--~kl~Dfg~~~~ 129 (291)
...++|||+++.||+++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999987753 58999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.58 E-value=2.8e-08 Score=83.93 Aligned_cols=161 Identities=17% Similarity=0.186 Sum_probs=99.2
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEeccCc---------------------------ceeecCC---cceeeehhhcCC
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK---------------------------GFCFEGH---RRALIYEFVSNG 56 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------------~~~~~~~---~~~lv~e~~~~g 56 (291)
+.++.|....||+.. ..+++|+..... ....... ..++||++++|.
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~ 101 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV 101 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence 457889999999863 568899876541 1111111 347789999998
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCC---------------------------------------
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC--------------------------------------- 97 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~--------------------------------------- 97 (291)
+|.+... ..++......++.+++..+..||+-.
T Consensus 102 ~l~~~~~--------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 102 PLTPLLL--------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCHHHH--------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred ECCcccc--------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 8865432 24566677777788888877777510
Q ss_pred ----------------CCCeeeeccCCCceEEcC--CCceEEeccCCccccCCCCceeeccCCCCCccccCcccccc---
Q 022826 98 ----------------NTRILHFDIKPHNILLDE--DFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR--- 156 (291)
Q Consensus 98 ----------------~~~ivH~dikp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--- 156 (291)
...++|||+++.||++++ .+.+.|+||+.+..-........... ...-..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~---~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLME---DDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCC---TTTSCCHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHh---hccccCHHHHHHHHH
Confidence 134799999999999988 45678999998764322111000000 000022332111
Q ss_pred cCC---------CccccccchhHHHHHHHHhCCCC
Q 022826 157 NFG---------EVSYKSDVYSYGMMVFEMTGVKN 182 (291)
Q Consensus 157 ~~~---------~~~~~~DiwslG~~l~~ll~g~~ 182 (291)
..+ ....-.+.|+++.++|.+.+|+.
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~ 285 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYM 285 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCH
Confidence 000 01122578999999999998884
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=3.1e-06 Score=69.92 Aligned_cols=111 Identities=17% Similarity=0.081 Sum_probs=76.9
Q ss_pred ccccCCce-eEEEEEecC-CCeEEEEEeccCc------------------------ceeecCCcceeeehhhcCCCHHHH
Q 022826 8 KLGQGGYG-GVYKGKLLD-GRNVAIKVLNETK------------------------GFCFEGHRRALIYEFVSNGSLEKF 61 (291)
Q Consensus 8 ~lg~G~~g-~V~~~~~~~-~~~vavK~~~~~~------------------------~~~~~~~~~~lv~e~~~~g~L~~~ 61 (291)
.+..|..+ .||+..... +..+++|+-+... .++......++||++++|.++.+.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~ 110 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV 110 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence 34445554 699987644 6789999876432 455667788999999999888776
Q ss_pred HhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCC--------------------------------------------
Q 022826 62 IYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC-------------------------------------------- 97 (291)
Q Consensus 62 l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~-------------------------------------------- 97 (291)
.... ......+..++...|..||+-.
T Consensus 111 ~~~~----------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 111 LEEY----------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHC----------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccCC----------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 5321 1123445666667777776500
Q ss_pred -----------CCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 98 -----------NTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 98 -----------~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
...++|||+.+.||++++++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237899999999999987767799998654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.11 E-value=2e-05 Score=62.15 Aligned_cols=102 Identities=14% Similarity=0.073 Sum_probs=67.9
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
-+|.++|.... ++++++++|.++.|.+..|.-.-.. ..-...=+.|..|++..+|.+-+.+ +.+.
T Consensus 33 vSL~eIL~~~~-----~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------- 97 (229)
T 2yle_A 33 LSLEEILRLYN-----QPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD------- 97 (229)
T ss_dssp EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred ccHHHHHHHcC-----CCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc-------
Confidence 37999998764 8999999999999999998876210 1112344457899999999888875 2111
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKN 182 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~ 182 (291)
.....+.|||... ...+.+.-|||||+++|.-+-...
T Consensus 98 -------~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 -------AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp ----------------CCSS---SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred -------ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhcCC
Confidence 0123566787763 255678889999999999985543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=1.8e-05 Score=66.74 Aligned_cols=110 Identities=18% Similarity=0.114 Sum_probs=71.9
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEeccCc---------------------------cee-ecCCcceeeehhhcCCCH
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK---------------------------GFC-FEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------------~~~-~~~~~~~lv~e~~~~g~L 58 (291)
+.++.|....||+. ++.+++|+..... .++ ......++||++++|..+
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l 100 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL 100 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred eecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence 45778888899988 5778899865321 122 123456799999999888
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcC------------------------------------------
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG------------------------------------------ 96 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~------------------------------------------ 96 (291)
..... ..++......++.++...|..||+-
T Consensus 101 ~~~~~--------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 101 GEDGM--------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp HHHHH--------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred chhhh--------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 66321 1233444444444455544444431
Q ss_pred ---------------CCCCeeeeccCCCceEEcC---CCce-EEeccCCcc
Q 022826 97 ---------------CNTRILHFDIKPHNILLDE---DFCP-KISDFGLAK 128 (291)
Q Consensus 97 ---------------~~~~ivH~dikp~Nill~~---~~~~-kl~Dfg~~~ 128 (291)
....++|+|+++.||+++. ++.+ .|+||+.+.
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 1245799999999999987 4555 799998764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.80 E-value=2.8e-05 Score=66.30 Aligned_cols=30 Identities=23% Similarity=0.206 Sum_probs=27.0
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
..++|||+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 789999999999999888889999998653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00012 Score=62.85 Aligned_cols=30 Identities=17% Similarity=0.160 Sum_probs=25.4
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
..++|+|+++.||++++++.+.|+||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 679999999999999964457899998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00051 Score=59.87 Aligned_cols=30 Identities=23% Similarity=0.281 Sum_probs=25.9
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
..++|||+.+.||+++.+ .++|+||..+..
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 679999999999999876 489999987653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00038 Score=57.88 Aligned_cols=29 Identities=24% Similarity=0.383 Sum_probs=25.8
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEecc
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNE 35 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~ 35 (291)
+.+|.|..+.||+....+|+.+++|+.+.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~ 49 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPD 49 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCT
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCC
Confidence 56899999999999998999999998654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0011 Score=55.49 Aligned_cols=30 Identities=23% Similarity=0.144 Sum_probs=25.2
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 45899999999999 5667889999987653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0039 Score=52.83 Aligned_cols=31 Identities=26% Similarity=0.301 Sum_probs=27.1
Q ss_pred CCeeeeccCCCceEEcCC----CceEEeccCCccc
Q 022826 99 TRILHFDIKPHNILLDED----FCPKISDFGLAKI 129 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~----~~~kl~Dfg~~~~ 129 (291)
..++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 679999999999999874 6789999997764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.73 E-value=0.013 Score=49.27 Aligned_cols=30 Identities=23% Similarity=0.319 Sum_probs=25.4
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
..++|+|+++.||++++++.+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 579999999999999887656899998653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.71 E-value=0.011 Score=49.70 Aligned_cols=28 Identities=36% Similarity=0.369 Sum_probs=24.5
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
..++|||+++.||+++ + .+.|+||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 5689999999999998 4 89999998654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0033 Score=52.89 Aligned_cols=51 Identities=16% Similarity=0.159 Sum_probs=39.0
Q ss_pred cccccCCceeEEEEEecCCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCCCH
Q 022826 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNGSL 58 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g~L 58 (291)
+.|+.|....+|+... +++.+++|+..... ..+......++|||++++..+
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 5688999999999976 57788999876432 334445678999999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.81 E-value=0.0093 Score=52.31 Aligned_cols=30 Identities=13% Similarity=0.300 Sum_probs=27.2
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
..++|||+++.||+++.++ +.|+||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 8899999999999998876 99999998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.83 E-value=0.016 Score=50.59 Aligned_cols=28 Identities=32% Similarity=0.358 Sum_probs=23.7
Q ss_pred eeeeccCCCceEE------cCCCceEEeccCCcc
Q 022826 101 ILHFDIKPHNILL------DEDFCPKISDFGLAK 128 (291)
Q Consensus 101 ivH~dikp~Nill------~~~~~~kl~Dfg~~~ 128 (291)
++|+|+.+.||++ +.+..+.++||..+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 345679999998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.90 E-value=0.085 Score=44.71 Aligned_cols=31 Identities=23% Similarity=0.283 Sum_probs=27.2
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 5699999999999999888899999986643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=92.33 E-value=0.14 Score=45.42 Aligned_cols=29 Identities=14% Similarity=0.068 Sum_probs=21.3
Q ss_pred cccccCCceeEEEEEecC-CCeEEEEEecc
Q 022826 7 NKLGQGGYGGVYKGKLLD-GRNVAIKVLNE 35 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~ 35 (291)
+.|+.|....+|++...+ ++.+++|+...
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~ 143 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGP 143 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCC
Confidence 568888889999998754 47899998754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=91.48 E-value=0.086 Score=45.14 Aligned_cols=29 Identities=21% Similarity=0.346 Sum_probs=24.2
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
..++|+|+++.||+++.++ +.|+||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 5689999999999998654 8999998664
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=90.42 E-value=0.1 Score=45.80 Aligned_cols=29 Identities=14% Similarity=0.242 Sum_probs=22.9
Q ss_pred cccccCCceeEEEEEecC--------CCeEEEEEecc
Q 022826 7 NKLGQGGYGGVYKGKLLD--------GRNVAIKVLNE 35 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~ 35 (291)
+.|+.|....+|++...+ ++.+++|+...
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~ 115 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN 115 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCC
Confidence 467888889999997642 57899999854
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=89.94 E-value=0.14 Score=44.15 Aligned_cols=30 Identities=30% Similarity=0.326 Sum_probs=26.1
Q ss_pred CCeeeeccCCCceEEcCC----CceEEeccCCcc
Q 022826 99 TRILHFDIKPHNILLDED----FCPKISDFGLAK 128 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~----~~~kl~Dfg~~~ 128 (291)
..++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 468999999999999876 789999998764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.35 E-value=0.99 Score=35.49 Aligned_cols=50 Identities=18% Similarity=0.269 Sum_probs=42.3
Q ss_pred CCCHHHHHHHHHHHHHHhH-HhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 73 KLKWEVLYKIAVGIARGLE-YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 73 ~~~~~~~~~i~~~l~~~l~-~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
..+....++++.+|+.... +++. -+|--++|+|++++.++.+++.-.|+-
T Consensus 81 ~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 81 KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEEECTTCCEEESCCEET
T ss_pred hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEEEeCCCcEEEEEcCCc
Confidence 6778889999999988666 5554 588999999999999999999988863
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=84.26 E-value=0.43 Score=41.76 Aligned_cols=30 Identities=20% Similarity=0.346 Sum_probs=26.0
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 45899999999999 7788999999987753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.38 E-value=1.1 Score=35.05 Aligned_cols=85 Identities=16% Similarity=0.178 Sum_probs=60.8
Q ss_pred CCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCceeeccCCCCCccccCc
Q 022826 72 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAP 151 (291)
Q Consensus 72 ~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 151 (291)
...+....++++.+|+....++++ -+|--++|+|++++.++.+++.-.|+-.. ++|
T Consensus 76 k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f~~~~~p~i~~RGik~~-------------------l~P 131 (215)
T 4ann_A 76 KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFFTRDGLPIAKTRGLQNV-------------------VDP 131 (215)
T ss_dssp GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEECTTSCEEESCCEETTT-------------------BSC
T ss_pred HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEEcCCCCEEEEEccCccC-------------------CCC
Confidence 467888899999999998866664 38999999999999999999998875321 111
Q ss_pred ccccccCCCccccccchhHHHHHHHHhCCCCCCccc
Q 022826 152 EVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVA 187 (291)
Q Consensus 152 E~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~ 187 (291)
. ..+...-.-++=+++..+++++..|..-
T Consensus 132 ~-------~~~ee~fL~qyKAliiall~~K~~Fe~l 160 (215)
T 4ann_A 132 L-------PVSEAEFLTRYKALVICAFNEKQSFDAL 160 (215)
T ss_dssp C-------CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred C-------CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 1 1122222345778888888887666543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 291 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-48 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-42 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-41 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-41 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-38 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-38 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-36 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-33 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-30 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-29 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-29 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-29 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-27 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-26 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-26 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-25 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-24 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-23 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-23 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-21 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-21 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-18 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-16 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-16 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-53
Identities = 68/285 (23%), Positives = 118/285 (41%), Gaps = 52/285 (18%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK--------------------------- 37
++G G +G VYKGK +VA+K+LN T
Sbjct: 12 VGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 38 -GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
G+ A++ ++ SL ++ K + L IA A+G++YLH
Sbjct: 70 MGYSTAPQL-AIVTQWCEGSSLYHHLHII-----ETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF-C 155
I+H D+K +NI L ED KI DFGLA + G++ ++APEV
Sbjct: 124 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 156 RNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214
++ S++SDVY++G++++E+ TG + ++ R L DL
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQL-----PYSNINNRDQIIFMVGRGYLSPDL---- 231
Query: 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSL 259
++ + M + C++ +RP +++ +E SL
Sbjct: 232 --SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-49
Identities = 69/279 (24%), Positives = 119/279 (42%), Gaps = 50/279 (17%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GF 39
F ++G G +G V+ G L+ VAIK + E G
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 40 CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
C E L++EF+ +G L ++ + L E L + + + G+ YL C
Sbjct: 69 CLEQAPICLVFEFMEHGCLSDYLRTQRGLFA-----AETLLGMCLDVCEGMAYLEEAC-- 121
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFG 159
++H D+ N L+ E+ K+SDFG+ + + S G + V + +PEVF +F
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVF--SFS 177
Query: 160 EVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEE 219
S KSDV+S+G++++E+ SE P+ E+ ED+ G +
Sbjct: 178 RYSSKSDVWSFGVLMWEV-------------FSEGKIPYENRSNSEVVEDI-STGFRLYK 223
Query: 220 DKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258
+ + + + C + P DRPA +R++ L +S
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-48
Identities = 59/274 (21%), Positives = 111/274 (40%), Gaps = 50/274 (18%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GF 39
F +LG G +G V GK +VAIK++ E G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 40 CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
C + +I E+++NG L ++ E + + + L ++ + +EYL +
Sbjct: 68 CTKQRPIFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLE---SK 119
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFG 159
+ LH D+ N L+++ K+SDFGL++ E S G++ V + PEV
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMY--S 176
Query: 160 EVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEE 219
+ S KSD++++G++++E+ S P+ + E E + QG+
Sbjct: 177 KFSSKSDIWAFGVLMWEI-------------YSLGKMPYERFTNSETAEHI-AQGLRLYR 222
Query: 220 DKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
+ K+ + C +RP ++ +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 8e-48
Identities = 59/295 (20%), Positives = 107/295 (36%), Gaps = 54/295 (18%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GF 39
+ +G+G +G V++GK G VA+K+ + +
Sbjct: 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 40 CFEGHRRA----LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
+ + L+ ++ +GSL ++ + E + K+A+ A GL +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-------RYTVTVEGMIKLALSTASGLAHLHM 118
Query: 96 GC-----NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS--MTGARGTVGY 148
I H D+K NIL+ ++ I+D GLA + GT Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 149 IAPEVFCRNF----GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRL 204
+APEV + E ++D+Y+ G++ +E+ + + D Y +
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
Query: 205 E------LEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
E E+ L + E R M + C N + R R+ + L
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-47
Identities = 66/285 (23%), Positives = 111/285 (38%), Gaps = 48/285 (16%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKGF------------------------C 40
+ KLGQG +G V+ G VAIK L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 41 FEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
++ E++S GSL F+ + + L+ L +A IA G+ Y+
Sbjct: 81 VSEEPIYIVTEYMSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVE---RMN 133
Query: 101 ILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGE 160
+H D++ NIL+ E+ K++DFGLA++ E + GA+ + + APE G
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALY--GR 190
Query: 161 VSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEED 220
+ KSDV+S+G+++ E+T + +P V + + D +G
Sbjct: 191 FTIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREV---LDQVERGYRMPCP 236
Query: 221 KEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRP 265
E + + C + P +RP + LE S +P
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 3e-47
Identities = 62/274 (22%), Positives = 109/274 (39%), Gaps = 50/274 (18%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GF 39
+LG G +G V+ G VA+K L +
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 40 CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
+ +I E++ NGSL F+ KL L +A IA G+ ++
Sbjct: 77 VTQEPIY-IITEYMENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEERN-- 129
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFG 159
+H D++ NIL+ + KI+DFGLA++ E + GA+ + + APE N+G
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAI--NYG 185
Query: 160 EVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEE 219
+ KSDV+S+G+++ E+ + P+ E+ ++L +G
Sbjct: 186 TFTIKSDVWSFGILLTEI-------------VTHGRIPYPGMTNPEVIQNL-ERGYRMVR 231
Query: 220 DKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
++ + C + P DRP + + +LE
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (381), Expect = 1e-44
Identities = 71/285 (24%), Positives = 122/285 (42%), Gaps = 50/285 (17%)
Query: 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------- 37
+ K+KLG G YG VY+G VA+K L E
Sbjct: 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 79
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
G C +I EF++ G+L ++ E + Q++ VL +A I+ +EYL +
Sbjct: 80 GVCTREPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEK-- 133
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
+H D+ N L+ E+ K++DFGL+++ G ++ + GA+ + + APE
Sbjct: 134 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAY- 190
Query: 158 FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217
+ S KSDV+++G++++E+ + +D VY+ LE +
Sbjct: 191 -NKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYELLE-------KDYRM 235
Query: 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262
E + K+ + C Q NPSDRP+ + + E I
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 280
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (381), Expect = 1e-44
Identities = 53/301 (17%), Positives = 108/301 (35%), Gaps = 72/301 (23%)
Query: 5 FKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK--------------------- 37
+ +G+G +G V++ + VA+K+L E
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 38 ------GFCFEGHRRALIYEFVSNGSLEKFIYEK------------------HPLETNQK 73
G C G L++E+++ G L +F+
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 74 LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133
L IA +A G+ YL + +H D+ N L+ E+ KI+DFGL++ +
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSS 192
+ + + ++ PE N + +SDV++YG++++E+ +
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQ---------- 241
Query: 193 EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEML 252
P++ E+ + G + ++ + C P+DRP+ + +L
Sbjct: 242 ----PYYGMAHEEVIYYV-RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
Query: 253 E 253
+
Sbjct: 297 Q 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-44
Identities = 63/299 (21%), Positives = 108/299 (36%), Gaps = 64/299 (21%)
Query: 4 SFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK-------------------- 37
SF LG G +G V + VA+K+L +
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 38 --------GFCFEGHRRALIYEFVSNGSLEKFIYEKH------------PLETNQKLKWE 77
G C G +I E+ G L F+ K + L E
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 78 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137
L + +A+G+ +L +H D+ NILL KI DFGLA+ + V
Sbjct: 146 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFP 197
AR V ++APE +++SDV+SYG+ ++E+ + ++ + S+ Y
Sbjct: 203 VKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY-- 258
Query: 198 HWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256
+ +G + +M + C +P RP ++V+++E +
Sbjct: 259 -----------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (379), Expect = 4e-44
Identities = 66/293 (22%), Positives = 114/293 (38%), Gaps = 61/293 (20%)
Query: 5 FKNKLGQGGYGGVYKGKL-LDGRN---VAIKVLNETK----------------------- 37
+ +G G +G V G L L G+ VAIK L
Sbjct: 30 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 89
Query: 38 ----GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
G + +I EF+ NGSL+ F+ + T L + GIA G++YL
Sbjct: 90 IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT-----VIQLVGMLRGIAAGMKYL 144
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES---IVSMTGARGTVGYIA 150
+H D+ NIL++ + K+SDFGL++ S S G + + + A
Sbjct: 145 ADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210
PE + + + SDV+SYG++++E+ P+W ++ +
Sbjct: 202 PEAI--QYRKFTSASDVWSYGIVMWEVMSYG-------------ERPYWDMTNQDVINAI 246
Query: 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL---DSLR 260
Q + + + L C Q + + RP ++V L+ + +SL+
Sbjct: 247 -EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 298
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 6e-44
Identities = 65/284 (22%), Positives = 108/284 (38%), Gaps = 54/284 (19%)
Query: 6 KNKLGQGGYGGVYKGKLL---DGRNVAIKVLN------ETKGF----------------- 39
+LG G +G V +G +VAIKVL +T+
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 40 ---CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
+ L+ E G L KF+ K +++ + ++ ++ G++YL
Sbjct: 74 LIGVCQAEALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLE-- 126
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES-IVSMTGARGTVGYIAPEVFC 155
+H D+ N+LL KISDFGL+K +S + + + + + APE
Sbjct: 127 -EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI- 184
Query: 156 RNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215
NF + S +SDV+SYG+ ++E S P+ K E+ + QG
Sbjct: 185 -NFRKFSSRSDVWSYGVTMWEAL-------------SYGQKPYKKMKGPEVMAFI-EQGK 229
Query: 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSL 259
E E ++ + C DRP V + + SL
Sbjct: 230 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 8e-44
Identities = 71/318 (22%), Positives = 126/318 (39%), Gaps = 65/318 (20%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDG---RNVAIKVLNETK----------------------- 37
F++ +G+G +G V K ++ + AIK + E
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 38 -----GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETN----------QKLKWEVLYKI 82
G C L E+ +G+L F+ + LET+ L + L
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 83 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGA 142
A +ARG++YL + +H D+ NIL+ E++ KI+DFGL++ V T
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE---VYVKKTMG 186
Query: 143 RGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYK 202
R V ++A E N+ + SDV+SYG++++E+ S P+
Sbjct: 187 RLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEI-------------VSLGGTPYCGMT 231
Query: 203 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLR-- 260
EL E L QG E+ ++ + C + P +RP+ +++ L L+ +
Sbjct: 232 CAELYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 290
Query: 261 IPPRPFLLSSGSQPDSSG 278
+ + + + D S
Sbjct: 291 VNTTLYEKFTYAGIDCSA 308
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (376), Expect = 1e-43
Identities = 58/276 (21%), Positives = 96/276 (34%), Gaps = 62/276 (22%)
Query: 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------- 37
++G G +G VY + + + VAIK ++ +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 38 -GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
G H L+ E+ + + K PL+ + + G +GL YLH
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ------EVEIAAVTHGALQGLAYLHS- 133
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF-C 155
++H D+K NILL E K+ DFG A I S V GT ++APEV
Sbjct: 134 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILA 185
Query: 156 RNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214
+ G+ K DV+S G+ E+ P + + +
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAER---------------KPPLFNMNAMSALYHIAQNE 230
Query: 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250
+ ++ C+Q P DRP +++
Sbjct: 231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-43
Identities = 57/274 (20%), Positives = 102/274 (37%), Gaps = 54/274 (19%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------GFC 40
+G+G +G V G G VA+K + G
Sbjct: 11 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 41 FEGHRR-ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
E ++ E+++ GSL ++ + L + L K ++ + +EYL
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEG---N 122
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFG 159
+H D+ N+L+ ED K+SDFGL K + + V + APE
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALRE--K 175
Query: 160 EVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEE 219
+ S KSDV+S+G++++E+ + V R+E +G + +
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVE-------KGYKMDA 221
Query: 220 DKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
+ V C + + RP+ ++ E LE
Sbjct: 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-43
Identities = 64/303 (21%), Positives = 102/303 (33%), Gaps = 69/303 (22%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRN------VAIKVLNETK--------------------- 37
F LG G +G V VA+K+L E
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 38 -------GFCFEGHRRALIYEFVSNGSLEKFIYEKH-----------------PLETNQK 73
G C LI+E+ G L ++ K E
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 74 LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133
L +E L A +A+G+E+L +H D+ N+L+ KI DFGLA+
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSE 193
+ V AR V ++APE G + KSDV+SYG++++E+ S
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEI-------------FSL 262
Query: 194 IYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
P+ L G + ++ ++ ++ C + RP+ + L
Sbjct: 263 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
Query: 254 GSL 256
L
Sbjct: 323 CQL 325
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-43
Identities = 65/293 (22%), Positives = 121/293 (41%), Gaps = 60/293 (20%)
Query: 4 SFKNKLGQGGYGGVYKGKLLDG-----RNVAIKVLNETK--------------------- 37
+ + +G G +G VYKG L VAIK L
Sbjct: 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 69
Query: 38 ------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLE 91
G + +I E++ NG+L+KF+ EK + L + GIA G++
Sbjct: 70 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMK 124
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC-HGRESIVSMTGARGTVGYIA 150
YL +H D+ NIL++ + K+SDFGL+++ E+ + +G + + + A
Sbjct: 125 YLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210
PE ++ + + SDV+S+G++++E+ + P+W E+ + +
Sbjct: 182 PEAI--SYRKFTSASDVWSFGIVMWEV-------------MTYGERPYWELSNHEVMKAI 226
Query: 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG---SLDSLR 260
G + + + + C Q + RP +V +L+ + DSL+
Sbjct: 227 -NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 5e-42
Identities = 62/289 (21%), Positives = 113/289 (39%), Gaps = 58/289 (20%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRN----VAIKVLNETK----------------------- 37
F +G+G +G VY G LLD A+K LN
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 38 ----GFCFEGHRRA-LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEY 92
G C ++ ++ +G L FI + + L + +A+G+
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGM-- 143
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE--SIVSMTGARGTVGYIA 150
+ + +H D+ N +LDE F K++DFGLA+ + +E S+ + TGA+ V ++A
Sbjct: 144 -KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210
E + + KSDV+S+G++++E+ + P+ ++ L
Sbjct: 203 LESLQT--QKFTTKSDVWSFGVLLWEL-------------MTRGAPPYPDVNTFDITVYL 247
Query: 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSL 259
LQG + + + V L C RP+ + +V + +
Sbjct: 248 -LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-41
Identities = 56/279 (20%), Positives = 99/279 (35%), Gaps = 54/279 (19%)
Query: 5 FKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------- 37
+G G YG K + DG+ + K L+
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 38 --GFCFEGHRRAL--IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
+ L + E+ G L I + Q L E + ++ + L+
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 94 HR--GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAP 151
HR +LH D+KP N+ LD K+ DFGLA+I + S GT Y++P
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSP 183
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211
E N + KSD++S G +++E+ + P + + EL +
Sbjct: 184 EQM--NRMSYNEKSDIWSLGCLLYELCALM--------------PPFTAFSQKELAGKI- 226
Query: 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250
+G Y+ ++ + + RP++ ++E
Sbjct: 227 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-41
Identities = 61/278 (21%), Positives = 102/278 (36%), Gaps = 56/278 (20%)
Query: 7 NKLGQGGYGGVYKGKLLD---GRNVAIKVLNETKG------------------------- 38
+LG G +G V KG + VA+K+L
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 39 --FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
E L+ E G L K++ + +K + + ++ ++ G++YL
Sbjct: 73 MIGICEAESWMLVMEMAELGPLNKYLQQNRH------VKDKNIIELVHQVSMGMKYLE-- 124
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES-IVSMTGARGTVGYIAPEVFC 155
+ +H D+ N+LL KISDFGL+K E+ + T + V + APE
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 156 RNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215
+ S KSDV+S+G++++E S P+ K E+ L +G
Sbjct: 184 Y--YKFSSKSDVWSFGVLMWEAF-------------SYGQKPYRGMKGSEVTAML-EKGE 227
Query: 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
R+M + C + +RP V L
Sbjct: 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-41
Identities = 68/300 (22%), Positives = 111/300 (37%), Gaps = 65/300 (21%)
Query: 5 FKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK--------------------- 37
LG+G +G V + R VA+K+L E
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 38 -------GFCFE-GHRRALIYEFVSNGSLEKFIYEKHPLETNQK----------LKWEVL 79
G C + G +I EF G+L ++ K K L E L
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 80 YKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSM 139
+ +A+G+E+L + + +H D+ NILL E KI DFGLA+ + V
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 140 TGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPH 198
AR + ++APE + +SDV+S+G++++E+ + + +
Sbjct: 194 GDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASP-------YPGVKIDE 244
Query: 199 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258
+RL+ +G +M L C PS RP + +VE L L +
Sbjct: 245 EFCRRLK-------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-41
Identities = 44/202 (21%), Positives = 83/202 (41%), Gaps = 42/202 (20%)
Query: 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------- 37
++LG G G V+K G +A K+++
Sbjct: 9 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 38 --GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
G + ++ E + GSL++ + + + ++L K+++ + +GL YL
Sbjct: 69 FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP------EQILGKVSIAVIKGLTYLRE 122
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
+I+H D+KP NIL++ K+ DFG++ + GT Y++PE
Sbjct: 123 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERL- 175
Query: 156 RNFGEVSYKSDVYSYGMMVFEM 177
S +SD++S G+ + EM
Sbjct: 176 -QGTHYSVQSDIWSMGLSLVEM 196
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-40
Identities = 58/281 (20%), Positives = 101/281 (35%), Gaps = 63/281 (22%)
Query: 5 FKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------- 37
F ++G+G + VYKG + VA L + K
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 38 ------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLE 91
L+ E +++G+L+ ++ +K +VL I +GL+
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQ 126
Query: 92 YLHRGCNTRILHFDIKPHNILL-DEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIA 150
+LH I+H D+K NI + KI D GLA + GT ++A
Sbjct: 127 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMA 181
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKRLELEED 209
PE++ + DVY++GM + EM T SE +Y+R+
Sbjct: 182 PEMYE---EKYDESVDVYAFGMCMLEMATSEYP--------YSECQNAAQIYRRVTSGVK 230
Query: 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250
DK ++ + CI+ N +R ++ ++
Sbjct: 231 ------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-40
Identities = 61/302 (20%), Positives = 105/302 (34%), Gaps = 59/302 (19%)
Query: 4 SFKNKLGQGGYGGVYKGKLLD-----GRNVAIKVLNETKG-------------------- 38
LG G +G VYKG + VAIK L E
Sbjct: 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71
Query: 39 ------FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEY 92
LI + + G L ++ E + L V IA+G+ Y
Sbjct: 72 HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIG-----SQYLLNWCVQIAKGMNY 126
Query: 93 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPE 152
L + R++H D+ N+L+ KI+DFGLAK+ E G + + ++A E
Sbjct: 127 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 153 VFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212
+++SDV+SYG+ V+E+ P+ E+ L
Sbjct: 184 SILH--RIYTHQSDVWSYGVTVWELMTFG-------------SKPYDGIPASEISSIL-E 227
Query: 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPPRPFLLSSGS 272
+G + + ++ + C + RP ++ + P+ +L+ G
Sbjct: 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS----KMARDPQRYLVIQGD 283
Query: 273 QP 274
+
Sbjct: 284 ER 285
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 4e-39
Identities = 62/275 (22%), Positives = 97/275 (35%), Gaps = 53/275 (19%)
Query: 5 FKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------- 37
LG+G YG V VA+K+++ +
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 38 -GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
G EG+ + L E+ S G L I E + + + + G+ YLH
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRI------EPDIGMPEPDAQRFFHQLMAGVVYLHG- 121
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156
I H DIKP N+LLDE KISDFGLA + + GT+ Y+APE+ +
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-K 178
Query: 157 NFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215
+ DV+S G+++ M G S + W K+ L +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKID-- 233
Query: 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250
++ + NPS R + + +
Sbjct: 234 ------SAPLALL---HKILVENPSARITIPDIKK 259
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 5e-39
Identities = 64/295 (21%), Positives = 119/295 (40%), Gaps = 65/295 (22%)
Query: 5 FKNKLGQGGYGGVYKGKLL--------DGRNVAIKVLNETK------------------- 37
LG+G +G V + + VA+K+L
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 38 ---------GFCFEGHRRALIYEFVSNGSLEKFIYEKHP----------LETNQKLKWEV 78
G C + +I E+ S G+L +++ + P ++L +
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 79 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVS 138
L A +ARG+EYL + + +H D+ N+L+ ED KI+DFGLA+ H +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 139 MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPH 198
T R V ++APE +++SDV+S+G++++E+ + + V
Sbjct: 194 TTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------VE 244
Query: 199 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
++K L+ +G ++ ++ ++ C PS RP ++VE L+
Sbjct: 245 ELFKLLK-------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-38
Identities = 54/283 (19%), Positives = 95/283 (33%), Gaps = 58/283 (20%)
Query: 5 FKNKLGQGGYGGVYKGKLL----DGRNVAIKVLNETK----------------------- 37
KLG G +G V +G+ +VA+K L
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 38 ------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLE 91
G + ++ E GSL + + L + AV +A G+
Sbjct: 72 NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMG 125
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICHGRESIVSMTGARGTVGYIA 150
YL + R +H D+ N+LL KI DFGL + + + V + + A
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210
PE S+ SD + +G+ ++EM + P ++ +
Sbjct: 183 PESL--KTRTFSHASDTWMFGVTLWEMF-------------TYGQEPWIGLNGSQILHKI 227
Query: 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253
+G ++ + + V + C + P DRP + + L
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-38
Identities = 60/293 (20%), Positives = 111/293 (37%), Gaps = 60/293 (20%)
Query: 4 SFKNKLGQGGYGGVYKGKL------LDGRNVAIKVLNETK-------------------- 37
+ +LGQG +G VY+G VAIK +NE
Sbjct: 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82
Query: 38 -------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETN----QKLKWEVLYKIAVGI 86
G +G +I E ++ G L+ ++ P N + ++A I
Sbjct: 83 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142
Query: 87 ARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTV 146
A G+ YL + +H D+ N ++ EDF KI DFG+ + + + V
Sbjct: 143 ADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 147 GYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206
+++PE G + SDV+S+G++++E+ Y+ L
Sbjct: 200 RWMSPESL--KDGVFTTYSDVWSFGVVLWEI----------------ATLAEQPYQGLSN 241
Query: 207 EEDLG--LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257
E+ L ++G ++ + + C Q NP RP+ ++ ++ ++
Sbjct: 242 EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-38
Identities = 60/277 (21%), Positives = 102/277 (36%), Gaps = 63/277 (22%)
Query: 5 FKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------- 37
LG+G +G VY + +A+KVL + +
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 38 ---GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
G+ + R LI E+ G++ + + + K + +A L Y H
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTATYITELANALSYCH 123
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF 154
R++H DIKP N+LL KI+DFG + T GT+ Y+ PE+
Sbjct: 124 SK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMI 176
Query: 155 CRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213
K D++S G++ +E G + F Y+ + ++
Sbjct: 177 EG--RMHDEKVDLWSLGVLCYEFLVG-------------KPPFEANTYQET-YKRISRVE 220
Query: 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250
+ E AR +I +++NPS RP + V+E
Sbjct: 221 FTFPDFVTEGARDLI---SRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 6e-38
Identities = 51/278 (18%), Positives = 96/278 (34%), Gaps = 57/278 (20%)
Query: 5 FKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------- 37
+LG G +G VYK + + A KV++
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
+ + ++ EF + G+++ + E + L + + L YLH
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLHD-- 128
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF--- 154
+I+H D+K NIL D K++DFG++ +I GT ++APEV
Sbjct: 129 -NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMCE 185
Query: 155 CRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213
YK+DV+S G+ + EM PH + + +
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEI---------------EPPHHELNPMRVLLKIAKS 230
Query: 214 GIEN-EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250
+ ++ C++ N R +++++
Sbjct: 231 EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-36
Identities = 56/287 (19%), Positives = 96/287 (33%), Gaps = 57/287 (19%)
Query: 5 FKNKLGQGGYGGVYKGKLLDGRN----VAIKVLNETK----------------------- 37
+G+G +G V++G + N VAIK
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 38 ----GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
G E +I E + G L F+ + L L A ++ L YL
Sbjct: 71 VKLIGVITENPVW-IIMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYL 124
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEV 153
R +H DI N+L+ + C K+ DFGL++ + G + + ++APE
Sbjct: 125 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKWMAPES 180
Query: 154 FCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213
NF + SDV+ +G+ ++E+ P K ++ +
Sbjct: 181 I--NFRRFTSASDVWMFGVCMWEI-------------LMHGVKPFQGVKNNDVIGRI-EN 224
Query: 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLR 260
G + + C +PS RP + L L+ +
Sbjct: 225 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 5e-35
Identities = 58/276 (21%), Positives = 97/276 (35%), Gaps = 64/276 (23%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKVLNETK--------------------------GF 39
K+GQG G VY + G+ VAI+ +N +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 40 CFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 99
G ++ E+++ GSL + E + + + LE+LH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM-------DEGQIAAVCRECLQALEFLHS---N 135
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFG 159
+++H DIK NILL D K++DFG +S + GT ++APEV R
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTR--K 191
Query: 160 EVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 218
K D++S G+M EM G P+ L + G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG---------------EPPYLNENPLRALYLIATNGTPEL 236
Query: 219 EDKEY----ARKMILVSLWCIQNNPSDRPAMNRVVE 250
++ E R + C+ + R + +++
Sbjct: 237 QNPEKLSAIFRDFL---NRCLDMDVEKRGSAKELLQ 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-33
Identities = 47/203 (23%), Positives = 75/203 (36%), Gaps = 41/203 (20%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETK-------------------------- 37
F LG+G + V + L R AIK+L +
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 38 ---GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
+ + + NG L K+I + + I LEYLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD------ETCTRFYTAEIVSALEYLH 125
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF 154
I+H D+KP NILL+ED +I+DFG AK+ GT Y++PE+
Sbjct: 126 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 155 CRNFGEVSYKSDVYSYGMMVFEM 177
SD+++ G +++++
Sbjct: 183 --TEKSACKSSDLWALGCIIYQL 203
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 120 bits (301), Expect = 6e-33
Identities = 53/290 (18%), Positives = 98/290 (33%), Gaps = 71/290 (24%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETK-------------------------- 37
K LG+G V + + A+K+++ T
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 38 ----------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIA 87
L+++ + G L ++ EK L + KI +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL------SEKETRKIMRALL 120
Query: 88 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVG 147
+ LH+ I+H D+KP NILLD+D K++DFG + E + GT
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 174
Query: 148 YIAPEVF----CRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYK 202
Y+APE+ N + D++S G++++ + G P W K
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG---------------SPPFWHRK 219
Query: 203 RLELEEDL--GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250
++ + + G + E +Y+ + + + P R +
Sbjct: 220 QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 120 bits (302), Expect = 1e-32
Identities = 49/275 (17%), Positives = 95/275 (34%), Gaps = 54/275 (19%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETK-------------------------- 37
+LG G +G V++ G N A K +
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
+ + +IYEF+S G L + + ++H K+ + + + +GL ++H
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 98 NTRILHFDIKPHNILLDEDFCP--KISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
+H D+KP NI+ K+ DFGL ++S+ TG + APEV
Sbjct: 145 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAE 198
Query: 156 RNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215
V Y +D++S G++ + + S F +
Sbjct: 199 G--KPVGYYTDMWSVGVLSYILL------------SGLSPFGGENDDETLRNVKSCDWNM 244
Query: 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250
++ + + +P+ R +++ +E
Sbjct: 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (291), Expect = 2e-31
Identities = 47/293 (16%), Positives = 86/293 (29%), Gaps = 53/293 (18%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETK-------------------------G 38
K+G G +G +Y G + G VAIK+
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
EG ++ E + + F + + + +A + +EY+H
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRKFS------LKTVLLLADQMISRIEYIHS--- 121
Query: 99 TRILHFDIKPHNIL---LDEDFCPKISDFGLAKIC-----HGRESIVSMTGARGTVGYIA 150
+H D+KP N L + I DFGLAK H GT Y +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210
E S + D+ S G ++ + + K++ ++
Sbjct: 182 INTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPP 263
+G +E + +C D+P + + ++
Sbjct: 240 LCKGYPSE-----FATYL---NFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 116 bits (292), Expect = 6e-31
Identities = 55/273 (20%), Positives = 99/273 (36%), Gaps = 60/273 (21%)
Query: 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK------------------------- 37
S +G+GG+G VY + D G+ A+K L++ +
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 38 -------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGL 90
+ + I + ++ G L + + + A I GL
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV------FSEADMRFYAAEIILGL 120
Query: 91 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIA 150
E++H +++ D+KP NILLDE +ISD GLA ++ S+ GT GY+A
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMA 173
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210
PEV + +D +S G M+F++ + + + +EL +
Sbjct: 174 PEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRP 243
R ++ +Q + + R
Sbjct: 233 S----------PELRSLL---EGLLQRDVNRRL 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 114 bits (287), Expect = 7e-31
Identities = 42/293 (14%), Positives = 90/293 (30%), Gaps = 57/293 (19%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVLNETK-------------------------GFCF 41
++G+G +G +++G LL+ + VAIK F
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71
Query: 42 EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRI 101
EG L+ + + + + + A + ++ +H +
Sbjct: 72 EGLHNVLVIDLLGPSLEDLLDLCGRKFS------VKTVAMAAKQMLARVQSIHE---KSL 122
Query: 102 LHFDIKPHNILLDEDFCP-----KISDFGLAKICHGRES-----IVSMTGARGTVGYIAP 151
++ DIKP N L+ + DFG+ K + GT Y++
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210
E S + D+ + G + G + + + Y + E ++
Sbjct: 183 NTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE-----RIGEKKQST 235
Query: 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPP 263
L+ + +E+ + M + P + + + L+ L
Sbjct: 236 PLRELCAGFPEEFYKYM----HYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 9e-30
Identities = 54/301 (17%), Positives = 97/301 (32%), Gaps = 55/301 (18%)
Query: 9 LGQGGYGGVYKGK-LLDGRNVAIKVLNETK--------------------------GFCF 41
LG G G V + A+K+L +
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 79
Query: 42 EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRI 101
++ E + G L I ++ +Q +I I ++YLH I
Sbjct: 80 GRKCLLIVMECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHS---INI 132
Query: 102 LHFDIKPHNILLDEDFCP---KISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
H D+KP N+L K++DFG AK S+ + T Y+APEV
Sbjct: 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVLGP-- 187
Query: 159 GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 218
+ D++S G++++ + + + + R+ E
Sbjct: 188 EKYDKSCDMWSLGVIMYIL----LCGYPPFYSNHGLAISPGMKTRI-RMGQYEFPNPEWS 242
Query: 219 EDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS--LDSLRIPPRPFLLSSGSQPDS 276
E E + +I ++ P+ R + E + + S ++P P S + D
Sbjct: 243 EVSEEVKMLI---RNLLKTEPTQRMTIT---EFMNHPWIMQSTKVPQTPLHTSRVLKEDK 296
Query: 277 S 277
Sbjct: 297 E 297
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 3e-29
Identities = 51/234 (21%), Positives = 85/234 (36%), Gaps = 51/234 (21%)
Query: 5 FKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------- 37
LG+G +G V+ + + AIK L +
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 38 ----GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
+ E+++ G L I H + A I GL++L
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD------LSRATFYAAEIILGLQFL 119
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEV 153
H I++ D+K NILLD+D KI+DFG+ K ++ GT YIAPE+
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEI 174
Query: 154 FCRNFGEVSYKSDVYSYGMMVFEM-------TGVKNNANVAVDRSSEIYFPHWV 200
+ ++ D +S+G++++EM G R ++P W+
Sbjct: 175 LLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL 226
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 110 bits (276), Expect = 4e-29
Identities = 46/201 (22%), Positives = 70/201 (34%), Gaps = 39/201 (19%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETK-------------------------- 37
F++ LG G + V + + VAIK + +
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72
Query: 38 -GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 96
G LI + VS G L I EK ++ + ++YLH
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYT------ERDASRLIFQVLDAVKYLHDL 126
Query: 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156
LDED ISDFGL+K+ ++ A GT GY+APEV +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQ 183
Query: 157 NFGEVSYKSDVYSYGMMVFEM 177
S D +S G++ + +
Sbjct: 184 --KPYSKAVDCWSIGVIAYIL 202
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 110 bits (276), Expect = 8e-29
Identities = 46/199 (23%), Positives = 77/199 (38%), Gaps = 42/199 (21%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVLNETK--------------------------GFC 40
+LG G +G V++ GR K +N
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 41 FEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 100
+ + LI EF+S G L I + + K+ + GL+++H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMHE---HS 147
Query: 101 ILHFDIKPHNILLDEDFCP--KISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
I+H DIKP NI+ + KI DFGLA + E + T T + APE+ R
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDR-- 202
Query: 159 GEVSYKSDVYSYGMMVFEM 177
V + +D+++ G++ + +
Sbjct: 203 EPVGFYTDMWAIGVLGYVL 221
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 4e-28
Identities = 46/274 (16%), Positives = 87/274 (31%), Gaps = 59/274 (21%)
Query: 8 KLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------GFCF 41
LG+G +G V++ + K +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 42 EGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRI 101
+I+EF+S + + I +L + + L++LH I
Sbjct: 72 SMEELVMIFEFISGLDIFERINTS-----AFELNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 102 LHFDIKPHNILLDEDFCP--KISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFG 159
HFDI+P NI+ KI +FG A+ + + Y APEV
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQH--D 178
Query: 160 EVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL--GLQGIE 216
VS +D++S G +V+ + +G P ++ E++ +
Sbjct: 179 VVSTATDMWSLGTLVYVLLSG---------------INPFLAETNQQIIENIMNAEYTFD 223
Query: 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250
E KE + + + + R + ++
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 5e-27
Identities = 46/200 (23%), Positives = 79/200 (39%), Gaps = 36/200 (18%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKVLNETK---------------------------G 38
+ +G+G YG V ++ VAIK ++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
+ ++ + +Y+ L Q L + + I RGL+Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYK---LLKTQHLSNDHICYFLYQILRGLKYIHSA-- 128
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICH-GRESIVSMTGARGTVGYIAPEVFCRN 157
+LH D+KP N+LL+ KI DFGLA++ + +T T Y APE+ +
Sbjct: 129 -NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 158 FGEVSYKSDVYSYGMMVFEM 177
G + D++S G ++ EM
Sbjct: 188 KG-YTKSIDIWSVGCILAEM 206
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 6e-27
Identities = 54/204 (26%), Positives = 78/204 (38%), Gaps = 40/204 (19%)
Query: 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK----------------------GFC 40
+ +G G +G VY+ KL D G VAIK + + K F
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 41 FEGHRR------ALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
+ + L+ ++V +H Q L + + R L Y+H
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVA---RHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 95 RGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEV 153
I H DIKP N+LLD D K+ DFG AK E VS +R Y APE+
Sbjct: 140 SF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPEL 193
Query: 154 FCRNFGEVSYKSDVYSYGMMVFEM 177
+ DV+S G ++ E+
Sbjct: 194 IFGATD-YTSSIDVWSAGCVLAEL 216
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 8e-27
Identities = 55/288 (19%), Positives = 103/288 (35%), Gaps = 52/288 (18%)
Query: 7 NKLGQGGYGGVYKGKLL--DGRNVAIKVLNETK--------------------------- 37
++G+G YG V+K + L GR VA+K +
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 38 ----GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYL 93
C + +++ + + E + + + RGL++L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 94 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEV 153
H ++H D+KP NIL+ K++DFGLA+I + ++ S+ T+ Y APEV
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV---VVTLWYRAPEV 186
Query: 154 FCRNFGEVSYKSDVYSYGMMVFEMTGVKN--NANVAVDRSSEIYFPHWVYKRLELEEDLG 211
+ + D++S G + EM K + VD+ +I + + D+
Sbjct: 187 LLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 212 LQGIENEEDKEYARKMILVSL---------WCIQNNPSDRPAMNRVVE 250
L + + + C+ NP+ R + +
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 102 bits (255), Expect = 2e-26
Identities = 55/276 (19%), Positives = 96/276 (34%), Gaps = 60/276 (21%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETK-------------------------- 37
LG GG V+ + L R+VA+KVL
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70
Query: 38 ---GFCFE----GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGL 90
G ++ E+V +L ++ + P+ + ++ + L
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT------PKRAIEVIADACQAL 124
Query: 91 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICHGRESIVSMTGARGTVGYI 149
+ H+ I+H D+KP NI++ K+ DFG+A+ I S+ GT Y+
Sbjct: 125 NFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 150 APEVFCRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKRLELEE 208
+PE V +SDVYS G +++E+ TG E F + +
Sbjct: 182 SPEQARG--DSVDARSDVYSLGCVLYEVLTG-------------EPPFTGDSPVSVAYQH 226
Query: 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPA 244
+ + + + V L + NP +R
Sbjct: 227 VREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 7e-26
Identities = 54/293 (18%), Positives = 93/293 (31%), Gaps = 64/293 (21%)
Query: 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------- 37
+ LG+G + VYK + + VAIK +
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 38 ---GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
+L+++F+ L + + +GLEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV------LTPSHIKAYMLMTLQGLEYLH 117
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF 154
+ ILH D+KP+N+LLDE+ K++DFGLAK + T T Y APE+
Sbjct: 118 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELL 172
Query: 155 CRNFGEVSYKSDVYSYGMMVFEM-TG---------------VKNNANVAVDRSSEIYFPH 198
D+++ G ++ E+ + +
Sbjct: 173 FGARM-YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231
Query: 199 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM 251
Y + + L I + + +I NP R + ++M
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDD-LLDLI---QGLFLFNPCARITATQALKM 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 8e-26
Identities = 54/280 (19%), Positives = 86/280 (30%), Gaps = 73/280 (26%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVLNETK----------------------------- 37
LG GG+G VY G + D VAIK + + +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 38 -----GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEY 92
+ LI E + L+ E+ + + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRH 125
Query: 93 LHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICHGRESIVSMTGARGTVGYIAP 151
N +LH DIK NIL+D + K+ DFG + T GT Y P
Sbjct: 126 C---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPP 178
Query: 152 EVFCRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210
E R + V+S G+++++M G + +++F V
Sbjct: 179 EWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV---------- 227
Query: 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250
+ +I WC+ PSDRP +
Sbjct: 228 ----------SSECQHLI---RWCLALRPSDRPTFEEIQN 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 100 bits (249), Expect = 2e-25
Identities = 57/285 (20%), Positives = 102/285 (35%), Gaps = 53/285 (18%)
Query: 7 NKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------G 38
K+G+G YG VYK + G A+K + K
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
R L++E + + + LE + + G+ Y H
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLE------SVTAKSFLLQLLNGIAYCHD--- 118
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
R+LH D+KP N+L++ + KI+DFGLA+ + T T+ Y AP+V
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEIVTLWYRAPDVL-MGS 175
Query: 159 GEVSYKSDVYSYGMMVFEM-TGV-----KNNANVAVDRSSEIYFPH---WVYKRLELEED 209
+ S D++S G + EM G + A+ + + P+ W + D
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 210 LGLQGIENEEDKEYARKM--ILVSL--WCIQNNPSDRPAMNRVVE 250
E + + + + + L ++ +P+ R + +E
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.2 bits (246), Expect = 6e-25
Identities = 52/286 (18%), Positives = 100/286 (34%), Gaps = 53/286 (18%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKVLNETK---------------------------- 37
K+G+G YG VYK + L G VA+K +
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
++ L++EF+ + L+KF+ + ++ + +GL + H
Sbjct: 68 DVIHTENKLYLVFEFL-HQDLKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
+LH D+KP N+L++ + K++DFGLA+ T T+ Y APE+
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGC 177
Query: 158 FGEVSYKSDVYSYGMMVFEM-TGV-----KNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211
S D++S G + EM T + + + P V
Sbjct: 178 -KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 212 LQGIENEEDKEYARKMILVS-------LWCIQNNPSDRPAMNRVVE 250
+++++ + + + +P+ R + +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 98.6 bits (245), Expect = 1e-24
Identities = 51/203 (25%), Positives = 79/203 (38%), Gaps = 46/203 (22%)
Query: 5 FKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------- 37
LG G +G V+ + +GR A+KVL +
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67
Query: 38 ---GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
G + + +I +++ G L + + V A + LEYLH
Sbjct: 68 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP------NPVAKFYAAEVCLALEYLH 121
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF 154
I++ D+KP NILLD++ KI+DFG AK GT YIAPEV
Sbjct: 122 SKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVV 173
Query: 155 CRNFGEVSYKSDVYSYGMMVFEM 177
+ D +S+G++++EM
Sbjct: 174 ST--KPYNKSIDWWSFGILIYEM 194
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.6 bits (237), Expect = 2e-23
Identities = 42/203 (20%), Positives = 74/203 (36%), Gaps = 43/203 (21%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETK-------------------------- 37
+ LG+G +G V + GR A+K+L +
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 38 ---GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 94
R + E+ + G L + + + + A + L
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY---------GAEIVSALE 119
Query: 95 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVF 154
+ +++ DIK N++LD+D KI+DFGL K + +M GT Y+APEV
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVL 177
Query: 155 CRNFGEVSYKSDVYSYGMMVFEM 177
+ D + G++++EM
Sbjct: 178 ED--NDYGRAVDWWGLGVVMYEM 198
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 2e-23
Identities = 56/283 (19%), Positives = 90/283 (31%), Gaps = 63/283 (22%)
Query: 5 FKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------- 37
+LG G + V K + G A K + + +
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 38 ------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLE 91
LI E V+ G L F+ EK L E + I G+
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVY 127
Query: 92 YLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLAKICHGRESIVSMTGARGTVG 147
YLH I HFD+KP NI+L + P KI DFGLA GT
Sbjct: 128 YLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPE 181
Query: 148 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207
++APE+ N+ + ++D++S G++ + + S F +
Sbjct: 182 FVAPEIV--NYEPLGLEADMWSIGVITYILL------------SGASPFLGDTKQETLAN 227
Query: 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250
E+E + + +P R + ++
Sbjct: 228 VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.1 bits (233), Expect = 9e-23
Identities = 42/200 (21%), Positives = 74/200 (37%), Gaps = 46/200 (23%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVLNETK----------------------------- 37
LG G +G V K G + A+K+L++ K
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
+ ++ E+V+ G + + A I EYLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS------EPHARFYAAQIVLTFEYLHS-- 159
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
+++ D+KP N+L+D+ +++DFG AK GR GT +APE+
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILS- 212
Query: 158 FGEVSYKSDVYSYGMMVFEM 177
+ D ++ G++++EM
Sbjct: 213 -KGYNKAVDWWALGVLIYEM 231
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 9e-23
Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 49/210 (23%)
Query: 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVL---NETKGFCFEGHRRA--------------- 47
K+GQG +G V+K + G+ VA+K + NE +GF R
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 48 ------------------LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARG 89
L+++F + K + ++ + G
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNG 129
Query: 90 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES--IVSMTGARGTVG 147
L Y+HR +ILH D+K N+L+ D K++DFGLA+ ++ T T+
Sbjct: 130 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 148 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 177
Y PE+ + D++ G ++ EM
Sbjct: 187 YRPPELL-LGERDYGPPIDLWGAGCIMAEM 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 93.8 bits (232), Expect = 1e-22
Identities = 49/289 (16%), Positives = 99/289 (34%), Gaps = 66/289 (22%)
Query: 5 FKNKLGQGGYGGVYKGK-LLDGRNVAIKVLNETK-------------------------- 37
KLG+G Y V++ + + V +K+L K
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADI 98
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
AL++E V+N ++ Q L + I + L+Y H
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLY---------QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 98 NTRILHFDIKPHNILLDEDFCP-KISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCR 156
I+H D+KPHN+++D + ++ D+GLA+ H + + + PE+
Sbjct: 150 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPEL-LV 202
Query: 157 NFGEVSYKSDVYSYGMMVFEMTGVK------NNANVAVDRSSEIYFPHWVY---KRLELE 207
++ Y D++S G M+ M K ++ + R +++ +Y + +E
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 208 EDLGLQGIENEEDKEYARKMILVSLW-------------CIQNNPSDRP 243
D I ++ + + ++ + R
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 311
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 2e-21
Identities = 60/287 (20%), Positives = 95/287 (33%), Gaps = 55/287 (19%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVLNETK----------------------------G 38
+G G YG V G VAIK L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 39 FCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 98
+F K L ++KL + + + + +GL Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGK--LMKHEKLGEDRIQFLVYQMLKGLRYIHAAGI 142
Query: 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNF 158
H D+KP N+ ++ED KI DFGLA+ MTG T Y APEV N+
Sbjct: 143 I---HRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVI-LNW 193
Query: 159 GEVSYKSDVYSYGMMVFEM-------TGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211
+ D++S G ++ EM G + + P +RL+ +E
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253
Query: 212 -LQGIENEEDKEYARKMILVS-------LWCIQNNPSDRPAMNRVVE 250
++G+ E K++A + S + + R +
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.2 bits (220), Expect = 2e-21
Identities = 43/200 (21%), Positives = 74/200 (37%), Gaps = 41/200 (20%)
Query: 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLN----------------------------ETK 37
K+G+G YG V+K K VA+K +
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 38 GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
+ L++EF + F N L E++ + +GL + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDS------CNGDLDPEIVKSFLFQLLKGLGFCH--- 118
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
+ +LH D+KP N+L++ + K+++FGLA+ S T+ Y P+V
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV--VTLWYRPPDVLFGA 176
Query: 158 FGEVSYKSDVYSYGMMVFEM 177
S D++S G + E+
Sbjct: 177 -KLYSTSIDMWSAGCIFAEL 195
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 3e-21
Identities = 49/279 (17%), Positives = 93/279 (33%), Gaps = 59/279 (21%)
Query: 5 FKNKLGQGGYGGVYKGKLL----DGRNVAIKVLNETK----------------------- 37
LG G YG V+ + + G+ A+KVL +
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 38 --------GFCFEGHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARG 89
+ LI ++++ G L + ++ ++ + +
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY---------VGEI 138
Query: 90 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYI 149
+ L I++ DIK NILLD + ++DFGL+K E+ + GT+ Y+
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF-CGTIEYM 197
Query: 150 APEVFCRNFGEVSYKSDVYSYGMMVFEM-TGVKNNANVAVDRSSEIYFPHWVYKRLELEE 208
AP++ D +S G++++E+ TG F K + E
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTG-------------ASPFTVDGEKNSQAEI 244
Query: 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNR 247
+ E +E + + + +P R
Sbjct: 245 SRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 86.2 bits (212), Expect = 6e-20
Identities = 39/207 (18%), Positives = 78/207 (37%), Gaps = 41/207 (19%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRALIYEFVSNGSLEKFIYEKH 66
KLG G + V+ K +++ +VA+K++ K + + + V++ K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 67 P-----------------------------------LETNQKLKWEVLYKIAVGIARGLE 91
++ + + +I+ + GL+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 92 YLHRGCNTRILHFDIKPHNILLD-EDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIA 150
Y+HR C I+H DIKP N+L++ D + +A + + T + T Y +
Sbjct: 140 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 151 PEVFCRNFGEVSYKSDVYSYGMMVFEM 177
PEV +D++S ++FE+
Sbjct: 198 PEVLLG--APWGCGADIWSTACLIFEL 222
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 3e-18
Identities = 51/198 (25%), Positives = 75/198 (37%), Gaps = 38/198 (19%)
Query: 8 KLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRALIYE--------------- 51
+G G G V + RNVAIK L+ + F + H + E
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 52 ---FVSNGSLEKF--IYEKHPLETNQKLK-------WEVLYKIAVGIARGLEYLHRGCNT 99
F +LE+F +Y L + E + + + G+++LH
Sbjct: 82 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGII 141
Query: 100 RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFG 159
H D+KP NI++ D KI DFGLA+ MT T Y APEV
Sbjct: 142 ---HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM-- 193
Query: 160 EVSYKSDVYSYGMMVFEM 177
D++S G ++ EM
Sbjct: 194 GYKENVDIWSVGCIMGEM 211
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.1 bits (186), Expect = 2e-16
Identities = 54/200 (27%), Positives = 82/200 (41%), Gaps = 40/200 (20%)
Query: 7 NKLGQGGYGGVYKGK-LLDGRNVAIKVLNETKGFCFEGHRRALIYE-------------- 51
+ +G G YG V G VA+K L+ + F H + E
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 52 ----FVSNGSLEKFIY----------EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 97
F SLE+F + + + QKL + + + I RGL+Y+H
Sbjct: 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRN 157
H D+KP N+ ++ED KI DFGLA+ MTG T Y APE+ N
Sbjct: 142 II---HRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIM-LN 192
Query: 158 FGEVSYKSDVYSYGMMVFEM 177
+ + D++S G ++ E+
Sbjct: 193 WMHYNQTVDIWSVGCIMAEL 212
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.9 bits (178), Expect = 4e-16
Identities = 20/201 (9%), Positives = 52/201 (25%), Gaps = 38/201 (18%)
Query: 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETKG------FCFEGHRRALIYEFVSNG 56
++ +G+G V+ +K + + +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 57 SLE---------------------KFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 95
E + E + +++ E ++ I + +
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 96 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFC 155
I+H D+ +N+L+ + I DF + + + F
Sbjct: 122 RG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNI----ITYFS 173
Query: 156 RNFGEVSYKSDVYSYGMMVFE 176
R + + D+ S + +
Sbjct: 174 RTYR---TEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 291 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.94 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.77 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.56 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.89 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.19 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.2 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=340.47 Aligned_cols=225 Identities=27% Similarity=0.318 Sum_probs=182.1
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||+||+|++. +|+.||||+++... +.+.++...++|||||.
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 456799999999999999885 49999999987543 66777888999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 87 gg~L~~~l~~~------~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 87 GGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp TEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCcHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999998543 579999999999999999999999 999999999999999999999999999998765544
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
.........||+.|+|||++.+. ..++.++|||||||++|+|++|..||.......... . ......
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-------~------~~~~~~ 223 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-------S------DWKEKK 223 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-------H------HHHTTC
T ss_pred ccccccceeeCcCccCHhHhcCC-CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-------H------HHhcCC
Confidence 44444567899999999999775 234788999999999999999999997654322100 0 000111
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
........++.++.+|+.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111223346678889999999999999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=338.58 Aligned_cols=237 Identities=27% Similarity=0.438 Sum_probs=180.1
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||+||+|+.. ..||||+++... +++ .....++|||||+
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~~~~~~lv~Ey~~ 86 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCE 86 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCC
T ss_pred EEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEE-eccEEEEEEecCC
Confidence 456799999999999999853 369999987543 444 3456889999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
+|+|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 87 ~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 87 GSSLYHHLHII-----ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEHHHHHHTS-----CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred CCCHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999654 2579999999999999999999999 999999999999999999999999999998765444
Q ss_pred ceeeccCCCCCccccCcccccccC-CCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNF-GEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~-~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
.........||+.|+|||++.+.. ..++.++|||||||++|||++|+.||....... ...... .... ..
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-------~~~~~~--~~~~-~~ 228 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-------QIIFMV--GRGY-LS 228 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-------HHHHHH--HHTS-CC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-------HHHHHH--hcCC-CC
Confidence 433445567899999999987542 357999999999999999999999986542210 000000 0000 11
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCC
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLR 260 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 260 (291)
.........++..+.+|+.+||+.||++|||+.|+++.|+.+.+.++
T Consensus 229 p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 11112233466789999999999999999999999999999877553
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=334.50 Aligned_cols=221 Identities=24% Similarity=0.333 Sum_probs=179.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||+|+||.||+|.+. +|+.||||+++... +.+......++|||||.+
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 456788999999999999875 49999999987544 566778889999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
|+|.+++.. ..+++..++.+++||+.||.|||+ ++|+||||||+|||++.+|.+||+|||++........
T Consensus 102 g~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 102 GSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CBHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CcHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999998754 379999999999999999999999 9999999999999999999999999999987654332
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||...... ......... ...
T Consensus 172 --~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~~~~~-----~~~ 234 (293)
T d1yhwa1 172 --KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATN-----GTP 234 (293)
T ss_dssp --CBCCCCSCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHH-----CSC
T ss_pred --cccccccCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCCCCHH--------HHHHHHHhC-----CCC
Confidence 22455789999999999876 7899999999999999999999998643211 000011001 111
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
....+..++..+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12223456788999999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-50 Score=332.26 Aligned_cols=230 Identities=26% Similarity=0.471 Sum_probs=176.3
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||+|+||.||+|++.+++.||||+++... +++..+...++||||+.+|+
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence 45678999999999999999888899999997654 67788889999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ...+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 87 L~~~l~~~-----~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 87 LSDYLRTQ-----RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp HHHHHHTT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred HHHHhhcc-----ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99998653 2578999999999999999999999 999999999999999999999999999998765433221
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
.....+|+.|+|||++.+. .++.++|||||||++|||+++..|+...... ......... +...
T Consensus 159 -~~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-------~~~~~~i~~-------~~~~ 221 (263)
T d1sm2a_ 159 -STGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDIST-------GFRL 221 (263)
T ss_dssp -------CTTSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-------HHHHHHHHH-------TCCC
T ss_pred -ecceecCcccCChHHhcCC--CCCchhhhcchHHHHHHHHHCCCCCCCCCCH-------HHHHHHHHh-------cCCC
Confidence 2334678999999999876 7899999999999999999976655433211 101111111 1111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
..+..++.++.+|+.+||+.||++|||++|+++.|+++.+
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1223345678999999999999999999999999999765
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-50 Score=331.73 Aligned_cols=217 Identities=26% Similarity=0.372 Sum_probs=179.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|++. +++.||+|++.+.. +++.++...++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 456789999999999999885 48999999986432 677788899999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
|.+|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~~~g~L~~~l~~~------~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 88 APLGTVYRELQKL------SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred cCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999765 479999999999999999999999 9999999999999999999999999999986554
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
.. .....||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ........ ...
T Consensus 159 ~~----~~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~---~~~- 220 (263)
T d2j4za1 159 SR----RTTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS---RVE- 220 (263)
T ss_dssp CC----CEETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH---TTC-
T ss_pred Cc----ccccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCCH--------HHHHHHHH---cCC-
Confidence 33 2345689999999999886 789999999999999999999999864321 11111110 000
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
...+..++..+.+|+.+||+.||++|||++|+++
T Consensus 221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1112335678899999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-49 Score=334.19 Aligned_cols=231 Identities=31% Similarity=0.513 Sum_probs=187.6
Q ss_pred hhhcccccCCceeEEEEEecC-CCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
.+.+.||+|+||+||+|.+.+ ++.||||+++... +.+.++...++|||||.+|+
T Consensus 20 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~ 99 (287)
T d1opja_ 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 99 (287)
T ss_dssp EEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcc
Confidence 457899999999999998865 8899999997654 67778889999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 100 l~~~l~~~----~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~- 171 (287)
T d1opja_ 100 LLDYLREC----NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT- 171 (287)
T ss_dssp HHHHHHHS----CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE-
T ss_pred hHHHhhhc----cccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCce-
Confidence 99999764 34689999999999999999999999 99999999999999999999999999999876543322
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
......+++.|+|||.+.+. .++.++|||||||++|+|+++..|+....+.. ...... ......
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~--~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-------~~~~~i-------~~~~~~ 235 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELL-------EKDYRM 235 (287)
T ss_dssp EETTEEECGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHH-------HTTCCC
T ss_pred eeccccccccccChHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-------HHHHHH-------hcCCCC
Confidence 23344578899999999876 78999999999999999999887765443211 000101 011112
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
..+..++..+.+|+.+||+.||++|||+.|+++.|+.++++
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 22334667899999999999999999999999999987654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.1e-49 Score=331.97 Aligned_cols=231 Identities=26% Similarity=0.435 Sum_probs=172.6
Q ss_pred chhhcccccCCceeEEEEEecC-CC---eEEEEEeccCc---------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GR---NVAIKVLNETK---------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~---~vavK~~~~~~---------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||+||+|++.. ++ .||||.+.... +++......++|||
T Consensus 28 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~E 107 (299)
T d1jpaa_ 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITE 107 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 3456899999999999998753 32 58899886543 67778889999999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
||.+|+|.+++... ...+++..+..++.||+.||.|||+ ++++||||||+||||+.++++||+|||+++...
T Consensus 108 y~~~g~L~~~~~~~-----~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 108 FMENGSLDSFLRQN-----DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp CCTTEEHHHHHHTT-----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred ecCCCcceeeeccc-----cCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 99999999988653 2579999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCceee---ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhh
Q 022826 132 GRESIVS---MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 132 ~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
....... .....+|+.|+|||.+.+. .++.++|||||||++|||++ |..||..... ........
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--------~~~~~~i~-- 247 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMTN--------QDVINAIE-- 247 (299)
T ss_dssp ----------------CGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHH--
T ss_pred CCCCcceeeecccccCCccccCHHHHhcC--CCCcccccccchHHHHHHHhCCCCCCCCCCH--------HHHHHHHH--
Confidence 4332211 2223468899999999875 88999999999999999998 7777764321 11111111
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
.+.....+..++..+.+|+.+||+.||++|||+.|+++.|+++++.
T Consensus 248 -----~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 248 -----QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -----TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1111222334667899999999999999999999999999998763
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=328.62 Aligned_cols=230 Identities=26% Similarity=0.447 Sum_probs=183.2
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||+|+||.||+|.+.+++.||||+++... +++. ....++||||+.+|+
T Consensus 15 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~ 93 (272)
T d1qpca_ 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGS 93 (272)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred eEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCc
Confidence 34678899999999999998888899999997654 4443 456789999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ....+++..+..++.||+.||.|||+ ++|+||||||+||+|+.++.+||+|||+++....... .
T Consensus 94 L~~~~~~~----~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~ 165 (272)
T d1qpca_ 94 LVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T 165 (272)
T ss_dssp HHHHTTSH----HHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred HHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcc-c
Confidence 99987654 33469999999999999999999999 9999999999999999999999999999987654332 2
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
......+++.|+|||.+.+. .++.++|||||||++|+|++|..|+...... ........ .....
T Consensus 166 ~~~~~~gt~~y~APE~~~~~--~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-------~~~~~~i~-------~~~~~ 229 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLE-------RGYRM 229 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHH-------TTCCC
T ss_pred cccccCCcccccChHHHhCC--CCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-------HHHHHHHH-------hcCCC
Confidence 23445678999999999865 7899999999999999999977666543221 11111111 11111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
..+..++..+.+|+.+||+.||++|||++++++.|+.+..
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 2233466789999999999999999999999999988654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=333.78 Aligned_cols=221 Identities=22% Similarity=0.351 Sum_probs=176.8
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|++. +++.||||++.... +.+.++...++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 567899999999999999885 59999999986432 566778889999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
|.+|+|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~~gg~L~~~~~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 90 AKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred cCCCCHHHhhhcc------CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999998765 579999999999999999999999 9999999999999999999999999999987765
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
...........||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ........ ....
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~-~~~~-- 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQKII-KLEY-- 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-TTCC--
T ss_pred CCcccccccccCCccccCceeeccC--CCCcccceehhhHHHHHHhhCCCCCCCcCH--------HHHHHHHH-cCCC--
Confidence 4433334556799999999999876 789999999999999999999999875321 11111111 0111
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..+..++..+.+|+.+||+.||++|||++|+++
T Consensus 228 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 112345677899999999999999999998643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=330.33 Aligned_cols=224 Identities=22% Similarity=0.325 Sum_probs=178.9
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcCC
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
.+.+.||+|+||.||+|++. +++.||||+++... +++.+....++|||||.+|
T Consensus 15 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g 94 (288)
T d2jfla1 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCC
Confidence 45688999999999999885 49999999987643 6777788899999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCce
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESI 136 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 136 (291)
+|.+++.+.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 95 ~L~~~~~~~~-----~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~- 165 (288)
T d2jfla1 95 AVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 165 (288)
T ss_dssp EHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred cHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence 9999986642 579999999999999999999999 9999999999999999999999999999875432211
Q ss_pred eeccCCCCCccccCccccccc---CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 137 VSMTGARGTVGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 137 ~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
......||+.|+|||++.+. ...++.++|||||||++|+|++|..||....... ..... . ...
T Consensus 166 -~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--------~~~~i---~--~~~ 231 (288)
T d2jfla1 166 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--------VLLKI---A--KSE 231 (288)
T ss_dssp -HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--------HHHHH---H--HSC
T ss_pred -cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--------HHHHH---H--cCC
Confidence 12456789999999998532 2367899999999999999999999986542210 01111 0 011
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
......+..++.++.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 232 PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112223456788999999999999999999999876
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=331.32 Aligned_cols=224 Identities=23% Similarity=0.357 Sum_probs=166.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceee--cCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCF--EGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~--~~~~~~lv~e 51 (291)
+.+.+.||+|+||.||+|++. +|+.||+|++.... +.+. .+...++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 456799999999999999875 49999999987654 3332 3456789999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCC-----eeeeccCCCceEEcCCCceEEeccCC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR-----ILHFDIKPHNILLDEDFCPKISDFGL 126 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~-----ivH~dikp~Nill~~~~~~kl~Dfg~ 126 (291)
||++|+|.+++.... .....+++..++.++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+
T Consensus 86 y~~~g~L~~~i~~~~--~~~~~l~e~~~~~i~~qi~~al~ylH~---~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 86 YCEGGDLASVITKGT--KERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp CCTTEEHHHHHHHHH--HHTCCCCHHHHHHHHHHHHHHHHHHHH---HCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred cCCCCcHHHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHH---hcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999999986532 134679999999999999999999998 55 99999999999999999999999999
Q ss_pred ccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh
Q 022826 127 AKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ........
T Consensus 161 a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~~~~~i~- 227 (269)
T d2java1 161 ARILNHDTSF--AKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIR- 227 (269)
T ss_dssp HHHC-------------CCCSCCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHH-
T ss_pred eeecccCCCc--cccCCCCcccCCHHHHcCC--CCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HHHHHHHH-
Confidence 9876543221 2346789999999999776 789999999999999999999999864321 11111111
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.-... ..+..++.++.+|+.+||+.||++|||+.|+++
T Consensus 228 --~~~~~----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 228 --EGKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --HTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --cCCCC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11111 122346678999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-49 Score=332.97 Aligned_cols=237 Identities=28% Similarity=0.412 Sum_probs=174.6
Q ss_pred chhhcccccCCceeEEEEEecC------CCeEEEEEeccCc----------------------------ce-eecCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD------GRNVAIKVLNETK----------------------------GF-CFEGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~----------------------------~~-~~~~~~~~ 47 (291)
+.+.+.||+|+||.||+|.+.. ++.||||+++... +. ...+...+
T Consensus 15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~ 94 (299)
T d1ywna1 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 94 (299)
T ss_dssp EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEE
Confidence 4567899999999999997642 4689999987543 22 23345688
Q ss_pred eeehhhcCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC
Q 022826 48 LIYEFVSNGSLEKFIYEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 117 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~ 117 (291)
+|||||++|+|.+++...... .....+++..++.++.||+.||.|||+ ++|+||||||+||+|+.++
T Consensus 95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKN 171 (299)
T ss_dssp EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECCCC
Confidence 999999999999999764311 113468999999999999999999999 9999999999999999999
Q ss_pred ceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccch
Q 022826 118 CPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFP 197 (291)
Q Consensus 118 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~ 197 (291)
.+||+|||+++...............||+.|+|||.+.+. .++.++|||||||++|+|+++..++.......
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~------ 243 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------ 243 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS------
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCHH------
Confidence 9999999999876655444444556789999999999876 78999999999999999998765433322211
Q ss_pred hhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 198 HWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
........... ....+..++.++.+++.+||+.||++|||+.|+++.|+++++
T Consensus 244 ~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 244 EEFCRRLKEGT-------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHHHTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCC-------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111111111 111223356678999999999999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-48 Score=330.81 Aligned_cols=222 Identities=24% Similarity=0.324 Sum_probs=168.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.+.||+|+||+||+|++. +++.||||++.... +++.++...++|||||+
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 456789999999999999885 48999999987543 56777888999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc---CCCceEEeccCCccccC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---EDFCPKISDFGLAKICH 131 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~---~~~~~kl~Dfg~~~~~~ 131 (291)
+|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+||++. .++.+||+|||++....
T Consensus 91 gg~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 91 GGELFDRIVEK------GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp SCBHHHHHHTC------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred CCcHHHhhhcc------cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999654 579999999999999999999999 9999999999999994 57899999999998654
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...... ....... . .
T Consensus 162 ~~~~---~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~---~-~ 224 (307)
T d1a06a_ 162 PGSV---LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDA--------KLFEQIL---K-A 224 (307)
T ss_dssp --------------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHH---T-T
T ss_pred CCCe---eeeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHh---c-c
Confidence 3322 2345689999999999876 7899999999999999999999998753211 0001110 0 0
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
...........++..+.+|+.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 225 EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111112223456778999999999999999999999987
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=322.56 Aligned_cols=218 Identities=25% Similarity=0.380 Sum_probs=171.6
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceee----cCCcceeee
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCF----EGHRRALIY 50 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~----~~~~~~lv~ 50 (291)
.+.+.||+|+||+||+|.+. +++.||+|++.... +.+. .....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45678999999999999875 48899999987543 2222 234578999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCC--eeeeccCCCceEEc-CCCceEEeccCCc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR--ILHFDIKPHNILLD-EDFCPKISDFGLA 127 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~dikp~Nill~-~~~~~kl~Dfg~~ 127 (291)
||+++|+|.+++.+. ..+++..++.++.||+.||.|||+ ++ |+||||||+||+++ .++.+||+|||++
T Consensus 92 E~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp ECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred eCCCCCcHHHHHhcc------ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 999999999999765 579999999999999999999999 88 99999999999996 5789999999999
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
+...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ......
T Consensus 163 ~~~~~~~----~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-------~~~~~~---- 224 (270)
T d1t4ha_ 163 TLKRASF----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRR---- 224 (270)
T ss_dssp GGCCTTS----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHH----
T ss_pred eeccCCc----cCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-------HHHHHH----
Confidence 8644332 234568999999999864 5899999999999999999999998643221 101111
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
+.....+.......+.++.+|+.+||+.||++|||+.|+++
T Consensus 225 --i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 225 --VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --HHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11111112223345567899999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=321.15 Aligned_cols=226 Identities=24% Similarity=0.430 Sum_probs=183.8
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+.++||+|+||+||+|++++++.||||+++... +++.++...++||||+.+|+
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence 46789999999999999999888899999998654 77788889999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|..++... ...+++..++.++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 86 l~~~~~~~-----~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 86 LLNYLREM-----RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp HHHHHHSG-----GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred HHHhhhcc-----ccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 99997654 3578999999999999999999999 99999999999999999999999999999865443222
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
......+|+.|+|||.+.+. .++.++|||||||++|||++ |+.||..... ......... +..
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~--~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--------~~~~~~i~~-------~~~ 219 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHIAQ-------GLR 219 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHHT-------TCC
T ss_pred eecccCCCCCcCCcHHhcCC--CCCcceeecccchhhHhHHhcCCCCCCCCCH--------HHHHHHHHh-------CCC
Confidence 22345678999999999876 78999999999999999998 6777754321 111111111 111
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEG 254 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~ 254 (291)
...+...+..+.+|+.+||+.||++|||++++++.|.+
T Consensus 220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 12233456789999999999999999999999999865
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=333.02 Aligned_cols=231 Identities=27% Similarity=0.422 Sum_probs=180.3
Q ss_pred hhhcccccCCceeEEEEEecC-C-----CeEEEEEeccCc----------------------------ceeecCCcceee
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-G-----RNVAIKVLNETK----------------------------GFCFEGHRRALI 49 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~----------------------------~~~~~~~~~~lv 49 (291)
.+++.||+|+||+||+|++.. + ..||+|++.... +.+......++|
T Consensus 40 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 119 (325)
T d1rjba_ 40 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119 (325)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEE
Confidence 456899999999999998643 2 268999986543 567778889999
Q ss_pred ehhhcCCCHHHHHhhcCCC-----------------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceE
Q 022826 50 YEFVSNGSLEKFIYEKHPL-----------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 112 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nil 112 (291)
||||++|+|.+++...... .....+++..++.++.|++.||.|||+ ++|+||||||+||+
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVL 196 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEE
T ss_pred EEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchhccc
Confidence 9999999999999765321 122468999999999999999999999 99999999999999
Q ss_pred EcCCCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCC
Q 022826 113 LDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRS 191 (291)
Q Consensus 113 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~ 191 (291)
++.++.+||+|||+++...............+|+.|+|||.+.+. .++.++|||||||++|+|++ |..||.......
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~ 274 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC--CCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999876655444344456679999999999876 88999999999999999997 788876432211
Q ss_pred ccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 022826 192 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLE 253 (291)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~ 253 (291)
....... .......+..++.++.+|+.+||+.||++|||++||++.|.
T Consensus 275 -------~~~~~~~-------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 275 -------NFYKLIQ-------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp -------HHHHHHH-------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -------HHHHHHh-------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 0011110 11111223345678999999999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-49 Score=334.80 Aligned_cols=232 Identities=23% Similarity=0.346 Sum_probs=176.7
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcC
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
.+.+.||+|+||+||+|++. +|+.||+|+++... +.+.+....++||||+.+
T Consensus 9 ~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~g 88 (322)
T d1s9ja_ 9 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 88 (322)
T ss_dssp EEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 35689999999999999875 48999999987543 677788889999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCC-CeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT-RILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
|+|.+++.+. ..+++..++.++.|++.||.|||+ . +|+||||||+||+++.+|.+||+|||+|.......
T Consensus 89 g~L~~~l~~~------~~l~~~~~~~~~~qil~aL~yLH~---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 89 GSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp EEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred CcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 9999999765 479999999999999999999997 5 89999999999999999999999999998654322
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhh-----------
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKR----------- 203 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~----------- 203 (291)
.....||+.|+|||++.+. .++.++||||+||++|+|++|+.||...................
T Consensus 160 ----~~~~~GT~~Y~APEvl~~~--~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 160 ----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp ----C---CCSSCCCCHHHHHCS--CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred ----cccccCCccccCchHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 2345789999999999886 79999999999999999999999997653321100000000000
Q ss_pred -----------------hhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 204 -----------------LELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 204 -----------------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
...................++.++.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000000000000111124567899999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-48 Score=323.88 Aligned_cols=232 Identities=27% Similarity=0.411 Sum_probs=182.4
Q ss_pred hhc-ccccCCceeEEEEEecC---CCeEEEEEeccCc---------------------------ceeecCCcceeeehhh
Q 022826 5 FKN-KLGQGGYGGVYKGKLLD---GRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 5 ~~~-~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+ +||+|+||.||+|.+.. +..||||+++... +++. .+..++||||+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~~lvmE~~ 90 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMA 90 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECC
T ss_pred ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec-cCeEEEEEEeC
Confidence 345 49999999999997642 4579999987543 4554 45678999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
++|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 91 ~~g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 91 GGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp TTEEHHHHHTTC-----TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred CCCcHHHHhhcc-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 999999998543 3579999999999999999999999 99999999999999999999999999999877654
Q ss_pred Cceee-ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 134 ESIVS-MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 134 ~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
..... .....+|+.|+|||.+.+. .++.++|||||||++|||++ |..||..... .. ......
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-------~~-~~~~i~------ 226 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------PE-VMAFIE------ 226 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-------HH-HHHHHH------
T ss_pred ccccccccccccCccccChHHHhCC--CCCccchhhcchHHHHHHHhCCCCCCCCCCH-------HH-HHHHHH------
Confidence 43322 3345678999999999876 78999999999999999997 7888764321 11 111111
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCC
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 262 (291)
.+.....+..++.++.+|+.+||+.||++|||+.++++.|+....++...
T Consensus 227 -~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 227 -QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred -cCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 11112223456678999999999999999999999999998877655444
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=322.25 Aligned_cols=231 Identities=26% Similarity=0.469 Sum_probs=176.6
Q ss_pred chhhcccccCCceeEEEEEecC-C----CeEEEEEeccCc---------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-G----RNVAIKVLNETK---------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~---------------------------~~~~~~~~~~lv~ 50 (291)
+.+++.||+|+||.||+|.+.. + ..||||+++... +++......++||
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 4567889999999999997654 2 369999987543 6777788899999
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
||+.++++.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+++..
T Consensus 89 e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 89 EYMENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp ECCTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EecccCcchhhhhccc-----ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999886642 579999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCc-eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 131 HGRES-IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 131 ~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
..... ........+|+.|+|||.+.+. .++.++|||||||++|||+++..|+...... ........
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-------~~~~~~i~---- 227 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAIN---- 227 (283)
T ss_dssp -------------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHH----
T ss_pred cCCCccceEeccCCCCccccCHHHHccC--CCCCcccccccHHHHHHHHhCCCCccccCCH-------HHHHHHHh----
Confidence 54322 2222345678999999999776 8899999999999999999987766543221 11111111
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
.+.....+..++..+.+|+.+||+.||++|||+.|+++.|+++++
T Consensus 228 ---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 228 ---DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ---TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 111122233456778999999999999999999999999998876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-48 Score=322.70 Aligned_cols=233 Identities=28% Similarity=0.445 Sum_probs=180.1
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g~ 57 (291)
+.+++.||+|+||.||+|++.+++.||||+++... +.+. .+..++||||+.+|+
T Consensus 19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~ 97 (285)
T d1fmka3 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGS 97 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCc
Confidence 35678999999999999999888889999997554 4553 456789999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|..++... ....+++..++.++.||+.||.|||+ .+|+||||||+||+|+.++++||+|||+++....... .
T Consensus 98 l~~~~~~~----~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~ 169 (285)
T d1fmka3 98 LLDFLKGE----TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 169 (285)
T ss_dssp HHHHHSHH----HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred hhhhhhhc----ccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence 99998664 33579999999999999999999999 9999999999999999999999999999986543322 1
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 217 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (291)
......+|+.|+|||.+.+. .++.++|||||||++|+|++|..|+....... . ...... .....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~------~-~~~~i~-------~~~~~ 233 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------E-VLDQVE-------RGYRM 233 (285)
T ss_dssp ------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHH-------TTCCC
T ss_pred eeccccccccccChHHHhCC--CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH------H-HHHHHH-------hcCCC
Confidence 22345679999999999876 78999999999999999999877665543211 0 011110 01111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCC
Q 022826 218 EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLR 260 (291)
Q Consensus 218 ~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 260 (291)
+.+..+++++.+++.+||+.||++|||+++|++.|+.......
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 2234466789999999999999999999999999999776543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-48 Score=327.70 Aligned_cols=218 Identities=26% Similarity=0.352 Sum_probs=175.4
Q ss_pred hhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehhh
Q 022826 4 SFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~~ 53 (291)
.+.+.||+|+||+||+|++. +++.||||+++... +++.+....++|||||
T Consensus 18 ~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 97 (309)
T d1u5ra_ 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 97 (309)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEec
Confidence 34578999999999999875 48899999987543 6777788899999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+|+|..++... .++++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 98 ~~g~l~~~~~~~------~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 98 LGSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp SEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred CCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 999887766543 579999999999999999999999 99999999999999999999999999999864332
Q ss_pred CceeeccCCCCCccccCccccccc-CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~-~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
....||+.|+|||++.+. ...++.++|||||||++|+|++|..||..... ....... . .
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--------~~~~~~i---~---~ 228 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHI---A---Q 228 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHH---H---H
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHH---H---h
Confidence 345689999999998753 24689999999999999999999998864321 0000010 1 1
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..........++..+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11111122346778999999999999999999999876
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-48 Score=321.73 Aligned_cols=224 Identities=27% Similarity=0.405 Sum_probs=174.9
Q ss_pred cccccCCceeEEEEEecC---CCeEEEEEeccCc----------------------------ceeecCCcceeeehhhcC
Q 022826 7 NKLGQGGYGGVYKGKLLD---GRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
++||+|+||.||+|.+.+ ++.||||+++... +++. .+..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence 469999999999997643 5689999986533 4553 4567899999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCc
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 135 (291)
|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 92 g~L~~~l~~~------~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhhc------cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 9999999764 579999999999999999999999 9999999999999999999999999999987654433
Q ss_pred ee-eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 136 IV-SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 136 ~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
.. ......+|+.|+|||.+.+. .++.++|||||||++|||++ |..||..... ........ .
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~~~~~~i~-------~ 225 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLE-------K 225 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHH-------T
T ss_pred ccccccccCCCceecCchhhcCC--CCCchhhhccchhhhhHHhhCCCCCCCCCCH--------HHHHHHHH-------c
Confidence 22 23345688999999999876 78999999999999999997 7888764321 10111111 1
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
+.....+..++.++.+|+.+||+.||++|||+.++++.|+....
T Consensus 226 ~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 11122234466789999999999999999999999998877543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=322.33 Aligned_cols=222 Identities=23% Similarity=0.295 Sum_probs=179.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------------~~~~~~~~~~lv 49 (291)
+.+++.||+|+||+||+|++. +|+.||||++++.. +++.+....++|
T Consensus 12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (293)
T d1jksa_ 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 91 (293)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467799999999999999885 59999999986432 677788889999
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC----ceEEeccC
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF----CPKISDFG 125 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~----~~kl~Dfg 125 (291)
||||.+|+|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++ .+|++|||
T Consensus 92 ~E~~~gg~L~~~i~~~------~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 92 LELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEcCCCccccchhccc------cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999765 479999999999999999999999 9999999999999998776 49999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLE 205 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (291)
++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||..... .......
T Consensus 163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i- 228 (293)
T d1jksa_ 163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANV- 228 (293)
T ss_dssp TCEECTTSCB---CSCCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH-
T ss_pred hhhhcCCCcc---ccccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCCCCH--------HHHHHHH-
Confidence 9987654432 2345679999999999875 789999999999999999999999875421 1000100
Q ss_pred hhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 LEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. ............++..+.+|+.+||+.||++|||+.|+++
T Consensus 229 --~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 229 --SA-VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --HT-TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --Hh-cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0111112233456778999999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.9e-47 Score=328.26 Aligned_cols=223 Identities=21% Similarity=0.323 Sum_probs=181.1
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||+|+||.||+|++. +|+.||||++.... +++.++...++|||||.+
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 107 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 457789999999999999875 49999999997654 677788899999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc--CCCceEEeccCCccccCCC
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD--EDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~--~~~~~kl~Dfg~~~~~~~~ 133 (291)
|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++......
T Consensus 108 g~L~~~l~~~-----~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 108 GELFEKVADE-----HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CBHHHHHTCT-----TSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999998543 2579999999999999999999999 9999999999999995 4678999999999876554
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
... ....||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ....... ... ..
T Consensus 180 ~~~---~~~~gT~~Y~aPEv~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i---~~~-~~ 242 (350)
T d1koaa2 180 QSV---KVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNV---KSC-DW 242 (350)
T ss_dssp SCE---EEECSCTTTCCHHHHHTC--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH---HHT-CC
T ss_pred ccc---ceecCcccccCHHHHcCC--CCChhHhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHH---HhC-CC
Confidence 432 335679999999999876 789999999999999999999999864321 1111111 111 11
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.........++..+.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122333456778999999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3e-47 Score=330.08 Aligned_cols=221 Identities=25% Similarity=0.352 Sum_probs=178.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|++. +|+.||||++.... +.+......|+|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 467799999999999999875 49999999986432 456677889999
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
||||.+|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||++..
T Consensus 86 mE~~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp ECCCCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEecCCCcHHHHHHhc------ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999765 578999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 130 CHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
+.... .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||........ . .....
T Consensus 157 ~~~~~----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~------~~~~~ 220 (364)
T d1omwa3 157 FSKKK----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----H------EIDRM 220 (364)
T ss_dssp CSSSC----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-----H------HHHHH
T ss_pred cCCCc----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-----H------HHHHh
Confidence 65432 2445789999999998643 3689999999999999999999999976433211 0 00000
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPA-----MNRVVE 250 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps-----~~ell~ 250 (291)
........+..++..+.+|+.+||+.||++||| ++|+++
T Consensus 221 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 221 --TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --SSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --cccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 011111122346678999999999999999999 688875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=325.22 Aligned_cols=225 Identities=21% Similarity=0.273 Sum_probs=176.7
Q ss_pred hcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------ceee----cCCcceeeehhhcCCCH
Q 022826 6 KNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------GFCF----EGHRRALIYEFVSNGSL 58 (291)
Q Consensus 6 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------~~~~----~~~~~~lv~e~~~~g~L 58 (291)
++.||+|+||.||+|++. +++.||||+++... +++. .+...|+|||||++|+|
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L 96 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL 96 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEH
T ss_pred eEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcH
Confidence 356999999999999874 59999999987654 2222 24568999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC---CCceEEeccCCccccCCCCc
Q 022826 59 EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---DFCPKISDFGLAKICHGRES 135 (291)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~---~~~~kl~Dfg~~~~~~~~~~ 135 (291)
.+++..+ ....+++..++.++.||+.||.|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 97 ~~~i~~~----~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~ 169 (335)
T d2ozaa1 97 FSRIQDR----GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169 (335)
T ss_dssp HHHHHSC----SCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC
T ss_pred HHHHHhc----CCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeeccCCCc
Confidence 9999764 23579999999999999999999999 99999999999999975 56799999999987654432
Q ss_pred eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccCC
Q 022826 136 IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 215 (291)
Q Consensus 136 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (291)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..||.............. .........
T Consensus 170 ---~~~~~gt~~y~aPE~~~~~--~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~--------~i~~~~~~~ 236 (335)
T d2ozaa1 170 ---LTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--------RIRMGQYEF 236 (335)
T ss_dssp ---CCCCSCCCSSCCCCCCCGG--GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------------CCCSCSSSC
T ss_pred ---cccccCCcccCCcHHHcCC--CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH--------HHhcCCCCC
Confidence 3456789999999999876 789999999999999999999999976543221100000 000001111
Q ss_pred CChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 216 ENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 216 ~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
+......++.++.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 22334567888999999999999999999999987
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=324.13 Aligned_cols=219 Identities=25% Similarity=0.334 Sum_probs=179.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|++. +|+.||||++++.. +.+.+....|+||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 457789999999999999875 59999999987542 567778889999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+||+++.+|.+||+|||+++....
T Consensus 87 ~~gg~L~~~~~~~------~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 87 ANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp CTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred cCCCchhhhhhcc------cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 9999999999765 588999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ....... ....+
T Consensus 158 ~~~--~~~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~~~~i-~~~~~-- 222 (337)
T d1o6la_ 158 DGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELI-LMEEI-- 222 (337)
T ss_dssp TTC--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH-HHCCC--
T ss_pred CCc--ccccceeCHHHhhhhhccCC--CCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHHHHHH-hcCCC--
Confidence 322 23456789999999999886 889999999999999999999998876431 1011111 11111
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRPA-----MNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps-----~~ell~ 250 (291)
..+..++.++.+|+.+||+.||.+|++ ++|+++
T Consensus 223 -----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 122346677899999999999999995 788876
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4e-47 Score=327.65 Aligned_cols=223 Identities=22% Similarity=0.289 Sum_probs=181.0
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc--------------------------ceeecCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK--------------------------GFCFEGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~~lv~e~~~~ 55 (291)
+.+.+.||+|+||.||+|++. +|+.||||+++... +++.++...++|||||.+
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 456789999999999999875 59999999987654 667778889999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEc--CCCceEEeccCCccccCCC
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD--EDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~--~~~~~kl~Dfg~~~~~~~~ 133 (291)
|+|.+++... ..++++..++.++.||+.||.|||+ ++|+||||||+||||+ .++.+||+|||++......
T Consensus 111 g~L~~~~~~~-----~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 111 GELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CBHHHHTTCT-----TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred ChHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999887543 3579999999999999999999999 9999999999999997 6789999999999877654
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhccc
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 213 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (291)
... ....+|+.|+|||++.+. .++.++|||||||++|+|++|..||...... ..... ... ...
T Consensus 183 ~~~---~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~---i~~-~~~ 245 (352)
T d1koba_ 183 EIV---KVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--------ETLQN---VKR-CDW 245 (352)
T ss_dssp SCE---EEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHH---HHH-CCC
T ss_pred Cce---eeccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH---HHh-CCC
Confidence 432 334579999999999876 7899999999999999999999998654211 00011 111 111
Q ss_pred CCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 214 GIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 214 ~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.........++.++.+|+.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122233456778999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-47 Score=320.56 Aligned_cols=234 Identities=27% Similarity=0.455 Sum_probs=181.3
Q ss_pred hhhcccccCCceeEEEEEecC--------CCeEEEEEeccCc----------------------------ceeecCCcce
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD--------GRNVAIKVLNETK----------------------------GFCFEGHRRA 47 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~----------------------------~~~~~~~~~~ 47 (291)
.+++.||+|+||.||+|+... +..||||+++... +.+.++...+
T Consensus 16 ~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~ 95 (299)
T d1fgka_ 16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 95 (299)
T ss_dssp EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred EEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEE
Confidence 467899999999999997532 2479999997654 6777888899
Q ss_pred eeehhhcCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC
Q 022826 48 LIYEFVSNGSLEKFIYEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 117 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~ 117 (291)
+||||+.+|+|.+++..+... .....+++..++.++.||+.||.|||+ .++|||||||+||+++.++
T Consensus 96 ~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~~~ 172 (299)
T d1fgka_ 96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDN 172 (299)
T ss_dssp EEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTC
T ss_pred EEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecCCC
Confidence 999999999999999765321 224578999999999999999999999 9999999999999999999
Q ss_pred ceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccc
Q 022826 118 CPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYF 196 (291)
Q Consensus 118 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~ 196 (291)
.+||+|||++................+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.....
T Consensus 173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~------- 243 (299)
T d1fgka_ 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------- 243 (299)
T ss_dssp CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------
T ss_pred CeEeccchhhccccccccccccccCCCChhhhhhhHhcCC--CCCchhhhHHhHHHHHHhccCCCCCCCCCCH-------
Confidence 9999999999877655444444556789999999999876 89999999999999999998 4555543211
Q ss_pred hhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 197 PHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
........ .+.....+..++..+.+|+.+||+.||++|||+.|+++.|++++.
T Consensus 244 -~~~~~~i~-------~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 -EELFKLLK-------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -HHHHHHHH-------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHH-------cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11111111 111122233456789999999999999999999999999999865
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1e-46 Score=314.98 Aligned_cols=224 Identities=21% Similarity=0.280 Sum_probs=181.5
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------------------ceeecCCc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------------------GFCFEGHR 45 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------------------~~~~~~~~ 45 (291)
+.+.+.||+|+||+||+|++. +++.||||+++... +.+.++..
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence 567899999999999999875 58999999986532 66777888
Q ss_pred ceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccC
Q 022826 46 RALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 46 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
.++||||+++|+|.+++... .++++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eEEEEEcCCCchHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999765 479999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeccCCCCCccccCccccccc----CCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRN----FGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVY 201 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~----~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~ 201 (291)
++........ .....||+.|.|||.+.+. ...++.++||||+||++|+|++|+.||..... ....
T Consensus 156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~~~ 224 (277)
T d1phka_ 156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLML 224 (277)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH
T ss_pred heeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HHHH
Confidence 9987654332 2446689999999998642 23578899999999999999999999975421 1111
Q ss_pred hhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 202 KRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.... ... ..........+++++.+|+.+||+.||++|||+.|+++
T Consensus 225 ~~i~-~~~---~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 225 RMIM-SGN---YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHH-HTC---CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHH-hCC---CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111 111 11122234457788999999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-47 Score=322.85 Aligned_cols=235 Identities=23% Similarity=0.400 Sum_probs=182.2
Q ss_pred chhhcccccCCceeEEEEEec------CCCeEEEEEeccCc---------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK---------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|+.. +++.||||+++... +.+......+++
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 456789999999999999864 25789999987543 667778889999
Q ss_pred ehhhcCCCHHHHHhhcCC------------------CCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCce
Q 022826 50 YEFVSNGSLEKFIYEKHP------------------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNI 111 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~------------------~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Ni 111 (291)
|||+.+|+|.+++..... ......+++..++.++.|++.||+|||+ ++++||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccce
Confidence 999999999999976432 1123458999999999999999999999 9999999999999
Q ss_pred EEcCCCceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCC
Q 022826 112 LLDEDFCPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRS 191 (291)
Q Consensus 112 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~ 191 (291)
+++.++.+||+|||+++...............+++.|+|||.+.+. .++.++|||||||++|||+++..++......
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~- 248 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH- 248 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC--CCChhhhhccchhhHHHHHccCCCCCCCCCH-
Confidence 9999999999999999866544433334456678999999999876 8999999999999999999987544332211
Q ss_pred ccccchhhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 022826 192 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSL 256 (291)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~ 256 (291)
........ .......+..++.++.+|+.+||+.||++|||+.|+++.|+++.
T Consensus 249 ------~e~~~~v~-------~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 ------EEVIYYVR-------DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp ------HHHHHHHH-------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ------HHHHHHHH-------cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11111111 11111223345667899999999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=318.27 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=182.3
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc-------------------------ceeecC----Ccceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK-------------------------GFCFEG----HRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~----~~~~lv~e~~ 53 (291)
+.+.++||+|+||.||+|++ +|+.||||+++... +++... ...++||||+
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence 45679999999999999986 78999999987654 344332 2578999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCC-----CCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC-----NTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~-----~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
.+|+|.+++++ .++++..++.++.|++.||.|||+.. .++|+||||||+||+|+.++.+||+|||++.
T Consensus 84 ~~g~L~~~l~~-------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 84 EHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp TTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999965 36899999999999999999999611 2599999999999999999999999999998
Q ss_pred ccCCCCcee--eccCCCCCccccCcccccccCC----CccccccchhHHHHHHHHhCCCCCCccccCCCccccch-----
Q 022826 129 ICHGRESIV--SMTGARGTVGYIAPEVFCRNFG----EVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFP----- 197 (291)
Q Consensus 129 ~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~----~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~----- 197 (291)
......... ......||+.|+|||++.+... .++.++|||||||++|+|++|..|+.............
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 765443322 2345678999999999865421 36779999999999999999987765433322111100
Q ss_pred -hhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 198 -HWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 198 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
.............................+.+|+.+||+.||++|||+.|+++.|+++.++
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 0000001001111111111222345677899999999999999999999999999987654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.7e-47 Score=316.60 Aligned_cols=231 Identities=22% Similarity=0.276 Sum_probs=174.1
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeec----CCccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFE----GHRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~----~~~~~l 48 (291)
+.+.+.||+|+||.||+|++. +++.||||+++... +++.. ....|+
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 456789999999999999875 59999999997543 22222 224789
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
||||+.+++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.++..+++|||.+.
T Consensus 89 vmE~~~g~~L~~~~~~~------~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEECCCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEECCCCCEehhhhccc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhh
Confidence 99999999999998765 479999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCc-eeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 129 ICHGRES-IVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 129 ~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
....... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||..... .........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~~~~- 228 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVR- 228 (277)
T ss_dssp ECC----------------TTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHH-
T ss_pred hhccccccccccccccCcccccCHHHHcCC--CCCcceecccchHHHHHHHhCCCCCCCcCH--------HHHHHHHHh-
Confidence 6543222 2223445689999999999876 789999999999999999999999865321 100000000
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHhhh
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRP-AMNRVVEMLEGSL 256 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-s~~ell~~L~~~~ 256 (291)
............++..+.+++.+||+.||++|| |++++++.|.++.
T Consensus 229 ---~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 229 ---EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ---CCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---cCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 011111122334677899999999999999999 8999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-46 Score=319.48 Aligned_cols=216 Identities=26% Similarity=0.355 Sum_probs=178.0
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||+||+|++. +|+.||||+++... +.+.+....++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 457799999999999999885 49999999986432 667778899999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
|.+|+|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+++....
T Consensus 86 ~~gg~l~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 86 IEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCSCBHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred cCCcccccccccc------ccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999998765 578899999999999999999999 9999999999999999999999999999987644
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
.. ...+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ........ ...
T Consensus 157 ~~-----~~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~-~~~--- 217 (316)
T d1fota_ 157 VT-----YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKIL-NAE--- 217 (316)
T ss_dssp CB-----CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH-HCC---
T ss_pred cc-----ccccCcccccCHHHHcCC--CCCchhhccccchhHHHHHhCCCCCCCcCH--------HHHHHHHH-cCC---
Confidence 32 346789999999999876 789999999999999999999999875321 11111111 001
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~ 250 (291)
...+..++..+.+++.+||..||.+|+ |++++++
T Consensus 218 ----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 111234567789999999999999996 8999876
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=318.39 Aligned_cols=230 Identities=20% Similarity=0.255 Sum_probs=182.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.+.+.||+|+||+||+|.+. +++.||||+++... +++.+....|+|||||.+|
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence 456799999999999999875 48999999998655 6677788999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCC--CceEEeccCCccccCCCC
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED--FCPKISDFGLAKICHGRE 134 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~--~~~kl~Dfg~~~~~~~~~ 134 (291)
+|.+++... +..+++..++.++.||+.||.|||+ ++|+||||||+||+++.+ +.++|+|||++.......
T Consensus 87 ~L~~~i~~~-----~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 87 DIFERINTS-----AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp BHHHHHTSS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred cHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 999999653 2479999999999999999999999 999999999999999754 589999999998765443
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcccC
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 214 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (291)
.. ....+++.|+|||.+.+. .++.++|||||||++|+|++|..||...... ....... . ....
T Consensus 159 ~~---~~~~~t~~y~ape~~~~~--~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--------~~~~~i~---~-~~~~ 221 (321)
T d1tkia_ 159 NF---RLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIM---N-AEYT 221 (321)
T ss_dssp EE---EEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHH---H-TCCC
T ss_pred cc---cccccccccccchhccCC--CCCchhhcccHHHHHHHHHhCCCCCCCCCHH--------HHHHHHH---h-CCCC
Confidence 32 234568999999999876 7899999999999999999999998754221 0111110 0 0111
Q ss_pred CCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHhhhc
Q 022826 215 IENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE--MLEGSLD 257 (291)
Q Consensus 215 ~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~--~L~~~~~ 257 (291)
........++.++.+|+.+||..||++|||+.|+++ ++.+-++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 266 (321)
T d1tkia_ 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCcc
Confidence 112223346778999999999999999999999987 4544333
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.1e-46 Score=319.74 Aligned_cols=216 Identities=21% Similarity=0.297 Sum_probs=177.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-----------------------------ceeecCCcceeeehh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~~~~~lv~e~ 52 (291)
+.+.+.||+|+||.||+|++. +|+.||||++.... +.+......++|+||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~ 122 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence 356689999999999999885 59999999986432 566777888999999
Q ss_pred hcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCC
Q 022826 53 VSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHG 132 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 132 (291)
+.+|+|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+++....
T Consensus 123 ~~~g~l~~~l~~~------~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 123 VAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp CTTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccchhhhHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999765 479999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhcc
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 212 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (291)
.. ....||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ........ ...
T Consensus 194 ~~-----~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~-~~~--- 254 (350)
T d1rdqe_ 194 RT-----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIV-SGK--- 254 (350)
T ss_dssp CB-----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HCC---
T ss_pred cc-----ccccCccccCCHHHHcCC--CCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHHHHh-cCC---
Confidence 32 345689999999999876 789999999999999999999999864321 11111110 010
Q ss_pred cCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 022826 213 QGIENEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVE 250 (291)
Q Consensus 213 ~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~ 250 (291)
...+..++.++.+|+.+||+.||.+|+ |++++++
T Consensus 255 ----~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 ----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 111234667889999999999999994 8999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-47 Score=319.42 Aligned_cols=232 Identities=22% Similarity=0.228 Sum_probs=170.2
Q ss_pred cccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------------ceeecCCcceeeehhhc
Q 022826 7 NKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.||+|+||+||+|++. +|+.||||+++... +++..+...++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 68999999999999875 49999999986432 56777888999999998
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
++++..+... ...+++..+..+++||+.||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~~~~~------~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 84 TDLEVIIKDN------SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp EEHHHHHTTC------CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred chHHhhhhhc------ccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 8776666532 3578899999999999999999999 999999999999999999999999999998765433
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchh-------hhhh-hhhh
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPH-------WVYK-RLEL 206 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~-------~~~~-~~~~ 206 (291)
.. .....+|+.|+|||++.+. ..++.++|||||||++|+|++|..||.............. ..+. ....
T Consensus 155 ~~--~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 155 RA--YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CC--CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred cc--ccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 22 2345689999999998654 3679999999999999999999988865432110000000 0000 0000
Q ss_pred hhhhcccCCCC----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 EEDLGLQGIEN----EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~~~~~~~~~~~----~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
........... ......+..+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000000000 011234678999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=312.20 Aligned_cols=223 Identities=26% Similarity=0.442 Sum_probs=170.9
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------ceeec-CCcceeeehhhcCCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------GFCFE-GHRRALIYEFVSNGS 57 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------~~~~~-~~~~~lv~e~~~~g~ 57 (291)
+.+.+.||+|+||.||+|++ +|..||||+++.+. +++.+ ....++||||+.+|+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~ 87 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred eEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence 34678999999999999988 57889999997665 45543 456799999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCCcee
Q 022826 58 LEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRESIV 137 (291)
Q Consensus 58 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 137 (291)
|.+++... ....+++..++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 88 L~~~l~~~----~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 88 LVDYLRSR----GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp HHHHHHHH----HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred HHHHHHhc----CCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 99999764 22468999999999999999999999 999999999999999999999999999998654322
Q ss_pred eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCC-CCCCccccCCCccccchhhhhhhhhhhhhhcccCCC
Q 022826 138 SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGV-KNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 216 (291)
Q Consensus 138 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (291)
....++..|+|||.+.+. .++.++|||||||++|||+++ ..|+...... . ...... .+..
T Consensus 158 --~~~~~~~~y~aPE~l~~~--~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-------~-~~~~i~-------~~~~ 218 (262)
T d1byga_ 158 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------D-VVPRVE-------KGYK 218 (262)
T ss_dssp ------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-------G-HHHHHT-------TTCC
T ss_pred --ccccccccCCChHHHhCC--CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-------H-HHHHHH-------cCCC
Confidence 234568899999999876 789999999999999999984 5544432111 0 011111 1111
Q ss_pred ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 217 NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 217 ~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
.+.+..++.++.+|+.+||+.||.+|||+.++++.|+++
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 222334567889999999999999999999999999885
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=318.41 Aligned_cols=237 Identities=27% Similarity=0.477 Sum_probs=187.9
Q ss_pred hhhcccccCCceeEEEEEec------CCCeEEEEEeccCc----------------------------ceeecCCcceee
Q 022826 4 SFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK----------------------------GFCFEGHRRALI 49 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv 49 (291)
.++++||+|+||.||+|++. +++.||||+++... +.+......++|
T Consensus 26 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lv 105 (311)
T d1t46a_ 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI 105 (311)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEE
Confidence 35789999999999999752 35689999997654 567777889999
Q ss_pred ehhhcCCCHHHHHhhcCCC------------CCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC
Q 022826 50 YEFVSNGSLEKFIYEKHPL------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 117 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~ 117 (291)
||||++|+|.+++...... .....+++..+..++.||+.||.|||+ ++++||||||+||+++.++
T Consensus 106 mE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~~~~ 182 (311)
T d1t46a_ 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGR 182 (311)
T ss_dssp EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETTT
T ss_pred EEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccccccC
Confidence 9999999999999765321 123468999999999999999999999 9999999999999999999
Q ss_pred ceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccch
Q 022826 118 CPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFP 197 (291)
Q Consensus 118 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~ 197 (291)
.++++|||+++...............+|+.|+|||.+.+. .++.++|||||||++|+|++++.|+.........
T Consensus 183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~---- 256 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---- 256 (311)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH----
T ss_pred cccccccchheeccCCCcceEeeecccChHHcCHHHhcCC--CCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH----
Confidence 9999999999987665544445566789999999999875 8899999999999999999966665544332211
Q ss_pred hhhhhhhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 198 HWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
...... .+.....+..++..+.+|+.+||+.||++|||+.++++.|++.+.+
T Consensus 257 --~~~~i~-------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 257 --FYKMIK-------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp --HHHHHH-------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHh-------cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 000010 0111122233567799999999999999999999999999987764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=313.71 Aligned_cols=229 Identities=23% Similarity=0.358 Sum_probs=170.2
Q ss_pred chhhcccccCCceeEEEEEecC----CCeEEEEEeccCc---------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD----GRNVAIKVLNETK---------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e 51 (291)
+.+++.||+|+||.||+|.+.. +..||||+++... +++ .....++|||
T Consensus 9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~iv~E 87 (273)
T d1mp8a_ 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIME 87 (273)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-ecCeEEEEEE
Confidence 4577999999999999997643 3468899886543 444 3567899999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+|+|.+++... ...+++..++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 88 ~~~~g~l~~~~~~~-----~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 88 LCTLGELRSFLQVR-----KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp CCTTEEHHHHHHHT-----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred eccCCcHHhhhhcc-----CCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheecc
Confidence 99999999987654 2578999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhhh
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEEDL 210 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (291)
..... ......+|+.|+|||.+.+. .++.++|||||||++|+|++ |..||...... ........
T Consensus 160 ~~~~~-~~~~~~gt~~y~apE~l~~~--~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--------~~~~~i~~---- 224 (273)
T d1mp8a_ 160 DSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIEN---- 224 (273)
T ss_dssp ------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHHHHT----
T ss_pred CCcce-eccceecCcccchhhHhccC--CCCCccccccchHHHHHHHhcCCCCCCCCCHH--------HHHHHHHc----
Confidence 43222 22334578999999999876 88999999999999999987 67666543221 01111111
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhcc
Q 022826 211 GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDS 258 (291)
Q Consensus 211 ~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~ 258 (291)
......+..++..+.+|+.+||+.||++|||+.||++.|+.++++
T Consensus 225 ---~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 225 ---GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 111122344667899999999999999999999999999988764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=321.25 Aligned_cols=219 Identities=22% Similarity=0.305 Sum_probs=179.6
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------------ceeecCCcceeeeh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------------GFCFEGHRRALIYE 51 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------------~~~~~~~~~~lv~e 51 (291)
+.+.+.||+|+||+||+|++. +++.||||++++.. +.+.++...|+|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 567899999999999999885 49999999996432 57777888999999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
|+.+|+|.+++... ..+++..++.++.||+.||.|||+ ++++||||||+|||++.++.+||+|||++....
T Consensus 84 y~~~g~L~~~i~~~------~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 84 YLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp CCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred ecCCCcHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999765 578999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhhhc
Q 022826 132 GRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 211 (291)
Q Consensus 132 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (291)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ......... .
T Consensus 155 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~----~ 218 (320)
T d1xjda_ 155 LGDA--KTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRM----D 218 (320)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH----C
T ss_pred cccc--cccccCCCCCcCCHHHHcCC--CCCchhhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHc----C
Confidence 4332 23446789999999999876 789999999999999999999999975421 111111110 1
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 022826 212 LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMN-RVVE 250 (291)
Q Consensus 212 ~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~-ell~ 250 (291)
.. ..+..++..+.+|+.+||..||++|||+. ++++
T Consensus 219 ~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11 11234567799999999999999999996 6754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=317.48 Aligned_cols=229 Identities=26% Similarity=0.416 Sum_probs=174.1
Q ss_pred chhhcccccCCceeEEEEEecC-CC----eEEEEEeccCc---------------------------ceeecCCcceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD-GR----NVAIKVLNETK---------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~---------------------------~~~~~~~~~~lv~ 50 (291)
+.+.+.||+|+||+||+|.+.. |+ .||+|.++... +++.+ ...++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeEEE
Confidence 3456899999999999998753 44 58899876433 45554 4567888
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
+++.+++|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 90 e~~~~~~l~~~~~~~-----~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 90 QLMPFGCLLDYVREH-----KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp ECCTTCBHHHHHHHT-----SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EeccCCccccccccc-----ccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 999999999988764 3689999999999999999999999 99999999999999999999999999999877
Q ss_pred CCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 131 HGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
.............+|+.|+|||.+.+. .++.++|||||||++|||++ |..||...... ........
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--------~~~~~i~~--- 228 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSILEK--- 228 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--------GHHHHHHH---
T ss_pred ccccccccccccccCccccChHHHhcC--CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHc---
Confidence 655444334445679999999999876 78999999999999999998 56555432110 01111111
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
+.....+..++..+.+|+.+||+.||++|||+.|+++.|+++.+
T Consensus 229 ----~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 229 ----GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 11112233456788999999999999999999999999988754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=311.57 Aligned_cols=235 Identities=26% Similarity=0.449 Sum_probs=181.8
Q ss_pred hhhcccccCCceeEEEEEecC--C--CeEEEEEeccCc---------------------------ceeec-CCcceeeeh
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD--G--RNVAIKVLNETK---------------------------GFCFE-GHRRALIYE 51 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~---------------------------~~~~~-~~~~~lv~e 51 (291)
.+.++||+|+||+||+|.+.+ + ..||||+++... +++.. +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 456889999999999998754 2 258999987533 45543 457889999
Q ss_pred hhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccC
Q 022826 52 FVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICH 131 (291)
Q Consensus 52 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 131 (291)
||++|+|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 110 ~~~~g~l~~~~~~~-----~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181 (311)
T ss_dssp CCTTCBHHHHHHCT-----TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred EeecCchhhhhccc-----cccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence 99999999998754 3577888999999999999999999 999999999999999999999999999998765
Q ss_pred CCCcee--eccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhhh
Q 022826 132 GRESIV--SMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEED 209 (291)
Q Consensus 132 ~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (291)
...... ......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||......... .. ....
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~---~~----~i~~--- 249 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TV----YLLQ--- 249 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCC------C---HH----HHHT---
T ss_pred ccccccceecccccccccccChHHHhcC--CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH---HH----HHHc---
Confidence 433221 22335678999999999876 7899999999999999999988887754432110 00 0100
Q ss_pred hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCC
Q 022826 210 LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIP 262 (291)
Q Consensus 210 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 262 (291)
+.....+..++..+.+|+.+||+.||++|||+.|+++.|+++++.....
T Consensus 250 ----g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 250 ----GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ----CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 1111122335567899999999999999999999999999998765443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=312.61 Aligned_cols=235 Identities=26% Similarity=0.461 Sum_probs=182.2
Q ss_pred hhhcccccCCceeEEEEEecC-CC--eEEEEEeccCc----------------------------ceeecCCcceeeehh
Q 022826 4 SFKNKLGQGGYGGVYKGKLLD-GR--NVAIKVLNETK----------------------------GFCFEGHRRALIYEF 52 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~ 52 (291)
.+++.||+|+||.||+|.+.+ +. .||||.++... +++..+...++||||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey 92 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence 567899999999999998754 44 57788875332 677778889999999
Q ss_pred hcCCCHHHHHhhcCC----------CCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEe
Q 022826 53 VSNGSLEKFIYEKHP----------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 122 (291)
Q Consensus 53 ~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~ 122 (291)
+++|+|.+++..... ......+++..+++++.||+.||.|||+ .+++||||||+|||++.++.+||+
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEEC
T ss_pred cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEEc
Confidence 999999999976421 1245789999999999999999999999 999999999999999999999999
Q ss_pred ccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhh
Q 022826 123 DFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYK 202 (291)
Q Consensus 123 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~ 202 (291)
|||+++....... .....+|..|+|||.+.+. .++.++|||||||++|+|++|..++..... ......
T Consensus 170 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~--~~~~~sDvwSfGvil~ell~~~~~p~~~~~-------~~~~~~ 237 (309)
T d1fvra_ 170 DFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYE 237 (309)
T ss_dssp CTTCEESSCEECC---C----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHH
T ss_pred ccccccccccccc---ccceecCCcccchHHhccC--CCCccceeehhHHHHHHHHhcCCCCCCCCC-------HHHHHH
Confidence 9999976433221 2334578999999999876 889999999999999999998765443321 111111
Q ss_pred hhhhhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCC
Q 022826 203 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLR 260 (291)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 260 (291)
... .+.....+..++.++.+|+.+||+.||++|||++|+++.|++++++..
T Consensus 238 ~i~-------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 238 KLP-------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp HGG-------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHH-------hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 111 111122233466789999999999999999999999999999987544
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=308.12 Aligned_cols=228 Identities=23% Similarity=0.359 Sum_probs=169.3
Q ss_pred chhhcccccCCceeEEEEEecC--C--CeEEEEEeccCc-----------------------------ceeecCCcceee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLD--G--RNVAIKVLNETK-----------------------------GFCFEGHRRALI 49 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~-----------------------------~~~~~~~~~~lv 49 (291)
+.+.+.||+|+||.||+|+... + ..||||++.... +++.+ ...++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 3456889999999999997532 3 378999987543 45543 567899
Q ss_pred ehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 50 YEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 50 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
|||+.+|++.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 89 ~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeecCcchhhhhhccc-----CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999887642 579999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCceee-ccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhC-CCCCCccccCCCccccchhhhhhhhhhh
Q 022826 130 CHGRESIVS-MTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-VKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 130 ~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
......... .....++..|+|||.+.+. .++.++||||||+++|||++ |..||...... . . .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-------~-~------~ 224 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------Q-I------L 224 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------H-H------H
T ss_pred cccCCCcceecCccccCcccCCHHHHhCC--CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-------H-H------H
Confidence 755443322 2344567899999999876 88999999999999999997 78777533110 0 0 0
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGS 255 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~ 255 (291)
..+.......+.+..++..+.+|+.+||+.||++|||+.++++.|++.
T Consensus 225 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111112223344667899999999999999999999999998763
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=311.04 Aligned_cols=212 Identities=25% Similarity=0.349 Sum_probs=171.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------------ceeecCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------------GFCFEGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------------~~~~~~~~~~ 47 (291)
+.+++.||+|+||.||+|++. +|+.||||++.... +.+......+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~ 85 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence 567899999999999999875 59999999986432 4556677888
Q ss_pred eeehhhcC-CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC-CCceEEeccC
Q 022826 48 LIYEFVSN-GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-DFCPKISDFG 125 (291)
Q Consensus 48 lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~-~~~~kl~Dfg 125 (291)
+|||++.+ +++.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 86 lv~e~~~~~~~l~~~~~~~------~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEeccCcchHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccc
Confidence 99999975 5788888665 579999999999999999999999 99999999999999985 4799999999
Q ss_pred CccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhh
Q 022826 126 LAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLE 205 (291)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (291)
++....... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||..... .
T Consensus 157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------------i- 216 (273)
T d1xwsa_ 157 SGALLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------I- 216 (273)
T ss_dssp TCEECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------H-
T ss_pred cceeccccc----ccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH--------------H-
Confidence 998654332 2456789999999999775 2457889999999999999999999864311 0
Q ss_pred hhhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 LEEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
...... .+..++.++.+|+.+||+.||++|||++|+++
T Consensus 217 ~~~~~~-------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 217 IRGQVF-------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHCCCC-------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhcccC-------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 000011 11235677899999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-44 Score=306.77 Aligned_cols=240 Identities=20% Similarity=0.269 Sum_probs=182.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.+.+.||+|+||.||+|++. +|+.||||++.... .+...+...++||||+. +
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~ 87 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-P 87 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-C
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-C
Confidence 567799999999999999875 48999999977544 44556677888999995 4
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC---CCceEEeccCCccccCCC
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---DFCPKISDFGLAKICHGR 133 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~---~~~~kl~Dfg~~~~~~~~ 133 (291)
+|...+... ...+++..+..++.|++.||.|||+ ++|+||||||+||+++. +..++|+|||+++.....
T Consensus 88 ~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 88 SLEDLFNFC-----SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp BHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred chhhhhhhc-----cCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 777766543 3689999999999999999999999 99999999999999853 457999999999876543
Q ss_pred Cce-----eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhhh
Q 022826 134 ESI-----VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELEE 208 (291)
Q Consensus 134 ~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (291)
... .......||+.|+|||.+.+. .++.++|||||||++|+|++|..||..................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~------ 231 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK------ 231 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTB--CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH------
T ss_pred ccccceeccccCCcCCCccccCHHHHhCC--CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc------
Confidence 221 122445689999999999876 7899999999999999999999999765443322211111000
Q ss_pred hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCC
Q 022826 209 DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRI 261 (291)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 261 (291)
.. ..........++.++.+++..||+.||++||++.++.+.|+.++.+...
T Consensus 232 ~~--~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~ 282 (299)
T d1ckia_ 232 KM--STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282 (299)
T ss_dssp HH--HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred cC--CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence 00 0001112234567899999999999999999999999999988765443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.8e-44 Score=304.26 Aligned_cols=242 Identities=17% Similarity=0.237 Sum_probs=189.4
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc-------------------------ceeecCCcceeeehhhcCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK-------------------------GFCFEGHRRALIYEFVSNG 56 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------------------~~~~~~~~~~lv~e~~~~g 56 (291)
+.+++.||+|+||+||+|++. +|+.||||+++... .++..+...++||||+ ++
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~ 85 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP 85 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CC
Confidence 567899999999999999875 48999999986543 5666778889999999 57
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcC-----CCceEEeccCCccccC
Q 022826 57 SLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-----DFCPKISDFGLAKICH 131 (291)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~-----~~~~kl~Dfg~~~~~~ 131 (291)
+|.+++... ...++...+..++.|++.||.|||+ ++|+||||||+||+++. ++.++|+|||+++...
T Consensus 86 ~l~~~~~~~-----~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 86 SLEDLLDLC-----GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp BHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CHHHHHHhh-----ccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 999998664 3579999999999999999999999 99999999999999964 5789999999998765
Q ss_pred CCCce-----eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh
Q 022826 132 GRESI-----VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 132 ~~~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
..... .......||+.|+|||.+.+. .++.++||||||+++|+|++|..||...........+. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~-----~i~~ 230 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE-----RIGE 230 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH-----HHHH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH-----HHHh
Confidence 32211 123445799999999999876 78999999999999999999999997654432211111 1110
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhccCCCCC
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLDSLRIPP 263 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 263 (291)
.. ...........+++++.+++..|++.+|++||+++.+.+.|++++++.+...
T Consensus 231 ~~---~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~ 284 (293)
T d1csna_ 231 KK---QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284 (293)
T ss_dssp HH---HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred cc---CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCC
Confidence 00 0000111223356779999999999999999999999999999888776554
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=311.14 Aligned_cols=235 Identities=23% Similarity=0.421 Sum_probs=184.8
Q ss_pred hhhcccccCCceeEEEEEec------CCCeEEEEEeccCc---------------------------ceeecCCcceeee
Q 022826 4 SFKNKLGQGGYGGVYKGKLL------DGRNVAIKVLNETK---------------------------GFCFEGHRRALIY 50 (291)
Q Consensus 4 ~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~ 50 (291)
.+.++||+|+||+||+|.+. +++.||||+++... +.+......++||
T Consensus 23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 102 (308)
T d1p4oa_ 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 102 (308)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence 45688999999999999763 25789999997543 6777788899999
Q ss_pred hhhcCCCHHHHHhhcCC----CCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCC
Q 022826 51 EFVSNGSLEKFIYEKHP----LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL 126 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~ 126 (291)
||+.+|+|.+++..... ......+++..+..++.|++.||.|||+ ++|+||||||+||+++.++++||+|||+
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEeeccc
Confidence 99999999999875321 1122457999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhh
Q 022826 127 AKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLEL 206 (291)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (291)
++...............+++.|+|||.+.+. .++.++||||||+++|+|++|..++...... .. ......
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~--~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~-~~~~i~- 249 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQ-VLRFVM- 249 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HH-HHHHHH-
T ss_pred ceeccCCcceeeccceecccccCCHHHHccC--CCCcccccccHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHH-
Confidence 9876555444444555679999999999876 7889999999999999999986544332211 11 111111
Q ss_pred hhhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhc
Q 022826 207 EEDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEMLEGSLD 257 (291)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~L~~~~~ 257 (291)
.......+..++..+.+++.+||+.||++|||+.++++.|++.++
T Consensus 250 ------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 ------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ------hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111122233456789999999999999999999999999988765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-45 Score=307.52 Aligned_cols=237 Identities=21% Similarity=0.283 Sum_probs=174.1
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||+||+|.+. +++.||||+++... +.+..+...++||||+
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 566789999999999999874 59999999986543 6677788899999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+ ++.+++... ....+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~-~~~~~~~~~----~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 84 HQ-DLKKFMDAS----ALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp SE-EHHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred CC-chhhhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 76 555555433 34679999999999999999999999 99999999999999999999999999999876443
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc-------chhhhhhhhhh
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY-------FPHWVYKRLEL 206 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 206 (291)
.. ......+|+.|+|||.+... ..++.++|||||||++|+|++|+.||........... .....+.....
T Consensus 156 ~~--~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 156 VR--TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp SB--CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cc--cceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 32 23445689999999998765 3568899999999999999999999864321100000 00000000000
Q ss_pred hh--hhcccCCCC----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 207 EE--DLGLQGIEN----EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 207 ~~--~~~~~~~~~----~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. ....+.... .....++..+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 000000000 111235678899999999999999999999988
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.1e-44 Score=302.09 Aligned_cols=236 Identities=22% Similarity=0.254 Sum_probs=173.2
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc----------------------------ceeecCCcceeeehhhc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFVS 54 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~~ 54 (291)
+.+.++||+|+||+||+|++.+++.||||+++... ..+......+++++++.
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence 45678999999999999999889999999997643 56777888899999998
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCCC
Q 022826 55 NGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGRE 134 (291)
Q Consensus 55 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 134 (291)
++.+..+... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+|++|||.+.......
T Consensus 84 ~~~~~~~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 84 QDLKKLLDVC------EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp EEHHHHHHTS------TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred hhhHHHHHhh------cCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 8666666533 3689999999999999999999999 999999999999999999999999999998754432
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc---------chhhh--hhh
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY---------FPHWV--YKR 203 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~---------~~~~~--~~~ 203 (291)
. ......+++.|+|||.+.+. ..++.++|||||||++|+|++|+.||........... ...+. ...
T Consensus 155 ~--~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 155 R--KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c--ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 2 12334578999999998764 4679999999999999999999999865421100000 00000 000
Q ss_pred hhhhhhhc--ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 204 LELEEDLG--LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 204 ~~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
........ ...........++..+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 000001122335677899999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=304.29 Aligned_cols=235 Identities=24% Similarity=0.310 Sum_probs=170.5
Q ss_pred chhhcccccCCceeEEEEEec-C-CCeEEEEEeccCc-------------------------------cee-----ecCC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-D-GRNVAIKVLNETK-------------------------------GFC-----FEGH 44 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~-------------------------------~~~-----~~~~ 44 (291)
+.+.+.||+|+||+||+|++. + ++.||||+++... +.+ ....
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~ 88 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence 456789999999999999874 4 6679999986432 122 1234
Q ss_pred cceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEecc
Q 022826 45 RRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 124 (291)
Q Consensus 45 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Df 124 (291)
..++++|++.++++...... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~e~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDKV-----PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp EEEEEEECCSCBHHHHHHHS-----CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred eEEEEEEeccCCchhhhhhc-----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecch
Confidence 67899999988766554433 33679999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchh------
Q 022826 125 GLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPH------ 198 (291)
Q Consensus 125 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~------ 198 (291)
|++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||..............
T Consensus 161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~--~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235 (305)
T ss_dssp CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hhhhhhcccc---cCCCcccChhhcCcchhcCC--CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence 9987643322 23556789999999999876 889999999999999999999999875422100000000
Q ss_pred -hhhhhhh--hhhhh--cccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 199 -WVYKRLE--LEEDL--GLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 199 -~~~~~~~--~~~~~--~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
..+.... ..... .............+..+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 00000 0000001112335667889999999999999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-44 Score=307.55 Aligned_cols=243 Identities=22% Similarity=0.222 Sum_probs=172.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------cee------ecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------GFC------FEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------~~~------~~~~~~~lv~e~~ 53 (291)
+...++||+|+||+||+|++. +|+.||||++.... +++ .+....++|||||
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~ 101 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECC
T ss_pred cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEecc
Confidence 455688999999999999885 49999999997655 222 1233468999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC-ceEEeccCCccccCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-CPKISDFGLAKICHG 132 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~ 132 (291)
+++.+..+.... .....+++..++.+++||+.||.|||+ ++|+||||||+|||++.++ .+||+|||++.....
T Consensus 102 ~~~~~~~l~~~~---~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 102 PETVYRVARHYS---RAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp SEEHHHHHHHHH---HTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred CCccHHHHHhhh---hccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 875433333222 134689999999999999999999999 9999999999999999775 899999999987654
Q ss_pred CCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc--------hhhhhhhh
Q 022826 133 RESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF--------PHWVYKRL 204 (291)
Q Consensus 133 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~--------~~~~~~~~ 204 (291)
... .....+++.|+|||.+.+. ..++.++||||+||++|+|++|..||............ ........
T Consensus 176 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 176 GEP---NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp TSC---CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred Ccc---cccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 432 2345689999999998764 37899999999999999999999998654321100000 00000000
Q ss_pred hhhhhhcccCCC-----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHhh
Q 022826 205 ELEEDLGLQGIE-----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE--MLEGS 255 (291)
Q Consensus 205 ~~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~--~L~~~ 255 (291)
........+... .......+..+.+|+.+||+.||++|||+.|+++ .++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 000000000000 0112235667899999999999999999999986 34443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=300.20 Aligned_cols=238 Identities=21% Similarity=0.267 Sum_probs=165.0
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ce--------eecCCc
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GF--------CFEGHR 45 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~--------~~~~~~ 45 (291)
+++.+.||+|+||+||+|++. +|+.||||++.... +. ......
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~ 91 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 91 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------C
T ss_pred EEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCce
Confidence 466789999999999999875 59999999986443 11 122456
Q ss_pred ceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccC
Q 022826 46 RALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 125 (291)
Q Consensus 46 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg 125 (291)
.+++||++.++.+..+.. ....+++..++.+++|++.||.|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 92 ~~iv~e~~~~~~~~~~~~------~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 92 IYLVFDFCEHDLAGLLSN------VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp EEEEEECCCEEHHHHHTC------TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEeccCCCccchhhh------cccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecc
Confidence 789999998766554442 33688999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCce--eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhh---
Q 022826 126 LAKICHGRESI--VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWV--- 200 (291)
Q Consensus 126 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~--- 200 (291)
++......... .......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99766533221 122345689999999998764 368899999999999999999999986432111000000000
Q ss_pred ----hh---hhhhhhhhc-ccCCCChhh-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 201 ----YK---RLELEEDLG-LQGIENEED-----KEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 201 ----~~---~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. ......... ......... ......+.+|+.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00 000000000 000001111 122456789999999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=300.57 Aligned_cols=226 Identities=23% Similarity=0.297 Sum_probs=176.7
Q ss_pred chhhcccccCCceeEEEEEec----CCCeEEEEEeccCc-------------------------------ceeecCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL----DGRNVAIKVLNETK-------------------------------GFCFEGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-------------------------------~~~~~~~~~~ 47 (291)
+++.+.||+|+||+||+|++. +|+.||||+++... +.+......+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 456789999999999999752 37899999986432 4556677888
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+++||+.+|+|.+++... ..+++..+..+++||+.||.|||+ ++++||||||+||+++.++.++|+|||++
T Consensus 106 ~v~e~~~~~~L~~~i~~~------~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEECCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeecccccHHHHHHHhc------ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999766 477899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhhhhhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKRLELE 207 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (291)
..+...... ......+++.|++||.+.+....++.++|||||||++|+|++|..||........ ...... .
T Consensus 177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~----~~~i~~----~ 247 (322)
T d1vzoa_ 177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISR----R 247 (322)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHH----H
T ss_pred hhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHH----h
Confidence 765433222 1234568999999999987655788899999999999999999999876543221 110000 0
Q ss_pred hhhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 022826 208 EDLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRP-----AMNRVVE 250 (291)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rp-----s~~ell~ 250 (291)
..... ...+..++..+.+|+.+||+.||++|| |++|+++
T Consensus 248 -~~~~~---~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 248 -ILKSE---PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -HHHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -cccCC---CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 00000 112234678899999999999999999 4788876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=300.31 Aligned_cols=236 Identities=24% Similarity=0.243 Sum_probs=166.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecC------Ccce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEG------HRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~------~~~~ 47 (291)
+.+.+.||+|+||+||+|.+. +|+.||||+++... +.+... ...|
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 99 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 99 (346)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence 345688999999999999875 49999999997533 222222 2468
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+||||+ +.+|..+++. ..+++..++.+++||+.||.|||+ ++|+||||||+|||++.++.+|++|||++
T Consensus 100 lv~e~~-~~~l~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp EEEECC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEecc-cccHHHHHHh-------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccce
Confidence 999999 5578877744 479999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc-------hhhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF-------PHWV 200 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~-------~~~~ 200 (291)
....... ....+|+.|+|||++.+. ..++.++||||+||++|+|++|+.||............ +...
T Consensus 169 ~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 169 RQADSEM-----TGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp EECCSSC-----CSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eccCCcc-----ccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 8754432 445689999999998764 36789999999999999999999998654321100000 0000
Q ss_pred hh----hhhhhhhhcccCCC----ChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhh
Q 022826 201 YK----RLELEEDLGLQGIE----NEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVEM--LEGS 255 (291)
Q Consensus 201 ~~----~~~~~~~~~~~~~~----~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~~--L~~~ 255 (291)
.. .............. .......+..+.+|+.+||..||.+|||+.|+++- ++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 00 00000000000000 11122345678899999999999999999999873 5443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.7e-43 Score=299.49 Aligned_cols=232 Identities=21% Similarity=0.298 Sum_probs=172.7
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------ceee--cCCcceeeehhhcC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------GFCF--EGHRRALIYEFVSN 55 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------~~~~--~~~~~~lv~e~~~~ 55 (291)
+.+.++||+|+||+||+|++. +++.||||+++... +.+. .....++|||||.+
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~ 116 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 116 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCS
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCC
Confidence 356789999999999999885 59999999988655 2332 34568899999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC-ceEEeccCCccccCCCC
Q 022826 56 GSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-CPKISDFGLAKICHGRE 134 (291)
Q Consensus 56 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 134 (291)
++|..+. ..+++..++.+++||+.||.|||+ ++|+||||||+|||++.++ .++|+|||++.......
T Consensus 117 ~~L~~~~---------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 117 TDFKQLY---------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp CBGGGTT---------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred CcHHHHh---------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 9986653 479999999999999999999999 9999999999999998655 69999999998765443
Q ss_pred ceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhhh---hhhhhh--
Q 022826 135 SIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYKR---LELEED-- 209 (291)
Q Consensus 135 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-- 209 (291)
. .....+|+.|+|||.+.+. ..++.++||||+||++|+|++|+.||....+.............. ......
T Consensus 185 ~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 185 E---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp C---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred c---ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 2 3445679999999998765 357899999999999999999999987654322110000000000 000000
Q ss_pred ---------hc--------ccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 210 ---------LG--------LQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 210 ---------~~--------~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. ...........++.++.+|+++||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000111122345678899999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-43 Score=300.38 Aligned_cols=237 Identities=22% Similarity=0.214 Sum_probs=167.1
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc---------------------------ceeecC----Ccceeee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK---------------------------GFCFEG----HRRALIY 50 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------------------~~~~~~----~~~~lv~ 50 (291)
+.+.+.||+|+||+||+|.+. +|+.||||++.... +++... ...++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 445689999999999999874 59999999997543 222221 1234555
Q ss_pred hhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcccc
Q 022826 51 EFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 130 (291)
Q Consensus 51 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~ 130 (291)
+++.+|+|.+++.. .++++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 90 ~~~~~g~L~~~l~~-------~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 90 THLMGADLYKLLKT-------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EECCCEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EeecCCchhhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 66778999999964 379999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCce-eeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccch--------hhhh
Q 022826 131 HGRESI-VSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFP--------HWVY 201 (291)
Q Consensus 131 ~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~--------~~~~ 201 (291)
...... .......+++.|+|||++... ..++.++||||+||++|+|++|..||............. ....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred cCCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 433222 123445689999999998654 367899999999999999999999986543211000000 0000
Q ss_pred hh---hhhhhhhcccCCCC----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 202 KR---LELEEDLGLQGIEN----EEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 202 ~~---~~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
.. .............. ......+..+.+|+.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000000111000 011234567899999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=292.31 Aligned_cols=236 Identities=19% Similarity=0.228 Sum_probs=177.0
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceeecCCcceeeehhh
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCFEGHRRALIYEFV 53 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~~~~lv~e~~ 53 (291)
+.+.+.||+|+||+||+|++. +++.||||+++... +.+......+++++++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 456789999999999999875 58999999986543 5667778888999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCccccCCC
Q 022826 54 SNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICHGR 133 (291)
Q Consensus 54 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 133 (291)
.+++|..++... ..+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||.+......
T Consensus 84 ~~~~l~~~~~~~------~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 84 DQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp SEEHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred cccccccccccc------cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 998888877543 588999999999999999999999 99999999999999999999999999999876543
Q ss_pred CceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccchhhhhh--------hhh
Q 022826 134 ESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYFPHWVYK--------RLE 205 (291)
Q Consensus 134 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~~~~~~~--------~~~ 205 (291)
... .....+++.|+|||.+.+. ..++.++|||||||++|+|++|+.||....+............. ...
T Consensus 155 ~~~--~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 155 VRC--YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSC--CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred Ccc--ceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 322 2233457889999998765 35789999999999999999999997543321110000000000 000
Q ss_pred h-hh-----hhcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 206 L-EE-----DLGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 206 ~-~~-----~~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
. .. ..............++..+.+|+.+||+.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00 000011112223445678899999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=292.86 Aligned_cols=231 Identities=26% Similarity=0.225 Sum_probs=162.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------cee------ecCCcce
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFC------FEGHRRA 47 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~------~~~~~~~ 47 (291)
+.+.+.||+|+||+||+|++. +|+.||||+++... +.+ ......|
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 445689999999999999886 49999999997543 222 1346778
Q ss_pred eeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCc
Q 022826 48 LIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 127 (291)
Q Consensus 48 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~ 127 (291)
+|||||.+ ++.+.+. ..+++..++.+++||+.||.|||+ .+|+|+||||+||+++.++.++++|||++
T Consensus 99 iv~Ey~~~-~l~~~~~--------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 99 LVMELMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEECCSE-EHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEeccch-HHHHhhh--------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhh
Confidence 99999976 4545442 468999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCcccc--------chhh
Q 022826 128 KICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIY--------FPHW 199 (291)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~--------~~~~ 199 (291)
+....... .....+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||........... .+..
T Consensus 167 ~~~~~~~~---~~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 167 RTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_dssp -----------------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred hccccccc---cccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHH
Confidence 86554332 2445679999999999876 889999999999999999999999864421110000 0000
Q ss_pred hhhhhh-----hhhh-------------hcccCCCChhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 022826 200 VYKRLE-----LEED-------------LGLQGIENEEDKEYARKMILVSLWCIQNNPSDRPAMNRVVE 250 (291)
Q Consensus 200 ~~~~~~-----~~~~-------------~~~~~~~~~~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~ 250 (291)
...... .... ..............+..+.+|+++||..||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 0000 00111122334567888999999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-41 Score=291.16 Aligned_cols=236 Identities=22% Similarity=0.219 Sum_probs=167.9
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc----------------------------ceee-----cCCccee
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK----------------------------GFCF-----EGHRRAL 48 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------------~~~~-----~~~~~~l 48 (291)
+.+.+.||+|+||+||+|++. +|+.||||+++... ..+. +....++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 345689999999999999875 59999999997543 1211 2334466
Q ss_pred eehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 49 IYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 49 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
+++++.+|+|.+++.. .++++..++.+++||+.||.|||+ ++|+||||||+||+++.+|.++++|||++.
T Consensus 100 i~~~~~gg~L~~~~~~-------~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp EEEECCSEEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEeecCCchhhhccc-------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhc
Confidence 7788889999999843 479999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc-------hhhhh
Q 022826 129 ICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF-------PHWVY 201 (291)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~-------~~~~~ 201 (291)
..... .....+++.|+|||.+.+. ..++.++|||||||++|+|++|..||............ .....
T Consensus 170 ~~~~~-----~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 170 HTDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp CCTGG-----GSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccCcc-----cccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 54322 2445678999999987664 36789999999999999999999998754321100000 00000
Q ss_pred h----hhhhhhhhcccCCCCh----hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHh
Q 022826 202 K----RLELEEDLGLQGIENE----EDKEYARKMILVSLWCIQNNPSDRPAMNRVVE--MLEG 254 (291)
Q Consensus 202 ~----~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~~l~~dP~~Rps~~ell~--~L~~ 254 (291)
. ................ .....+..+.+|+.+||..||++|||+.|+++ ++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 0 0000000000000000 11234667899999999999999999999987 4544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-37 Score=268.69 Aligned_cols=235 Identities=21% Similarity=0.254 Sum_probs=161.2
Q ss_pred chhhcccccCCceeEEEEEec-CCCeEEEEEeccCc------------------------------------cee--ecC
Q 022826 3 NSFKNKLGQGGYGGVYKGKLL-DGRNVAIKVLNETK------------------------------------GFC--FEG 43 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------------------------------~~~--~~~ 43 (291)
+.+.++||+|+||+||+|++. +|+.||||+++... .++ ...
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~ 94 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 94 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence 557899999999999999875 59999999987653 011 112
Q ss_pred CcceeeehhhcCCCH-HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCC-----
Q 022826 44 HRRALIYEFVSNGSL-EKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF----- 117 (291)
Q Consensus 44 ~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~----- 117 (291)
...++++.++..+.. ....... ....+++..+..+++||+.||.|||+ ..+|+||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 95 NGVHVVMVFEVLGENLLALIKKY----EHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp TEEEEEEEECCCCEEHHHHHHHT----TTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred cceeeeeeecccccccccccccc----cccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccc
Confidence 233445555444433 3333222 45788999999999999999999995 27899999999999997665
Q ss_pred -ceEEeccCCccccCCCCceeeccCCCCCccccCcccccccCCCccccccchhHHHHHHHHhCCCCCCccccCCCccccc
Q 022826 118 -CPKISDFGLAKICHGRESIVSMTGARGTVGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGVKNNANVAVDRSSEIYF 196 (291)
Q Consensus 118 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiwslG~~l~~ll~g~~~~~~~~~~~~~~~~ 196 (291)
.++++|||.+...... .....+|+.|+|||++.+. .++.++||||+||++++|++|+.||............
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhcccc--CCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 3899999998754322 2445689999999999875 7899999999999999999999998755332111000
Q ss_pred h-------------hhhhhhhhh-hhhh-------cccCC-----------CChhhHHHHHHHHHHHHHhhhcCCCCCCC
Q 022826 197 P-------------HWVYKRLEL-EEDL-------GLQGI-----------ENEEDKEYARKMILVSLWCIQNNPSDRPA 244 (291)
Q Consensus 197 ~-------------~~~~~~~~~-~~~~-------~~~~~-----------~~~~~~~~~~~l~~l~~~~l~~dP~~Rps 244 (291)
. ......... .... ..... ........+..+.+|+.+||..||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 0 000000000 0000 00000 01123467888999999999999999999
Q ss_pred HHHHHH
Q 022826 245 MNRVVE 250 (291)
Q Consensus 245 ~~ell~ 250 (291)
++|+|+
T Consensus 322 a~e~L~ 327 (362)
T d1q8ya_ 322 AGGLVN 327 (362)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=5.4e-24 Score=167.21 Aligned_cols=112 Identities=17% Similarity=0.191 Sum_probs=86.8
Q ss_pred chhhcccccCCceeEEEEEecCCCeEEEEEeccCc------------------------------------c----eeec
Q 022826 3 NSFKNKLGQGGYGGVYKGKLLDGRNVAIKVLNETK------------------------------------G----FCFE 42 (291)
Q Consensus 3 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------------------~----~~~~ 42 (291)
+.++++||+|+||.||+|.+.+|+.||||+++... + ....
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 35789999999999999998889999999876422 0 0011
Q ss_pred CCcceeeehhhcCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCCCCCeeeeccCCCceEEcCCCceEEe
Q 022826 43 GHRRALIYEFVSNGSLEKFIYEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 122 (291)
Q Consensus 43 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~ 122 (291)
....+++||++++..+. .++......++.|++.++.|||+ .+|+|+||||+|||++++ .++|+
T Consensus 82 ~~~~~lvme~~~~~~~~-------------~l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 82 WEGNAVLMELIDAKELY-------------RVRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EETTEEEEECCCCEEGG-------------GCCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEEC
T ss_pred ecCCEEEEEeecccccc-------------chhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEE
Confidence 12346889999875442 23334467899999999999999 999999999999999976 48999
Q ss_pred ccCCccccC
Q 022826 123 DFGLAKICH 131 (291)
Q Consensus 123 Dfg~~~~~~ 131 (291)
|||++....
T Consensus 145 DFG~a~~~~ 153 (191)
T d1zara2 145 DFPQSVEVG 153 (191)
T ss_dssp CCTTCEETT
T ss_pred ECCCcccCC
Confidence 999987643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.94 E-value=1.2e-05 Score=63.96 Aligned_cols=106 Identities=16% Similarity=0.071 Sum_probs=69.5
Q ss_pred cCCceeEEEEEecCCCeEEEEEeccCc---------------------------ceeecCCcceeeehhhcCCCHHHHHh
Q 022826 11 QGGYGGVYKGKLLDGRNVAIKVLNETK---------------------------GFCFEGHRRALIYEFVSNGSLEKFIY 63 (291)
Q Consensus 11 ~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------------~~~~~~~~~~lv~e~~~~g~L~~~l~ 63 (291)
.++.+.||+... +++.++||...... .+...+...++||++++|.++.+...
T Consensus 24 G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~ 102 (263)
T d1j7la_ 24 GMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE 102 (263)
T ss_dssp CCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT
T ss_pred CCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc
Confidence 344578999864 56677888876432 34445667789999999988765542
Q ss_pred hcCCCCCCCCCCHHHHHHHHHHHHHHhHHhhcCC----------------------------------------------
Q 022826 64 EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC---------------------------------------------- 97 (291)
Q Consensus 64 ~~~~~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~---------------------------------------------- 97 (291)
.. .. ...++.+++..+..||+..
T Consensus 103 ~~--------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (263)
T d1j7la_ 103 DE--------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY 171 (263)
T ss_dssp TC--------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHH
T ss_pred cc--------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHH
Confidence 11 11 2233445555555555410
Q ss_pred ----------CCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 98 ----------NTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 98 ----------~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
...++|+|+.|.||++++++..-|+||+.+.
T Consensus 172 ~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 172 DFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237899999999999987666799998654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.77 E-value=2.4e-05 Score=61.90 Aligned_cols=29 Identities=21% Similarity=0.173 Sum_probs=24.6
Q ss_pred CeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 100 RILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 100 ~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
.++|+|+.|.||+++++..+-|+||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 47999999999999987667799998653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.56 E-value=0.00019 Score=60.60 Aligned_cols=30 Identities=23% Similarity=0.272 Sum_probs=25.8
Q ss_pred CCeeeeccCCCceEEcCCCceEEeccCCccc
Q 022826 99 TRILHFDIKPHNILLDEDFCPKISDFGLAKI 129 (291)
Q Consensus 99 ~~ivH~dikp~Nill~~~~~~kl~Dfg~~~~ 129 (291)
..++|||+.+.|||+++++ ++|+||..+..
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 4689999999999998774 89999987654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.89 E-value=0.0019 Score=52.73 Aligned_cols=29 Identities=31% Similarity=0.363 Sum_probs=23.4
Q ss_pred CCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 98 NTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 98 ~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
..+++|+|+.+.||+++++ ..++||+-+.
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 4678999999999999743 4589998654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.19 E-value=0.018 Score=46.27 Aligned_cols=32 Identities=22% Similarity=0.274 Sum_probs=27.6
Q ss_pred CCCCeeeeccCCCceEEcCCCceEEeccCCcc
Q 022826 97 CNTRILHFDIKPHNILLDEDFCPKISDFGLAK 128 (291)
Q Consensus 97 ~~~~ivH~dikp~Nill~~~~~~kl~Dfg~~~ 128 (291)
...+++|+|+.++||+++.+...-|+||+.+.
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccccCCcchhhhhcccccceeEecccccc
Confidence 35789999999999999988777899998653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.20 E-value=0.059 Score=44.65 Aligned_cols=29 Identities=14% Similarity=0.242 Sum_probs=22.0
Q ss_pred cccccCCceeEEEEEecC--------CCeEEEEEecc
Q 022826 7 NKLGQGGYGGVYKGKLLD--------GRNVAIKVLNE 35 (291)
Q Consensus 7 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~ 35 (291)
++|+.|---.+|++...+ .+.|++++...
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~ 84 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN 84 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC
Confidence 568889999999997643 35688888763
|